
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-10201-10500*
  '(".4035delA" ".5" ".5266dupC" "A-519G" "A-CDK" "A-CDK2" "A-E" "A-H"
    "A-allele" "A-type" "A1" "A1062T" "A1062T," "A14N" "A18N" "A1YA" "A202T"
    "A279T" "A4" "A431-epidermoid-carcinoma" "A5359G" "A5780G" "A630P" "A7"
    "A859T" "AAAGUG" "AAGCTTAA" "AAGGUG" "AAP-113" "ABCDE" "ABSciex" "AC-40"
    "ACAs" "ACMG" "ACPP" "ACRV1" "ACSLs" "ACTL9" "ACYP2" "AD-CMC" "AD001" "AD8"
    "ADAD1" "ADHWDSKNVSCKNC" "AEW" "AEW541" "AFAC10" "AFF1" "AFF4" "AG1487"
    "AGAACAgggTGTTCT" "AGC" "AGCTTAA" "AGS-T" "AHZ" "AIB" "AID-YFP-tagged"
    "AIF-mediated" "AIPI" "AIY" "AJAP1" "AJCC" "AKP" "AKT-consensus"
    "AKT-dependent" "AKT-interaction" "AKT-stability" "AKT2-NTag" "AKT2-Tag"
    "AKT2-dependent" "AKT2-interaction" "AKT2-interactions" "ALIS" "ALLM"
    "ALLs" "ALSPAC" "AM" "AMO-j11" "AMPK-LKB1-independent"
    "AMPK-TSC-independent" "AMPKa1" "ANAM" "AOV" "AP" "AP-1-Luc"
    "AP-1-associated" "AP-1-induced" "AP-1-like" "AP-1A" "AP-1B"
    "AP1-GR-mediated" "AP1-mediated" "AP16" "AP24534" "AP5" "APBT2" "APBT6"
    "APID" "APOBEC3C" "APOBEC3H" "APPBP1" "AR-cistrome" "AR-co-activator"
    "AR-transcriptional" "AR-transcriptome" "ARIBD1" "ARIC" "ARID" "ARID1a"
    "ARPC" "ARPCs" "ARVO" "ARv" "ARvs" "AR–DNA" "AS-PCR" "ASCL" "ASCL3" "ASH1L"
    "ASK-JNK" "ASP-PCR" "ASP–PCR" "AST487" "ASTEC" "ASTN2" "ATCC" "ATD"
    "ATP-binding" "ATP-competitive" "AUC5" "AUF" "AUG" "AV6" "AX" "AXIN"
    "AY288918" "AZD" "AZD-7762" "AZD6474" "AbD" "Abcam" "Abertawe" "Abnet" "Ac"
    "Ac-Tub" "AcK" "Acan" "Accell" "Acethylphenothiazine" "Acs"
    "Actin-dependant" "Actinobacter" "Actinobacteria" "Actinomycetaceae"
    "Ad-E2F1" "Ad-LacZ" "Ad-β-gal" "AdCre" "AdDUSP4-mediated" "Adeno"
    "Adeno-Null" "AdenoCre" "Adenoma" "Adenovirus-Cre-injectedTsc1" "AfA"
    "AfAs" "Affymetrix" "Africa" "African" "African-American" "Africans"
    "AhCre" "Ahr" "Aicardi" "Aicardi-Goutières" "Akt-C" "Akt-activation"
    "Akti1" "Ala20" "Alaskan" "Alexa" "Align-GVGD" "Alzheimer" "Alzheimer's"
    "Alzheimer´s" "Alzheimer’s" "Ambasta" "America" "American" "Americans"
    "Aminocyclobutyl" "Amit" "Amon" "Amplex" "Amyere" "Andersen"
    "Andersen–Tawil" "Anderson" "Andreev" "Angel2" "Angelo" "Anglo"
    "Anglo-Celtic" "AnnexinV-FITC" "Arg‐I" "Arg‐II‐S6K1‐p66Shc"
    "Arg‐II‐induced" "Arg‐II‐knockout" "Arg‐II‐mediated"
    "Arg‐II–S6K1–JNK‐p66Shc" "Arkhipov" "Arkwright" "Armand" "Armitage"
    "Armstrong" "Arq501" "Arq761" "Aryankalayil" "AsA" "AsAs" "Ashkenazi"
    "Asian" "Asians" "Asp-Glu-Ala-Asp" "Asp104" "Aurkb" "Australia" "Autopol"
    "Aux1–Swa2p" "Avl9p" "Avon" "Avruch" "Axel" "Axltide" "Axograph" "Aβ"
    "A–1C" "A–1D" "A–4C" "A–ECFP" "A–EYFP" "A→G" "B-CDK1" "B-catenin" "B-form"
    "B-lymphoma" "B-lymphomas" "B-to-T-cell" "B-to-T-cell-connecting" "B-type"
    "B1" "B2" "B23" "B721.221-GFP-H-RasG12V" "B721.221-cell" "BAF250a"
    "BAK-BH3" "BAK-groove" "BAPTA-AM" "BAW667" "BAW667+PPY-A" "BBB" "BBSRO"
    "BC11A" "BCAAs" "BCL2-family" "BCL2-like" "BCL2-rheostat" "BCL6-mediated"
    "BCL6long" "BCL6short" "BCP-ALL" "BCR-ABL1" "BCRABL1" "BCSS" "BD" "BED"
    "BEH" "BFC" "BGJ398" "BGK" "BH-3-only" "BH3-domain" "BH3-only" "BIO"
    "BIRB0796" "BLC2" "BMG" "BMIs" "BMOE" "BMS" "BODIPY-GTP" "BRAF-genotype"
    "BRAF-wildtype" "BRCA1-null" "BRCA1-proficient" "BRCAPro"
    "BRCT–BRCT-mediated" "BRD" "BSC" "BSSRO" "BUN" "BV" "BX41" "BXPC3s"
    "Background" "Bacpac" "Bacteroidetes" "Bai" "Balb" "Baltimore" "Bannayan"
    "Bannayan-Zonana" "Barlow" "Barone" "Barr" "Barrett" "Basaki" "Basel"
    "Bashir" "Bassarova" "Bax-induced" "Bax-molecule" "Bax-monomer-mediated"
    "Bax-nanodisc" "Bcl" "Bcl-XL" "Bcl-xl" "Bcl2" "Bcl2-family" "Bcl6-ChIP"
    "BclxS" "BeadChips" "Beadchip" "Beckman" "Beclin1-core" "Begg" "Begg's"
    "Begger" "Begg’s" "Belarus" "Benassi" "Benfu" "Benjamini"
    "Benjamini-Hochberg" "Benkirane" "Benkirane’s" "Bergmann" "Berkhout"
    "Berlin" "Berquin" "Beta-catenin" "Bethesda" "BhGLM" "Bhakat" "BiFC"
    "Biacore" "Biesecker" "Bim-S" "Bim-interaction" "Bingxiang" "Bio-Plex"
    "Bio-Rad" "BioCarta" "Biochemicals" "Biolabs" "Bioreagents" "Biosystems"
    "Birmingham" "Bismaleimidoethane" "Bitplane" "Blaschko" "Blick" "BmRNA"
    "Boder" "Boerner" "Bogdani" "Bokemeyer" "Bonferroni" "Bortezomib-treatment"
    "Bouchard" "Bouchat" "Bouin" "Bouin’s" "Boveri" "Bowtell" "Boyages"
    "Boyden" "BrCl" "BrF" "Bradford" "Bradford-Hill" "BrafV6" "Branched-chain"
    "Brca1-null" "Brd4" "Bregma" "Brenner" "Breslow" "Bridgeport" "British"
    "Broders" "Browser" "Bruker" "Brunger" "Bryan" "Brysk" "BstYI" "BubR1-APC"
    "Buisson" "Burga" "Burkett" "Burlingame" "Burnett" "Buschke"
    "Buschke-Ollendorff" "Busser" "B–2D" "B–2E" "B–6F" "B–C" "C-1562T"
    "C-2399A" "C-Cdc20" "C-Cdh1" "C-Luc" "C-Tag" "C-labelled" "C-luc"
    "C-promoter" "C-rich" "C-term" "C-terminally" "C-tract" "C1" "C11orf21"
    "C17-sphingosine" "C18-1.7" "C18-5" "C181S" "C184S" "C186S" "C1rl" "C2"
    "C3" "C35-co-transfected" "C3H10T1" "C4" "C4-2-D2" "C5" "C5orf32" "C7" "C8"
    "C8-D30" "C8-S" "C9" "CA-Stat3-expressing" "CA154291-01" "CAAX" "CACGTG"
    "CADMA" "CAF1B" "CAGA12" "CALB" "CALYPSO" "CARN-like" "CARNS" "CARe"
    "CASMC" "CATCHR" "CATSHL" "CB17-SCID-hu" "CBB" "CBDCA" "CC" "CC+GC" "CCAAT"
    "CCAGGAA" "CCCAGGAA" "CCD-841-CoN" "CCND" "CCR" "CCR5delta32" "CCT007093"
    "CCT128930" "CCTNs" "CCW" "CD-FBS" "CD135" "CD3ξ-Zap70" "CD8αα" "CD90"
    "CDC34~Ub" "CDCl" "CDH-2" "CDHR3" "CDK4-D-type" "CDK6-specific"
    "CDK9-associated" "CDKN2B-AS1" "CDKNA" "CDKNIs" "CDNK1A" "CDR1" "CDR3"
    "CDR3s" "CDRs" "CEAS" "CEP104" "CEP17" "CEP8" "CEU" "CFSs" "CFU-Cs" "CFU-F"
    "CFU-Fs" "CG05" "CG06" "CGP049090" "CGP53353" "CGRRF1" "CGTH" "CGTH-W1"
    "CH11" "CHAT5" "CHAT8" "CHCHD5" "CHIP-Slug" "CHTN" "CIA2" "CIA2A,"
    "CIA2A-IRP2" "CID755673" "CIMP-H" "CJO" "CK5-HG" "CK5-cancers" "CK5-cells"
    "CK5-epithelial" "CK5-invasive" "CK5-normal" "CK5-of" "CK5-perineural"
    "CK5-population" "CK5-prostate" "CKD4" "CKDN2B" "CKIδ" "CKT" "CLASP" "CLF"
    "CLIA" "CLR" "CLU-1" "CMC" "CMM" "CMTMRos" "CNKI" "CNVs" "COG" "COL1A"
    "COLD-PCR" "COMMA1-D" "COMPASS" "CONAN" "CONAN-1" "CONSORT" "CORM"
    "CORM-II" "CORUM" "COS-1" "COUP" "COUP-TF" "CPEB4" "CPI203" "CPT11"
    "CPT11-treated" "CQ" "CR+PR" "CRB1" "CREB-like" "CREBL2" "CRIB"
    "CRL4-DCAF1in" "CRLCF1" "CRLF" "CRLF1-FL" "CRLF1-sh2" "CRLF1-Δ34N" "CRM"
    "CRM-197" "CROI" "CRYSOL" "CSPP" "CTCAE" "CTCE" "CTCE-9908" "CTD-2536C1"
    "CTD2174F1" "CTGH" "CTGTCATT" "CTIF" "CTTACT" "CTV" "CTY" "CUTLL1" "CVL"
    "CXCMotif" "CXXC" "CYMC" "CYY" "CaCl" "CaaL" "Caenorhabditis" "Calbiochem"
    "Caledonia" "Calu" "Canada" "Capsulin" "Carcinoma" "Carlsbad" "Carmo"
    "Carmo-Fonseca" "Carpinteria" "Carrano" "Carta" "Cary" "Case1" "Case2"
    "Case3" "Case7" "CaspACE" "Caspase-3" "Castleman" "Caucasian" "Caucasians"
    "Cavalieri" "Caymen" "Cbl2-binding" "Cbp\\PAG" "Cdc18" "Cdc42" "Cdc6"
    "Cdk4" "Cdkn1a" "Cedars-Sinai" "Cell-permeable" "Cell-to-cell"
    "CellProfiler" "CellTiter" "Cenciarelli" "Cereseto" "ChIP" "ChIP-PCR"
    "ChIP-on-chip" "ChIP-over-Input" "ChIP-qPCR" "ChIP-signal" "Chaetomium"
    "Chan" "Chardin" "Charlson" "Chc1-RFP" "Chemicon" "Chepatitis" "Cherrin"
    "Chetrit" "Chi-Square" "Chi-square" "Children" "Chk1" "Choi" "Chomatin"
    "Chompret" "Chr" "Chr12p13" "Chr19q12-q13" "Chr22q13.32-13.33" "Chrom"
    "Chun" "Chung" "CiD" "Cia2" "Ciechanover" "Cip" "Cip1" "Ck5-cells" "Cl"
    "Clark" "Clarke" "Clarke-Pearson" "CldU" "Cleveland" "ClinicalTrials"
    "Clinico" "Clinico-pathological" "ClueGO" "Cntfr" "CoA-carboxylase" "CoIP"
    "CoPP" "CoPP-IX" "Cochrane" "Cohen" "Coley" "Collins" "Comple"
    "Conacci-Sorrell" "Concannon" "Conclusion" "Connecticut" "Contente"
    "Coomassie" "Copy-neutral" "Corcoran" "Corynebacteria" "Corynebacterium"
    "Coustry" "Cowden" "Cox4il" "Cre-injectedTsc1" "Cremer" "Crisponi" "Crohn"
    "Crohn's" "Crohn’s" "Crosstalk" "Cruz" "Cs" "Cs-methanesulfonate" "CsCl"
    "CsOH" "CshRNA" "Csm2" "CtBP24" "Ctgf" "Ctnnb" "Cueva" "Cul1"
    "Cul4–DDB1–Cdt2-dependent" "Cullin-RING" "Cy1" "Cytometer" "Cytoscape"
    "Czech" "Cα" "C–activator" "D-2HG" "D-APC" "D-box" "D-loop" "D-loops"
    "D-myo-inositol-1" "D08-0493MG" "D1–D3" "D2" "D2-40" "D2-hydroxyglutarate"
    "D2159MG" "D270MG" "D270MG-sham" "D2C7" "D2HGA2" "D3" "D300H-R310H" "D355T"
    "D3E" "D4" "D4-isotopic" "D4-succinylated" "D4D6" "D7S2418" "D7S503"
    "DAB2IP-deficent" "DAK-H1-WT" "DAKO" "DALIS" "DCK" "DDR-proficient"
    "DEAR1-KD-10A" "DEAR1-rescue" "DENND1B" "DExD" "DExD-box" "DFS " "DGUOK"
    "DGY" "DHO" "DHPLC" "DIV" "DIV-5DIV" "DIV-DM" "DIWK" "DJ" "DK" "DKO" "DLD1"
    "DMAG" "DMEM" "DMFS" "DN2" "DN3" "DNA-Damage" "DNA-Damage-Induced"
    "DNA-damage-independent" "DNA-damage-induced" "DNA-methyltransferase"
    "DNA-protein" "DNA-protein-binding" "DNA-protein-complex" "DNA–FLA"
    "DNA–protein" "DNF" "DNFs" "DNMTI" "DNQ" "DNaseI" "DNp73" "DO-1" "DOI"
    "DOTAP" "DPO" "DPO-PCR" "DPQ" "DQ-BSA" "DQAD" "DR1mut" "DRB-Sensitivity"
    "DRBDs" "DRBPs" "DREME" "DSBs" "DSHB" "DSS-mouse" "DUF59" "DUSPP6" "DVPK"
    "DXS6789" "DXS6807" "DXS7132" "DXS8377" "DZNep" "Dahl" "Dahse" "Danish"
    "Danvers" "Darby" "DataAnalyzer" "Daugaard" "Davis" "Dbp2p" "Ddx"
    "Ddx5-DQAD" "Ddx5-GNT" "Deazaneplanocin" "Deng" "Denmark" "Dennis"
    "Deoxynyboquinone" "Depolarization-induced" "Deshaies" "DetectX" "Detroit"
    "Dex" "Dex+E2" "Dex-inducibility" "Dezenove" "Dgkβ" "Dharmacon"
    "Dichlorobenzyloxy" "Diego" "Disheveled-2" "Disulfiram" "DmNek2" "Doherty"
    "Dojindo" "Dominant-negative" "Donnell" "Double-fluorescence" "Dox" "Dre2"
    "DshR" "DshRNA" "Du" "Dulbecco" "Dulbecco's" "Duncan" "Dunnett" "DuoSet"
    "Duplication-method" "Dura" "Dusseldorf" "Dutch" "DyLight" "E-APC"
    "E-Abstract" "E-box" "E-boxes" "E-cad" "E-caderina" "E-cadherin-catenin"
    "E-cadherinpositive" "E-dependent" "E-domain" "E-induced" "E-initiated"
    "E100f" "E100i" "E12" "E14TG2a" "E1A" "E1α" "E1β" "E2+Dex"
    "E2+Dex-dependent" "E2-ERα" "E2-ERα-dependent" "E2-ERα-mediated" "E24"
    "E25" "E2A-PBX1" "E2F1-1-284" "E2F1and" "E2~SUMO" "E2~Ub" "E2–E3" "E2–RING"
    "E2–Ub" "E3-Ub" "E3-ligase" "E3-ligases" "E3-ubiquitin" "E3–E2" "E3–E2-Ub"
    "E3–Ub" "E3–UbcH5–Ub" "E4" "E47" "E4B" "E60A" "E616del" "E7" "E746-A750"
    "E9.5" "EAMY" "EBRs" "EBUS" "EBUS-TBNA" "ECCC" "ECFP-FOXO3" "ECFP-Mcl1L"
    "ECFP-Mcl1L-overexpressing" "ECFP-Shp2" "ECOG" "EEME" "EF2-activity"
    "EF2-interaction" "EFGR" "EGF-ligand" "EGF-like" "EGFP-reporter" "EGFP-tag"
    "EGFR-CME" "EGFR-E3" "EGFR-NCE" "EGFR-RT52" "EGFR-Y1045" "EGFR-family"
    "EGFR-ligand" "EGFR-pY1045" "EGFR-pY1068" "EGFR-total" "EGFR-vIII" "EGFR1"
    "EGFRvIII" "EGFRvIII-ECD-protein-coated" "EGFRvIII-derived"
    "EGFRvIII-only-expressing" "EGFRvIII-reactive" "EGFRwt" "EH" "EH2"
    "EIRVGxxYQAxI" "EJCs" "EKP" "ELISAs" "ELKS" "ELKS-1" "ELKS1" "ELKS2" "ELM"
    "ELM2-SANT" "ELM2-SANT-containing" "EMEA" "EMRA" "EMT-like" "ENCylopedia"
    "EPSC1" "EPSC2" "ER+BC" "ER+BC-treated" "ER-Golgi" "ER-resident"
    "ER-to-Golgi" "ER2" "ERAMUNE01" "ERE-TK-LUC" "ERE-e1b-Luc" "ERE-e1b-luc"
    "ERE-tk-Luc" "EREs" "ERK-pathway" "ERK-targeting" "ERP29" "ERtm" "ERα+Ets1"
    "ERα+Ets1+estradiol" "ERα+estradiol" "ERα-only" "ERβ-only"
    "ERβ-only-containing" "ER–Golgi" "ESCRT" "ESCRTs" "ESE" "ESEfinder" "ESEm"
    "ESI-MS" "ESI–MS" "ETGE" "ETV1sh2" "EU" "EV-HPV" "EYFP" "EYFP-Mcl1L"
    "Eastman" "Eberhardy" "Ecker" "Ectopically-produced" "Eder" "Edmonson"
    "Edmonson-Steiner" "Edwards" "Egger" "Egger's" "Egger’s" "Eighty-four"
    "Eilers" "Eisenman" "El" "El-Sibai" "Elkabets" "Elongn" "Elongn-C"
    "Emiliani" "Endo-MT" "EndoMT" "England" "English" "Enhancer-Promoter"
    "Enogene" "Enquobahrie" "EntroGen" "Epacs" "Epcam" "EphA2-Kinase"
    "EphA2-host" "EphA2-immunoprecipitates" "EphA2-shRNA" "EphA2-sterile"
    "EphA2-ΔKD" "EphA2-ΔSAM" "EphA2sh-RNA" "EphR" "Ephrin-EphR" "Epicardin"
    "Epidermodysplasia" "Epithelial-mesenchymal" "Epithelial–mesenchymal"
    "Epon" "Eppendorf" "Epsin-15" "Epsin15" "Eptsein" "Eptsein-Barr" "ErbB"
    "ErbB2-mediated" "Eric" "Ericson" "Erk1" "Erk1,2" "Eskimos" "Et"
    "Ethylene-diamine" "Ets1" "Ets1-expressing" "Euclidean" "Europe" "European"
    "Europeans" "Evans" "Evdokimova" "Exo70p" "Exo84p" "Exome" "E–3N" "E–5G"
    "E–derived" "F-domain" "F1" "F1F0" "F2" "F357A" "FACSDiva" "FAD"
    "FADD-independently" "FAIRE" "FAIRE-seq" "FAM110" "FAM110B" "FAS-receptor"
    "FASL" "FBXL1" "FC=1.19" "FC=1.2" "FC=1.4" "FERM" "FEV1" "FGFR-IIIb"
    "FGFR3-Capan-2" "FGFR3-IIIb" "FGFR3-IIIc" "FGFR3-TAAC3" "FHL5"
    "FHRE-luciferase" "FHRE-reporter" "FITC-avidin" "FK1" "FK288"
    "FK506-FKBP12" "FLAG" "FLAG-epitope-tagged" "FLAG-tag" "FLT3-ITD" "FMG"
    "FMN" "FMS-like" "FNAs" "FOB" "FOXM" "FOXM1c" "FOXM1c-expressing"
    "FOXO3-CrmA" "FOXO3-dnBID" "FOXO3-shCtr" "FP-6500" "FPKM" "FPs" "FR4"
    "FSWAP" "FTS-A" "FUT9" "FXRα" "Fab" "Fab225" "Fab425" "FabC225"
    "Factor-Kappa" "Faiola" "Fallot" "FamHS" "FamTaG" "Family-wide" "Farina"
    "Farina-Sarasquesta" "Farnham" "Fauci" "Fbxw" "Fc" "FcεRI-dependent" "Fc’s"
    "FdUrd" "Fe" "Fe(CN)" "Fe-only" "FeCl" "Features" "Federico" "Fei" "Feng"
    "Fifty-eight" "Fifty-six" "Figo" "Fine-needle" "Fingert" "Finland"
    "Firmucutes" "Fischer" "Fischer’s" "Fiure" "Five-week-old" "FiveTsc1" "Fl"
    "Flag" "Flag-Slug-4SA" "Flag-Slug-WT" "Flatmark" "FlowJo" "Fogelman"
    "Follow-up" "Fonseca" "Forkhead" "Forkhead-box"
    "Formylmethionyl-Leucyl-Phenylalanine" "Forty-eight" "Forty-five"
    "Forty-four" "Forty-one" "FosL" "France" "Francisco" "Franciszek" "Frasier"
    "Fraumeni" "Fredlund" "Freesurfer" "French" "French-Canadian" "Frescas"
    "Friedenreich" "Fs" "Fuc" "Fucα1-3" "Fucα1-4" "Fugene" "Fuhrman" "Furhman"
    "Furugaki" "Fv" "Fyn" "Förster" "Förster-resonance" "F–1P" "F–2I" "G-Luc"
    "G-actin" "G-agarose" "G-allele" "G-boxes" "G-coupled" "G-loop" "G0" "G1"
    "G1-S" "G1-to-S" "G1–S" "G2-M" "G2-versus" "G2M" "G2–M" "G3-unifocal"
    "G5-1" "G5-11" "G5-12" "G5-13" "G5-14" "G5-16" "G5-17" "G5-2" "G5-3" "G5-4"
    "G5-5" "G5-6" "G5-7" "G5-7-H" "G5-7–associated" "G5-7–treated" "G5-8"
    "G5-9" "G5-X-2" "G6P" "G9a-like-protein" "GA" "GAD" "GBAM1" "GBR-FKBP5"
    "GCCCGGCCGGTC" "GCCCGGCCGGTCTTCTTGTAATGT" "GCCTTTCAGTGCAGAGTA" "GCGCGA"
    "GCN" "GCN4" "GCNs" "GDC0941-treated" "GEE" "GEF-induced" "GEF-mediated"
    "GENOA" "GENT" "GFAP-IκBα-dn" "GFAP-Iκbα-dn" "GFP-AID-tagged"
    "GFP-H-Ras-enriched" "GFP-H-RasG12V" "GFP-H-RasG12V-labeled"
    "GFP-H-RasG12V-rich" "GFP-LC3B" "GFP-PAK1-S223A" "GFP-Snc1p" "GFP-TAp63α"
    "GFP-TAp73α" "GFP-Tat" "GFP-mut-Cterm" "GFP-βcat-Cterm" "GFP + " "GG"
    "GGC-GAC" "GGT-GTT" "GH-promoter" "GI" "GIP-receptor" "GKS3β" "GLI1ΔNES"
    "GLI1ΔNLS" "GLOBOCAN" "GNE-929" "GP2-293" "GPCR-G" "GR-N" "GRE" "GREs" "GS"
    "GS20656" "GSE10950" "GSE12236" "GSE15852" "GSE28735" "GSE36112" "GSE46695"
    "GSE6532" "GSE8611" "GSK3-β-dependent" "GSK3αon" "GSK3β-CA" "GSK3β-CA."
    "GSK3β-CHIP-Slug" "GST-A1YA" "GST-AKT-PH" "GST-ATM-2" "GST-DOC-1R"
    "GST-GR-DBD" "GST-GR-LBD" "GST-GR-N" "GST-Lst1p" "GST-MDM2Δp53" "GST-Nyv1p"
    "GST-S100" "GST-S92" "GST-Sec22p" "GST-Sec23p" "GST-Sec24p" "GST-Sec31p"
    "GST-Sec9c" "GST-Snc2p" "GST-Sso2p" "GST-cat" "GST-pulldown" "GST-tail"
    "GT-box" "GT-boxes" "GVGD" "GWA" "GWASs" "GWFDAAA" "GWS" "Gadd45a-null"
    "Gatti" "Gefitinib" "Geleziunas" "Genbank" "GeneCards" "GeneChip"
    "GeneCopoeia" "GeneLink" "GeneSapiens" "GeneTex" "Genetically-encoded"
    "Genome-scale" "Genome-wide" "Genomes" "Gerald" "Germ-line" "German"
    "Germany" "Gfp" "Giacca" "Gibco" "Gifford" "Glasgow" "Glc7p" "GlcNAc-R"
    "Gleason" "Gli" "Gli-reporter" "Gliadel" "Gln26" "Gly158-Asp172"
    "Glycotope" "GmbH" "Goeman" "GoldenGate" "Golgi-to-ER" "Gollapudi"
    "Goodarzi" "Gotlieb" "Gottle" "Goutières" "Gram-negative" "Graph-Pad"
    "GraphPad" "Grb2" "Grb2-pY580" "Greece" "Griess" "Guccione"
    "Guerra–Rebollo" "Guiter" "Gupta" "Gut-associated" "Gy" "Gö6976"
    "Göttingen" "H&E" "H-89–insensitive" "H-89–sensitive" "H-RasG12V"
    "H-RasG12V-labeled" "H-bonds" "H-histone" "H1" "H168R" "H17E2" "H1975"
    "H1N1" "H2" "H2009" "H2Bub" "H2Bub-dependent" "H2Bub-independent" "H3"
    "H3-T11" "H3-dependent" "H3-histone" "H3-like" "H3K18" "H3K18ac" "H3K27"
    "H3K4Q" "H3K4m2" "H3K4m3" "H3K9" "H3KR" "H3R2" "H3ac-SET1C" "H4" "H4K20"
    "H4KR" "H5" "H7" "H77s" "H83,86L" "HA-A1YA" "HA-S6KΔC" "HA-TAp73"
    "HA-TAp73α" "HA-affinity" "HA-tag" "HAECs" "HALST" "HC1954" "HCASM"
    "HCASMC" "HCC728" "HCC829" "HCN" "HCV-like" "HDFs" "HEAT" "HECT-family"
    "HER1–3" "HER1–4" "HER1–4-specific" "HER2+" "HER2+MMTV-PyMT" "HER2+human"
    "HER2-negative" "HER2-normal" "HER2–4" "HFD" "HFSN1" "HG-U133" "HG=28.2%"
    "HG=40" "HG=47.1%" "HGC" "HGC-T" "HIES-related" "HIF" "HIF1-α" "HIPK2Δp53"
    "HIV+ " "HIV-1pNL4-3" "HIVE" "HIV + " "HK" "HLA-DQ" "HMEC-76NE6" "HMTI"
    "HMTIs" "HMVEC-d" "HNSCCs" "HOSE" "HOSE11-24-96" "HOSE17-1" "HOSE96-9-18"
    "HOXB8" "HPC" "HPCs" "HPLC-MS" "HPRT" "HPV16-positives" "HR-HPV" "HR-HPVs"
    "HR=0.43" "HR=0.59" "HR=0.67" "HR=0.70" "HR=0.73" "HR=1.0" "HR=1.03"
    "HR=1.2" "HR=1.3" "HRV" "HRs" "HS7" "HSP70-interaction" "HSPB" "HSPB1-V5"
    "HTB-9" "HTC116" "HTC75" "HTM" "HTTLPR" "HV" "HVC" "HWE" "HXL" "Hace"
    "Hace1-HECT" "Hammerman" "HapMap" "Hardie" "Hardy-Weinberg"
    "Hardy–Weinberg" "Harstfield" "Hartsfield" "Hausser" "Hawthorne" "Hayden"
    "Hedgehog-targeted" "Heine" "Heinrich" "Heinrich-Heine" "Henan" "Henderson"
    "Henrich" "Henriksson" "Hercules" "Hershko" "Hetero-complexes" "Hexyloxy"
    "Hh" "High-levels" "High-risk" "Hinkes" "Hippo" "Hippo-RASSF1-LATS" "Hirai"
    "Hirsch" "Hirsh" "His-Beclin1" "His-GLI" "His-GLI1" "His-KEAP1" "His-Nedd8"
    "His-V5-XPA" "His-tag" "His17" "His6-Sso1p" "Hmatoxylin" "Hochberg"
    "Hodgkin" "Hodgkins" "Hodgkin’s" "Hoechst" "Hofmann" "Hogdall" "Hollywood"
    "Homberg" "Homo-complexes" "Hong" "Hoogsteen" "Hopkins" "Hoppe" "Horvath"
    "Hoshida" "Hospicell" "Hospicells" "Houston" "HpaII" "Hrr25p" "HsDMC1"
    "HsRAD" "HsRAD51-HsRAD51C" "HsRAD51-ssDNA" "HsRAD51B" "HsRAD51B-HsRAD51C"
    "HsRAD51B-HsRAD51C-HsRAD51D-HsXRCC2" "HsRAD51C" "HsRAD51C-HsXRCC3"
    "HsRAD51D" "HsRAD51D-HsXRCC2" "HsRPA" "HsXRCC2" "HsXRCC3" "Hsa-miR-185"
    "Hsp-90" "Hsp27+DTT" "Hsp27+compound+DTT" "Hsp27-2" "Huang" "Huntington’s"
    "Huygens" "Hydroxyl-coenzyme" "Hyperplasia" "Hz" "I-Bet" "I-II" "I-Smads"
    "I-x-V" "IAA" "IAPP-mCherry-tagged" "IASLC" "IBiD" "IC-50" "IC50" "ICGC"
    "ICI" "ICN" "ICU" "IDD-C2" "IFN-λ" "IFNy" "IGF-1-signaling"
    "IGF-1–stimulated" "IGF-IIR" "IHF" "III-IV" "IIIα" "III–IV" "IIa" "IIα"
    "IKBKE-mediated" "IKK-ε" "IL-12betaR" "IL-6Rα" "IL21R" "IL6-Rα" "IMC-41A10"
    "IMC-EB10" "IMPUTE2" "IMRT" "IN" "IN-LEDGF" "INCB018429" "INI-1" "INK4A"
    "INPC" "INSS" "IOVS" "IP+WB" "IPF" "IPG-IEF" "IPT" "IPW" "IQR" "IRB"
    "IRD=0.7" "IRES-Trans" "IRF3-mediated" "ISC" "ISEm" "ISGs" "ISH" "ISI"
    "ISKS" "ISP8" "ISS" "ITAF" "ITAM-like" "ITC" "IVIG" "IVIS" "IVS" "IVS2 +1G"
    "IW" "IgA" "IgG-immunoprecipitates" "IgG1κ" "Igfr" "Iida" "IkBαDN" "Ikeda"
    "Illumina" "ImageJ" "Imaris" "Immobilon-P" "Immuno-histochemical"
    "Immuno-histochemistry" "ImmunoResearch" "Immunoassay" "Importin-α"
    "In-Colorectal-Cancer" "In-depth" "In-house-developed" "Inc" "Indians"
    "Indofine" "Induna" "Infante" "Ingrid" "Innes" "InsP" "Insulin-induced"
    "Integration-site" "Inter-individual" "Invitrogen" "Invivogen" "Iowa"
    "Isodon" "Iss1p" "Iwata" "IκBα-dn" "IκBαDN" "I–1L" "I–III" "J-La" "J-Lat"
    "J-Sm" "J6" "J82" "J89GFP" "JAM-A–null" "JBTS" "JEFF" "JELIS" "JEY" "JFF"
    "JFH-1" "JFH1" "JFP" "JGW" "JHS" "JHS-ARIC" "JIR" "JJC" "JMD" "JMH"
    "JMML-like" "JO" "JP" "JPX-9" "JQ-1" "JQ1" "JR" "JTE" "JTE-013" "JUND"
    "JWH" "JXZ" "JYJ" "JYL" "JYS" "JaCOP" "Jackson" "Jacobs" "Jacquemin" "Jag1"
    "Janku" "Japan" "Japanese" "Jasco" "Jason" "Jass" "Jeong" "Jewish" "Jews"
    "Jiang" "Jimenez-Sainz" "Johansson" "John-Aryankalayil" "Johns" "Johnsons"
    "Jordan" "Jurchott" "K-cells" "K-linkage" "K-linked" "K11A" "K14cre" "K19A"
    "K19Q" "K19R" "K203" "K29A" "K29R" "K3-MARCH" "K375A-K420A" "K486" "K6"
    "K6R" "K7" "K7R" "K8" "K88A" "K88R" "KAAD" "KAAD-cyclopamine" "KARPAS"
    "KB1" "KC3" "KCNKs" "KD2" "KDEL" "KEGG" "KEN-box" "KF" "KFERQ" "KFK" "KJL"
    "KLuc" "KOCL" "KOCL-48" "KOs" "KTS" "KW-2449" "KX" "KXS" "KXXS" "KY" "KYC"
    "Kabat" "Kac" "Kakizaki" "Kallmann" "Kamura" "Kaplan" "Kaplan-Meier"
    "Kaplan–Meier" "Kaposi" "Kaposi's" "Kappa-light-chain-enhancer" "Karn"
    "Karnofsky" "Karsten" "Karyorrhexis" "Kase" "Kato" "Kawate" "Kd" "Keil"
    "Keller" "Khalil" "Khodarev" "Ki-67" "Ki67neg" "Kim" "Kinase-refractile"
    "Kinexus" "Kip" "Kir" "Kirsten" "Klichko" "Kloog" "Knapp" "Knock-in"
    "Knowles" "Knudson" "Kodak" "Kolacna" "Kolmogorov" "Kolmogorov-Smirnov"
    "Kolmogorov–Smirnoff" "Korea" "Korean" "Kossa" "Koury" "Kozaki" "Kozlov"
    "Kramer" "Kriegsheim" "Krogan" "Krogan’s" "Kruppel-Like" "Kruskal-Wallis"
    "Kruskal–Wallis" "Krüppel" "Krüppel-like" "Ksucc" "Ku" "Kuo" "Kurman"
    "König" "L-shaped" "L-type" "L1" "L2" "L26A-geminin" "L3" "L858R" "L8A4"
    "LADY" "LAI" "LBD" "LC3-I" "LC3B-I" "LC3B-II" "LC3II" "LCQ" "LD50"
    "LEF-dependent" "LEF-mediated" "LEOPARD" "LEfSe" "LFB" "LFIP" "LFL" "LJJ"
    "LKBl" "LL360" "LLN" "LN95" "LNCaP" "LNCaP-LN3" "LNCaP-LUC" "LOC283155"
    "LPARs" "LQ" "LQQAA" "LR" "LREVMESAVGNSSGSGQNEE" "LRFS" "LRY" "LRs"
    "LSC-1800" "LSL-td" "LSRFortessa" "LTNP" "LTR-CAT" "LTR-luc" "LTR5" "LTRs"
    "LUSC" "LUSC-21-1078" "LUSC-21-5485" "LUTS" "LV-K" "LV-WT" "LXRα" "LXXLL"
    "LY29004" "Labtech" "Laemmli" "Laevis" "Lan" "Langevin" "Langmuir"
    "Lapachone" "Large-Scale" "Large-scale" "Larman" "Larsen" "Larsson"
    "Lasergene" "Lasham" "Latvia" "Lauren" "Laurens" "Ldb17p" "Le" "Lehr"
    "Leica" "Leidner" "Lentiviral-mediated" "Lerner" "Let-7a" "Let-7b"
    "Leucine-insulin-mTORC1" "LeukemiaNet" "Levkowitz" "Lgr5-EGFP-IRES-CreERT2"
    "Li" "Li-Fraumeni" "Li-Fraumeni-like" "Liao" "LigI" "LightMix" "Lindhurst"
    "Linker" "Lipid-Raft" "Lipid-raft" "Liposomes" "Lipotoxicity-induced"
    "Liprin-α2" "Liu" "Liu-Bryan" "Live-cell" "Localizes" "Loesch"
    "Log-binomial" "Log-rank" "Lohr" "Loi" "Lombardo" "Longley" "Lonza" "Lopez"
    "Lopez-Knowles" "Loss-of-function" "Low-dose" "Lu" "Lublin" "Lukaszczyk"
    "Luo" "Luu" "Ly294002-protective" "Lyn" "Lyngby" "Lys50" "M-G5-7" "M0"
    "M210B4" "M5" "M6" "MAGI-1b" "MAN1Luhm" "MAN1N" "MAP-like" "MAP-ratios"
    "MAPPER" "MAPkinases" "MARK" "MBI" "MBP-experiments" "MBP-procedure"
    "MBP-purification" "MCF10A-DEAR1-KD" "MCM2-7" "MCM2–7" "MCM2–7-ΔC6" "MCODE"
    "MDA-PDA" "MDA453R" "MDV" "ME-PCR" "MEDLINE" "MEFV" "MEK-DD" "MEKi" "MEME"
    "MEN5" "MEN8" "METTL" "MFS" "MHC-1" "MHC-I" "MHz" "MI-888" "MILLIPLEX"
    "MIR1208" "MIR168a" "MK2i" "MKC" "MKC-LC" "MKI" "ML171" "MLLC" "MLN-518"
    "MM" "MM-AN" "MM-MC" "MM9" "MMCLs" "MMP114" "MMP14p" "MMP1A-519G" "MMQO"
    "MMT14" "MMTV-PyMT" "MNM" "MOG-G-CCM" "MOI" "MOIs" "MPE" "MPM2-positive"
    "MPNST2" "MPNST7" "MPNST9" "MR1-1-PE38" "MRCT" "MRN" "MRP-7" "MS" "MS110"
    "MSI-H" "MSI-H–positive" "MSI-L" "MSI-Low" "MST3Gal" "MSeA" "MTPS" "MTS"
    "MUR" "MYC-coactivator" "MYC-null" "MYC-protein-expressing"
    "MYC-protein-negative" "MYC-protein-positive" "MYCN-protein-negative"
    "MYCN-protein-positive" "MYO9" "MYPT" "Madin" "Madin-Darby" "Madin–Darby"
    "Madrid" "Magi-6" "Malays" "Malaysia" "Manassas" "Manganaro" "Mannheim"
    "Mantel-Cox" "Marban" "Marcello" "Marfan" "Margolis" "Marshfield"
    "Massilia" "Masson" "Mathews" "Matlab" "Matsumura" "Matsuoka" "Matthijs"
    "MaxQuant" "Maybridge" "Mazal" "McConnell" "McCray" "Mcl1-stability"
    "Mcl1ES" "Mcl1L" "Mcl1jh" "Mcl1s" "Mcm6-C" "MeCN-H" "MeOD" "MeOD-d4" "Mec1"
    "Mediterranean" "Meier" "Mek" "Mek1" "Melbourne" "Memeo" "Menten" "Merck"
    "Meta-regression" "MetaMorph" "Metabochip" "Metacore" "Methanesulfonamide"
    "Methodology" "Meyer" "Meyov2" "Mg-ATP" "MgATP" "MiR-124" "MiR-18a"
    "MiR-195" "MiR-204" "MiR-224" "MiR-329" "MiR-379" "MiR-9" "MiR181a"
    "MiRa-221" "MiSeq" "Michael" "Michaelis" "Michaelis-Menten" "Michigan"
    "MicoRNAs" "Micosystems" "MicroRNA-29" "MicroSource" "Micromass"
    "Microsatellite-Unstable" "Microsoft" "Milan" "Milk-driven" "Milk-mediated"
    "Milliplex" "Millipore" "Milner" "Minas" "Mir-17-92" "Misale" "Mito-Carta"
    "MitoTracker" "Mitosis-Karyorrhexis" "Mitui" "Miyazaki" "Mn" "Mo7ep210"
    "MoMLV" "Modeling" "MolBiol" "Molt3" "Montano" "Moracellaceae" "Moreno"
    "Morgagni" "Morrison" "MouseT1" "Mousnier" "MsCl" "MspI" "Mst1" "MudPIT"
    "Multi-Reg" "Multi-Reg's" "Multi-ethnic" "Multivariable-adjusted" "Munc18a"
    "Munc18b" "Munfus" "Munfus-McCray" "Munich" "Muredach" "Murrayafoline"
    "Mus81-Eme1" "Musgroove" "Mx1-Cre+andFbxw7" "Mx1-Cre+mice" "MyD88s" "Myc"
    "Myc-EphA2" "Myc-and" "Myeov2ΔFD" "Myo2p" "Mytl" "Müllerian" "MβCD" "M–1P"
    "N+1" "N-HRV" "N-PAC" "N-Phe" "N-SH2" "N-SH2-PTP" "N-acetyl" "N-degron"
    "N-dimethylsphingosine" "N-end" "N-labeled" "N-linked" "N-methyl"
    "N-methylation" "N-nitrosoguanidine" "N-recognin" "N0" "N0-1" "N08-30"
    "N09-24" "N100b" "N1ICD" "N4" "N52A" "N52D" "N66A" "N66D"
    "N7-methylguanine" "N=10" "N=15" "N=39" "NAPDH" "NBUD" "NCE-defective"
    "NCH" "NCH-51" "NCI" "NCOAs" "NCT01237067" "NCT01445418" "NDW" "NEQAS"
    "NER-defective" "NF-B" "NF-kBp50" "NF-κB-we" "NF-κB1" "NF-κBp50" "NFKB"
    "NHBE" "NHBEC" "NHBLI" "NHL-GWAS" "NHR" "NHRs" "NHT" "NINDS" "NINDS-II"
    "NKGD2" "NKX3" "NL4-3" "NL81A" "NLS-like" "NMSCs" "NO" "NOD-SCID" "NODSCID"
    "NPV" "NQO1+
cells"
    "NQO1+cells" "NQO1-cells" "NRAF" "NRG1-dependent" "NT-sh" "NTC-mimic"
    "NTPases" "NTUH" "NTW" "NVP" "NVP-AST487" "NXT" "NYHP" "Na" "NaH" "Naidu"
    "Naik" "Najy" "Naka" "Nakamura" "Nakayama" "Namoline" "NanoPro" "Naples"
    "Nashville" "Nathanson" "Nault" "Navarro" "Nerve" "Nes-GFP" "NetPhos"
    "Netherlands" "NeuAcα2" "Neurobasal-A" "Neurolucida" "Neuromab"
    "Neuroscreen-1" "New" "Next-generation" "Ni-NTA" "NiCl" "Nikulenkov"
    "Ninety-six" "Niu" "Nmethyltrifluoromethanesulfonamide" "Nonidet" "Noonan"
    "Normanno" "North-Europe" "Notch" "Notch-dependent" "Notch-mediated"
    "Notch1ΔE" "Notch1ΔE-ires-mCherry" "Notch1ΔE-transduced" "Notch1–4"
    "Novartis" "Novex" "Nox" "Nox4A" "Nox4B" "Nox4GFP" "Noxa" "Noxa-levels"
    "Noxa-precipitates" "NuRD" "Nus" "Nus-Tag" "O-R" "O-alkylated"
    "O-glycosylation" "OB-fold" "OC" "OCM" "OL" "OMIM" "OMM" "OP43" "OPB-31121"
    "OPC" "OPCs" "OPH" "OPUS" "OR=1.26" "OR=1.33" "OR=1.51" "ORC" "ORC-Cdc6"
    "ORC1-6" "ORP-150" "ORR" "ORs" "OSCC_30" "OV-C35-M1" "OV-C35-M2"
    "OV-C35-M3" "OV-MV1" "OV-MV2" "OVCA18" "OVID" "Oakland" "Oblinger" "Ogino"
    "Ogiso" "Ohta" "Okita" "Ole" "Oligodeoxythymidine" "Ollendorff" "Olympus"
    "Omapatrilat" "Omics" "Omni2.5" "OmniExpress" "Oncomine" "OneStep" "Ono"
    "Onouchi" "Operon" "Optimem" "Oregon" "Orthoclone" "Orthomyxoviridae"
    "OsO4" "Oslo" "Osmr" "Ott" "Over-activated" "O–3Q" "P1" "P1-P3" "P11–16"
    "P2" "P223L" "P4D1" "P5-P7" "P5D2" "P6" "P65A" "P7" "P95L" "P=0.0022"
    "P=0.0026" "P=0.0029" "P=0.008" "P=0.0084" "P=0.0248" "P=0.155" "P=0.46"
    "PAC" "PACAP-dependent" "PACAP-induced" "PAGE" "PAK-family" "PANC-1-P"
    "PANC-1-RR" "PARGi" "PARP-inhibitor-induced" "PAX5-C20orf112" "PBAF" "PBD"
    "PBMs" "PBST" "PC12-C2" "PC12-ER-CF" "PC12-ER-DF" "PC12-ER-Y537S"
    "PC12-ER2" "PCR–ASP" "PDA" "PDAs" "PDGF-A-D" "PDGF-CC" "PDGF-CC-mediated"
    "PDGF-DD" "PDGF-α" "PDGF-αR" "PDGF-β" "PDGF-βR" "PDGFRα" "PDGFRβα" "PDK"
    "PDZ3" "PDZ4" "PDZ6" "PE-like" "PE38KDEL" "PEARKO" "PEG400" "PEO" "PEST"
    "PEST-sequence" "PESTfind" "PFAM" "PGL3-SOCS3-107Luc" "PGTP" "PHA"
    "PHA-680632" "PHASER" "PHENIX" "PI-FACS" "PI3K-CA" "PI3K-like" "PI3KKs"
    "PI3K→PDPK1" "PIC" "PIKKs" "PINA" "PINK1-KDD" "PIPES" "PKA-and"
    "PKB-phosphorylation-independent" "PKCßII" "PKCβII" "PKCθ" "PKC‐β" "PKC‐β2"
    "PKD-consensus" "PKF115-854" "PLCgγPKCβ" "PLX4720" "PMDM6" "PMDM6-F"
    "PNA-PCR" "PNFs" "PNU74654" "POT1-TPP1-insensitive" "PP2A-like" "PPY-A"
    "PPY-A+BAW667" "PPY-A+SCF-block" "PPY-A-treated" "PQ" "PQ-loop" "PQR"
    "PRDM-1" "PRIDE" "PRKRA" "PRMI" "PROMO" "PSCC" "PSTAIRE" "PTEN-intact"
    "PTEN-null" "PTEN-proficient" "PTMScout" "PTP-3" "PTPMeg2" "PTPN" "PY100"
    "PZ-HPV-7" "Pagano" "Pair-wise" "Paired-box" "Paired-pulse" "Pakistan"
    "Pakistani" "Palacios" "Pan-caspase" "Panupinthu" "Parkinson" "Paro"
    "Partek" "Patel" "PathDetect" "Pb" "Pb-Cre4" "Pcorr" "Pearson" "Pecam"
    "Pekar" "Pemetrexed" "Penn" "Pennsylvania" "Perez-Valles" "PerkinElmer"
    "Petrelli" "PhastCons" "Phenomenex" "Philippines" "PhosphoGRID"
    "PhosphoNET" "Phosphoinositide-3-kinas" "Photoshop" "Phox47" "Pickart"
    "Picrotoxin" "Pierre" "Pineles" "Piscataway" "PlGF-Flt-1signaling" "Plamer"
    "Planelles" "Plus-agarose" "Pmp" "Poblogaeth" "Pod-1" "Pod1" "Poisson"
    "Pol1" "PolII" "Poland" "PolyPhen-2" "PolyPhen2" "Polβ" "Popov"
    "Portuguese" "Post-diagnosis" "Post-integration" "Poznan" "Pph21p" "PrDOS"
    "Prahallad" "Prifysgol" "Principal" "Pro-MMP-1" "Pro-Ron" "Pro98" "ProMix"
    "Promega" "PromoCell" "Prosite" "Protein-level" "Proteome-wide"
    "ProteomeXchange" "Prx-1" "Puerto" "Pull-down" "Punjab" "Punjabi" "PyMol"
    "PαS" "Pβ-catenin" "P = 0.038" "Q-ChIP" "Q-Q" "Q-SNARE" "Q-Trap" "Q-test"
    "Q1" "Q3" "QC1–7" "QChIP" "QD-IHF" "QD-quantification" "QDs" "QIAGEN"
    "QIIME" "QO" "QS" "QSTAR" "QTOF" "QW" "Qa" "Qa-SNARES" "Qb" "Qbc-SNARE"
    "Qiao" "Qiaquick" "QqTOF" "Quantile-quantile" "QuikChange" "Qur" "Q–1T"
    "R&D" "R-Bioconductor" "R-RasGAP" "R-RasGTPase" "R-SNARE" "R-SNAREs"
    "R-type" "R0" "R122" "R248K_R250K" "R249S" "R273C" "R273H" "R3" "R32LY542F"
    "R5-tropic" "R5P" "R848" "R90K" "RACK1s" "RAD3-related" "RAD51B-RAD51C-DNA"
    "RAD57" "RADα" "RADβ" "RAPGAP" "RAS-RAF-pathway" "RAS-association" "RASM"
    "RB-deficeint" "RBAP-46" "RCGTG" "RCS" "RDVATSPI" "RE-responsive"
    "RECORD-1" "REFMAC" "REx" "RFB" "RFIII" "RFLP" "RI-BPI" "RIG-I-like" "RIIβ"
    "RING" "RING-CH" "RING-finger-dependent" "RING–E2" "RING–E2–Ub"
    "RING–TKBD-mediated" "RING–Ub" "RIPA" "RMAvalues" "RMSD" "RNA" "RNA22"
    "RNAi" "RNeasy" "ROKβ" "RP11-1109D18" "RP11-29C18" "RP11-482D24"
    "RP11-647D11" "RPTEC" "RPTECs" "RQ-PCR" "RR=10.7" "RR=2.71" "RR=2.76"
    "RRE-containing" "RRL" "RRLs" "RRRCWWG" "RRRCWWGYYY" "RS6" "RSNpS" "RSXpS"
    "RTK-proximal" "RTKs" "RXXSX" "RXXSX-COOH" "Rac-interacting" "Rac1"
    "Rac1-regulatory" "Rac1-v12" "Rac1GEF" "Rac1GTP" "Rac1GTPlevels" "Rac1V12G"
    "RacGTP" "Rad3" "Rad3-related" "Rad51-ssDNA" "Radioactive" "Raf-induced"
    "Rafati" "Raf→MEK" "Rahal" "Rahl" "Ral-effector" "RalGAP1" "RalGAP2"
    "Ramon" "Rantala" "Rap-dependent" "Rapgef3" "Ras-like" "Rat" "Rb"
    "Rb-family" "Rbpj" "Rbpjk" "Re-ChIP" "Re-expression" "Re-introduction"
    "Rebollo" "Reg" "Reg's" "RegulomeDB" "Reinersman" "Rembrandt" "Renca-lacZ"
    "Renilla" "Results" "Retrovirology" "Rett" "Rev" "Rho-GAP-like" "Rho-GTP"
    "Rho-like" "RhoA" "RhoA-GTP" "RhoA-GTPase" "RhoAV14" "RhoG" "RhoGTPases"
    "Rhodes" "Rich-Edwards" "Richard" "Rico" "Rictor-deficient" "Riviere"
    "Rocchi" "Roche" "Rockford" "Rockville" "Rodier" "Rodland" "Rohr" "Rohr’s"
    "Ron" "Ron+HNSCC" "Ron+HNSCCs" "Rong" "Roock" "Rosa26" "Rosa26-CreERT2"
    "Roschke" "Rostene" "Roswell" "Rotterdam" "Routy" "Rs4368253" "Rs4406737"
    "Rs9273363" "RskS380" "RuCl" "Rudin" "Rudolph" "Rugowski" "Runx2-null"
    "Ruohola" "Ruschoff" "Rusnak" "Russia" "Rustom" "RxxLxxI" "Ryu" "S-JH"
    "S-methionine" "S-transferases" "S1" "S152R" "S1981" "S1C" "S1D" "S1E"
    "S1F" "S223A" "S223E" "S235" "S236" "S23A" "S23L" "S240" "S240R" "S240R,"
    "S240R-DNA" "S2A" "S2B" "S2C" "S2D" "S2LMH2EEE-S4LMH2" "S2MH2-P" "S3"
    "S363" "S3LMH2EEE" "S3MH2-P" "S3c" "S411A+S424A" "S424" "S45del" "S4A"
    "S4B" "S4C" "S4D" "S4LMH2" "S4MH2" "S5A" "S6" "S6A" "S6K" "S6K1ca"
    "S6K1‐JNK" "S6K1‐JNK‐p66Shc" "S6K1‐T389" "S6K1‐induced" "S6K1‐mediated"
    "S6K1‐p66Shc" "S6KS5A" "S6‐S235" "S7" "S76A" "S7D" "S8" "S8A" "S8A," "S8B"
    "S8C" "S9" "SAHC" "SARM1-His" "SAXS" "SA‐β‐gal" "SBCS" "SCC01-04-A01"
    "SCC10A" "SCC4115" "SCC4120" "SCOS1" "SCOS2" "SCOS3" "SCOS4"
    "SDH-mABC1-PIC-ANT-ATPase" "SDP" "SDS–polyacrylamide" "SEC4"
    "SET1C-Mediated" "SET1C-independent" "SET1C-mediated" "SET1C-p300"
    "SET1C-p53" "SF2-ESE" "SGY1528" "SH2-phosphotyrosine" "SHA" "SHIV" "SIFT"
    "SILAC-TAP" "SIM3" "SIMs" "SIRT" "SIRT5H158Y" "SIRTs" "SISSRs" "SIT4"
    "SIVE" "SIVagm" "SIVcpz" "SIVden" "SIVgsn" "SIVmac" "SIVmon" "SIVmus"
    "SJ23B" "SK-N-DZ" "SK28" "SKCO" "SKCO-15" "SKF" "SLAAR" "SLe" "SMAD-driven"
    "SMAD3-induced" "SMART" "SMJ" "SMRT-SANT" "SNAG" "SNAIL1" "SNARES" "SNC1"
    "SNF-related" "SNMMs" "SNP" "SNP-probe" "SNPs" "SOCS3-elevating" "SOLAR"
    "SOS" "SP3-Luc" "SPSS" "SQ22,536" "SREBP-1b" "SRH" "SRSs" "SSBR" "SSCP"
    "ST3GAL" "ST3Gal" "ST6Gal" "ST88.14" "ST8Sia" "STAT-binding-sites"
    "STAT-signaling" "STAT3-independent" "STAT3C" "STAT5B-null" "STAT5Blow"
    "STAT5Bmutated" "STAT5Bnull" "STAT5Δ" "STAT6VT" "STRING" "STin2" "STs"
    "SU11275" "SURF" "SVWI38" "SVWI38s" "SVZ" "SWI1-like" "SWItch" "SWItching"
    "SYD-1" "SYD-2s" "SYD1A" "SYD1s" "Saarland" "Sahu" "Sainz" "Saleh" "Samiri"
    "Sanger" "Santa-Cruz" "Sap155p" "Sap185p" "Sap190p" "Sap4p" "Sar1p"
    "Sar1p-GTP" "Sarasquesta" "Sauerwald" "Savitsky" "Saxena" "Sca" "Scansite"
    "Schlemm" "Schlemm’s" "Schmidt" "Schneider" "Schroder" "Schwann" "Schwarz"
    "Scotland" "Scr" "Scribbe" "Sdh" "Sec10p" "Sec10p-13xmyc" "Sec13p"
    "Sec13p-Sec31p" "Sec15-3xGFP" "Sec1p" "Sec22p" "Sec23p-Sec24p" "Sec31"
    "Sec3p" "Sec4-GTP" "Sec4p–Sec15p" "Sec5-3xGFP" "Sec5p" "Sec6-2xmCH"
    "Sec8-2xmCH" "Sec8p" "Sec9p" "Segat" "SelectScreen" "Self-directed"
    "Selleck" "Semi-quantitative" "Semmes" "Semmes-Weinstein" "Sendai"
    "Sep-Pak" "Seqpos" "Sequenom" "Ser-15-p53" "Ser159" "Ser1981" "Sertoli"
    "Set1C" "Setx" "Seventy-five" "Seventy-two" "Sh-Angel1-expressing" "Shanxi"
    "Shao" "Shapira" "Sharpless" "Sheffield" "Shih" "Shikano" "Shimada"
    "Shimane" "Shimizu" "Shlomo" "Short-interfering" "Short-term" "Shp2-YPet"
    "Shu1" "Shytaj" "Si" "Si-H" "SiSIRT1" "Sialyl" "Sialyl-Lewis" "Sibai"
    "Siegel" "Sigma–Aldrich" "Significance" "Siliciano" "Silva" "SimpleM"
    "Sinai" "Single-cell" "Single-domain" "Single-nucleotide" "Single-round"
    "Single-strand" "Sirt1under" "Sit4p-HA" "Siwak" "Sixty-one" "Sjogren"
    "Sjostrom" "Sjögren" "Skaar" "Skowronski" "Skowyra" "Skp1" "Skp1-Cul1-Fbox"
    "Skts" "Skts5" "Slit-Robo1" "Sloan" "Slovak" "Slower-migrating"
    "Slug+inhibitor" "Slug-mediated" "Sluis-Cremer" "Sm" "Smad2" "Smads"
    "Small-molecule" "Smeenk" "Smg" "Smirnoff" "Smirnov" "Snail" "Snail1"
    "Snc1p–Sso1p–Sec9p" "Snc2-M2" "Snc2-M2p" "Snc2p–Sec6p" "Snc–Sec6p" "Snider"
    "Soderberg" "Sok" "Somers" "Sonvilla" "Sorenson" "Soret" "Sorrell" "Sos"
    "South-European" "Sowinski" "Spain" "Spanish" "SpeI" "Spearman"
    "Spearman’s" "Spectrophotometer" "Spingosine" "Spingosine-1-phosphate"
    "Spivak" "Spliceview" "SqCC" "Src-family" "Src-regulatory" "Sso1p"
    "Sso1p–Sec9p" "Sso2p" "Stanford" "Stat3" "Stat3-inhibitor-V" "Stat5a"
    "Steiner" "Stejiv" "Stevens" "Stevens-Johnsons" "Stommel" "Stransky"
    "Stratagene" "Stratech" "Stratford" "Strebel" "Strep" "Strep-Tactin"
    "StrepII" "StrepII-tags" "Stress-induced" "Stressgen" "Strohmaier"
    "Structure-activity" "Sub-G1" "SubG1" "Sugiura" "SunFire"
    "Super-resolution" "Suppl1" "Sutherland" "Suv4-20h1.1" "Swa2p" "Swansea"
    "Swant" "Sweden" "Swedish" "Swiss" "Switzerland" "Synapse-Defective-1A"
    "Synchem" "T-1296C" "T-7f" "T-BEAS-2B" "T-X-X-X-Phospho-S" "T-acute"
    "T-allele" "T-cell" "T-lymphocytic" "T-lymphoid" "T-lymphoma" "T-lymphomas"
    "T-oligo" "T-oligo-induced" "T-oligo-mediated" "T1" "T109-F113" "T134A"
    "T166A" "T180" "T185" "T2" "T202" "T284" "T284R" "T284R," "T284R-DNA" "T2D"
    "T2N1M0" "T2–T4∶42.11%" "T3" "T359" "T4" "T421" "T47DR" "T7" "T7-eEF1A1"
    "T790M" "T9A" "T=0" "TAA" "TACAAGAA" "TAE" "TAM-67" "TAP-MS" "TAP-Tag"
    "TAP-Tags" "TAP-experiments" "TAP-p15" "TAPI" "TARBP" "TATA" "TATA-box"
    "TAZ-regulated" "TAZ2" "TAZS89A" "TAZΔ393" "TAp63a" "TAp73-292" "TAp73β"
    "TBH" "TBS" "TBST" "TCA-3" "TCF-binding" "TCGA-21-1083" "TCM" "TCP" "TCRαβ"
    "TDA" "TDL" "TEADs" "TEFb" "TEV" "TFBS" "TFSEARCH" "TGACGTCA" "TGACTAA"
    "TGACTTCA" "TGCYY" "TGF-β1compared" "TGFαrelease" "THM" "TKBD"
    "TKBD-peptide" "TKI-258" "TKI-EGFR-based" "TL" "TMA3" "TMPSS2" "TNBCs"
    "TNF-treatment" "TOP" "TOPOIIα" "TP-38" "TPC" "TPTWQ" "TRANSFAC" "TRAPPI"
    "TRAPPII" "TRC-Hs1.0" "TREC" "TRECs" "TRF2DN" "TRIM32-luc" "TROSY"
    "TROSY-HSQC" "TRUSS" "TTAAGCTT" "TTCCTGGGA" "TTGTTTAC" "TTT" "TTT-RUVBL1"
    "TUNEL" "TURBT" "TV" "TW" "TWIST1" "TY" "Tabchy" "Table1" "Tactin" "TagSNP"
    "TagSNPs" "Tah18" "Taillé" "Taipale" "Taiwan" "Taiwanese" "Talavera"
    "Tallele" "Tansey" "TaqMan" "Taqman" "TargetP" "Targetscan" "Tas" "Tat"
    "Tat-SEC" "Tat-independent" "Tat-induced" "Tat-interacting" "Tat-mediated"
    "Tat-transactivation" "Tawil" "Tax" "Tax-2" "Tax-HA" "Tax-NBs"
    "Tax-induced" "Tax-mediated" "Tecan" "Tek" "Tengs" "Tennessee" "Testa"
    "Tet-off-inducible" "Tetrahymena" "Tetralogy" "Th-17" "Th1-helper"
    "Th1-polarization" "Th17" "Th2-helper" "The-reconstitution" "TheK" "Thermo"
    "Thermo-Scientific" "Thiel" "Thin-layer" "Thin-section" "Thirty-eight"
    "Thirty-four" "Thirty-three" "Thomas" "Thomsen" "Thomsen-Friedenreich"
    "Thr-pro" "Thr-specific" "Thr14" "Thr163" "Thr1989" "ThreeTsc1"
    "Tiam1-C-1199" "Tiam1-C1199-induced" "Tice" "Time-cause" "Time-course"
    "Tip110" "Tip110-immunoprecipitates" "Tip110ΔCT" "Tip110ΔNT" "Togashii"
    "Tokyo" "Toll" "Toll-Like" "Toll-like" "Tommiska" "Topflash" "TopoIIα"
    "Toronto" "Torrance" "Tothill" "Toumi" "Tpr" "Tra2β" "Trans-synaptic"
    "Transcriptome" "Tribolium" "Trifluoromethanesulfonamides" "TrioD1" "TrioN"
    "Tripterygium" "Tris-Glycine-SDS" "Tris-HCl" "Tris-glycine" "Trithorax"
    "Trk1" "Trojan" "Trono" "Trs33p" "TrueBlot" "Tryptophan-GH-IGF-1-mTORC1"
    "Tryptophan-GIP-GH-IGF-1-mTORC1" "Ttm1" "Tuj-1" "Tuj1" "Tukey"
    "Tukey–Kramer" "Tumor-node-metastasis" "Tunisia" "Turbo-Frodo"
    "Twenty-eight" "Twenty-five" "Twenty-four" "Twenty-seven" "Twenty-two"
    "Two-hybrid" "Two-locus" "Tyagi" "Tyr15" "Tyr216" "Tyr23" "Tyr279" "T→A"
    "U-2940" "U-box-type" "U-test" "U1" "U133" "U20S" "U251" "U2AF65-ISE"
    "UCBs" "UCSC" "UFMG" "ULM" "ULN" "UNAIDS" "UOK101" "UPA" "UPLC" "UPN"
    "URLs" "USA" "UTRdb" "UTRs" "UV," "UV-C" "UV-irradiated" "UV-irradiation,"
    "UVC" "Ub-tail" "UbK63R," "Uba3" "UbcH5B-RING" "Ub–E2" "Ub–E3" "Ub–RING"
    "Ub–linker" "Ub–pCBL-B" "Ufd2p" "Ugi" "Ultima" "Umezu" "Umezu-Goto"
    "UniProt" "United" "Upf" "Upf1-Upf2-Ufp3" "Upf3B-binding" "Upfs" "Uppsala"
    "Uso1p" "Utah" "Uwe" "Uzoh" "V-HA-RAS" "V-RAF-1" "V1–V3" "V2" "V274F" "V5"
    "V600E" "VAD" "VBR" "VDN" "VE1-antibody" "VECs" "VEH" "VFW" "VH" "VHH" "VI"
    "VISCONTI" "VL" "VLDL" "VM" "VPC23019" "VPREB1" "VSV-G" "VSV-G-pseudotyped"
    "VSV-G–GFP" "VT" "VTIFV" "VTRSNS" "VWR" "VZ" "Valencia" "Valka" "Valles"
    "Vanderbilt" "Vcr-R" "Vector" "Venn" "Ventura" "Verdin" "Verhage"
    "Verhagen" "Vervoorts" "Vialight" "Vibraplex" "ViennaLab" "Vimentin"
    "VirHostNet" "Viro" "Viro-Immunological" "Visudyne" "Vivanco" "Vladich"
    "Vlastots" "Vogelstein" "Vos" "Voss" "Vpr-host" "Vpu" "Vpu-defective"
    "Vpu-like" "Vpu26" "Vukmanovic-Stejiv" "Vαβ" "W-1" "W437X" "W448X" "WASP"
    "WB" "WERI1" "WHO" "WI" "WI38s" "WNT" "WNT-receptor" "WQ" "WSP" "WST"
    "WST-8" "WT-FBXO28" "WT-GR" "WT-MYC" "WT-NS" "WT-renilla" "WT1-B" "WT1-D"
    "WT1-like" "WTE" "WTcells" "WTor" "WXXF" "WXXF-motif" "WZ" "WZ-4002"
    "Waals" "Wagner" "Wahl" "Walker" "Wallis" "Wanfang" "Warburg" "Warsaw"
    "Washington" "Watson" "Watson–Crick" "Watters" "Weil" "Weinberg"
    "Weinstein" "Weissman" "Welcker" "Weril" "Western" "Western-blots"
    "Western-blotting" "Whatman" "Wheeler" "WhenCapn4" "Whitfield" "Whitney"
    "Whole-genome" "Whole-mount" "Wilcoxon" "Wiley" "Willers" "Willet" "Wilson"
    "Wisconsin" "Wt-EphA2" "Wt-EphA2-Myc" "Wt-HA-c-Cbl" "Wt-c-Cbl" "Wu"
    "Wuillème" "Wuillème-Toumi" "X-chromosomal" "X-inactivation" "X-ray"
    "X-rays" "X1" "X11α" "X12" "X1w" "X4" "XAR" "XC" "XG" "XIV" "XIX"
    "XPA-UVDE" "XPA-importin-α7" "XPA-ΔNLS" "XPol" "XPro1595" "XRCC1-BRCTII"
    "XRCC1-defective" "XRCC1BII" "XRCC1LL360" "XRCC1w" "XRCC1–LigIIIα" "XRad"
    "XTT" "XX" "Xia" "Xiangya" "Xiao" "Xq28" "XtraCount" "Xu" "Xue" "Y-family"
    "Y10" "Y100d" "Y100e" "Y1045" "Y182" "Y187" "Y202" "Y204" "Y2H" "Y38X"
    "Y39F" "Y50F" "Y53G8AR" "Y542Y542" "Y5R1c52" "Y845" "YAP1-1" "YAP5SA"
    "YAPS94A" "YAPS94A," "YB-1ΔC" "YB-1ΔN" "YDF" "YFPc" "YFPn" "YHL017W"
    "YHR122w" "YZ" "Yahata" "Yamada" "Yamauchi" "Yang" "Yang-1" "Yang1" "Yao"
    "Yap1081" "Yap1802p" "Yasmin" "Ykt6p" "York" "Ypt1p" "Yu" "Yunnan"
    "YxxxxLΦ" "Z-Don" "Z-VAD" "Z-scores" "Z=0.727" "ZBRK" "ZL" "ZLZ" "ZO"
    "Zalaudek" "Zeichner" "Zeiss" "Zeste" "Zhang" "Zhao" "Zhiliang" "Zhong"
    "Zhou" "Zn" "Zn-finger" "Zn1" "Zonana" "ZsGreen" "Zuo" "aCGH" "aa1-129"
    "aa130-324" "ab77400" "aberrance" "absorbance" "acetic-acid-solubilized"
    "acetyl-lysine" "acetylation-mimetic" "acetylome" "acid-dependent"
    "acid-soluble" "acids-PCR" "aciduria" "acral" "acti" "acti-vation"
    "actin-polymerization" "activated-cell" "activators" "active-site"
    "activities" "acyl" "ad-enocarcinomas" "add-back" "adduct" "adducts"
    "adeno-null" "adenoma-carcinoma" "adenyl" "adenylate" "adenylyl" "adherens"
    "adhesiveness" "adipocyte-like" "adipose-derived" "adnexa" "adreno"
    "adreno-medullary" "adult-UC" "adult-onset" "adults" "advanced-stage"
    "advancements" "aesthesiometer" "affinity-purification" "agar"
    "age-associated" "aggresome-like" "aging‐associated" "agonists" "aily-1"
    "aircrafts" "albicans" "albus" "alcohol-HCV" "alfa" "alfa-fetoprotein"
    "algorithm" "algorithms" "alguns" "alkali–metal–cation" "alkyl"
    "all-or-nothing" "allele-specific–based" "allelesGT" "allergy-specific"
    "allograft" "aloisine" "alpha-positive" "alpha-target" "already-available"
    "already-latent" "alternative-splice" "alveoli" "alveus" "ambos" "amd"
    "amines" "amino-acid" "amino-terminal" "amino-terminus" "aminoacyl"
    "aminobenzamide" "aminocaproyldihydrocinnamoyl" "aminocyclobutanol"
    "aminocyclobutanyl" "aminocyclopentanol" "aminoethyl" "aminoethyl-N"
    "ammonium" "amphisomes" "amplicon" "amplicons" "amplitudes" "amygdala"
    "anE" "anE2-dependent" "analisados" "analyser" "anchorage-independence"
    "and12±1.5%" "andCtnnb" "andDrosophila" "andEef1a1" "andF" "andFbxw7"
    "andGT" "andKras" "andLRP1" "andPTPN11" "andPten" "andR26" "and\\or"
    "andand" "andmSYD1A" "androgen-dependence" "androgen-deprivation"
    "androgen-independence" "and 3N" "aneuploid" "aneuploidy" "aneurysm"
    "aneurysms" "angiography" "anhydride" "anilinoquinazoline" "anolides"
    "anorectum" "anosmia" "anterograde" "antibody–immunoreactive" "antifungals"
    "antigen-retrieval" "antigen-specificity" "antigenome" "antimiR"
    "antiphospholipid" "antiproteases" "antivirus" "análise"
    "aorta–gonad–mesonephros" "apical-basal" "apical–basal" "aplasia" "apm4"
    "apocrine" "apoform" "apoptosis-signaling" "apoptosis-stimuli"
    "apoptotic-like" "apraxia" "apresentaram" "apresentava" "apresentavam"
    "aquire" "area-under-the-curve" "arginase‐II" "armamentarium" "arquitetura"
    "array-comparative" "arylcarbonyl" "asFbxw7" "asparginyl" "aspartates"
    "aspartyl" "aster-like" "asthma-like" "astroglial-derived" "at-risk"
    "ataxis" "atfor" "ath-miR159a" "atherosclerosis‐prone" "ation" "atmSYD1A"
    "atomic-level" "atypia" "auhors" "aureus" "auto-poly" "autogenes"
    "autoradiography" "autosomal-dominant" "auxillin" "avidity-driven" "axial"
    "b-glycerophosphate" "baPWV" "bacterial-induced" "bacterially-expressed"
    "barbed-end" "basal-like" "base-pair" "base-pairs" "basic-helix-loop-helix"
    "basso" "bead-based" "beads-on-a-string" "bearingKras" "begun" "benzo"
    "benzyl" "beta-PIX" "beta-chain" "beta-oxidation" "beta-papillomavirus"
    "beta-thalassemia" "betaine" "better-understood" "between-site"
    "between-study" "between-trial" "betweenGT" "betweenKras" "betweenness"
    "bi" "bi-allelic" "bi-directionally" "bi-functional" "bi-orientation"
    "bi-parametric" "bi-phasic" "bilayer" "bilayers" "biliverdin" "biliverdine"
    "binding-defective" "binding-only" "biochemists" "bioisostere"
    "biomolecules" "biopsy-proven" "biotin-dUTP" "biotin-streptavidin"
    "birthweights" "bismaleimidohexane" "bisphosphate" "bivariate" "blastocyst"
    "blocker" "blockers" "blood-brain" "blood–brain" "bluetongue" "bodyweight"
    "bona" "bona-fide" "bone-marrow" "bothKras" "bothp53" "bothpY542"
    "box-containing" "boxplots" "bp" "brachial-ankle" "branched-chain"
    "break-apart" "break-dependent" "breakapart" "breakpoints" "breathlessness"
    "broad-range" "broad-spectrum" "broader" "broadest" "bromo-adjacent"
    "bromobenzamide" "bromobenzoyl" "bromophenyl" "bronchoscopy" "bryostatin"
    "build-up" "butanol" "butyldimethylsilyl" "butyldimethylsilyloxy" "by-pass"
    "by-product" "by-products" "c-Cbl-C3HC4C5" "c-Cbl-TKB" "c-FLIP-1" "c-Flip"
    "c-means" "c-neu" "cAMP-affinity" "cAMP-agarose" "cAMP-and" "cAMP-binding"
    "cAMP–Rapgef2–ERK" "cAb-Lys3" "cBio" "cGGGCATGCCCg" "cIEF" "cMax" "cN0"
    "cNSIP" "cPARP" "cRNA" "cRNP" "cSCC" "cSCCs" "cXPA" "cacodylate"
    "cadaverine" "caderina" "café-au-lait" "callosum" "calmodulin-like"
    "calorimetry" "calvaria" "camelid" "camelids" "canonical-like" "cap-column"
    "cap-complex" "cap-dependent" "capacitance" "capsid" "caracterização"
    "carbonyl" "carbonyls" "carboplatin+olaparib" "carboplatinum"
    "carboplatin–olaparib" "carboxyl" "carboxyl-termini" "carboxylase-α"
    "cardia" "cardio" "cargo-modifying" "cargos" "carotid" "carriers"
    "carry-over" "cartographies" "case-control" "case-parent" "case-parents"
    "case-specific" "case–control" "caso" "casos" "catM" "catalyse"
    "catenin-mediated" "catenina" "cation–π" "causal-effect"
    "caveolin-dependant" "cavernosa" "ccRCC" "cecum" "celiac" "cell-autonomous"
    "cell-cycle-specific" "cell-density" "cell-division-cycle" "cell-intrinsic"
    "cell-permeable" "cell-to-cell" "cell-viral" "cells" "cells-MST3GalIV"
    "cells-of-origin" "cells–have" "cellularly-expressed" "cellulo"
    "central-memory" "centriole" "centrosomal-originated" "cerebellum"
    "cerebrum" "cerevisiae" "cervical-derived" "cetuximab-like"
    "chain-associated" "chain-reaction" "channel-expressing" "chaperonins"
    "characteristica" "charcoal-dextran" "charcoal-stripped" "cheaper"
    "checkpoint-activating" "checkpoint-blind" "checkpoint-derived"
    "checkpoint-mediated" "checkpoint-produced" "checkpoint-proficient"
    "checkpoint–dependent" "chemiluminescence-based" "chemo"
    "chemo-radiotherapy" "chemo-sensitivity" "chemoattractant"
    "chemoradiotherapy" "chemoresistance" "chemoresistant" "chemoresponse"
    "chi-square" "chimerism" "chiral-auxiliary-cleaved" "chloro" "chlorophenyl"
    "chlorophenylthio" "cholesterol-lowering" "choroid" "chosen" "chrRCC"
    "chrRCCs" "chromaffin" "chromagen" "chroman-4-one" "chromatid" "chromatids"
    "chromophobe" "chromosomal-bound" "chromosome-bound" "cinco" "circuitry"
    "cis-elements" "cis-regulatory" "cisternae" "citologia" "citológica"
    "classificação" "clean-up" "clear-cell" "clearer" "clinic-pathologic"
    "clinically-derived" "clinicians" "clinics–agnostic" "clinostat"
    "cloud-like" "coactivator-3" "coauthors" "cobblestone-like" "coding-gene"
    "codon" "codons" "coelomates" "coexistant" "cofractionate"
    "cognitive-affective" "coil-coil" "coiled-coil" "coiled-coil-forming"
    "coli" "collagens" "collectivegroup" "collectives" "colonocytes"
    "colony-formation" "colony-forming" "colorectum" "colostrum" "com"
    "combinada" "comedonecrose" "commercially-available" "commonalities"
    "commonest" "comorbid" "comorbidities" "completa" "complex-1" "complicit"
    "component-1" "component-2" "conductance" "conformationally-flexible"
    "conformations" "conformer" "conformers" "confounders" "congenita"
    "conjunctiva" "consensus-driven" "considerada" "considerando"
    "consideredGT" "constitutively-activated" "contact-dependent"
    "control-nevi" "control-nevus" "convection-enhanced" "copie" "copy-neutral"
    "copy-number" "cord-blood-derived" "core-domain" "core-structure"
    "coregulator-binding" "corr" "corr=0.003" "corr=0.006" "corr=0.027"
    "corr=0.039" "corticosteroids" "cost-effective" "counter-part"
    "counter-productive" "counter-regulating" "counter-screen" "covariate"
    "covariates" "coworkers" "cow´s" "cpg-2" "crepitus" "cribriform" "crista"
    "cross-compensation" "cross-competition" "cross-complementation"
    "cross-dimer" "cross-react" "cross-reactivity" "cross-referenced"
    "cross-regulation" "cross-regulatory" "cross-resistance" "cross-section"
    "cross-sectional" "cross-sections" "cross-species" "cross-validation"
    "crossedR26" "crossover" "cruciforms" "cryo-EM" "cryo-electron"
    "cryo-microscopy" "cut-off" "cutaneus" "cutouts" "cyan" "cyclinD-CDK"
    "cystectomy" "cytAco" "cytb" "cytochromeb" "cytoflow" "cytologists"
    "cytology" "cytomatrix" "cytoplasimc" "cytoplasmo" "cytosol-to-membrane"
    "cytotoxicty" "cytotrophoblasts" "d-f" "d2EGFP" "dEGFR" "dG" "dT50" "dTMPs"
    "damage-dependent" "damage-independent" "damage-induced" "damage-inducible"
    "damage-responsive" "damage-signaling" "danger-associated" "datas"
    "dataset" "datasets" "datasheet" "dbSNP" "dbSNP-Reference" "ddAd"
    "de-hydroxylated" "de-regulation" "de-repression" "de-ubiquitinase"
    "de-ubiquitinases" "deamidation-regulated" "death-receptor"
    "death-receptor-induced" "death=2.49" "deaths" "decamer" "decamers"
    "decay-promoting" "decimeters" "decisionally-impaired" "deconjugate"
    "deeper" "deficeint" "degron" "degrons" "del158-172" "del4" "del5395"
    "delE746-A750" "delGly158-Asp172" "delta-mtDNA" "deoxynucleoside"
    "deoxynucleosides" "deoxynucleotide" "deoxynucleotidyl" "deoxyphorbol"
    "deoxyuridine" "depolarization-induced" "deprivation-induced" "der"
    "derivates" "dermato" "dermato-pathologist" "dermatophytes" "deste"
    "detachment-induced" "dextran-488" "di-Ub" "di-basic" "di-methylated"
    "di-nucleotide" "di-phosphoserine" "diabetes-like" "diaminobenzidine"
    "diazepin-quinazolin-amine" "dichlorobenzyl" "dichlorodihydrofluorescein"
    "dichroism" "dideoxy" "diet-derived" "diet-induced" "diethyl" "diferentes"
    "differentiation-4" "differentiation–βIII-tubulin" "differents"
    "diffuse-type" "diflavin" "difluoride" "difluorocytidine" "difícil"
    "digoxigenin-dUTP" "dihydroethidium" "dihydrolipoamide" "dihydrothymine"
    "dihydroxyvitamin" "dimer-to-monomer" "dimerization-competent"
    "dimethoxybenzamide" "dimethoxybenzoyl" "dimethoxybenzyl"
    "dimethoxybenzyloxy" "dimethylbenzyl" "dimethylbenzyloxy"
    "dimethylformamide" "dimethylphenyl" "dimethylsphingosine"
    "dimethylsulfoxide" "dimethylsulphoxide" "dinucleotides"
    "dioxole-5-carboxylic" "dipeptidyl" "diphenylene" "diphenylethyl"
    "diphenyltetrazolium" "diphosphate" "diphthotoxin" "diploid" "dis"
    "disaggregate" "disassemble" "disbalance" "disc-like" "discoidin"
    "discrepant" "disease-causative" "disease-relevant" "dismutes" "disome"
    "disomy" "distinção" "disufiram" "dithiobis" "diverter" "dnBID" "dnFADD"
    "dodecamer" "domain–peptide" "doman" "dominant-negative"
    "dominant‐negative" "dominant–negative" "donor-derived" "dorso"
    "dorso-lateral" "dose-dependently" "dose-independent" "dose-limiting"
    "dose-response" "dose-responses" "dose–response" "dot-like" "double-blind"
    "double-hexamer" "double-label" "double-positive" "double-strand"
    "double-threshold" "down-expressing" "down-modulates" "down-modulating"
    "down-stream" "downsteam" "doxorubin" "doxorubucin" "doxy" "doxy-treatment"
    "doxycyline" "drawn" "drinkers" "droplets" "dropwise" "drug-delivery"
    "drug-like" "drug-overhang" "drug-receptor" "drugs" "ds" "dsDNA" "dsFv"
    "duct-lobular" "duplexes" "dust-mite" "dye-treated" "dyschezia"
    "dysesthesia" "dysfunction-induced" "dysfunctions" "dyslipidaemia"
    "dysmenorrhoea" "dyspareunia" "dysplasia" "dysplasias" "dyspnea" "d–f"
    "eEF" "eIF4E," "eIF4E-dependent" "eLife" "eQTL" "eQTLs" "eSNPs" "eYFPmice"
    "eYFPmodel" "early-onset" "early-passage" "early-phase" "early-stage"
    "echocardiography" "ectdomain" "ectodomain" "ectodomains"
    "ectopically-expressed" "eczematoid" "ed" "edema" "effets"
    "efflux-deficient" "efore" "eitherKras" "electrospray" "element-binding"
    "elliptical-shaped" "eluate" "em" "email" "ena1-4" "enantiomers"
    "end-binding" "end-organ" "end-to-end" "endo-exonuclease-phosphatase"
    "endocrinology" "endometria" "endometriod" "endometrioid" "endometrium"
    "endometroid" "endonuclease-exonuclease-phosphatase"
    "endothelial-dependent" "endpoint" "endpoints" "enhancer-1"
    "enhancer-binding" "enhancer-core" "enhancer-of-zeste" "enhancer-promoter"
    "enhancer–promoter" "enmenol" "enocarcinomas" "entanto" "entero"
    "entero-insular" "enteroendocrine" "enthalpy" "entre" "entropy"
    "envelope-deficient" "enzymes" "eosin" "epicardium" "epidermoid"
    "epigallocatechin" "epigenetic-transcription" "epigenome" "epithelia"
    "epithelia-mesenchymal-transition" "epithelial-derived" "epithelial-like"
    "epithelial-mesenchymal" "epithelial-specific" "epithelial-targeted"
    "epithelial-to-mesenchymal" "epithelial–mesenchymal" "epithelial–targeted"
    "epitheliod" "epithelioid" "epithelium" "epitheloid" "equi" "equi-molar"
    "equiv" "erbB" "eriocalyxin" "erlotiinb" "erlotinb" "erythrocytes"
    "erythroderma" "erythroplakias" "estradiol-dependence"
    "estrogen-dependence" "estudo" "ethmoid" "ethnic-specific" "eukaryocytes"
    "euploidy" "ever-increasing" "ex" "ex--vivo" "ex-smokers" "ex-vivo" "ex3"
    "excited-state" "excitosome" "executer" "exercise-induced" "exocrine"
    "exoenzyme" "exogenously-expressed" "exon-intron" "exon3" "exon7" "exons"
    "exon–junction" "exosome" "exotoxin" "expct" "explant" "explants"
    "expression+loss" "expression=28" "expression–drug" "expression–may"
    "expressão" "extra-helical" "extra-mitochondrial" "extra-mitochondrially"
    "extra-nuclear" "extra-pulmonary" "extravasate" "extron" "fF" "fNSIP"
    "facto" "factor-1" "factor-2" "factors" "failsafe" "fall-off"
    "false-discovery" "family-wide" "far-distal" "far-reaching" "farnesyl"
    "farnesylamine" "fat-diet" "fed" "feedforward" "female-related"
    "ferredoxin" "fetoprotein" "fiber-like" "fibrillations" "fibro"
    "fibroblast-like" "fibroid" "fibulin-like" "fide" "field-to-field"
    "fifty-five" "fillopodia" "fine-needle" "fine-tune" "fine-tuned"
    "fine-tuning" "first-degree" "first-in-human" "first-line" "first-phase"
    "firsts" "flat-bottomed" "flavanoid" "flavanoids" "flavoenzyme" "flexure"
    "flora" "flow-mediated" "flow-through" "flowcytometry" "flown"
    "flowthrough" "flucloxacilline" "fluid-phase" "fluorescence-polarization"
    "fluoresces" "fluorine-18" "fluoro" "fluorodeoxyglucose"
    "fluorodeoxyglucose-avid" "fluorograms" "fluorophore" "fluorophores" "foi"
    "follow-up" "followup" "foram" "forbidden" "forceps" "forksolin" "formazan"
    "formyl" "forty-four" "fossa" "fossae" "founder-effect" "four-aa"
    "four-nucleotide" "four-way" "frameshift" "frameshifts" "framshift"
    "free-survival" "freeze-thaw" "from1.3" "from1.8" "fromBrca1" "fromKras"
    "fromMyc" "fromR26" "fromp53" "front-line" "front–back" "fsk" "fter"
    "fucosyl" "full-scale" "full-texts" "full-thickness" "fumarate"
    "function-2" "functionalis" "function–phenotypic" "function–which"
    "fusion-ready" "g-l" "gARPC" "gARPCs" "gDNA" "gain-of-active"
    "gain-of-function" "gain-of-functions" "galactopyranosyl" "gallate"
    "gallbladder" "gamma-knife" "gamma-radiation" "gammaglobulin" "gastro"
    "gastro-esophageal" "gate-keeper" "gatekeeper" "gavage" "geladanamycin"
    "geminin-Cherry" "geminin-Venus" "gender-by-SNP" "gene-5" "gene-carrier"
    "gene-dosage" "gene-environment" "gene-gene" "genes" "genetically-altered"
    "genetrap" "gene–environment" "gene–environmental" "gene–gene" "genic"
    "genome-wide" "genome-wide-significant" "genotype-phenotype" "genotypealso"
    "germ-line" "germinal-center" "germline" "giants" "glama" "glia" "globulin"
    "glomeruli" "glucosaminoglycan" "glutamate-induced" "glutamate-rich"
    "glutamyl-like" "glycan" "glycans" "glycerophosphate" "glycinamide"
    "glycosyl-phosphatidylinositol" "glycosylase-formed"
    "glycosylase-generated" "go-go" "goes" "gonadogrophs" "gone" "gpK8.1A"
    "gpl" "gpl60" "grade-3" "greater" "greatest" "green-labeled" "ground-based"
    "group-mean" "growth-repressive" "growth-stimulatory" "guanidinum"
    "gut-associated" "gut-derived" "gw" "g–i" "h-time" "hActin" "hCOMPASS"
    "hMCP-1" "hRapgef2" "hSET1" "hSOCS3" "hSOCS3-1.1kbp" "hSOCS3-1.7kbp"
    "hSYD1A" "hTRIM" "hTRIM32-luciferase" "hUpf" "hUpf2-binding" "hacker"
    "haeme" "hairpin-binding" "half-life" "half-lives" "half-maximal"
    "half-site" "half-sites" "haploChIP" "haplogroup" "haplotype" "haplotypes"
    "harmartin" "head-and-neck" "head-to-head" "heat-denaturation" "heat-shock"
    "heatmap" "heatshock" "heavier" "heavy-to-light" "helices"
    "helix-loop-helix" "helix–Ub" "helix–loop–helix" "hemagiomas"
    "hemangiosarcomas" "hematopoietic-specific" "hematoxylin-eosin"
    "hemiglossectomy" "hemoproteins" "hepatocarcinomas" "heptad"
    "heregulin-alpha" "hetero-complexes" "hetero-dimer" "hetero-dimers"
    "hetero-hexamer" "hetero-oligomerization" "hetero-oligomers" "heteroplasmy"
    "heterotetramers" "heterotopies" "heterotrimer" "heterotrimers"
    "heterozygote" "heterozygousPb" "heterozygousPb-Cre4" "hexahistidine"
    "hexamer" "hexamers" "hexanucleotide" "hidden" "high-FRET" "high-accuracy"
    "high-affinity" "high-confidence" "high-density" "high-dose"
    "high-expression" "high-grade" "high-impact" "high-incidence" "high-level"
    "high-molecular-weight" "high-penetrance" "high-performance" "high-power"
    "high-resolution" "high-risk" "higher-order" "higher-risk"
    "higher–molecular" "highlightedER" "highly-conserved" "highly-expressed"
    "highthroughput" "hilar" "hindbrain" "hindlimbs" "hippocampi" "histo"
    "histochemistry" "histologically-defined" "histologies" "histology"
    "histopathology" "histoquímica" "history–on" "histotype" "histotypes"
    "hnRNPs" "hoc" "holoform" "homeodomain" "homo-complexes" "homo-oligomeric"
    "homo-oligomerization" "homogenates" "homolog" "homologs" "homologyin"
    "homoplasmy" "homotrimer" "homotrimers" "homozygote" "homozygotes"
    "homozygousPb" "homozygousPb-Cre4" "hormone-independence" "host-cell"
    "host-influenza" "host-viral" "host-virus" "hot-spot" "hotspot" "hotspots"
    "hr" "hrr25" "hrr25-5" "hsa-miR-185" "hsa-miR-27a" "hsa-miR-27b"
    "humanFBXW7" "hyaline-like" "hydride" "hydrogen-bond" "hydrogenase-like"
    "hydroxy" "hydroxyacyl-coenzyme" "hydroxyl" "hydroxylases" "hydroxyphenyl"
    "hydroxysteroid" "hydroxytryptamine" "hyper" "hyper-immunoglobulin"
    "hyper-proliferation" "hyper-proliferative" "hyper-recombinogenic"
    "hyper-replication" "hyper-response" "hyperaldosteronism"
    "hypergammaglobulinemia" "hyperinsulinaemia" "hyperinsulinemia"
    "hyperparameters" "hyperpolarization-activated" "hypo-responsive"
    "hypodiploid" "hypoesthesia" "hypoglycemia" "hypopharynx" "hypotonia"
    "hypoxia-mimetic" "hypoxia-related" "i-iii" "iCycler" "iTRAQ" "ice-cold"
    "ice-water" "identifier" "identifyFBXW7" "ie" "ifferences" "ii" "iii" "ikd"
    "ileum" "ilium" "ill-defined" "immediate-early" "immotile"
    "immune-affinity" "immune-compensatory" "immune-compromised"
    "immune-deficient" "immune-deficienthumanized" "immune-electron"
    "immune-mediated" "immune-precipitated" "immune-purified"
    "immune-reactivity" "immune-system-related" "immuno" "immuno-electron"
    "immuno-histochemical" "immuno-histochemistry" "immuno-precipitated"
    "immuno-precipitation" "immuno-precipitations" "immunoaffinity-based"
    "immunobiology" "immunochemistry" "immunocomplex" "immunocytochemistry"
    "immunodeficient-human" "immunofluoresce" "immunoglobulin" "immunogold"
    "immunohistochemistry" "immunohistology" "immunologists" "immunophenotype"
    "immunophenotypes" "immunoprecipitation-mass" "immunoscore"
    "immunotherapies" "immunotherapy" "implicações" "importantes" "importin-2α"
    "importin-α" "importin-α1" "importin-α4-XPA" "importin-α5"
    "importin-α7-beads" "importin-β" "importins-α1" "importins-α4"
    "improtin-2α" "imuno" "imuno-histoquímica" "imunofenotípica"
    "imunofenótipo" "imunofenótipos" "imunoprecipitates" "in-between" "in-cell"
    "in-depth" "in-frame" "in-gel" "in-growth" "in-house" "in-human" "in-line"
    "in-situ" "in-vitro" "in-vivo" "inCapn4" "inGT" "inKras" "inMDA"
    "inMDA-MB-231" "inPR" "inPten" "inR26" "inStat3" "inTsc1" "inU87MG"
    "inandE" "inbcl" "inbcl-x" "includingGT" "inconclusive," "incosistant"
    "incretin" "indel" "indels" "individual-level" "individual-related"
    "indoline-3" "induced-apoptosis" "inflammation-associated"
    "inflammation-induced" "information-dependent" "ingrowth" "inhV"
    "inhibites" "inhibitor-STI-571" "inhibitor-tTG" "inhibitors"
    "inhibitors-of" "initiated-BER" "initiators" "injectedTsc1" "inmSYD1A"
    "inor" "inositide" "inositol-tetraphosphate" "insightful" "insipidus"
    "insulin-GSK-3-p27" "insulin-dependent" "insulin-independent"
    "insulin-induced" "insulin-producing" "insulin-stimulated" "integrators"
    "intensely-studied" "inter-chain" "inter-subunit" "interactant"
    "interactome" "interactomes" "interdomain" "interfinger" "intergrin"
    "intermediate-sized" "intermembrane" "internalization–most" "interobserver"
    "interquartile" "interstitium" "interstrand" "interwoven" "intra"
    "intra-Golgi" "intra-ductal" "intra-lesional" "intra-molecularly"
    "intra-oral" "intra-osseous" "intra-peritoneal" "intra-tibia" "intra-tumor"
    "intra-tumoral" "intraclass" "invasion-associated" "invasion-promoter"
    "invasion–metastasis" "inverse-variance" "inwardly-rectifying" "in–out"
    "iodoacetamide" "iodobenzamide" "iodobenzoxyamides" "iodobenzoyl"
    "iodophenyl" "ionic" "ionizing-radiation" "irradiation-dependent"
    "irradiation-induced" "isPLA" "ischemia-reperfusion" "islets" "iso"
    "isoflurane" "isomer" "isomer-methylmalonyl" "isomers" "isopeptide"
    "isotope-coded" "isotype" "isozyme" "isozymes" "iv" "iv-ix"
    "jatrophanediterpene" "junction-associated" "k-means" "kHz" "kappa-B"
    "karyopherins" "karyotype" "kbp" "keratinocyte-tropic" "ketoacid"
    "key-steps" "kg" "kinase-defective" "kinase-substrate" "kinasee" "kinome"
    "knock-down" "knock-downs" "knock-in" "knockdown–has" "knocked-down"
    "knockin" "knocking-down" "labeling-intensity" "laboratory-developed"
    "laboratory-specific" "lambda" "lamelliopodia" "lamellopodia"
    "lamellopodin" "large-cell" "large-scale" "laser-induced" "late-acting"
    "late-onset" "late-stage" "latentlyHIV" "latentlyHIV-1-infected" "lavage"
    "leakiness" "left-censoring" "left-right" "left-sided" "left-side–specific"
    "lenti" "lenti-viral" "lenti-virally" "lesão" "lesões" "let-7b" "let7a"
    "let7b" "let7c" "let7f" "leukemia-1" "levels" "lifecycle" "lifespan"
    "ligand-competitive" "ligand-drug" "ligand-reponsive" "light-chain"
    "likley" "limma" "lineage-specific" "linfoblastoid" "lipid-kinase"
    "lipofectamine" "lipoproteins" "liposome" "liprin-mSYD1A" "liprin-α"
    "liprin-α1" "liprin-α2" "liprin-α2-SAM" "littermate" "littermates"
    "live-cell" "live-threatening" "lo" "lobulares" "lobules" "log-additive"
    "log-log" "log2" "logettes" "long-chain" "long-lasting" "long-lived"
    "long-patch" "long-range" "long-standing" "long-time" "long-timescale"
    "loss-of" "loss-of-function" "loss-to-follow" "losts" "low-affinity"
    "low-dose" "low-expression" "low-grade" "low-incidence" "low-intermediate"
    "low-level" "low-moderate" "low-oxygen" "low-penetrance" "low-percentage"
    "low-quality" "low-risk" "low-volume" "lower-contrast" "lpha"
    "luciferase-reporter" "lumens" "luminex" "luminometer" "lung-only"
    "lyastes" "lymphadenectomy" "lymphnode" "lymphnodes" "lymphoblastoid"
    "lymphoid-enhancer-factor-1" "lymphoma-extra" "lymphopenia"
    "lysine-to-arginine" "lysis" "l‐arginine" "m3" "m5" "m5-m7" "m6" "m7"
    "m7-GTP" "m8" "mAb425" "mCMV" "mCPY" "mEPSC" "mEPSCs" "mFISH" "mFlt1" "mJ"
    "mK" "mPankoMab" "mRNA" "mRNA-level" "mRNA4" "mSAs-LGD" "mSYD1" "mSYD1B"
    "mTORC1-driver" "mTerc" "macro-microvascular" "macro-vascular"
    "macronodules" "macropahges" "macrophage-tropic" "macropinocytosis-like"
    "main-chain" "male-pattern" "mammary-specific" "manic-depressive"
    "marcadores" "marrow-derived" "masse" "masses" "masspec" "mastectomy"
    "matched-pair" "materno" "materno-neonatal" "matix" "mdMSC" "mdMSCs"
    "mean ± standard" "mean±S" "mean±sd" "mean±standard" "mean ± SD"
    "mechanisms" "median=0" "median=1.16" "median=1.20" "median=1.22"
    "median=1.38" "median=1.7%" "median=11.1%" "median=2.5%" "median=2.9%"
    "median=27.1%" "median=28.8%" "median=5" "median=5.2%" "median=5.7%"
    "median=5.8%" "median=5.9%" "median=6.1%" "median=8.1%" "median=8.9%"
    "medicalgenome" "megabases" "melanocortin" "melanogaster" "mellitus"
    "membrane-distal" "membrane-proximal" "mesenchymal-epithelial"
    "mesenchymal-like" "mesenchymal-related" "mesenchyme" "mesensphere"
    "mesenspheres" "meshwork" "mesoderm" "messengerRNAs" "mesylate"
    "meta-regression" "meta-static" "metabolized-PA" "metabolome" "metagene"
    "metal-ion-affinity" "metastasis-suppressive" "metastectomy"
    "methanesulfonate" "methanesulfonyl" "methanesulfonyl-methylamino"
    "methanesulfonylamino" "methanesulfonylmethylamino" "methide"
    "methoxybenzamide" "methoxybenzoxyamides" "methoxybenzoyl"
    "methoxylbenzamide" "methoxyphenyl" "methyLight" "methyl-CpG-binding"
    "methyl-lysine" "methyl-phosphate-capping" "methyladenine" "methylamino"
    "methylarginine" "methylation-defective" "methylcyclobutanamine"
    "methylcyclobutyl" "methylene" "methylenedioxybenzamide" "methylmalonyl"
    "methylmalonyllysine" "methylmethane" "methylome" "methylsulfonamide"
    "methylsulfonamides" "methylsulfonamido" "methylsulfonylamide"
    "methyltranferases" "miR-100" "miR-101" "miR-103" "miR-106b" "miR-107"
    "miR-10a" "miR-122" "miR-1225-5p" "miR-124" "miR-1246" "miR-125"
    "miR-129-3p" "miR-130b" "miR-133" "miR-135" "miR-135a" "miR-135b" "miR-141"
    "miR-143" "miR-144" "miR-145" "miR-146" "miR-148a" "miR-15" "miR-150"
    "miR-155" "miR-155-induced" "miR-17" "miR-17-92" "miR-17–92" "miR-182"
    "miR-185" "miR-185-binding" "miR-18a" "miR-1915" "miR-192" "miR-195"
    "miR-196a" "miR-196b" "miR-199a" "miR-19a" "miR-19b" "miR-19b-1" "miR-20"
    "miR-200" "miR-200b" "miR-203" "miR-204" "miR-204-SIRT1" "miR-205"
    "miR-208a" "miR-20a" "miR-210" "miR-215" "miR-218" "miR-22" "miR-222"
    "miR-223" "miR-224" "miR-26" "miR-26a" "miR-26b" "miR-28" "miR-29a"
    "miR-300" "miR-301b" "miR-30d" "miR-31" "miR-329" "miR-329-expression"
    "miR-329-inhibited" "miR-329-overexpressing" "miR-370" "miR-371-5p"
    "miR-372" "miR-373" "miR-379" "miR-379-410" "miR-382" "miR-3928" "miR-429"
    "miR-449a" "miR-451" "miR-452" "miR-454" "miR-486-3p" "miR-494" "miR-663"
    "miR-675" "miR-744" "miR-766" "miR-9" "miR-92" "miR-93" "miR-99" "miR-99a"
    "miR-99b" "miR-transfer" "miR17" "miR175p" "miR181a" "miR198" "miR19a"
    "miR20a" "miR27b" "miR379" "miR92a" "miR99b" "miRNA" "miRNA-101"
    "miRNA-106a" "miRNA-18a" "miRNA-421" "miRNA-TAR5p" "miRNA106a"
    "miRNA18a-ATM" "miRNA421" "miRNAome" "miRSVR" "miRanda" "micriobiome"
    "micro-environmental" "micro-heterogenous" "micro-irradiation"
    "micro-ribonucleic" "micro-vascular" "microRNA-21" "microRNA-26a"
    "microRNA-34b" "microRNASeq" "microacinar-like" "microautophagy"
    "microbial-derived" "microbiota" "microdomains" "microform" "microglubulin"
    "micrographs" "micrometastases" "microparticles" "microsatellite"
    "microsatellite-unstable" "microsecond" "microtitre" "microvasculature"
    "microvessel" "midbrain" "midbrain–hindbrain" "midline" "migraineurs"
    "mileu" "milk-derived" "milk-miR-29b-mediated" "milk´s" "mimic-100"
    "minheryin" "mini-pumps" "mini-satellites" "mini-virus" "minimise"
    "minisatellite" "minor-groove" "minutum" "min–48" "mir" "mir-29a" "mir-29c"
    "mis-localization" "mis-segregation" "missense" "missesne"
    "mitochondrial-dependent" "mitoses" "mitotic-checkpoint" "mixed-lineage"
    "moDCs" "mock-depleted" "mock-infected" "mock-treated" "moderate-to-severe"
    "modifica" "modifica-tions" "mono-SUMOylated" "mono-dansyl"
    "mono-palmitoylated" "mono-palmitoylation" "monoamine" "monocyte-derived"
    "monocytogenes" "monodisperse" "monolayer" "monomethyl"
    "monomethyl-transferase" "mononucleosomes" "monophophate" "monosomy"
    "monotherapy" "month-old" "morbidities" "more-or-less" "morfologia"
    "morpholino" "morpholinos" "morphology-based" "mortem" "mother-bud"
    "motif-containing" "motile" "mouse-IgG" "msyd-1a" "msyd1b" "mtAco" "mu"
    "muCIA" "muCIA2A" "muCIA2A-myc" "mucosa" "muito" "multi-cellular"
    "multi-center" "multi-centric" "multi-copy" "multi-domain" "multi-drug"
    "multi-ethnic" "multi-functional" "multi-kinase" "multi-log" "multi-organ"
    "multi-parametric" "multi-protein" "multi-reference" "multi-round"
    "multi-species" "multi-step" "multi-subunit" "multi-system" "multicentre"
    "multichip" "multiforme" "multigene" "multilevel" "multilineage"
    "multimarker" "multimer" "multimers" "multiple-cloning" "multiple-dose"
    "multiplex-ligation-dependent" "multiprotein" "multistage" "multisubunit"
    "multisystem" "multivariant" "multivariate" "muscle-invasive" "musculus"
    "mutSIRT1" "mutW7" "mutated-AML" "mutation-negatives" "mutations" "myDC"
    "myDCs" "myc-CK1δ" "myelopathy" "myocardium" "myocytes" "myometrium"
    "myotubules" "myr-mSYD1A" "myrAKT" "myristate" "n-Hexyloxy" "n=10" "n=103"
    "n=11" "n=12" "n=13" "n=15" "n=2" "n=23" "n=3" "n=30" "n=34" "n=35" "n=4"
    "n=40" "n=5" "n=6" "n=8" "nCLU" "nLC" "nLC-MALDI-TOF" "nLC-Q-TOF" "nXPA"
    "nano" "nano-molar" "nano-scale" "nanometer-scale" "nanoscale" "nanosecond"
    "nanotube-like" "naphthoyl" "naphthyl" "naphthylamide" "narignenin"
    "narrow-spectrum" "nasopharynx" "naïve" "ncomms3218" "near-confluent"
    "near-normal" "near-total" "nearTGFBR2" "nearest" "necropsy" "neg"
    "negativa" "negative-sense" "negativo" "neoadjuvant" "neointima"
    "neonate´s" "nephrology" "network-based" "neural-like" "neural-specific"
    "neurite" "neurodegeneration-dependent" "neuroendocrine" "neuromodulators"
    "neuronal-like" "neuronal-specific" "neuropathology" "neurosphere"
    "neurospheres" "neurotrauma" "neutropenia" "neutrophilia" "neutrophin"
    "never-smokers" "never-smoking" "newer" "newly-formed" "next-generation"
    "nigra" "nigro" "nigro-striatal" "nitrilotriacetate" "nitro"
    "nitrosoguanidine" "nitrotetrazolium" "node-negative" "nonLR" "noncognate"
    "nonendocrine" "nonfat" "nonhistone" "nonhuman" "nonimmune" "nonmalignant"
    "nonmeta" "nonmeta-bolizable" "nonmuscle" "nonpolypoid" "nonprogressors"
    "nonrandom" "nonredundant" "nonresponders" "nonsense-mediated"
    "nonsignificant" "nonsmall" "nonsolid" "nontarget" "normal-like" "nother"
    "nt" "nt-long" "nthe" "nuc-0" "nuclear-only" "nucleases" "nucleate"
    "nucleates" "nucleo" "nucleophosmin1" "nucleoproteins" "nucleosme"
    "nucleosome-1" "nucleotide-long" "nucleotides" "nucleur" "nucleus-only"
    "n " "n = 15" "n " "n = 5" "n " "n = 10" "n = 15" "n = 40" "oBII"
    "objetivo" "observada" "occurrences" "octamers" "oestrogen"
    "of-transcription" "ofFbxw7" "ofGT" "ofK" "ofPR" "ofPTPN11" "ofPten"
    "ofTsc1" "off-set" "off-target" "ofp53" "oil-red" "oldR26" "oligo"
    "oligo's" "oligodontia" "oligomycin" "oligonucleotide-PCR" "oligos"
    "omega-3" "omentum" "omphalitis" "on-going" "on-target" "on-treatment"
    "on-trial" "onco-miR" "onco-suppressive" "oncogenes" "oncologists"
    "oncology" "oncometabolite" "one-dimensional" "one-electron" "one-man"
    "one-quarter" "one-sided" "one-third" "one-way" "ontogeny" "ony" "on–off"
    "oocytes" "open-angle" "open-label" "ophthalmology" "orEef1a1" "orFbxw7"
    "orKras" "orMyc" "organelle" "organelles" "organic-soluble" "organoid"
    "oropharynx" "orpcDNA" "ortholog" "orthologue" "orthologues" "orthrologue"
    "ossicle" "ossicles" "osteoblast-like" "osteoblasts" "osteogenic-like"
    "osteoid–like" "osteopenia" "osteotomy" "ou" "out-of-frame" "outcompete"
    "outcompetes" "outgrown" "outs" "outut" "ovarian-stomach" "over-activate"
    "over-activated" "over-activation" "over-interpret" "over-interpretation"
    "over-representation" "over-riding" "over-stimulate" "overabundance"
    "overview" "oxidases" "oxidoreductions" "oxoG" "oxoacid" "oxoglutarate"
    "oxyethidium" "oxygenase-1" "oxygenases" "p120-VE" "p15INK4"
    "p16-ECFP-FOXO3wt" "p16-FOXO3" "p16-Leiden" "p16-defective"
    "p16-proficient" "p18INK4C" "p21-FL" "p21-positive" "p24gag" "p2xNF-κB-LUC"
    "p300-ASH2L" "p300-dependent" "p300-enhanced" "p38i" "p38β"
    "p38β-FoxO-BNIP3" "p3xE2F-luc" "p48XPE" "p4EBP1" "p53-DNA" "p53-SET1C"
    "p53-and" "p53-binding-site" "p53-dependent" "p53-family"
    "p53-haploinsufficient" "p53-like" "p53-null" "p53-p300" "p53C" "p53RE"
    "p53REs" "p53shRNA" "p53shRNAi" "p53‐S15" "p66Shc‐S36" "p66Shc‐S36A"
    "p73-binding" "p73-inducible" "p73DD" "p73KO" "p73α" "p90rskSer380"
    "p=0.0001" "p=0.0002" "p=0.0003" "p=0.0007" "p=0.0009" "p=0.001" "p=0.002"
    "p=0.003" "p=0.0031" "p=0.0036" "p=0.004" "p=0.0045" "p=0.0049" "p=0.005"
    "p=0.0053" "p=0.0057" "p=0.006" "p=0.0069" "p=0.007" "p=0.009" "p=0.01"
    "p=0.012" "p=0.013" "p=0.014" "p=0.015" "p=0.016" "p=0.017" "p=0.0185"
    "p=0.02" "p=0.020" "p=0.022" "p=0.023" "p=0.024" "p=0.027" "p=0.028"
    "p=0.0297" "p=0.03" "p=0.031" "p=0.0359" "p=0.037" "p=0.038" "p=0.04"
    "p=0.042" "p=0.0455" "p=0.046" "p=0.047" "p=0.048" "p=0.049" "p=0.05"
    "p=0.056" "p=0.059" "p=0.06" "p=0.064" "p=0.066" "p=0.077" "p=0.08"
    "p=0.086" "p=0.093" "p=0.095" "p=0.10" "p=0.12" "p=0.125" "p=0.14" "p=0.15"
    "p=0.16" "p=0.21" "p=0.24" "p=0.243" "p=0.25" "p=0.257" "p=0.277" "p=0.29"
    "p=0.3" "p=0.319" "p=0.32" "p=0.329" "p=0.349" "p=0.4" "p=0.41" "p=0.42"
    "p=0.427" "p=0.45" "p=0.47" "p=0.486" "p=0.502" "p=0.51" "p=0.54" "p=0.56"
    "p=0.596" "p=0.6" "p=0.63" "p=0.7" "p=0.71" "p=0.72" "p=0.77" "p=0.79"
    "p=0.8" "p=0.802" "p=0.813" "p=0.8365" "p=0.95" "p=0.96" "p=0.965"
    "p=0.975" "p=0.99" "p=0.998" "p=3.1x10" "p=7.6x10" "p=8.3x10" "pAR-binding"
    "pAldGCB" "pBabe" "pBabe-puro" "pC" "pC-inducible" "pCBL" "pCBL-B"
    "pCBL-B-E2–ZAP-70" "pCBL-B–E2-Ub–ZAP-70" "pCD" "pCDNA-ERα" "pCMV" "pCR"
    "pCR3.1-ERα" "pCRKL" "pChk1" "pCofilin" "pControl" "pEGFP" "pEGFP-C1"
    "pEGFP-hGLI1" "pEGFPC1" "pEGFPC1-Tat" "pEGFR" "pEGFR+HNSCCs" "pF" "pFAK"
    "pFKHR" "pFLAG-CDK2" "pFLAG-DOC-1R" "pG68" "pGL2-Bim-Basic" "pGL2-basic"
    "pGL3-Basic" "pGL3-SOCS3-107-pSTAT" "pGL3-SOCS3-107-pSTAT-SP3"
    "pGL3-SOCS3-107Luc" "pGL3-SOCS3-107SP3" "pGL3-basic" "pGL3SOCS3-107-SP3"
    "pGL4-Basic" "pGL4-hSOCS3-1.1" "pGSK-3β" "pGSK3β" "pH" "pH2AX" "pH77s-full"
    "pHlourin" "pHsp27" "pH " "pI" "pI-pC-treatedMyc" "pIFNB" "pIFNB1-LUC"
    "pISG" "pISG56-LUC" "pJFH" "pJFH1-full" "pKIT" "pLEX-STAT3α" "pLEX-STAT3β"
    "pLL3.7-based" "pMEC" "pMECs" "pMIR" "pMIR-REPORT" "pMLC" "pMOTIF" "pN"
    "pNF-κB-Luc" "pNL4-3" "pNPM1" "pOS8" "pP53" "pPAK1" "pPI3-K" "pPKCα-p120"
    "pPKR" "pRB" "pRPA32" "pRTS-1" "pS" "pS344-FBXO28" "pS474-PAK4" "pSTAT"
    "pSTAT3" "pSTAT3α" "pSTAT6" "pSUPER" "pT" "pT2-4" "pT3" "pTEpY" "pTNM"
    "pTQ" "pTXpY" "pTip110-HA" "pTip110ΔCT" "pTip110ΔNT" "pTopBP1"
    "pTyr363-linker" "pUC" "pY-null" "pY-peptide" "pY100" "pY1068" "pY1086"
    "pY1173" "pY397-FAK" "pY527" "pY542-Grb2" "pY774" "pZluc" "pZluc-TK"
    "padrão" "pair-sib" "pair-wise" "paired-box" "pairwise" "palmitoyl"
    "palmitoyl-CoA" "pan-WT" "pan-isoform" "pan-neuroligin" "pan-specific"
    "pan-therapy" "pancreatitis" "papillae" "papillary-pattern" "paracrine"
    "paralog" "paralogues" "parametrium" "paratope" "paratopes" "parenchyma"
    "parent-child" "parkinsonism" "patho" "pathobiology" "pathogen-associated"
    "pathogen-induced" "pathomorphologists" "pathophysiology" "pathways"
    "pathway–which" "pattern-recognition" "pcDNA-His-GLI1" "pcDNA3"
    "pcDNA3-transfected" "peGFPN1" "pediatric-CD" "pediatric-UC"
    "pediatric-control" "pellucida-like" "pemetrexed-cisplatin" "penetrance"
    "penetrant" "penicillin–streptomycin" "penile"
    "pentafluorobenzenesulphonyl" "pentaspan" "pentoxide" "pentylamine"
    "peptidases" "peptide-ion" "peptidoglycans" "peptidyl-prolyl" "per-test"
    "perhaps" "peri-nuclear" "peri-operative" "pericardium" "pericyte-like"
    "peritoneum" "permeant" "peroxidasin-like" "person-years" "perturbance"
    "perturbation-based" "perturbation-induced" "phenotype-genotype" "phenyl"
    "phenyl-methylene" "phophatidylinositol"
    "phorbol-12-myristat-13-acetate-induced" "phorbol-13-monoesters"
    "phosphaditylinositols" "phosphate-binding" "phosphatidyl-inositide"
    "phosphatidyl-inositol-3-related" "phosphatidylinositol-3-kinase–like"
    "phosphatome" "phospho-EGFR" "phospho-Src" "phospho-c-Met" "phosphoAkt"
    "phosphoSTAT3" "phosphoantibodies" "phosphoarray" "phosphoatase-mediated"
    "phosphohistone" "phosphoinositide-3-kinase-like" "phosphoinositol"
    "phosphoinositol-3-kinase" "phospholoipid" "phosphonomethylene"
    "phosphopeptide" "phosphopeptides" "phosphoproteome" "phosphor-Ser"
    "phosphor-mimetic" "phosphor-mimic" "phosphor-proteome" "phosphor-serine"
    "phosphor-specific" "phosphor-tyrosine" "phosphorprotein" "phosphorylaiton"
    "phosphosignals" "phosphosite" "phosphosites" "phosphotidyl"
    "phosphotidylinositol" "phosphotidylinositol-3-kinase" "phosphotyrosines"
    "photo-carcinogenesis" "photo-damage" "photo-damage-induced"
    "photo-stability" "photomicrograph" "photomicrographs" "photoproducts"
    "phyla" "phyllostachysin" "phylogeny" "physician-referral" "physio"
    "physio-pathological" "physiopathology" "phytosterols" "pico" "pico-L"
    "picrosirius" "piperonyloyl" "pixel" "placebo-controlled" "planaria"
    "plasmacytes" "plasmacytoid" "plasmon" "platinum-and" "platinum–DNA"
    "pleiotropy" "plekstrin" "pleomorfismo" "pleomorphism" "plexiform"
    "plexinB1-mediated" "ploidy" "plugin" "plus-labeled" "pm" "pnCLU" "pode"
    "point-of-no-return" "polarimeter" "polarity-associated"
    "polarization-based" "pole-associated" "poly-ADP-ribose" "poly-sumoylation"
    "polyA" "polyADP" "polyI∶C" "polyRNA" "polycomb-repressive" "polycytidine"
    "polyendocrinopathy" "polyether" "polymerase-1" "polymerase-chain"
    "polymorphism" "polymorphisms" "polyphenol" "polyphenols" "polyploid"
    "polyproteins" "polysomy" "polyubiquitine" "polyubiquitine-chains"
    "polyvinylidene" "poorer" "pore-blocking" "pore-formation" "pore-forming"
    "positiva" "positive-sense" "positividade" "positivo" "post-GWAS"
    "post-SCI" "post-autopsy" "post-culturing" "post-diagnosis" "post-entry"
    "post-exercise" "post-hoc" "post-infection" "post-inflammatory"
    "post-initiation" "post-injury" "post-integration" "post-integrative"
    "post-irradiation" "post-mitotic" "post-mortem" "post-nocodazole"
    "post-operative" "post-pemetrexed" "post-prandial" "post-pubertal"
    "post-radiation" "post-radiotherapy" "post-test" "post-transcriptional"
    "post-transcriptionally" "post-transduction" "post-transfection"
    "post-translational" "post-translationally" "post-transplant"
    "post-treatment" "post-tumor" "post-zygotic" "postmitochondria"
    "postmortem" "pph21" "prebound" "prebud" "precursors" "prednisone-therapy"
    "preexposure" "preimmune" "presença" "preterm" "pretest" "pri" "pri-let-7"
    "primaryKras" "primer-template" "prion-like" "prionoid" "prionoids"
    "priori" "prioritise" "pro-MMP-1" "pro-and" "pro-angiogenic" "pro-calcific"
    "pro-cancer" "pro-catabolic" "pro-death" "pro-differentiation"
    "pro-hypertrophic" "pro-inflammation" "pro-inflammatory" "pro-malignant"
    "pro-metastasic" "pro-metastasis" "pro-metastatic" "pro-migratory"
    "pro-neoplastic" "pro-osteoblastic" "pro-osteogenic" "pro-proliferative"
    "pro-recombinase" "pro-survival" "pro-tumor" "pro-tumorigenic" "pro-viral"
    "proMMP13" "proMMP2" "probands" "procaine" "procaspase-3" "prodeath"
    "proenzymes" "proepicardium" "progalanin" "progenitors" "progeny"
    "progression-free" "proinflammation-associated" "prokaryotes" "prolate"
    "proliferator-activated" "proline-stretch" "promoter-distal"
    "promoter-proximal" "promoters" "proof-of-concept" "prostatectomy"
    "prostratrin" "protease-sensitivity" "protein-10" "protein-5" "protein-A"
    "protein-DNA" "protein-RNA" "protein-fusion" "protein-interaction"
    "protein-level" "protein-lipidic" "protein-peptide"
    "protein-protein-interactions" "proteins" "protein–DNA" "protein–drug"
    "protein–platinum" "proteolipid" "proteome" "proteome-wide" "proteomes"
    "proteosome" "proto" "protooncogenes" "proven" "pro­vide" "pro–α-factor"
    "psCLU" "pseudo-stratification" "pseudosubstrate" "public-health"
    "publically-available" "pull-down" "pull-downs" "pulmosphere"
    "pulmospheres" "pulsatile" "punctae" "puro" "pyrene-DNA"
    "pyrimidine-pyrimidone" "p " "p = 0.001" "p = 0.007" "p = 0.01" "p = 0.001"
    "p = 0.002" "p = 0.01" "p = 0.017" "p = 0.02" "p = 0.03" "p = 0.05"
    "p = 0.06" "p = 0.08" "p≤0.05" "q-value" "qMSP" "qVD" "qVD-OPH" "quadrad"
    "quadrupole" "quantile-quantile" "quantitative-RT-PCR" "quatrefoil" "quinone
oxidoreductase"
    "rAAV" "rAAV2-PDGF-B" "rAPCL730" "rASB10" "rASB10v3" "rabbit-IgG"
    "race-specific" "radiation-induced" "radiation-initiated"
    "radiation-stimulated" "radiation-treated" "radiation-type-dependent"
    "radiatum" "radio-resistance" "radio-therapy" "radioactively-labeled"
    "radiochemotherapy" "radioresistance" "radioresistant" "ramus"
    "random-effect" "rank-sum" "rapalog" "rapaloges" "rapalogues" "rapalouge"
    "rapamcyin" "rarer" "ratio=2.4" "rationally-designed" "rbiology" "re-ChIP"
    "re-administration" "re-analyzed" "re-challenged" "re-creation"
    "re-distributed" "re-distribution" "re-emergence" "re-engineered"
    "re-engineering" "re-entry" "re-establish" "re-established" "re-evaluate"
    "re-evaluation" "re-examined" "re-exposing" "re-express" "re-expressed"
    "re-expressing" "re-expression" "re-grow" "re-ignition" "re-implantation"
    "re-incubated" "re-initiation" "re-introducing" "re-introduction"
    "re-ligation" "re-modeling" "re-opened" "re-organization" "re-plated"
    "re-replicating" "re-replication" "re-sensitize" "re-stimulation"
    "re-treatment" "re-wiring" "re2063640" "reaction-restriction" "read-out"
    "readily-detectable" "readily-releasable" "readout" "readouts"
    "reagents-analytic" "reappraise" "receptor-1" "receptor-2"
    "receptor-intrinsic" "receptor-ligand" "receptor-proximal" "receptor-α"
    "receptor-γ" "recognin" "recombination-mediated" "recontact"
    "recto-sigmoid" "rectosigmoid" "red-S" "red-labeled" "red-stained"
    "reference-based" "referent=CC" "refractile" "region-leucine" "regionsr"
    "regulatep53" "regulators" "reiterant" "relapse-free-survival"
    "relatedness" "renal-cell" "replication-associated" "replication-blocking"
    "replication-born" "replication-competent" "replication-impeding"
    "replicon" "repopulate" "reporter-coding" "representativeness" "repressors"
    "reproductive-age" "reseveratrol" "residuals" "residue–residue" "responder"
    "responders" "response-element" "resultes" "reticulophagy" "reticulum"
    "retinamide" "retrotransposon" "retrovirals" "retrovirus" "reverse-phase"
    "reverse-trancriptase" "reverse-transcripase" "revertant" "rhEcad"
    "rhabdomyosarcomas" "rhe" "rhodamine123" "ribose" "ribose-5-phosphate"
    "riboside" "rictor-deficient" "right-sided" "right-sidedness" "ring-finger"
    "risen" "risk-associated" "risk-to-benefit" "rno" "rod-like" "rotamer"
    "round-bottom" "rous" "rs1001581" "rs1005346" "rs10069690" "rs10243618"
    "rs10269422" "rs1042522" "rs10440635" "rs10497813" "rs10504861" "rs1059513"
    "rs10915437" "rs11172113" "rs11187870" "rs113420705" "rs113686495"
    "rs113953523" "rs11636802" "rs11688943" "rs11764116" "rs1178108"
    "rs1178112" "rs1178355" "rs11920625" "rs12134493" "rs12136718" "rs12190287"
    "rs12190287-G" "rs12190827" "rs12192087" "rs12192087-C" "rs12524865"
    "rs12526453" "rs12540872" "rs12949918" "rs13006529" "rs1333049"
    "rs13401811" "rs1359742" "rs143181039" "rs1462872" "rs1464510" "rs16905644"
    "rs16967637" "rs1726610" "rs17388568" "rs1745837" "rs17483466" "rs17533090"
    "rs17576" "rs17749316" "rs1802904" "rs182455" "rs1946816" "rs1998359"
    "rs2003869" "rs20541" "rs2063640" "rs2069772" "rs2079147" "rs2101521"
    "rs2147420" "rs2155388" "rs2227932" "rs2232157" "rs2232157G" "rs2232157T"
    "rs2232158" "rs2232158C" "rs2232158G" "rs2233678" "rs2233679" "rs2233682"
    "rs2237570" "rs22531" "rs2268641" "rs2274223" "rs2285332" "rs243317"
    "rs2521269" "rs25487" "rs25531" "rs2677879" "rs2724635" "rs2786098"
    "rs2817461" "rs28493229" "rs288979" "rs3025058" "rs3217989" "rs33917957"
    "rs35128104" "rs35682" "rs35683" "rs35748167" "rs3765524" "rs3769821"
    "rs3769825" "rs3788853" "rs3834129" "rs3918242" "rs4368253" "rs4406737"
    "rs4481204" "rs4559" "rs4730751" "rs4796793" "rs494379" "rs4969170"
    "rs4977574" "rs4987852" "rs4987855" "rs4987856" "rs4987885" "rs500766"
    "rs502281" "rs5030980" "rs53576" "rs56085230" "rs5749511" "rs6021270"
    "rs6475606" "rs6478241" "rs6503695" "rs6738825" "rs6790925" "rs6805118"
    "rs7015657" "rs7169431" "rs7217655" "rs72689236" "rs749924" "rs7578199"
    "rs757978" "rs7705526" "rs7720838" "rs7768030" "rs801540" "rs898518"
    "rs912127" "rs9273363" "rs9303280" "rs932169" "rs9349379" "rs9860547"
    "rs989692" "rtTA" "rubescens" "ruled-out" "run-on" "runt-domain" "ryan"
    "sCLU" "sEGFRvIII" "sEcad-HER" "sEcad-HER1interactions" "sEcad-HER1–4"
    "sFlt1" "sHSPs" "sICAM-1" "sIL-6R" "sIL6-Rα" "salt-and-pepper"
    "salt-bridge" "same-class" "sapiens" "sc-5778" "sc-965" "scFv-IT"
    "scFv-ITs" "scatterplot" "scdsFv" "scintillant" "screenings" "sec12-4"
    "sec4-8" "second-generation" "second-line" "second-most-common"
    "second-phase" "second-site" "secretome" "securin-Venus" "selenomethionine"
    "self-association" "self-cannibalization" "self-destruction"
    "self-destructive" "self-duplication" "self-evidently" "self-inhibited"
    "self-interaction" "self-reactive" "self-renew" "self-renewal"
    "self-renewprimarily" "self-sufficiency" "semi" "semi-preparative"
    "semi-quantitative" "semi-solid" "sense-mediated" "sensitizer"
    "sensitizers" "sentinel-node" "separation-of-function" "seperate" "septo"
    "septo-optic-like" "seq" "seqMINER" "sequelae" "sequence-based"
    "sequence-independent" "sequence-specific" "serine-threnine" "serosa"
    "sessile" "several-micro-second" "sh-EphA2" "sh177" "shBRCA1" "shCCAR1"
    "shCTL" "shCdk4" "shCdk4-1" "shCdk4-3" "shCdk4-4" "shCont" "shCtr" "shCtrl"
    "shDEAR1" "shDUSP6" "shDUSP7" "shEphA2" "shKIT" "shLUC" "shLuc" "shMyeov2"
    "shNS" "shNek2" "shRNA-expressing" "shRNA1" "shRNA2" "shRNA2-infected"
    "shROCK1" "shROCK1#1" "shROCK1-#1" "shSAFB1" "shTAZ" "shUNG" "shYAP"
    "sham-irradiated" "sharpest" "shock-induced" "shock-triggered"
    "short-chain" "short-hairpin" "short-in" "short-interfering" "short-patch"
    "short-term" "shorter-term-selected" "si-Cdh1" "siAPCLs" "siATDC" "siBRCA1"
    "siBrca1" "siCDC" "siCDC20-arrested" "siCdk2" "siCdk4" "siCo" "siCont"
    "siFBXO28" "siFlt-1" "siILK" "siKPNA2" "siKPNA2#1" "siKPNA2#1cells"
    "siKPNA2#2" "siLSD#1" "siLSD#2" "siLuc" "siNeg" "siNek2" "siPARG" "siPLK1"
    "siPP" "siPP6-07" "siPP6-08" "siPP6-transfected" "siRNA+pcDNA3.1+Myc"
    "siRNALKB" "siRNALKB1-transfected" "siRNAi" "siROCK" "siROCK1-#2"
    "siROCK1-#3" "siROCK1-1" "siROCK1-2" "siRPL11" "siRPL23" "siRPL29"
    "siRPL30" "siRPL37" "siRPL5" "siRPS14" "siRPS15" "siRPS20" "siRPS6"
    "siRhoA-1" "siRhoA-2" "siST6" "siSTAT6" "siScr" "siUNG" "sialyl-Lewis"
    "side-by-side" "side-chain" "side-chains" "sidechain" "sidedness" "sig"
    "sigmoid" "sign-out" "signal-signal" "signal-to-background"
    "signalling-competent" "signficant" "silico" "simpler" "simplest"
    "single-base" "single-break" "single-cell" "single-chain" "single-dose"
    "single-locus" "single-marker" "single-molecule" "single-mutant"
    "single-nucleotide" "single-particle" "single-round" "single-strand"
    "single-turnover" "sirtuin" "site-selection" "sitesn" "situ" "six-day"
    "six-subunit" "six-well" "sixty-five" "sixty-two" "sjTREC" "sjTRECs"
    "skin-derived" "slightly-decreased" "slow-down" "slow-infusion"
    "slow-release" "slower-migrating" "small-angle" "small-cell"
    "small-hairpin" "small-interfering" "small-lung" "small-molecule"
    "small-vessel" "smokers" "snMcl1" "snap-frozen" "snc1" "snc2" "snc2-M2"
    "snc2-V39M42A" "solid-phase" "solid-predominant" "solutes" "solution-phase"
    "solvent-accessible" "somente" "spaceflight" "spacer" "spacers"
    "spatially-targeted" "spatio" "spatio-temporal" "spatio-temporally"
    "specific-inhibition" "spectrometer" "spectrometers" "sphere-forming"
    "spheres" "sphingosine" "spindle-like" "spinning-disk" "spirooxindoles"
    "splice-variant" "spongiosum" "spretus" "squamous-cell" "ss"
    "stable-isotope" "stably-bound" "stady" "stainings" "standard-of-care"
    "steady-state" "steady-states" "stellate" "stem-cell" "stem-loop"
    "stemness" "stent" "stents" "step-down" "step-up" "step-wise" "stepwise"
    "stereo-hindrance" "strain-dependent" "strain-induced" "strain-specific"
    "stranded-RNA" "stress-activated" "stress-induced" "stress-inducible"
    "stress-mediated" "stress-responsive" "stress-specific" "stressful"
    "stressors" "stress–induced" "stress–response" "stroma-dominant"
    "stroma-poor" "stroma-rich" "stromal-expressed" "strong,"
    "structurally-unrelated" "structure-activity" "structure-based"
    "structure-specific" "structure–activity" "structure–function"
    "study-atherosclerosis" "study-collective" "sub-G1" "sub-celluar"
    "sub-cellular" "sub-class" "sub-clinical" "sub-complex" "sub-complexes"
    "sub-confluent" "sub-cutaneous" "sub-cytotoxic" "sub-endothelial"
    "sub-fraction" "sub-lethal" "sub-localization" "sub-micro" "sub-normal"
    "sub-nuclear" "sub-optimal" "sub-pathways" "sub-polysomal" "sub-polysomes"
    "sub-population" "sub-populations" "sub-progeny" "sub-region" "sub-regions"
    "sub-section" "sub-stoichiometric" "sub-types" "subG1" "subclass"
    "subclasses" "subcomplexes" "subfamilies" "subgoup" "sublines" "submicron"
    "subnetworks" "subset " "subsite" "subsites" "substrate-enzyme"
    "substrate-recognition" "substrates" "subsulfide" "subtype"
    "subtype-PDGF-CC" "succinate" "succinimidyl" "succinyl" "succinyl-CoA"
    "succinyllysine" "succinylome" "sugar-phosphate" "sulfhydryl"
    "sulfhydryl-to-sulfhydryl" "sulfide" "sulfonamide" "sulfonate"
    "sun-exposure" "super-shifted" "superactivate" "supercomplexes"
    "supernatant" "supernatants" "suppressor-of-fused" "supra-lethal"
    "surface-plasmon" "survive-to" "susbtantia" "switch-like"
    "symmetricDrosophilaEGFR" "synapse" "synapse-defective-1" "synapses"
    "synaptophysin-like" "synaptophysin-mCherry-positive" "syncollin-pHluorin"
    "syndoromes" "syndrome-like" "synergises" "synergism" "syngergy"
    "synthesis-gluconeogensis" "t-statistic" "tARPC" "tARPCs" "tEGFR" "tSNARE"
    "tSNAREs" "tTG" "tTG's" "tachycardia" "tacrolimus" "tagged-Tat"
    "tail-anchored" "tail-like" "tail-mediated" "tail-vein" "target-gene"
    "target-genes" "td" "tdRFP" "telomerase-accessory" "telomerase-associated"
    "telomerase-negative" "temperature-sensitive" "template-containing"
    "template-directed" "ten-times" "teniacide" "tensin-like" "tensins" "tert"
    "tetBim-ECFP-Mcl1L" "tetBim-EYFP-Mcl1L" "tetNoxa-ECFP-Mcl1L"
    "tetNoxa-EYFP-Mcl1L" "tetrakisphosphate" "tetramethylbenzidine"
    "tetranucleotides" "tetraphosphate" "tetraploid" "tetrasulfides"
    "tetrazolium" "tetrazorium" "tg" "thanKras" "thanp53" "thatGT" "thatPten"
    "theFbxw7" "theGT" "theKras" "thePR" "thePTPN11" "thePten" "theTsc1"
    "theapy" "theharrest" "thermocycler" "thiamine" "thiazoyl" "third-line"
    "thirty-eight" "thoughbcl" "thoughbcl-x" "three-dimensional"
    "three-quarter" "three-quarters" "three-stage" "three-strand"
    "three-tiered" "three-week" "threnine" "thrombocythemia" "thromospondin-1"
    "thymii" "thymine-thymine" "thymineless" "time-course" "time-courses"
    "time-dependently" "time-frame" "time-lapse" "time-of-flight" "time-point"
    "time-points" "timecourse" "timeframe" "timonae" "tinham" "tions"
    "tissue-specific" "titer" "titers" "toPten" "toll-like" "toolkits"
    "top-left" "top-right" "top53" "topologies" "topology" "totRNA"
    "toxicity-associated" "trafficking-competent" "trafficking-incompetent"
    "trans-activator" "trans-element" "trans-elements" "trans-membrane"
    "trans-synaptic" "transactivation-defective" "transamidation-defective"
    "transcription-PCR" "transcription-factor-binding"
    "transcription-regulatory" "transcriptionally-independent" "transdominant"
    "transducer" "transfectant" "transferase–mediated" "transformants"
    "transgenes" "transit-amplifying" "transitional-type" "transplantedp53"
    "transport-defective" "transwell" "transwells" "trastuzamab" "trcp"
    "treated-SW620" "treatedMyc" "treatments" "tri-lineage" "triacsin" "triage"
    "triangular-shaped" "tricalcium" "triethylammonium"
    "trifluoromethanesulfonamide" "trifluoromethanesulfonyl-methylamino"
    "trifluoromethyl" "trifluoromethylsulfonamide"
    "trifluoromethylsulfonamides" "trifluoromethylsulfonyl" "trimethylate"
    "triphosphate" "triphosphotases" "triple-helical" "triple-negative"
    "triple-transgenic" "trisphosphate" "trisubstituted-alcohol-containing"
    "trypsin-like" "tryptophan-X-X-phenylalanine" "ts" "tsO45" "tu" "tubal"
    "tube-forming" "tubo-ovarian" "tubule" "tubules" "tumo"
    "tumor-node-metastasis" "tumor-normal" "tumor-permissive" "tumor-promoting"
    "tumor-selectivity" "tumor-suppressive" "tumour-growth"
    "tumour-node-metastasis" "tumour-relevant" "tumour-suppressing"
    "tumour-suppressive" "tumour-suppressor" "tunica" "turn-over" "two-color"
    "two-hit" "two-hybrid" "two-member" "two-pore-domain" "two-sample"
    "two-site" "two-stage" "two-state" "two-step" "two-tailed" "two-thirds"
    "two-tiered" "two-way" "type-2" "type-II" "type 2α"
    "tyrosine-kinase-binding" "tyrosine-to-phenylalanine" "tyrosyl" "uORFs"
    "ubiquitination-defective" "ubiquitination-incompetent" "ubiquitine"
    "ubiquitine-ligase" "ubiquitin–proteasome-system" "udergo" "ueous" "ul"
    "ulators" "ultra-low" "ultrasonography" "ultrastructure"
    "ultraviolet-induced" "umor" "un" "unbridles" "uncharac" "uncoupler" "und"
    "undecamer" "under-expressed" "under-expression" "under-powered"
    "under-replicated" "undergoes" "undergone" "underpinnings" "undertaken"
    "undirect" "uni" "uni-directional" "univariate" "unresponsiveness" "untill"
    "untington" "up-front" "up-to-date" "upregulaton"
    "upstream-downstream–type" "uptake-deficient" "upto" "uracil-DNA" "uracils"
    "urea" "ureter" "urethra" "urothelium" "users" "ust" "uterine-specific"
    "utero" "utero-placental" "uveal" "v-Ki-Ras-transformed" "v-Ki-ras2" "vRNP"
    "vRNPs" "vaccina" "vacuole" "vaginalis" "vanadium" "vandeta" "vandeta-nib"
    "var" "variable-region" "vasculatures" "vasculitides" "vasculogenic-like"
    "vector-alone" "vehicle-treated" "venepuncture" "vera" "verruciformis"
    "vesicle-associated" "vesicles-rich" "vessel-like" "vide"
    "video-microscopy" "vii" "vii-ix" "villi" "vinte" "viral-host-environment"
    "viral-induced" "virally-encoded" "viremia" "virologists" "virotherapy"
    "virus-1" "virus-EphA2" "virus-like" "virus-treated" "vis-à-vis" "vitro"
    "viz" "vmiRNAs" "vol" "vs.1" "vs.GT" "water-insoluble" "water-soluble"
    "wavelet" "weak-FRET" "web-based" "webserver" "website" "well-adapted"
    "well-characterised" "well-conserved" "well-defined" "well-designed"
    "well-differentiated" "well-documented" "well-formed" "well-insulated"
    "well-matched" "well-moderate" "well-moderately" "well-ordered"
    "well-organized" "well-studied" "well-tolerated" "well-trained"
    "well-written" "western-blots" "western-blotting" "whereasGT" "whilep53"
    "whipple" "whole-animal" "whole-body" "whole-cell" "whole-exome"
    "whole-genome" "wide-spectrum" "wildtype-tumors" "wild‐type" "wilfordii"
    "winged-helix" "winged-helix-box-class-O3" "with-anolides" "withCtnnb1"
    "withE2-stimulated" "withGT" "withPR" "withdrawn" "within-physiological"
    "within-site" "wk" "work-up" "workers" "workflow" "workup" "world-wide"
    "written" "wt-FOXO3" "wtSlug" "x-E-x-x-aromatic" "x-Q-x-x-D" "x-ray"
    "xenopus" "ximelagatran" "xl" "yAPC1289-15" "yAPC1289-15R" "yAPC1289-20R1"
    "yAPC1404" "yAPC1466" "yAPC1466-15" "yAPC1728-15R" "yAPC777" "yAPCL"
    "yAPCL1090" "yAPCL1179" "yAPCL1241" "yAPCL1257" "yAPCL1390" "yAPCL1728"
    "yAPCL1728-15" "yAPCL1728-15R" "yap1801" "yap1802" "year-long" "year-old"
    "yetFbxw7" "ypoxia" "z-VAD" "z-stacks" "zVAD" "zeocin" "zinc-dependent"
    "zinc-mediated" "zona" "zymography" "×
10"
    "×1" "×10" "×100" "×2" "×B" "×FLAG" "×Flag" "×TOP-flash" "× 10" "× 100"
    "× 2" "áreas" "Δ-RING-TRIM32-MUT" "Δ0.02" "Δ0.58" "Δ1-110" "Δ11" "Δ294–439"
    "Δ2–123" "Δ314" "Δ367–439" "Δ393" "Δ410" "Δ431–490" "Δ542" "Δ580" "Δ6–185"
    "Δ959–1030" "ΔA" "ΔAF-2" "ΔATF3" "ΔC" "ΔCREB" "ΔCT" "ΔCt " "ΔE" "ΔEnv"
    "ΔF-FBXO28" "ΔFD" "ΔKD" "ΔMock" "ΔN" "ΔNES" "ΔNLS" "ΔNT" "ΔNp63" "ΔNp73"
    "ΔNp73α" "ΔOB" "ΔPEST" "ΔPQ" "ΔRING" "ΔRRM" "ΔSAM" "ΔXPol" "ΔXPolκ" "ΔYRL"
    "Δbromo" "Δc-term" "Δp53" "Δp85" "Δsit4" "Δψm" "ΨKX" "ΨKXE"
    "α-GFP-antibodies" "α-amino" "α-and" "α-cell" "α-cells" "α-corrected"
    "α-enolase" "α-helical" "α-helices" "α-helix" "α-hydroxylase" "α-ketoacid"
    "α-lactalbumin" "α-β" "α2β1" "α2β8" "α3" "α3β1" "α6" "α7" "αCD28" "αCD3"
    "αCDK4" "αCDK6" "αERKO" "αV" "αcyclinD3" "αp27" "β-Lap" "β-Lap-induced"
    "β-Lap-treated" "β-Lapachone" "β-Lapachone-induced" "β-ME" "β-carotene"
    "β-cat" "β-catM" "β-catenin-centric" "β-catenina" "β-form"
    "β-glycerophosphate" "β-helix" "β-lap" "β-lap-exposed" "β-lap-induced"
    "β-lap-resistant" "β-lap-resistant
231-NQ-cells"
    "β-lap-treated" "β-lapachone" "β-lapachone-induced" "β-microseminoprotein"
    "β-trcp" "β1" "β2-microglubulin" "β4" "β6" "β8" "βERKO" "βIII-tubulin"
    "γ-Tub" "γ-chain" "γ-globulin" "γ-irradiation" "γ-phosphate" "γ-radiation"
    "γ-rays" "γSI" "γc" "γhistone2AX" "δ-1" "δ-cells" "δ→MARCKS" "ε-amino"
    "ε-dependent" "κ-deficient" "κ-deleted" "κ-dependent" "κ-depleted"
    "κ-immunodepleted" "κ-knockout" "κ-like" "κ-proficient" "κB-luc"
    "λ-anti-terminator" "λN-peptide" "μCi" "μHC" "μg" "μg " "μg " "μl" "μl "
    "μmol" "σ1" "ψ-K-x-D" "ϕX174" "ᵧ-irradiation" "‘Hospicells’" "‘cistrome’"
    "‘ectodomains’" "‘hotspots’" "„central" "−141" "−200b" "−429" "−β" "≧31.2%"
    "ﬂavonoids"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-10201-10500*
  '("Brysk" "EFO-21/siKPNA2#1cells" "EFO-21/siKPNA2#1" "EFO-21/KPNA2" "HOSE"
    "karyopherins" "P =0.012" "pTXpY" "IW" "TV" "VT" "WQ" "VTIFV" "TPTWQ"
    "Denmark" "Lyngby" "NetPhos" "CCT007093"
    "premature dephosphorylation/inactivation" "10 Gy" "hexanucleotide"
    "seperate" "glucocorticoid-treated T-lymphomas" "T-lymphomas" "T-lymphoma"
    "non-inhibitory" "G 2 M" "subG 1" "rapalog" "Corcoran"
    "proliferation/viability" "T47DR" "MDA453R" "235/6" "240/4" "12-hour"
    "NU/NU" "IC 50 s" "IC 50" "surgically obtained excisional biopsies"
    "Elkabets" "Serial FNAs" "FNAs" "Ser 235/236" "LKBl" "PDK" "T 202 /Y 204"
    "#97" "#59" "S 240/244" "S 235/236" "MKC" "lipid/protein phosphatase"
    "CTCE" "Further, co-culture" "sig" "pFKHR" "Zonana" "Bannayan" "Cowden"
    "1x10" "200 ng/mL" "ΔCt " "HV" "FMG" "Sonvilla" "rhabdomyosarcomas"
    "exocrine" "anti-apoptotic/pro-apoptotic" "ZsGreen" "FGFRs" "mean ± SD"
    "1/100" "mesenchymal-like" "ataxis" "Parkinson" "Fingert" "ALIS" "DALIS"
    "KFERQ" "Microautophagy" "microautophagy" "rASB10" "Higher Pearson’s"
    "simpler" "K-linked" "sh177" "rASB10v3" "German" "Oregon" "Schlemm’s"
    "Schlemm" "IOP" "POAG" "aggresome-like" "amphisomes" "a Pearson’s"
    "Bitplane" "HTM" "meshwork" "1–3 µ" "±standard" "CD1c+" "systemic p38i"
    "heatshock" "venepuncture" "TDL" "undetectable baseline secretion, p38i"
    "RskS380" "Poly I:C/R848" "MEKi" "p38 is" "BIRB0796" "plasmacytoid"
    "immunotherapies" "moDCs" "myDCs" "adoptive immunotherapy" "p38i" "myDC"
    "co-cultures" "p  = 0.45" "n  = 8" "mean ± standard" "1–3 µ" "toll-like"
    "NHBLI" "PolyPhen-2" "Tribolium" "hTERTs" "Sauerwald" "co-assembled"
    "A202T" "Zhong" "3×FLAG" "×FLAG" "RRL" "retrotransposon" "RRLs"
    "Heterozygotes" "congenita" "= 55" "∼5%" "Non-synonymous" "Gifford"
    "Unfavorable Histology" "2/8" "30/38" "karyorrhexis" "42/48" "P=0.0029"
    "=39" "-non-amplified" "2/43" "INSS" "1pLOH" "≥18 months"
    "synthesis/accumulation" "INPC" "a unique subtype" "-Non-Amplified" "MKI"
    "Karyorrhexis" "NBUD" "=0.0022" "N=10" "=0.0084" "N=15" "N=8"
    "Non-Amplified" "hyperparameters" "the freely available R package BhGLM"
    "multimarker" "hydroxytryptamine" "melanocortin" "rs35682" "rs1745837"
    "BhGLM" "rs4969170" "Y5R1c52" "rs2268641" "rs912127" "rs4481204"
    "rs1946816" "rs5030980" "untill" "NYHP" "Chung" "rs35683"
    "simultaneously model multiple SNPs" "AGRP" "BMIs" "York" "~23%" "GLI1ΔNES"
    "GLI1ΔNLS" "ΔNES" "semi-quantitative real-time PCR" "Δp85" "puro" "pBabe"
    "/glycogen synthase kinase-3β" "non-classical" "~ 50%" "CBB" "Namoline"
    "monoamine" "/M" "opening/closing" "nanosecond" "H3K4m2" "siLSD#2"
    "Broders" "Xiangya" "CDH-2" "SNAG" "anti-sense" "tSNARE" "AP-1B" "Avl9p"
    "Yap1802p" "Snc1/2p" "SEC4" "0–1 µ" "Qbc" "Sec9p" "Snc2-M2p" "tSNAREs"
    "liposomes" "Liposomes" "Sso1p" "Nyv1p" "SNARES" "Qb" "Qa" "GST-Sso2p"
    "GST-Sec22p" "Snc1/2" "snc" "SNC2" "SNC1" "snc1" "snc2" "Sec5-3xGFP" "Chc1"
    "yap1801" "yap1802" "Importantly, both chc1" "Sec15-3xGFP" "YHL017W"
    "disassemble" "auxillin" "Swa2p" "Ldb17p" "apm4" "chc1" "Snc1p" "sec4-8"
    "Sec4p" "Exo70p" "Sec3p" "Exo84p" "Sec10p" "Sec8p" "Sec5p" "prebud"
    "CATCHR" "quatrefoil" "liposome" "Sec6p" "Snc2p" "Snc" "OsO 4" "anti-His"
    "3p" "60A" "= 13 µ" "= 18 µ" "Ku70/80" "PI3KKs" "pTopBP1" "Thr1989" "ABCDE"
    "PQR" "PIKKs" "pG68" "pRPA32" "phosphosignals" "SpeI" "gDNA" "ds/ssDNA"
    "RAD3" "replication-born DSBs" "yield replication-associated DSBs"
    "100,000 g" "Ser1981" "3 B" "2 B" "Switzerland" "Basel" "Novartis"
    "Visudyne" "Δ393" "TAZS89A" "YAP5SA" "shTAZ" "shCTL" "shYAP" "dermato"
    "TEADs" "hepatocarcinomas" "Mst1/2" "YAP/TAZ" "YAP1/2" "2–3 " "×
10"
    "5 ×
10"
    "anti-phospho" "=29" "Broader" "non-β-cell" "vs. 1" "1-AKP+insulin+GLP-1"
    "non- β-cell" "cells/tissue" "BrdU+" "Ins+" "1-AKP+insulin"
    "1-AKP+insulin+glucagon-like peptide-1" "AKP" "WB"
    "cyclin-dependent kinase 4/6" "mitogen/s" "threnine"
    "replacement/transplantation" "n = 4" "5-Bromo-2" "Cip/Kip" "McConnell"
    "intra-" "HFSN1" "p16-/-" "p16+/+" "Sharpless"
    "absent (U2OS), very low (EH2), normal-like" "normal-like" "EH2"
    "interaction/regulation" "non-autonomous" "Cueva" "AUF1-" "AUF"
    "non-cancerous" "a 2N" "Second, only two polymorphisms" "unresponsiveness"
    "Onouchi" "echocardiography" "re-administration" "non-responders" "Kuo"
    "Shimizu" "intravenous immunoglobulin (IVIG)"
    "different ethnic population, genetic polymorphisms" "dilatation/ectasia"
    "aneurysm" "rs113420705" "rs28493229" "IVIG" "anti-inflammation" "48±18"
    "20/559" "ISKS" "LFS/LFL" "10/17" "Chompret" "BRCA1/ 2" "= 9" "= 4"
    "allograft" "p=0.013" "mortality/RRT" "non-CC" "RRT" "vasculitides (AAV)"
    "vasculitides" "Secondary endpoints" "the composite endpoint" "rs4730751"
    "Birmingham" "AAV" "14/23" "p≤0.05" "p=0.007" "nanoscale" "QDs" "erlotiinb"
    "teniacide" "i.e . T790M" "™eg2" "BUN" "20mg/kg/d" "40mg/kg/d" "IHF" "QD"
    "HCC827/ER" "PTPMeg2" "InStat 3" "Nu/Nu" "mean ± SD" "TCA -3" "tions"
    "modifica" "transwells" "shCtrl" "shSAFB1" "p21/Cip1" "Deazaneplanocin"
    "trimethylate" "ACPP" "nonmeta" "boxplots" "medicalgenome" "GENT"
    "MST1/Hippo" "= 18" "G 0 /G 1" "H4K20" "= 0.0023" "the DN-associated SNPs"
    "rs1005346" "Leiden" "rs1001581" "The most significant SNP" "DN/nevi"
    "rs25487" "genotyped/imputed" "rs2079147" "the most significant SNPs" "CMM"
    "≥ 50" "non-carriers" "P =0.0003" "Accordingly, discrepant" "Ikeda"
    "Yamada" "bronchoscopy" "Dahse" "ng/μl" "intrabronchial forceps biopsy"
    "forceps" "Togashii" "Warsaw" "Poznan" "Lublin" "pulsatile" "McCray"
    "Munfus" "delE746-A750" "n  " "IASLC" "= 9" "= 0" "3/6" "= 2" "p  = 0.12"
    "= 6" "p  = 0.014" "a bound Fe/S" "dimeric subcomplexes" "subcomplexes"
    "1-like" "MudPIT" "muCIA2A" "muCIA2A-myc" "CIA2A-" "CIA2B-" "CIA"
    "undecamer" "CIA2A" "CIA2" "-dihydrothymine" "dihydrothymine" "FMN"
    "autoradiography" "REMSA" "mtAco" "holoform" "apoform" "cytAco"
    "the pooled siRNAs, quantitative real-time PCR" "muCIA" "CIA2A,"
    "ferredoxin" "Cia2" "diflavin" "NTPases" "4Fe-4S" "sulfide" "ISC" "Fe/S"
    "CARNS" "8-oxo-guanine" "NKX3" "10 Gy" "Δ431–490" "ATM-2" "pP53" "siLuc"
    "LMI" "anti-digoxigenin" "Luu" "proto" "chrRCCs" "Gupta" "Memeo" "Mazal"
    "Somers" "/CEP" "Furhman" "Pairwise" "distal tubules" "Fuhrman"
    "the distal tubules" "hindbrain" "chrRCC" "10q" "TW" "Glycotope" "Karsten"
    "Uwe" "rbiology" "tumo" "mPankoMab" "Khodarev" "Niu" "uni-" "Knowles"
    "Bassarova" "Pekar" "auhors" "Boyages" "Vlastots" "collectivegroup"
    "Wallis" "multicentric/multifocal" "Munich" "p = 0.038" "p = 0.005"
    "p = 0.004" "10-year" "p = 0.037" "= 0.068" "= 1.0" "p = 0.003" "p = 0.024"
    "non-isogenic" "WTor" "CD-FBS" "FOXO1/3" "charcoal/dextran (CD)" "FOXO 1/3"
    "WTcells" "IC50" "2ng/ml" "cells/ well" "M210B4" "Naka" "active BCR-ABL1"
    "Surprisingly, shKIT" "Y202/204" "Mo7ep210" "6-week" "PPY-A+SCF-block"
    "a composite readout" "~49%" "Additionally, BAW667" "shKIT" "pCRKL" "pKIT"
    "BAW667" "non-BCR-ABL1" "BCR-ABL1/KIT" "Co-treatment" "~45%" "+200" "BstYI"
    "the public cancer microarray database ONCOMINE" "ONCOMINE" "LNCaP/shNS"
    "shNS" "shCCAR1" "CoIP" "10.1038/ncomms3218" "doi" "Wnt/β-catenin"
    "dysplastic macronodules" "cirrhotic macronodules"
    "cirrhotic preneoplastic macronodules" "20 cirrhotic macronodules"
    "non-mutated" "non-related" "mTerc" "Nault"
    "human hepatocellular carcinomas (59%), cirrhotic preneoplastic macronodules"
    "macronodules" "P =0.004" "P =0.0007" "P =0.01" "coronary stents" "stent"
    "40-O-hydroxyethyl-derivative" "newer" "tacrolimus" "mg/kg/day"
    "FKBP12/12.6" "myocardium" "EBA" "ryan" "pearson" "pPKCα"
    "SRL-treated HAECs" "HAECs" "p120-VE" "EBAE" "Evans" "HAEC" "edema"
    "stents" "APBT2" "APBT6" "cytologic atypia" "papillae"
    "transitional epithelium" "deeper" "underwent pulmonary metastectomy"
    "3/18" "8/19" "11/19" "15/18" "metastectomy" "P =0.014" "P =0.028" "=0.022"
    "n =6" "n =5" "=17" "P =0.015" "P =0.017" "P =0.21" "8/11" "head-to-head"
    "4/29" "n =2" "n =4" "=16" "P =0.0001"
    "the diagnostic surgical pathology workup" "workup" "~2%" "6–7" "non-ROS1"
    "solid-predominant histology" "followup"
    "nonneoplastic alveolar epithelium" "breakapart" "ACAs" "D4D6" "p=0.05"
    "Feng" "ZL" "AX" "clinically treated biopsy" "mTORC1/C2"
    "18.4% or 11.7% even at 5 Gy" "mTORC1/2" "miR-99b" "radioresistant" "n =10"
    "× 100" "G0/G1" "AJC" "ZO-1/2" "RAPGAP" "Rap1a/b"
    "enhanced perijunctional pMLC" "pMLC" "IEC" "PDZ-GEF1/2"
    "Supplemental Figure S2B" "IECs" "σ1_G381A" "SKCO-15" "SKCO" "_G381A"
    "monolayers" "σ1" "ZO" "adherens" "nonmuscle" "Δ Ct" "1H" "intermembrane"
    "uncoupler" "-chlorophenyl" "chlorophenyl" "PREVSP" "TargetP" "CMTMRos"
    "MitoTracker" "W437X" "KDD" "preimmune" "S4B" "-diphenyltetrazolium"
    "pPAK1 S" "RDVATSPI" "GeneCards" "PAK1 S223" "n = 8" "nu/nu" "CCTNs"
    "organoid" "RFLP" "non-lesional" "Blaschko" "CCTN" "Biesecker" "Lindhurst"
    "4EGI-1" "4EASO" "H2009" "factor 4F" "Igfr" "rous" "glucosaminoglycan"
    "Bryan" "nontarget" "Griess" "12-month" "NQO1+
cells"
    "β-lap-treated NQO1+ cells" "NQO1+ cells" "β-lap-resistant
231-NQ-cells"
    "β-lap-exposed 231-NQ+ cells" "β-lap-resistant 231-NQ-cells"
    "Exogenous co-administration" "β-lap-treated 231-NQ-cells"
    "Similarly, exogenous catalase (≥500 U) significantly protected
231-NQ+cells"
    "NQO1+MCF-7 cells" "Biosystems" "Mn" "231-NQ+cells" "strong TUNEL+"
    "incremental
increases to 2–3 µmol/L"
    "DOX" "231-NQ+ cells" "oxidoreductions" "231-NQ-cells" "231-NQ-" "231-NQ+"
    "oligomycin" "·−" "TUNEL+" "killed ≥50" "NQO1+" "mol/L" "DNQ"
    "Deoxynyboquinone" "NAD+/ATP" "supra-lethal, non-achievable"
    "non-achievable" "N-nitrosoguanidine" "nitrosoguanidine" "-nitro"
    "polymerase-1" "lapachone" "NAD(P)H:quinone
oxidoreductase"
    "Lapachone" "≥2
µ"
    "LD 50" "non-responsive" "co-treatments" "co-addition" "≥2 µ" "JYS" "JYJ"
    "Oh" "DPO" "Taqman" "pT1/T2" "pT3/T4" "PCR" "LOD" "p = 0.001" "p = 0.007"
    "SMJ" "V-HA-RAS rat sarcoma viral oncogene homolog"
    "V-RAF-1 murine leukemia viral oncogene homolog"
    "V-AKT murine thymoma viral oncogene homolog" "Dipeptidyl"
    "Glucagon-like peptide-1" "pri" "Hoppe" "milk-derived BCAAs" "Milk´s"
    "dihydrolipoamide" "BCKD" "ketoacid" "BAT" "milk-derived miR-29a"
    "most easily hydrolysed BCAAs" "birthweights" "neonate´s" "forbidden" "MIR"
    "Intestinal cells release exosomes" "exosomes" "exosome" "colostrum"
    "miR-26a"
    "miR-21 (24,137), miR-99a (24,097), miR-148a (16,597), miR-30d (14,089), miR-200c (11,010), miR-26b"
    "miR-99a" "miR-148a" "miR-30d" "miR-26b" "d" "eukaryocytes"
    "enteroendocrine" "IGF-1-signaling" "Edwards" "entero" "dipeptidyl"
    "the intestinal incretin glucagon-like peptide-1" "incretin" "BCAAs"
    "milk´s" "Cow´s" "cow´s" "´s" "glucagon-like peptide-1" "materno"
    "insulin/IGF-1" "UPA" "amplicon" "17q" "Δ Np73-transfected" "Δ Np73-"
    "siRNA+pcDNA3.1+Myc" "Y39F/Y50F" "Hong"
    "cell proliferation, migration, soft agar" "P =0.009" "α / β" "Tax-2"
    "CDK4-cyclin D3-p21-Tax" "Rat/ LV" "Rat/LV" "Ac/P" "anti-AcK" "anti-Tax"
    "the isoelectric pH" "TEV" "PBM" "Scribbe" "HDAC5/7" "1 × 10"
    "Anti-phospho" "2 × 10" "p21 was" "VBR" "Proteolipid" "Littermates"
    "Nerve/glial" "Adenomatous polyposis coli" "Hmatoxylin" "Immunoglobulin"
    "cytoplamic/membrane" "Patel" "Gottle"
    "neuronal precursors, axon guidance/pathfinding"
    "axon guidance/pathfinding" "a highly efficacious chemoattractant" "Basso"
    "neuropathology" "immunohistochemical stainings" "stainings"
    "recently, using XPro1595" "XPro1595" "GSE46695"
    "using three biological replicates" "2-mm" "basso" "OPCs" "proteolipid"
    "SCI" "neurotrauma" "P = 0.038" "P = 0.04" "in 1X" "several- micro-second"
    "andDrosophila" "symmetricDrosophilaEGFR" "long-time" "ectdomain"
    "microsecond" "Brunger" "Axel" "rotamer" "EGF-like" "ligand-bound dEGFR"
    "IVs" "all ligand-free, inactive ectodomains" "‘ectodomains’" "DOI"
    "Arkhipov" "eLife" "dEGFR" "Cα" "-CTT-54.2" "= 0.55" "Rho kinase1"
    "PhosphoNET" "Kinexus" "KXXS" "KXS" "siCont" "shROCK1" "shROCK1#1" "shCont"
    "dequenched DQ-BSA labeled vesicles co-localizing" "siROCK" "punctae"
    "LC3II" "HBSS" "KC3" "outgrown" "n = 5" "n = 6" "Protein A/G"
    "co-localizing" "non-treated" "autogenes" "HFD" "mild NAFLD" "AM/PI"
    "droplets" "reticulophagy" "NAFLD" "1.35–1.69" "ECCC" "1.47-1.64"
    "OR =1.33" "AG+" "six studies, ethnic-specific ORs" "1.21–1.45" "OR=1.33"
    "Neither Begg’s" "+AG" "1.15-1.39" "Henan" "Shanxi" "Abnet" "GWS"
    "a nonsynonymous SNP" "MEDLINE" "AG/GG" "= 0.50" "= 10" "P = 0.007" "=83"
    "= 30" "P =0.049" "=1.21" "= 0.022" "P = 0.024" "= 1.03" "= 1.22" "= 47"
    "A5780G" "=1.33" "= 1" "non-amplified" "collectives" "derivates"
    "non-intestinal" "CEP17" "or 2+" "immunoscore" "Ruschoff" "Hofmann"
    "p=0.014" "FDA/EMEA" "p=0.802" "p=0.004" "Lauren" "EMEA" "disome"
    "expression/amplification" "Laurens" "immunoreactivity/expression" "gastro"
    "co-regulation" "p=0.024" "and 3+" "=0.014" "=0.004" "Ets1-bound NCOAs"
    "A/B/C" "pCDNA" "NCOAs" "Optimem" "control/estradiol" "/day"
    "non-estradiol" "function-2" "LXXLL" "NCOA" "n = 10" "Cyclin B1 protein"
    "scatterplot" "14q32" "p=0.42" "ueous" "CellTiter" "= -0.31" "n=30" "n=103"
    "=34" "n=35" "=30" "=103" "computational algorithms" "messengerRNAs"
    "MicoRNAs" "=23" "n=40" "=35" "siRPS20" "siRPS15" "siRPL37" "siRPL11"
    "p53 C" "Morrison" "catalyses" "ADHWDSKNVSCKNC" "2B" "Rac1 GTP" "Rac1V12G"
    "pNPM1" "73±13.8%" "Rac1Q61L" "proline-rich-" "RhoG" "Nucleo"
    "inactive RhoGTPases" "nucleophosmin1" "GEF-mediated" "n = 15"
    "protein phosphatase 2A" "thiamine" "S-transferases (GST)" "OMM" "G6P"
    "viz" "adeno" "≤0.05" "Adeno" "HK" "6P" "1×1" "pcDNA 3" "1p/19q" "anti-HCV"
    "Kawate" "Hoshida" "the biological subclasses" "Shimada" "≤12" "and 3-year"
    "3-year" "Steiner" "Edmonson" "8q24/CEP8" "48/65"
    "Extralesional parenchyma" "Clinico" "8q24" "polysomy" "fetoprotein" "alfa"
    "from 1.8" "=0.020" "sensitivity analysis, Begger’s" "Begger" "coauthors"
    "Mytl" "Egger  " "Begg  " "CC+GC" "Indians" "Malays" "Naidu" "Segat"
    "rs2233682" "rs2233679" "rs2233678" "Ser/Thr-Pro" "= 1" "p = 0.02" "Misale"
    "losts" "CADMA" "amplicons" "30∼80%" "DNA/percentage" "ul" "mg/m 2"
    "P = 0.038" "1/8" "executer" "pathobiology" "protooncogenes"
    "viral genes/oncogenes" "active pSTAT3" "phosphotidyl" "flowcytometry"
    "E6/E7" "photomicrographs" "equi" "expression/accumulation"
    "viral oncoprotein E6 & E7" "pSTAT3/STAT3" "20/30"
    "constitutively active pSTAT3" "viral oncogenes E6 & E7" "& E7" "upto"
    "12 h" "non- overlapping" "Interestingly, co-transfection" "Vs" "Yang-1"
    "MMCLs" "anti-Rabbit" "proepicardium" "epicardium" "neointima" "Epicardin"
    "Capsulin" "Interestingly, rs12524865" "HALST" "+KTS" "Frasier" "−KTS"
    "KTS" "WTE" "heterozygous HCASMC" "rs12190827" "C/G" "TaqMan" "ASE" "CASMC"
    "ΔJun" "fsk" "adenylyl" "AP-1-like" "rs12192087" "RASM" "HCASM" "TGACTTCA"
    "TFSearch" "PROMO" "JUND" "TFBS"
    "FAIRE-seq (Formaldehyde-Assisted Isolation of Regulatory Elements)"
    "HCASMC" "FAIRE-seq" "seq" "FAIRE" "DNaseI" "ENCylopedia" "eSNPS" "eSNPs"
    "Metabochip" "workflow" "rs12524865" "haploChIP" "PEO" "6q23.2"
    "rs12190287" "Log2" "−7" "= 1.87" "∼20-fold" "and 3q13.3" "non-fragile"
    "MRN" "approximately 1.85 kb/min" "kb/min" "Barr" "Eptsein" "JEFF"
    "lymphoblastoid" "under-replicated CFSs" "CFSs" "ESCRTs" "ESCRT"
    "residue/s" "Epsin 15" "nonLR" "EphR" "non-c-Cbl" "Fiure"
    "using anti-EphA2 antibody, strong co-IP" "–TKB" "ΔSAM" "ΔKD" "P4D1" "≥90%"
    "pPI" "pFAK" "ed" "Epsin15" "pixel" "intergrin" "β6" "Un" "LRs"
    "viral capsid" "multi-centric Castleman's" "Castleman" "non-LR" "Kaposi's"
    "IIA" "α3β1" "HFF" "LR" "Anti-rabbit" "≥80" "CD34 +" "Luo" "Ugi" "FdUrd"
    "thymineless" "TOPOIIα" "IIα" "withdrawn" "dTMPs" "dU" "CldU" "66 shUNG"
    "NODSCID" "shUNG" "siUNG" "GARFT" "formyl" "glycinamide" "re-sensitize"
    "p = 0.047" "= 0.71" "n=4" "MBC" "doxorubin" "CALB" "VMBC" "3 +" "and 2 +"
    "p = 0.009" "p = 0.031" "p = 0.027" "p = 0.32" "p = 0.006" "p = 0.066"
    "a healthy mucosa" "Knapp" "noncancerous endometrium"
    "transcripts/proteins" "ASTEC" "1+" "BMI" "adnexa" "parametrium" "serosa"
    "endometria" "P  = 0.007" "w / v" "FosL" "thanp53" "Activating Protein -1"
    "Rugowski" "top53" "fromp53" "picrosirius" "K8+" "histotype" "PRL/" "FVB/N"
    "hemangiosarcomas" "histotypes" "p=0.16" "epithelial-to-mesenchymal"
    "p=0.06" "=0.024" "Mcl1jh" "und" "recognition/degradation" "caspase 3/8"
    "CH11" "FASL-" "tetBim-EYFP-Mcl1L" "Toumi" "Wuillème" "tetNoxa-EYFP-"
    "tetNoxa-ECFP-Mcl1L" "ubiquitine" "doxycyline" "EYFP-" "SH-EP/Mcl1L"
    "Ser159/Thr163" "snMcl1" "nother" "ust" "Mcl1ES" "BclxS" "Mcl1s"
    "polyubiquitine" "Importantly, Mcl1L delGly158-Asp172" "delGly158-Asp172"
    "Mcl1L" "leukemia-1" "VFW" "Aryankalayil" "−141" "−429" "Kase"
    "Histopathology" "miR-200b" "euclidean" "mir" "ARVO" "IOVS" "ophthalmology"
    "ingrowth" "conjunctiva" "≥ 2" "P =0.02" "P =0.007" "uni" "perturbance"
    "auto-poly" "K203/486R" "R122/138A," "Duplexes"
    "F1 + F2 or make strong non-covalent" "cruciforms" "minimise" "ation" "Ryu"
    "interdomain" "ΨKX" "ds" "Non-covalent" "S4A" "2  + " "1 H" "2 H" "5 × 10"
    "2 h" "μg " "LJJ" "ZLZ" "JXZ" "HXL" "JYL" "diaminobenzidine" "cystectomy"
    "monolayer" "bodyweight" "covariate"
    "2 and 3 tumors ( P = 0.005 and 0.046, respectively, Figure  xref , Table  xref ), pT1 ( P = 0.013), pT2-4"
    "pT2-4" "representativeness"
    "this study, quantitative real-time polymerase chain reaction (qRT-PCR), western blotting, immunohistochemistry (IHC)"
    "immunohistochemistry (IHC)" "phosphorprotein" "clinical/prognostic" "pTNM"
    "the most common histological subtype" "pT" "pN-" "pN" "113/213" "6/86"
    "Spearman’s" "UCBs" "UCB" "= 64" "P = 0.028" "P = 0.003" "= 0.004"
    "P = 0.046" "P = 0.005" "Muredach" "Ingrid" "CCW" "QW" "BGK" "TY" "JFF"
    "LQ" "LRY" "KFK" "LFB" "JIR" "TBH" "JGW" "CJO" "WSP" "JFP" "JJC" "DHO"
    "SRH" "XG" "THM" "NDW" "ARIC" "JHS" "the smaller haplotype" "Europeans"
    "FamHS" "rs7768030" "megabases" "approximately 20 SNPs"
    "top genome-wide significant SNPs"
    "all previously reported suggestive SNPs" "our 67 most significant SNPs"
    "website" "suggestive AA SNPs" "SimpleM" "QQ" "GENOA" "CARDIA"
    "the largest AA CAC dataset" "angiography" "rs16905644" "9p21"
    "Americans (AA)" "non-genetic" "n = 5" "≥ 50" "= 1" "~2.5" "+ 1" "HTC116"
    "CXXC" "H3R2" "enhancer/promoter" "Tetrahymena" "mononucleosomes" "H2Bub"
    "H3K18ac" "H3K18" "succinimidyl" "dithiobis" "lysine-to-arginine"
    "SET1C/SAM" "p300/acetyl" "IBiD" "MLL3/4C" "Δbromo" "MLL3/4" "H4KR" "H3KR"
    "H3K4Q" "SET1C-mediated" "octamers" "SET1C-Mediated" "COMPASS/Set1C"
    "SET1C" ": A" "hSET1" "~10-fold" "Swiss" "Meanwhile, X1 pm" "LL360/361DD"
    "PARGi" "siPARG" "Keil" "Induna" "UVC" "UVDE" "X1w/oBII" "methylmethane"
    "sulfonate" "apraxia" "LigIIIα" "Polβ" "IIIα" "LigI" "duplex DNA, DSBs"
    "SSBR" "polyADP" "pm" "BRCTII" "n  = 10" "PRIDE" "ProteomeXchange"
    "retinamide" "Innes"
    "Protein Interaction Network Analysis (PINA), Agile Protein Interaction DataAnalyzer (APID)"
    "DataAnalyzer (APID)" "APID" "DataAnalyzer" "PINA" "Replicate"
    "The neutral antagonist BMS" "BMS" "homogenates" "TOF" "nLC" "Omics" "BCAR"
    "Musgroove" "Johansson" "alpha-positive" "μl " "n =8" "I–III" "non-target"
    "=1.0" "=1.3" "anti-tumour" "Bhakat" "crista" "delta-mtDNA" "ALLM" "OXPHOS"
    "7,8-dihydro-8-oxoguanine" "oxoG" "1–3 " "protein A/G" "ANTI-FLAG" "2DG"
    "2 h" "Rustom" "Arkwright" "Davis" "Sowinski" "mono-palmitoylation"
    "GFP-H-RasG12V" "C181S/C184S" "farnesyl" "GFP-H-RasG12V-labeled"
    "submicron" "nm/s" "B721.221-GFP-H-RasG12V" "Tek" "B/T" "anti-GM130"
    "re-treatment" "re-challenged" "corticosteroids" "CALYPSO"
    "carboplatin/olaparib" "Nonsignificant" "neutropenia" "ICU" "CTCAE"
    "sequelae" "BRCAPro" "dyspnea" "tachycardia" "erythroderma" "P =0.0002"
    "P =0.005" "P =0.003" "robust responders" "Voss" "monophophate" "crossover"
    "rapalouge" "LLN" "ULN" "Karnofsky" "Rapalogues" "rapaloges" "rapamcyin"
    "kinasee" "phophatidylinositol" "rapalogues" "E-dependent" "Zhiliang"
    "Benfu" "Xiao" "Bingxiang" "S1E" "U251cell lines" "theharrest" "inhibites"
    "pEGFP" "Lipofectamine" "G1/G0" "14q32.31" "multiforme (GBM)" "multiforme"
    "S1D" "G1/G" "1 h" "MILLIPLEX" "SKF" "immunoassay" "microdomains (PAG)"
    "microdomains" "Cbp\\PAG" "Anti-Lyn" "\\PAG" "PKCβII" "anti-phospho-c-Met"
    "anti-phospho-Src" "Milliplex" "luminex" "diphthotoxin" "CRM" "TAPI" "Calu"
    "H1975" "PKCßII" "B-lymphomas" "Non-Targeting" "I/II/III" "T3/T4" "T1/T2"
    "P = 0.023" "P = 0.015" "moderate/poor" "PhosphoGRID" "Sap190p" "Sap185p"
    "Sap155p" "Sap4p" "siPP" "cisternae" "BFA"
    "a second siRNAi duplex, siPP6-07" "siRNAi" "tsO45"
    "a second siRNA duplex, siPP6-07" "siPP6-07" "siPP6-08" "TRAPPII" "CKIδ"
    "CK1δ" "cofractionate" "SIT4" "Ruohola" "vacuole" "mCPY" "CPY" "-ProMix"
    "ProMix" "hrr25-5" "-Hrr25p" "Sec13p" "-Sit4p" "hexahistidine" "Pph21p"
    "Sec31p" "Lst1p" "Sec24p" "Glc7p" "ts" "phosphatome" "ER-to-Golgi" "Ypt1p"
    "TRAPPI" "Sec23p" "Sec13p-Sec31p" "anterograde" "Sit4p" "Hrr25p"
    "Sec23p-Sec24p" "Sar1p" "COPII" "Anti-mouse" "S1C" "facto"
    "ischemia-reperfusion injury, immune system disorders, liver disease, diabetes, obesity, atherosclerosis, Alzheimer’s"
    "biomolecules" "ML171" "v12" "co-knockdown" "Acethylphenothiazine"
    "diphenylene" "flavoenzyme" "morpholinos" "pentafluorobenzenesulphonyl"
    "kd" "NTB" "nitrotetrazolium" "the red fluorescent compound oxyethidium"
    "oxyethidium" "dihydroethidium" "dichlorodihydrofluorescein" "re-entry"
    "6q21" "breakpoints" "Daugaard" "Hace" "1 h" "μg " "re-expressing" "D-type"
    "Ole" "Manganaro" "neutral hydroxyl" "‑phosphate" "Krüppel" "nonhistone"
    "non-covalent" "257IKVV260" "ψ-K-x-D/E" "polyproteins" "N-end"
    "A subsequent study undertaken" "recognin" "‑substrate" "Mousnier" "32-kD"
    "‑derived Growth factor" "Epithelium" "anti-parallel" "/I" "4IBV" "H-bonds"
    "R273C/S240R," "R273C/T284R," "tetranucleotides" "R273C/S240R" "R273H/T284"
    "non-esterified" "R273C/T284R" "R273H/S240R" "guanidinum" "cGGGCATGCCCg"
    "dodecamer" "R273H/T284R," "non-physiological" "entropy" "enthalpy" "Zn"
    "‘hotspots’"
    "our previously studied wild-type (wt) p53-DNA complexes showing non-canonical Hoogsteen A/T"
    "A/T" "Watson" "Hoogsteen" "YFPc" "YFPn" "anti-phosphoAkt" "HTC75"
    "telosome/shelterin" "the reporter survive," "inconclusive," "untington"
    "BSR" "mCMV" "a clear phenotypic readout" "NF-κB1" "1:10,000" "MHC-1"
    "Zalaudek" "NRAF" "Lentiginous/epitheloid" "lentiginous/epitheloid"
    "p=0.63" "n=6" "n=2" "Wilcoxon" "=13" "Codon" "n=5" "=1" "acral" "Breslow"
    "interobserver" "Clark" "the mutated BRAF V600E -protein" "V600E -protein"
    "concordant cases immunohistochemistry" "VE1" "=0.028" "p=0.023" "n=12"
    "autocrine/paracrine" "both global genome" "the smaller," "sharpest"
    "hour post UV-irradiation," "co-imported" "UV-irradiation ( xref ),"
    "G-agarose" "-α7" "α7" "α4" "-α5" "-α3" "Importin-α7" "Importin-α4"
    "His-V5-XPA" "UV," "XPA-ΔNLS" "NLS-like" "-RKRQR-" "bulky DNA adducts"
    "UV-irradiation," "importin-α4" "importin-α7" "pentaspan" "mesoderm" "ARPC"
    "RPTEC" "gARPC" "tARPC"
    "the CD106 (Vascular Cell Adhesion Molecule 1, VCAM1) expression ( xref ),"
    "tARPCs" "gARPCs" "glomeruli" "interstitium" "adipocyte-like" "nephrology"
    "stemness" "miR-1225-5p" "RPTECs" "ARPCs" "RNA22" "S8B" "S2B" "S2A"
    "neuronal-like" "Hyper" "E616del" "missesne" "pSTAT3" "pLEX" "TAA" "Lohr"
    "STAT3α" "STAT3β" "n = 40" "withGT" "allelesGT" "consideredGT" "ofGT"
    "betweenGT" "TheGT" "theGT" "≥15" "≤14" "Hu" "= 1.16–1.65" "inGT"
    "includingGT" "vs.GT" "= 1.22–1.71" "CNKI" "whereasGT" "andGT" "thatGT"
    "Wanfang" "ISI" "DENND1B" "=  0.068" "p = 0.08" "= 0.068" "= 1.47" "= 1.16"
    "= 1.38" "= 1.22" "siRNALKB"
    "69 (92.0%), 58 (77.3%), 65 (86.7%), 50 (66.7%)," "nmol/L" "cytoflow"
    "effets"
    "3-Keto-N-(aminoethyl-N'-aminocaproyldihydrocinnamoyl) cyclopamine (KAAD-cyclopamine),"
    "3-Keto-N-" "KAAD-cyclopamine" "KAAD" "-aminocaproyldihydrocinnamoyl"
    "aminocaproyldihydrocinnamoyl" "aminoethyl" "strong," "Wilson" "FGFR2-"
    "FGFR" "intraclass" "too stringent," "AEW541-" "AEW" "Greater" "AEW541"
    "broadest" "PCA" "RMAvalues" "multichip" "topologies" "S7D" "nonrandom"
    "CLR" "relatedness" "some metric," "SOS" "PTPN" "Biological replicates"
    "CV" "four biological replicates" "topology"
    "computational network inference algorithms" "≤0.25" "anorectum" "fossa"
    "ethmoid"
    "BRAF and NRAS mutations, respectively ( xref ; xref ; xref ; xref ),"
    "SNMMs" "SNMM" "μ g " "P =0.027" "Smirnoff" "mortem" "rs53576" "Freesurfer"
    "rs182455" "their basolateral amygdala" "STin2"
    "two previously studied SNPs" "HTTLPR" "Amygdala" "amygdala" "9/9" "=82"
    "highly concordant ( xref )," "Larsen" "Chimerism" "DLI" "logs/month"
    "chimerism" "-V617F-positive" "ΔCt" "=100" "NEQAS"
    "routine diagnostic purposes," "&MPNr-EuroNet" "LeukemiaNet"
    "thrombocythemia" "vera"
    "nine different DNA-based quantitative PCR (qPCR) assays,"
    "conditional p53 f/f" "interstrand" "BRCA1-deleted pMECs"
    "pleiotropic effects," "NRF2-driven transactivation," "," "COMMA" "siScr"
    "siBrca1" "p21/Cdkn1a" "p16/INK4A" "4-wk-old" "pMEC" "KLuc" "ETGE"
    "MaSCs/basal" "K14cre" "Bf/+" "the mammary gland epithelium" "f/+" "KB1"
    "pMECs" "shLUC" "−dox" "+dox" "dox" "anti–mouse" "anti–rabbit" "Anti–mouse"
    "F/R" "p16/" "/+ mice" "#4" "Gliadel" "_43" "Schmidt" "14E1" "repopulate"
    "regrow" "8/8" "EGFR1" "EGFRwt/EGFRvIII" "D270MG-D2C7-" "0.18–2.5" "1.6×10"
    "EGFRvIII-ECD-protein-coated" "Piscataway" "Biacore" "-PE38KDEL" "PE38KDEL"
    "Fv" "FR4" "Kabat" "dsFv" "IgG1κ" "Nus" "D2C7-" "D2C7" "L8A4" "anti-EGFRwt"
    "MR1-1" "exotoxin" "2–7" "the classical glioblastoma subtype" "EGFRwt-"
    "D2159MG" "D08-0493MG" "TheK" "D270MG" "KDEL" "scdsFv" "=4" "P =0.002"
    "P =0.006" "miRNA18a" "P=0.008" "pCMV" "miRNA 106a" "miRNA 18a" "Tommiska"
    "ATM—pS1981-ATM" "-106a" "106a" "18a" "P=0.001" "P=0.012" "= 11"
    "non-specificity" "Gotlieb" "FCA" "Hospicell" "microglubulin" "IIR" "gpl"
    "our laboratory and named ‘Hospicells’" "‘Hospicells’" "Hospicells"
    "Co-culture" "2 h" "co-cultured" "_R250K" "Betaine" "HCV/ethanol" "betaine"
    "FHRE-reporter" "FHRE" "MAPkinases" "phosphoantibodies" "cIEF"
    "methylarginine" "IEF" "+ 6" "Plex" "qMSP" "pCD" "colonic biopsies"
    "pControl" "pUC" "≥75%" "colonocytes" "non-steroidal" "n = 12" "NTW" "ANAM"
    "VDN" "LE" "LO" "Burga" "Willers" "IRIF" "Rebollo"
    "associated non-neoplastic normal breast epithelium" "Donnell" "Buisson"
    "Perez-Valles" "Milner" "Valles" "Bouin’s" "Bouin" "Bogdani" "7G2"
    "dot-like" "AP16" "immunohistology" "PDA" "PDAs" "6174delT" "185delAG"
    "Jews" "MS110" "5382insC" "SIRTs" "methyltranferases" "TTGTTTAC"
    "multilevel" "stellate" "Deng" "Recently van der Vos" "Vos" "VLDL"
    "translocation/retention" "hypoglycemia" "hemagiomas" "outs" "I:U"
    "Goutières" "Aicardi" "Shapira" "a subgenomic dengue virus replicon"
    "replicon" "interactant" "transdominant" "antigenome" "×Flag" "firsts"
    "Rico" "Puerto" "H1N1" "PAC" "König" "DRBDs" "DRBPs" "betweenness" "U-test"
    "VirHostNet" "PRKRA" "the respiratory epithelium" "DRBD"
    "strain-specific virus-host interactomes" "the public datasets"
    "nucleoproteins" "a comprehensive overview" "a global overview"
    "co-evolution" "1 h" "72 h" "2H" "Longley" "Rocchi" "LUTS" "Hoechst"
    "c-FLIP-1" "Hsp27-2" "postmitochondria" "1 :  10,000" "72 h" "priori"
    "Stransky" "subsite" "plekstrin" "2-year" "interquartile" "IQR" "IMRT"
    "carboplatinum" "cavity/sinus" "vis"
    "the oropharyngeal and sinonasal subsites" "subsites" "n = 3" "Furugaki"
    "Sugiura" "Petrelli" "axial" "chemoradiotherapy" "even pulmonary alveoli"
    "alveoli" "non-smoking" "risen" "= 4" "= 9" "= 15" "CD19+" "Schroder" "72h"
    "pSTAT6-" "HPRT" "at least four phenotypically different cellular subtypes"
    "STAT6VT" "siSTAT6" "siST6" "BCL6 long" "siCo" "BCL6+/pSTAT6+" "and12±1.5%"
    "pSTAT6+" "BCL6+" "cutouts" "Guiter" "the recurrent chromosome 9p" "BCL6−"
    "BCL" "pSTAT6−" "pSTAT6" "de-repression" "p =0.04" "p =0.05" "~46%"
    "receivingBach2 +/+" "IL7-dependentBach2 +/+" "-tg" "tg" "failsafe"
    "BCR-ABL1-" "BCR-ABL1" "6q15" "bivariate" "COG" "100,000/μl" "MRD"
    "dominant-negative PAX5-C20orf112" "ALLs" "1-3" "RTCGD" "amongBach2 +/+"
    "inBach2 +/+" "andBach2 +/+" "QChIP" "ofBach2 +/+" "μHC" "-DJ" "DJ" "GFP +"
    "~20%" "aberrance" "U2AF65-ISE" "7/8" "Tra2β" "ESEm" "ISEm"
    "further construct AR-V7 minigenes" "minigenes"
    "one exonic splicing enhancer (ESE)" "enhancer (ESE)"
    "One intronic splicing enhancer (ISE)" "enhancer (ISE)" "TMPSS2" "MDV"
    "LN95" "intronic splicing enhancers (ISE)" "enhancers (ISE)"
    "exonic splicing enhancers (ESE)" "enhancers (ESE)" "ISE" "ESE" "ss" "ARv"
    "ARvs" "3/3" "3b" "3B" "AdenoCre" "Testa" "JR" "S235/S236" "BWH" "p4EBP1"
    "S240/244" "theTsc1" "inTsc1" "Adenovirus-Cre-injectedTsc1" "S235/236"
    "AE1/AE3" "Immunohistochemistry (IHC)" "Necropsy" "cc"
    "the abdominal peritoneum" "harmartin" "vaginalis" "tunica" "pericardium"
    "peritoneum" "2 – 3" "Busser" "Siwak" "Panupinthu" "Amit" "Jeong" "Boerner"
    "Rodland" "#98" "Normanno" "Wu" "#84" "Jurchott" "#102" "#86" "Evdokimova"
    "Bergmann" "omentum" "2h" "TGFαrelease" "#103" "Lombardo" "Tice" "Ohta"
    "Snider" "Talavera" "Rusnak" "p44/42MAPK/p90RSK/YB-1" "Andreev"
    "p44/42MAPK/p90RSK" "Ericson" "Cherrin" "UPN" "Hirai" "RSK1/2" "p44/42MAPK"
    "#112" "#90" "Lu" "Eder" "LPARs" "1h" "#85" "#89"
    "two independent ovarian cancer datasets" "Tothill" "Bowtell" "Berquin"
    "Sutherland" "Stratford" "Yahata" "Kamura" "Basaki" "Lasham" "Yu" "Umezu"
    "Tabchy" "Okita" "Chetrit" "Clarke" "Siegel" "LPAR" "p = 0.15" "= 0.0059"
    "p = 0.03" "50 fold" "~70 %" "signaling/cell growth"
    "the predominant RCC subtype" "ccRCC" "upregulaton" "UOK101" "FoxO1/3"
    "AMP mimetic 5-aminoimidizole-4-carboxamide riboside (AICAR)"
    "riboside (AICAR)" "riboside" "L/L" "TTT" "p38β" "Tsc1/2"
    "non-phosphorylatable" "Sorrell" "degrons" "GKS3β" "CL1-5/wtSlug"
    "CL1-5/4SA" "trcp" "the nonphosphorylatable Slug-4SA" "Slug-4SA" "4SA"
    "refractile" "nonphosphorylatable Slug-4SA" "wtSlug" "spindle-like" "Ufd2p"
    "E4B" "quadrad" "~200-fold" "α3" "K11A" "T9A" "auto-" "pCBL" "TKBD"
    "isopeptide" "non-RING" "E2~Ub" "clinicaltrials" "Fogelman" "covariates"
    "p=0.15" "as 1+" "p=0.037" "p=0.04" "p=0.027" "p=0.006" "Samiri" "Vαβ"
    "revertant" "Burkett"
    "weakly virulent keratinocyte-tropic human beta-papillomavirus genotypes"
    "Y38X" "verruciformis" "Epidermodysplasia" "TCRαβ" "CD8αα" "ITAM-like"
    "had only mild T cell lymphopenia" "neutrophilia" "omphalitis" "TrioN"
    "WASP" "CaaL" "Formylmethionyl-Leucyl-Phenylalanine" "G-boxes"
    "triphosphotases" "non-functional" "Non-phosphorylated" "DN3"
    "stem / progenitor" "Ras-like" "NKGD2" "Richard" "Coley" "co-isolated"
    "R90K" "LQQAA" "co-purification" "co-isolate" "WXXF" "Weil" "Langevin"
    "Riviere" "deoxynucleoside" "uracils" "primate foamy retrovirus" "TARBP"
    "viral SRSs" "SRSs" "Tas" "SRS" "shorter 21–23 nucleotide duplexes"
    "armamentarium" "co-transfecting" "in 1x" "–7" "Let-7b" "miR-129-3p"
    "miR-449a" "HOXB8" "miR-196b" "umor" "MiR-135b" "miR-135b" "miR-135a"
    "at 5q32" "miR181a" "MiR181a" "miR-486-3p" "miRNAome" "let-7b" "miR-10a"
    "synergistic co-regulators" "A Spearman’s" "miR-130b" "miR-301b" "miR-106b"
    "DNF" "the Knudson’s" "Knudson" "Schwann" "clinically visible PNFs" "PNFs"
    "DNFs" "café-au-lait" "plexiform" "= 5" "P  = 0.003" "= 6" "co-regulators"
    "miR-18a" "miR-20a" "miR-19a" "immunologists" "biochemists" "virologists"
    "Saxena" "hacker" "AIPI" "co-stimulatory" "osteopenia" "Acan"
    "fibrillations" "dihydroxyvitamin" "XIV" "crepitus" "2 D 3" "MSeA"
    "methyladenine" "Qiao" "duplexes" "methanesulfonate (MMS)"
    "apurinic/apyrimidinic" "selenomethionine" "non-genotoxic" "re-grow"
    "-7-dependent" "-7" "Huang" "Paracrine" "hindlimbs" "EKP" "zVAD" "Wnt/"
    "planaria" "non-apoptotic" "microparticles" "ER/microsomal" "TOM"
    "cytotoxicty" "ERP29" "peptidyl" "reticulum" "methide" "wilfordii"
    "Tripterygium" "PPI" "Undirect" "undirect" "12 h" "β 1"
    "the normal alveolar epithelium" "Jag1/2" "Rbpjk" "re-initiation" "p=0.038"
    "eYFPmice" "p=0.0007" "primaryKras" "secondary pulmospheres"
    "intrinsically more chemoresistant" "bearingKras" "3+/+" "secondary 3+"
    "non-TPC" "Non-3+" "non-3+" "betweenKras" "eYFPmodel" "β4" "pulmospheres"
    "andKras" "bothKras" "Pulmosphere" "pulmosphere" "inKras" "fromKras"
    "thanKras" "Epcam" "eitherKras" "the distal lung epithelium" "AdCre"
    "tdRFP" "eYFP" "orKras" "murine alveolar epithelium" "fl/fl" "theKras"
    "Pecam" "TPCs" "TPC" "Rosa26" "p=0.001" "=0.038" "p=0.02" "hyper-"
    "V600E -induced" "/+mice" "AhCre" "masses" "AZD-7762" "AZD"
    "PLX4720/Gefitinib" "The murine intestinal cancer cell line MouseT1"
    "MouseT1" "Prahallad" "frameshift-causing indels" "indels" "S152R" "and 3N"
    "and 3N" "V637E -induced" "LSL-V637E /+cohort" "LSL-R172H/+" "E-induced"
    "BrafV6" "V637E -Induced" "E -induced" "F–2I" "n " "mSAs" "nonpolypoid"
    "a serrated eosinophilic adenomatous epithelium" "LSL-V637E /+mice"
    "nonhyperplastic surrounding mucosa" "LSL-V637E /+intestines" "mSH" "LI"
    "villi" "LSL-V637E /+animals" "LSL-V637E /+" "knockin" "Jass"
    "uniform cytologic atypia" "eosinophilic epithelium"
    "only minimal dysplasia" "rectosigmoid" "sessile" "subset " "1 × 10" "= 6"
    "n = 12" "n = 15" "p = 0.002" "2–3 " "cellulo" "p53 R248Q" "virus-1"
    "bluetongue" "DyLight 650-labeled p53C" "soluble p53 GFP" "/K +"
    "Trypsin/EDTA" "trypsin/EDTA" "DyLight" "prionoid" "prion-like"
    "pancreatitis" "co-aggregate" "p53C" "«prion-like" "prionoids"
    "co-aggregation" "Aβ" "common/rare" "The ATR synonymous rs1802904 SNP"
    "rs11920625" "p=0.0185" "ACRV1" "rs2155388" "a synonymous ATR SNP"
    "rs2227932" "rs6805118" "rs1802904" "UBCS" "Utah" "GoldenGate" "SBCS"
    "Sheffield" "tagSNPs" "tagSNP" "p=0.21" "=7" "IMPUTE2" "ﬂavonoids"
    "Murrayafoline" "Enmenol" "eriocalyxin" "minheryin" "enmenol" "14β-OH"
    "phyllostachysin" "TOPflash" "BioCarta" "advancements" "nano" "rubescens"
    "Isodon" "Goeman" "Horvath" "=1.16 µ" "median=5.9%" "median=2.9%" "=6"
    "median=28.8%" "moderate/low" "median= 0" "median=1.3 µ" "= 1.3 µ"
    "=1.20 µ" "Ck5+" "median=0" "p=0.049" "p=0.12" "median=1.7%" "=1.7%" "CK5+"
    "Micosystems" "Leica" "co-stained" "median=8.9%" "H&E" "NPHP" "JBTS"
    "nucleates" "immotile" "p=0.002" "=27" "non-malignant" "=1.38 µ" "=0.10"
    "=47" "= 80%" "=1.22 µ" "=0.71" "=0.16" "+ 1" "/cancer" "anti-rabbit-IgG"
    "anti-mouse-IgG" "n=8" "Taipale" "KARPAS" "DMAG" "geladanamycin" "erlotinb"
    "WZ-4002" "WZ" "Spaceflight" "ISS" "CTGH" "MYO9" "flown" "aircrafts"
    "clinostat" "W-1" "Vibraplex" "SAHC" "CGTH" "spaceflight" "Dahl" "antimiR"
    "Enquobahrie" "Pineles" "∼40–50%" "miRSVR" "NF-kBp50" "kBp"
    "hydroxysteroid" "hypoxia inducible factor-1α" "PE-like" "preterm"
    "NF-κBp50" "Bp" "cytotrophoblasts" "Toll-like" "pJFH" "pPKR" "H77s"
    "non-HCC" "antivirus" "HVC" "p38MAPK" "L/well" "2 ×10" "JFH-1" "Rong"
    "Iwata" "TFSEARCH" "at least 3 h" "mJ/cm2" "activity/expression" "mJ/cm 2"
    "co-repressor" "anti-human" "cells/mL" "transcripts/precursors" "Yunnan"
    "reappraise" "Lan" "del/del" "CTGTCATT" "bp/del" "T/C" "indel" "CTTACT"
    "rs113686495" "rs3769821" "rs3834129" "δ-1" "Biphasic GSIS" "fluoresces"
    "pHlourin" "pHluorin" "fluorophores" "fluorophore" "refilling/mobilization"
    "Kakizaki" "GSIS" "TIRF" "832/13" "gonadogrophs" "Sec6/8" "capacitance"
    "excitosome" "= 1.49" "6/8" "CID755673" "Hausser" "14-3-3γ" "RSXpS" "RSNpS"
    "to 14-3-3" "the active PKD1 protein co-localized" "pS474-PAK4" "masspec"
    "Phosphosite" "VTRSNS" "pMOTIF" "cNSIP" "alveolar epithelium" "fNSIP"
    "Masson" "EFGR" "Hardie" "pentoxide-" "pentoxide" "vanadium" "nonsmall"
    "the hyperplastic alveolar epithelium" "IPF" "n = 11" "CQ" "GFP-LC3B"
    "hypodiploid" "oxygenases" "certain omega-3" "DHA" "μ L" "μ g/mL"
    "N-acetyl" "its subsequent ubiquitination/degradation" "rAPCL730" "yAPC777"
    "the active yAPCL1241" "yAPC1466" "Hetero" "yAPCL1728" "yAPCL1257"
    "yAPC1289-15" "Pβ-catenin" "20R1" "15Rs" "yAPCL1179" "yAPCL1241" "TOP/FOP"
    "fiber-like" "yAPCL" "stady" "siAPCLs" "CiD" "20Rs" "15RA" "20R3"
    "subsequent ubiquitination/degradation" "presence/absence" "DLD1" "Schwarz"
    "palmitoyl" "ASCL3" "ASCL" "SM" "Carotid" "caspase-3/7" "7.72±0.09-fold"
    "ACSLs" "Kossa" "Triacsin" "1.53±0.04-fold" "1.57±0.06-fold" "triacsin"
    "chemoattractant" "Rotterdam" "JELIS" "Miyazaki" "non-calcifying" "ACS"
    "ACSL" "HASMC" "κB" "cells/cm 2" "cytoplasm/nucleus" "E-cadherin" "E-cad"
    "transfectants" "OLs" "63.5/46.0" "/OSCC" "NPV" "expression+loss"
    "nuclear/cytoplasmic" "95% C" "OL" "dysplasias" "catM" "3/30"
    "cytoplasmic/nuclear" "DFS " "61/105" "27/30" "Dysplasia" "/ E" "= 11"
    "= 0.024" "p = 0.002" "= 0.038" "= 9.0" "p = 0.05" "p = 0.017" "= 56"
    "=  0" "= 15" "= 0.014" "= 7" "=  0.003" "= 5" "p = 0.01" "95% CI "
    "p = 0.001" "p = 0.03" "= 2" "p = 0.06" "= 10" "≥50" "= 3" "= 0.003" "= 8"
    "hemoproteins" "Taillé" "Ambasta" "RCS" "Oligo" "RuCl" "CORM" "Biliverdin"
    "cytochromeb" "Soret" "cytb" "a strict co-localization" "8E9" "Nox4GFP"
    "dismutes" "Amplex" "CoPP" "Nox4B" "Nox4A" "Genbank" "ß-effects"
    "biliverdin" "BV" "biliverdine" "FAD" "Coustry" "Nox" "oxidases" "REx"
    "C-20/A4" "OA" "SubG1" "2 ng/ml" "Oxygenase-1" "co-workers" "oxygenase-1"
    "anti-body" "anti-proliferation" "KOCL-48" "KOCL" "polyphenols" "JMD"
    "-epigallocatechin" "epigallocatechin" "gallate" "p44/42" "≤5" "pH2AX"
    "Detroit" "CPT11" "AMPKa1" "shDUSP7" "ShDUSP6" "shDUSP6" "S1981" "10 h"
    "anti-tumorigenic" "multivariant" "antagonistic pleiotropy" "pleiotropy"
    "one-quarter" "complicit" "Fraumeni" "non-Asian"
    "specific geographical regionsr" "sitesn" "regionsr"
    "alternatively employing SEER" "employing SEER" "Japan:United" "residuals"
    "non-epithelial" "OPC" "Armitage" "ASR" "Xue" "Ventura" "Bradford"
    "approximately one-quarter" "SEER" "GLOBOCAN" "P = 0.001" "P = 0.05" "= 28"
    "P = 0.06" "P = 0.08" "= 17" "P = 0.03" "~8%" "anti- apoptotic"
    "non-invasive" "mutation/deletion" "Unbridles" "1p" "SNAI1/2" "TWIST1/2"
    "DshR" "Imaris" "unbridles" "g" "a heterozygous genotype"
    "the normal bronchial epithelium" "normal bronchial epithelium" "atypia"
    "loss/downregulation" "adjacent normal ductal epithelium"
    "strong co-localization" "KD2" "CAGA12" "CshRNA" "DshRNA" "ULA" "shDEAR1"
    "invasive/metastatic" "CONAN" "Rudin" "ICGC" "cBio" "ureter" "Hodgkins"
    "Genotypes" "1p35" "ZEB1/2" "SNAIL1/2" "4/10" "and 2D" "8/10" "omapatrilat"
    "OCTAVE" "Omapatrilat" "Vanderbilt/Marshfield" "CRB1" "rs989692" "ets"
    "Rs2724635" "Tallele" "Rs500766" "rs2724635" "rs500766" "Vanderbilt"
    "ximelagatran" "Nashville/Marshfield" "ONTARGET" "Endpoint" "Wisconsin"
    "Marshfield" "Tennessee" "Nashville" "=0.068" "P =0.03" "5 ×10" "P -values"
    "nCLU" "pnCLU" "androgen receptor (AR) cellular translocation/trafficking"
    "NHT" "Egr1/sCLU" "PZ-HPV-7" "psCLU" "early growth response-1" "sCLU"
    "CRPC" "= 0.02" "P = 0.01" "bio"
    "primary human PTEN-deleted glioma neurospheres" "Michael"
    "diphenyltetrazolium" "deoxynucleotidyl" "PKCII"
    "extracellular signal–regulated kinase 1/2" "ATD" "SelectScreen" "anti-GBM"
    "N08-30" "N09-24" "NHNP" "neurospheres" "G5-X-2" "chloro" "fluoro-"
    "fluoro" "methylene" "bis" "-triphosphate" "μCi" "hexane/ethyl"
    "three-quarters" "Minas" "Semi" "Silva" "Anderson" "nonsolid" "lobules"
    "Acs" "cribriform" "5/28" "2/25" "Jacobs" "microacinar-like" "mastectomy"
    "PLCIS" "apocrine" "pode destacar diferentes imunofenótipos"
    "classificação" "diferentes" "pode" "citológica" "análise" "combinada"
    "com" "imunofenótipos" "positivo" "lobulares" "áreas" "negativo"
    "imunofenótipo" "o" "lesões" "apresentava" "marcadores" "ambos" "negativa"
    "caso" "Em" "observada" "completa" "positividade" "comedonecrose" "tinham"
    "apresentaram" "citologia" "somente" "apresentavam" "Dezenove" "positiva"
    "considerada" "histoquímica" "imuno" "presença" "pleomorfismo"
    "considerando" "analisados" "foram" "cinco" "vinte" "E-caderina" "padrão"
    "imunofenotípica" "caracterização" "na" "catenina" "caderina" "expressão"
    "foi" "estudo" "deste" "objetivo" "ductal ou" "ou" "lesão" "morfologia"
    "difícil" "muito" "casos" "alguns" "em" "entanto"
    "carcinoma ductal in situ tem importantes implicações" "implicações"
    "importantes" "entre" "distinção" "immunophenotypes" "lobular cytology"
    "immunophenotype" "pleomorphism" "CISM" "iso" "Akti1/2" "active RhoA"
    "Rictor-deficient mdMSCs" "mdMSC" "mdMSCs" "anti-adipogenic" "BBSRO"
    "previously reported gene polymorphisms" "METTL"
    "nonsynonymous polymorphisms" "Rett" "18p11.32" "severe hypotonia"
    "hypotonia" "ARID" "pellucida-like" "SWI1-like" "aesthesiometer"
    "Weinstein" "Semmes" "the Cohen’s" "Cohen" "targeted nonsynonymous SNPs"
    "targeted only nonsynonymous SNPs" "a nonsynonymous genetic polymorphism"
    "rs2677879" "rs2063640" "rs502281"
    "the nonsynonymous rs2677879 polymorphism" "BeadChips" "Dysesthesia"
    "Hypoesthesia" "underwent BSSRO" "dysesthesia" "hypoesthesia"
    "osteotomy (BSSRO)" "BSSRO" "osteotomy" "ramus" "= 5" "associated biopsies"
    "deletion/loss" "CDKNA" "11q" "endpoint" "=11" "p=0.012" "p=0.009" "CNV"
    "9p" "≤ 24" "≤24" "6p" "non-deleted/non-mutant" "p=0.059" "Nathanson"
    "Infante" ":A" "loss/mutation" "V600E/K" "=12" "= 12" "=0.017" "≥ 1" "‐p53"
    "‐knockout" "Arg‐II‐Induced" "S6K1‐T389" "Arg‐II‐mediated" "‐negative"
    "NOS/NO" "‐associated" "‐I" "‐SMA" "atherosclerosis‐prone" "p66Shc‐S36"
    "Arg‐II‐S6K1‐p66Shc" "S6K1‐p66Shc" "p66Shc‐S36A" "S6‐S235/236" "‐S6K1"
    "S6K1‐JNK‐p66Shc" "S6K1‐JNK" "‐36" "‐JNK" "S6K1ca" "CGP53353" "Gö6976"
    "PKC‐β" "‐S235" "‐mediated" "‐β" "‐p66Shc" "Arg‐II‐induced" "‐induced"
    "‐NOHA" "‐S36" "‐T389" "p53‐S15" "‐S15" "‐FLUOS" "‐gal" "‐2DA" "Δψm" "‐1"
    "•−" "wild‐type" "‐type" "‐prone" "arginase‐II" "l‐arginine"
    "senescence/apoptosis" "‐arginine" "cell senescence/apoptosis" "—c" "c"
    "wild‐type Arg‐II" "‐deficient" "Arg‐II" "‐II" "α/β" "100 mg/kg"
    "T202/Y204" "expct" "Ttm1" "SHIV" "an artificial lipid bilayer" "AD8"
    "MoMLV" "SIVden" "SIVmus" "SIVmon" "SIVgsn" "the R5-tropic AD8" "DIWK"
    "SIVcpz" "Vpu26" "Lopez" "capsid" "heptad"
    "the ectodomain failed to affect BST-2 function [ xref ]" "rod-like"
    "Kaposi" "Strebel" "gpl60" "begun" "radioresistance" "CAAX" "Armand"
    "Chardin" "Pierre" "all memory CD8 + T cell subsets" "B-lymphoma"
    "albicans" "vaccina" "phosphoSTAT3" "senescent/exhausted" "ifferences"
    "EMRA" "TCR/costimulation" "γc" "TAE" "CTV" "memory CD8 + T cell subsets"
    "formation/maintenance" "strong TCR/co-stimulatory" "IFN-λ" "IFN-α/β"
    "non Hodgkin’s" "multiple memory CD8 + T cell subsets" "IL21R" "2-3"
    "co-stimulation" "n=3" "=15" "CCR7 +" "NVP" "vandeta" "anolides" "AST487"
    "farnesylamine" "non-transmissibility" "Cytometer" "SPSS" "+++" "cells/ml"
    "medium/well" "lipofectamine" "AUG" "whipple" "= 0.038" "3 × 10" "48 h"
    "Jimenez-Sainz" "Kriegsheim" "MYPT" "tyrosine kinase-3" "RhoA/ROCK1/Erk1/2"
    "co-localisation" "Sainz" "constitutively-activated RhoA"
    "constitutively-active RhoA" "co-location"
    "selenite deactivated RhoA/ROCK1" "RhoA/ROCK1" "Δ-RING-TRIM32-MUT" "VZ/SVZ"
    "the ventricular zone (VZ)/subventricular zone (SVZ)"
    "/subventricular zone (SVZ)" "SVZ" "VZ" "Tuj-1" "DIV-5DIV" "DKO"
    "GeneCopoeia" "neural-like" "hTRIM32-luc" "p53RE" "hTRIM" "FamTaG" "p73KO"
    "neurosphere" "E14TG2a" "DNp73" "anti-T7" "ΔNp73 α" "C57BL/6" "HA-TAp73 α"
    "TAp73 β" "TAp73−/−" "non-p16 INK4A" "doxy" "CEM/p16" "sensitizer" "shCtr"
    "Molt4/FOXO3" "Molt3/FOXO3" "sublines" "CEM/FOXO3" "OPH" "qVD"
    "4-OH-tamoxifen" "responders (PPR)" "responders" "sensitizers" "FASL" "ITD"
    "phosphoinositol-3-kinase" "dnBID" "dnFADD" "4OH-tamoxifen-regulated"
    "ERtm" "T-acute" "phosphoinositol" "5x10" "48h"
    "normal epithelial cell-to-cell"
    "potential clinicopathological confounders" "confounders" "non-recurrence"
    "normal colorectal epithelium" "micrometastases" "normal colorectal mucosa"
    "Forkhead/winged-helix-box-class-O3" "=28" "P =0.001" "Forkhead/winged"
    "Prx-1" "VAD" "induction/resistance" "IARC" "subsulfide" "NiCl" "P-value"
    "1 × 1" "udergo" "MDM2Δp53" "Comple" "co-overexpressed" "ΔRING"
    "PathDetect" "Δp53" "genotypealso" "rs3765524" "rs11187870" "Begg’s"
    "the non-cardia gastric cancer subtypes" "GA" "non-cardia" "Dura" "Plamer"
    "GWASs" "Hinkes" "isozymes" "10q23" "bisphosphate" "Eastern Europe"
    "Southern and Eastern Africa" "cardia" "rs2274223" "non-smokers"
    "p = 0.001" "P = 0.002" "= 1.47" "K29R" "K19A" "K88R" "K29A" "K7R" "K88A"
    "pEGFPC1" "sHSPs" "outcompetes" "spatio" "CLASP" "commonalities"
    "chaperonins" "immunogold" "aster-like" "coverslip" "HSPB1−" "HSPB1+"
    "HSPB1-" "HSPB" "Non-centrosomal" "non-centrosomal" "∼10%" "cRNA"
    "viral titer" "HBEC" "viral titers" "MOI" "M2/M1" "vRNP" "interactomes"
    "oligos" "non-structural" "cRNP" "vRNPs" "NA" "Orthomyxoviridae"
    "which causes approximately 500,000 deaths/year" "deaths/year" "hnRNPs"
    "#3" "non-targeting" "Non-targeting" "1∶10,000" "M1/M2" "physio" "masse"
    "Oblinger" "Gollapudi" "AOV" "InhV" "inhV" "PC12-ER-Y537S"
    "The deleted E-domain" "E-domain" "F-domain" "ΔA" "PC12-ER-" "ER2" "ICI"
    "Lonza" "Vialight" "adenyl" "17β estradiol" "A/B" "non-transcriptional"
    "thePTPN11" "andPTPN11" "E76K/+" "tyrosyl" "#220"
    "subsequent cell-based screenings" "screenings" "CADD"
    "B cell acute lymphoblastic leukemia/lymphoma" "#220–324" "drug-like"
    "chromophobe" "severe diabetes mellitus" "mellitus" "=232" "=65"
    "constitutively active myrAKT" "myrAKT" "transformed epithelia" "Sm"
    "interfinger" "pSUPER" "Y53G8AR" "rno" "renal proximal tubules"
    "mouse renal proximal tubules" "superactivate" "homeodomain" "~30%"
    "originally two aspartate codons" "Flatmark" "thoughbcl" "signficant"
    "3P/3A" "PESTfind" "inbcl" "N52A/N66A" "Koury" "erythrocytes" "Schneider"
    "aspartates" "laevis" "reiterant" "the esophageal mucosa" "prodeath"
    "simplest" "aspartyl" "asparginyl" "PEST" "pCDNA3" "3P" "p53 −/−" "2.0×10"
    "×1" "TAP/MS" "embryonic rat cardiac myocytes" "diverter"
    "cardiac myocytes" "myocytes" "NTag" "heavy:light" "fter" "efore"
    "-L-lysine" "Tactin" "Strep" "StrepII" "TAP-MS" "interactome"
    "which forms phosphatidylinositol-(3,4,5)-trisphosphate" "-trisphosphate"
    "trisphosphate" "growth factor-1" "CCT128930" "× 2" "Anti-Rabbit"
    "Anti-Mouse" "Anti-FLAG" "doman" "/Tyr 741" "Hammerman" "Spearman"
    "co-clustering" "EV" "important integrators" "integrators"
    "Robust co-clustering" "+Tyr 740" "1–3 " "co-cluster"
    "The unambiguous phosphorylation dataset" "two biological replicates"
    "replicates" "h" "Absorbance" "-tetramethylbenzidine"
    "tetramethylbenzidine" "2D10" "Abcam" "ELISAs" "DuoSet" "Lysis" "R&D"
    "approximately 10 μl" "amd" "triethylammonium" "PerkinElmer" "Ultima"
    "scintillant" "RFB" "KKSRGDYMTMQIG" "Axltide" "atfor" "TDA" "Matlab"
    "Benjamini" "Hochberg" "Scansite" "Pfam" "the phosphoproteomic dataset"
    "PTMScout" "Dataset" "10:89:1" "Phosphopeptide" "sapiens" "QSTAR" "QqTOF"
    "vol" "flowthrough" "FeCl" "-nitrilotriacetate" "nitrilotriacetate"
    "eluate" "pY100" "4G10" "ABSciex" "plex" "iTRAQ" "Pak" "iodoacetamide"
    "P5D2" "Iowa" "AbD" "FlowJo" "FACSDiva" "analyser" "LSRFortessa" "Kodak"
    "XAR" "pico" "Stratech" "anti-phosphotyrosine" "Nonidet" "Stratagene" "XL"
    "Invivogen" "zeocin" "type 2α" "-domain-containing" "non-catalytic"
    "toolkits" "discoidin" "co-regulated" "non-phosphorylated" "anti-rabbit"
    "Tris/HCl" "phospholipase C-like" "at least 10 exons" "C-rich" "Tip110ΔCT"
    "Tip110ΔNT" "YB-1ΔC" "YB-1ΔN" "ΔNT" "ΔNLS" "ΔRRM" "ΔCT" "isotype" "lyastes"
    "pTip110-HA" "importin-2α" "pcDNA3" "peptidases (USP)" "peptidases" "CYMC"
    "orthrologue" "gene/protein" "immunobiology" "Fischer’s" "Fischer"
    "Houston" "Selleck" "tetrazorium" "thiazoyl" "Rockford" "pTEpY" "Millipore"
    "Novex" "Laemmli" "the brown chromagen" "chromagen" "Carpinteria" "DAKO"
    "Immunohistochemistry" "Danvers" "WI" "Lasergene" "Hawthorne" "GeneLink"
    "Hercules" "Bio" "iCycler" "Qiaquick" "BX41" "Tokyo" "Olympus" "Mannheim"
    "Biochemicals" "Burlingame" "RP11-29C18" "RP11-482D24" "RP11-1109D18"
    "RP11-647D11" "CTD-2536C1" "CTD2174F1" "Chr22q13.32-13.33" "Oakland"
    "Bacpac" "CBDCA" "Shimane" "amplification/mutation" "Wagner" "endometriod"
    "chemoresistant" "prototypic histology" "≥1" "Univariate"
    "co-amplification" "endometrioid" "Active phospho-ERK1/2" "22q11" "& E"
    "non-small" "p = 0.002" "STAT3/miR-92a" "AAGGUG" "MiR-18a" "AAAGUG"
    "miR92a" "13q31–q32" "anti-miR-92a" "Stat3C" "miRanda" "TargetScan"
    "STAT3C" "xl" "Bcl" "Anti-miR-92a" "zymography" "S3C" "α 5" "SDP" "PSCC"
    "=9.0" "=1.49" "Often patients undergoing inguinal lymphadenectomy"
    "standard inguinal lymphadenectomy" "erbB" "spongiosum" "lymphnode"
    "clinically negative lymphnodes" "regional lymphadenectomy" "lymphnodes"
    "lymphadenectomy" "around 0,5-1" "N0-1" "cavernosa" "Naples" "Federico"
    "Penile" "= 3" "p = 0.01" "≥2" "≥ 80" "× 2" "5-year" "KY"
    "nuclear/cytoplasm" "FOXM1c" "FOXM" "clearer" "lamelliopodia" "Amyere"
    "fillopodia" "SVWI38" "the normal WI38s" "SVWI38s" "re-distribution"
    "outcompete" "DNA/protein" "+179/+149" "wildtype" "−179" "+52/+60"
    "TGACGTCA" "+149" "−2436" "even normal myometrium" "limma" "Barrett"
    "fibroid" "Collagens" "Ono" "the normal uterine myometrium" "Case 3"
    "Case 2" "Case 1" "MAPPER" "Alpha- target" "Case7" "mu" "Case3" "Case2"
    "Case1" "component-2" "component-1" "Myometrium" "Navarro" "alpha-target"
    "non-cell" "Cntfr" "Crisponi" "misfolding/aggregation" "stressors" "Δ34N"
    "soluble CLC/CLF" "JAK1/2" "heterodimeric CLC/CLF" "CRLF" "CLC/CLF" "NBA"
    "six-day" "undifferentiated/naïve" "LD50" "timecourse" "RA/TPA" "vii"
    "Tuj1" "TPA" "nigro" "acute parkinsonism" "parkinsonism" "Huntington’s"
    "Huntington" "co-ligand" "≥0.95" "oncologists" "cytology" "L858R/T790M"
    "gatekeeper" "anilinoquinazoline" "non-smoker" "=C3+" "100–1" "cytologists"
    "LightMix" "EntroGen" "Dutch" "=80%" "GmbH" "ViennaLab" "MolBiol" "QS"
    "Pathomorphologists" "Lukaszczyk" "Franciszek" "pathomorphologists"
    "Oncology" "TBNA" "EBUS" "FNA" "2+" "responder" "ADAD1" "Johnsons"
    "Stevens" "rs1998359" "rs17388568" "rs6021270" "celiac" "rs9860547"
    "rs10497813" "Crohn’s" "rs7720838" "4p14" "18/23" "rs9303280" "rs2101521"
    "=1.7×10" "rs17533090" "23andMe" "GEE" "ALSPAC" "Avon" "5q22.1" "3×10"
    "6p21" "=5" "prostatectomy" "Michigan" "/E" "heatmap"
    "the same directional transcriptome" "thatPten" "thePten" "littermate"
    "robust transcriptome" "andR26" "∼44%" "DREME" "wt" "inR26" "andPten"
    "penile" "InPten" "inPten" "approximately 80% ofPten f/f" "ofPten" "f/f"
    "toPten" "crossedR26" "homozygousPb" "heterozygousPb" "Pb" "outut" "&E"
    "72-hours" "/  +" "disbalance" "S6KS5A" "S6KΔC" "the Avruch’s" "Avruch"
    "dis" "inositide" "hyperinsulinemia" "AGC" "S/T" "JWH" "SHA" "WK" "JMH"
    "AHZ" "British" "only two SNPs" "GAD" "fossae" "non-risk" "AG/AA" "TC/CC"
    "co-dominant" "the homozygous genotype" "phosphorylation/activation"
    "Vladich" "5q31-33" "rs1059513" "rs20541" "Abertawe" "Prifysgol"
    "Poblogaeth" "Swansea" "IOW" "= 2" "β 1  " "12q13" "P  = 0.002" "= 0.028"
    "= 0.037" "CAF1B" "co-exist" "eIF4E:eIF4GI" "Willet" "co-distributed"
    "co-distributes" "co-fractionating" "phylogeny" "strict co-localization"
    "GST-A1YA" "HA-A1YA" "A1YA" "at least three orthologs" "pairwise"
    "orthologs" "+6" "IPs" "Prosite" "webserver" "YxxxxLΦ" "ERE-CCND1-" "60a"
    "CCND1-" "CCND" "AF2/LBD" "VEH" "pCR" "GREs" "pulldown" "TCA-3" "XX"
    "AGAACAgggTGTTCT" "the EBRs tested in the presence of E2+Dex ( xref  H )"
    "GBR" "GRE" "ERE" "EBR-CCND1-" "E2+Dex" "trastuzamab" "/G 1 phase"
    "coactivator-3" "Dex" "EBRs" "co-occupancy" "insipidus"
    "septo-optic-like dysplasia" "septo" "heterotopies" "endocrinology" "dbSNP"
    "TKD" "oligodontia" "anosmia" "Uniprot" "ie" "radial aplasia" "aplasia"
    "callosum" "Milder" "hand/foot" "microform" "cerebrum" "midline" "ontogeny"
    "Kallmann" "Hartsfield" "Harstfield" "Polyphen 2" "Omni 2.5 "
    "at least 48 h" "glutathione peroxidase-1" "MOIs" "formazan" "IkBαDN"
    "HMVEC" "preexposure" "anti-BrDU" "5-bromo-2" "Korean" "Africans" "Egger's"
    "Begg's" "1.07–1.23" "Shao" "English" "homozygote" "ORs" "= 1.22"
    "rs1042522" "95 %CI" "95 %CIs" "proMMP13" "cytoplasimc" "re-modeling"
    "/mT 3" "mK" "nucleur" "FOPFlash (FOP)" "FOPFlash" "TOPFlash (TOP)"
    "TOPFlash" "cytoplasmo" "∼40%" "231-K8ikd" "ikd" "Krüppel-like" "Balb/c"
    "non-tumorigenic" "pY397" "∼70%" "non-tumor" "NAPDH" "dG"
    "deoxynucleosides" "-deoxyuridine" "deoxyuridine" "TAp73β" "GFP"
    "-RRRCWWGYYY-" "-RRRCWWG" "RRRCWWG" "6-phosphate-gluconolactone" "μg/ml"
    "anti-BrdU" "ΔNp73α" "p53  −/−" "p53  +/+" "Δ Np73" "TAp73  −/−"
    "HsRAD51:HsRAD51B-HsRAD51C" "prokaryotes" "RADβ" "RADα" "subfamilies"
    "RecA/RAD51" "ϕX174" "RFIII" "HsRAD51-HsRAD51C" "•BLM" "Ni" "–HsRPA"
    "HsRPA" "++" "•HsRAD51+HsRAD51B-HsRAD51C" "ofK" "HsRAD51B-HsRAD51C"
    "the bound HsRAD51B-HsRAD51C" "300s-600s" "HsRAD51B" "HsRAD51C" "Z-scores"
    "anti-recombinogenic" "homologs" "dsDNA" "HsXRCC3" "HsXRCC2" "HsRAD"
    "D-loops" "hilar" "Biopsy" "fluorodeoxyglucose" "35-year-old" "Stanford"
    "non–small-cell" "Roswell" "tetrasulfides" "DMFS" "Sweden" "Uppsala"
    "immunoglobulin" "LXRα" "ER+" "gallbladder" "anti-proliferative"
    "dietary phytosterols" "phytosterols" "the premature termination codons"
    "Du" "morpholino" "framshift" "Barone" "Verhagen" "Mitui" "Japanese"
    "Nakamura" "gatti" "Jacquemin" "Li" "Cavalieri" "gammaglobulin" "IgA"
    "Jiang" "Concannon" "Matsuoka" "Kozlov" "Goodarzi" "Watters" "Savitsky"
    "11q23.1" "Gatti" "Barlow" "Boder" "bronchial epithelium explants"
    "explants" "explant" "NHBEC" "non-Hodgkin’s" "Duncan" "pChk1" "-UTR-mut"
    "pMIR" "Gy" "neg" "Rad3" "phosphoinositide-3-kinase-like" "co-transfection"
    "NOD/SCID" "pZluc" "rhodamine123" "albus" "polyether" "NCI/ADR-RES"
    "P -value" "μ g" "μ g/ml" "μ l" "+64" "+52" "Topflash" "Col1 A" "Col1A"
    "Ad-E2F1" "COL1A" "Zhang" "+47" "GCGCGA" "+54" "+71" "rs2232158" "μg"
    "rs2232157" "calvaria" "FOB" "Non-canonical" "p = 0.08" "comorbid"
    "squamous histology" "Angelo" "Memorial Sloan" "MSKCC" "Sloan" "Reinersman"
    "Leidner" "p=0.51" "AsAs" "p=0.08" "p=0.03" "p= 0.06" "AsA" "CONSORT" "Afa"
    "p=0.01" "Charlson" "AfA" "Pennsylvania" "AfAs" "T2D" "oncometabolite"
    "5-hydroxymethyl-cytosine" "oxoglutarate" "Sdh" "fumarate" "E1α"
    "heterotetramers" "*100%/" "MaxQuant" "D4-isotopic succinate" "CORUM"
    "respiratory chain supercomplexes" "supercomplexes" "subnetworks" "MCODE"
    "STRING" "KOs" "PFAM" "oxoacid" "Succinylome" "Carta" "UniProt" "KF" "+1"
    "M1/M2 (PKM)" "Warburg" "isozyme" "a previously reported algorithm"
    "Hydroxyl" "HPLC-MS/MS" "nonredundant" "HPLC-MS" "proteomes" "Ksucc"
    "Proteome" "methylmalonyl" "isomer" "immunochemistry" "methylmalonyllysine"
    "succinyllysine" "acetylome" "Kac" "succinate" "succinylome" "succinyl"
    "= 8" "= 2" "MUR" "IVS2 +1G" "Spanish" "≤45" "19/1,978" "24/5,496"
    "28/3,228" "Slovak" "2/145" "10/82" "8/89" "10/172" "30/516" "America"
    "51/1,303" "5/169" "Australia" "15/507" "France" "French" "5/118" "16/909"
    "9/1,228" "+50A" "NHLBI" "+44insA" "Punjab" "PolyPhen2" "SIFT" "GVGD"
    "Punjabi" "30-year-old" "DHPLC" "BRCA1/2-" "Finland" "Jewish" "Ashkenazi"
    "Czech" "Russia" "Belarus" "Poland" "del5395" "IVS2 +1G" "Philippines"
    "Malaysia" "Korea" "IVS" "OMIM" "34-year-old" "Pakistan" "Pakistani" "2 +"
    "= 27" "2 +" "CKT" "KJL" "BFC" "CYY" "KYC" "histo" "Kozaki" "Wheeler"
    "Keller" "coexistant" "Sok" "stepwise" "and 2+" "4+" "3+" "GCN" "GCNs"
    "buccal mucosa" "EGFRwt" "oncology" "hypopharynx" "OC" "=  0" "P - values"
    "FAM110B" "centrosome/MTOC" "FAM110" "CSPP" "17q12–21" "Smirnov"
    "Kolmogorov" "UTRdb" "ITAF" "IRES" "UVB" "polyRNA/totRNA"
    "a genome-wide overview" "overview" "p  " "≥1.5" "≤0.67" "≥1.50"
    "polysomal mRNA/change" "polyRNA" "totRNA" "GeneChip" "non-depleted"
    "Subset" "eEF" "nucleo" "onco" "basal-like" "U133" "24 h" "OCM" "ORC/Cdc6-"
    "MCM2–7-ΔC6" "ORC/Cdc6" "hexamer" "hetero" "CVL" "protein 3G" "Yang"
    "Trithorax" "var" "Orthoclone" "CXCMotif" "COUP" "BmRNA" "Enhancer"
    "DeoxyPhorbol" "TriPhosphate" "DeoxyNucleotide" "factor-1" "C-promoter"
    "intentional re-ignition" "methylome" "Spivak" "disufiram" "Retrovirus"
    "residual viral viremia" "disulfiram" "RNA/ml" "Francisco" ":I16" "Moreno"
    "Suppl 1" "Spain" "Madrid" "Ramon" ":O2" "Geleziunas" "Suppl1" "copies"
    "residual low-level viremia" "latent proviral genomes" "the Margolis’s"
    "cutaneus" "This latter multicentre" "multicentre" "Routy" "Margolis"
    "anti-HIV-1" "ClinicalTrials" "ERAMUNE01"
    "both undetectable plasma viremia" "Viro" "VISCONTI" "nucleases"
    "relapsed Hodgkin’s" "relapsed Hodgkin" "XIX" "Henrich" "Hodgkin"
    "CCR5delta32" "Berlin" "vmiRNAs" "miR-29a" "miR27b" "linfoblastoid" "PTGS"
    "RRE" "infectious retroviral progeny" "the Trono’s" "Trono"
    "the repressive nucleosome-1" "The Emiliani’s" "Emiliani" "Lys50/51" "PBAF"
    "monomethyl" "Ott" "PHA" "The Montano’s" "Montano" "Klichko" "LAI"
    "prostratrin" "AFF4" "Marcello" "Setx" "assembly factor 1-like" "pulldowns"
    "Krogan’s" "Krogan" "Bouchat" "Zeichner" "5-Aza-CdR" "histopathology"
    "-difluorocytidine" "difluorocytidine"
    "the primary antiviral mechanism/activity" "procaine"
    "undetectable plasma viremia" "nonprogressors" "Palacios" "non-methylated"
    "the Fauci’s" "the Hirsh’s" "Hirsh" "methylated CpG dinucleotides" "Chun"
    "Fauci" "Hirsch" "the Planelles’s" "dinucleotides" "DZNep" "the Karn’s"
    "Zeste" "Karn" "monocytic/macrophages" "hCOMPASS" "The Rohr’s" "HIV-1+"
    "HMTI" "minutum" "Chaetomium" "HMTIs" "G9a-like-protein (GLP)" "postmortem"
    "Rohr’s" "Rohr" "Benkirane’s" "HIV+ " "H3K9" "HIV + " "Burnett"
    "non-tumor-promoting" "AV6" "NCH-51" "NCH" "latentlyHIV" "Marban" "LTR5"
    "Giacca" "the Verdin’s" "Paro" "deoxynucleotide" "non-cycling"
    "the Benkirane’s" "Skowronski" "Benkirane" "Cereseto" "STAT5Δ/p50"
    "the viral LTR" ":O3" "Retrovirology" "Rafati" "Henderson" "J89GFP"
    "Sluis-Cremer" "Cremer" "Disulfiram (DSF)" "Disulfiram" "aloisine" "MMQO"
    "timonae" "Massilia" "bryostatin" "phorbol-13-monoesters" "deoxyphorbol"
    "jatrophanediterpene" "HS7" "the viral genome" "the Berkhout’s" "RNAPII"
    "non-randomly" "SIVmac" "Shytaj" "SIVagm" "anti-retrovirals"
    "elective necropsy" "necropsy" "hu" "nonhuman" "viral progeny"
    "anti-latency" "ΔEnv" "the Collins’s" "Collins" "Doherty" "Saleh"
    "Siliciano" "αCD3/αCD28" "Planelles" "Tyagi" "Sahu" "VSVG" "d2EGFP"
    "Tat/TAR" "Ben Berkhout's" "Berkhout" "TAR" "rtTA" "p24gag" "pNL4-3" "LTR"
    "copie" "Subsets" "CCR7+" "Lerner" "CD133+" "multipotent HPCs" "HPCs" "HPC"
    "Naïve" "The residual viremia" "Poisson" "the viral lifecycle" "lifecycle"
    "CD27+" "CCR7-" "CCR" "TCM" "copies/ml" "CROI" "Baltimore" "David" "LTRs"
    "ileum" "The low-level residual viremia" "residual viremia"
    "a repressive nucleosme" "TEFb" "nucleosme"
    "a persistent residual low-level viremia" "goes" "re-emergence" "UNAIDS"
    "persistent residual viremia" "viremia" "H3K27" "I/II" "factor/lymphoid"
    "CD8+" "5-aza-2" "GFP + " "non-infected" "CD31+" "cell-to-cell"
    "co-morbidities" "SU11275" "the c-Met-N375S genotypes"
    "c-Met-N375S polymorphism" "c-Met-N375S genotypes" "0.60-1.91"
    "homozygous (G/G) c-Met-N375S genotypes" "G/G" "A/G" "A/A"
    "the c-Met-N375S polymorphism" "Caucasians" "Asians" "Tengs" "African"
    "IPT" "7q21-q31" "chemoresponse" "non-cancer" "95% CIs" "case/control"
    "48 h" "diluent or complementary oligonucleotide and 3AB" "3AB"
    "immunotherapy" "CaspACE" "proenzymes" "and 3AB" "aminobenzamide" "TTAGGG"
    "oligo's" "anti-Mouse" "OP43" "non-homologous" "MPE" "metabolome"
    "epigenome" "discrepant" "=−19.8" "HR=0.43" "0.76–1.38" "IRD=0.7" "=1.03"
    "=−9.7" "HR=0.73" "non-users" "HPFS" "person-years" "non-melanoma" "=0.43"
    "Rapgef3/4" "exogenous hRapgef2" "myristate" "Gα s" "retrovirus" "hRapgef2"
    "~100 kD" "nonendocrine" "acti" "ddAd" "PACAP-induced" "uncharac"
    "SQ22,536" "progalanin" "chlorophenylthio" "neurites" "un" "chromaffin"
    "adreno" "diphosphate (GDP)" "cAMP-bound Epacs" "diphosphate" "Epacs"
    "CNGC" "HCN" "Neuroscreen-1" "neuroendocrine" "Δ C" "2 × 10" "Sirtuin"
    "Eric Verdin’s" "Verdin" "Eric" "Ac" "phosphoproteome" "~65%" "_30"
    "Menten" "Michaelis" "urea" "SIRT" "Sirtuins" "sirtuins" "sirtuin"
    "multistage" "ANE" "erythroplakias" "μmol/L" "24 h" "~90%" "non-synonymous"
    "QO" "YZ" "XC" "Wahl" "Stommel" "Cell-to-cell" "μmol/l" "switch-like"
    "Kirsten rat sarcoma viral oncogene homolog" "mucinous histology" "aquire"
    "Danish" "Hogdall" "8/154" "and 2/90" "tubal" "Swedish" "FIGO" "Figo" "vs"
    "established clinicopathological and molecular characteristica"
    "characteristica" "153/154" "Brenner" "Kurman" "Shih"
    "most commonly affecting codons" "v" "histological subtype" "endometroid"
    "ony" "mucinous histological subtype" "OCSS" "163 incident EOC" "Malmö"
    "EOC" "= 0. 035" "= 2.51" "= 0.035"
    "increasing cellular migration/invasion" "Yao" "Loesch" "NTUH" "p  "
    "a publicly available gene expression dataset" "MTS" "invasion/migration"
    "datasheet" "invasive/migration" "non-endothelial cell" "receptor-2"
    "receptor-1" "= 0.003" "4, 5-dimethylthiazol-2-yl" "5 × 10"
    "phospho-ERK 1/2" "Penicillin/Streptomycin" "p38 MAPK" "Benassi"
    "Matsumura" "epithelioid" "Multivariate" "MFS" "LRFS" "epitheliod" "p "
    "360–2" "Chan" "soluble E-, P- or N-cadherin ectodomains" "ectodomains"
    "adhesiveness" "multigene" "diagnosis/prognosis" "135–2" "= 0.02" "= 0.004"
    "= 0" "= 0.0022" "&D" "= 7" "pEGFR+" "IMC" "phosphoarray" "Met/Ron"
    "synergism" "XTT" "Ron+" "nonrecurrent HNSCCs" "the recurrent HNSCCs"
    "progressed/recurred" "recurrent HNSCCs" "CHTN" "IRB" "Recurrent HNSCCs"
    "perineural/vascular" "Ron+HNSCCs" "the squamous epithelium"
    "the nonmalignant squamous mucosa" "only 58.4% (90 out of 154) HNSCCs"
    "IPW" "treating recurrent or metastatic HNSCCs" "synergises" "Ron/pEGFR"
    "Ron+HNSCC" "nonmalignant" "expression/phosphorylation" "∼80%" "=10"
    "=0.019" "3/4" "P- value" "=40" "_43delinsTT" ".5:1295" "disomy" "monosomy"
    "choroid" "Uveal" "emphasises" "uveal" "n =3" "=8" "=2" "∼90%"
    "phosphosite" "non-essential" "re-creation" "vi" "Oslo" "Milan"
    "pY1068/pY1086" "non-gradually" "1068/1086" "1045/1068/1086+" "co-IP"
    "1068/1086+" "1045+" "re-engineered" "re-engineering"
    "the relevant phosphosites" "anti-pY1045" "pY1068/1086" "non-threshold"
    "the indirect Cbl-binding phosphosites" "pY1086" "SILAC" "‘reverse' ELISA"
    "phosphosites" "non-clathrin" "NCE" "LC-MS/MS" "non-denaturing"
    "re-introduction" "minisatellite" "photoproducts" "Bi" "iv" "xenopus"
    "XRad" "ΔXPolκ" "ΔXPol" "ΔMock" "RPA-bound ssDNA" "Xpol" "XPol" "HU" "si"
    "several bulky adducts" "Y-family" "ssDNA" "48 h" "× 100" "24 h"
    "ST3Gal IV/SLe" "Friedenreich" "Thomsen" "glycosyl" "10 h" "10h" "-MST3Gal"
    "secretome" "MST3Gal" "STs" "3-STs" "VI" "galactopyranosyl" "ST3Gal"
    "catalyse" "3Galβ1-4" "3Galβ1-3" "Fuc" "sialyl" "glycans" "glycan" "Sialyl"
    "/Tyr204" "non-reducing" "-TAp73" "polyA" "p53-/-" "cPARP" "ribose"
    "TAp73α-" "TAp73α" "ΔNp73" "HA-TAp73α" "p73α" "TAp73-" "myotubules"
    "aminoacyl" "lpha" "TAp73" "ΔN" "paralogues" "p73-" "p53-" "p" "Zhou"
    "Numerous computational algorithms" "a mutational hotspot" "hotspot"
    "hotspots" "1.06–2.40" "1.15–2.57" "non-D-loop" "×100"
    "mono- nucleotide/di-nucleotide" "378/645" "heteroplasmy" "homoplasmy"
    "polycytidine" "D-loop" "Taiwanese"
    "a nonsynonymous single nucleotide polymorphism (SNP)" "polymorphism (SNP)"
    "Larman" "a double-stranded circular genome" "Taiwan" "haplogroup" "= 0.16"
    "= 0.02" "Actinomycetaceae" "antifungals" "flucloxacilline" "dermatophytes"
    "Gram-negative flora" "flora" "typical human-associated phyla" "IFNy"
    "microbiota" "Corynebacteria" "24h" "Firmucutes" "LEfSe" "phyla"
    "Actinobacter" "Moracellaceae" "QIIME" "MiSeq" "micriobiome" "non-affected"
    "Naik" "ilium" "Bacteroidetes" "FMF" "MEFV" "Actinobacteria"
    "predominantly Staphylococcus aureus" "aureus" "eczematoid" "Th17"
    "polyendocrinopathy" "oropharynx" "mucosa" "Corynebacterium" "Table 1"
    "non-parametric" "MMP1A-519G" "rs5749511" "rs494379" "datas"
    "higher aortic PWV" "aortic PWV" "Yasmin" "TL" "5A/5A" "rs17576"
    "1.34-2.07" "Polymorphism" "corr" "EH" "baPWV" "FMD" "PWV" "Armstrong"
    "heterozygotes" "ISH" "5A/6A" "rs3025058" "rs3918242" "Pcorr" "=0.003"
    "mMol/L" "the associated SNPs" "URLs" "RegulomeDB" "rs9349379" "Le"
    "fucosyl" "FUT9" "cerebellum" "eQTLs" "possible non-proximity"
    "monogenic Marfan’s" "monogenic Marfan" "aneurysms" "Marfan" "nearest"
    "Affymetrix" "the 12 genome-wide significant top SNPs" "prioritise"
    "associated SNPs" "rs6790925" "rs6478241" "ASTN2" "rs7015657" "rs10504861"
    "centrosomal protein CEP104" "CEP104" "8q21" "1p13" "1p36" "aciduria"
    "7p14" "6q16" "FHL5" "AJAP1" "migraineurs" "GWA" "eQTL" "IMPUTE 2" "= 7"
    "FERM" "phosphopeptides" "Caenorhabditis" "ortholog" "switches/gates"
    "sequence-specific promoters/enhancers" "FSWAP" "C-SH2/pY542"
    "the available pY580" "C-SH2/pY580" "Δ542" "Δ580" "13aa" "13aa-region"
    "51aa-long" "YDF" "YPet"
    "these unnatural chemical modifications mimicking phosphotyrosines" "Pmp"
    "phosphonomethylene" "LEOPARD" "Noonan" "FPs" "vide" "pY580" "pY542"
    "phosphotyrosines" "/40" "deficeint" "likley"
    "several mysterious oberservations" "Weril" "doxorubucin" "non-CIN" "+/−6%"
    "ploidy" "Roschke" "NCI" "polyploid" "aneuploid" "ICN" "rhe" "co-depleted"
    "non-transformed" "cetuximab-like" "a concave paratope" "convex paratopes"
    "highly convex paratopes" "paratopes" "CDR3s" "a convex paratope" "camelid"
    "sidechain" "carbonyl" "bound VHH" "the ternary VHH:FabC225:sEGFR" "Y100d"
    "VHH:FabC225:sEGFR" "E100i" "LEEK" "CDRs" "ID 1YY9" "FabC225:sEGFR" "Waals"
    "Ogiso" "≈90" "Y100e" "carbonyls" "CDR3" "CDR1" "RMSD" "PHENIX" "REFMAC"
    "PHASER" "a 7D12-EgA1-like biparatopic inhibitor CONAN-1" "7D12-EgA1-like"
    "CONAN-1" "EgA1:sEGFR" "VHH:sEGFR" "FabC225" "Fab425" "mAb425" "sEGFRd3"
    "sEGFRvIII" "Langmuir" "plasmon" "EgA1" "7D12" "epidermoid" "glama" "VL"
    "VH" "camelids" "the convex VHH paratope" "paratope" "VHH" "–OH"
    "enantiomers" "InsP" "bulkier" "Helices" "dichroism" "EIRVGxxYQAxI" "cyan"
    "ammonium" "HDAC:corepressor" "ELM2" "D-myo-inositol-1" "tetrakisphosphate"
    "Alzheimer’s" "SANT" "ELM" "NuRD" "tetraphosphate" "ΔC" "~10%" "IAA"
    "1:1:1" "HRV" "-APC/C" "Inactive APC/C" "pseudosubstrate" "× 1" "~70%"
    "co-incubation" "Huygens" "Metamorph" "the Pearson’s" "ImageJ" "JaCOP"
    "fluorograms" "Neurolucida" "Photoshop" "Zeiss" "at least 83 synapses"
    "Göttingen" "XtraCount" "Morgagni" "Fei" "alveus" "Fe(CN)" "Epon" "Fe"
    "cacodylate" "Bregma" "Axograph" "CsOH" "methanesulfonate" "kHz" "NaH"
    "isoflurane" "MgATP" "CsCl" "AP5" "Picrotoxin" "CaCl" "DIV" "coverslips"
    "SMART" "Accell" "Fugene" "Jasco" "Spectrophotometer" "Förster" "mg/ml"
    "tu" "PrDOS" "ImmunoResearch" "Jackson" "Alexa" "anti-bassoon" "anti-homer"
    "anti-flag" "anti-ELKS 1b/2" "Chemicon" "Swant" "GeneTex" "DSHB" "Enogene"
    "Neuromab" "ELKS 1" "Verhage" "Matthijs" "MAEPLLRKTFSRLRGREK"
    "overall synaptic vesicle accumulation inmSYD1A KO synapses" "inmSYD1A"
    "X11α/" "SYD-2s" "PQ-loop" "PQ" "radiatum" "ultrastructure"
    "hippocampal synapses" "genetrap" "blastocyst" "Pearson" "ELKS2" "ΔYRL"
    "IDD" "readouts" "Rho-GAP-like" "lenti" "hSYD1A" "mEPSC" "mEPSCs" "SYD1A"
    "wavelet" "mSYD1B" "mSYD1" "the most plausible candidate orthologues"
    "_001159536" "_082151.1" "Synapses" "syd-1" "orthologues" "SYD-1" "ELKS"
    "mature synapses" "cytomatrix" "presynaptic membrane organelles"
    "a profound re-organization" "organelles" "mSYD1A" "Synapse"
    "Co-localization" "/2" "highly aggressive T-ALL subtypes" "γSI" "GI"
    "genomes" "PolII" "Notch/Rbpj" "enhancers" "CUTLL1" "FPKM" "Notch/Myc"
    "IVIS" "CPI203" "JQ1" "JQ-1" "treatedMyc" "Notch1ΔE" "orMyc" "fromMyc"
    "pI:pC" "Aurkb" "re-established" "GFP+" "ISP8" "Notch1ΔE-ires-mCherry"
    "GFP/+" "karyotype" "mFISH" "situ" "2×10" "ΔPEST" "heavier" "andEef1a1"
    "ΔE" "mutW7/+" "orEef1a1" "WBC" "mutW7" "Δ/+" "F/F" "theFbxw7" "thymii"
    "mut/+" "Δ/" "Mx1-Cre+mice" "utero" "Fbxw7-" "Fbxw" "LIC" "heterozygote"
    "degron" "Missense" "solutes" "synapses" "the neuronal synapse" "synapse"
    "GFP-mut-Cterm" "-GWFDAAA" "GWFDAAA" "GFP-βcat-Cterm" "Carboxyl" "Boyden"
    "TEER" "PDZ4" "PDZ3" "Co-Localizes" "noncognate" "co-purified" "retest"
    "carboxyl" "co-localizes" "endpoints" "coworkers" "Liu" "vitro" "GBAM1"
    "siNeg" "siPLK1" "photomicrograph" "U251" "titer" "histologies" "DGUOK"
    "LOF" "highthroughput" "proteome" "kinome" "anti-mouse" "-UTR-Smg5" "CTIF"
    "redirects" "Smg5-" "Smg" "-UTRs" "UTRs"
    "simultaneously knocks down both paralogs" "renilla"
    "a premature translation termination codon" "DQAD" "GNT" "Ddx"
    "fluorescent micrographs" "hUpf" "immunocomplex"
    "the eukaryotic initiation factor 4G" "factor 4G"
    "Functional Upf1-Upf2-Ufp3" "yet bound Upfs" "ionic" "Upfs" "non-sense"
    "paralogs" "EJCs" "SURF" "uORFs" "frameshifts" "Non-sense-mediated" "EJC"
    "Upf" "premature termination codons" "Co-immunoprecipitation"
    "co-regulator" "the actual penetrance" "broader" "recontact" "hoc" "pre-"
    "Washington" "email" "written" "preconception/prenatal" "pretest" "ACMG"
    "3.5-nm" "reconfirms" "phospholoipid"
    "the fully hydrated phospholipid bilayer" "conformer" "conformers"
    "micrographs" "an elliptical-shaped lipid bilayer" "Bare nanodiscs"
    "prolate" "bare nanodiscs" "Nanodiscs form elliptical lipid bilayers"
    "Nanodiscs" "Coomassie" "nanodisc" "bilayers" "monodisperse" "cryo" "1–3"
    "nanodiscs" "bilayer" "Dulbecco's" "eosin" "co-localized" "scratch/wound"
    "Scr" "co-localize" "progeny" "a transcriptional co-regulator"
    "matix (ECM)" "matix" "insightful" "co-localization" "immunocytochemistry"
    "2.0× 10" "co-repressors" "epithelial-like" "carotid" "hemiglossectomy"
    "CLIA" "AP24534" "μg/mL" "BGJ398" "co-occur" "LUSC" "LUSC-21-1078"
    "co-occurred" "IIIc" "tumor/normal" "exome" "SqCC" "=0" "=3" "μL" "KO"
    "Histology" "Chomatin" "histochemistry"
    "reduced ductal branching/expansion" "Sca" "lo" "non-overlapping"
    "Nkx3.1 -/-" "PEARKO" "TUNEL" "Immuno" "CDKNIs" "expression/activity"
    "readout" "urethra" "the glandular epithelium" "littermates" "f" "LADY"
    "ventral lobe Id4-/- tubules" "dorso" "Dunnett" "n " "fibro" "lumens"
    "glandular histology" "Id4+/+" "Id4+/-" "Id4 -/-" "Sertoli"
    "primary Sjögren’s" "Sjögren" "non-bHLH" "E2A" "mechanisms/pathways"
    "tubule" "tubules" "Id4-/-" "Non-specific" "PEG400" "Bioreagents"
    "Stressgen" "BD" "Calbiochem" "glycerophosphate" "b" "RIPA" "TECAN" "2–3"
    "Dojindo" "WST" "cells/well" "Carlsbad" "Gibco" "PRMI" "Hopkins" "Johns"
    "Vogelstein" "Manassas" "protein/fluorescent"
    "the sigmoidal dose-dependent FP" "Diego" "Graphpad" "Invitrogen"
    "globulin" "PMDM6" "Tecan" "-Glu-Ac3c-Leu-Asn-NH 2"
    "5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-" "Si" "dropwise" "MsCl" "equiv"
    "methanesulfonamide" "Aminocyclobutyl" "2.40-2.30" "2.30-2.20" "2.06-1.96"
    "methylsulfonamido" "2.44-2.22" "1.96-1.82" "-3-hydroxy-3-methylcyclobutyl"
    "TBS" "hydroxy" "diphenylethyl" "methylcyclobutyl" "-butyldimethylsilyl"
    "butyldimethylsilyl" "methylcyclobutanamine" "-butyldimethylsilyloxy"
    "butyldimethylsilyloxy" "3.40-3.30" "2.04-1.86" "1.80-1.60" "1.56-1.42"
    "1.14-1.00" "2.20-2.06" "1.84-1.60" "1.56-1.40" "1.38-1.24"
    "aminocyclopentanol" "hydroxycyclopentyl" "3.98-3.84" "3.84-3.70"
    "indoline-3" "3-chloro-2-fluorophenyl" "-6-Chloro-4" "Na" "adduct"
    "aminocyclobutanol" "2.30-2.06" "1.94-1.80" "HZ" "NH" "MeOD"
    "-neopentyl-2-oxospiro" "semi" "isomers" "hydroxycyclobutyl" "decimeters"
    "automatic polarimeter" "Rudolph" "polarimeter" "Autopol" "analytical UPLC"
    "BEH" "UPLC" "a Thermo-Scientific LCQ Fleet mass spectrometer" "LCQ"
    "spectrometers" "SunFire" "mesylate" "aminocyclobutanyl" "amines" "h-time"
    "gavage" "cMax" "a shorter T 1/2" "1/2" "-butanol" "butanol" "tert" "FP"
    "hydroxyl" "MI-888" "spirooxindoles" "= 1.68" "= 3" "= 0" "Ogino"
    "Sarasquesta" "Farina" "Liao" "Kato" "Iida" "Janku" "co-occurrence"
    "co-existence" "Yamauchi" "FFPE" "1.04–2.19" "non-significant" "63/105"
    "Subtypes" "Anglo" "biologically relevant subset" "colorectum"
    "phosphaditylinositols" "CIMP" "methyLight" "Melbourne" "≥3" "= 0"
    "Adenoviral re-expression" "microvessel"
    "nodular and metastatic melanoma frozen" "mg/kg" "VM"
    "indirect immunofluoresce" "immunofluoresce" "siILK" "pGSK-3β" "MetaMorph"
    "endoMT" "disaggregate" "vasculatures" "DPQ" "extravasate"
    "microvasculature" "EndoMT" "chemo-" "chemo" "monotherapy"
    "Migration/invasion" "fibroblast-like" "adducts" "melanogaster"
    "peptidoglycans" "virotherapy" "antiviral ISGs" "JFH1" "pISG" "PNU74654"
    "BIO" "co-staining" "HN" "monocytogenes" "5/6" "pIFNB1" "pIFNB" "nonimmune"
    "polyI∶C" "SSMD" "DExD" "ISGs" "canonical-like" "Sendai" "anti-FLAG"
    "cells/cm2" "pg/mL" "skin/hair follicle" "IIa" "A-allele" "T-allele"
    "G-allele" "Bonferroni" "rs1178108" "rs801540" "Ahr"
    "tumor allelic ratio greater" "our previously generated datasets" "SYPL"
    "aCGH" "musculus" "spretus" "Skts" "cSCCs" "NMSCs" "NMSC" "Non-melanoma"
    "SKTS5" "7q31" "7p21" "Skts5" "cSCC" "non-coding" "thePR"
    "the uterine mesenchyme" "mesenchyme" "ultrasonography" "CD3-" "CD"
    "month-old" "phosphohistone" "interwoven" "uteri" "andCtnnb" "Ctnnb"
    "withPR" "functionalis" "zona" "eutopic endometrium"
    "adenomatous polyposis coli (APC)" "coli (APC)" "oestrogen"
    "pathophysiology" "dysmenorrhoea" "dyschezia" "dyspareunia" "inPR" "cre/+"
    "myometrium" "ofPR" "ex3" "/+" "withCtnnb1" "physiopathology" "macropahges"
    "Rostene" "neuromodulators" "PDGF-βR"
    "a larger immediate Notch transcriptome" "indirect paracrine" "Alzheimer's"
    "HIVE" "Alzheimer" "BBB" "a known vascular permeant" "SIVE" "co-morbidity"
    "Akt/glycogen synthase kinase-3β" "hippocampi" "rAAV"
    "the existing hippocampal circuitry" "circuitry"
    "an increased neuronal damage/loss" "PDGF-BB mediated LTP ex vivo"
    "neurite" "blocker" "nigra" "susbtantia" "blockers" "midbrain" "PDGF-α"
    "-CC" "neuronal injury/death" "Trojan" "a vascular permeant" "glia"
    "Americans" "a cerebrovascular permeant" "permeant" "stem/progenitor" "GS"
    "JO" "Sequenom" "JP" "the intronic rs288979 SNP" "minigene" "rarer"
    "Some associated CNVs" "CNVs" "genic" "1.5x10" "1.15-2.30" "haplotypes"
    "Exome" "NCBI" "CEU" "HapMap" "browser" "UCSC" "PhastCons" "Spliceview"
    "ESEfinder" "Genotype" "identifier" "multisystem" "cardio" "LFIP"
    "rs288979" "an uncommon TagSNP" "TagSNP" "rs56085230" "TagSNPs" "probands"
    "Fallot" "Tetralogy" "BAK-BH3:BAK-groove" "Co-IP" "E24/E25" "leakiness"
    "supernatant" "Bismaleimidoethane" "BMOE" "sulfhydryl" "x" "multimer"
    "multimers" "bismaleimidohexane" "−/−cells" "2IMS" "PyMol" "nucleate"
    "intra" "undergoes" "narignenin" "co-treatment" "AP1-" "AP" "S3c"
    "reseveratrol" "forksolin" "INCB018429" "adenylate" "correct dyslipidaemia"
    "hyperinsulinaemia" "dyslipidaemia" "anti-inflammatory" "-4H-chromen-4-one"
    "flavanoid" "Flavanoids" "Kramer" "Tukey" "luminometer" "frozen"
    "Supernatants" "Eppendorf" "μl/dish" "DetectX" "thermocycler" "hSOCS3"
    "hMCP-1" "hActin" "OneStep" "RNeasy" "SDS/PAGE" "Biolabs" "England" "Cruz"
    "w/v" "pH " "Labtech" "BMG" "lysis" "μl" "MicroSource" "Roche" "DOTAP"
    "Renilla" "pGL4-hSOCS3-1.1" "microtitre" "COS-1" "Promega" "hSOCS3-1.1kbp"
    "Canada" "Toronto" "Mathews" "Jason" "kbp" "PromoCell" "v/v"
    "penicillin/streptomycin" "Dulbecco" "DMEM" "Scotland" "Glasgow" "Homberg"
    "Saarland" "Thiel" "Gerald" "luc" "pAldGCB" "Luc" "CCCAGGAA" "TACAAGAA"
    "TTCCTGGGA" "-GCCCGGCCGGTC" "GCCCGGCCGGTC" "CCAGGAA"
    "pGL3-SOCS3-107-pSTAT-SP3" "pGL3-SOCS3-107-pSTAT" "QuikChange" "AGCTTAA"
    "TGACTAA" "TTAAGCTT" "-GCCCGGCCGGTCTTCTTGTAATGT" "GCCCGGCCGGTCTTCTTGTAATGT"
    "AAGCTTAA" "-GCCTTTCAGTGCAGAGTA" "GCCTTTCAGTGCAGAGTA" "pGL3-SOCS3-107Luc"
    "pSTAT" "Hollywood" "Sinai" "Shlomo" "Germany" "Dusseldorf" "Heine"
    "Heinrich" "MRCT" "NINDS" "2-phenyl-1H-quinolin-4-one" "Maybridge"
    "Synchem" "Caymen" "chroman-4-one" "5,7-dihydroxy-2-" "Indofine"
    "hydroxyphenyl" "Aldrich" "IL6-Rα" "IL-6Rα" "polyphenol" "flavanoids"
    "VECs" "phospho-ERK1/2" "transfectant" "oocytes" "PGTP" "PSTAIRE" "coli"
    "viral supernatants" "proteosome" "pFLAG" "Laevis" "11q13" "DOC-1R"
    "coelomates" "SIMs" "TROSY" "N-labeled" "MAN1N" "HSQC"
    "active R-Smad-Smad4 heterotrimers" "Kd" "co-eluted" "homotrimer" "S4LMH2"
    "heterotrimers" "S3MH2-P" "S2MH2-P" "S4MH2" "chosen"
    "LDALFQGVPPNKSIYDVWVSHPRDL" "SIM" "heterotrimer" "PDB 1U7V" "α2β8" "β8"
    "CRYSOL" "MAN1LUHM" "ULM" "MAN1Luhm" "approximately 25 fold greater"
    "K375A-K420A" "D300H-R310H" "S2LMH2EEE" "EEME" "homotrimers" "UHM" "helix"
    "Smad2/3" "isothermal calorimetry (ITC)" "ITC" "calorimetry" "SAXS"
    "paralog" "Ollendorff" "Buschke" "dysplasia" "Smads" "and 3D"
    "co-activators" "stressful" "4p16.3" "haeme" "/Tyr 204" "metagene" "Blick"
    "RCGTG" "hydroxylases" "ypoxia" "CATSHL" "Germline" "phosphotidylinositol"
    "UC" "urothelium" "triphosphate" "Oligodeoxythymidine" "oligo" "HNSCC"
    "Chepatitis" "ELISA" "radiochemotherapy" "neoadjuvant" "NFKB" "titers"
    "drawn" "more favorable DFS" "significantly longer DFS" "longer DFS"
    "greatest" "Whitney" "AJCC" "Greece" "Mediterranean" "Eskimos" "Alaskan"
    "HNSCCs" "Tunisia" "Africa" "nasopharynx" "commonest" "histology"
    "9 hyperplastic nasopharyngeal biopsies" "nasopharyngeal biopsies"
    "biopsies" "= 0.16" "= 0.36" "= 0.020" "= 0.034" "= 0.022" "95% CI "
    "= 0.018" "= 0.024" "= 0.014" "antiproteases" "Ets" "supernatants" "PBMs"
    "hrs" "pg/ml" "6-minute" "FEV1" "FVC" "GG" "Weinberg" "homozygotes"
    "and 2G/2G" "non-cystic" "nthe" "-β1" "Polymorphisms" "lavage" "initiators"
    "collagens" "breathlessness" "2G/2G" "1G/1G" "1G/2G" "HRCT" "polymorphism"
    "β1" "monocyte/" "incosistant" "differents" "subgoup" "Begg" "Egger’s"
    "Egger" "ECOG" "extron" "Panitumumab based theapy" "theapy" "OVID" "n "
    "OPUS" "Bokemeyer" "nonresponders" "the Hayden’s" "Hayden" "PFS" "ORR"
    "HRs" "Cochrane" "= 0.004" "= 0.022" "= 0.018" "furthers" "overabundance"
    "DmNek2" "tetraploid" "complex/cyclosome" "shNek2" "premature centriole"
    "siCdk4" "shCdk4-1" "centriole" "shCdk4" "CCLE" "hyper"
    "multipolar mitoses" "mitoses" "euploidy" "Theodor Boveri’s" "Boveri"
    "re-expressed" "G 1 /S" "Elongn" "myelodysplastic syndoromes (MDS)"
    "syndoromes" "deconjugate" "homolog" "APPBP1/Uba3" "milder" "Co-expression"
    "co-precipitated" "Myeov2ΔFD" "ΔFD" "plasmacytes" "organelle" "anti-Flag"
    "#2" "Anti-Flag" "resultes" "Rb"
    "immortalized human bronchial cell line NHBE" "NHBE" "11q22–23" "siATDC"
    "the normal bronchial epithelia" "epithelia" "non-small-cell" "= 0.0022"
    "Xu" "Sjostrom" "helices" "Rodier" "Deshaies" "Amon" "Rahal" "multisubunit"
    "Zhao" "Tansey" "Thomas" "Popov" "Choi" "TRUSS" "NI" "BCSS" "Loi" "Rhodes"
    "GeneSapiens" "dominant-negative ΔF-FBXO28" "Ecker" "K6R" "Vervoorts"
    "Faiola" "E-box" "around 3/4" "Whitfield" "Dox"
    "a minimal promoter/reporter" "promoter/luciferase" "Welcker" "Soderberg"
    "isPLA" "MBI" "MBII" "Strohmaier" "Carrano" "Lehr" "der" "Kim" "E-boxes"
    "Fredlund" "Eisenman" "Operon" "ΔF-FBXO28" "CHX" "S-G2/M phase"
    "pS344-FBXO28" "pS" "LREVMESAVGNSSGSGQNEE" "phosphopeptide" "CDK1/2" "HDFs"
    "diploid" "Dennis" "Qiagen" "Rantala" "CSMA" "cyclin-dependent kinase 1/2"
    "Rahl" "Guccione" "Farnham" "Eberhardy" "Bouchard" "CACGTG" "Penn" "Meyer"
    "Henriksson" "Larsson" "Eilers" "Nakayama" "Frescas" "Skaar"
    "multi-subunit E3s" "Skowyra" "Cenciarelli" "Bai" "non-proteolytic"
    "Weissman" "Pickart" "Ciechanover" "Hershko" "Pagano" "Bashir" "downsteam"
    "= 0.018" "= 0.024" "= 0.020" "= 0.003" "G1/S" "co-activator"
    "HSCs/progenitors" "Ex"
    "efficiently form clonal multipotent self-renewing mesenspheres"
    "mesenspheres/well" "spheres/well" "HSC/progenitor" "nonsignificant"
    "mesensphere" "co-culture" "Cs"
    "co-cultured nonadherent PDGFRα + CD51 + mesenspheres" "ossicles" "gw"
    "parenchyma" "logettes" "td" "∼30%" "PαS" "co-segregate" "Multilineage"
    "wk" "Gfp" "Nes-" "Nes" "co-segregated" "Fs" "∼75%" "∼60%" "CD90" "ossicle"
    "Very few MSC-associated antigens" "Several MSC-associated antigens"
    "multilineage" "cultured human PDGFRα + CD51 + nonadherent mesenspheres"
    "co-segregates" "mesenspheres" "∼25%" "the predominant receptor subtypes"
    "proliferation/migration" "lamellopodia" "SCC10A" "TNBCs"
    "demonstrating sEcad-HER1 interactions" "sEcad-HER1 interactions"
    "paracrine" "Transwell" "HER2 +" "inMDA" "exogenous rhEcad/Fc"
    "HER2+/E-cadherin" "the rhEcad/Fc’s" "Fc" "rhEcad/Fc" "HER1–3"
    "HER2+ human" "HER2+ MMTV-PyMT" "Zuo" "Darby" "Madin" "Najy" "Xia" "mileu"
    "ectodomain" "TNBC" "HER2+" "PyMT" "sEcad" "anti-apoptotic" "–4-"
    "endometrium" "affinity/stability" "Smeenk" "binding/function" "iii"
    "Nikulenkov" "inor" "non-specific" "the well-studied CDNK1A" "prebound"
    "APOBEC3H" "andand" "≥2-fold" "TGCYY" "MEME" "Contente" "TGYCC" "TRANSFAC"
    "GCN4" "just one decamer" "spacers" "nt" "previously established decamers"
    "andF" "inandE" "SISSRs" "DO-1" "dimethylsulfoxide (DMSO)"
    "dimethylsulfoxide" "spacer" "non-canonical"
    "RRRCWWGYYY(N 0-13 )RRRCWWGYYY" "‘cistrome’" "dimethylsulphoxide (DMSO)"
    "dimethylsulphoxide" "two contiguous RRRCWWGYYY decamers" "decamer"
    "decamers" "RRRCWWGYYY" "∼2-fold" "∼20%" "log 2" "1 × 10" "Eastman"
    "Sorenson" "timeframe" "ATM−/−" "DSB" "J/m 2" "UV-" "PI3K-like" "g/ml"
    "average nucleolar EU" "CellProfiler" "Fonseca" "Carmo" "Jordan"
    "nucleolar Ku" "EU" "DSBs" "Ku" "TATA" "Pol1" "anti-cancer" "SSCP"
    "benign prostatic epithelium" "epithelium" "A5359G" "shRNA1"
    "non-silencing" "ii" "LN3" "RacGTP" "3p21" "RhoGTPases" "Wiley"
    "73:1326–1335" "Cdc18" "orthologue" "G1-to-S" "re-replicating" "chromatids"
    "L26A" "the homologous D-box" "D-box" "RxxLxxI" "siCDC" "EYFP" "ECFP"
    "re-replication" "Venus" "bi" "chromatid" "hexamers" "APC/C" "-to-S" "∼50%"
    "the most important NHRs" "homologyin" "multiprotein" "Oncomine" "anE"
    "plugin" "ClueGO" "Cytoscape" "DAVID" "Metacore" "highlightedER" "Browser"
    "BED" "transcriptomes" "SeqPos" "CEAS" "Seqpos" "Venn" "cistromes"
    "seqMINER" "cistrome" "genome-wide cartographies" "cartographies"
    "underpinnings" "these two important NHRs" "EREs" "NHR" "NHRs"
    "transcriptome" "log2" "3 × 10" "Kloog" "Sibai" "El" "Khalil" "Reg's"
    "fide" "bona" "19q12–13" "dataset" "exoenzyme" "pCofilin"
    "amplification/overexpression" "βIII-tubulin" "1×10" "Osmr" "Ctgf"
    "Rembrandt" "Chr" "the Mesenchymal subtype"
    "Proneural and Proliferative GBM subtypes" "ulators" "reg"
    "a computational algorithm" "subclass" "algorithm" "Reg" "Multi"
    "subclasses" "RhoA" "5 × 10" "migration/invasion" "levels/activities"
    "tensins" "neutrophin" "or/and" "vIII" "Partek" "datasets"
    "ubiquitination/degradation" "phosphorylaiton" "DVPK" "DGY" "EAMY" "CTY"
    "MTPS" "JEY" "SLAAR" "AIY" "pY1068" "pY1045" "tEGFR" "pEGFR" "hr" "TKB"
    "a dividing memory Treg subset" "naïve/high" "non-dividing" "subset"
    "dividing/non-dividing" "undergone" "sjTRECs" "sjTREC" "TREC" "RTE" "TRECs"
    "Netherlands" "#1" "#5" "Immunoassay" "NanoPro" "STAT5Bnull" "#6"
    "lymphopenia" "MFI" "Stejiv" "naïve" "antigens" "non-redundant"
    "hypergammaglobulinemia" "transducers" "vivo" "ex" "× 10" "CD8 +" "triage"
    "clinicians" "poorer" "enocarcinomas" "sidedness" "BSC" "et" "Roock"
    "algorithms" "codons" "Valencia" "Inc" "QIAGEN" "cheaper" "comorbidities"
    "Cl" "univariate" "GAC" "Microsatellite" "amplitudes" "codon"
    "splenic flexure" "sigmoid" "flexure" "cecum" "Bethesda" "aneuploidy"
    "germline" "biopsy" "Sanger" "Kirsten" "dideoxy" "microsatellite" "95% CI"
    "C-terminally" "the K + uptake-deficient strain SGY1528" "transformants"
    "occlude" "RXXSX" "KCNKs" "hyperaldosteronism" "à" "KCNK" "Wt" "Tawil"
    "Andersen" "Δ314/315" "Kolacna" "GIRK" "Shikano" "SGY1528" "proven"
    "transgenes" "Golgi-to-ER" "COP" "Kir" "cargos" "conductance"
    "retention/retrieval" "cerevisiae" "× 10" "area-under-the-curve (AUC)"
    "rs898518" "missense" "intron" "non-Hodgkin" "antigen" "Rs4368253" "=0.02"
    "rs4987856" "CLL/lymphoma" "rs4987852" "rs4987855" "exons" "Rs4406737"
    "uncommon SNPs" "penetrant" "rs11636802" "15q21.3" "rs7169431" "= 1.68×10"
    "Rs9273363" "6p21.32" "the previously reported rs757978 SNP" "=0.01"
    "rs13401811" "the previously reported SNP" "2q13" "=5.40×10" "at 5p15.33"
    "=1.92×10" "=1.68" "=2.71" "the most significant imputed SNPs"
    "The most significant SNPs" "only 372 bp" "bp" "=7.76" "=2.51" "=1.27"
    "=2.50" "=4.24" "=2.15" "C11orf21" "=1.22" "silico" "5×10" "Genomes"
    "P-values" "lambda" "Omni2.5" "Beadchip" "OmniExpress" "Illumina"
    "~8.5-fold" "8q22.3" "5p15.33" "10q23.31" "18q21.33" "11p15.5" "4q25"
    "2q33.1" "9p21.3" "18q21.32" "15q15.1" "and 2p22.2" "×10" "GWAS" "=1.60"
    "tTG's" "Perhaps" "perhaps" "Vivanco" "chemoresistance" "HA" "Levkowitz"
    "biotin" "~80%" "~50%" "soft agar" "agar" "AG1487" "cadaverine (MDC)"
    "cadaverine" "pentylamine (BPA)" "pentylamine" "lifespan" "TCGA" "Genome"
    "advanced/aggressive" "immuno" "acyl" "GTP-binding protein/acyl" "tTG"
    "g/mL" "anti-metastatic" "greater" "anti-metastasis" "LNM" "microRNASeq"
    "Targetscan" "Dharmacon" "multivariate" "DFS" "Meier" "Kaplan" "subsets"
    "UICC" "Gleason" "USA" "non-metastatic" "extravasation/inflammation"
    "N-dimethylsphingosine" "feedforward" "Crohn's" "Crohn" "patho"
    "VCAM-1/ICAM-1" "orpcDNA" "pcDNA3.1" "pcDNA" "VCAM-1/" "JTE-013" "JTE"
    "sphingosine" "dimethylsphingosine"
    "senescence-associated endothelial dysfunctions" "vascular dysfunctions"
    "dysfunctions" "Spingosine" "lipoproteins" "subtypes" "subtype" "ESI–MS"
    "replicate" "primary Sjogren’s" "antiphospholipid" "Sjogren" "anti-tumor"
    "introns" "rs4796793" "rs17749316" "SNP" "Haplotype" "=0.018" "=0.037"
    "rs16967637" "CG/GG" "genotypes" "=CC" "P-trend" "rs932169" "=0.39" "CC/CT"
    "=0.42" "=0.49" "95%CI" "genotype" "CC" "rs7217655" "=0.0020" "rs6503695"
    "rs12949918" "=0.047" "haplotype" "HWE" "multi" "kinase/signal"
    "Connecticut" "transducer" "19p13" "-to-" "motile" "co-transfected"
    "Annexin V/FITC" "FACS" "HGC" "EMT-like" "-UTR" "UTR" "Asian" "transwell"
    "undertaken" "U/mL" "mmol/L" "PS" "Uzoh" "enhancer" "IHC" "ErbB" "KEGG"
    "genes/pathways" "BC11A" "DCK" "Euclidean" "4x44K" "α5" "osteoblasts"
    "co-ordinately" "re-expression" "genome" "immunohistochemistry"
    "Transcriptome" "pre" "Pre" "DK" "MNM" "American" "Portuguese" "group D1"
    "non-HBOC" "Valka" "easier" "polymorphisms" "BRCA1/2" ".5266dupC"
    ".4035delA" "hidden" "penetrance" "Latvia" "Europe" "breast/ovarian"
    "frameshift" "SNPs" "European" "HBOC" "Thermo" "PBST" "nonfat" "difluoride"
    "polyvinylidene" "Cary" "absorbance" "PIPES" "mg/mL" "pH" "Microsoft"
    "GraphPad" "5-diphenyl-2" "4,5-dimethylthiazol-2-yl" "-tetrazolium"
    "tetrazolium" "Bridgeport" "VWR" "Rockville" "ATCC" "Dimethylbenzyloxy"
    "methanesulfonylamino" "Dimethoxybenzyloxy" "BrF" "methylamino"
    "methanesulfonyl" "Hexyloxy" "n" "3-benzodioxole-5-carboxamide"
    "naphthalenecarboxamide" "-4-iodobenzamide" "ESI-MS" "-4-methoxybenzamide"
    "BrCl" "-4-bromobenzamide" "-phenyl" "Dichlorobenzyloxy" "piperonyloyl"
    "naphthoyl" "iodobenzoyl" "dimethoxybenzoyl" "methoxybenzoyl"
    "bromobenzoyl" "arylcarbonyl" "-N-methyltrifluoro-methanesulfonamide"
    "-Nmethyltrifluoromethanesulfonamide" "Nmethyltrifluoromethanesulfonamide"
    "-4-nitrophenyl" "Hz" "N-Methyl-N-" "-trifluoromethanesulfonamide"
    "dimethoxybenzyloxy" "-4-" "N-methylation" "°C" "Et"
    "Trifluoromethanesulfonamides" "2-amino-5-nitrophenols" "UV" "mL/min"
    "O/CH 3" "OH" "Torrance" "Phenomenex" "Beckman" "CDCl" "MHz" "Bruker"
    "Cleveland" "spectrometer" "electrospray" "QTOF" "quadrupole" "Micromass"
    "Merck" "Whatman" "activity/stability" "methoxylbenzamide" "CNS" "gone"
    "pHsp27" "iodobenzoxyamides" "methoxybenzoxyamides" "sulfonamides"
    "methylsulfonamides" "trifluoromethylsulfonamides" "methylsulfonylamide"
    "methylenedioxybenzamide" "naphthylamide" "dimethoxybenzamide"
    "bromobenzamide" "iodobenzamide" "methoxybenzamide" "dichlorobenzyl"
    "dimethoxybenzyl" "trifluoromethanesulfonamide"
    "more reactive trifluoromethanesulfonic anhydride" "diethyl" "anhydride"
    "-dimethylformamide (DMF)" "2-amino-5-nitrophenol" "-dimethylformamide"
    "dimethylformamide" "hydride" "trifluoromethylsulfonyl"
    "This intermediate either underwent N-methylation" "nitro" "sulfonamide"
    "Methanesulfonamide" "benzyl" "Trifluoromethyl" "bioisostere"
    "trifluoromethyl" "trifluoromethylsulfonamide" "4-methylene-dioxyphenyl"
    "naphthyl" "iodophenyl" "dimethylphenyl" "methoxyphenyl" "bromophenyl"
    "alkyl" "dimethylbenzyl" "methylsulfonamide" "phenyl"
    "methanesulfonylmethylamino" "dimethylbenzyloxy" "benzo" "SAR"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-10201-10500*
  '(("MRE11–RAD50–NBS1" . SPARSER::COLLECTION)
    ("what role KPNA2" . SPARSER::PROTEIN)
    ("KPNA2 and c-Myc" . SPARSER::COLLECTION)
    ("TGF- β 1 and IFN- γ" . SPARSER::COLLECTION) ("meiotic" . SPARSER::DRUG)
    ("cancer-associated cargo proteins" . SPARSER::PROTEIN)
    ("c-Myc-luciferase" . SPARSER::COLLECTION)
    ("GAPDH and lamin B" . SPARSER::COLLECTION)
    ("subcellular fractionation," . SPARSER::PROTEIN)
    ("c-Myc and FOXO3a" . SPARSER::COLLECTION)
    ("our immunohistochemical (IHC) analysis," . SPARSER::PROTEIN)
    ("epithelial ovarian carcinoma (EOC)," . SPARSER::PROTEIN)
    ("c-nu" . SPARSER::PROTEIN) ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("cyclinD1" . SPARSER::PROTEIN) ("IFN- γ" . SPARSER::PROTEIN)
    ("TGF- β 1" . SPARSER::PROTEIN) ("PLAG1" . SPARSER::PROTEIN)
    ("karyopherin α" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KPNA2" . SPARSER::PROTEIN)
    ("Karyopherin alpha" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wip1-BAX" . SPARSER::COLLECTION) ("Bax and Wip1" . SPARSER::COLLECTION)
    ("Wip1-RUNX2-BAX" . SPARSER::COLLECTION)
    ("AKT and PKC ζ" . SPARSER::COLLECTION) ("SL" . SPARSER::PROTEIN)
    ("Mdm2 and Wip1" . SPARSER::COLLECTION)
    ("the IR-treated BAX T172D mutant" . SPARSER::MUTANT)
    ("approximately 40%," . SPARSER::PROTEIN)
    ("wild-type BAX or the mutants T172D, T174D," . SPARSER::COLLECTION)
    ("the mutants T172D, T174D," . SPARSER::PROTEIN)
    ("okadaic acid," . SPARSER::PROTEIN)
    ("the T172D, T174D," . SPARSER::PROTEIN)
    ("the T14D, S55A, T56D, S72A, T85D, and T127D mutants"
     . SPARSER::COLLECTION)
    ("the T14D, S55A, T56D, S72A, T85D," . SPARSER::PROTEIN)
    ("BAX-Wip1" . SPARSER::COLLECTION) ("Wip1/BAX" . SPARSER::COLLECTION)
    ("the anti-GFP" . SPARSER::ANTIBODY)
    ("anti-Wip1 or anti-FLAG" . SPARSER::COLLECTION)
    ("GFP-BAX" . SPARSER::COLLECTION) ("Wip1-Flag" . SPARSER::COLLECTION)
    ("GST-BAX" . SPARSER::COLLECTION) ("-BAX" . SPARSER::COLLECTION)
    ("considerably less mitochondrion-associated BAX" . SPARSER::PROTEIN)
    ("BAX proteins further, mitochondrial proteins" . SPARSER::PROTEIN)
    ("cellular IR" . SPARSER::PROTEIN) ("p38 MAPK" . SPARSER::PROTEIN)
    ("kinases and Wip1" . SPARSER::COLLECTION)
    ("the p38 MAPK-p53 and MKK-JNK-c-Jun pathways," . SPARSER::COLLECTION)
    ("MKK-JNK-c-Jun" . SPARSER::COLLECTION)
    ("p38 MAPK-p53" . SPARSER::PROTEIN-PAIR) ("MKK" . SPARSER::PROTEIN-FAMILY)
    (", finally, Wip1" . SPARSER::PROTEIN)
    ("ATM-Chk1/Chk2-p53" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("Wip1 and BAX" . SPARSER::COLLECTION) ("p87" . SPARSER::PROTEIN)
    ("p31" . SPARSER::PROTEIN) ("p180" . SPARSER::PROTEIN)
    ("B9)" . SPARSER::PROTEIN) ("Wip 1" . SPARSER::PROTEIN)
    ("MKK4" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 4" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN) ("PKC ζ" . SPARSER::PROTEIN)
    ("γ -H2AX" . SPARSER::PROTEIN) ("mdm2" . SPARSER::PROTEIN)
    ("PP2C" . SPARSER::PROTEIN) ("type 2C" . SPARSER::PROTEIN)
    ("PPM1D" . SPARSER::PROTEIN) ("Mg 2+ /Mn 2+ dependent" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN)
    ("checkpoint kinase 1" . SPARSER::PROTEIN) ("Wip1" . SPARSER::PROTEIN)
    ("phosphatase 1" . SPARSER::PROTEIN)
    ("dexamethasone or doxorubicin" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D/Cdk" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor and AFX" . SPARSER::COLLECTION) ("AFX" . SPARSER::PROTEIN)
    ("dioxin" . SPARSER::MOLECULE) ("-TGTCCT-3" . SPARSER::COLLECTION)
    ("the respective genes" . SPARSER::GENE)
    ("p27 and Skp2" . SPARSER::COLLECTION)
    ("Skp2 and p27" . SPARSER::COLLECTION) ("HA-Skp2" . SPARSER::COLLECTION)
    ("Obviously, p27" . SPARSER::PROTEIN)
    ("control (scramble)-infected cells ( xref )," . SPARSER::PROTEIN)
    ("p27 and glucocorticoid" . SPARSER::COLLECTION)
    ("Cdk4 and Cdk6" . SPARSER::COLLECTION)
    ("Cyclin D3 and p27" . SPARSER::COLLECTION)
    ("almost no Dex-inducibility ( xref )," . SPARSER::PROTEIN)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("cyclin D3 or c-myc" . SPARSER::COLLECTION)
    ("cyclin D3 and p27" . SPARSER::COLLECTION)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("Glucocorticoids and its analogs" . SPARSER::COLLECTION)
    ("Skp2-p27" . SPARSER::COLLECTION)
    ("p27 and cyclin D3" . SPARSER::COLLECTION)
    ("INK4a/ARF family" . SPARSER::COLLECTION)
    ("lymphoid and non-lymphoid" . SPARSER::COLLECTION)
    ("cyclin D3 and/or c-myc" . SPARSER::COLLECTION)
    ("DNA-sequences" . SPARSER::DNA)
    ("the cell cycle inhibitor p27 and its negative regulator Skp2"
     . SPARSER::COLLECTION)
    ("protein and E3" . SPARSER::COLLECTION)
    ("Glucocorticoids" . SPARSER::PROTEIN)
    ("Glucocorticoid" . SPARSER::PROTEIN) ("ADP-Ribose" . SPARSER::MOLECULE)
    ("TATA box-binding protein" . SPARSER::PROTEIN) ("CA-3" . SPARSER::PROTEIN)
    ("A-2" . SPARSER::PROTEIN) ("3–2" . SPARSER::PROTEIN)
    ("FOXO3A" . SPARSER::PROTEIN) ("p27–30" . SPARSER::PROTEIN)
    ("F-box protein Skp2" . SPARSER::PROTEIN) ("ARF family" . SPARSER::PROTEIN)
    ("Cyclin D3" . SPARSER::PROTEIN)
    ("the dual PI3K/mTOR inhibitors or the pan-PI3K inhibitors"
     . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("convenient," . SPARSER::PROTEIN)
    ("BEZ235 ( xref ) and GDC-0980 ( xref )" . SPARSER::COLLECTION)
    ("a dual PI3K and mTOR inhibitor" . SPARSER::INHIBITOR)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("NRG1 and IGF1" . SPARSER::COLLECTION)
    ("IGF1 or NRG1" . SPARSER::COLLECTION)
    ("human recombinant IGF1 ( xref and xref ) or NRG1 ( xref and xref )"
     . SPARSER::COLLECTION)
    ("possible ligands" . SPARSER::LIGAND)
    ("beginning treatment, both pAkt and pS6" . SPARSER::COLLECTION)
    ("pAkt and pS6" . SPARSER::COLLECTION)
    ("either BYL719 (25 mg/kg) or RAD001 (0.5 mg/kg)" . SPARSER::COLLECTION)
    ("minimal antitumor activity," . SPARSER::PROTEIN)
    ("p110α and mTORC1" . SPARSER::COLLECTION)
    ("BYL719 and RAD001" . SPARSER::COLLECTION)
    ("mTORC1 and p110α" . SPARSER::COLLECTION)
    ("responding patient (patient 6, who progressed on BYL719 after 3.6 months of treatment), pS6"
     . SPARSER::PROTEIN)
    ("Strikingly, pS6" . SPARSER::PROTEIN)
    ("possibly other PI3K/Akt inhibitors" . SPARSER::INHIBITOR)
    ("RICTOR or RAPTOR" . SPARSER::COLLECTION)
    ("BYL719 and MCF7R" . SPARSER::COLLECTION) ("RAPTOR" . SPARSER::PROTEIN)
    ("RICTOR" . SPARSER::PROTEIN)
    ("FRAP1 (mTOR) and phosphoinositide-dependent kinase-1 (PDPK1)"
     . SPARSER::COLLECTION)
    ("BYL719 or GDC-0941" . SPARSER::COLLECTION)
    ("BYL719 or MCF7R" . SPARSER::COLLECTION)
    ("neither BYL719 nor GDC-0941" . SPARSER::COLLECTION)
    ("both MCF7 and MCF7R cells," . SPARSER::COLLECTION)
    ("DR" . SPARSER::MOLECULE)
    ("the sensitive parental cells pS6" . SPARSER::PROTEIN)
    ("both parental and resistant cells," . SPARSER::PROTEIN)
    ("pS6(240/4) and," . SPARSER::COLLECTION)
    ("a more distal component" . SPARSER::COMPONENT)
    ("-mut" . SPARSER::COLLECTION) ("PTEN or INPP4B" . SPARSER::COLLECTION)
    ("p110α-targeted drugs and delay" . SPARSER::COLLECTION)
    ("a  2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("k  2" . SPARSER::PROTEIN)
    ("k  1" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("FRAP1" . SPARSER::PROTEIN) ("INPP4B" . SPARSER::PROTEIN)
    ("p110δ" . SPARSER::PROTEIN) ("p110β" . SPARSER::PROTEIN)
    ("BYL719" . SPARSER::DRUG) ("RAF/MEK" . SPARSER::COLLECTION)
    ("Science Translational Medicine ( xref )," . SPARSER::PROTEIN)
    ("Medicine" . SPARSER::DRUG) ("Indeed, TORC1" . SPARSER::PROTEIN)
    ("COT" . SPARSER::PROTEIN) ("a robust biomarker" . SPARSER::MOLECULE)
    ("RAF and MEK inhibitors (dabrafenib and trametinib) ( xref ),"
     . SPARSER::PROTEIN)
    ("dabrafenib and trametinib" . SPARSER::COLLECTION)
    ("P-S6 and P-ERK" . SPARSER::COLLECTION)
    ("P-ERK or P-S6" . SPARSER::COLLECTION)
    ("TORC1 or PI3K" . SPARSER::COLLECTION)
    ("most apoptotic proteins" . SPARSER::PROTEIN)
    ("PI3K–TORC" . SPARSER::COLLECTION) ("TORC" . SPARSER::PROTEIN-FAMILY)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("p90 ribosomal S6 kinase (RSK)," . SPARSER::PROTEIN)
    ("the predominant upstream regulator" . SPARSER::REGULATOR)
    ("–AKT" . SPARSER::COLLECTION)
    ("vemurafenib or selumetinib" . SPARSER::COLLECTION)
    ("the selective RAF inhibitor vemurafenib (PLX4032) and the selective MEK inhibitor selumetinib (AZD6244)"
     . SPARSER::COLLECTION)
    ("selumetinib" . SPARSER::DRUG) (", robust biomarkers" . SPARSER::MOLECULE)
    ("serial fine-needle aspiration biopsies," . SPARSER::PROTEIN)
    ("RAF or MEK" . SPARSER::COLLECTION) ("RAF and MEK" . SPARSER::COLLECTION)
    ("BCL-XL" . SPARSER::PROTEIN) ("ABT-263" . SPARSER::DRUG)
    ("MART1" . SPARSER::PROTEIN) ("HMB45" . SPARSER::DRUG)
    ("ABT263" . SPARSER::DRUG) ("PI3K–AKT" . SPARSER::PROTEIN)
    ("extracellular signal – regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLX4032" . SPARSER::DRUG) ("P-S6" . SPARSER::PROTEIN)
    ("osteosclerotic reactions," . SPARSER::PROTEIN)
    ("a faster rate," . SPARSER::PROTEIN)
    ("both low Akt1 (Neo) and high Akt1 (HA-Akt1)" . SPARSER::COLLECTION)
    ("Akt/CXCR4" . SPARSER::COLLECTION)
    ("an osteosclerotic phenotype," . SPARSER::PROTEIN)
    ("Akt and CXCR4" . SPARSER::COLLECTION) ("DU145-neo" . SPARSER::COLLECTION)
    ("DU145-Neo" . SPARSER::COLLECTION) ("DU145-HA-Akt1" . SPARSER::COLLECTION)
    ("HA-Akt1" . SPARSER::COLLECTION)
    ("both lipid and protein phosphatase activity [ xref ]"
     . SPARSER::COLLECTION)
    ("CXCR4 and CXCL12" . SPARSER::COLLECTION)
    ("CXCL12 and CXCR4" . SPARSER::COLLECTION)
    ("MMAC1/TEP1" . SPARSER::COLLECTION)
    ("CXCL12 and its receptors" . SPARSER::COLLECTION)
    ("its two distinct receptors, CXCR4 and CXCR7" . SPARSER::COLLECTION)
    ("CXCR4 and CXCL12 and Akt" . SPARSER::COLLECTION)
    ("CXCL12 and Akt" . SPARSER::COLLECTION)
    ("CXCL12/CXCR4" . SPARSER::COLLECTION) ("AMD3100" . SPARSER::DRUG)
    ("Akt-induced" . SPARSER::PROTEIN) ("BPH-1" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN) ("TEP1" . SPARSER::PROTEIN)
    ("MMAC1" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("JI" . SPARSER::PROTEIN) ("soft tissue cancers, FGFR3" . SPARSER::PROTEIN)
    ("late embryonic stages," . SPARSER::PROTEIN)
    ("RNA and tissue" . SPARSER::COLLECTION)
    ("Consequently, active mutants" . SPARSER::MUTANT)
    ("Accordingly, FGFR3" . SPARSER::PROTEIN)
    ("Importantly, frequent loss of heterozygosity" . SPARSER::PROTEIN)
    ("colorectal cancers," . SPARSER::PROTEIN)
    ("mesenchymal cells, FGFR3" . SPARSER::PROTEIN)
    ("Further, FGFR3" . SPARSER::PROTEIN)
    ("strong staining," . SPARSER::PROTEIN)
    ("undetectable," . SPARSER::PROTEIN)
    ("BAX and Bcl-2" . SPARSER::COLLECTION)
    ("mesenchymal cells," . SPARSER::PROTEIN)
    ("p53 and Phospho-p53" . SPARSER::COLLECTION)
    ("ERKs and P38" . SPARSER::COLLECTION)
    ("RAS and the downstream MAP Kinases," . SPARSER::COLLECTION)
    ("PI3Kinase/Akt" . SPARSER::COLLECTION)
    ("FGF2 and FGF9" . SPARSER::COLLECTION)
    ("FGF17 and FGF18" . SPARSER::COLLECTION)
    ("FGF4 and FGF23" . SPARSER::COLLECTION)
    ("available FGFs" . SPARSER::PROTEIN)
    ("mesenchymal cell features (Mia PaCa-2 and PANC-1), FGFR3"
     . SPARSER::PROTEIN)
    ("tumor suppressive effects," . SPARSER::PROTEIN)
    ("FGFR-IIIc" . SPARSER::COLLECTION) ("distinct FGFR3" . SPARSER::PROTEIN)
    ("-IIIc" . SPARSER::COLLECTION) ("FGFR3-IIIc-KD" . SPARSER::COLLECTION)
    ("IIIc" . SPARSER::PROTEIN) ("FGFR3-IIIc" . SPARSER::COLLECTION)
    ("types and models" . SPARSER::COLLECTION)
    ("the strong immunoglobulin heavy chain promoter," . SPARSER::PROTEIN)
    ("muscle-invasive lesions," . SPARSER::PROTEIN)
    ("intestinal mouse tissues," . SPARSER::PROTEIN)
    ("FGFs and FGFRs" . SPARSER::COLLECTION) ("FGFs" . SPARSER::PROTEIN)
    (", STATs in epithelial-like cells and MAP Kinases in mesenchymal-like cells"
     . SPARSER::COLLECTION)
    ("p42 MAPK" . SPARSER::PROTEIN) ("P-p38" . SPARSER::PROTEIN)
    ("P-ERK" . SPARSER::PROTEIN) ("FGF18" . SPARSER::PROTEIN)
    ("FGF17" . SPARSER::PROTEIN) ("FGF23" . SPARSER::PROTEIN)
    ("FGF4" . SPARSER::PROTEIN) ("PANC-1 " . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN)
    ("MAP Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Huntington" . SPARSER::PROTEIN)
    ("a highly polymorphic gene" . SPARSER::GENE) ("ESP" . SPARSER::PROTEIN)
    ("optineurin" . SPARSER::PROTEIN)
    ("the archetypal glaucoma-causing genes," . SPARSER::PROTEIN)
    ("Optineurin" . SPARSER::PROTEIN) ("ASB10 and Rab7" . SPARSER::COLLECTION)
    ("larger structures (5–9 µm in diameter)," . SPARSER::PROTEIN)
    ("usually spherical," . SPARSER::PROTEIN)
    ("multiple autophagic biomarkers" . SPARSER::MOLECULE)
    ("the autophagic pathway—via HDAC6" . SPARSER::PROTEIN)
    ("HDAC6 and p62" . SPARSER::COLLECTION)
    ("the T255T synonymous mutation," . SPARSER::PROTEIN)
    ("MG132 and bafilomycin A1" . SPARSER::COLLECTION)
    ("ASB10 (red) or LC3 (green) antibodies" . SPARSER::COLLECTION)
    ("MG132-treated HTM cells, LC3-II" . SPARSER::PROTEIN)
    ("known autophagy inhibitors (wortmannin and bafilomycin A1) and an inhibitor"
     . SPARSER::COLLECTION)
    ("wortmannin and bafilomycin A1" . SPARSER::COLLECTION)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("ASB10 or GFP" . SPARSER::COLLECTION) ("ASB10-GFP" . SPARSER::COLLECTION)
    ("LC3 and Rab7" . SPARSER::COLLECTION)
    ("ubiquitin and HDAC6" . SPARSER::COLLECTION)
    ("Finally, Rab7" . SPARSER::PROTEIN) ("ASB10-" . SPARSER::PROTEIN)
    ("an archetypal biomarker" . SPARSER::MOLECULE) ("Rab7" . SPARSER::PROTEIN)
    ("the endocytic pathway," . SPARSER::PROTEIN)
    ("the small GTPase Rab7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a cytosolic form (LC3-I) and an autophagosome-associating form (LC3-II)"
     . SPARSER::COLLECTION)
    ("the multifunctional scaffold protein, p62" . SPARSER::PROTEIN)
    ("HDAC6 and HSP70" . SPARSER::COLLECTION)
    ("Histone deacetylase 6 (HDAC6) and HSP70" . SPARSER::COLLECTION)
    ("the step-wise degradation process," . SPARSER::PROTEIN)
    ("Recently, linkage-specific antibodies" . SPARSER::ANTIBODY)
    ("Conversely, K63-linked ubiquitin" . SPARSER::PROTEIN)
    ("Polyubiquitin" . SPARSER::PROTEIN)
    ("Cullin5 and elongin" . SPARSER::COLLECTION)
    ("elongin" . SPARSER::PROTEIN)
    ("ubiquitin-proteasomal" . SPARSER::COLLECTION)
    ("perinuclear," . SPARSER::PROTEIN)
    ("larger, approximately 72 kDa" . SPARSER::PROTEIN)
    ("rASB" . SPARSER::PROTEIN)
    ("two commercially available ASB10 antibodies" . SPARSER::ANTIBODY)
    ("distinct," . SPARSER::PROTEIN)
    ("For instance, ASB3 and ASB9" . SPARSER::COLLECTION)
    ("ASB3 and ASB9" . SPARSER::COLLECTION)
    ("receptor and creatine kinase" . SPARSER::COLLECTION)
    ("ANK" . SPARSER::PROTEIN) ("ASB" . SPARSER::PROTEIN)
    ("A synonymous T255T variant" . SPARSER::VARIANT)
    ("the causative gene" . SPARSER::GENE)
    ("ankyrin repeat and suppressor of cytokine signaling"
     . SPARSER::COLLECTION)
    ("a degenerative optic neuropathy," . SPARSER::PROTEIN)
    ("ubiquitin or HDAC6" . SPARSER::COLLECTION)
    ("the larger structures," . SPARSER::PROTEIN)
    ("ubiquitin and the α4 subunit" . SPARSER::COLLECTION)
    ("anti-ASB10 and various biomarkers" . SPARSER::COLLECTION)
    ("proteasomal and autophagy-lysosomal" . SPARSER::COLLECTION)
    ("Ankyrin repeat and suppressor of cytokine signaling"
     . SPARSER::COLLECTION)
    ("Rab family" . SPARSER::PROTEIN)
    ("Histone deacetylase 6" . SPARSER::PROTEIN) ("alpha 4" . SPARSER::PROTEIN)
    ("Cullin5" . SPARSER::PROTEIN) ("2–4 µ" . SPARSER::PROTEIN)
    ("ANK2" . SPARSER::PROTEIN) ("alpha4" . SPARSER::PROTEIN)
    ("insulin receptor substrate 4" . SPARSER::PROTEIN)
    ("ASB4" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("ASB9" . SPARSER::PROTEIN) ("ASB3" . SPARSER::PROTEIN)
    ("GLC1F" . SPARSER::PROTEIN) ("open angle" . SPARSER::PROTEIN)
    ("glaucoma 1" . SPARSER::PROTEIN) ("bafilomycin A1" . SPARSER::DRUG)
    ("LAMP1" . SPARSER::PROTEIN) ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("α4" . SPARSER::PROTEIN) ("ASB10" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("GMP" . SPARSER::GMP) ("only MK2," . SPARSER::PROTEIN)
    ("p38-MK2-Rsk-GSK3β" . SPARSER::COLLECTION)
    ("hydrolase and TTP" . SPARSER::COLLECTION) ("TTP" . SPARSER::PROTEIN)
    ("p38-Rsk" . SPARSER::COLLECTION) ("Cytokine" . SPARSER::PROTEIN)
    ("IL-23, IL-1β and IL-6" . SPARSER::COLLECTION)
    ("IL-12 and Th-1" . SPARSER::COLLECTION)
    ("healthy donor DC IL-12 production," . SPARSER::PROTEIN)
    ("p38-MK2-Rsk" . SPARSER::COLLECTION)
    ("MK2 and RskS380" . SPARSER::COLLECTION)
    ("ERK and Rsk" . SPARSER::COLLECTION)
    ("ERK, p38 and Rsk" . SPARSER::COLLECTION) ("RskS" . SPARSER::PROTEIN)
    ("IL-10 and IL-12" . SPARSER::COLLECTION)
    ("p38 and ERK" . SPARSER::COLLECTION) ("p35 and p40" . SPARSER::COLLECTION)
    ("p19, p35 and p40" . SPARSER::COLLECTION)
    ("p35, p40 and p19" . SPARSER::COLLECTION)
    ("p38γ and δ," . SPARSER::COLLECTION)
    ("IL-12, IL-10 and IL-1β" . SPARSER::COLLECTION)
    ("IL-1β, IL-23 and IL-10" . SPARSER::COLLECTION)
    ("p38, myDC and moDC" . SPARSER::COLLECTION)
    ("IL-6 and IL-1β" . SPARSER::COLLECTION) ("TLR " . SPARSER::PROTEIN-FAMILY)
    ("moDC and myDC" . SPARSER::COLLECTION) ("Interleukin" . SPARSER::PROTEIN)
    ("the distal Rsk kinase" . SPARSER::KINASE)
    ("p38-MK2" . SPARSER::COLLECTION) ("Rsk" . SPARSER::PROTEIN)
    ("IL-1β, IL-6, IL-10, IL-12 and IL-23" . SPARSER::COLLECTION)
    ("moDC" . SPARSER::PROTEIN) ("ATF1" . SPARSER::PROTEIN)
    ("LSP1" . SPARSER::PROTEIN) ("Th-1" . SPARSER::PROTEIN)
    ("p40" . SPARSER::PROTEIN) ("CD303" . SPARSER::PROTEIN)
    ("IL-23p19" . SPARSER::PROTEIN) ("IL-23A" . SPARSER::PROTEIN)
    ("IL-12p40" . SPARSER::PROTEIN) ("IL-12B" . SPARSER::PROTEIN)
    ("IL-12p35" . SPARSER::PROTEIN) ("IL-12A" . SPARSER::PROTEIN)
    ("IL23A" . SPARSER::PROTEIN) ("IL12B" . SPARSER::PROTEIN)
    ("IL12A" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("TLR7" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD1c" . SPARSER::PROTEIN) ("IL-12p70" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN) ("phenotypic consequence," . SPARSER::PROTEIN)
    ("hTERTs" . SPARSER::PROTEIN) ("pure form" . SPARSER::FORM)
    ("poison" . SPARSER::MOLECULE)
    ("telomerase-accessory proteins" . SPARSER::PROTEIN)
    ("Finally, some hTERT variants" . SPARSER::VARIANT)
    ("the 19 disease-associated alleles" . SPARSER::ALLELE)
    ("Many disease-associated hTERT variants" . SPARSER::VARIANT)
    ("disease-associated variants" . SPARSER::VARIANT)
    ("the disease-associated mutants" . SPARSER::MUTANT)
    ("a POT1-TPP1-insensitive mutant" . SPARSER::MUTANT)
    ("the previously described G100V mutant" . SPARSER::MUTANT)
    ("hTR and various hTERT alleles" . SPARSER::COLLECTION)
    ("loading control," . SPARSER::PROTEIN)
    ("dyskerin and Nop10" . SPARSER::COLLECTION) ("Nop10" . SPARSER::PROTEIN)
    ("some disease-associated hTERT variants" . SPARSER::VARIANT)
    ("telomerase activity and processivity," . SPARSER::COLLECTION)
    ("24 disease-associated hTERT variants" . SPARSER::VARIANT)
    ("the disease-associated alleles" . SPARSER::ALLELE)
    ("One hTERT mutant, G100V," . SPARSER::PROTEIN)
    ("hTERT and hTR" . SPARSER::COLLECTION)
    ("hTERT or hTR" . SPARSER::COLLECTION) ("Heterozygotes" . SPARSER::PROTEIN)
    ("TINF2 and RTEL1" . SPARSER::COLLECTION)
    ("Insufficient telomerase activity" . SPARSER::PROTEIN)
    ("TR or TERT" . SPARSER::COLLECTION)
    ("a reverse transcriptase subunit TERT ( xref , xref ) and multiple accessory proteins"
     . SPARSER::COLLECTION)
    ("multiple accessory proteins" . SPARSER::PROTEIN)
    ("TERC" . SPARSER::PROTEIN) ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the previously reported disease-associated hTERT alleles"
     . SPARSER::ALLELE)
    ("multiple disease-associated hTERT variants" . SPARSER::VARIANT)
    ("hTR" . SPARSER::RNA) ("POT1-TPP1" . SPARSER::COLLECTION)
    ("telomerases" . SPARSER::PROTEIN) ("hPOT1" . SPARSER::PROTEIN)
    ("Telomerase activity" . SPARSER::PROTEIN) ("TINF2" . SPARSER::PROTEIN)
    ("MYCN-protein" . SPARSER::COLLECTION)
    ("protein and MYC protein" . SPARSER::COLLECTION)
    ("MYC-protein" . SPARSER::COLLECTION) ("MYC-MAX" . SPARSER::COLLECTION)
    ("MYCN or MYC" . SPARSER::COLLECTION)
    ("significantly worse 3-year EFS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYCN and," . SPARSER::COLLECTION)
    ("MYCN/MYC protein" . SPARSER::COLLECTION)
    ("MYCN and MYC" . SPARSER::COLLECTION)
    ("TH positive cells, often sporadic," . SPARSER::PROTEIN)
    ("MYCN/MYC" . SPARSER::COLLECTION)
    ("genotype-phenotype discordant neuroblastomas," . SPARSER::PROTEIN)
    ("MYCN -Non-Amplified ( MYCN -NA) tumors (31.7±11.7%)," . SPARSER::PROTEIN)
    ("Surprisingly, EFS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-NA" . SPARSER::COLLECTION)
    ("these prognostic indicators," . SPARSER::PROTEIN)
    ("MYCN and MYC protein" . SPARSER::COLLECTION) ("CD20" . SPARSER::PROTEIN)
    ("CD99" . SPARSER::PROTEIN) ("PGP9.5" . SPARSER::PROTEIN)
    ("gene or group" . SPARSER::COLLECTION) ("avalable," . SPARSER::PROTEIN)
    ("GLP1R and NPY1R" . SPARSER::COLLECTION)
    ("neuropeptides and peptide" . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN)
    ("Neuropeptide Y and neuropeptide Y" . SPARSER::COLLECTION)
    ("NPY1R and NPY5R" . SPARSER::COLLECTION) ("Pima" . SPARSER::DRUG)
    ("Serotonin" . SPARSER::MOLECULE) ("SOCS3 and STAT3" . SPARSER::COLLECTION)
    ("exogenous GLP-1" . SPARSER::PROTEIN) ("AGRP" . SPARSER::PEPTIDE)
    ("a nonsynonymous mutant" . SPARSER::MUTANT)
    ("plausible," . SPARSER::PROTEIN) ("peptide ( AGRP )" . SPARSER::PEPTIDE)
    ("Agouti" . SPARSER::PROTEIN-FAMILY) ("Ghrelin" . SPARSER::PROTEIN)
    ("gene ( GHRL )" . SPARSER::GENE) ("ghrelin" . SPARSER::PROTEIN)
    ("Leptin" . SPARSER::PROTEIN) ("CPE" . SPARSER::PROTEIN)
    ("GHRL" . SPARSER::PROTEIN) ("highly heritable," . SPARSER::PROTEIN)
    ("Carboxypeptidase E" . SPARSER::PROTEIN)
    ("Neuropeptide Y" . SPARSER::PROTEIN) ("5-HT" . SPARSER::PROTEIN)
    ("TTC8" . SPARSER::PROTEIN) ("BBS7" . SPARSER::PROTEIN)
    ("BBS5" . SPARSER::PROTEIN) ("BBS4" . SPARSER::PROTEIN)
    ("ARL6" . SPARSER::PROTEIN) ("BBS2" . SPARSER::PROTEIN)
    ("BBS1" . SPARSER::PROTEIN) ("HTR2C" . SPARSER::PROTEIN)
    ("neuropeptide Y" . SPARSER::PROTEIN)
    ("glucagon-like peptide 1" . SPARSER::PROTEIN)
    ("carboxypeptidase E" . SPARSER::PROTEIN) ("MC4R" . SPARSER::PROTEIN)
    ("melanocortin 4 receptor" . SPARSER::PROTEIN) ("NPY1R" . SPARSER::PROTEIN)
    ("NPY5R" . SPARSER::PROTEIN) ("HTR2A" . SPARSER::PROTEIN)
    ("GLP1R" . SPARSER::PROTEIN) ("AKT2/GSK3β" . SPARSER::COLLECTION)
    ("the classical downstream effector, AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p110 and p85" . SPARSER::COLLECTION)
    ("PI3K-subunits" . SPARSER::COLLECTION)
    ("either less specific pharmacologic PI3K inhibitors" . SPARSER::INHIBITOR)
    ("BRAF/MEK/ERK" . SPARSER::COLLECTION) ("HA-SUFU" . SPARSER::COLLECTION)
    ("GLI" . SPARSER::PROTEIN) ("PKA and CK-1" . SPARSER::COLLECTION)
    ("RET and MATN2" . SPARSER::COLLECTION)
    ("exogenous Gli1" . SPARSER::PROTEIN)
    ("AKT2 and myr-AKT2" . SPARSER::COLLECTION)
    ("Gli1-GFP" . SPARSER::COLLECTION)
    ("Similarly, cyclopamine," . SPARSER::PROTEIN)
    ("approximately 67% and 40%," . SPARSER::PROTEIN)
    ("pcDNA" . SPARSER::PROTEIN)
    ("Interestingly, silencing AKT2," . SPARSER::PROTEIN)
    ("a robust luciferase reporter system ( xref )," . SPARSER::PROTEIN)
    ("Interestingly, AKT2" . SPARSER::PROTEIN)
    ("Recently, isoform" . SPARSER::ISOFORM)
    ("Interestingly, Gli1" . SPARSER::PROTEIN)
    ("Gli2 and Gli3" . SPARSER::COLLECTION) ("/casein" . SPARSER::COLLECTION)
    ("Gli1, Gli2 and Gli3" . SPARSER::COLLECTION) ("Gli2" . SPARSER::PROTEIN)
    ("a pediatric neuroendocrine tumor," . SPARSER::PROTEIN)
    ("exogenous Gli1 protein" . SPARSER::PROTEIN) ("SUFU" . SPARSER::PROTEIN)
    ("PI3K/AKT2" . SPARSER::COLLECTION) ("Bis–Tris" . SPARSER::MOLECULE)
    ("MATN2" . SPARSER::PROTEIN) ("CK-1" . SPARSER::PROTEIN)
    ("Gli3" . SPARSER::PROTEIN) ("LSD1 and amine" . SPARSER::COLLECTION)
    ("pargyline, tranylcypromine and polyamine" . SPARSER::COLLECTION)
    ("polyamine" . SPARSER::MOLECULE) ("pargyline" . SPARSER::DRUG)
    ("a widely acting suppressor" . SPARSER::SUPPRESSOR)
    ("Indeed, CDH-1" . SPARSER::PROTEIN) ("a systemic," . SPARSER::PROTEIN)
    ("In fact, LSD1/CoREST complex" . SPARSER::BIO-COMPLEX)
    ("Snail and slug" . SPARSER::COLLECTION)
    ("several hundred nanosecond time scales reversibly ( xref , xref ),"
     . SPARSER::PROTEIN)
    ("More importantly, LSD1" . SPARSER::PROTEIN) ("CtBP" . SPARSER::PROTEIN)
    ("AO" . SPARSER::PROTEIN) ("H3K4 (H3K4m3) ( xref )," . SPARSER::PROTEIN)
    ("Tranylcypromine" . SPARSER::DRUG)
    ("anti-LSD1 and anti-H3K4m2" . SPARSER::COLLECTION)
    ("siRNA and tranylcypromine" . SPARSER::COLLECTION)
    ("tranylcypromine" . SPARSER::DRUG)
    ("LSD1 and CDH-2" . SPARSER::COLLECTION)
    ("LSD1, CDH-1 and CDH-2" . SPARSER::COLLECTION)
    ("5 (17%) benign colon tissues," . SPARSER::PROTEIN)
    ("significantly higher expression," . SPARSER::PROTEIN)
    ("flavin" . SPARSER::MOLECULE) ("LSD1/CoREST" . SPARSER::COLLECTION)
    ("anchors" . SPARSER::ANCHOR) ("LSD1–CoREST" . SPARSER::COLLECTION)
    ("Snail/Slug" . SPARSER::COLLECTION) ("Snail/Gfi-1" . SPARSER::COLLECTION)
    ("‘hook'" . SPARSER::PROTEIN-FAMILY) ("hook" . SPARSER::PROTEIN-FAMILY)
    ("LSD1, Snail and Slug" . SPARSER::COLLECTION)
    ("snai1, slug, zeb1, zeb2 and twist," . SPARSER::COLLECTION)
    ("zeb2" . SPARSER::PROTEIN) ("zeb" . SPARSER::PROTEIN)
    ("slug" . SPARSER::PROTEIN) ("intercellular adhesion," . SPARSER::PROTEIN)
    ("CDH" . SPARSER::PROTEIN) ("non-selective" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN) ("H3-K9" . SPARSER::PROTEIN)
    ("H3-K4" . SPARSER::PROTEIN) ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("2–4 " . SPARSER::PROTEIN) ("TG-3" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("s5a" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE) ("amine oxidase" . SPARSER::PROTEIN)
    ("Gfi-1" . SPARSER::PROTEIN) ("snai1" . SPARSER::PROTEIN)
    ("CDH-1" . SPARSER::PROTEIN) ("v-SNARE and t-SNAREs" . SPARSER::COLLECTION)
    ("the exocyst and other elements" . SPARSER::COLLECTION)
    ("the ternary Snc1p–Sso1p–Sec9p complex" . SPARSER::BIO-COMPLEX)
    ("the Sso1p–Sec9p binary tSNARE complex" . SPARSER::BIO-COMPLEX)
    ("the pure Sec6p homodimer" . SPARSER::HOMODIMER)
    ("sec6" . SPARSER::PROTEIN)
    ("Sec6p and the Qbc-SNARE Sec9p," . SPARSER::COLLECTION)
    ("Sec6p and Snc2p" . SPARSER::COLLECTION)
    ("Qbc-SNARE" . SPARSER::PROTEIN-PAIR)
    ("the exocytic v-SNARE," . SPARSER::PROTEIN) ("LLC-PK1" . SPARSER::PROTEIN)
    ("TGN" . SPARSER::PROTEIN)
    ("an exocytic rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endocytic compartments," . SPARSER::PROTEIN)
    ("exocytic v-SNAREs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sec5" . SPARSER::PROTEIN)
    ("vesicle-associated exocyst components" . SPARSER::COMPONENT)
    ("GFP-Snc1" . SPARSER::COLLECTION) ("Aux1" . SPARSER::PROTEIN)
    ("Aux" . SPARSER::PROTEIN)
    ("relatively modest affinity," . SPARSER::PROTEIN)
    ("Snc" . SPARSER::PROTEIN) ("vSNARE and rab" . SPARSER::COLLECTION)
    ("Sec4–Sec15" . SPARSER::COLLECTION) ("Snc–Sec6p" . SPARSER::PROTEIN-PAIR)
    ("Sec4p" . SPARSER::PROTEIN) ("–1 µ" . SPARSER::PROTEIN)
    ("Snc2p and Sec9p" . SPARSER::COLLECTION) ("only ∼50%," . SPARSER::PROTEIN)
    ("often misshapen," . SPARSER::PROTEIN) ("viable," . SPARSER::PROTEIN)
    ("NBD" . SPARSER::PROTEIN)
    ("either Snc2p or the Snc2-M2p mutant" . SPARSER::COLLECTION)
    ("Liposomes" . SPARSER::PROTEIN)
    ("the exocytic SNARE complex" . SPARSER::BIO-COMPLEX)
    ("its own," . SPARSER::PROTEIN)
    ("Sec6p (1–411) and Sec8p (1–236)" . SPARSER::COLLECTION)
    ("Sec6p (1–292) and Sec8p (1–236)" . SPARSER::COLLECTION)
    ("a soluble protein" . SPARSER::PROTEIN)
    ("vSNARE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GST-VAMP4" . SPARSER::COLLECTION) ("GST-VAMP3" . SPARSER::COLLECTION)
    ("Exoc3" . SPARSER::PROTEIN) ("Sec6p–Snc2p" . SPARSER::COLLECTION)
    ("Sec6p" . SPARSER::PROTEIN) ("Snc2p–Sec6p" . SPARSER::PROTEIN-PAIR)
    ("GST-Snc1p" . SPARSER::COLLECTION) ("GST-Nyv1p" . SPARSER::PROTEIN-PAIR)
    ("syntaxin" . SPARSER::PROTEIN) ("Snc1p and Snc2p" . SPARSER::COLLECTION)
    ("a glutamine (Q-SNARE) or arginine (R-SNARE)" . SPARSER::COLLECTION)
    ("Snc2p" . SPARSER::PROTEIN) ("GST-Snc2p" . SPARSER::COLLECTION)
    ("t-SNARE" . SPARSER::COLLECTION)
    ("a physical interaction, either direct or indirect," . SPARSER::PROTEIN)
    ("Snc2-V39A," . SPARSER::COLLECTION) ("Sec6-GFP" . SPARSER::COLLECTION)
    ("fluorescent protein–tagged exocyst alleles" . SPARSER::ALLELE)
    ("nearly inviable," . SPARSER::PROTEIN) ("chc1" . SPARSER::PROTEIN)
    ("the cortical pool ( xref )," . SPARSER::PROTEIN)
    ("Snc1p" . SPARSER::PROTEIN) ("GFP-Snc1p" . SPARSER::COLLECTION)
    ("exocytic fusion," . SPARSER::PROTEIN) ("Snc1/2p" . SPARSER::COLLECTION)
    ("synaptobrevin" . SPARSER::PROTEIN)
    ("clathrin and its associated components" . SPARSER::COLLECTION)
    ("some key secretory vesicle component" . SPARSER::COMPONENT)
    ("its associated components" . SPARSER::COMPONENT)
    ("internal puncta," . SPARSER::PROTEIN)
    ("cortical puncta," . SPARSER::PROTEIN) ("Chc1" . SPARSER::PROTEIN)
    ("Chc1-RFP" . SPARSER::COLLECTION)
    ("tethering complexes" . SPARSER::BIO-COMPLEX)
    ("the clathrin-associated components" . SPARSER::COMPONENT)
    ("ldb" . SPARSER::PROTEIN-FAMILY)
    ("the strong GAL1 promoter," . SPARSER::PROTEIN)
    ("clathrin and clathrin-associated components," . SPARSER::COLLECTION)
    ("clathrin-associated components," . SPARSER::PROTEIN)
    ("clathrin and clathrin adaptor proteins, several other clathrin-associated proteins"
     . SPARSER::PROTEIN)
    ("clathrin and clathrin" . SPARSER::COLLECTION)
    ("AP-180/CALM" . SPARSER::COLLECTION) ("AP180/CALM" . SPARSER::COLLECTION)
    ("CALM" . SPARSER::PROTEIN)
    ("clathrin heavy chain and light chain" . SPARSER::COLLECTION)
    ("clc1" . SPARSER::PROTEIN) ("galactose" . SPARSER::MOLECULE)
    ("Sec15-GFP" . SPARSER::COLLECTION)
    ("the redundant exocytic v-SNAREs, Snc1p and Snc2p" . SPARSER::COLLECTION)
    ("v-SNAREs, Snc1p and Snc2p" . SPARSER::COLLECTION)
    ("the exocyst and components" . SPARSER::COLLECTION)
    ("Sec4p–Sec15p" . SPARSER::PROTEIN-PAIR)
    ("Sec15p and Sec4-GTP" . SPARSER::COLLECTION)
    ("secretory vesicles," . SPARSER::PROTEIN)
    ("the strong, inducible GAL1 promoter" . SPARSER::PROMOTER)
    ("the vesicle-associated rab, Sec4p," . SPARSER::PROTEIN)
    ("subunits, Sec3p and Exo70p" . SPARSER::COLLECTION)
    ("subunits, Exo70p and Exo84p" . SPARSER::COLLECTION)
    ("the optimal orientation," . SPARSER::PROTEIN)
    ("arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GARP" . SPARSER::PROTEIN)
    ("Sec1-munc18" . SPARSER::COLLECTION)
    ("rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("clathrin and clathrin-associated components" . SPARSER::COLLECTION)
    ("clathrin-associated components" . SPARSER::COMPONENT)
    ("SNAREs" . SPARSER::PROTEIN)
    ("clathrin and proteins" . SPARSER::COLLECTION)
    ("t-SNAREs" . SPARSER::PROTEIN) ("Ccp1" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("VAMP4" . SPARSER::PROTEIN) ("VAMP3" . SPARSER::PROTEIN)
    ("Sso1" . SPARSER::PROTEIN) ("v-SNARE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("swa2" . SPARSER::PROTEIN) ("ccp1" . SPARSER::PROTEIN)
    ("Yap1801" . SPARSER::PROTEIN) ("Yap1802" . SPARSER::PROTEIN)
    ("SEC15" . SPARSER::PROTEIN-FAMILY) ("Avl9" . SPARSER::PROTEIN)
    ("avl9" . SPARSER::PROTEIN) ("CCP1" . SPARSER::PROTEIN)
    ("Swa2" . SPARSER::PROTEIN) ("Ldb17" . SPARSER::PROTEIN)
    ("AP-180" . SPARSER::PROTEIN) ("AP-3" . SPARSER::PROTEIN)
    ("AP180" . SPARSER::PROTEIN) ("v-SNAREs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sec2p" . SPARSER::PROTEIN-FAMILY) ("sec2-41" . SPARSER::PROTEIN)
    ("Myo2" . SPARSER::PROTEIN) ("type V" . SPARSER::PROTEIN)
    ("Sec15p" . SPARSER::PROTEIN) ("Sec1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Snc2" . SPARSER::PROTEIN) ("Snc1" . SPARSER::PROTEIN)
    ("Sec4" . SPARSER::PROTEIN)
    ("broken replication intermediates, DNA-PKcs" . SPARSER::PROTEIN)
    ("soluble nuclear proteins" . SPARSER::PROTEIN)
    ("duplex DNA" . SPARSER::DNA) ("xDNA-PKcs" . SPARSER::COLLECTION)
    ("PKcs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("replication-born DSBs," . SPARSER::PROTEIN)
    ("DNA-PKcs () or Ku70 (Fig. S3 B)," . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG)
    ("ATM and Chk2" . SPARSER::COLLECTION) ("ATM/Chk2" . SPARSER::COLLECTION)
    ("ATR and DNA-PKcs" . SPARSER::COLLECTION)
    ("DNA-PKcs or ATR" . SPARSER::COLLECTION)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPA32 and Chk1" . SPARSER::COLLECTION)
    ("streptavidin–biotin" . SPARSER::COLLECTION)
    ("DNA-PKcs and RPA32" . SPARSER::COLLECTION)
    ("-biotin" . SPARSER::COLLECTION)
    ("The gapped circular plasmid DNA" . SPARSER::DNA)
    ("Chk1 and RPA32" . SPARSER::COLLECTION)
    ("an open circular form," . SPARSER::PROTEIN)
    ("a singularly active DNA damage signaling complex" . SPARSER::BIO-COMPLEX)
    ("linear duplex DNA" . SPARSER::DNA)
    ("the DNA duplex ( xref )," . SPARSER::PROTEIN) ("pRPA" . SPARSER::PROTEIN)
    ("pG" . SPARSER::MOLECULE)
    ("a linear duplex DNA molecule" . SPARSER::MOLECULE)
    ("DNA-PKcs and ATM" . SPARSER::COLLECTION)
    ("DNA and four-way" . SPARSER::COLLECTION)
    ("RPA and Chk1" . SPARSER::COLLECTION) ("Ku70–Ku80" . SPARSER::COLLECTION)
    ("ATR–ATRIP" . SPARSER::COLLECTION) ("protein A (RPA)" . SPARSER::PROTEIN)
    ("ssDNA or ds/ssDNA" . SPARSER::COLLECTION)
    ("RPA32 and TopBP1" . SPARSER::COLLECTION)
    ("gapped linear duplex DNA" . SPARSER::DNA)
    ("DNA-PKcs and ATR" . SPARSER::COLLECTION)
    ("ATR and Chk1" . SPARSER::COLLECTION) ("KU70" . SPARSER::PROTEIN)
    ("RPA70" . SPARSER::PROTEIN) ("xChk1" . SPARSER::PROTEIN)
    ("AMP-PNP" . SPARSER::MOLECULE) ("ETP-46464" . SPARSER::DRUG)
    ("IC86621" . SPARSER::DRUG) ("KU-55933" . SPARSER::DRUG)
    ("Mus81" . SPARSER::PROTEIN) ("PI3" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRAF V600E and NRAS Q61K" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION)
    ("the aromatic heterocyclic small-molecule verteporfin" . SPARSER::DRUG)
    ("verteporfin" . SPARSER::DRUG)
    ("the
latter study,"
     . SPARSER::PROTEIN)
    ("the 4T1 mammary carcinoma cell line," . SPARSER::PROTEIN)
    ("CCN2/CTGF" . SPARSER::COLLECTION)
    ("6-μm thick histological sections," . SPARSER::PROTEIN)
    ("a strong inhibitory activity," . SPARSER::PROTEIN)
    ("Merlin/NF2" . SPARSER::COLLECTION) ("P-YAP/TAZ" . SPARSER::COLLECTION)
    ("the more aggressive," . SPARSER::PROTEIN)
    ("Noteworthy, both TAZ" . SPARSER::PROTEIN)
    ("A classical target
gene"
     . SPARSER::GENE)
    ("transcriptional co-activators" . SPARSER::PROTEIN)
    ("TEAD" . SPARSER::PROTEIN) ("YAP1 and YAP2" . SPARSER::COLLECTION)
    ("YAP1-2" . SPARSER::COLLECTION)
    ("protocadherin" . SPARSER::PROTEIN-FAMILY)
    ("Kibra" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MST and LATS" . SPARSER::COLLECTION) ("LATS1/2" . SPARSER::COLLECTION)
    ("kinases, MST and
LATS"
     . SPARSER::COLLECTION)
    ("MST" . SPARSER::PROTEIN) ("/CTGF" . SPARSER::COLLECTION)
    ("/connective-tissue growth factor" . SPARSER::COLLECTION)
    ("S-100" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming
growth factor"
     . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("P-YAP" . SPARSER::PROTEIN)
    ("YAP2" . SPARSER::PROTEIN) ("FAT4" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN)
    ("connective-tissue growth factor" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN) ("IRS-Ras/Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("IRS-PI3K-Akt/PKB" . SPARSER::COLLECTION)
    ("PKB and IRS" . SPARSER::COLLECTION) ("streptozotocin" . SPARSER::DRUG)
    ("betatrophin" . SPARSER::PROTEIN)
    ("small molecule GSK-3 inhibitor and mitogen/s, particularly 1-AKP+insulin,"
     . SPARSER::PROTEIN)
    ("cyclin D3-CDK4/6" . SPARSER::COLLECTION)
    ("p27(Kip1) and other CDK inhibitors," . SPARSER::COLLECTION)
    ("GSK-3 and insulin," . SPARSER::COLLECTION)
    ("stimulatory signals," . SPARSER::PROTEIN) ("Ins-" . SPARSER::PROTEIN)
    ("p27(Kip1) levels, xref (4) GLP-1 analog, exendin-4," . SPARSER::PROTEIN)
    ("inhibitor, xref  ,  xref and insulin" . SPARSER::COLLECTION)
    ("inhibitor and mitogen/s" . SPARSER::COLLECTION)
    ("both p27(Kip1) and p18Ink4c" . SPARSER::COLLECTION)
    ("cyclinD3 and CDK4/6" . SPARSER::COLLECTION)
    ("cyclin D3, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("cyclin D3 and CDK4" . SPARSER::COLLECTION)
    ("cyclin D3 and vice versa" . SPARSER::COLLECTION)
    ("cyclin and CDK" . SPARSER::COLLECTION)
    ("either p27(Kip1) or p-p27(T187)" . SPARSER::COLLECTION)
    ("cyclinD-CDK" . SPARSER::PROTEIN-PAIR)
    ("D-type cyclins and their cognate kinase partners, cyclin-dependent kinase 4/6 (CDK4/6),"
     . SPARSER::COLLECTION)
    ("cyclinE and its cognate kinase partner, CDK2" . SPARSER::COLLECTION)
    ("cyclinE-CDK2" . SPARSER::COLLECTION)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY)
    ("the 2 important negative cell cycle regulators, p27(Kip1) and GSK-3"
     . SPARSER::COLLECTION)
    ("somatostatin" . SPARSER::PROTEIN)
    ("GSK-3 and mitogen/s" . SPARSER::COLLECTION) ("Ink4d" . SPARSER::PROTEIN)
    ("p107 and p130" . SPARSER::COLLECTION) ("-CDK4/6" . SPARSER::COLLECTION)
    ("KPC" . SPARSER::PROTEIN)
    ("p27(Kip1) (a cyclin-dependent kinase [CDK] inhibitor), glycogen synthase kinase-3 (GSK-3) (a serine-threnine protein kinase), cyclin D3 (a member of D-type cyclins) and retinoblastoma (Rb) protein (a tumor suppressor)"
     . SPARSER::COLLECTION)
    ("p27(Kip1) (a cyclin-dependent kinase [CDK] inhibitor), glycogen synthase kinase-3 (GSK-3) (a serine-threnine protein kinase), cyclin D3"
     . SPARSER::PROTEIN)
    ("almost complete," . SPARSER::PROTEIN)
    ("p27(Kip1) and p18(Ink4c)" . SPARSER::COLLECTION)
    ("p27(Kip1), p-p27(S10), p18(Ink4c) and GSK-3" . SPARSER::COLLECTION)
    ("p27(Kip1), p-p27(S10), p18" . SPARSER::PROTEIN)
    ("Additionally, p-p27(S10)," . SPARSER::PROTEIN)
    ("cyclinD-CDK4/6" . SPARSER::COLLECTION) ("p-p27" . SPARSER::COLLECTION)
    ("cyclinD" . SPARSER::PROTEIN) ("somatostatin –1" . SPARSER::PROTEIN)
    ("insulin – 1" . SPARSER::PROTEIN) ("S21" . SPARSER::PROTEIN)
    ("IRS2" . SPARSER::PROTEIN) ("GLP-1 receptor" . SPARSER::PROTEIN)
    ("exendin-4" . SPARSER::PROTEIN) ("cyclinD3" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("p18Ink4c" . SPARSER::PROTEIN) ("GSK-3α" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("Ink4b" . SPARSER::PROTEIN)
    ("P18" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("D-type" . SPARSER::PROTEIN) ("Ink4c" . SPARSER::PROTEIN)
    ("PCNA and Ki-67" . SPARSER::COLLECTION)
    ("Indeed, AUF1" . SPARSER::PROTEIN) ("p53 and C-Myc" . SPARSER::COLLECTION)
    ("-ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("p16 and p21 protein" . SPARSER::COLLECTION)
    ("Likewise, using different p16" . SPARSER::PROTEIN)
    ("genes and oncogenes" . SPARSER::COLLECTION)
    ("UV light" . SPARSER::PROTEIN) ("p14/p53" . SPARSER::COLLECTION)
    ("AUF1 and the CDKN1A ARE" . SPARSER::COLLECTION)
    ("mutated CDKN1A ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("a mutated putative ARE and a 70-nt" . SPARSER::COLLECTION)
    ("a mutated putative ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("GH1" . SPARSER::PROTEIN) ("p16 and AUF1" . SPARSER::COLLECTION)
    ("AUF1-siRNA" . SPARSER::COLLECTION) ("AUF1-mRNAs" . SPARSER::COLLECTION)
    ("a biphasic curve," . SPARSER::PROTEIN)
    ("p16 and p21 proteins" . SPARSER::COLLECTION)
    ("noteworthy," . SPARSER::PROTEIN)
    ("IPTG, EH1 and EH2" . SPARSER::COLLECTION)
    ("EH1 and EH2" . SPARSER::COLLECTION) ("IPTG" . SPARSER::MOLECULE)
    ("CDKN1A and CDKN2A" . SPARSER::COLLECTION)
    ("activators and suppressors" . SPARSER::COLLECTION)
    ("their tumor suppressive function, p16 and p21" . SPARSER::COLLECTION)
    ("p16 and p21" . SPARSER::COLLECTION)
    ("a universal cyclin-dependent kinase inhibitor," . SPARSER::PROTEIN)
    ("cyclins/CDKs" . SPARSER::COLLECTION)
    ("cyclin D-CDK4/6" . SPARSER::COLLECTION) ("CDKI" . SPARSER::DRUG)
    ("/p53/p21" . SPARSER::COLLECTION) ("pRB/p16 INK4A" . SPARSER::COLLECTION)
    ("AUF1 and CDKN2A" . SPARSER::COLLECTION)
    ("AUF1-associated RNAs" . SPARSER::RNA)
    ("p16 INK4a and p21" . SPARSER::COLLECTION)
    ("CDKN2A and CDKN1A" . SPARSER::COLLECTION) ("C-Myc" . SPARSER::PROTEIN)
    ("MED6" . SPARSER::PROTEIN) ("MED5" . SPARSER::PROTEIN)
    ("p16 protein" . SPARSER::PROTEIN) ("EH1" . SPARSER::PROTEIN)
    ("AUF1" . SPARSER::PROTEIN) ("p16 INK4a" . SPARSER::PROTEIN)
    ("the allele and genotype frequencies" . SPARSER::COLLECTION)
    ("ITPKC (rs28493229) and CASP3 (rs113420705)" . SPARSER::COLLECTION)
    ("CASP3 and ITPKC" . SPARSER::COLLECTION)
    ("TGF-β2 and SMAD3" . SPARSER::COLLECTION) ("/NFAT" . SPARSER::COLLECTION)
    ("ITPKC and CASP3" . SPARSER::COLLECTION) ("CAL" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate 3-kinase C ( ITPKC , rs28493229) and caspase-3 ( CASP3 , rs113420705)"
     . SPARSER::COLLECTION)
    ("ITPKC" . SPARSER::PROTEIN) ("ITPR1" . SPARSER::PROTEIN)
    ("inositol 1,4,5-triphosphate receptor" . SPARSER::PROTEIN)
    ("TGF-β2" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate 3-kinase C" . SPARSER::PROTEIN)
    ("mutagen" . SPARSER::MOLECULE)
    ("a possible survival bias," . SPARSER::PROTEIN)
    ("LFS or Chompret" . SPARSER::COLLECTION)
    ("those carrying putatively pathogenic variants" . SPARSER::VARIANT)
    ("pathogenic variants" . SPARSER::VARIANT)
    ("somatically xref ," . SPARSER::PROTEIN)
    ("the Australian arm" . SPARSER::PROTEIN)
    ("Only 10/17 (59%) pedigrees met" . SPARSER::AMINO-ACID)
    ("a clinic-based, prospective cohort" . SPARSER::MOLECULE)
    ("LFS" . SPARSER::PROTEIN) ("differing institutions," . SPARSER::PROTEIN)
    ("the Northern European cohort" . SPARSER::MOLECULE)
    ("systemic sclerosis, caveolin-1" . SPARSER::PROTEIN)
    ("genotype and Kaplan-Meier" . SPARSER::COLLECTION)
    ("The Northern European cohort" . SPARSER::MOLECULE)
    ("GPA" . SPARSER::PROTEIN)
    ("the Northern European cohort, genomic DNA" . SPARSER::DNA)
    ("Northern European Cohort" . SPARSER::MOLECULE)
    ("AA and AC" . SPARSER::COLLECTION)
    ("an essential protein" . SPARSER::PROTEIN) ("ANCA" . SPARSER::PROTEIN)
    ("genotype and the studied endpoints" . SPARSER::COLLECTION)
    ("an essential structural protein" . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN)
    ("Antineutrophil cytoplasmic antibody" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("Caveolin-1" . SPARSER::PROTEIN)
    ("antineutrophil cytoplasmic antibody" . SPARSER::PROTEIN)
    ("JAK or c-Src" . SPARSER::COLLECTION)
    ("Importantly, niclosamide" . SPARSER::DRUG)
    ("its downstream effectors, Bcl2 and Bcl-XL, in both HCC827 and HCC827/ER cells ( xref ), suggesting that niclosamide functions as a STAT3 inhibitor to block erlotinib-activated STAT3/Bcl2/Bcl-XL survival pathway in human lung cancer cells"
     . SPARSER::COLLECTION)
    ("effectors, Bcl2 and Bcl-XL" . SPARSER::COLLECTION)
    ("Interestingly, niclosamide" . SPARSER::DRUG)
    ("JAK2 and Src" . SPARSER::COLLECTION)
    ("JAK2 and c-Src" . SPARSER::COLLECTION)
    ("JAK or Src kinase" . SPARSER::COLLECTION)
    ("p-STAT3/Bcl2/Bcl-xL" . SPARSER::COLLECTION)
    ("Interestingly, Mcl-1" . SPARSER::PROTEIN)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("erlotinib or niclosamide" . SPARSER::COLLECTION)
    ("platelets" . SPARSER::PROTEIN)
    ("primary antibodies and QD-conjugated secondary antibodies"
     . SPARSER::COLLECTION)
    ("QD705 (green) and QD605 (red)" . SPARSER::COLLECTION)
    ("QD-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("combined erlotinib and niclosamide showed complete tumor regression ( xref ),"
     . SPARSER::PROTEIN)
    ("erlotinib and niclosamide" . SPARSER::COLLECTION)
    ("niclosamide and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib (40mg/kg/d) ( xref ), niclosamide" . SPARSER::DRUG)
    ("Conversely, erlotinib" . SPARSER::DRUG)
    ("c-Src and JAK2" . SPARSER::COLLECTION)
    ("STAT3 kinases ( i.e . c-Src or JAK2) and phosphatase ( i.e . PTPMeg2)"
     . SPARSER::COLLECTION)
    ("c-Src or JAK2" . SPARSER::COLLECTION)
    ("Interestingly, erlotinib" . SPARSER::DRUG)
    ("Bcl-2 and Bcl-XL" . SPARSER::COLLECTION)
    ("EGFR and MET" . SPARSER::COLLECTION)
    ("Bcl-2/Bcl-XL" . SPARSER::COLLECTION)
    ("JAK and Src" . SPARSER::COLLECTION)
    ("kinase (JAK) or growth factor receptor-associated tyrosine kinase (Src)"
     . SPARSER::COLLECTION)
    ("growth factor receptor-associated tyrosine kinase" . SPARSER::PROTEIN)
    ("Importantly, erlotinib" . SPARSER::DRUG)
    ("Additionally, erlotinib" . SPARSER::DRUG)
    ("STAT3-Bcl2/Bcl-XL" . SPARSER::COLLECTION)
    ("a well-defined subset" . SPARSER::PROTEIN)
    ("States and accounts" . SPARSER::COLLECTION)
    ("Niclosamide" . SPARSER::DRUG) ("niclosamide" . SPARSER::DRUG)
    ("erlotinib-sensitive parental HCC827 cells," . SPARSER::PROTEIN)
    ("Bcl2 and Bcl-XL" . SPARSER::COLLECTION)
    ("STAT3/Bcl2/Bcl-XL" . SPARSER::COLLECTION)
    ("JAK2 or c-Src" . SPARSER::COLLECTION)
    ("Bcl2/Bcl-XL" . SPARSER::COLLECTION) ("eg2" . SPARSER::PROTEIN)
    ("CC -3" . SPARSER::PROTEIN) ("QD705" . SPARSER::MOLECULE)
    ("QD605" . SPARSER::MOLECULE) ("ABT-737" . SPARSER::DRUG)
    ("SAFB1 and its associated proteins" . SPARSER::COLLECTION)
    ("EED and SUZ12" . SPARSER::COLLECTION) ("antiandrogen" . SPARSER::DRUG)
    ("scaffold/matrix" . SPARSER::COLLECTION) ("MARs" . SPARSER::PROTEIN)
    ("protein and a negative regulator" . SPARSER::COLLECTION)
    ("LATS" . SPARSER::PROTEIN)
    ("control (shCtrl) cells ( xref )," . SPARSER::PROTEIN)
    ("p27/Kip1" . SPARSER::COLLECTION) ("Conversely, SAFB1" . SPARSER::PROTEIN)
    ("SUZ12 and EED" . SPARSER::COLLECTION)
    ("an occasional EZH2 partner," . SPARSER::PROTEIN)
    ("all three essential components" . SPARSER::COMPONENT)
    ("EED" . SPARSER::PROTEIN) ("EZH2 and SAFB1" . SPARSER::COLLECTION)
    ("the PRC2 repressive complex" . SPARSER::BIO-COMPLEX)
    ("SAFB1 and EZH2" . SPARSER::COLLECTION)
    ("MST1 and MST1" . SPARSER::COLLECTION)
    ("KLK2 and PSA" . SPARSER::COLLECTION)
    ("PSA and KLK2" . SPARSER::COLLECTION)
    ("the amplified PSA promoter and enhancer regions ( xref )"
     . SPARSER::COLLECTION)
    ("SAFB1 and MST1" . SPARSER::COLLECTION)
    ("AR and MST1" . SPARSER::COLLECTION)
    ("purified recombinant MST1 and SAFB1-GST fusion proteins"
     . SPARSER::COLLECTION)
    ("MST1 and SAFB1" . SPARSER::COLLECTION)
    ("SAFB1-GST" . SPARSER::COLLECTION) ("MST1 and AR" . SPARSER::COLLECTION)
    ("SAFB1, MST1 and AR" . SPARSER::COLLECTION)
    ("AR—KAT2B" . SPARSER::COLLECTION) ("SAFB1 and AR" . SPARSER::COLLECTION)
    ("AR and SAFB1" . SPARSER::COLLECTION)
    ("an AR coregulatory protein" . SPARSER::PROTEIN)
    ("the nonmeta-bolizable androgen R1881," . SPARSER::PROTEIN)
    ("SAFB1/AR" . SPARSER::COLLECTION)
    ("endogenous AR and endogenous SAFB1" . SPARSER::COLLECTION)
    ("FXR" . SPARSER::PROTEIN) ("kr" . SPARSER::PROTEIN-FAMILY)
    ("COPA" . SPARSER::PROTEIN)
    ("anti-SAFB1, MST1 and AKT1" . SPARSER::COLLECTION)
    ("MST1/STK4" . SPARSER::COLLECTION)
    ("a more aggressive phenotype," . SPARSER::PROTEIN)
    ("AR and prostate-specific antigen" . SPARSER::COLLECTION)
    ("coregulatory proteins" . SPARSER::PROTEIN)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("CT-L" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("hsp27" . SPARSER::PROTEIN) ("hormone-sensitive" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SUZ12" . SPARSER::PROTEIN)
    ("PMEPA1" . SPARSER::PROTEIN) ("KAT2B" . SPARSER::PROTEIN)
    ("LRH-1" . SPARSER::PROTEIN) ("RORα" . SPARSER::PROTEIN)
    ("STK4" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("SAFB1" . SPARSER::PROTEIN) ("p16-Leiden" . SPARSER::PROTEIN-PAIR)
    ("XRCC1 and CDK6" . SPARSER::COLLECTION)
    ("its obvious relevance, CDK6" . SPARSER::PROTEIN)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("CDKN2A mutation positive families only ( P <0.05 for all 4 SNPs),"
     . SPARSER::PROTEIN)
    ("Two genes, CDK6 ( P =0.0001) and XRCC1 ( P =0.0003),"
     . SPARSER::COLLECTION)
    ("additional susceptibility genes or other genetic or epigenetic mechanisms involving CDKN2A contributing"
     . SPARSER::COLLECTION)
    ("CDK6 and XRCC1" . SPARSER::COLLECTION)
    ("Conditional logistic regression," . SPARSER::PROTEIN)
    ("ERCC5" . SPARSER::PROTEIN) ("ERCC2" . SPARSER::PROTEIN)
    ("APEX1" . SPARSER::PROTEIN) ("ERCC4" . SPARSER::PROTEIN)
    ("DRD2" . SPARSER::PROTEIN) ("TYRP2" . SPARSER::PROTEIN)
    ("TYRP1" . SPARSER::PROTEIN) ("SLC24A5" . SPARSER::PROTEIN)
    ("SLC24A2" . SPARSER::PROTEIN) ("OCA2" . SPARSER::PROTEIN)
    ("ING2" . SPARSER::PROTEIN) ("ING1" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN) ("CCND3" . SPARSER::PROTEIN)
    ("CCNA1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("MC1R" . SPARSER::PROTEIN) ("subsequent treatment," . SPARSER::PROTEIN)
    ("methodological differences," . SPARSER::PROTEIN)
    ("CE-IVD" . SPARSER::COLLECTION) ("IVD" . SPARSER::PROTEIN)
    ("the NSCLC-NOS pathological category (first patients were treated surgically in 2003),"
     . SPARSER::PROTEIN)
    ("TKI-EGFR" . SPARSER::COLLECTION)
    ("previously reported," . SPARSER::PROTEIN) ("-EGFR" . SPARSER::COLLECTION)
    ("the Caucasian population," . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("delE" . SPARSER::PROTEIN) ("mutated DNA" . SPARSER::DNA)
    ("PNA–LNA" . SPARSER::COLLECTION) ("LNA" . SPARSER::PROTEIN)
    ("FLA" . SPARSER::PROTEIN) ("6.3 " . SPARSER::PROTEIN)
    ("Notably, IOP1" . SPARSER::PROTEIN) ("CIA1-CIA2A" . SPARSER::COLLECTION)
    ("CIA2A" . SPARSER::PROTEIN)
    ("the DNA helicases XPD and RTEL1, as well as DNA polymerases"
     . SPARSER::COLLECTION)
    ("Similarly, CIA2B" . SPARSER::PROTEIN)
    ("Intriguingly, CIA1" . SPARSER::PROTEIN)
    ("CIA2A-IRP2" . SPARSER::PROTEIN-PAIR)
    ("IRP1 and IRP2" . SPARSER::COLLECTION)
    ("the CIA2B-associated proteins" . SPARSER::PROTEIN)
    ("POLD1 and GPAT" . SPARSER::COLLECTION)
    ("CIA1, CIA2B and MMS19" . SPARSER::COLLECTION)
    ("only one CIA2 gene" . SPARSER::GENE)
    ("NBP35 and IOP1" . SPARSER::COLLECTION)
    ("IRP2 and CIA2A" . SPARSER::COLLECTION)
    ("both CIA1 ( xref , red box and xref ) and MMS19 ( xref )"
     . SPARSER::COLLECTION)
    ("IOP1 and CIA2A," . SPARSER::COLLECTION)
    ("CIA1-CIA2B-MMS19" . SPARSER::COLLECTION)
    ("associated proteins" . SPARSER::PROTEIN)
    ("CIA1, CIA2B or MMS19" . SPARSER::COLLECTION)
    ("FLAG-CIA1" . SPARSER::COLLECTION) ("CIA2B-myc" . SPARSER::COLLECTION)
    ("CIA2B and MMS19" . SPARSER::COLLECTION)
    ("both the Fe/S protein IRP1 and its non-Fe/S counterpart IRP2"
     . SPARSER::COLLECTION)
    ("glyceraldehyde 3-phosphate dehydrogenase (GAPDH)" . SPARSER::PROTEIN)
    ("ferritin and TfR" . SPARSER::COLLECTION)
    ("holo-transferrin" . SPARSER::COLLECTION) ("TfR" . SPARSER::PROTEIN)
    ("CIA2B-MMS19" . SPARSER::COLLECTION)
    ("CIA2B or CIA2A" . SPARSER::COLLECTION) ("apoprotein" . SPARSER::MOLECULE)
    ("FXN" . SPARSER::PROTEIN) ("Substrate and product" . SPARSER::COLLECTION)
    ("Substrate" . SPARSER::SUBSTRATE) ("the enzyme’s" . SPARSER::ENZYME)
    ("-DHT" . SPARSER::COLLECTION) ("-thymine" . SPARSER::MOLECULE)
    ("A clinically relevant example" . SPARSER::EXAMPLE)
    ("DPYD and GPAT" . SPARSER::COLLECTION)
    ("CIA1 or CIA2B" . SPARSER::COLLECTION)
    ("IRP1-associated IRE" . SPARSER::PROTEIN) ("ME" . SPARSER::PROTEIN)
    ("ferritin" . SPARSER::PROTEIN) ("CTP" . SPARSER::PROTEIN)
    ("the mitochondrial Fe/S proteins aconitase (mtAco) and succinate dehydrogenase (SDH)"
     . SPARSER::COLLECTION)
    ("the extra-mitochondrial compartment," . SPARSER::PROTEIN)
    ("CIA1, CIA2A or CIA2B" . SPARSER::COLLECTION)
    ("CIA2B or CIA1" . SPARSER::COLLECTION)
    ("CIA2B and CIA1" . SPARSER::COLLECTION)
    ("soluble cytosolic proteins" . SPARSER::PROTEIN)
    ("Importantly, CIA2A-directed siRNAs" . SPARSER::PROTEIN)
    ("Actin and MIA40" . SPARSER::COLLECTION) ("digitonin" . SPARSER::MOLECULE)
    ("CIA1, CIA2A, and CIA2B" . SPARSER::COLLECTION)
    ("CIA1, CIA2A and CIA2B" . SPARSER::COLLECTION)
    ("CIA1 and CIA2B" . SPARSER::COLLECTION)
    ("MMS19-CIA1-CIA2B" . SPARSER::COLLECTION)
    ("IOP1, CIA1, CIA2B (FAM96B; xref ) and numerous cytosolic-nuclear Fe/S proteins ( xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("DPYD and DNA polymerase" . SPARSER::COLLECTION)
    ("IRP1 and GPAT" . SPARSER::COLLECTION)
    ("The latter protein" . SPARSER::PROTEIN)
    ("Cia1 and Cia2" . SPARSER::COLLECTION) ("Mms19" . SPARSER::PROTEIN)
    ("Cia1" . SPARSER::PROTEIN) ("Cfd1-Nbp35" . SPARSER::COLLECTION)
    ("hydrogenase" . SPARSER::PROTEIN) ("oxidoreductase" . SPARSER::PROTEIN)
    ("Cfd1 and Nbp35" . SPARSER::COLLECTION) ("Cfd1" . SPARSER::PROTEIN)
    ("NFS1-ISD11" . SPARSER::COLLECTION) ("apoproteins" . SPARSER::MOLECULE)
    ("IRE" . SPARSER::PROTEIN) ("aconitase" . SPARSER::PROTEIN)
    ("the bifunctional iron regulatory protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FANCJ" . SPARSER::PROTEIN) ("DPYD" . SPARSER::PROTEIN)
    ("GPAT" . SPARSER::PROTEIN)
    ("phosphoribosylpyrophosphate" . SPARSER::MOLECULE)
    ("inorganic cofactors" . SPARSER::PROTEIN)
    ("CIA2A-CIA1" . SPARSER::COLLECTION)
    ("CIA2B or MMS19" . SPARSER::COLLECTION)
    ("protein (IRP)" . SPARSER::PROTEIN) ("IRP" . SPARSER::PROTEIN)
    ("CIA2B-CIA1-MMS19" . SPARSER::COLLECTION)
    ("CIA2A or CIA2B" . SPARSER::COLLECTION) ("CIA" . SPARSER::PROTEIN)
    ("citrate synthase" . SPARSER::PROTEIN) ("POLE1" . SPARSER::PROTEIN)
    ("IREB2" . SPARSER::PROTEIN) ("DNA-binding protein" . SPARSER::PROTEIN)
    ("member 3" . SPARSER::PROTEIN) ("Golgin subfamily A" . SPARSER::PROTEIN)
    ("UDP-glucose 6-dehydrogenase" . SPARSER::PROTEIN)
    ("NTHL1" . SPARSER::PROTEIN) ("RTEL1" . SPARSER::PROTEIN)
    ("RLI1" . SPARSER::PROTEIN) ("PRIM2" . SPARSER::PROTEIN)
    ("DNA2" . SPARSER::PROTEIN) ("Pol3" . SPARSER::PROTEIN)
    ("MIA40" . SPARSER::PROTEIN) ("POLD1" . SPARSER::PROTEIN)
    ("IOP1" . SPARSER::PROTEIN) ("NBP35" . SPARSER::PROTEIN)
    ("Nar1" . SPARSER::PROTEIN) ("Nbp35" . SPARSER::PROTEIN)
    ("ISD11" . SPARSER::PROTEIN) ("NFS1" . SPARSER::PROTEIN)
    ("cysteine desulfurase" . SPARSER::PROTEIN)
    ("iron-sulfur cluster" . SPARSER::MOLECULE) ("FBXL5" . SPARSER::PROTEIN)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("mitochondrial aconitase" . SPARSER::PROTEIN)
    ("Iron-sulfur" . SPARSER::MOLECULE) ("IRP1" . SPARSER::PROTEIN)
    ("IRP2" . SPARSER::PROTEIN) ("MMS19" . SPARSER::PROTEIN)
    ("CIAO1" . SPARSER::PROTEIN) ("CIA1" . SPARSER::PROTEIN)
    ("FAM96B" . SPARSER::PROTEIN) ("CIA2B" . SPARSER::PROTEIN)
    ("iron-sulfur" . SPARSER::MOLECULE) ("a ubiquitous DNA" . SPARSER::DNA)
    ("Topoisomerase" . SPARSER::PROTEIN) ("In fact, NKX3.1" . SPARSER::PROTEIN)
    ("oxidative DNA damage," . SPARSER::PROTEIN)
    ("mutational nucleotide" . SPARSER::NUCLEOTIDE)
    ("oxidative damage," . SPARSER::PROTEIN)
    ("NKX3.1(Y222F) and the wild-type protein" . SPARSER::COLLECTION)
    ("SQ or TQ" . SPARSER::COLLECTION) ("ATM-2" . SPARSER::PROTEIN)
    ("TQ" . SPARSER::DRUG) ("ATM and NKX3.1" . SPARSER::COLLECTION)
    ("cellular NKX3.1" . SPARSER::PROTEIN) ("exogenous ATM" . SPARSER::PROTEIN)
    ("exogenous ATM," . SPARSER::PROTEIN) ("ATM or ATM" . SPARSER::COLLECTION)
    ("Tyrosine" . SPARSER::AMINO-ACID) ("ATM and ATM" . SPARSER::COLLECTION)
    ("GST-ATM-2" . SPARSER::COLLECTION)
    ("its cognate DNA binding domain, T179A ( xref ) and N174Q ( xref ),"
     . SPARSER::COLLECTION)
    ("complex and DNA" . SPARSER::COLLECTION)
    ("MYC-NKX3.1" . SPARSER::COLLECTION) ("Flag-ATM" . SPARSER::COLLECTION)
    ("P53 and NKX3.1" . SPARSER::COLLECTION)
    ("Ku55933 and caffeine" . SPARSER::COLLECTION)
    ("γH2AX and pATM" . SPARSER::COLLECTION)
    ("the histone variant H2AX and downstream effectors,"
     . SPARSER::COLLECTION)
    ("MDC1 and 53BP1" . SPARSER::COLLECTION)
    ("invasive prostate cancer," . SPARSER::PROTEIN)
    ("a haploinsufficient prostate cancer suppressor protein"
     . SPARSER::PROTEIN)
    ("NKX3.1 and ATM" . SPARSER::COLLECTION) ("GST-P" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN)
    ("macrophage scavenger receptor 1" . SPARSER::PROTEIN)
    ("Ku55933" . SPARSER::DRUG) ("I-SceI" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("histone2" . SPARSER::PROTEIN) ("Bisulfite" . SPARSER::MOLECULE)
    ("pathological tumour stage," . SPARSER::PROTEIN)
    ("pRCC and ccRCC" . SPARSER::COLLECTION)
    ("proximal tubule cells," . SPARSER::PROTEIN)
    ("distal tubules," . SPARSER::PROTEIN)
    ("the PAX2 gene and chromosome 10 centromeric region," . SPARSER::PROTEIN)
    ("gene and chromosome" . SPARSER::COLLECTION)
    ("troublesome," . SPARSER::PROTEIN)
    ("the clinicopathological data," . SPARSER::PROTEIN)
    ("NaCl and urea" . SPARSER::COLLECTION)
    ("a benign one," . SPARSER::PROTEIN)
    ("the eosinophilic variant" . SPARSER::VARIANT)
    ("Most RCTs display characteristic histological features,"
     . SPARSER::PROTEIN)
    ("haematoxylin" . SPARSER::MOLECULE) ("pRCC" . SPARSER::PROTEIN)
    ("Pax2" . SPARSER::PROTEIN) ("Pax-2" . SPARSER::PROTEIN)
    ("CK" . SPARSER::PROTEIN) ("mad" . SPARSER::PROTEIN)
    ("a multifunctional epithelial glycoprotein" . SPARSER::PROTEIN)
    ("epithelial-mesenchymal transition (EMT)," . SPARSER::PROTEIN)
    ("multicentric tumor foci" . SPARSER::PROTEIN)
    ("cadherin/catenin" . SPARSER::COLLECTION)
    ("the invasive component" . SPARSER::COMPONENT)
    ("further studies," . SPARSER::PROTEIN) ("ß-catenin" . SPARSER::COLLECTION)
    ("multifocal tumors (p = 0.001)," . SPARSER::PROTEIN)
    ("ductal breast cancer," . SPARSER::PROTEIN)
    ("invasive lobular cancer," . SPARSER::PROTEIN)
    ("the histological tumor type," . SPARSER::PROTEIN)
    ("group and p" . SPARSER::COLLECTION)
    ("MUC1 and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and MUC1" . SPARSER::COLLECTION)
    ("a previous paper, PankoMab" . SPARSER::DRUG) ("PankoMab" . SPARSER::DRUG)
    ("Many monoclonal antibodies" . SPARSER::ANTIBODY)
    ("The larger," . SPARSER::PROTEIN) ("MUC" . SPARSER::PROTEIN)
    ("a complex transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("Epithelial mucin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin/catenin" . SPARSER::COLLECTION)
    ("the E-cadherin-related transcriptional repressor Snail or the c-Jun activation domain-binding protein-1 (Jab1),"
     . SPARSER::COLLECTION)
    ("multifunctional signaling proteins" . SPARSER::PROTEIN)
    ("a controversial issue," . SPARSER::PROTEIN)
    ("worldwide prevailing suggestions," . SPARSER::PROTEIN)
    ("the unifocal group," . SPARSER::PROTEIN)
    ("MUC1, E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("MUC1, β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("MUC-1, β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("anti-MUC1" . SPARSER::DRUG) ("IRS 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRS 4" . SPARSER::PROTEIN) ("beta-Catenin" . SPARSER::PROTEIN)
    ("E-Cadherin " . SPARSER::PROTEIN)
    ("mucin-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Jab1" . SPARSER::PROTEIN)
    ("MUC1" . SPARSER::PROTEIN) ("MUC-1" . SPARSER::PROTEIN)
    ("ribosomal protein S6 and EIF4EBP1" . SPARSER::COLLECTION)
    ("GNE" . SPARSER::PROTEIN) ("a predictive biomarker," . SPARSER::PROTEIN)
    ("suggestive," . SPARSER::PROTEIN)
    ("p70S6K and EIF4EBP1" . SPARSER::COLLECTION)
    ("AKT1 E17K and AKT1 wild type MCF-10A cells," . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("Parental MCF-7 cells, derivatives" . SPARSER::DERIVATIVE)
    ("E545K, and AKT1" . SPARSER::COLLECTION)
    ("PIK3CA E545K," . SPARSER::PROTEIN)
    ("qualitative signaling changes," . SPARSER::PROTEIN)
    ("PI3K and mitogen activated protein kinase" . SPARSER::COLLECTION)
    ("insulin-stimulated fibroblasts," . SPARSER::PROTEIN)
    ("Het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("straightforward," . SPARSER::PROTEIN)
    ("These isogenic cell lines," . SPARSER::PROTEIN)
    ("especially relevant," . SPARSER::PROTEIN)
    ("a single genotypic change," . SPARSER::PROTEIN)
    ("PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("GDC-0941 and MK-2206" . SPARSER::COLLECTION)
    ("the PI3K inhibitor GDC-0941 and the allosteric AKT inhibitor MK-2206"
     . SPARSER::COLLECTION)
    ("AKT proteins and several known AKT" . SPARSER::COLLECTION)
    ("other AKT target proteins and downstream effectors"
     . SPARSER::COLLECTION)
    ("/AKT/mTOR" . SPARSER::COLLECTION) ("SGK3" . SPARSER::PROTEIN)
    ("AKT 1" . SPARSER::PROTEIN) ("EIF4EBP1" . SPARSER::PROTEIN)
    ("TORC1 complex" . SPARSER::BIO-COMPLEX) ("AS160" . SPARSER::PROTEIN)
    ("FOXO 1" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("NVP-BEZ235" . SPARSER::DRUG)
    ("dasatinib, nilotinib and ponatinib" . SPARSER::COLLECTION)
    ("bosutinib" . SPARSER::DRUG) ("AKT and MEK" . SPARSER::COLLECTION)
    ("primitive CML progenitor cells," . SPARSER::PROTEIN)
    ("only modest imatinib" . SPARSER::DRUG)
    ("primitive CML progenitor cells ( xref ), both imatinib" . SPARSER::DRUG)
    ("primitive CML cells," . SPARSER::PROTEIN)
    ("imatinib and BAW667 ( xref )" . SPARSER::COLLECTION)
    ("SCF and greater" . SPARSER::COLLECTION)
    ("PPY-A-treated CD34 + 38 + cells," . SPARSER::PROTEIN)
    ("Strikingly, SCF" . SPARSER::PROTEIN)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("AKT (downstream of PI3K) and ERK1/2 (downstream of MEK)"
     . SPARSER::COLLECTION)
    ("PI3K and MEK" . SPARSER::COLLECTION)
    ("Either imatinib or PPY-A," . SPARSER::COLLECTION)
    ("difficult," . SPARSER::PROTEIN)
    ("KIT and BCR-ABL1" . SPARSER::COLLECTION)
    ("primitive cells," . SPARSER::PROTEIN)
    ("more primitive CML cells," . SPARSER::PROTEIN)
    ("IL-3 or GM-CSF" . SPARSER::COLLECTION)
    ("SCF, GM-CSF or IL-3" . SPARSER::COLLECTION)
    ("biochemical inhibitors," . SPARSER::PROTEIN)
    ("minimal," . SPARSER::PROTEIN) ("SCF/KIT" . SPARSER::COLLECTION)
    ("IL-3, GM-CSF and SCF" . SPARSER::COLLECTION) ("CRKL" . SPARSER::PROTEIN)
    ("Imatinib (2 μM) and dasatinib (50 nM)" . SPARSER::COLLECTION)
    ("pBCR-ABL1" . SPARSER::COLLECTION) ("PPY" . SPARSER::PROTEIN)
    ("KIT or PDGFR" . SPARSER::COLLECTION) ("DDR1/2" . SPARSER::COLLECTION)
    ("ARG" . SPARSER::PROTEIN) ("primitive progenitors," . SPARSER::PROTEIN)
    ("mature CML progenitor cells," . SPARSER::PROTEIN)
    ("Foxo3A" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("CSF-1R" . SPARSER::PROTEIN) ("ABL2" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("NAR Online," . SPARSER::PROTEIN)
    ("chromatin looping and AR transcription complex assembly by stabilizing AR-GATA2 association"
     . SPARSER::COLLECTION)
    ("AR-GATA2" . SPARSER::COLLECTION) ("AIB1/SRC3" . SPARSER::COLLECTION)
    ("RIP140 and Suv4-20h1.1" . SPARSER::COLLECTION)
    ("h1.1" . SPARSER::PROTEIN)
    ("co-activators and co-repressors" . SPARSER::COLLECTION)
    ("co-activators" . SPARSER::PROTEIN)
    ("Mediator complex and Pol II" . SPARSER::COLLECTION)
    ("Indeed, CCAR1" . SPARSER::PROTEIN)
    ("AR, GATA2 and CCAR1" . SPARSER::COLLECTION)
    ("Specifically, CCAR1" . SPARSER::PROTEIN)
    ("global gene expression analysis," . SPARSER::PROTEIN)
    ("co-activator" . SPARSER::PROTEIN) ("GATA2 and AR" . SPARSER::COLLECTION)
    ("PSA-LUC" . SPARSER::COLLECTION) ("DAPA" . SPARSER::PROTEIN-FAMILY)
    ("CCAR1 and GATA2" . SPARSER::COLLECTION)
    ("AR and Pol" . SPARSER::COLLECTION)
    ("AR-co-activator" . SPARSER::PROTEIN-PAIR)
    ("ligand and," . SPARSER::COLLECTION)
    ("PSA, TMPRSS2 and KLK2" . SPARSER::COLLECTION)
    ("TMPRSS2 and KLK2" . SPARSER::COLLECTION)
    ("MED1 and Pol" . SPARSER::COLLECTION)
    ("AR, MED1 and Pol" . SPARSER::COLLECTION)
    ("LNCaP-LUC" . SPARSER::PROTEIN-PAIR)
    ("UGT2B15 and UGT2B17" . SPARSER::COLLECTION)
    ("DHT and CCAR1" . SPARSER::COLLECTION)
    ("PSA and probasin" . SPARSER::COLLECTION) ("SLC16A6" . SPARSER::PROTEIN)
    ("LNCaP and VCaP cells," . SPARSER::COLLECTION)
    ("the enhancer (ARE III located 4.2 kb upstream of transcription start site) and promoter (ARE I and II located 170 and 400 bp upstream of transcription start site)"
     . SPARSER::COLLECTION)
    ("MED1/TRAP220" . SPARSER::COLLECTION) ("kallikrein" . SPARSER::PROTEIN)
    ("CCAR1 and DBC1" . SPARSER::COLLECTION)
    ("Similarly, HA-tagged CCAR1" . SPARSER::PROTEIN)
    ("ERα and glucocorticoid receptor" . SPARSER::COLLECTION)
    ("CCAR1 and AR" . SPARSER::COLLECTION) ("DBC1" . SPARSER::PROTEIN)
    ("ERα target genes and estrogen-dependent growth" . SPARSER::COLLECTION)
    ("FoxA1 and GATA2" . SPARSER::COLLECTION)
    ("FoxA1, GATA2 and Oct1" . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("AR and other NRs" . SPARSER::COLLECTION)
    ("NRs and gene" . SPARSER::COLLECTION)
    ("enhancers and promoters" . SPARSER::COLLECTION)
    ("AR and GATA2" . SPARSER::COLLECTION)
    ("AR, MED1 and RNA polymerase II" . SPARSER::COLLECTION)
    ("1-B" . SPARSER::PROTEIN) ("AIB1" . SPARSER::PROTEIN)
    ("COUP-TFI" . SPARSER::PROTEIN)
    ("COUP transcription factor 1" . SPARSER::PROTEIN)
    ("Suv4-20" . SPARSER::PROTEIN) ("UGT2B15" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("KLK4" . SPARSER::PROTEIN)
    ("KLK2" . SPARSER::PROTEIN) ("TRAP220" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("Mix 1" . SPARSER::PROTEIN) ("Oct1" . SPARSER::PROTEIN)
    ("FoxA1" . SPARSER::PROTEIN) ("MED1" . SPARSER::PROTEIN)
    ("CCAR1" . SPARSER::PROTEIN) ("Interestingly, both HCC" . SPARSER::PROTEIN)
    ("TERT and Wnt/β-catenin" . SPARSER::COLLECTION)
    ("classical HCA" . SPARSER::PROTEIN)
    ("HNF1A , CTNNB1 , IL6ST , GNAS or STAT3" . SPARSER::COLLECTION)
    ("GNAS" . SPARSER::PROTEIN) (", classical driver genes" . SPARSER::GENE)
    ("the first recurrent gene" . SPARSER::GENE)
    ("GLUL and LGR5" . SPARSER::COLLECTION)
    ("TERT and CTNNB1" . SPARSER::COLLECTION) ("GLUL" . SPARSER::PROTEIN)
    ("Interestingly, β-catenin" . SPARSER::PROTEIN) ("HCAs" . SPARSER::PROTEIN)
    ("cirrhosis and non-mutated" . SPARSER::COLLECTION)
    ("less frequently TERT messenger RNA" . SPARSER::RNA)
    ("almost all HCCs" . SPARSER::PROTEIN)
    ("a typical ETS/TCF-binding sequence," . SPARSER::PROTEIN)
    ("HCA" . SPARSER::PROTEIN) ("cirrhotic macronodules," . SPARSER::PROTEIN)
    ("ARID1A and ARID2" . SPARSER::COLLECTION)
    ("ras/raf/map" . SPARSER::COLLECTION)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TP53 and CTNNB1" . SPARSER::COLLECTION)
    ("hepatocellular carcinomas," . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL6ST" . SPARSER::PROTEIN) ("HNF1A" . SPARSER::PROTEIN)
    ("LGR5" . SPARSER::PROTEIN) ("AXIN1" . SPARSER::PROTEIN)
    ("RPS6KA3" . SPARSER::PROTEIN) ("ARID2" . SPARSER::PROTEIN)
    ("endothelial FKBP12.6" . SPARSER::PROTEIN)
    ("SRL and its analogs (i.e. everolimus)" . SPARSER::COLLECTION)
    ("CNI" . SPARSER::PROTEIN) ("SRL-FKBP12" . SPARSER::COLLECTION)
    ("calcineurin" . SPARSER::PROTEIN) ("mTOR/Akt" . SPARSER::COLLECTION)
    ("the mouse aortic endothelium," . SPARSER::PROTEIN)
    ("a serine/threonine kinase and downstream effector" . SPARSER::COLLECTION)
    ("Akt/PKB, a serine/threonine kinase and downstream effector"
     . SPARSER::COLLECTION)
    ("EBF and SRL" . SPARSER::COLLECTION)
    ("albumin (EBA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pPKCα–p120" . SPARSER::COLLECTION) ("pPKCα" . SPARSER::PROTEIN)
    ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pPKCα-p120" . SPARSER::PROTEIN-PAIR)
    ("increasing vascular permeability," . SPARSER::PROTEIN)
    ("threonine/serine" . SPARSER::COLLECTION)
    ("a ubiquitous, cytosolic 12-KD FK506 binding protein and key stabilizing component"
     . SPARSER::COLLECTION)
    ("FKBP12, a ubiquitous, cytosolic 12-KD FK506 binding protein and key stabilizing component"
     . SPARSER::COLLECTION)
    ("a ubiquitous, cytosolic 12-KD FK506 binding protein" . SPARSER::PROTEIN)
    ("foamy macrophages" . SPARSER::PROTEIN) ("sirolimus" . SPARSER::DRUG)
    ("SRL-FKBP12.6" . SPARSER::COLLECTION) ("albumin" . SPARSER::PROTEIN)
    ("transendothelial electrical resistance (TEER)," . SPARSER::PROTEIN)
    ("SRL or siRNA" . SPARSER::COLLECTION) ("stabilizer" . SPARSER::MOLECULE)
    ("ryanodine" . SPARSER::PROTEIN) ("intimal lipid" . SPARSER::LIPID)
    ("EBF" . SPARSER::PROTEIN) ("DES" . SPARSER::PROTEIN)
    ("SRL" . SPARSER::PROTEIN) ("Sirolimus" . SPARSER::DRUG)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("MLC-2" . SPARSER::PROTEIN) ("myosin light chain-2" . SPARSER::PROTEIN)
    ("Torin2" . SPARSER::DRUG) ("torin2" . SPARSER::DRUG)
    ("FK506" . SPARSER::DRUG) ("p120" . SPARSER::PROTEIN)
    ("p120-catenin" . SPARSER::PROTEIN) ("RyR2" . SPARSER::PROTEIN)
    ("FKBP12.6" . SPARSER::PROTEIN)
    ("KRAS and/or PIK3CA ," . SPARSER::COLLECTION)
    ("the associated benign Brenner tumor," . SPARSER::PROTEIN)
    ("Ali" . SPARSER::PROTEIN)
    ("loss of heterozygosity and promoter" . SPARSER::COLLECTION)
    ("an atypical proliferative Brenner tumor," . SPARSER::PROTEIN)
    ("a benign Brenner tumor, CDKN2A" . SPARSER::PROTEIN)
    ("both p16 (INK4a) and p14 (ARF)," . SPARSER::COLLECTION)
    ("a benign Brenner tumor component" . SPARSER::COMPONENT)
    ("dense fibromatous tissue," . SPARSER::PROTEIN)
    ("the atypical component" . SPARSER::COMPONENT)
    ("the benign component" . SPARSER::COMPONENT)
    ("seven atypical proliferative Brenner tumors (APBT2 and APBT6), three somatic mutations,"
     . SPARSER::PROTEIN)
    ("20 benign Brenner tumors," . SPARSER::PROTEIN)
    ("the benign Brenner tumor component" . SPARSER::COMPONENT)
    ("the benign epithelial component," . SPARSER::PROTEIN)
    ("complex fibrovascular papillae," . SPARSER::PROTEIN)
    ("CDKN2A and," . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("the atypical epithelial component" . SPARSER::COMPONENT)
    ("all atypical proliferative Brenner tumors," . SPARSER::PROTEIN)
    ("13 benign Brenner tumors," . SPARSER::PROTEIN)
    ("tumors, usually benign," . SPARSER::PROTEIN)
    ("PPP2R1A" . SPARSER::PROTEIN) ("FOXL2" . SPARSER::PROTEIN)
    ("AKR1C3" . SPARSER::PROTEIN)
    ("our mucinous lung cancer cohort" . SPARSER::MOLECULE)
    ("TTF-1 and napsin A" . SPARSER::COLLECTION)
    ("underwent pancreatic adenocarcinoma resections," . SPARSER::PROTEIN)
    ("G12C, G12V, G12D," . SPARSER::PROTEIN)
    ("G12D, G12V, G12R," . SPARSER::PROTEIN)
    ("primary mucinous lung cancer," . SPARSER::PROTEIN)
    ("CK20 and CDX2" . SPARSER::COLLECTION)
    ("mucinous features," . SPARSER::PROTEIN) ("MUC2" . SPARSER::PROTEIN)
    ("napsin A" . SPARSER::PROTEIN) ("CK20" . SPARSER::PROTEIN)
    ("multifocal (2+) expression patterns triggering confirmatory FISH"
     . SPARSER::PROTEIN)
    ("an excellent screening tool," . SPARSER::PROTEIN)
    ("typically weak," . SPARSER::PROTEIN) ("solid," . SPARSER::PROTEIN)
    ("never smokers," . SPARSER::PROTEIN) ("ALK and ROS" . SPARSER::COLLECTION)
    ("often cumbersome," . SPARSER::PROTEIN)
    ("EGFR , KRAS , and/or ALK alterations," . SPARSER::COLLECTION)
    ("this cohort underwent paired FISH" . SPARSER::PROTEIN)
    ("vesicular chromatin" . SPARSER::PROTEIN) ("Fish" . SPARSER::PROTEIN)
    ("limited smoking history and mutation-negative ACA ( xref ),"
     . SPARSER::PROTEIN)
    ("the ROS1 (D4D6) IHC antibody" . SPARSER::PROTEIN)
    ("A ROS1 IHC antibody" . SPARSER::PROTEIN)
    ("FIG1-ROS1" . SPARSER::COLLECTION)
    ("diagnostic reagents" . SPARSER::MOLECULE)
    ("clinically validated, commercially-available reagents"
     . SPARSER::MOLECULE)
    ("FIG1" . SPARSER::PROTEIN) ("SDC4" . SPARSER::PROTEIN)
    ("SLC34A2" . SPARSER::PROTEIN) ("CD74" . SPARSER::PROTEIN)
    ("GW" . SPARSER::PROTEIN) ("YG" . SPARSER::MOLECULE)
    ("FW" . SPARSER::MOLECULE) ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("its dual inhibitor AZD8055" . SPARSER::DRUG)
    ("an mTORC1/C2 dual inhibitor," . SPARSER::PROTEIN)
    ("mTOR and miR-99b" . SPARSER::COLLECTION)
    ("subcutaneous PANC-1" . SPARSER::PROTEIN)
    ("Intriguingly, AZD8055" . SPARSER::DRUG)
    ("mTORC2 substrate AKT and downstream proteins" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("mRNA as well as protein levels," . SPARSER::COLLECTION)
    ("Meanwhile, Bcl-2, Bcl-XL and Mcl-1" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-XL and Mcl-1" . SPARSER::COLLECTION)
    ("Ras/PI3K/PTEN/Akt/mTOR" . SPARSER::COLLECTION)
    ("dual mTOR inhibitor AZD8055" . SPARSER::DRUG)
    ("synergistic anti-angiogenic" . SPARSER::DRUG)
    ("rapamycin and its analogs everolimus (RAD001), temsirolimus (CCI-779)"
     . SPARSER::COLLECTION)
    ("ridaforolimus" . SPARSER::DRUG) ("late diagnosis," . SPARSER::PROTEIN)
    ("mTOR dual inhibitor AZD8055" . SPARSER::DRUG)
    ("Sulforhodamine B" . SPARSER::MOLECULE)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("/2 " . SPARSER::PROTEIN) ("miR-199a-3p" . SPARSER::MOLECULE)
    ("AP23573" . SPARSER::DRUG) ("CCI-779" . SPARSER::DRUG)
    ("RAD001" . SPARSER::DRUG) ("AZD8055" . SPARSER::DRUG)
    ("PANC-1" . SPARSER::PROTEIN) ("Rap2c and," . SPARSER::COLLECTION)
    ("intestinal epithelial afadin ( xref ) or JAM-A ( xref )"
     . SPARSER::COLLECTION)
    ("intestinal epithelial afadin" . SPARSER::PROTEIN)
    ("PDZ-GEF1 or rap2c" . SPARSER::COLLECTION) ("JAM-A–" . SPARSER::PROTEIN)
    ("cKO" . SPARSER::PROTEIN)
    ("the apical junctional complex (AJC)" . SPARSER::BIO-COMPLEX)
    ("actin and myosin light chain" . SPARSER::COLLECTION)
    ("afadin, another JAM-A–associated plaque protein" . SPARSER::PROTEIN)
    ("a previously uncharacterized GTPase" . SPARSER::GTPASE)
    ("EPAC and RAPGAP" . SPARSER::COLLECTION)
    ("Rap1 and," . SPARSER::COLLECTION) ("EPAC" . SPARSER::PROTEIN)
    ("afadin and/or ZO-2" . SPARSER::COLLECTION)
    ("afadin and ZO-2" . SPARSER::COLLECTION)
    ("the proteomic PDZ array," . SPARSER::PROTEIN)
    ("PDZ-GEF1 and JAM-A" . SPARSER::COLLECTION)
    ("PDZ-GEF2 or Rap1a/b" . SPARSER::COLLECTION)
    ("two polarized, nontransfected, human IECs" . SPARSER::PROTEIN)
    ("Supplemental Figure S2," . SPARSER::PROTEIN)
    ("JAM-A and ZO-1" . SPARSER::COLLECTION)
    ("JAM-A–associated scaffold proteins" . SPARSER::PROTEIN)
    ("perijunctional actin" . SPARSER::PROTEIN)
    ("the cortical actomyosin belt," . SPARSER::PROTEIN)
    ("perijunctional actin-GFP" . SPARSER::COLLECTION)
    ("actin-GFP" . SPARSER::COLLECTION)
    ("actin–green fluorescent protein" . SPARSER::COLLECTION)
    ("IECs" . SPARSER::PROTEIN) ("larger solutes," . SPARSER::PROTEIN)
    ("junction-associated Rap2c" . SPARSER::PROTEIN)
    ("σ1_G381A, IECs" . SPARSER::PROTEIN)
    ("afadin and JAM-A" . SPARSER::COLLECTION)
    ("Rap2c or JAM-A" . SPARSER::COLLECTION)
    ("JAM-A and Rap2" . SPARSER::COLLECTION)
    ("Rap2c and JAM-A" . SPARSER::COLLECTION)
    ("apical cell junctions," . SPARSER::PROTEIN)
    ("Rap2b and Rap2c" . SPARSER::COLLECTION)
    ("the only other known substrate" . SPARSER::SUBSTRATE)
    ("afadin and ZO-1" . SPARSER::COLLECTION)
    ("phosphorylated, tight-junction–associated JAM-A" . SPARSER::PROTEIN)
    ("the higher–molecular weight species," . SPARSER::PROTEIN)
    ("this previous report," . SPARSER::PROTEIN)
    ("afadin and PDZ-GEF1" . SPARSER::COLLECTION)
    ("a 37-kDa" . SPARSER::COLLECTION)
    ("JAM-A and PDZ-GEF1" . SPARSER::COLLECTION)
    ("Rap1a and Rap1b" . SPARSER::COLLECTION)
    ("Rap1a or Rap1b" . SPARSER::COLLECTION)
    ("Afadin and PDZ-GEF1" . SPARSER::COLLECTION)
    ("PDZ-GEF2 or Rap1" . SPARSER::COLLECTION) ("Afadin" . SPARSER::PROTEIN)
    ("JAM-A and ZO" . SPARSER::COLLECTION)
    ("ZO-1 and ZO-2" . SPARSER::COLLECTION)
    ("JAM-A and ZO-1/2" . SPARSER::COLLECTION)
    ("junction-associated JAM-A" . SPARSER::PROTEIN)
    ("JAM-A and ZO-2" . SPARSER::COLLECTION)
    ("ZO-2 and JAM-A" . SPARSER::COLLECTION)
    ("JAM-A–associated effector proteins" . SPARSER::PROTEIN)
    ("the apical junctional complex" . SPARSER::BIO-COMPLEX)
    ("TJ-associated JAM-A" . SPARSER::PROTEIN)
    ("subconfluent monolayers" . SPARSER::PROTEIN)
    ("JAM-A and barrier" . SPARSER::COLLECTION) ("dextrans" . SPARSER::DEXTRAN)
    ("the apical cytoskeleton," . SPARSER::PROTEIN)
    ("JAM-A and certain scaffold proteins" . SPARSER::COLLECTION)
    ("altered intestinal permeability ( xref )," . SPARSER::PROTEIN)
    ("nectin, another afadin-associated adherens protein," . SPARSER::PROTEIN)
    ("nectin" . SPARSER::PROTEIN) ("JAM-A and afadin" . SPARSER::COLLECTION)
    ("ZO-1 and its closely related family member, ZO-2," . SPARSER::COLLECTION)
    ("cytoplasmic scaffold or plaque proteins" . SPARSER::COLLECTION)
    ("TJ proteins and the apical cytoskeleton ( xref ; xref ; xref ; xref ),"
     . SPARSER::COLLECTION)
    ("the apical cytoskeleton ( xref ; xref ; xref ; xref ),"
     . SPARSER::PROTEIN)
    ("the TJ-associated apical cytoskeleton," . SPARSER::PROTEIN)
    ("larger molecules" . SPARSER::MOLECULE)
    ("intestinal permeability," . SPARSER::PROTEIN)
    ("Intriguingly, JAM-A-deficient cell lines and mice," . SPARSER::PROTEIN)
    ("claudins" . SPARSER::PROTEIN) ("tetraspan" . SPARSER::PROTEIN)
    ("TJ-associated transmembrane proteins" . SPARSER::PROTEIN)
    ("Rap1a" . SPARSER::PROTEIN) ("ZO-1 and afadin" . SPARSER::COLLECTION)
    ("tight junctions (TJs)," . SPARSER::PROTEIN)
    ("a TJ-associated protein" . SPARSER::PROTEIN)
    ("epithelial tight junctions (TJs)," . SPARSER::PROTEIN)
    ("afadin" . SPARSER::PROTEIN)
    ("epithelial tight junctions," . SPARSER::PROTEIN)
    ("siRNA–mediated" . SPARSER::PROTEIN) ("STX2" . SPARSER::PROTEIN)
    ("Ral-GDS" . SPARSER::PROTEIN) ("T3D" . SPARSER::PROTEIN)
    ("sodium sulfate" . SPARSER::MOLECULE) ("rap2c" . SPARSER::PROTEIN)
    ("myosin 2" . SPARSER::PROTEIN) ("Rap2a" . SPARSER::PROTEIN)
    ("Rap2b" . SPARSER::PROTEIN) ("Rap1b" . SPARSER::PROTEIN)
    ("claudin 10" . SPARSER::PROTEIN) ("PDZ-GEF2" . SPARSER::PROTEIN)
    ("Rap2c" . SPARSER::PROTEIN) ("ZO-2" . SPARSER::PROTEIN)
    ("JAM-A" . SPARSER::PROTEIN) ("SARM1-TRAF6-PINK1" . SPARSER::COLLECTION)
    ("VDAC1 and MFN1/2" . SPARSER::COLLECTION) ("PARL" . SPARSER::PROTEIN)
    ("rhomboid" . SPARSER::PROTEIN-FAMILY)
    ("In fact, SARM1" . SPARSER::PROTEIN)
    ("evolutionally most ancient," . SPARSER::PROTEIN)
    ("TRAM" . SPARSER::PROTEIN) ("TIRAP" . SPARSER::PROTEIN)
    ("PINK1-KDD or TRAF6" . SPARSER::COLLECTION)
    ("PINK1-KDD" . SPARSER::PROTEIN-PAIR)
    ("PINK1 or TRAF6" . SPARSER::COLLECTION)
    ("Flag-parkin" . SPARSER::COLLECTION) ("Parkin" . SPARSER::PROTEIN)
    ("OPA3-PINK1" . SPARSER::COLLECTION)
    ("ubiquitination-defective TRAF6-C70A mutant" . SPARSER::MUTANT)
    ("Flag-ubiquitin" . SPARSER::COLLECTION)
    ("dominant-negative TRAF2" . SPARSER::PROTEIN)
    ("Tom 20 and cytochrome c" . SPARSER::COLLECTION)
    ("dominant-negative TRAF6" . SPARSER::PROTEIN)
    ("K63-TUBE1" . SPARSER::COLLECTION) ("EtBr" . SPARSER::PROTEIN)
    ("rotenone" . SPARSER::PROTEIN) ("valinomycin" . SPARSER::MOLECULE)
    ("Valinomycin" . SPARSER::MOLECULE) ("hydrazine (CCCP)" . SPARSER::DRUG)
    ("uniporter" . SPARSER::PROTEIN) ("CCCP" . SPARSER::MOLECULE)
    ("hydrazine" . SPARSER::DRUG)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("TRAF6 and SARM1" . SPARSER::COLLECTION)
    ("UbcH13/Uev1a" . SPARSER::COLLECTION)
    ("GST-partial" . SPARSER::COLLECTION) ("S2, B and C" . SPARSER::COLLECTION)
    ("Ub-K63R" . SPARSER::COLLECTION)
    ("PINK1 and ubiquitin" . SPARSER::COLLECTION)
    ("TRAF2 or TRAF6" . SPARSER::COLLECTION)
    ("TRAF2 and TRAF6" . SPARSER::COLLECTION)
    ("TRAF2-Myc" . SPARSER::COLLECTION) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("TRAF6-Myc" . SPARSER::COLLECTION) ("PINK1–SARM1" . SPARSER::COLLECTION)
    ("Tubulin and Bcl-2" . SPARSER::COLLECTION)
    ("antibody and MitoTracker" . SPARSER::COLLECTION)
    ("C-terminal Flag-tagged serial deletion mutants" . SPARSER::MUTANT)
    ("ARM" . SPARSER::PROTEIN) ("PINK1 and SARM1" . SPARSER::COLLECTION)
    ("PINK1-HA" . SPARSER::COLLECTION)
    ("PINK1-hemagglutinin" . SPARSER::COLLECTION)
    ("SARM1-Flag" . SPARSER::COLLECTION)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("PINK1—sterile" . SPARSER::COLLECTION) ("MFN1/2" . SPARSER::COLLECTION)
    ("anion" . SPARSER::MOLECULE) ("OMI/HTRA2" . SPARSER::COLLECTION)
    ("OMI" . SPARSER::PROTEIN) ("SNCA" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor–associated factor 6 (TRAF6),"
     . SPARSER::PROTEIN)
    ("TIR" . SPARSER::PROTEIN-FAMILY) ("parkin" . SPARSER::PROTEIN)
    ("SARM1 and TRAF6" . SPARSER::COLLECTION) ("LC-3" . SPARSER::PROTEIN)
    ("TIR-1" . SPARSER::PROTEIN) ("OPA3" . SPARSER::PROTEIN)
    ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tom 20" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TUBE1" . SPARSER::PROTEIN)
    ("C–E" . SPARSER::PROTEIN) ("Uev1a" . SPARSER::PROTEIN)
    ("UbcH13" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("interleukin 1 receptor" . SPARSER::PROTEIN) ("MFN1" . SPARSER::PROTEIN)
    ("mitofusin 1" . SPARSER::PROTEIN) ("VDAC1" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN) ("LRRK2" . SPARSER::PROTEIN)
    ("HTRA2" . SPARSER::PROTEIN) ("DJ-1" . SPARSER::PROTEIN)
    ("SARM1" . SPARSER::PROTEIN) ("PINK1" . SPARSER::PROTEIN)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("a catalytically competent conformation" . SPARSER::BIO-CONFORMATION)
    ("Cdc42 or Rac" . SPARSER::COLLECTION)
    ("Sphingosine" . SPARSER::SPHINGOSINE)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("the principal PAK isoform" . SPARSER::ISOFORM)
    ("EGFR-ERK-CK2" . SPARSER::COLLECTION) ("-ERK" . SPARSER::COLLECTION)
    ("the autoinhibitory conformation" . SPARSER::BIO-CONFORMATION)
    ("the dimeric PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-KD" . SPARSER::COLLECTION) ("GST-PAK1 S223A" . SPARSER::COLLECTION)
    ("GFP-PAK1-KD" . SPARSER::COLLECTION) ("TBB" . SPARSER::PROTEIN)
    ("GST-PAK1-KD" . SPARSER::COLLECTION)
    ("CK2-catalyzed PAK1 S223 phosphorylation," . SPARSER::PROTEIN)
    ("GFP-PAK1" . SPARSER::COLLECTION) ("Ps" . SPARSER::PROTEIN)
    ("215 RDVATSPI S PTENNTTPPDAL 235 ," . SPARSER::PROTEIN)
    ("Scaffold" . SPARSER::SCAFFOLD) ("-PAK1" . SPARSER::COLLECTION)
    ("an inactive dimer" . SPARSER::DIMER)
    ("actin or actin-associated proteins" . SPARSER::COLLECTION)
    ("actin-associated proteins" . SPARSER::PROTEIN) ("Nck" . SPARSER::PROTEIN)
    ("CRIB" . SPARSER::DRUG) ("PAK1–3" . SPARSER::COLLECTION)
    ("Cdc42 and Rac" . SPARSER::COLLECTION)
    ("a monomeric PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an active monomer" . SPARSER::MONOMER)
    ("an inactive PAK1 dimer" . SPARSER::DIMER)
    ("sphingosine 1-phosphate" . SPARSER::DRUG) ("CKIP-1" . SPARSER::PROTEIN)
    ("KSR1" . SPARSER::PROTEIN) ("myelin basic protein" . SPARSER::PROTEIN)
    ("CK2α" . SPARSER::PROTEIN) ("CRN2" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2) ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("PAK1 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P21-activated kinase 1" . SPARSER::PROTEIN)
    ("even organoid EN," . SPARSER::PROTEIN)
    ("a post-zygotic somatic mutation," . SPARSER::PROTEIN)
    ("EN2" . SPARSER::PROTEIN) ("EN1" . SPARSER::PROTEIN)
    ("preclinical studies," . SPARSER::PROTEIN)
    ("eIF4E (LY2275796 or 4EASO) and 4EGI-1" . SPARSER::COLLECTION)
    ("Two different translational inhibitors" . SPARSER::INHIBITOR)
    ("-GTP" . SPARSER::NUCLEOTIDE) ("ERK and c-jun" . SPARSER::COLLECTION)
    ("Akt and 4E-BP1" . SPARSER::COLLECTION)
    ("c-Met or IGFR" . SPARSER::COLLECTION)
    ("IGFR and c-Met" . SPARSER::COLLECTION)
    ("IGFR or c-MET" . SPARSER::COLLECTION)
    ("alternate signaling pathways," . SPARSER::PROTEIN)
    ("Akt and 4EBP-1" . SPARSER::COLLECTION) ("-mRNA" . SPARSER::COLLECTION)
    ("the correct biomarker" . SPARSER::MOLECULE)
    ("c-Met and IGFR" . SPARSER::COLLECTION) ("IGFR" . SPARSER::PROTEIN)
    ("eIF4E and a small-molecule inhibitor" . SPARSER::COLLECTION)
    ("Erlotinib" . SPARSER::DRUG)
    ("erlotinib and 2 different cap-dependent translation inhibitors"
     . SPARSER::INHIBITOR)
    ("cap-dependent protein translation," . SPARSER::PROTEIN)
    ("For 3" . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("5-2" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::PROTEIN)
    ("LY2275796" . SPARSER::DRUG) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("ribonucleoside" . SPARSER::MOLECULE)
    ("normal chondrocytes" . SPARSER::PROTEIN)
    ("AMPK pharmacologic activators AICAR and A-769662" . SPARSER::COLLECTION)
    ("three-dimensional chondrocyte-alginate" . SPARSER::MOLECULE)
    ("the pharmacologic AMPK activators AICAR and highly AMPK-selective A-769662"
     . SPARSER::COLLECTION)
    ("the pharmacologic AMPK activators AICAR" . SPARSER::PROTEIN)
    ("AMPK pharmacologic activators AICAR (1 mM) and A-769662 (0.5 mM)"
     . SPARSER::COLLECTION)
    ("AMPK pharmacologic activators AICAR" . SPARSER::PROTEIN)
    ("GAG" . SPARSER::PROTEIN)
    ("cultured human knee osteoarthritic chondrocytes" . SPARSER::PROTEIN)
    ("LKB1 and AMPKα" . SPARSER::COLLECTION)
    ("MMP-3 and MMP-13" . SPARSER::COLLECTION)
    ("AMPK pharmacologic activators" . SPARSER::ACTIVATOR)
    ("alginate" . SPARSER::MOLECULE)
    ("Conversely, AMPK pharmacological activators" . SPARSER::ACTIVATOR)
    ("collagen and proteoglycans" . SPARSER::COLLECTION)
    ("catabolic activity," . SPARSER::PROTEIN)
    ("mechanical and inflammatory insults," . SPARSER::PROTEIN)
    ("biomechanical injury," . SPARSER::PROTEIN)
    ("LKB1 and AMPK" . SPARSER::COLLECTION)
    ("AICAR and A-769662" . SPARSER::COLLECTION)
    ("nitric oxide, MMP-3 and MMP-13" . SPARSER::COLLECTION)
    ("IL-1β and TNFα" . SPARSER::COLLECTION)
    ("protein phosphatase 2C" . SPARSER::PROTEIN)
    ("transforming growth factor beta-activated kinase 1" . SPARSER::PROTEIN)
    ("A-769662" . SPARSER::DRUG) ("Liver kinase B1" . SPARSER::PROTEIN)
    ("other NQO1 bioactivatable drugs" . SPARSER::DRUG)
    ("β-Lap-treated NQO1+ breast cancer cells," . SPARSER::PROTEIN)
    ("β-lap-exposed NQO1+ cells," . SPARSER::PROTEIN)
    ("exogenous
catalase"
     . SPARSER::PROTEIN)
    ("ROS and NOS" . SPARSER::COLLECTION)
    ("β-lap-exposed NQO1" . SPARSER::PROTEIN)
    ("NQO1/Catalase" . SPARSER::COLLECTION)
    ("catalase and/or CuZnSOD" . SPARSER::COLLECTION)
    ("NOS and posttranslational GAPDH" . SPARSER::COLLECTION)
    ("posttranslational GAPDH" . SPARSER::PROTEIN)
    (",
µ"
     . SPARSER::PROTEIN)
    ("β-lap-treated MCF-7 cells," . SPARSER::PROTEIN)
    ("PARP1/p53" . SPARSER::COLLECTION) ("chelator" . SPARSER::MOLECULE)
    ("BAPTA" . SPARSER::MOLECULE) ("-calpain" . SPARSER::COLLECTION)
    ("STS" . SPARSER::PROTEIN)
    ("Consistently,
catalase"
     . SPARSER::PROTEIN)
    ("PARP1 and p53" . SPARSER::COLLECTION)
    ("Exogenous catalase" . SPARSER::PROTEIN) ("CuZnSOD" . SPARSER::PROTEIN)
    ("β-lap-exposed 231-NQ+ cells
( xref , left),"
     . SPARSER::PROTEIN)
    ("Alkaline" . SPARSER::PROTEIN) ("GSSG" . SPARSER::DRUG)
    ("ultimately hyperactive PARP1" . SPARSER::PROTEIN)
    ("futile redox" . SPARSER::PROTEIN) ("rather sharp," . SPARSER::PROTEIN)
    ("doxorubicin (DOX, 5 µmol/L, 30 min) or
H 2 O 2 (200 µmol/L, 30 min)"
     . SPARSER::COLLECTION)
    ("b5R and p450R" . SPARSER::COLLECTION) ("p450R" . SPARSER::PROTEIN)
    ("b5R" . SPARSER::PROTEIN) ("Seahorse" . SPARSER::PROTEIN)
    ("robust futile redox" . SPARSER::PROTEIN)
    ("NADH, β-lap and NQO1" . SPARSER::COLLECTION)
    ("a robust OCR," . SPARSER::PROTEIN)
    ("NQO1-driven futile redox" . SPARSER::PROTEIN)
    ("NQO1 bioactivatable drugs," . SPARSER::PROTEIN)
    ("NQO1/catalase" . SPARSER::COLLECTION)
    ("ROS or chelating
Ca 2+  ER"
     . SPARSER::COLLECTION)
    ("β-lap-induced
lethality,"
     . SPARSER::PROTEIN)
    ("Catalase" . SPARSER::PROTEIN)
    ("the only other NQO1 bioactivatable drug" . SPARSER::DRUG)
    ("oxygen and theoretically creating dramatically elevated levels of
superoxide (O 2  ∸ )"
     . SPARSER::COLLECTION)
    ("hydroquinone and semiquinone" . SPARSER::COLLECTION)
    ("semiquinone" . SPARSER::MOLECULE) ("hydroquinone" . SPARSER::MOLECULE)
    ("an NQO1-dependent futile redox" . SPARSER::PROTEIN)
    ("Lap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-PARP1" . SPARSER::COLLECTION)
    ("causes dramatic intracellular nucleotide loss," . SPARSER::PROTEIN)
    ("lap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    (", as well as dormant cancer cells," . SPARSER::COLLECTION)
    ("other NQO1 bioactivatable
drugs"
     . SPARSER::DRUG)
    ("NQO1:catalase" . SPARSER::BIO-COMPLEX)
    ("exogenous enzyme," . SPARSER::PROTEIN)
    ("essential nucleotides" . SPARSER::NUCLEOTIDE)
    ("DNA
single strand break-dependent PARP1 hyperactivation,"
     . SPARSER::PROTEIN)
    ("a futile redox" . SPARSER::PROTEIN) ("–3 µ" . SPARSER::PROTEIN)
    ("p450" . SPARSER::PROTEIN-FAMILY) ("γ-H 2 AX" . SPARSER::PROTEIN)
    ("zVAD-FMK" . SPARSER::DRUG)
    ("serum
albumin"
     . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("quinone
oxidoreductase"
     . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("SYK" . SPARSER::PROTEIN)
    ("an easily applicable," . SPARSER::PROTEIN) ("PRISM" . SPARSER::PROTEIN)
    ("rather expensive equipment," . SPARSER::PROTEIN)
    ("ABI" . SPARSER::PROTEIN-FAMILY) ("/ERK/MAPK" . SPARSER::COLLECTION)
    ("POP7" . SPARSER::PROTEIN) ("BCM and SMJ" . SPARSER::COLLECTION)
    ("BCM" . SPARSER::DRUG) ("70-kD" . SPARSER::PROTEIN)
    ("Tuberin" . SPARSER::PROTEIN) ("GHR" . SPARSER::PROTEIN)
    ("DPPIV" . SPARSER::PROTEIN) ("labeled exosomal miRs" . SPARSER::PROTEIN)
    ("milk proteins and exosomal miRs" . SPARSER::COLLECTION)
    ("the mammary gland," . SPARSER::PROTEIN) ("just food" . SPARSER::MOLECULE)
    ("the Neolithic period," . SPARSER::PROTEIN)
    ("Intriguingly, let-7" . SPARSER::RNA) ("Lin28a" . SPARSER::PROTEIN)
    ("miR-21-" . SPARSER::PROTEIN) ("BCAA-" . SPARSER::PROTEIN)
    ("mTORC1-S6K1" . SPARSER::COLLECTION) ("a major miR" . SPARSER::PROTEIN)
    ("Intriguingly, miR-29b" . SPARSER::MOLECULE)
    ("acyltransferase" . SPARSER::PROTEIN) ("BCKD" . SPARSER::PROTEIN)
    ("lipid and energy" . SPARSER::COLLECTION)
    ("the adipogenic transcription factor CCAAT" . SPARSER::PROTEIN)
    ("CCAAT" . SPARSER::PROTEIN) ("mature adipocytes" . SPARSER::PROTEIN)
    ("sterol regulatory element-binding protein (SREBP) cleavage-activating protein"
     . SPARSER::PROTEIN)
    ("SREBP" . SPARSER::PROTEIN-FAMILY) ("sterol" . SPARSER::PROTEIN)
    ("Insulin-induced gene 1 (insig-1) mRNA" . SPARSER::PROTEIN)
    ("the mTORC1 signaling pathway, milk-derived exosomal miR-21"
     . SPARSER::PROTEIN)
    ("specific exosomal miRs," . SPARSER::PROTEIN)
    ("soluble milk proteins, especially whey," . SPARSER::PROTEIN)
    ("BCAA" . SPARSER::PROTEIN) ("Nordic countries," . SPARSER::PROTEIN)
    ("bovine milk-derived miRs" . SPARSER::PROTEIN)
    ("the faster growing species Bos taurus ," . SPARSER::PROTEIN)
    ("In fact, miR-21" . SPARSER::PROTEIN)
    ("an even more powerful archaic regulatory network," . SPARSER::PROTEIN)
    ("both amino acid- and miR-mediated pathways" . SPARSER::COLLECTION)
    ("amino acid-" . SPARSER::AMINO-ACID)
    ("amply translation initiation," . SPARSER::PROTEIN)
    ("eIF4E-eIF4G" . SPARSER::COLLECTION)
    ("4E-BP-1 and PDCD4" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("milk-derived miR-21" . SPARSER::PROTEIN)
    ("Sprouty1 and Sprouty2" . SPARSER::COLLECTION)
    ("Exosomal miR-21," . SPARSER::PROTEIN)
    ("cow´s milk-derived miRs" . SPARSER::PROTEIN)
    ("a diet-derived miR," . SPARSER::PROTEIN)
    ("milk´s exosomal miRs" . SPARSER::PROTEIN)
    (", bovine milk´s predominant miR species, miR-21," . SPARSER::PROTEIN)
    ("CD63- and CD81-containing tetraspanin molecules" . SPARSER::COLLECTION)
    ("CD63-" . SPARSER::PROTEIN) ("the intestinal barrier" . SPARSER::PROTEIN)
    ("Remarkably, miRs" . SPARSER::PROTEIN) ("pH2" . SPARSER::PROTEIN)
    ("RNAse" . SPARSER::PROTEIN) ("milk-derived miRs" . SPARSER::PROTEIN)
    ("exosomal miRs" . SPARSER::PROTEIN) ("horizontal miR" . SPARSER::PROTEIN)
    ("milk´s exosomal microRNAs" . SPARSER::RNA)
    (", milk-derived amino acids" . SPARSER::AMINO-ACID)
    ("leucine and tryptophan" . SPARSER::COLLECTION)
    ("dual control," . SPARSER::PROTEIN)
    ("GH and amino acid" . SPARSER::COLLECTION)
    ("leucine and free IGF-1 serum levels" . SPARSER::COLLECTION)
    ("essential amino acids" . SPARSER::AMINO-ACID)
    ("dietary glucose" . SPARSER::PROTEIN)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("the pituitary," . SPARSER::PROTEIN) ("GIPR" . SPARSER::PROTEIN)
    ("enzyme dipeptidyl peptidase IV," . SPARSER::PROTEIN)
    ("proteins and caseins" . SPARSER::COLLECTION)
    ("caseins" . SPARSER::PROTEIN-FAMILY)
    ("4E-BP-1 (formerly termed PHAS-I) and S6K," . SPARSER::COLLECTION)
    ("dehydrogenase (GDH)" . SPARSER::PROTEIN)
    ("proteins, especially leucine," . SPARSER::PROTEIN)
    ("Water soluble, easily hydrolysable whey proteins" . SPARSER::PROTEIN)
    ("leucine, isoleucine and valine" . SPARSER::COLLECTION)
    ("Casein" . SPARSER::PROTEIN) ("GH and IGF-1" . SPARSER::COLLECTION)
    ("lactalbumin" . SPARSER::PROTEIN) ("Tryptophan" . SPARSER::AMINO-ACID)
    ("milk-derived exosomal regulatory microRNAs (miRs), especially miR-21,"
     . SPARSER::PROTEIN)
    ("protein-" . SPARSER::PROTEIN)
    ("protein and casein" . SPARSER::COLLECTION) ("casein" . SPARSER::PROTEIN)
    ("Importantly, milk exosomes," . SPARSER::PROTEIN)
    ("glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), insulin, growth hormone (GH) and insulin-like growth factor-1 (IGF-1)"
     . SPARSER::COLLECTION)
    ("growth hormone (GH)" . SPARSER::PROTEIN)
    ("preferential amino acids," . SPARSER::PROTEIN) ("GH" . SPARSER::PROTEIN)
    ("GIP" . SPARSER::PROTEIN)
    ("Sterol regulatory element-binding transcription factor 1"
     . SPARSER::PROTEIN)
    ("SPRY2" . SPARSER::PROTEIN) ("Son of sevenless" . SPARSER::PROTEIN)
    ("Ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("HA-RAS" . SPARSER::PROTEIN) ("V-RAF" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-Phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase kinase 1" . SPARSER::PROTEIN)
    ("amino acid transporter" . SPARSER::PROTEIN)
    ("Phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("Insulin receptor" . SPARSER::PROTEIN)
    ("Insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("Insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("Growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("GRB2" . SPARSER::PROTEIN) ("Glucagon-like peptide" . SPARSER::PROTEIN)
    ("GIP receptor" . SPARSER::PROTEIN)
    ("Glucose-dependent insulinotropic polypeptide" . SPARSER::PROTEIN)
    ("Growth hormone receptor" . SPARSER::PROTEIN)
    ("Growth hormone" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase kinase 4" . SPARSER::PROTEIN)
    ("Eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("Eukaryotic translation initiation factor 4A" . SPARSER::PROTEIN)
    ("Eukaryotic translation initiation factor 4E-binding protein 1"
     . SPARSER::PROTEIN)
    ("V-AKT" . SPARSER::PROTEIN)
    ("Adenosine monophosphate" . SPARSER::MOLECULE)
    ("Amino acids" . SPARSER::AMINO-ACID) ("miR-126" . SPARSER::PROTEIN)
    ("RNA-binding protein" . SPARSER::PROTEIN)
    ("Muscle specific" . SPARSER::PROTEIN)
    ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("let7" . SPARSER::RNA)
    ("PPARγ" . SPARSER::PROTEIN) ("branched chain" . SPARSER::PROTEIN)
    ("C/EBPβ" . SPARSER::PROTEIN) ("Insig-1" . SPARSER::PROTEIN)
    ("insig-1" . SPARSER::PROTEIN) ("Sprouty2" . SPARSER::PROTEIN)
    ("Sprouty1" . SPARSER::PROTEIN) ("LDLRAP1" . SPARSER::PROTEIN)
    ("CD81" . SPARSER::PROTEIN) ("CD63" . SPARSER::PROTEIN)
    ("IGFBP-2" . SPARSER::PROTEIN) ("IGFBP-1" . SPARSER::PROTEIN)
    ("PHAS-I" . SPARSER::PROTEIN) ("4E-BP-1" . SPARSER::PROTEIN)
    ("glucose - dependent insulinotropic polypeptide" . SPARSER::PROTEIN)
    ("IGF-1-" . SPARSER::PROTEIN) ("PDCD4" . SPARSER::PROTEIN)
    ("programmed cell death 4" . SPARSER::PROTEIN) ("GLP-1" . SPARSER::PROTEIN)
    ("glucagon-like peptide" . SPARSER::PROTEIN)
    ("glucose-dependent insulinotropic polypeptide" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("AKT and nuclear NF κ B p65" . SPARSER::COLLECTION)
    ("TAp73 and Δ Np73" . SPARSER::COLLECTION)
    ("MMP-9, UPA and VEGF" . SPARSER::COLLECTION)
    ("ovarian cancer progression," . SPARSER::PROTEIN)
    ("quantitative real-time PCR," . SPARSER::PROTEIN)
    ("HER/ERBB2" . SPARSER::COLLECTION)
    ("ovarian cancer cells," . SPARSER::PROTEIN) ("Trypan" . SPARSER::DRUG)
    ("the chemo-resistant ovarian cancer cell line," . SPARSER::PROTEIN)
    ("OV" . SPARSER::MOLECULE) ("p53 and Δ Np73" . SPARSER::COLLECTION)
    ("p73 (TAp73) and p53" . SPARSER::COLLECTION)
    ("C17ORF37" . SPARSER::PROTEIN)
    ("breast cancer-associated gene 3" . SPARSER::PROTEIN)
    ("p21 and Bax" . SPARSER::COLLECTION)
    ("pro-apoptotic functions," . SPARSER::PROTEIN)
    ("TAp73 and p53" . SPARSER::COLLECTION)
    ("an N-terminal transactivation domain-containing isoform (TAp73) and a dominant-negative isoform"
     . SPARSER::COLLECTION)
    ("a dominant-negative isoform" . SPARSER::ISOFORM)
    ("AKT and NF κ B" . SPARSER::COLLECTION) ("GRB7" . SPARSER::PROTEIN)
    ("Myc-C" . SPARSER::PROTEIN)
    ("TATA-box binding protein" . SPARSER::PROTEIN)
    ("a 37 " . SPARSER::PROTEIN) ("MV1" . SPARSER::MOLECULE)
    ("β -Actin" . SPARSER::PROTEIN) ("MIEN1" . SPARSER::PROTEIN)
    ("BCA3" . SPARSER::PROTEIN) ("gene 3" . SPARSER::PROTEIN)
    ("NF κ B" . SPARSER::PROTEIN) ("PPR and FB" . SPARSER::COLLECTION)
    ("the actual enzymes" . SPARSER::ENZYME)
    ("The weakly transforming Tax-2 protein" . SPARSER::PROTEIN)
    ("p21-cyclin D2-CDK6" . SPARSER::COLLECTION)
    ("p21-cyclin D2-CDK4" . SPARSER::COLLECTION)
    ("cyclin D2 and CDK6" . SPARSER::COLLECTION)
    ("CDK4-cyclin D" . SPARSER::COLLECTION) ("κB" . SPARSER::PROTEIN)
    ("the acetyltransferase p300 and the deacetylase HDAC7,"
     . SPARSER::COLLECTION)
    ("the acetylation-mimetic K 346 Q mutant," . SPARSER::PROTEIN)
    ("CDK4, cyclin D3 and p21" . SPARSER::COLLECTION)
    ("the non-acetylated K 346 R mutant or the acetylation mimetic K 346 Q mutant (Figure  xref B)"
     . SPARSER::COLLECTION)
    ("the acetylation mimetic K 346 Q mutant" . SPARSER::MUTANT)
    ("anti-cyclin D3, anti-CDK4, anti-p21 and anti-HA" . SPARSER::COLLECTION)
    ("low stoichiometric binding ratio, p21" . SPARSER::PROTEIN)
    ("p21 or p27" . SPARSER::COLLECTION)
    ("CDK4-D-type" . SPARSER::PROTEIN-PAIR)
    ("CDK4-cyclin D3" . SPARSER::COLLECTION) ("HA-hDLG" . SPARSER::COLLECTION)
    ("Tax-mediated NF-κB activation," . SPARSER::PROTEIN)
    ("RelA and p300" . SPARSER::COLLECTION) ("κB-luc" . SPARSER::PROTEIN-PAIR)
    ("three transformed Rat/LV-WT, Rat/LV-K 346 R and Rat/LV-K 346 Q"
     . SPARSER::PROTEIN)
    ("LV-" . SPARSER::MOLECULE) ("LV" . SPARSER::MOLECULE)
    ("p300 or HDAC7" . SPARSER::COLLECTION)
    ("p300 and HDAC7/5" . SPARSER::COLLECTION) ("NB" . SPARSER::PROTEIN)
    ("HDAC5-Flag" . SPARSER::COLLECTION)
    ("Interestingly, anti-AcK 346 Tax antibody" . SPARSER::ANTIBODY)
    ("HDAC7-Flag" . SPARSER::COLLECTION) ("p300-HA" . SPARSER::COLLECTION)
    ("p300 and HDAC7" . SPARSER::COLLECTION)
    ("a phosphorylated form (P, form 3) and an acetylated and phosphorylated form (Ac/P, form 4),"
     . SPARSER::COLLECTION)
    ("orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("Trichostatin" . SPARSER::MOLECULE) ("IIb" . SPARSER::DRUG)
    ("the acetyltransferase p300 or the class IIa deacetylase HDAC7"
     . SPARSER::COLLECTION)
    ("a newly developed rabbit polyclonal antibody" . SPARSER::ANTIBODY)
    ("CDK4-cyclin D3-p21" . SPARSER::COLLECTION)
    ("the 20 C-terminal amino acids of Tax, which have been directly implicated in Tax transforming"
     . SPARSER::PROTEIN)
    ("NF-κB and the transcriptional coactivator p300
[ xref ]"
     . SPARSER::COLLECTION)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HBZ" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("hDLG, hScrib and MAGI-1" . SPARSER::COLLECTION)
    ("hScrib" . SPARSER::PROTEIN)
    ("CDK4/6-cyclin D3-p21" . SPARSER::COLLECTION)
    ("the SRF
[ xref - xref ] and the AP1
[ xref , xref ]"
     . SPARSER::COLLECTION)
    ("HAM/TSP" . SPARSER::COLLECTION) ("TSP" . SPARSER::PROTEIN)
    ("HAM" . SPARSER::PROTEIN)
    ("the acetyltransferase p300 and the deacetylase HDAC7"
     . SPARSER::COLLECTION)
    ("hDLG" . SPARSER::PROTEIN)
    ("the acetylation mimetic K 346 Q mutant," . SPARSER::PROTEIN)
    ("the acetyltransferase p300 and the deacetylases HDAC5/7"
     . SPARSER::COLLECTION)
    ("Tax-1" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("MT4" . SPARSER::PROTEIN) ("CdCl 2" . SPARSER::MOLECULE)
    ("P 50" . SPARSER::PROTEIN) ("K10" . SPARSER::PROTEIN)
    ("HDAC7" . SPARSER::PROTEIN) ("Rat-1" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("HDAC5" . SPARSER::PROTEIN)
    ("DMM" . SPARSER::DRUG) ("BF" . SPARSER::MOLECULE)
    ("the immunohistochemical," . SPARSER::PROTEIN) ("TNFR" . SPARSER::PROTEIN)
    ("triton" . SPARSER::MOLECULE) ("ssf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Paraformaldehyde" . SPARSER::DRUG)
    ("asf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dramatic gene" . SPARSER::GENE)
    ("soluble TNF," . SPARSER::PROTEIN)
    ("TNFR1 or TNFR2" . SPARSER::COLLECTION)
    ("very distinct," . SPARSER::PROTEIN)
    ("its receptor CXCR4 [ xref ] or CXCR7 [ xref ]" . SPARSER::COLLECTION)
    ("the mature CNS, CXCL12" . SPARSER::PROTEIN)
    ("CXCL12 and its receptor" . SPARSER::COLLECTION)
    ("receptors, CXCR4 and CXCR7" . SPARSER::COLLECTION)
    ("microglia/macrophage" . SPARSER::COLLECTION)
    ("microglia and/or infiltrating macrophages" . SPARSER::COLLECTION)
    ("reactive astrocytes" . SPARSER::PROTEIN) ("mature," . SPARSER::PROTEIN)
    ("/CC1" . SPARSER::COLLECTION) ("our previous studies," . SPARSER::PROTEIN)
    ("soluble TNF" . SPARSER::PROTEIN) ("Foxc2" . SPARSER::PROTEIN)
    ("Chemokines and their receptors" . SPARSER::COLLECTION)
    ("Chemokines" . SPARSER::PROTEIN) ("LM" . SPARSER::MOLECULE)
    ("neuroinflammatory processes," . SPARSER::PROTEIN)
    ("Sox17 and Lingo-1" . SPARSER::COLLECTION)
    ("Ki67, Sox17, CD11b, TLR4, CXCR4, Lingo-1, ICAM1 and CNPase"
     . SPARSER::COLLECTION)
    ("Lingo-1" . SPARSER::PROTEIN) ("CNPase" . SPARSER::PROTEIN)
    ("genes and transcripts" . SPARSER::COLLECTION) ("PLP" . SPARSER::PROTEIN)
    ("mature oligodendrocytes," . SPARSER::PROTEIN)
    ("a significantly smaller lesion volume," . SPARSER::PROTEIN)
    ("a brain injury model astroglial NF-κB" . SPARSER::PROTEIN)
    ("supraspinal and propriospinal axons," . SPARSER::PROTEIN)
    ("uncontrolled," . SPARSER::PROTEIN)
    ("peripheral leukocytes" . SPARSER::PROTEIN)
    ("microglia/leukocytes" . SPARSER::COLLECTION)
    ("astroglial NF-κB" . SPARSER::PROTEIN) ("myelin" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN)
    ("Glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("TNFR1" . SPARSER::PROTEIN)
    ("myelin oligodendrocyte glycoprotein" . SPARSER::PROTEIN)
    ("Iκbα" . SPARSER::PROTEIN) ("B-D" . SPARSER::PROTEIN)
    ("CXCR7" . SPARSER::PROTEIN) ("Sox17" . SPARSER::PROTEIN)
    ("TNFR2" . SPARSER::PROTEIN) ("Olig2" . SPARSER::PROTEIN)
    ("CC1" . SPARSER::PROTEIN) ("IgG2 b" . SPARSER::BIO-COMPLEX)
    ("CCL2" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("NG2" . SPARSER::PROTEIN) ("toll-like receptor 4" . SPARSER::PROTEIN)
    ("the symmetric EGFR dimer" . SPARSER::DIMER)
    ("the latter dimers" . SPARSER::DIMER)
    ("their symmetric counterparts," . SPARSER::PROTEIN)
    ("particular," . SPARSER::PROTEIN)
    ("hEGFR and dEGFR" . SPARSER::COLLECTION) ("x" . SPARSER::PROTEIN)
    ("the symmetric human EGFR dimer" . SPARSER::DIMER)
    ("the symmetric Drosophila EGFR (dEGFR) dimer," . SPARSER::PROTEIN)
    ("the symmetrical human EGFR (hEGFR) dimer" . SPARSER::DIMER)
    ("particularly strong," . SPARSER::PROTEIN)
    ("In fact, EGFR" . SPARSER::PROTEIN) ("EGFR-EGFR" . SPARSER::COLLECTION)
    ("hEGFR" . SPARSER::PROTEIN) ("only one ligand" . SPARSER::MOLECULE)
    ("only symmetric dimers" . SPARSER::DIMER) ("letter" . SPARSER::MOLECULE)
    ("the crystallographic analysis," . SPARSER::PROTEIN)
    ("tyrosine or phenylalanine" . SPARSER::COLLECTION)
    ("EGFR and dEGFR" . SPARSER::COLLECTION) ("heregulin" . SPARSER::PROTEIN)
    ("3 monomer ( xref ) and our model" . SPARSER::COLLECTION)
    ("2 heterodimer and the resulting ligand-free heterodimer"
     . SPARSER::COLLECTION)
    ("the former case," . SPARSER::PROTEIN) ("the former," . SPARSER::PROTEIN)
    ("LTF" . SPARSER::PROTEIN) ("missing ligand" . SPARSER::LIGAND)
    ("IIs" . SPARSER::PROTEIN) ("the transmembrane helix" . SPARSER::PROTEIN)
    ("a symmetric conformation" . SPARSER::BIO-CONFORMATION)
    ("constitutively bent ( xref ; xref ; xref ; xref )," . SPARSER::PROTEIN)
    ("the (ligand-bound) active dimer" . SPARSER::DIMER)
    ("the conformations and stability" . SPARSER::COLLECTION)
    ("only one member," . SPARSER::PROTEIN)
    ("proteins and dEGFR" . SPARSER::COLLECTION)
    ("ovarian cancer," . SPARSER::PROTEIN) ("aggressive forms" . SPARSER::FORM)
    ("the same ErbB protein or two different ErbB proteins"
     . SPARSER::COLLECTION)
    ("TIP3" . SPARSER::PROTEIN) ("glutamine residue" . SPARSER::MOLECULE)
    ("AR and c-Met" . SPARSER::COLLECTION) ("HGF/c-Met" . SPARSER::COLLECTION)
    ("a diagnostically and therapeutically elusive androgen-independent disease state"
     . SPARSER::BIO-STATE)
    ("functional PSMA" . SPARSER::PROTEIN)
    ("a specific PSMA fluorescent inhibitor" . SPARSER::INHIBITOR)
    ("a more aggressive, androgen-independent prostate cancer disease state"
     . SPARSER::BIO-STATE)
    ("AR and PSMA" . SPARSER::COLLECTION)
    ("AR and prostate specific membrane antigen" . SPARSER::COLLECTION)
    ("PSMA" . SPARSER::PROTEIN) ("HGF/SF" . SPARSER::COLLECTION)
    ("hepatocyte growth factor/scatter factor" . SPARSER::COLLECTION)
    ("a more aggressive disease state" . SPARSER::BIO-STATE)
    ("prostate specific membrane antigen" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN)
    ("ROCK1 and Beclin1" . SPARSER::COLLECTION)
    ("JNK and MAPK" . SPARSER::COLLECTION)
    ("ROCK1 and DAPK" . SPARSER::COLLECTION) ("ZIPK" . SPARSER::PROTEIN)
    ("DAPK" . SPARSER::PROTEIN) ("Beclin1 and Bcl-2" . SPARSER::COLLECTION)
    ("mutational analysis," . SPARSER::PROTEIN)
    ("nutritional stress," . SPARSER::PROTEIN)
    ("UVRAG-Beclin1" . SPARSER::COLLECTION)
    ("p62/SQSTM1" . SPARSER::COLLECTION) ("Flp-Cre" . SPARSER::COLLECTION)
    ("Flp" . SPARSER::PROTEIN) ("Bcl-2/Beclin1" . SPARSER::COLLECTION)
    ("WT, T119A (phospho-mutant) and T119E (phospho-mimetic) mutant"
     . SPARSER::COLLECTION)
    ("Beclin1/Bcl-2" . SPARSER::COLLECTION)
    ("Vps34 and UVRAG" . SPARSER::COLLECTION) ("Vps34" . SPARSER::PROTEIN)
    ("Bcl-2 and Beclin1" . SPARSER::COLLECTION)
    ("Myc-ROCK1" . SPARSER::COLLECTION)
    ("possible substrates" . SPARSER::SUBSTRATE)
    ("Flag-Beclin1" . SPARSER::COLLECTION)
    ("kinase and ROCK1" . SPARSER::COLLECTION)
    ("autophagic flux," . SPARSER::PROTEIN)
    ("a multifunctional adaptor protein" . SPARSER::PROTEIN)
    ("autophagic vacuole maturation  xref  ," . SPARSER::PROTEIN)
    ("autophagic flux, Bafilomycin A1," . SPARSER::PROTEIN)
    ("Additionally, using shRNA (shROCK1-#1), as well as siROCK1-#2 and siROCK1-#3,"
     . SPARSER::COLLECTION)
    ("Additionally, using shRNA (shROCK1-#1)," . SPARSER::PROTEIN)
    ("Rhotekin" . SPARSER::PROTEIN)
    ("Y27632-treated cells," . SPARSER::PROTEIN)
    ("ROCK1 or Beclin1" . SPARSER::COLLECTION) ("CFP" . SPARSER::PROTEIN)
    ("Beclin1 and ROCK1" . SPARSER::COLLECTION)
    ("ER/mitochondria" . SPARSER::COLLECTION)
    ("Beclin1, PKM2, XRCC6 and STK38" . SPARSER::COLLECTION)
    ("Interestingly, ROCK" . SPARSER::PROTEIN-FAMILY)
    ("Beclin1, as well as UVRAG," . SPARSER::COLLECTION)
    ("a coiled-coil, UV irradiation resistance-associated gene,"
     . SPARSER::PROTEIN)
    ("Vps" . SPARSER::PROTEIN) ("a well-conserved protein" . SPARSER::PROTEIN)
    ("At least 15 different proteins" . SPARSER::PROTEIN)
    ("long-lived proteins," . SPARSER::PROTEIN)
    ("cell-cell adhesion, migration, invasion, transformation, mitosis, DNA-damage"
     . SPARSER::DNA)
    (", migration, invasion, transformation, mitosis, DNA-damage"
     . SPARSER::DNA)
    ("migration, invasion, transformation, mitosis, DNA-damage" . SPARSER::DNA)
    (", invasion, transformation, mitosis, DNA-damage" . SPARSER::DNA)
    ("invasion, transformation, mitosis, DNA-damage" . SPARSER::DNA)
    (", transformation, mitosis, DNA-damage" . SPARSER::DNA)
    ("transformation, mitosis, DNA-damage" . SPARSER::DNA)
    (", mitosis, DNA-damage" . SPARSER::DNA)
    ("mitosis, DNA-damage" . SPARSER::DNA) (", DNA-damage" . SPARSER::DNA)
    ("Two ROCK isoforms exist—ROCK1 (ROKβ) and ROCK2 (ROKα)"
     . SPARSER::COLLECTION)
    ("ezrin/radixin/moesin" . SPARSER::COLLECTION) ("IRS" . SPARSER::PROTEIN)
    ("Beclin1-UVRAG" . SPARSER::COLLECTION)
    ("Beclin1-Bcl-2" . SPARSER::COLLECTION) ("UVRAG" . SPARSER::PROTEIN)
    ("a proximal component" . SPARSER::COMPONENT)
    ("microcystin-LR" . SPARSER::MOLECULE) ("Bcl-XL" . SPARSER::PROTEIN)
    ("death associated protein kinase" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("STK38" . SPARSER::PROTEIN)
    ("XRCC6" . SPARSER::PROTEIN) ("ATG6" . SPARSER::PROTEIN)
    ("ROKα" . SPARSER::PROTEIN) ("JIP-3" . SPARSER::PROTEIN)
    ("JNK interacting protein" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN) ("Rho kinase" . SPARSER::PROTEIN)
    ("PUMA/BAX" . SPARSER::COLLECTION) ("p53-PUMA-Bax" . SPARSER::COLLECTION)
    ("Bcl-2 and BAX" . SPARSER::COLLECTION)
    ("hepatocytic apoptosis," . SPARSER::PROTEIN)
    ("Bax/Bak" . SPARSER::COLLECTION)
    ("the most severe lipotoxicity," . SPARSER::PROTEIN)
    ("excessive FFAs" . SPARSER::PROTEIN)
    ("p53, p85, DRAM and BAX" . SPARSER::COLLECTION)
    ("severe hepatosteatosis, p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("our previous results," . SPARSER::PROTEIN)
    ("LC3 II, DRAM and BAX" . SPARSER::COLLECTION)
    ("DRAM and BAX" . SPARSER::COLLECTION)
    ("severe cases, other pro-apoptotic factors," . SPARSER::PROTEIN)
    ("DRAM, LC3 II, p85 or BAX" . SPARSER::COLLECTION)
    ("p85 or BAX" . SPARSER::COLLECTION) ("BAX and DRAM" . SPARSER::COLLECTION)
    ("p53 and its target genes, PUMA, BAX and DRAM," . SPARSER::COLLECTION)
    ("PUMA, BAX and DRAM" . SPARSER::COLLECTION)
    ("p53 and its target genes" . SPARSER::COLLECTION)
    ("a vacuolar H + -ATPase inhibitor," . SPARSER::PROTEIN)
    ("BafA" . SPARSER::PROTEIN)
    ("both late and early apoptosis," . SPARSER::PROTEIN)
    ("Calcein" . SPARSER::MOLECULE)
    ("triglycerides and LDH" . SPARSER::COLLECTION)
    ("mild steatosis, p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DRAM and Sestrin2" . SPARSER::COLLECTION)
    ("PUMA and BAX" . SPARSER::COLLECTION)
    ("a primary apoptotic inducer" . SPARSER::PROTEIN)
    ("mild hepatosteatosis," . SPARSER::PROTEIN) ("DRAM" . SPARSER::PROTEIN)
    ("keratin 18" . SPARSER::PROTEIN) ("1 A" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("Sestrin2" . SPARSER::PROTEIN)
    ("oleic acid" . SPARSER::MOLECULE)
    ("damage-regulated autophagy modulator" . SPARSER::PROTEIN)
    ("multifactorial diseases," . SPARSER::PROTEIN)
    ("available," . SPARSER::PROTEIN)
    ("variant and gene" . SPARSER::COLLECTION)
    ("Recently, PLCE1" . SPARSER::PROTEIN)
    ("recently, meta-analysis," . SPARSER::PROTEIN)
    (", G allele or its carriers" . SPARSER::COLLECTION)
    ("the PLCE1 rs2274223 genotype and ESCC risk," . SPARSER::COLLECTION)
    ("generally inconsistent and inconclusive," . SPARSER::PROTEIN)
    ("gene (PLCE1) gene" . SPARSER::GENE)
    ("northern China," . SPARSER::PROTEIN)
    ("the Caspian Sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Overall, PLCE1 rs2274223 G allele (G vs. A: OR=1.26, 95% CI: 1.15-1.39 for ESCC; OR=1.51, 95% CI: 1.35–1.69 for GCA) and its carrier (GG +AG vs. AA: OR = 1.23; 95% CI =1.02-1.49 for ESCC; OR =1.62; 95% CI =1.15-2.29 for GCA)"
     . SPARSER::COLLECTION)
    ("GCA" . SPARSER::PROTEIN) ("ras-related protein" . SPARSER::PROTEIN)
    ("gastric cancer patients," . SPARSER::PROTEIN)
    ("other chemotherapeutic drugs or trastuzumab" . SPARSER::COLLECTION)
    ("drugs or trastuzumab" . SPARSER::COLLECTION)
    ("Geldanamycin" . SPARSER::DRUG) ("p53 and v-Src" . SPARSER::COLLECTION)
    ("gastric and gastroesophageal carcinomas," . SPARSER::PROTEIN)
    ("this explorative study," . SPARSER::PROTEIN)
    ("esophageal adenocarcinomas," . SPARSER::PROTEIN)
    ("gastric cancer," . SPARSER::PROTEIN)
    ("homogenous reaction conditions," . SPARSER::PROTEIN)
    ("2 immunohistochemically 2+," . SPARSER::PROTEIN)
    ("type and better" . SPARSER::COLLECTION)
    ("a possible valuable molecule" . SPARSER::MOLECULE)
    ("Contrary," . SPARSER::PROTEIN) ("FDA and EMEA" . SPARSER::COLLECTION)
    ("possible," . SPARSER::PROTEIN)
    ("polysome (19%) and 21 patients (6.1%)" . SPARSER::COLLECTION)
    ("this potentially targetable molecule" . SPARSER::MOLECULE)
    ("Laurens intestinal type" . TYPE)
    ("HSP 90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERα and NCOAs" . SPARSER::COLLECTION)
    ("receptors or estrogen" . SPARSER::COLLECTION)
    ("an orthotopic, nude mouse model ( xref )," . SPARSER::PROTEIN)
    ("estrogen-" . SPARSER::MOLECULE) ("Ras/Raf/MAPK" . SPARSER::COLLECTION)
    ("Further, Ets1" . SPARSER::PROTEIN)
    ("dual KI67/CD31" . SPARSER::COLLECTION)
    ("KI67/CD31" . SPARSER::COLLECTION)
    ("hypoxia and substrate" . SPARSER::COLLECTION)
    ("Unfortunately, Ki67" . SPARSER::PROTEIN) ("-S-G 2" . SPARSER::COLLECTION)
    ("components and growth factors" . SPARSER::COLLECTION)
    ("25 mM glucose, 4 mM glutamine and 10% FBS" . SPARSER::COLLECTION)
    ("pulldown" . SPARSER::PROTEIN) ("proteins or ERα" . SPARSER::COLLECTION)
    ("NCOA1, NCOA2 and NCOA3" . SPARSER::COLLECTION)
    ("ERα and NCOA1" . SPARSER::COLLECTION)
    ("Ets1 and p160" . SPARSER::COLLECTION)
    ("Ets1, ERα and NCOAs" . SPARSER::COLLECTION)
    ("GST-Ets1" . SPARSER::COLLECTION) ("PGR and TFF1" . SPARSER::COLLECTION)
    ("PGR and trefoil factor 1" . SPARSER::COLLECTION)
    ("Ets1 and NCOA1" . SPARSER::COLLECTION)
    ("pCDNA-ERα" . SPARSER::PROTEIN-PAIR) ("pSG5-Ets1" . SPARSER::COLLECTION)
    ("NCOA1 or NCOA2" . SPARSER::COLLECTION)
    ("ERα, ERα+estradiol, ERα+Ets1 and ERα+Ets1+estradiol"
     . SPARSER::COLLECTION)
    ("receptors and Ets" . SPARSER::COLLECTION)
    ("both Ets1 and additional estradiol" . SPARSER::COLLECTION)
    ("residual estrogens" . SPARSER::MOLECULE)
    ("ligand and AF2-independent activation of ERα" . SPARSER::COLLECTION)
    ("a previous study xref ," . SPARSER::PROTEIN)
    ("exogenous estradiol" . SPARSER::PROTEIN)
    ("estradiol and Ets1" . SPARSER::COLLECTION)
    ("Ets1 and ERα" . SPARSER::COLLECTION)
    ("ERE2-TK-LUC" . SPARSER::COLLECTION) ("Coactivators" . SPARSER::PROTEIN)
    ("Finally, dual CD31 and Ki-67" . SPARSER::COLLECTION)
    ("CD31 and Ki-67" . SPARSER::COLLECTION)
    ("Ets1/estradiol" . SPARSER::COLLECTION)
    ("significantly larger uteri" . SPARSER::PROTEIN)
    ("Estradiol" . SPARSER::PROTEIN)
    ("exogenous 17β-estradiol" . SPARSER::PROTEIN)
    ("human Ets1 and firefly luciferase" . SPARSER::COLLECTION)
    ("androgen, progesterone and glucocorticoid" . SPARSER::COLLECTION)
    ("Ets2 and GA" . SPARSER::COLLECTION)
    ("approximately 50 kD," . SPARSER::PROTEIN)
    ("ERα and Ets1" . SPARSER::COLLECTION)
    ("vitamin D and PPARα" . SPARSER::COLLECTION)
    ("the vitamin D receptor, ERα, androgen receptor and the peroxisome proliferator-activated receptor-α (PPARα)"
     . SPARSER::COLLECTION)
    ("RID" . SPARSER::DRUG) ("p/CAF" . SPARSER::PROTEIN)
    ("/p300" . SPARSER::COLLECTION) ("ETV4/PEA3" . SPARSER::COLLECTION)
    ("Ras/Raf/MAP kinase" . SPARSER::COLLECTION) ("-GGA" . SPARSER::MOLECULE)
    ("GGA" . SPARSER::MOLECULE) ("AIB" . SPARSER::DRUG)
    ("Ets1 and Ets2" . SPARSER::COLLECTION)
    ("Ets1, Ets2, ER81, PEA3 and ESE1" . SPARSER::COLLECTION)
    ("estrogen and progesterone receptor" . SPARSER::COLLECTION)
    ("ERα and p160" . SPARSER::COLLECTION)
    ("GST-pulldown" . SPARSER::COLLECTION)
    ("progesterone receptor and trefoil factor 1" . SPARSER::COLLECTION)
    ("ERα and the p160 nuclear receptor coactivator (NCOA/SRC) family"
     . SPARSER::COLLECTION)
    ("NCOA/SRC" . SPARSER::COLLECTION) ("KI67" . SPARSER::PROTEIN)
    ("carbonic anhydrase IX" . SPARSER::PROTEIN) ("S-G 2" . SPARSER::PROTEIN)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("20 kD" . SPARSER::PROTEIN) ("75 kD" . SPARSER::PROTEIN)
    ("50 kD" . SPARSER::PROTEIN) ("ERE2" . SPARSER::PROTEIN)
    ("SRC2" . SPARSER::PROTEIN) ("S 5" . SPARSER::MOLECULE)
    ("PPARα" . SPARSER::PROTEIN) ("CARM-1" . SPARSER::PROTEIN)
    ("NCOA2" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("NCOA3" . SPARSER::PROTEIN) ("SRC1" . SPARSER::PROTEIN)
    ("NCOA1" . SPARSER::PROTEIN) ("ESE1" . SPARSER::PROTEIN)
    ("PEA3" . SPARSER::PROTEIN) ("ER81" . SPARSER::PROTEIN)
    ("Ets2" . SPARSER::PROTEIN) ("Ets1" . SPARSER::PROTEIN)
    ("NTC" . SPARSER::PROTEIN)
    ("other clinicopathological parameters," . SPARSER::PROTEIN)
    ("malignant (n=103)," . SPARSER::PROTEIN) ("MRPL19" . SPARSER::PROTEIN)
    ("Mitochondrial Ribosomal Protein L19" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("interleukin-11" . SPARSER::PROTEIN)
    ("RPL11 and various p53" . SPARSER::COLLECTION)
    (", namely Mdm2 and miR-34a mRNAs" . SPARSER::PROTEIN)
    ("Mdm2 and miR-34a" . SPARSER::COLLECTION)
    ("Mdm2, Noxa or Bax" . SPARSER::COLLECTION) ("Pidd" . SPARSER::PROTEIN)
    ("RPL23, RPS7 and RPS25" . SPARSER::COLLECTION)
    ("Finally, different RPs" . SPARSER::PROTEIN)
    ("Mdm2 or p53" . SPARSER::COLLECTION) ("Mdm2-p53" . SPARSER::COLLECTION)
    ("GFP-RPL37" . SPARSER::COLLECTION) ("RPs and p53" . SPARSER::COLLECTION)
    ("Dai" . SPARSER::PROTEIN) ("some ribosomal proteins" . SPARSER::PROTEIN)
    ("free ribosomal proteins" . SPARSER::PROTEIN)
    ("ribosomal stress," . SPARSER::PROTEIN)
    ("ectopically expressed ribosomal proteins" . SPARSER::PROTEIN)
    ("The three ribosomal proteins" . SPARSER::PROTEIN)
    ("Similarly, siRNA" . SPARSER::PROTEIN)
    ("RPL37 and MdmX" . SPARSER::COLLECTION)
    ("Mdm2 and MdmX" . SPARSER::COLLECTION) ("Mdm" . SPARSER::PROTEIN)
    ("individual Myc-tagged RPs and HA-tagged MdmX, RPS15 and RPS20"
     . SPARSER::COLLECTION)
    ("MdmX, RPS15 and RPS20" . SPARSER::COLLECTION)
    ("Ccng1, Bax, Noxa and Tigar" . SPARSER::COLLECTION)
    ("Tigar" . SPARSER::PROTEIN)
    ("Mdm2 ( xref ) and miR-34a ( xref )" . SPARSER::COLLECTION)
    ("Specifically, RPS15 and RPS20," . SPARSER::PROTEIN)
    ("Ccng1" . SPARSER::PROTEIN) ("TIGAR" . SPARSER::PROTEIN)
    ("p21 and Puma" . SPARSER::COLLECTION)
    ("nucleolar disruption," . SPARSER::PROTEIN)
    ("cause ribosomal stress, p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mdm2 and RPs" . SPARSER::COLLECTION)
    ("RPS20 and Mdm2" . SPARSER::COLLECTION) ("Myc-RP" . SPARSER::COLLECTION)
    ("Flag-Mdm2" . SPARSER::COLLECTION)
    ("the N-terminal 220 amino acids of Mdm2," . SPARSER::PROTEIN)
    ("Interestingly as well, RPS15 and RPS20" . SPARSER::COLLECTION)
    ("RPS15 and RPS20" . SPARSER::COLLECTION)
    ("RPs and Mdm2" . SPARSER::COLLECTION)
    ("Mdm2 and regulators" . SPARSER::COLLECTION)
    ("RPS7 or RPL11" . SPARSER::COLLECTION)
    ("More recently, RPL26" . SPARSER::PROTEIN) ("-Myc" . SPARSER::COLLECTION)
    ("RPL5 and RPL11" . SPARSER::COLLECTION)
    ("basal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("various ribosomal proteins" . SPARSER::PROTEIN)
    ("p53, Mdm2 and MdmX" . SPARSER::COLLECTION)
    ("Rather, MdmX" . SPARSER::PROTEIN)
    ("hetero-oligomers" . SPARSER::PROTEIN-PAIR)
    ("Molecularly, p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPL37, RPS15 and RPS20" . SPARSER::COLLECTION)
    ("Mdm2-p53-MdmX" . SPARSER::COLLECTION) ("MdmX" . SPARSER::PROTEIN)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("both co-expressed Flag-tagged Mdm2 and HA-tagged p53"
     . SPARSER::COLLECTION)
    ("RP-Mdm2-p53" . SPARSER::COLLECTION) ("RP" . SPARSER::PROTEIN)
    ("RPs" . SPARSER::PROTEIN) ("RPS9" . SPARSER::PROTEIN)
    ("RPS23" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("RPL30" . SPARSER::PROTEIN) ("RPL29" . SPARSER::PROTEIN)
    ("RPL24" . SPARSER::PROTEIN) ("RPL7A" . SPARSER::PROTEIN)
    ("Diamond-Blackfan anemia" . SPARSER::PROTEIN)
    ("Ubiquitin Ligase" . SPARSER::PROTEIN) ("full–length" . SPARSER::PROTEIN)
    ("Zinc finger" . SPARSER::PROTEIN) ("RPS3" . SPARSER::PROTEIN)
    ("RPL26" . SPARSER::PROTEIN) ("RPS27L" . SPARSER::PROTEIN)
    ("RPS27A" . SPARSER::PROTEIN) ("RPS27" . SPARSER::PROTEIN)
    ("RPS25" . SPARSER::PROTEIN) ("RPS14" . SPARSER::PROTEIN)
    ("RPS7" . SPARSER::PROTEIN) ("RPL23" . SPARSER::PROTEIN)
    ("RPL11" . SPARSER::PROTEIN) ("RPL5" . SPARSER::PROTEIN)
    ("RPS20" . SPARSER::PROTEIN) ("RPL37" . SPARSER::PROTEIN)
    ("a previous study," . SPARSER::PROTEIN) ("/MAPK" . SPARSER::COLLECTION)
    ("Recently, GSK3β" . SPARSER::PROTEIN)
    ("technical restriction," . SPARSER::PROTEIN)
    ("developmental signalling pathways," . SPARSER::PROTEIN)
    ("GSK3β/EZH2" . SPARSER::COLLECTION) ("migrated cells," . SPARSER::PROTEIN)
    ("CNE-1" . SPARSER::PROTEIN) ("HPF" . SPARSER::PROTEIN)
    ("EZH2 and p-GSK3β (Ser9)," . SPARSER::COLLECTION)
    ("HPFs" . SPARSER::PROTEIN)
    ("EZH2 and p-GSK3β (Ser9)" . SPARSER::COLLECTION)
    ("eIF2B" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin/S6K" . SPARSER::COLLECTION)
    ("/p90RSK" . SPARSER::COLLECTION)
    ("β-catenin and Tau" . SPARSER::COLLECTION)
    ("GSK3β and EZH2" . SPARSER::COLLECTION) ("p-GSK3β" . SPARSER::COLLECTION)
    ("a possible substrate" . SPARSER::SUBSTRATE)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LMP2B" . SPARSER::PROTEIN) ("LMP2A" . SPARSER::PROTEIN)
    ("DNMT3B" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("Lithium chloride" . SPARSER::DRUG)
    ("element binding protein" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("Enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("caveolin-1 and PACSIN2, NPM1 and Rac1" . SPARSER::COLLECTION)
    ("PACSIN2, NPM1 and Rac1" . SPARSER::COLLECTION)
    ("the active Rac1 polybasic region mutant" . SPARSER::MUTANT)
    ("Rac1 and RhoA" . SPARSER::COLLECTION)
    ("proteins and GEFs" . SPARSER::COLLECTION)
    ("Finally, Rac1" . SPARSER::PROTEIN) ("NES" . SPARSER::PROTEIN)
    ("RhoGDI, caveolin-1 and PACSIN2" . SPARSER::COLLECTION)
    ("homologue or isoform" . SPARSER::COLLECTION)
    ("NPM1, NPM2 and NPM3" . SPARSER::COLLECTION)
    ("GTP loading of Rac1 and cell spreading" . SPARSER::COLLECTION)
    ("NPM1 and Rac1" . SPARSER::COLLECTION)
    ("nucleophosmin-anaplastic lymphoma kinase" . SPARSER::COLLECTION)
    ("the latter option," . SPARSER::PROTEIN) ("Rac1Q61L" . SPARSER::PROTEIN)
    ("NPM1 nucleolar localization ( xref )," . SPARSER::PROTEIN)
    ("the active Rac1 polybasic region mutant, NPM1" . SPARSER::PROTEIN)
    (", Rac1Q61L" . SPARSER::PROTEIN)
    ("the polybasic domain," . SPARSER::PROTEIN)
    ("bacterially purified GST or GST-Rac1 proteins" . SPARSER::COLLECTION)
    ("the hypervariable C-terminus," . SPARSER::PROTEIN)
    ("NPM1 and full-length" . SPARSER::COLLECTION)
    ("GFP-NPM1" . SPARSER::COLLECTION) ("GST-Rac1" . SPARSER::COLLECTION)
    ("a polybasic domain," . SPARSER::PROTEIN)
    ("Rac2 or RhoG" . SPARSER::COLLECTION)
    ("Rac1 and NPM1" . SPARSER::COLLECTION)
    ("its hypervariable C-terminus," . SPARSER::PROTEIN)
    ("Rac1 and SET/I2PP2A" . SPARSER::COLLECTION)
    ("two proto-oncogenes NPM1 and the RhoGTPase Rac1" . SPARSER::COLLECTION)
    ("casein kinase 2 and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("specific tubular structures," . SPARSER::PROTEIN)
    ("WAVE/Arp2/3" . SPARSER::COLLECTION) ("WAVE" . SPARSER::PROTEIN)
    ("RhoGDI" . SPARSER::PROTEIN)
    ("an inactive GDP-bound state and an active GTP-bound state"
     . SPARSER::COLLECTION)
    ("a multifunctional nucleo-cytoplasmic shuttling protein"
     . SPARSER::PROTEIN)
    ("caveolin-1 and PACSIN2" . SPARSER::COLLECTION)
    ("controls many biological processes," . SPARSER::PROTEIN)
    ("NPM3" . SPARSER::PROTEIN) ("NPM2" . SPARSER::PROTEIN)
    ("Tiam1" . SPARSER::PROTEIN) ("NMP1" . SPARSER::PROTEIN)
    ("V12" . SPARSER::PROTEIN) ("Nup214" . SPARSER::PROTEIN)
    ("Rac1 C" . SPARSER::PROTEIN) ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("Arp2/3" . SPARSER::PROTEIN) ("Pak1" . SPARSER::PROTEIN)
    ("p21-activated kinase1" . SPARSER::PROTEIN) ("PACSIN2" . SPARSER::PROTEIN)
    ("Vpr-HIF-1 alpha" . SPARSER::COLLECTION)
    ("a single viral protein" . SPARSER::PROTEIN)
    ("transcriptome and proteome" . SPARSER::COLLECTION)
    ("AK2-FADD-caspase-10" . SPARSER::COLLECTION)
    ("Glutamate dehydrogenase 2 (GLUD2), Adenylate kinase 2 (AK2) and Transketolase (TKT)"
     . SPARSER::COLLECTION)
    ("Transketolase" . SPARSER::PROTEIN) ("Glutathione" . SPARSER::DRUG)
    ("Rev/RRE-containing viral RNA" . SPARSER::RNA)
    ("USO1 also known as Golgi complex-associated protein p115"
     . SPARSER::PROTEIN)
    ("MIF" . SPARSER::PROTEIN) ("gp120 and HYOU1" . SPARSER::COLLECTION)
    ("HYOU1/ORP150" . SPARSER::COLLECTION)
    ("Interestingly, TfR1" . SPARSER::PROTEIN)
    ("a cell membrane-associated glycoprotein" . SPARSER::PROTEIN)
    ("HYOU1 and USO1" . SPARSER::COLLECTION) ("ORP" . SPARSER::PROTEIN)
    ("PKM2, G6PD and fumarate hydratase" . SPARSER::COLLECTION)
    ("pyruvate, NADPH and malate" . SPARSER::COLLECTION)
    ("malate" . SPARSER::MOLECULE)
    ("Interestingly, HIF-1 alpha" . SPARSER::PROTEIN)
    ("pyruvate and one molecule" . SPARSER::COLLECTION) ("PEP" . SPARSER::DRUG)
    ("PG" . SPARSER::PROTEIN) ("Hexokinase" . SPARSER::PROTEIN)
    ("adeno-Vpr" . SPARSER::COLLECTION) ("HK-1" . SPARSER::PROTEIN)
    (", gene expression (8%), RNA metabolism (8%), cell cycle (6%), extracellular matrix organization (6%), signal transduction (5%), cell adhesion molecules"
     . SPARSER::MOLECULE)
    ("Adeno-Vpr" . SPARSER::COLLECTION)
    ("both light and heavy media" . SPARSER::COLLECTION)
    ("heavy media" . SPARSER::PROTEIN) ("Macrophages" . SPARSER::PROTEIN)
    ("ICAT" . SPARSER::PROTEIN) ("EBP" . SPARSER::PROTEIN)
    (", extracellular Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vpr-hypoxia inducible factor 1" . SPARSER::COLLECTION)
    ("glutamate dehydrogenase 2 (GLUD2), adenylate kinase 2 (AK2) and transketolase (TKT)"
     . SPARSER::COLLECTION)
    ("TKT" . SPARSER::PROTEIN) ("transketolase" . SPARSER::PROTEIN)
    ("Cultured human monocytic cells, U937," . SPARSER::PROTEIN)
    ("viral protein Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alpha-ketoglutarate" . SPARSER::DRUG)
    ("Adenylate kinase 2" . SPARSER::PROTEIN)
    ("Glutamate dehydrogenase 2" . SPARSER::PROTEIN)
    ("GSTP1" . SPARSER::PROTEIN)
    ("macrophage migration inhibitory factor" . SPARSER::PROTEIN)
    ("p115" . SPARSER::PROTEIN) ("ORP150" . SPARSER::PROTEIN)
    ("glutathione S-transferase Pi 1" . SPARSER::PROTEIN)
    ("matrin 3" . SPARSER::PROTEIN)
    ("vesicle docking protein" . SPARSER::PROTEIN) ("USO1" . SPARSER::PROTEIN)
    ("HYOU1" . SPARSER::PROTEIN)
    ("hypoxia up-regulated protein 1" . SPARSER::PROTEIN)
    ("TfR1" . SPARSER::PROTEIN) ("transferrin receptor-1" . SPARSER::PROTEIN)
    ("fumarate hydratase" . SPARSER::PROTEIN)
    ("Fumarate hydratase" . SPARSER::PROTEIN)
    ("Glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Growth factor receptor-binding protein" . SPARSER::PROTEIN)
    ("K+" . SPARSER::MOLECULE) ("type 5" . SPARSER::PROTEIN)
    ("HIF-1 alpha" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("AK2" . SPARSER::PROTEIN) ("adenylate kinase 2" . SPARSER::PROTEIN)
    ("GLUD2" . SPARSER::PROTEIN)
    ("glutamate dehydrogenase 2" . SPARSER::PROTEIN)
    ("gene in breast [ xref ] and gastric cancer [ xref ]"
     . SPARSER::COLLECTION)
    ("-c-myc" . SPARSER::COLLECTION)
    ("disomic and polysomic status," . SPARSER::PROTEIN)
    ("the largest HCC" . SPARSER::PROTEIN)
    ("synchronous HCCs" . SPARSER::PROTEIN) ("HCCs" . SPARSER::PROTEIN)
    ("recurrent HCC" . SPARSER::PROTEIN) ("metastatic HCC" . SPARSER::PROTEIN)
    ("FISH and immunohistochemistry" . SPARSER::COLLECTION)
    ("which aims" . SPARSER::PROTEIN)
    ("1.38 (IC 95%, 1.14–1.67) and 2.82 (IC 95%, 1.02–7.79),"
     . SPARSER::PROTEIN)
    ("disomic and polysomic groups," . SPARSER::PROTEIN)
    ("polysomic or disomic c-myc" . SPARSER::PROTEIN) ("HbsAg" . SPARSER::DRUG)
    ("c-myc and 8q24/CEP8" . SPARSER::COLLECTION)
    ("inhibitors and drugs" . SPARSER::COLLECTION)
    ("molecular level, no definitive tissue biomarkers" . SPARSER::MOLECULE)
    ("HCC and 5-year" . SPARSER::COLLECTION)
    ("AFP and c-myc" . SPARSER::COLLECTION) ("AFP" . SPARSER::PROTEIN)
    ("hepatocellular carcinoma," . SPARSER::PROTEIN)
    ("the centromeric part" . SPARSER::COMPONENT)
    ("Trp-Trp" . SPARSER::COLLECTION) ("cis and trans" . SPARSER::COLLECTION)
    ("PPIase" . SPARSER::PROTEIN)
    ("allele and heterozygote" . SPARSER::COLLECTION)
    ("Caucasian," . SPARSER::PROTEIN)
    (", namely two variants" . SPARSER::VARIANT)
    ("Peptidyl-prolyl" . SPARSER::COLLECTION) ("Peptidyl" . SPARSER::PROTEIN)
    ("11 eligible studies," . SPARSER::PROTEIN) ("Genotype" . SPARSER::PROTEIN)
    ("cis/trans" . SPARSER::COLLECTION) ("peptidyl" . SPARSER::PROTEIN)
    ("Thr-pro" . SPARSER::MOLECULE) ("CK-2" . SPARSER::PROTEIN)
    ("NIMA-interacting 1" . SPARSER::PROTEIN) ("PIN1" . SPARSER::PROTEIN)
    ("EGFR mutation recently xref ," . SPARSER::PROTEIN)
    ("too few," . SPARSER::PROTEIN) ("ARMS" . SPARSER::PROTEIN)
    ("DNA/amount" . SPARSER::PROTEIN)
    ("total DNA and KRAS mutant DNA" . SPARSER::COLLECTION)
    ("100 ng KRAS wild-type DNA and 0.01 ng KRAS mutant DNA"
     . SPARSER::COLLECTION)
    ("only KRAS mutant DNA" . SPARSER::DNA)
    ("our former study," . SPARSER::PROTEIN)
    ("EGFR-antibody" . SPARSER::COLLECTION)
    ("the Food and Drug Administration" . SPARSER::COLLECTION)
    ("Medicines" . SPARSER::DRUG) ("PNA" . SPARSER::PROTEIN)
    ("viral oncogenes E6 and E7," . SPARSER::PROTEIN)
    ("GRIM-19 and SOCS-1" . SPARSER::COLLECTION)
    ("cell surface growth factor and cytokine receptors (EGFR, c-Met, IL-23R) or cytoplasmic protooncogenes"
     . SPARSER::COLLECTION)
    ("IL-6, IL-22, EGF, IL-23 and IL-10" . SPARSER::COLLECTION)
    ("K-Ras, Src and c-Abl" . SPARSER::COLLECTION)
    ("p53/pRB" . SPARSER::COLLECTION) ("WAF1/CIP1" . SPARSER::COLLECTION)
    ("transformed phenotype," . SPARSER::PROTEIN)
    ("subsequent DNA-binding activity," . SPARSER::PROTEIN)
    ("p53, pRB and E6 and E7" . SPARSER::COLLECTION)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("SP-1, NF-1, YY1 or Oct-1" . SPARSER::COLLECTION)
    ("viral E6, E7" . SPARSER::PROTEIN-FAMILY)
    ("These viral oncogenes" . SPARSER::ONCOGENE)
    ("viral oncogenes, E6 and E7" . SPARSER::COLLECTION)
    ("intact red-stained mitochondria" . SPARSER::PROTEIN)
    ("curcumin or AG490" . SPARSER::COLLECTION)
    ("AnnexinV-PI" . SPARSER::COLLECTION)
    ("its upstream activator caspase-9 and downstream substrate, Poly [ADP-ribose] polymerase 1 (PARP-1)"
     . SPARSER::COLLECTION)
    ("late apoptosis," . SPARSER::PROTEIN)
    ("the treated cells," . SPARSER::PROTEIN)
    ("curcumin and AG490-treated SiHa cells using flowcytometry by staining with Annexin V-propidium iodide (PI) which distinguishes live cells from the cells undergoing apoptosis or necrosis"
     . SPARSER::COLLECTION)
    ("curcumin- and AG490" . SPARSER::COLLECTION)
    ("curcumin as well as AG490" . SPARSER::COLLECTION)
    ("Curcumin and AG490" . SPARSER::COLLECTION)
    ("curcumin-treated cells," . SPARSER::PROTEIN)
    ("curcumin and AG490-mediated inhibition of STAT3 phosphorylation"
     . SPARSER::COLLECTION)
    ("curcumin- and AG490-induced inhibition of constitutively active STAT3"
     . SPARSER::COLLECTION)
    ("viral E6 and E7" . SPARSER::COLLECTION)
    ("cellular p53 and pRB" . SPARSER::COLLECTION)
    ("curcumin-" . SPARSER::DRUG) ("curcumin and AG490" . SPARSER::COLLECTION)
    ("Curcumin" . SPARSER::DRUG)
    ("curcumin and tyrphostin" . SPARSER::COLLECTION)
    ("tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trypsinization" . SPARSER::PROTEIN)
    ("tumor suppressor gene, p53 and pRB" . SPARSER::COLLECTION)
    ("HPV16 viral oncogenes, E6 and E7," . SPARSER::PROTEIN)
    ("viral oncoproteins E6 and E7" . SPARSER::COLLECTION)
    ("p53 or pRB" . SPARSER::COLLECTION)
    ("cervical cancer cells, cellular proteins" . SPARSER::PROTEIN)
    ("the contrary," . SPARSER::PROTEIN)
    ("E6, E7, p53 and pRB" . SPARSER::COLLECTION)
    ("p53 and the hypophyosphorylated pRB protein" . SPARSER::COLLECTION)
    ("p53 or antibody" . SPARSER::COLLECTION)
    ("respective proteins" . SPARSER::PROTEIN)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("STAT3 and E6/E7" . SPARSER::COLLECTION)
    ("their respective cellular targets, p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AG490 and curcumin" . SPARSER::COLLECTION)
    ("YY1 and glucocorticoid" . SPARSER::COLLECTION)
    ("KRF-1" . SPARSER::COLLECTION) ("NF-1" . SPARSER::PROTEIN)
    ("these viral oncogenes" . SPARSER::ONCOGENE) ("LCR" . SPARSER::PROTEIN)
    ("key cell cycle regulators p53 and the retinoblastoma (Rb) proteins,"
     . SPARSER::COLLECTION)
    ("AG490 or curcumin" . SPARSER::COLLECTION)
    ("p53 and pRb" . SPARSER::COLLECTION) ("E6 and E7" . SPARSER::COLLECTION)
    ("mcl-1" . SPARSER::PROTEIN) ("GRIM-19" . SPARSER::PROTEIN)
    ("c-Abl" . SPARSER::PROTEIN) ("IL-23R" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("Tumor Antigen" . SPARSER::DRUG)
    ("RB protein" . SPARSER::PROTEIN) ("SP-1" . SPARSER::PROTEIN)
    ("p97" . SPARSER::PROTEIN)
    ("Poly [ADP-ribose] polymerase 1" . SPARSER::PROTEIN)
    ("18h" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("JAK-2" . SPARSER::PROTEIN) ("Oct-1" . SPARSER::PROTEIN)
    ("TEF-2" . SPARSER::PROTEIN) ("TEF-1" . SPARSER::PROTEIN)
    ("P97" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("Importantly, potent anti-MM drugs" . SPARSER::DRUG)
    ("Bcl2-A1 and Mcl1" . SPARSER::COLLECTION)
    ("RelA or YY1" . SPARSER::COLLECTION)
    ("pro-apoptotic genes and/or tumor suppressor genes" . SPARSER::COLLECTION)
    ("pro-tumorigenic gene promoters" . SPARSER::PROMOTER)
    ("here identified both YY1 and RelA" . SPARSER::COLLECTION)
    ("a novel YY1-RelA transcriptional repressive complex and its role"
     . SPARSER::COLLECTION)
    ("a novel YY1-RelA transcriptional repressive complex"
     . SPARSER::BIO-COMPLEX)
    ("a transcriptional repressive complex" . SPARSER::BIO-COMPLEX)
    ("YY1 and NF-κB" . SPARSER::COLLECTION)
    ("Bim-EL, Bim-L and Bim-S" . SPARSER::COLLECTION)
    ("pro and anti-apoptotic" . SPARSER::COLLECTION)
    ("semi-solid methylcellulose" . SPARSER::DRUG)
    ("methylcellulose" . SPARSER::DRUG)
    ("control-ShRNA or ShRNA" . SPARSER::COLLECTION)
    ("either control ShRNA or two different ShRNAs" . SPARSER::COLLECTION)
    ("ShRNAs" . SPARSER::RNA) ("ShRNA" . SPARSER::PROTEIN)
    ("a transcriptional activator or a repressor" . SPARSER::COLLECTION)
    ("the classical NF-κB" . SPARSER::PROTEIN)
    ("RelB-p52" . SPARSER::COLLECTION) ("NIK" . SPARSER::PROTEIN)
    ("RelA-p50" . SPARSER::COLLECTION) ("cRel and RelB" . SPARSER::COLLECTION)
    ("cRel" . SPARSER::PROTEIN) ("APRIL and BAFF" . SPARSER::COLLECTION)
    ("BAFF" . SPARSER::PROTEIN) ("APRIL" . SPARSER::PROTEIN)
    ("RAS and BRAF" . SPARSER::COLLECTION)
    ("MMSET/FGFR3" . SPARSER::COLLECTION) ("MMSET" . SPARSER::PROTEIN)
    ("PCs" . SPARSER::PROTEIN)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("RelA-YY1" . SPARSER::COLLECTION) ("RelA and YY1" . SPARSER::COLLECTION)
    ("YY1 and RelA" . SPARSER::COLLECTION)
    ("YY1 or RelA" . SPARSER::COLLECTION) ("YY1-RelA" . SPARSER::COLLECTION)
    ("Yin" . SPARSER::PROTEIN)
    ("NF-κB and its target genes" . SPARSER::COLLECTION)
    ("alpha Tubulin" . SPARSER::PROTEIN) ("CD138" . SPARSER::PROTEIN)
    ("Bcl2-A1" . SPARSER::PROTEIN) ("pGL2" . SPARSER::PROTEIN)
    ("Sh-RNAs" . SPARSER::RNA) ("Bim-L" . SPARSER::PROTEIN)
    ("Bim-EL" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("Cyclin D 2" . SPARSER::PROTEIN)
    ("vascular wall GWAS genes" . SPARSER::GENE)
    ("TCF21 and its downstream targets" . SPARSER::COLLECTION)
    ("CREB/ATF" . SPARSER::COLLECTION)
    ("Caucasian cohorts" . SPARSER::MOLECULE)
    ("primarily rs12524865 ( P  = 3.40×10 −3 )," . SPARSER::PROTEIN)
    ("both developed and developing countries," . SPARSER::PROTEIN)
    ("the coronary vasculature" . SPARSER::PROTEIN)
    ("ischemia and hypoxia" . SPARSER::COLLECTION) ("Wt1" . SPARSER::PROTEIN)
    ("PDGF-BB/PDGFR-β" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("Interestingly, genes" . SPARSER::GENE)
    ("c-Jun readily forms heterodimers" . SPARSER::HETERODIMER)
    ("ATF2 and ATF3" . SPARSER::COLLECTION)
    ("CRE and AP-1" . SPARSER::COLLECTION)
    ("injured mouse femoral arteries," . SPARSER::PROTEIN)
    ("another stress-inducible gene" . SPARSER::GENE)
    ("The prototypical basic region-leucine zipper (bZip) protein, c-JUN"
     . SPARSER::PROTEIN)
    ("bZip" . SPARSER::PROTEIN-FAMILY) ("JunD or ATF3" . SPARSER::COLLECTION)
    ("coronary SMC" . SPARSER::PROTEIN) ("CDKN2A/p19ARF" . SPARSER::COLLECTION)
    ("PDGFD" . SPARSER::PROTEIN) ("AP-1 and active" . SPARSER::COLLECTION)
    ("ATF/CREB" . SPARSER::COLLECTION) ("AP-1 and CREB" . SPARSER::COLLECTION)
    ("ATF/CREB binding" . SPARSER::COLLECTION) ("GTCA" . SPARSER::PROTEIN)
    ("Interestingly, PDGF-BB" . SPARSER::PROTEIN)
    ("TGF-β1 or PDGF-BB" . SPARSER::COLLECTION)
    ("Consistently, WT1 siRNA" . SPARSER::PROTEIN)
    ("-GCGTGGGAGT-3" . SPARSER::COLLECTION) ("tcf21" . SPARSER::PROTEIN)
    ("wt1" . SPARSER::PROTEIN)
    ("H3K27ac (marks active enhancers) and H3K27" . SPARSER::COLLECTION)
    ("FOSB and MYOG" . SPARSER::COLLECTION) ("MYOG" . SPARSER::PROTEIN)
    ("FOSB" . SPARSER::PROTEIN) ("Interestingly, c-Jun" . SPARSER::PROTEIN)
    ("c-Jun and ATF3" . SPARSER::COLLECTION)
    ("peaked around 6 hours," . SPARSER::PROTEIN)
    ("greater normalized C/G ratios," . SPARSER::PROTEIN)
    ("heterozygous CG HCASMC," . SPARSER::PROTEIN)
    ("PDGF-BB and TGF-β1" . SPARSER::COLLECTION)
    ("Concordantly, c- JUN and ATF3" . SPARSER::COLLECTION)
    ("c- JUN and ATF3" . SPARSER::COLLECTION)
    ("PMA and PDGF-BB" . SPARSER::COLLECTION) ("SMCs" . SPARSER::PROTEIN)
    ("the AP-1 factors c-Jun, JunD, as well as ATF3" . SPARSER::COLLECTION)
    ("super-shifted complexes" . SPARSER::BIO-COMPLEX)
    ("c-Jun and JunD" . SPARSER::COLLECTION)
    ("JunD and ATF3" . SPARSER::COLLECTION) ("AP-1-luc" . SPARSER::COLLECTION)
    ("MEKK" . SPARSER::PROTEIN)
    ("Surprisingly, neither PMA nor forskolin" . SPARSER::COLLECTION)
    ("Surprisingly, neither PMA" . SPARSER::PROTEIN)
    ("AP-1 and CRE" . SPARSER::COLLECTION)
    ("AP-1 or CRE" . SPARSER::COLLECTION)
    ("classical c-Jun/c-Fos AP-1 complex xref ," . SPARSER::PROTEIN)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION) ("c-Jun/ATF" . SPARSER::COLLECTION)
    ("ATF" . SPARSER::PROTEIN)
    ("a classical AP-1 7-mer (closely resembling a TPA element),"
     . SPARSER::PROTEIN)
    ("134,171,000–134,341,000" . SPARSER::PROTEIN)
    ("fine-mapping" . SPARSER::PROTEIN)
    ("platelet derived growth factor receptor beta (PDGFR-β) and Wilms tumor 1 (WT1)"
     . SPARSER::COLLECTION)
    ("Tcf21" . SPARSER::PROTEIN)
    ("the vascular developmental factor, TCF21 ," . SPARSER::PROTEIN)
    ("H3K27Ac" . SPARSER::MOLECULE) ("H3K4Me3" . SPARSER::PROTEIN)
    ("thrombospondin-1" . SPARSER::PROTEIN) ("ATF2" . SPARSER::PROTEIN)
    ("Pod-1" . SPARSER::PROTEIN) ("p19ARF" . SPARSER::PROTEIN)
    ("CREB binding" . SPARSER::PROTEIN-FAMILY)
    ("thromboxane A2" . SPARSER::MOLECULE) ("TCF21 protein" . SPARSER::PROTEIN)
    ("c- JUN" . SPARSER::PROTEIN) ("ATF3" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("Chr6" . SPARSER::PROTEIN)
    ("platelet derived growth factor receptor beta" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("Wilms tumor 1" . SPARSER::PROTEIN)
    ("PDGFR-β" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor beta" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN) ("Pod1" . SPARSER::PROTEIN)
    ("TCF21" . SPARSER::PROTEIN) ("further instability," . SPARSER::PROTEIN)
    ("genome-wide DNA" . SPARSER::DNA) ("FHIT" . SPARSER::PROTEIN)
    ("sporadic cancers," . SPARSER::PROTEIN)
    ("ssDNA and CFSs" . SPARSER::COLLECTION)
    ("secondary structures, ssDNA" . SPARSER::PROTEIN)
    ("ATM and/or Chk2" . SPARSER::COLLECTION)
    ("Chk1, p53 or RPA2" . SPARSER::COLLECTION)
    ("ssDNA and PCNA" . SPARSER::COLLECTION)
    ("Indeed, ssDNA foci form" . SPARSER::FORM)
    ("replisome" . SPARSER::PROTEIN) ("Surprisingly, ATR" . SPARSER::PROTEIN)
    ("unequal IdU" . SPARSER::DRUG) ("asymmetrical forks," . SPARSER::PROTEIN)
    ("the major CFS" . SPARSER::PROTEIN)
    ("ATR and Mre11" . SPARSER::COLLECTION)
    ("Mre11-Rad50-Nbs1" . SPARSER::COLLECTION) ("mirin" . SPARSER::DRUG)
    ("ssDNA and/or PCNA" . SPARSER::COLLECTION) ("modest," . SPARSER::PROTEIN)
    ("mitotic exit," . SPARSER::PROTEIN)
    ("ATM ( xref ) and H2AX ( xref and xref )" . SPARSER::COLLECTION)
    ("Strikingly, CldU foci" . SPARSER::PROTEIN)
    ("Noticeably, Rad17" . SPARSER::PROTEIN)
    ("ATR, TopBP1, Claspin, RPA2 and Rad9" . SPARSER::COLLECTION)
    ("ATR and RPA2" . SPARSER::COLLECTION)
    ("aphidicolin or HU" . SPARSER::COLLECTION)
    ("ATR, TopBP1, Hus1 or Chk1" . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("kinases, ATM and ATR" . SPARSER::COLLECTION)
    ("Strikingly, FRA3B" . SPARSER::PROTEIN)
    ("the most instable part" . SPARSER::COMPONENT)
    ("ATR or Chk1" . SPARSER::COLLECTION)
    ("Chk1, ATM or p53" . SPARSER::COLLECTION)
    (", in lymphocytes and fibroblasts, that moderate replication stresses like"
     . SPARSER::COLLECTION)
    ("Chk1 or p53" . SPARSER::COLLECTION) ("CFS" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("266A" . SPARSER::PROTEIN)
    ("band 3" . SPARSER::PROTEIN) ("RPA2" . SPARSER::PROTEIN)
    ("FRA3B" . SPARSER::PROTEIN) ("endothelial," . SPARSER::PROTEIN)
    ("dermal endothelial cells xref ," . SPARSER::PROTEIN)
    ("Ub and DUBs" . SPARSER::COLLECTION) ("DUBs" . SPARSER::PROTEIN)
    ("clathrin ( xref ) and polyubiquitination" . SPARSER::COLLECTION)
    ("dimerized EphA2" . SPARSER::PROTEIN) ("TKB" . SPARSER::PROTEIN)
    ("c-Cbl-TKB" . SPARSER::PROTEIN-PAIR)
    ("K3-MARCH (membrane-associated RING-CH) ligase and the Ub"
     . SPARSER::COLLECTION)
    ("UbcH5/Ubc13" . SPARSER::COLLECTION) ("tropomyosin" . SPARSER::PROTEIN)
    ("TrkA" . SPARSER::PROTEIN)
    ("the key cargo-modifying Ub ligases" . SPARSER::LIGASE)
    ("K63-polyUb" . SPARSER::COLLECTION) ("polyUb" . SPARSER::PROTEIN)
    ("Epsin or Epsin15" . SPARSER::COLLECTION)
    ("FAK, Src, PI-3K, c-Cbl and clathrin" . SPARSER::COLLECTION)
    ("Src and PI-3K" . SPARSER::COLLECTION) ("Clathrin" . SPARSER::PROTEIN)
    ("CCP" . SPARSER::PROTEIN)
    ("integrin-associated signaling," . SPARSER::PROTEIN)
    ("LysoTracker (green) ( xref , second and third panels),"
     . SPARSER::PROTEIN)
    ("LysoTracker" . SPARSER::DRUG)
    ("viral gene expression," . SPARSER::PROTEIN)
    ("si-cont" . SPARSER::COLLECTION) ("cont" . SPARSER::PROTEIN)
    ("p-EphA2" . SPARSER::COLLECTION)
    ("EphA2 and clathrin heavy chain" . SPARSER::COLLECTION)
    ("TK and SAM" . SPARSER::COLLECTION) ("HA-c-Cbl" . SPARSER::COLLECTION)
    ("Wt" . SPARSER::PROTEIN) ("c-Cbl-G306E," . SPARSER::COLLECTION)
    ("Wt-c-Cbl" . SPARSER::PROTEIN-PAIR)
    ("Strong polyubiquitination" . SPARSER::PROTEIN)
    ("HA-cCbl" . SPARSER::COLLECTION) ("cCbl" . SPARSER::PROTEIN)
    ("Myc-EphA2" . SPARSER::COLLECTION) ("transfectable," . SPARSER::PROTEIN)
    ("Eph-" . SPARSER::PROTEIN) ("Eph" . SPARSER::PROTEIN)
    ("faint lys 48-linked polyubiquitination" . SPARSER::PROTEIN)
    ("ephA1" . SPARSER::PROTEIN) ("ephA" . SPARSER::PROTEIN-FAMILY)
    ("lys" . SPARSER::AMINO-ACID)
    ("The typical polyubiquitin" . SPARSER::PROTEIN)
    ("virus only infection (Unt)," . SPARSER::PROTEIN)
    ("monoubiquitin" . SPARSER::PROTEIN) ("si-c-Cbl" . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::PROTEIN)
    ("a critical endocytic effector molecule" . SPARSER::MOLECULE)
    ("clathrin dependent endocytic marker transferrin" . SPARSER::PROTEIN)
    ("transferrin" . SPARSER::PROTEIN) ("Unt" . SPARSER::MOLECULE)
    ("p-clathrin" . SPARSER::COLLECTION) ("p-c-Cbl" . SPARSER::COLLECTION)
    ("p-PI3-K" . SPARSER::COLLECTION)
    ("FAK, Src and PI3-K-p85 signal molecules" . SPARSER::COLLECTION)
    ("functional EphA2" . SPARSER::PROTEIN)
    ("endocytic effector molecules" . SPARSER::MOLECULE)
    ("p-PI3-K-p85" . SPARSER::COLLECTION) ("p-FAK" . SPARSER::COLLECTION)
    ("PI3-K-p85" . SPARSER::COLLECTION)
    ("integrins and other receptors" . SPARSER::COLLECTION)
    ("FAK, Src and PI3-K" . SPARSER::COLLECTION)
    ("mock-infected NLR fractions," . SPARSER::PROTEIN)
    ("KSHV entry receptors and endocytic effectors" . SPARSER::COLLECTION)
    ("integrins and clathrin" . SPARSER::COLLECTION)
    ("c-Cbl or clathrin" . SPARSER::COLLECTION)
    ("EphA2, c-Cbl and clathrin" . SPARSER::COLLECTION)
    ("c-Cbl and clathrin" . SPARSER::COLLECTION)
    ("c-Cbl and myosin" . SPARSER::COLLECTION)
    ("c-Cbl, clathrin and clathrin" . SPARSER::COLLECTION)
    ("endocytic effectors" . SPARSER::EFFECTOR)
    ("p-myosin" . SPARSER::COLLECTION) ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EphA2 and α3β1" . SPARSER::COLLECTION)
    ("αVβ3 or αVβ5" . SPARSER::COLLECTION)
    ("EphA2 and integrin" . SPARSER::COLLECTION)
    ("shRNA or EphA2" . SPARSER::COLLECTION)
    ("the internalized KSHV viral (ORF73) DNA" . SPARSER::DNA)
    ("tyrosine kinase (TK)" . SPARSER::PROTEIN) ("Ephrins" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("actin-myosin" . SPARSER::COLLECTION)
    ("associated signal molecules" . SPARSER::MOLECULE)
    ("soluble integrins and anti-integrin antibodies" . SPARSER::ANTIBODY)
    ("integrins and anti-integrin" . SPARSER::COLLECTION)
    ("FAK, Src, PI3-K, RhoGTPases, NF-κB and ERK1/2" . SPARSER::COLLECTION)
    ("human microvascular dermal endothelial (HMVEC-d) cells,"
     . SPARSER::PROTEIN)
    ("various viral envelope glycoproteins and multiple cell surface molecules,"
     . SPARSER::COLLECTION)
    ("various viral envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dynein" . SPARSER::PROTEIN) ("matrix (ECM)" . SPARSER::PROTEIN-FAMILY)
    ("the characteristic component" . SPARSER::COMPONENT)
    ("DCs" . SPARSER::MOLECULE) ("MCD" . SPARSER::PROTEIN)
    ("polyubiquitination and clathrin" . SPARSER::COLLECTION)
    ("αVβ5, αVβ3 and α3β1" . SPARSER::COLLECTION)
    ("EphA2 and c-Cbl" . SPARSER::COLLECTION)
    ("polyubiquitination and virus-EphA2" . SPARSER::COLLECTION)
    ("EphA2's" . SPARSER::PROTEIN-FAMILY) ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("EphA2 and clathrin" . SPARSER::COLLECTION)
    ("integrin-c-Cbl" . SPARSER::COLLECTION) ("EphA2" . SPARSER::PROTEIN)
    ("EphA" . SPARSER::PROTEIN-FAMILY) ("MnCl2" . SPARSER::DRUG)
    ("AP-2" . SPARSER::PROTEIN) ("Protein-A" . SPARSER::PROTEIN)
    ("CD-" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("ORF 73" . SPARSER::PROTEIN) ("prolactin receptor" . SPARSER::PROTEIN)
    ("Ubc13" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("nerve growth factor receptor" . SPARSER::PROTEIN)
    ("Tyrosine Kinase" . SPARSER::PROTEIN) ("FK-1" . SPARSER::PROTEIN)
    ("Rab5" . SPARSER::PROTEIN) ("p-Src" . SPARSER::PROTEIN)
    ("sh-RNA" . SPARSER::RNA) ("LANA-1" . SPARSER::PROTEIN)
    ("ORF73" . SPARSER::PROTEIN)
    ("envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("target cell" . SPARSER::PROTEIN) ("heparan sulfate" . SPARSER::MOLECULE)
    ("αVβ5" . SPARSER::PROTEIN) ("αVβ3" . SPARSER::PROTEIN)
    ("EphrinA2" . SPARSER::PROTEIN)
    ("pemetrexed and methoxyamine" . SPARSER::COLLECTION)
    ("a cleavable complex" . SPARSER::BIO-COMPLEX)
    ("clastogenic," . SPARSER::PROTEIN) ("TopoII" . SPARSER::PROTEIN)
    ("UNG −/− MEFs ( xref ) and raltitrexed" . SPARSER::COLLECTION)
    ("5-FU and FdUrd" . SPARSER::COLLECTION) ("dUTPase" . SPARSER::PROTEIN)
    ("fluoropyrimidine" . SPARSER::DRUG)
    ("supplemental thymidine," . SPARSER::PROTEIN)
    ("UNG expression significantly impact pemetrexed sensitivity,"
     . SPARSER::PROTEIN)
    ("TYMS and pemetrexed" . SPARSER::COLLECTION)
    ("UNG and other genes," . SPARSER::COLLECTION)
    ("aldehydes" . SPARSER::MOLECULE) ("PR-1 and PR-2" . SPARSER::COLLECTION)
    ("cisplatin or temozolomide" . SPARSER::COLLECTION)
    ("parental cells, p" . SPARSER::PROTEIN)
    ("Clonogenic sublines, PR-1 and PR-2," . SPARSER::PROTEIN)
    ("Supplemental thymidine" . SPARSER::PROTEIN)
    ("10 µM supplemental thymidine," . SPARSER::PROTEIN)
    ("supplemental thymidine" . SPARSER::PROTEIN)
    ("genomic uracil" . SPARSER::DRUG)
    ("PCNA and other replication fork components" . SPARSER::COLLECTION)
    ("a complimentary experiment," . SPARSER::PROTEIN)
    ("6 and 24 hours, respectively, p" . SPARSER::PROTEIN)
    ("etoposide and hydroxyurea" . SPARSER::COLLECTION)
    ("bi-parametric flow cytometry" . SPARSER::PROTEIN) ("IdU" . SPARSER::DRUG)
    ("pemetrexed( xref ) and support" . SPARSER::COLLECTION)
    ("chemiluminescent aldehyde" . SPARSER::MOLECULE)
    ("ARP" . SPARSER::PROTEIN)
    ("raltitrexed and 5-fluorouracil" . SPARSER::COLLECTION)
    ("temozolomide or cisplatin" . SPARSER::COLLECTION)
    ("raltitrexed" . SPARSER::DRUG)
    ("moderate and high baseline UNG expression," . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN) ("RQ" . SPARSER::MOLECULE)
    ("lung cancer histological subtypes" . SPARSER::PROTEIN)
    ("TYMS, DHFR and GARFT" . SPARSER::COLLECTION) ("dTTP" . SPARSER::MOLECULE)
    ("dihydrofolate reductase (DHFR)" . SPARSER::PROTEIN)
    ("dTMP" . SPARSER::MOLECULE) ("deoxythymidine" . SPARSER::MOLECULE)
    ("dUMP" . SPARSER::DUMP) ("DHFR" . SPARSER::PROTEIN)
    ("TYMS" . SPARSER::PROTEIN) ("folate" . SPARSER::MOLECULE)
    ("antifolate" . SPARSER::MOLECULE) ("Pemetrexed" . SPARSER::DRUG)
    ("methoxyamine (MX)" . SPARSER::DRUG) ("MX" . SPARSER::PROTEIN)
    ("methoxyamine" . SPARSER::DRUG)
    ("pemetrexed-resistant histological subtypes" . SPARSER::PROTEIN)
    ("DNA glycosylase (UNG)" . SPARSER::PROTEIN) ("UNG" . SPARSER::PROTEIN)
    ("Uracil" . SPARSER::DRUG) ("5-FU" . SPARSER::PROTEIN)
    ("PR1" . SPARSER::PROTEIN) ("gene2" . SPARSER::PROTEIN)
    ("gene1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PR-2" . SPARSER::PROTEIN)
    ("PR-1" . SPARSER::PROTEIN) ("MBD4" . SPARSER::PROTEIN)
    ("chk1" . SPARSER::PROTEIN) ("Histone-H3" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE)
    ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("visceral sites," . SPARSER::PROTEIN) ("poor OS2" . SPARSER::MOLECULE)
    ("a poor OS2" . SPARSER::MOLECULE)
    ("recurrent disease," . SPARSER::PROTEIN) ("brain)" . SPARSER::PROTEIN)
    ("OS2" . SPARSER::MOLECULE) ("Altogether, estrogens" . SPARSER::MOLECULE)
    ("aromatase–COX2" . SPARSER::COLLECTION)
    ("Aromatase and COX2" . SPARSER::COLLECTION)
    ("noncancerous endometrial tissue," . SPARSER::PROTEIN)
    ("Indeed, GPER" . SPARSER::PROTEIN)
    ("estrogen receptor (GPER)" . SPARSER::PROTEIN)
    ("classical ERs" . SPARSER::PROTEIN) ("GPER" . SPARSER::PROTEIN)
    ("molecules or proteins" . SPARSER::COLLECTION)
    ("endometrial cancer," . SPARSER::PROTEIN)
    ("NFkB-regulated cytokines and their receptors and," . SPARSER::COLLECTION)
    ("receptors and," . SPARSER::COLLECTION) ("PRD" . SPARSER::PROTEIN)
    ("peroxiredoxin" . SPARSER::PROTEIN)
    ("proteomic approach," . SPARSER::PROTEIN)
    ("the less aggressive type" . TYPE)
    ("hyperestrogenic state" . SPARSER::BIO-STATE)
    ("the studied EC showed strong cytoplasmic immunoreactivity,"
     . SPARSER::PROTEIN)
    ("peripheral sites," . SPARSER::PROTEIN) ("Aromatase" . SPARSER::PROTEIN)
    ("ERα (Fig.  xref ) and Ki-67 (Fig.  xref )" . SPARSER::COLLECTION)
    ("ERα and COX2" . SPARSER::COLLECTION)
    ("ERβ and aromatase" . SPARSER::COLLECTION)
    ("cyclooxygenase II (COX2)," . SPARSER::PROTEIN)
    ("intratissular estrogens" . SPARSER::MOLECULE)
    ("normal premenopausal endometrium," . SPARSER::PROTEIN)
    ("progestogens" . SPARSER::MOLECULE)
    ("aromatase and COX2" . SPARSER::COLLECTION)
    ("ERβ and ERα" . SPARSER::COLLECTION)
    ("ERβ and COX2" . SPARSER::COLLECTION)
    ("COX2 and aromatase" . SPARSER::COLLECTION)
    ("cyclooxygenase" . SPARSER::PROTEIN)
    ("membrane estrogen receptor" . SPARSER::PROTEIN)
    ("aromatase activity" . SPARSER::PROTEIN) ("ER-beta" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("PGE2" . SPARSER::DRUG)
    ("nonluminal breast cancers," . SPARSER::PROTEIN)
    ("the mammary compartment," . SPARSER::PROTEIN)
    ("JunB, as well as JunD (not shown)" . SPARSER::COLLECTION)
    ("c-Jun and FosL" . SPARSER::COLLECTION)
    ("two well-characterized mediators of PRL’s" . SPARSER::PROTEIN)
    ("the mammary gland, Elf5 and Stat5 xref , xref (data not shown),"
     . SPARSER::PROTEIN)
    ("Elf5 and Stat5" . SPARSER::COLLECTION)
    ("the pro-angiogenic ligand, Vegfa ," . SPARSER::PROTEIN)
    ("Vegfa" . SPARSER::PROTEIN) ("Col1a2" . SPARSER::PROTEIN)
    ("p16 Ink4a and p19 Arf" . SPARSER::COLLECTION)
    ("locally invasive," . SPARSER::PROTEIN)
    ("high molecular weight cytokeratins ( xref ) and cytokeratin"
     . SPARSER::COLLECTION)
    ("BALB/c" . SPARSER::COLLECTION)
    ("aggressive claudin-low carcinomas," . SPARSER::PROTEIN)
    ("mammary pathogenesis," . SPARSER::PROTEIN)
    ("NRL-PRL" . SPARSER::COLLECTION) ("PRLR" . SPARSER::PROTEIN)
    ("triple negative breast cancers," . SPARSER::PROTEIN)
    ("c-Jun and FosL1" . SPARSER::COLLECTION) ("FosL1" . SPARSER::PROTEIN)
    ("Cathepsin L" . SPARSER::PROTEIN) ("Elf5" . SPARSER::PROTEIN)
    ("Col1a1" . SPARSER::PROTEIN) ("cathepsin L" . SPARSER::PROTEIN)
    ("Mmp2" . SPARSER::PROTEIN)
    ("therapeutic gene in neuroblastoma and other malignancies"
     . SPARSER::COLLECTION)
    ("Instead, Noxa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/Bim" . SPARSER::COLLECTION)
    ("a strong BH3-only protein" . SPARSER::PROTEIN)
    ("pro-apoptotic Bcl2 proteins" . SPARSER::PROTEIN)
    ("a pro-apoptotic Bcl2-protein" . SPARSER::COLLECTION)
    ("Bcl2-protein" . SPARSER::COLLECTION)
    ("its BH1 domain, [ xref ] or Bim-interaction [ xref ]"
     . SPARSER::COLLECTION)
    ("JNK and GSK-3β" . SPARSER::COLLECTION)
    ("a possible candidate," . SPARSER::PROTEIN)
    ("MULE/ARF-BP1" . SPARSER::COLLECTION)
    ("β-TrCP and SCF" . SPARSER::COLLECTION)
    ("etoposide or doxorubicin" . SPARSER::COLLECTION)
    ("this pro-apoptotic protein" . SPARSER::PROTEIN)
    ("Bim and Mcl1L" . SPARSER::COLLECTION)
    ("BclxL and Mcl1L" . SPARSER::COLLECTION)
    ("BclxL and Noxa" . SPARSER::COLLECTION)
    ("Noxa or Bim" . SPARSER::COLLECTION)
    ("the pro-apoptotic binding partner Noxa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("bortezomib" . SPARSER::DRUG)
    ("proline and glutamate" . SPARSER::COLLECTION)
    ("SH-EP/Ctr" . SPARSER::COLLECTION) ("Ctr" . SPARSER::PROTEIN)
    ("the smaller variant" . SPARSER::VARIANT) ("Bortezomib" . SPARSER::DRUG)
    ("the most proline- and glutamate-rich part" . SPARSER::COLLECTION)
    ("glutamate-rich part" . SPARSER::COMPONENT)
    ("proline-" . SPARSER::AMINO-ACID)
    ("GSK3β, ERK or JNK" . SPARSER::COLLECTION) ("SH-EP" . SPARSER::PROTEIN)
    ("Bax or Bak" . SPARSER::COLLECTION)
    ("Such a pro-apoptotic variant" . SPARSER::VARIANT)
    ("a pro-apoptotic BH3-only protein" . SPARSER::PROTEIN)
    ("Pro-apoptotic variants" . SPARSER::VARIANT)
    ("several pro-apoptotic Mcl1 variants" . SPARSER::VARIANT)
    ("ubiquitinase" . SPARSER::UBIQUITINASE)
    ("FBW7 and β-TRCP" . SPARSER::COLLECTION) ("MULE" . SPARSER::PROTEIN)
    ("Proteasomal" . SPARSER::PROTEIN) ("Bim and Puma" . SPARSER::COLLECTION)
    ("pro-apoptotic Bak" . SPARSER::PROTEIN)
    ("Bak-oligomerisation" . SPARSER::COLLECTION)
    ("oligomerisation" . SPARSER::PROTEIN-FAMILY) ("Bak" . SPARSER::PROTEIN)
    ("pro-apoptotic Bim" . SPARSER::PROTEIN)
    ("JNK and GSK3β" . SPARSER::COLLECTION)
    ("pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("growth factor- and cytokine" . SPARSER::COLLECTION)
    ("growth factor-" . SPARSER::GROWTH-FACTOR)
    ("significantly more pro-apoptotic Bim" . SPARSER::PROTEIN)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("caspase 3/caspase 8" . SPARSER::COLLECTION) ("ERK-1" . SPARSER::PROTEIN)
    ("ARF-BP1" . SPARSER::PROTEIN) ("USP9X" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN) ("Pin-1" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN)
    ("three-dimensional protein" . SPARSER::PROTEIN)
    ("more traditional protein-based drugs" . SPARSER::DRUG)
    ("sequence-based miRNA drugs" . SPARSER::DRUG)
    ("PECAM1 and VWF" . SPARSER::COLLECTION) ("−106a" . SPARSER::COLLECTION)
    ("ZEB1 and ZEB1" . SPARSER::COLLECTION)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("MMP-7, SNAI1 and SNAI2" . SPARSER::COLLECTION)
    ("chronic ultraviolet radiation exposure," . SPARSER::PROTEIN)
    ("=−2.04" . SPARSER::COLLECTION)
    ("miRNAs ( xref ) and mRNAs ( xref )" . SPARSER::COLLECTION)
    ("VWF" . SPARSER::PROTEIN) ("ACTA" . SPARSER::PROTEIN)
    ("=−1.1" . SPARSER::COLLECTION) ("=−1.0" . SPARSER::COLLECTION)
    ("snail" . SPARSER::PROTEIN) ("/SPARC" . SPARSER::COLLECTION)
    ("TGB" . SPARSER::PROTEIN) ("osteonectin" . SPARSER::PROTEIN)
    ("=−1.36" . SPARSER::COLLECTION) ("FC" . SPARSER::PROTEIN)
    ("retina" . SPARSER::DRUG) ("transcriptomes" . SPARSER::PROTEIN)
    ("E-cadherin and polarity factor genes," . SPARSER::COLLECTION)
    ("ZEB1/ZEB2" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("fibronectin, vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("−18a" . SPARSER::COLLECTION)
    ("pterygium, 25 miRNAs and 31 mRNAs" . SPARSER::COLLECTION)
    ("IGFBP3" . SPARSER::PROTEIN) ("RARRES1" . SPARSER::PROTEIN)
    ("SERPINE2" . SPARSER::PROTEIN) ("SERPINB13" . SPARSER::PROTEIN)
    ("EFEMP1" . SPARSER::PROTEIN)
    ("extracellular matrix protein 1" . SPARSER::PROTEIN)
    ("TGFβ2" . SPARSER::PROTEIN) ("MMP-7" . SPARSER::PROTEIN)
    ("miR-29c" . SPARSER::PROTEIN) ("LTBP1" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("C-C motif" . SPARSER::PROTEIN) ("AQP1" . SPARSER::PROTEIN)
    ("aquaporin 1 (Colton blood group)" . SPARSER::PROTEIN)
    ("actin, alpha 2, smooth muscle, aorta" . SPARSER::PROTEIN)
    ("zinc finger E-box binding homeobox 1" . SPARSER::PROTEIN)
    ("catenin beta-1" . SPARSER::PROTEIN)
    ("transforming growth factor beta 2" . SPARSER::PROTEIN)
    ("transcription factor 4" . SPARSER::PROTEIN)
    ("notch 1" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 2" . SPARSER::PROTEIN)
    ("latent transforming growth factor beta binding protein 2"
     . SPARSER::PROTEIN)
    ("fibronectin 1" . SPARSER::PROTEIN) ("COL3A1" . SPARSER::PROTEIN)
    ("PECAM1" . SPARSER::PROTEIN) ("LTBP2" . SPARSER::PROTEIN)
    ("exosome component 10" . SPARSER::PROTEIN) ("EXOSC10" . SPARSER::PROTEIN)
    ("MIR29C" . SPARSER::PROTEIN) ("MIR29B" . SPARSER::RNA)
    ("MIR200B" . SPARSER::PROTEIN) ("miR-200a" . SPARSER::MOLECULE)
    ("directly modifying PARP-1's" . SPARSER::PROTEIN)
    ("protein or SUMO" . SPARSER::COLLECTION)
    ("the conformation of PARP-1's" . SPARSER::BIO-CONFORMATION)
    ("major chemical" . SPARSER::MOLECULE)
    ("chromatin-associated molecules" . SPARSER::MOLECULE)
    ("available, PARP-1" . SPARSER::PROTEIN)
    ("this situation, PARP-1's" . SPARSER::PROTEIN)
    ("chromatin-associated proteins and PARP-1" . SPARSER::COLLECTION)
    ("proteins and PARP-1" . SPARSER::COLLECTION)
    ("DNA-associated processes," . SPARSER::PROTEIN)
    ("conformation and accessibility" . SPARSER::COLLECTION)
    ("controversial xref ," . SPARSER::PROTEIN)
    ("that PARP-1's" . SPARSER::PROTEIN)
    ("the chromatin-associated fractions" . SPARSER::COMPONENT)
    ("SSBs and/or DSBs" . SPARSER::COLLECTION)
    ("protein or DNA" . SPARSER::COLLECTION)
    ("heat, osmotic, ethanol" . SPARSER::MOLECULE)
    ("-SUMO-3" . SPARSER::COLLECTION)
    ("the respective mutants" . SPARSER::MUTANT)
    ("bioinformatic analysis," . SPARSER::PROTEIN)
    ("a relevant site in vitro (Fig. S4)," . SPARSER::PROTEIN)
    ("at least one additional lysine" . SPARSER::AMINO-ACID)
    ("the respective lysines" . SPARSER::AMINO-ACID)
    ("-SUMO-1" . SPARSER::COLLECTION) ("-PARP-1" . SPARSER::COLLECTION)
    ("a biotin linkage, a 15 bp duplex DNA" . SPARSER::DNA)
    ("Ubc9 and DNA" . SPARSER::COLLECTION) ("Ubc9-SUMO" . SPARSER::COLLECTION)
    ("soluble protein," . SPARSER::PROTEIN)
    ("the latter case," . SPARSER::PROTEIN)
    ("Similarly, plasmid DNA" . SPARSER::DNA)
    (", R122/138A," . SPARSER::PROTEIN)
    ("only slightly more efficient," . SPARSER::PROTEIN)
    ("longer duplexes (Fig. S6)," . SPARSER::PROTEIN)
    ("a previous report xref ," . SPARSER::PROTEIN)
    ("a point mutation, R122I," . SPARSER::PROTEIN)
    ("double-stranded DNA and a hairpin" . SPARSER::COLLECTION)
    ("-adenine and C" . SPARSER::COLLECTION)
    ("-cytosine" . SPARSER::NUCLEOBASE) ("-adenine" . SPARSER::NUCLEOBASE)
    ("relevant forms" . SPARSER::FORM)
    ("controlling PARP-1's" . SPARSER::PROTEIN)
    ("other chromatin-associated proteins" . SPARSER::PROTEIN)
    ("SUMO-2 and SUMO-3" . SPARSER::COLLECTION)
    ("cytokines, Ca 2+ and heat" . SPARSER::COLLECTION)
    ("unusual DNA structures," . SPARSER::PROTEIN)
    ("SSBs and DSBs" . SPARSER::COLLECTION)
    ("the major acceptor" . SPARSER::MOLECULE)
    ("chromatin-associated targets," . SPARSER::PROTEIN)
    ("DNA-" . SPARSER::DNA)
    ("enzyme (E2) and ligase (E3)," . SPARSER::COLLECTION)
    ("TDG" . SPARSER::PROTEIN) ("Thymine" . SPARSER::MOLECULE)
    ("the enzyme's" . SPARSER::ENZYME) ("intact," . SPARSER::PROTEIN)
    ("the heat shock-induced HSP70.1 promoter" . SPARSER::PROMOTER)
    ("small ubiquitin-related modifier (SUMO)" . SPARSER::PROTEIN)
    ("nucleic acid metabolism," . SPARSER::PROTEIN)
    ("a 15 " . SPARSER::PROTEIN) ("a 11 " . SPARSER::PROTEIN)
    ("SUMO-1" . SPARSER::PROTEIN) ("SUMO-3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SUMO-2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA Glycosylase" . SPARSER::PROTEIN) ("HSP70.1" . SPARSER::PROTEIN)
    ("small ubiquitin-related modifier" . SPARSER::PROTEIN)
    ("Hematoxylin and eosin" . SPARSER::COLLECTION)
    ("diamine" . SPARSER::MOLECULE) ("Radical" . SPARSER::MOLECULE)
    ("pT1, pT2-4, pN- or pT2-4/" . SPARSER::COLLECTION)
    ("pTN" . SPARSER::PROTEIN) ("aggressive features," . SPARSER::PROTEIN)
    ("IHC," . SPARSER::PROTEIN) ("YAP 1 and Ki67" . SPARSER::COLLECTION)
    ("labeling index (LI)," . SPARSER::PROTEIN)
    ("YAP1 and Ki-67" . SPARSER::COLLECTION)
    ("well-known clinical pathological prognostic parameters,"
     . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("YAP 1" . SPARSER::PROTEIN)
    ("Yes-associated protein 1" . SPARSER::PROTEIN) ("Pre" . SPARSER::PROTEIN)
    ("JAS" . SPARSER::PROTEIN-FAMILY) ("JH" . SPARSER::PROTEIN)
    ("APR" . SPARSER::PROTEIN) ("MPR" . SPARSER::PROTEIN)
    ("IBB" . SPARSER::PROTEIN-FAMILY) ("PAP" . SPARSER::MOLECULE)
    ("LCB" . SPARSER::PROTEIN) ("LAC" . SPARSER::PROTEIN)
    ("MK" . SPARSER::PROTEIN) ("DMB" . SPARSER::PROTEIN)
    ("DNP" . SPARSER::DRUG) ("DAB" . SPARSER::MOLECULE) ("MEG" . SPARSER::DRUG)
    ("SKG" . SPARSER::PROTEIN) ("LAL" . SPARSER::PROTEIN)
    ("Lipoprotein" . SPARSER::PROTEIN) ("SRY" . SPARSER::PROTEIN)
    ("MESA" . SPARSER::PROTEIN)
    ("an appropriate ethnic-specific LD focus," . SPARSER::PROTEIN)
    ("the well-documented 9p21 and PHACTR1 regions," . SPARSER::PROTEIN)
    ("PCSK9 and LPA" . SPARSER::COLLECTION)
    ("largely negative," . SPARSER::PROTEIN)
    ("Finally, environmental factors," . SPARSER::PROTEIN)
    ("denser, race-specific gene maps" . SPARSER::PROTEIN)
    ("some other CAC and CAD EA loci," . SPARSER::COLLECTION)
    ("AA and EA" . SPARSER::COLLECTION) ("AA " . SPARSER::MOLECULE)
    ("this smaller AA region," . SPARSER::PROTEIN)
    ("cardiovascular endpoints," . SPARSER::PROTEIN)
    ("SOX9 and PRKCA" . SPARSER::COLLECTION)
    ("Principal components" . SPARSER::COMPONENT)
    ("the GeneSTAR study," . SPARSER::PROTEIN) ("yrs" . SPARSER::PROTEIN)
    ("genotypes" . SPARSER::PROTEIN)
    ("other ethnic groups," . SPARSER::PROTEIN)
    ("Subclinical traits," . SPARSER::PROTEIN)
    ("CAC/CHD" . SPARSER::COLLECTION) ("CAC " . SPARSER::PROTEIN)
    ("associated genetic variants" . SPARSER::VARIANT)
    ("CAC" . SPARSER::PROTEIN) ("Lp(a)" . SPARSER::PROTEIN)
    ("Proprotein convertase subtilisin/kexin type 9" . SPARSER::PROTEIN)
    ("sex determining region Y" . SPARSER::PROTEIN)
    ("Neuregulin 1" . SPARSER::PROTEIN)
    ("Phosphatase and actin regulator 1" . SPARSER::PROTEIN)
    ("PCSK9" . SPARSER::PROTEIN) ("p300-ASH2L" . SPARSER::PROTEIN-PAIR)
    ("the DNA-damage-induced SET1C and H3K4" . SPARSER::COLLECTION)
    ("Enhancer" . SPARSER::PROTEIN)
    ("the recently described H3R2 symmetric dimethylation ( xref ),"
     . SPARSER::PROTEIN)
    ("the endogenous p53- and p300-activated p21/WAF1 gene"
     . SPARSER::COLLECTION)
    ("p53, as well as p300," . SPARSER::COLLECTION) ("Trr" . SPARSER::PROTEIN)
    ("p53- and p300-dependent H3K4 trimethylation in vitro and in vivo,"
     . SPARSER::COLLECTION)
    ("WDR82 or CFP1" . SPARSER::COLLECTION)
    ("a p53- and p300-dependent manner," . SPARSER::COLLECTION)
    ("MLL1 and MLL3/4" . SPARSER::COLLECTION) ("tri-" . SPARSER::PROTEIN)
    ("SAGA" . SPARSER::PROTEIN) ("p300 and H2Bub" . SPARSER::COLLECTION)
    ("unacetylated nucleosomal substrates," . SPARSER::PROTEIN)
    ("H2B and SET1C" . SPARSER::COLLECTION)
    ("SET1C activity, as well as their cooperativity," . SPARSER::COLLECTION)
    ("either WT H2B or a semisynthetic H2Bub analog ( xref , xref )"
     . SPARSER::COLLECTION)
    ("a semisynthetic H2Bub analog" . SPARSER::ANALOG)
    ("the more direct biochemical experiments," . SPARSER::PROTEIN)
    ("CFP1/SET1C" . SPARSER::COLLECTION)
    ("SET1C and Both H3K4" . SPARSER::COLLECTION)
    ("p53 and Pol" . SPARSER::COLLECTION)
    ("enhancer and promoter" . SPARSER::COLLECTION)
    ("p53 and SET1C" . SPARSER::COLLECTION)
    ("p21/WAF1 promoter-associated H3K4" . SPARSER::PROTEIN)
    ("both protein ( xref ) and messenger RNA (mRNA) ( xref ) levels,"
     . SPARSER::COLLECTION)
    ("messenger RNA (mRNA) ( xref ) levels," . SPARSER::PROTEIN)
    ("CFP1 or WDR82" . SPARSER::COLLECTION)
    ("a p53-associated SET1C" . SPARSER::PROTEIN)
    ("GST-p53" . SPARSER::COLLECTION)
    ("IgG or an anti-MLL1 antibody" . SPARSER::COLLECTION)
    ("a further analysis, p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-SET1 and anti-CFP1" . SPARSER::COLLECTION)
    ("p53- and p300-dependent transcription," . SPARSER::COLLECTION)
    ("a semisynthetic methyl-lysine analog" . SPARSER::ANALOG)
    ("reported previously ( xref )," . SPARSER::PROTEIN)
    ("TAZ1 and TAZ2" . SPARSER::COLLECTION) ("NCoA6" . SPARSER::PROTEIN)
    ("NCoA" . SPARSER::PROTEIN) ("p300 and," . SPARSER::COLLECTION)
    ("SET1C and H3K4" . SPARSER::COLLECTION)
    ("p300 and its resident bromodomain" . SPARSER::COLLECTION)
    ("nucleosomal histones ( xref )," . SPARSER::PROTEIN)
    ("DY" . SPARSER::MOLECULE)
    ("a bromodomain-deleted p300 mutant" . SPARSER::MUTANT)
    ("intact ACF1" . SPARSER::PROTEIN)
    ("Flag:PA1 or Flag:UTX" . SPARSER::COLLECTION)
    ("Flag:UTX" . SPARSER::BIO-COMPLEX) ("Flag:PA1" . SPARSER::BIO-COMPLEX)
    ("UTX" . SPARSER::PROTEIN) ("KR" . SPARSER::PROTEIN-FAMILY)
    ("p53 or p300" . SPARSER::COLLECTION) ("p300-SET1C" . SPARSER::COLLECTION)
    ("p53 and p300/acetyl-CoA" . SPARSER::COLLECTION)
    ("robust p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("octamer" . SPARSER::PROTEIN)
    ("synergistic SET1C and p300" . SPARSER::COLLECTION)
    ("p53-p300" . SPARSER::PROTEIN-PAIR)
    ("3, as well as other histone modifications," . SPARSER::COLLECTION)
    ("SET1/MLL" . SPARSER::COLLECTION) ("diverse cofactors" . SPARSER::PROTEIN)
    ("SET1C and p300" . SPARSER::COLLECTION) ("SET1C" . SPARSER::PROTEIN)
    ("p300 and SET1C" . SPARSER::COLLECTION) ("p21/WAF1" . SPARSER::COLLECTION)
    ("p53-SET1C" . SPARSER::COLLECTION) ("H3K27ac" . SPARSER::MOLECULE)
    ("TAZ1" . SPARSER::PROTEIN) ("MED17" . SPARSER::PROTEIN)
    ("ACF complex" . SPARSER::PROTEIN) ("ACF1" . SPARSER::PROTEIN)
    ("K18" . SPARSER::PROTEIN) ("SET domain" . SPARSER::PROTEIN)
    ("WDR82" . SPARSER::PROTEIN) ("CFP1" . SPARSER::PROTEIN)
    ("Set1C" . SPARSER::BIO-COMPLEX) ("DPY30" . SPARSER::PROTEIN)
    ("ASH2L" . SPARSER::PROTEIN) ("RbBP5" . SPARSER::PROTEIN)
    ("Set1" . SPARSER::PROTEIN) ("MLL4" . SPARSER::PROTEIN)
    ("MLL3" . SPARSER::PROTEIN) ("MLL2" . SPARSER::PROTEIN)
    ("MLL1" . SPARSER::PROTEIN) ("SET1B" . SPARSER::PROTEIN)
    ("SET1A" . SPARSER::PROTEIN) ("SET1" . SPARSER::PROTEIN)
    ("ovarian, bladder, gastric, pancreatic, colorectal, skin and lung,"
     . SPARSER::PROTEIN)
    ("Finally, XRCC1" . SPARSER::PROTEIN) ("REGgamma" . SPARSER::PROTEIN)
    ("SSBs as well as wild-type XRCC1," . SPARSER::COLLECTION)
    ("BRCTII" . SPARSER::PROTEIN)
    ("a homodimer or a heterodimer" . SPARSER::COLLECTION)
    ("LigIIIα and XRCC1-BRCTII" . SPARSER::COLLECTION)
    ("XRCC1-BRCTII" . SPARSER::COLLECTION)
    ("XRCC1 that determines the retention of the XRCC1–LigIIIα complex and other repair proteins"
     . SPARSER::COLLECTION)
    ("XRCC1 and other SSBR proteins" . SPARSER::COLLECTION)
    ("WT XRCC1 and X1 pm" . SPARSER::COLLECTION)
    ("XRCC1 or X1 pm" . SPARSER::COLLECTION) ("‘fix’" . SPARSER::PROTEIN)
    ("fix" . SPARSER::PROTEIN) ("GFP–LigIIIα" . SPARSER::COLLECTION)
    ("Parg" . SPARSER::PROTEIN) ("laser-induced SSBs" . SPARSER::PROTEIN)
    ("broken DNA" . SPARSER::DNA) ("XRCC1 and LigIIIα" . SPARSER::COLLECTION)
    ("Ligase" . SPARSER::LIGASE) ("LigIIIα" . SPARSER::PROTEIN)
    ("XRCC1–LigIIIα" . SPARSER::COLLECTION)
    ("XRCC1 and its partners," . SPARSER::COLLECTION)
    ("NTH1, OGG1 and APE1" . SPARSER::COLLECTION)
    ("NTH1, OGG1, NEIL1 and APE1" . SPARSER::COLLECTION)
    ("EM9" . SPARSER::PROTEIN) ("PNK and APTX" . SPARSER::COLLECTION)
    ("XPA-UVDE" . SPARSER::COLLECTION)
    ("X1w/oBII and X1 pm" . SPARSER::COLLECTION)
    ("X1w/oBII" . SPARSER::PROTEIN) ("dimers (CPD)" . SPARSER::DIMER)
    ("CPD" . SPARSER::PROTEIN) ("UVDE" . SPARSER::PROTEIN)
    ("UV damage endonuclease (UVDE)" . SPARSER::PROTEIN)
    ("endonuclease (UVDE)" . SPARSER::PROTEIN)
    ("SSBs and forms" . SPARSER::COLLECTION)
    ("a mutant XRCC1 lacking the BRCT II domain (X1w/oBII) and the XRCC1 phosphorylation mutant XRCC1 (X1 pm)"
     . SPARSER::COLLECTION)
    ("at least two XRCC1-dependent pathways," . SPARSER::PROTEIN)
    ("Iduna" . SPARSER::PROTEIN) ("-DNA" . SPARSER::DNA)
    ("polynucleotide kinase (PNK) and aprataxin (APTX)" . SPARSER::COLLECTION)
    ("a ubiquitous protein kinase, CK2," . SPARSER::PROTEIN)
    ("aprataxin" . SPARSER::PROTEIN) ("/polymerase" . SPARSER::COLLECTION)
    ("a molecular scaffold or matchmaker," . SPARSER::COLLECTION)
    ("DNA polymerase beta, PNK, APTX, PCNA and ligase" . SPARSER::COLLECTION)
    ("APTX" . SPARSER::PROTEIN) ("PNK" . SPARSER::PROTEIN)
    ("SSB" . SPARSER::PROTEIN) ("PARG" . SPARSER::PROTEIN)
    ("XRCC1 " . SPARSER::PROTEIN) ("PSME3" . SPARSER::PROTEIN)
    ("PA28γ" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("RNF146" . SPARSER::PROTEIN) ("α at" . SPARSER::PROTEIN)
    ("NEIL1" . SPARSER::PROTEIN) ("NTH1" . SPARSER::PROTEIN)
    ("Xrcc1" . SPARSER::PROTEIN) ("PJ34" . SPARSER::DRUG)
    ("methyl-methane" . SPARSER::MOLECULE) ("PARP2" . SPARSER::PROTEIN)
    ("DNA polymerase beta" . SPARSER::PROTEIN)
    ("siRNA and ligand" . SPARSER::COLLECTION) ("retinoids" . SPARSER::DRUG)
    ("The pure anti-oestrogen fulvestrant" . SPARSER::DRUG)
    ("MCF7 and LCC2 cells ( xref )," . SPARSER::COLLECTION)
    ("VEGF and VEGFR2" . SPARSER::COLLECTION)
    ("HDAC1 and DNMT1" . SPARSER::COLLECTION)
    ("Interestingly, AM580" . SPARSER::MOLECULE) ("neu-" . SPARSER::PROTEIN)
    ("ER- and RARA-connected proteome" . SPARSER::COLLECTION)
    ("the protein interactome around ER and RARA" . SPARSER::COLLECTION)
    ("parental MCF7" . SPARSER::PROTEIN)
    ("ER-associated state" . SPARSER::BIO-STATE)
    ("ER and RAR" . SPARSER::COLLECTION) ("RAR" . SPARSER::PROTEIN)
    ("RARs" . SPARSER::PROTEIN)
    ("high intratumoural RARA levels," . SPARSER::PROTEIN)
    ("E2- and RA-regulated genes ( xref and xref )" . SPARSER::COLLECTION)
    ("a tamoxifen-sensitive and -resistant cell line, MCF7 and LCC2,"
     . SPARSER::COLLECTION)
    ("predictive markers," . SPARSER::PROTEIN)
    ("the ER- and RARA-connected proteome" . SPARSER::COLLECTION)
    ("RA-regulated genes and RARA- and ER-binding sites, which were higher"
     . SPARSER::COLLECTION)
    ("RARA- and ER-binding sites," . SPARSER::COLLECTION)
    ("fulvestrant and 4-OHT" . SPARSER::COLLECTION)
    ("RARA-" . SPARSER::PROTEIN)
    ("RA-regulated genes and genomic ER-" . SPARSER::COLLECTION)
    ("ER- and RARA-associated gene" . SPARSER::COLLECTION)
    ("genomic ER-" . SPARSER::PROTEIN) ("RARA-associated gene" . SPARSER::GENE)
    ("fulvestrant-" . SPARSER::DRUG)
    ("the contrary, fulvestrant" . SPARSER::DRUG)
    ("ER and fulvestrant" . SPARSER::COLLECTION)
    ("Fulvestrant" . SPARSER::DRUG) ("VEGF/VEGFR2" . SPARSER::COLLECTION)
    ("fenretinide" . SPARSER::DRUG) ("retinoid" . SPARSER::PROTEIN)
    ("Interestingly, fulvestrant" . SPARSER::DRUG)
    ("the parental cell line MCF7" . SPARSER::PROTEIN)
    ("RARA and ER" . SPARSER::COLLECTION)
    ("MCF7 and LCC2," . SPARSER::COLLECTION)
    ("this smaller cohort" . SPARSER::MOLECULE)
    ("tumour size, nodal status, ER, progesterone receptor, histological type, histological grade, HER2 or VEGF"
     . SPARSER::COLLECTION)
    ("HER2 or VEGF" . SPARSER::COLLECTION) ("shorter RFS" . SPARSER::PROTEIN)
    ("enzyme-linked immunosorbent assay (ELISA)," . SPARSER::PROTEIN)
    ("overlapped E2- ,RA- and both E2-" . SPARSER::COLLECTION)
    ("RA-" . SPARSER::PROTEIN) ("E2-" . SPARSER::MOLECULE)
    ("E2 or RA" . SPARSER::COLLECTION)
    ("4-OHT and fulvestrant" . SPARSER::COLLECTION)
    ("E2, 4-OHT and another ER inhibitor, fulvestrant" . SPARSER::COLLECTION)
    ("ER and RARA, mRNA and protein-level" . SPARSER::COLLECTION)
    ("RARA, mRNA and protein-level" . SPARSER::COLLECTION)
    ("respective subcellular fraction" . SPARSER::COMPONENT)
    ("Subcellular fractions" . SPARSER::COMPONENT)
    ("Quantitative proteomics link RARA" . SPARSER::PROTEIN)
    ("BC cell lines, parental MCF7" . SPARSER::PROTEIN)
    ("the prognostic and predictive settings xref  xref  xref ,"
     . SPARSER::PROTEIN)
    ("transcriptome" . SPARSER::PROTEIN)
    ("new predictive biomarkers or therapeutic targets xref"
     . SPARSER::COLLECTION)
    ("new predictive biomarkers" . SPARSER::MOLECULE)
    ("ER and RARA" . SPARSER::COLLECTION)
    ("phosphoinositide 3 kinase and mitogen-activated protein kinase"
     . SPARSER::COLLECTION)
    ("finding reliable predictive biomarkers" . SPARSER::MOLECULE)
    ("reproductive physiology," . SPARSER::PROTEIN)
    ("retinoic acid receptor alpha (RARA)" . SPARSER::PROTEIN)
    ("RARA" . SPARSER::PROTEIN)
    ("quantitative mass spectrometry-based proteomics," . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("ICI 182780" . SPARSER::DRUG) ("AM580" . SPARSER::MOLECULE)
    ("Retinoic acid" . SPARSER::MOLECULE)
    ("phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("anti-oestrogen" . SPARSER::DRUG)
    ("retinoic acid receptor alpha" . SPARSER::PROTEIN)
    ("mitochondrial OGG1" . SPARSER::PROTEIN)
    ("angiotensin" . SPARSER::PROTEIN)
    ("cleaved PARP ( xref ) and Annexin V" . SPARSER::COLLECTION)
    ("typical shaped mitochondria" . SPARSER::PROTEIN)
    ("Likewise, Sirt3" . SPARSER::PROTEIN) ("Flag-OGG1" . SPARSER::COLLECTION)
    ("an IgG or an antibody" . SPARSER::COLLECTION)
    ("the mitochondrial OGG1" . SPARSER::PROTEIN)
    ("Sirt3 and NAD +" . SPARSER::COLLECTION)
    ("Sirt3 or NAD +" . SPARSER::COLLECTION)
    ("the immune-purified proteins" . SPARSER::PROTEIN)
    ("OGG1 and Sirt3" . SPARSER::COLLECTION)
    ("substrate and enzyme" . SPARSER::COLLECTION)
    ("Sirt3 or an siRNA" . SPARSER::COLLECTION)
    ("oxidative stress," . SPARSER::PROTEIN)
    ("Sirt3 and OGG1" . SPARSER::COLLECTION) ("Oxygen" . SPARSER::MOLECULE)
    ("cyclophilin" . SPARSER::PROTEIN)
    ("mitochondrial redox" . SPARSER::PROTEIN) ("GDH" . SPARSER::PROTEIN)
    ("Sirt1–Sirt7" . SPARSER::COLLECTION) ("hOGG1" . SPARSER::PROTEIN)
    ("α -tubulin" . SPARSER::PROTEIN) ("Sir3" . SPARSER::MOLECULE)
    ("E64d" . SPARSER::MOLECULE)
    ("8-Oxoguanine-DNA glycosylase 1" . SPARSER::PROTEIN)
    ("ALDH2" . SPARSER::PROTEIN) ("Sirt7" . SPARSER::PROTEIN)
    ("Sirt2" . SPARSER::PROTEIN) ("sirtuin 2" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("OGG1" . SPARSER::PROTEIN)
    ("8-oxoguanine-DNA glycosylase 1" . SPARSER::PROTEIN)
    ("Sirt3" . SPARSER::PROTEIN) ("Sirtuin 3" . SPARSER::PROTEIN)
    ("a very recent study," . SPARSER::PROTEIN)
    ("tubular TNTs," . SPARSER::PROTEIN) ("calcein" . SPARSER::MOLECULE)
    ("optimal Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("active caspase-3 and membrane-anchored Fas ligand" . SPARSER::COLLECTION)
    ("the TNTs and the Jurkat cell body," . SPARSER::COLLECTION)
    ("H-Ras and other PM-anchored proteins," . SPARSER::COLLECTION)
    ("the TNT and the Jurkat cell body, FRAP" . SPARSER::COLLECTION)
    ("its lateral diffusion," . SPARSER::PROTEIN)
    ("glycosylphosphatidylinositol" . SPARSER::MOLECULE)
    ("reduced post-translational palmitoylation," . SPARSER::PROTEIN)
    ("a stringent gating algorithm (see the Materials and methods section for further details),"
     . SPARSER::PROTEIN)
    ("multi-parametric digital flow cytometry analysis," . SPARSER::PROTEIN)
    ("a quantitative approach," . SPARSER::PROTEIN)
    ("the Golgi complex and the PM" . SPARSER::COLLECTION)
    ("the latter receptor" . SPARSER::RECEPTOR)
    ("H-Ras and CD86" . SPARSER::COLLECTION)
    ("fluorochrome" . SPARSER::MOLECULE)
    ("anti-Ras and anti-GFP" . SPARSER::COLLECTION)
    ("Our previous studies," . SPARSER::PROTEIN)
    ("membrane patches containing lipidated membrane-anchored H-Ras proteins"
     . SPARSER::PROTEIN)
    ("the green-labeled TNT" . SPARSER::PROTEIN)
    ("a typical B721.221-derived H-RasG12V-labeled TNT" . SPARSER::PROTEIN)
    ("the red-labeled TNT" . SPARSER::PROTEIN)
    ("entirely GFP-H-RasG12V-labeled," . SPARSER::PROTEIN)
    ("a lipophilic membrane dye PKH26GL" . SPARSER::DRUG)
    ("TNT" . SPARSER::PROTEIN) ("nanotube" . SPARSER::MOLECULE)
    ("this mechanical cell separation," . SPARSER::PROTEIN)
    ("an inner PM-associated GTPase," . SPARSER::PROTEIN)
    ("membrane-associated proteins," . SPARSER::PROTEIN)
    ("-H-Ras" . SPARSER::COLLECTION)
    ("PM-associated proteins," . SPARSER::PROTEIN)
    ("GFP-H-Ras" . SPARSER::COLLECTION) ("TNTs" . SPARSER::PROTEIN)
    ("nanotubes" . SPARSER::MOLECULE) ("PKH26" . SPARSER::DRUG)
    ("RASG12V" . SPARSER::PROTEIN) ("PKH26GL" . SPARSER::DRUG)
    ("RasG12V" . SPARSER::PROTEIN) ("Ras family" . SPARSER::PROTEIN)
    ("latrunculin B" . SPARSER::DRUG) ("CD86" . SPARSER::PROTEIN)
    ("a progressive slow-infusion," . SPARSER::PROTEIN)
    ("cisplatin or oxaliplatin" . SPARSER::COLLECTION)
    ("dysfunctional BRCA1" . SPARSER::PROTEIN) ("DNA–platinum" . SPARSER::DNA)
    ("hapten" . SPARSER::MOLECULE)
    ("pegylated liposomal doxorubicin" . SPARSER::PROTEIN)
    ("longer," . SPARSER::PROTEIN)
    ("concurrent grade 2 elevated creatinine" . SPARSER::PROTEIN)
    ("creatinine" . SPARSER::PROTEIN)
    ("intravenous diphenhydramine, ranitidine, and/or methylprednisolone"
     . SPARSER::COLLECTION)
    ("intravenous diphenhydramine, ranitidine," . SPARSER::PROTEIN)
    ("methylprednisolone" . SPARSER::DRUG) ("diphenhydramine" . SPARSER::DRUG)
    ("ranitidine" . SPARSER::DRUG)
    ("11.5 cumulative carboplatin" . SPARSER::DRUG)
    ("cyclophosphamide and gemcitabine" . SPARSER::COLLECTION)
    ("cyclophosphamide" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("carboplatin and olaparib" . SPARSER::COLLECTION)
    ("platinums" . SPARSER::MOLECULE)
    ("the tumour microenvironment, DNA damage and repair, and/or cell cycle-specific categories,"
     . SPARSER::COLLECTION)
    ("angiogenesis inhibitors ( xref ) and poly ADP ribose polymerase (PARP) inhibitors"
     . SPARSER::COLLECTION)
    ("Carboplatin" . SPARSER::DRUG)
    ("Cisplatin and carboplatin, elemental platinum-based chemotherapeutic agents,"
     . SPARSER::PROTEIN)
    ("Cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("IL-5" . SPARSER::PROTEIN)
    ("identifying predictive biomarkers" . SPARSER::MOLECULE)
    ("an indirect inhibitor" . SPARSER::INHIBITOR)
    ("Perifosine" . SPARSER::PROTEIN)
    ("an orally available alkylphospholipid" . SPARSER::DRUG)
    ("alkylphospholipid" . SPARSER::DRUG) ("perifosine" . SPARSER::PROTEIN)
    ("mRNA and TORC2" . SPARSER::COLLECTION)
    ("cyclin D1 and HIF-2α" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("LY294002 and wortmannin" . SPARSER::COLLECTION)
    ("MK2206 and ATP-competitive catalytic inhibitors such as GSK690693 and GDC-0941"
     . SPARSER::COLLECTION)
    ("GSK690693 and GDC-0941" . SPARSER::COLLECTION)
    ("GDC-0980 and BEZ235" . SPARSER::COLLECTION)
    ("Several dual PI3-K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("PI3-K/mTOR" . SPARSER::COLLECTION)
    ("the currently available rapalogues," . SPARSER::PROTEIN)
    ("PI3-K and mTOR" . SPARSER::COLLECTION) ("the 4E-BP’s" . SPARSER::PROTEIN)
    ("S6K and S6 Ribosomal protein" . SPARSER::COLLECTION)
    ("receptor and Akt" . SPARSER::COLLECTION)
    ("PI3-K and Akt" . SPARSER::COLLECTION)
    ("failed either sorafenib, sunitinib or both" . SPARSER::COLLECTION)
    ("ral" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nal" . SPARSER::PROTEIN)
    ("sunitinib" . SPARSER::DRUG) ("Everolimus" . SPARSER::MOLECULE)
    ("IFN-α and temsirolimus" . SPARSER::COLLECTION)
    ("a retrospective analysis," . SPARSER::PROTEIN) ("dl" . SPARSER::MOLECULE)
    ("Temsirolimus" . SPARSER::DRUG) ("TORC1 and TORC2" . SPARSER::COLLECTION)
    ("subtypes, those expressing both HIF-1α and HIF-2α and those expressing HIF-2α"
     . SPARSER::COLLECTION)
    ("the more relevant HIF" . SPARSER::PROTEIN-FAMILY)
    ("the p70RSK and the 4E-BPs" . SPARSER::COLLECTION)
    ("the p70 S6 Kinase (S6K) and the eukaryotic initiation factor 4E binding proteins (4E-BP1 and 4E-BP2),"
     . SPARSER::COLLECTION)
    ("4E-BP1 and 4E-BP2" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("PI3-K/Akt/mTOR" . SPARSER::COLLECTION) ("Group B" . SPARSER::PROTEIN)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GDC-0941" . SPARSER::DRUG)
    ("GDC-0980" . SPARSER::DRUG) ("MAP-K" . SPARSER::PROTEIN)
    ("AMP-K" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("PI3-Ks" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("Ribosomal protein" . SPARSER::PROTEIN) ("Mnk1" . SPARSER::PROTEIN)
    ("fas ligand" . SPARSER::PROTEIN) ("von Hippel Lindau" . SPARSER::PROTEIN)
    ("Grb10" . SPARSER::PROTEIN) ("p70RSK" . SPARSER::PROTEIN-FAMILY)
    ("4E-BP2" . SPARSER::PROTEIN) ("S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("TORC2" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("Protein Kinase B" . SPARSER::PROTEIN) ("sulphoxide" . SPARSER::DRUG)
    ("Propidium" . SPARSER::MOLECULE) ("Cyclin D1-Cdk4" . SPARSER::COLLECTION)
    ("increased messenger RNA (mRNA) and/or protein expression of E2F1 [ xref ]"
     . SPARSER::COLLECTION)
    ("E2F1 protein and high-grade glioma, E2F1" . SPARSER::COLLECTION)
    ("Akt, p21 and cyclin D1" . SPARSER::COLLECTION)
    ("kinase and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("pGL3–E2F1-3" . SPARSER::COLLECTION)
    ("GFP-γ-tubulin" . SPARSER::COLLECTION) ("E2F1-3" . SPARSER::COLLECTION)
    ("pBABE-E2F1-3" . SPARSER::COLLECTION) ("pBABE-E2F1" . SPARSER::COLLECTION)
    ("two publicly available algorithms (TargetScan and miRanda),"
     . SPARSER::PROTEIN)
    ("MiR-329 directly targets E2F1" . SPARSER::PROTEIN)
    ("miR-329-overexpressing LN18" . SPARSER::PROTEIN)
    ("important class of oncogenes and tumor suppressor genes [ xref ]"
     . SPARSER::COLLECTION)
    ("LN18 and T98G cell lines," . SPARSER::COLLECTION)
    ("Bromodeoxyuridine" . SPARSER::DRUG) ("p 21" . SPARSER::PROTEIN)
    ("JAB and JMDP" . SPARSER::COLLECTION) ("JMDP" . SPARSER::PROTEIN)
    ("MAP 8-Plex" . SPARSER::COLLECTION) ("Plex" . SPARSER::PROTEIN)
    ("JAB" . SPARSER::PROTEIN) ("PS" . SPARSER::PROTEIN)
    ("Rack1" . SPARSER::PROTEIN) ("PI3 kinase and c-Met" . SPARSER::COLLECTION)
    ("receptors and kinases" . SPARSER::COLLECTION)
    ("RACK1 and Cbp\\PAG, Lyn and Cbp\\PAG" . SPARSER::COLLECTION)
    ("complexes or signalosomes" . SPARSER::COLLECTION)
    ("signalosomes" . SPARSER::BIO-COMPLEX)
    ("glycosphingolipid" . SPARSER::MOLECULE)
    ("EGFR/c-Met" . SPARSER::COLLECTION) ("ErbB2/ErbB3" . SPARSER::COLLECTION)
    ("Heterodimers" . SPARSER::HETERODIMER)
    ("EGFR/ErbB1" . SPARSER::COLLECTION)
    ("metalloprotease inhibitor, nor TAPI," . SPARSER::COLLECTION)
    ("Yet, neither GM6001," . SPARSER::PROTEIN)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("EGFR and ErbB3" . SPARSER::COLLECTION)
    ("Lyn or Src regulatory kinases and phosphatases" . SPARSER::COLLECTION)
    ("Lyn or Src" . SPARSER::COLLECTION) ("anti-p-c-Met" . SPARSER::COLLECTION)
    ("PKC, RACK1 and Cbp\\PAG" . SPARSER::COLLECTION)
    ("RACK1 and Cbp\\PAG" . SPARSER::COLLECTION)
    ("Cbp/PAG or RACK1" . SPARSER::COLLECTION)
    ("reciprocal studies, both anti-Cbp/PAG and anti-RACK1"
     . SPARSER::COLLECTION)
    ("anti-Cbp/PAG and anti-RACK1" . SPARSER::COLLECTION)
    ("PAG" . SPARSER::PROTEIN) ("Cbp" . SPARSER::PROTEIN)
    ("proteins, RACK1 and Cbp/PAG" . SPARSER::COLLECTION)
    ("EGFR, PKCßII and Lyn" . SPARSER::COLLECTION)
    ("CDK1/cdc2" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("a more specific, cell-permeable, PKCβII peptide inhibitor"
     . SPARSER::INHIBITOR)
    ("secondary kinase targets," . SPARSER::PROTEIN)
    ("Akt and GSK-3β" . SPARSER::COLLECTION)
    ("preferentially targets PKCβ" . SPARSER::PROTEIN)
    ("enzastaurin" . SPARSER::DRUG)
    ("nonspecific control (NC) siRNA" . SPARSER::PROTEIN)
    ("Lyn-siRNA" . SPARSER::COLLECTION) ("EGFR or c-Met" . SPARSER::COLLECTION)
    ("the secondary antibody" . SPARSER::PROTEIN)
    ("anti-EGFR and pSrc" . SPARSER::COLLECTION)
    ("Lyn and pSrc" . SPARSER::COLLECTION)
    ("anti-p-c-met" . SPARSER::COLLECTION) ("pSrc" . SPARSER::PROTEIN)
    ("anti-ErbB3 and anti-ErbB2" . SPARSER::COLLECTION)
    ("erlotinib and AG1478" . SPARSER::COLLECTION)
    ("Lyn, Src and an isoform" . SPARSER::COLLECTION)
    ("Lyn and Src" . SPARSER::COLLECTION) ("EGFR or Akt" . SPARSER::COLLECTION)
    ("kinases (SFK)" . SPARSER::PROTEIN)
    ("upstream intracellular kinases" . SPARSER::KINASE)
    ("intracellular kinases" . SPARSER::KINASE)
    ("TACE/ADAM17" . SPARSER::COLLECTION) ("TACE" . SPARSER::PROTEIN)
    ("AR, TGFα, EPR, HB-EGF and HRG/NRG" . SPARSER::COLLECTION)
    ("HRG" . SPARSER::PROTEIN) ("EPR" . SPARSER::PROTEIN)
    ("heparin binding-EGF (HB-EGF) and TNFα" . SPARSER::COLLECTION)
    ("Ligands" . SPARSER::LIGAND) ("HER2/Neu" . SPARSER::COLLECTION)
    (", amplified," . SPARSER::PROTEIN) ("EGFR and Src" . SPARSER::COLLECTION)
    ("RACK1 and Cbp/PAG" . SPARSER::COLLECTION)
    ("kinases and PKCßII" . SPARSER::COLLECTION)
    ("Lyn and PKC" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("IGFR-1" . SPARSER::PROTEIN)
    ("\\or" . SPARSER::PROTEIN) ("PI3Kinase" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN) ("cdc2" . SPARSER::PROTEIN)
    ("PKCα" . SPARSER::PROTEIN) ("c-met" . SPARSER::PROTEIN)
    ("erbB1" . SPARSER::PROTEIN) ("MAP 8" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN) ("anti-ErbB2" . SPARSER::DRUG)
    ("GSK-3" . SPARSER::PROTEIN) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("LY317615" . SPARSER::DRUG) ("ADAM17" . SPARSER::PROTEIN)
    ("Diphtheria toxin" . SPARSER::PROTEIN) ("Cbp/PAG" . SPARSER::PROTEIN)
    ("RACK1" . SPARSER::PROTEIN) ("RASSF1A and EGFR" . SPARSER::COLLECTION)
    (", " . SPARSER::PROTEIN)
    ("cell cycle-suppressive actions," . SPARSER::PROTEIN)
    ("Gly12Asp, and GGC-GAC" . SPARSER::COLLECTION)
    ("GGC-GAC" . SPARSER::PROTEIN-PAIR) ("GGT-GAT" . SPARSER::COLLECTION)
    ("RASSF1A and K-ras" . SPARSER::COLLECTION)
    ("RASSF1A and RAS" . SPARSER::COLLECTION)
    ("BRAF [ xref ] and NF1 [ xref ]" . SPARSER::COLLECTION)
    ("RAS-RAF-MEK-ERK" . SPARSER::COLLECTION) ("RASSF1A  " . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN)
    ("the ER and Golgi complex" . SPARSER::COLLECTION)
    ("previously published high-throughput studies ( xref ),"
     . SPARSER::PROTEIN)
    ("Saps" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("the temperature-sensitive sec12-4 mutant," . SPARSER::PROTEIN)
    ("a tail-anchored, cis -Golgi membrane protein" . SPARSER::PROTEIN)
    ("a Golgi-restricted soluble N -ethylmaleimide–sensitive factor attachment protein receptor (SNARE)"
     . SPARSER::RECEPTOR)
    ("receptor (SNARE)" . SPARSER::RECEPTOR) ("BFA" . SPARSER::MOLECULE)
    ("giantin" . SPARSER::PROTEIN)
    ("the mock-treated cells," . SPARSER::PROTEIN)
    ("vesicular stomatitis virus G (VSV-G) protein" . SPARSER::PROTEIN)
    ("a temperature-sensitive form" . SPARSER::FORM)
    ("membrane traffic," . SPARSER::PROTEIN)
    ("mock-treated cells (lanes 1–3)," . SPARSER::PROTEIN)
    ("CK1δ" . SPARSER::PROTEIN) ("myc-CK1δ" . SPARSER::PROTEIN-PAIR)
    ("GST-Hrr25" . SPARSER::COLLECTION) ("TRAPP" . SPARSER::PROTEIN-FAMILY)
    ("Sit4p and Hrr25p" . SPARSER::COLLECTION)
    ("an allele of SSD1 that supports growth and secretion"
     . SPARSER::COLLECTION)
    ("SSD1 and SIT4" . SPARSER::COLLECTION) ("ssd1" . SPARSER::PROTEIN)
    ("the polymorphic gene SSD1" . SPARSER::PROTEIN)
    ("a severe growth defect," . SPARSER::PROTEIN)
    ("Components" . SPARSER::COMPONENT)
    ("Interestingly, sit4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER and Golgi complex" . SPARSER::COLLECTION)
    ("the ER and Golgi complex," . SPARSER::COLLECTION)
    ("Sec23p and Sec24p" . SPARSER::COLLECTION) ("Sec24p" . SPARSER::PROTEIN)
    ("Sec23p" . SPARSER::PROTEIN)
    ("GST-Sec23p and GST-Sec24p" . SPARSER::COLLECTION)
    ("GST-Sec24p" . SPARSER::PROTEIN-PAIR)
    ("GST-Sec23p" . SPARSER::PROTEIN-PAIR) ("-Sit4p" . SPARSER::COLLECTION)
    ("SAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lst1p and Sec31p" . SPARSER::COLLECTION) ("Sit4p" . SPARSER::PROTEIN)
    ("Sit4p-HA" . SPARSER::COLLECTION) ("Lst1p" . SPARSER::PROTEIN)
    ("Sec31p and Lst1p" . SPARSER::COLLECTION)
    ("GST-Lst1p" . SPARSER::COLLECTION) ("Sec31p" . SPARSER::PROTEIN)
    ("GST and GST-Sec31p" . SPARSER::COLLECTION)
    ("GST-Sec31p" . SPARSER::COLLECTION)
    ("intestinal alkaline phosphatase (CIP)" . SPARSER::PROTEIN)
    ("Available antibodies" . SPARSER::ANTIBODY)
    ("subunits, Sec24p and Sec31p" . SPARSER::COLLECTION)
    ("SIT" . SPARSER::PROTEIN)
    ("the 29 nonessential phosphatases" . SPARSER::PHOSPHATASE)
    ("ER-to-Golgi traffic ( xref )," . SPARSER::PROTEIN)
    ("the essential phosphatases," . SPARSER::PROTEIN)
    ("the temperature-sensitive (ts) mutants" . SPARSER::MUTANT)
    ("phosphoserine/phosphothreonine" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("DSP" . SPARSER::PROTEIN) ("COPII" . SPARSER::PROTEIN)
    (", COPII" . SPARSER::PROTEIN)
    ("a multimeric guanine nucleotide exchange factor (GEF),"
     . SPARSER::PROTEIN)
    ("sit" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sit4p/PP6" . SPARSER::COLLECTION)
    ("K-N" . SPARSER::PROTEIN) ("Anti–" . SPARSER::ANTIBODY)
    ("IC261" . SPARSER::DRUG) ("sec12" . SPARSER::PROTEIN)
    ("N -ethylmaleimide–sensitive factor attachment protein"
     . SPARSER::PROTEIN)
    ("GOS-28" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("Sec31A" . SPARSER::PROTEIN) ("mTrs120" . SPARSER::PROTEIN)
    ("ERGIC-53" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("S3B" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("SSD1" . SPARSER::PROTEIN) ("Sap185" . SPARSER::PROTEIN)
    ("intestinal alkaline phosphatase" . SPARSER::PROTEIN)
    ("Pph21" . SPARSER::PROTEIN) ("Ssu72" . SPARSER::PROTEIN)
    ("Cdc14" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("magnesium-dependent" . SPARSER::PROTEIN) ("Ypt1" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("Hrr25" . SPARSER::PROTEIN) ("Sec23" . SPARSER::PROTEIN-FAMILY)
    ("Sar1" . SPARSER::PROTEIN) ("PP6" . SPARSER::PROTEIN)
    ("Sit4" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("chronic elevated cellular ROS and ROS-induced DNA damage response signaling,"
     . SPARSER::COLLECTION)
    ("chronic elevated cellular ROS" . SPARSER::PROTEIN)
    ("disease, Parkinson’s disease, Huntington disease, rheumatoid arthritis,"
     . SPARSER::PROTEIN)
    ("the transformed phenotype xref ," . SPARSER::PROTEIN)
    ("Hace1-Rac1-NADPH oxidase" . SPARSER::COLLECTION)
    (", elevated ROS" . SPARSER::PROTEIN) ("Ros" . SPARSER::PROTEIN)
    ("both Nox1- and Nox2-containing complexes" . SPARSER::COLLECTION)
    ("Nox1-" . SPARSER::PROTEIN) ("somewhat contentious," . SPARSER::PROTEIN)
    ("Nox4, Nox5 and DUOX" . SPARSER::COLLECTION) ("Nox5" . SPARSER::PROTEIN)
    ("DUOX" . SPARSER::PROTEIN)
    ("the NADPH oxidase subunit, Noxa1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pathologic conditions," . SPARSER::PROTEIN)
    ("cellular H 2 O 2" . SPARSER::DRUG)
    ("oxygen and NADPH" . SPARSER::COLLECTION)
    ("Finally, EHT1864" . SPARSER::DRUG)
    ("Rac1 and cyclin D1" . SPARSER::COLLECTION)
    ("ROS, Rac1 and cyclin D1" . SPARSER::COLLECTION)
    ("ATM and γH2AX" . SPARSER::COLLECTION) ("acute ROS" . SPARSER::PROTEIN)
    ("exogenous H 2 O 2" . SPARSER::DRUG)
    ("IR or urethane" . SPARSER::COLLECTION)
    ("wt and Nox4" . SPARSER::COLLECTION)
    ("Nox1 ( Nox1  −/− ) or Nox4 ( Nox4  −/− )," . SPARSER::COLLECTION)
    ("CS" . SPARSER::PROTEIN)
    ("Hace1 preferentially targets NOXA1-associated Rac1" . SPARSER::PROTEIN)
    ("NOXA1 and Hace1" . SPARSER::COLLECTION)
    ("NOXA1 and Rac1" . SPARSER::COLLECTION)
    ("GFP-Hace1" . SPARSER::COLLECTION) ("-TRAP" . SPARSER::COLLECTION)
    ("TRAP" . SPARSER::PROTEIN)
    ("SKOV3 ovarian carcinoma cells," . SPARSER::PROTEIN)
    ("Nox1 or Nox3" . SPARSER::COLLECTION)
    ("either the ML171 NADPH oxidase inhibitor or Hace1 overexpression ( xref )"
     . SPARSER::COLLECTION)
    ("Both wt Rac1 and the Rac1-v12 mutant" . SPARSER::COLLECTION)
    ("Rac1-v12" . SPARSER::PROTEIN-PAIR)
    ("Nox1, Nox2 and Nox3" . SPARSER::COLLECTION)
    ("Nox1, NOXA1, NOXO1 or Rac1" . SPARSER::COLLECTION)
    ("Nox1, NOXO1 or Rac1" . SPARSER::COLLECTION) ("APO" . SPARSER::PROTEIN)
    ("apocynin" . SPARSER::MOLECULE) ("DPI" . SPARSER::PROTEIN)
    ("iodonium" . SPARSER::MOLECULE) ("fluorescein" . SPARSER::MOLECULE)
    ("which displays 74.7% DNA sequence homology" . SPARSER::PROTEIN)
    ("hace1" . SPARSER::PROTEIN)
    ("membrane-associated NADPH oxidase" . SPARSER::PROTEIN)
    ("DCFDA" . SPARSER::DRUG) ("diacetate" . SPARSER::MOLECULE)
    ("IR and urethane" . SPARSER::COLLECTION)
    ("Rac1 and NADPH oxidase" . SPARSER::COLLECTION)
    ("p47phox, p67phox, NOXA1 and NOXO1" . SPARSER::COLLECTION)
    ("E3 ligases, X-linked and cellular inhibitors" . SPARSER::COLLECTION)
    ("urethane" . SPARSER::MOLECULE) ("Hace1" . SPARSER::PROTEIN)
    ("l −1" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("NoxA1" . SPARSER::PROTEIN) ("Rac1-3" . SPARSER::PROTEIN)
    ("Rac1-1" . SPARSER::PROTEIN) ("1-C" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("anti-oxidants" . SPARSER::DRUG) ("EHT1864" . SPARSER::DRUG)
    ("Nox3" . SPARSER::PROTEIN) ("NOXO1" . SPARSER::PROTEIN)
    ("NOXA1" . SPARSER::PROTEIN) ("p47phox" . SPARSER::PROTEIN)
    ("p22phox" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("Ankyrin repeat" . SPARSER::PROTEIN) ("HACE1" . SPARSER::PROTEIN)
    ("cellular cofactors" . SPARSER::PROTEIN)
    (", viral proteins" . SPARSER::PROTEIN)
    ("ubiquitin and E3" . SPARSER::COLLECTION)
    ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("mutant S57A," . SPARSER::PROTEIN) ("phosphoryl" . SPARSER::MOLECULE)
    ("the Ser/Thr-specific kinases and the Tyr-specific kinases"
     . SPARSER::COLLECTION)
    ("Phosphorylation predominantly targets protein" . SPARSER::PROTEIN)
    ("Ser, Thr or Tyr" . SPARSER::COLLECTION)
    ("substrates and phosphatases" . SPARSER::COLLECTION)
    ("Krüppel-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KAP1 or TRIM28" . SPARSER::COLLECTION)
    ("the C-terminal last 24–44 aa" . SPARSER::MOLECULE)
    ("p300 and aa" . SPARSER::COLLECTION)
    ("Structurally, both p300/CBP" . SPARSER::COLLECTION)
    ("HATs, p300 and GCN5" . SPARSER::COLLECTION)
    ("proteins and nonhistone" . SPARSER::COLLECTION)
    ("I-V" . SPARSER::PROTEIN) ("RanGAP1/SUMO1" . SPARSER::COLLECTION)
    (", conjugated SUMO proteins" . SPARSER::PROTEIN)
    ("SUMO1-3" . SPARSER::COLLECTION) ("SUMOs" . SPARSER::PROTEIN)
    ("SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("a globular ubiquitin-like shape," . SPARSER::PROTEIN)
    ("isopeptidases" . SPARSER::PROTEIN) ("Aos1" . SPARSER::PROTEIN)
    ("PIAS" . SPARSER::PROTEIN-FAMILY)
    ("Ku70 and hRad18" . SPARSER::COLLECTION)
    ("the cellular proteins VBP1 and Cul2/VHL Ub ligase complex"
     . SPARSER::COLLECTION)
    ("viral infection, HIV PIC" . SPARSER::BIO-COMPLEX)
    ("hRad18 and Ku70" . SPARSER::COLLECTION)
    ("proteins, hRad18 and Ku70" . SPARSER::COLLECTION)
    ("Cul2/VHL" . SPARSER::COLLECTION) ("Huwe1" . SPARSER::PROTEIN)
    ("both the prefoldin chaperone subunit von Hippel-Lindau binding protein 1 (VBP1) and the Cul2/von Hippel–Lindau protein (VHL) ligase"
     . SPARSER::COLLECTION)
    ("Cul2/von Hippel–Lindau protein" . SPARSER::COLLECTION)
    ("prefoldin" . SPARSER::PROTEIN-FAMILY) ("Ub-Ub" . SPARSER::COLLECTION)
    ("K63R" . SPARSER::PROTEIN) ("Ub mutant K48R," . SPARSER::PROTEIN)
    ("nonproteolytic functions," . SPARSER::PROTEIN)
    ("Nonconventional chains," . SPARSER::PROTEIN)
    ("the C-terminal Gly of the preceding Ub, forming different Lys-Gly"
     . SPARSER::PROTEIN)
    ("Lys-Gly" . SPARSER::COLLECTION)
    ("other viral proteins," . SPARSER::PROTEIN)
    ("Polyubiquitinated" . SPARSER::PROTEIN)
    ("Ub-activating enzyme (E1), Ub-conjugating enzyme (E2) and Ub-ligase (E3)"
     . SPARSER::COLLECTION)
    ("the C-terminal Gly of Ub" . SPARSER::PROTEIN)
    ("viral replication," . SPARSER::PROTEIN)
    ("For instance, p300" . SPARSER::PROTEIN)
    ("multifunctional properties," . SPARSER::PROTEIN)
    ("numerous cellular cofactors" . SPARSER::PROTEIN)
    ("viral protein expression, transcription," . SPARSER::PROTEIN)
    ("a pleiotropic protein" . SPARSER::PROTEIN)
    ("a 288-aa, 32-kD viral protein" . SPARSER::PROTEIN)
    ("zinc-binding" . SPARSER::PROTEIN)
    ("three viral enzymes, reverse transcriptase, protease"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIV-1 infection, several viral proteins," . SPARSER::PROTEIN)
    ("proteins, both pathogen proteins as well as the proteins"
     . SPARSER::COLLECTION)
    ("p300 and Ku70" . SPARSER::COLLECTION) ("viral DNA" . SPARSER::DNA)
    ("a key viral enzyme" . SPARSER::ENZYME)
    ("trans isomerase" . SPARSER::PROTEIN)
    ("Interferon-induced" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN)
    ("chromatin remodeling factor" . SPARSER::PROTEIN)
    ("GCN5" . SPARSER::PROTEIN) ("SIM2" . SPARSER::PROTEIN)
    ("SIM1" . SPARSER::PROTEIN) ("RanGAP1" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM5α" . SPARSER::PROTEIN) ("SUMO1" . SPARSER::PROTEIN)
    ("SUMO3" . SPARSER::PROTEIN) ("SUMO2" . SPARSER::PROTEIN)
    ("SUMO4" . SPARSER::PROTEIN) ("SUMO 1" . SPARSER::PROTEIN)
    ("RAN binding protein 2" . SPARSER::PROTEIN)
    ("capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lens epithelium-derived growth factor" . SPARSER::PROTEIN)
    ("hRad18" . SPARSER::PROTEIN)
    ("UBA and WWE domain containing 1" . SPARSER::PROTEIN)
    ("VBP1" . SPARSER::PROTEIN)
    ("von Hippel-Lindau binding protein 1" . SPARSER::PROTEIN)
    ("UBR4" . SPARSER::PROTEIN) ("UBR2" . SPARSER::PROTEIN)
    ("UBR1" . SPARSER::PROTEIN) ("E6-AP" . SPARSER::PROTEIN)
    ("K63" . SPARSER::PROTEIN) ("K33" . SPARSER::PROTEIN)
    ("Gag-pol" . SPARSER::PROTEIN) ("Gag-Pol polyprotein" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("derived Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IBS" . SPARSER::DRUG) ("both DNA-contact" . SPARSER::DNA)
    ("both p53 and its DNA target" . SPARSER::COLLECTION)
    ("the tetrameric complex" . SPARSER::BIO-COMPLEX)
    ("the suppressor mutations, T284R and S240R," . SPARSER::COLLECTION)
    ("CATG" . SPARSER::PROTEIN)
    ("the wt and the rescued complexes" . SPARSER::COLLECTION)
    ("conformation and protein–DNA" . SPARSER::COLLECTION)
    ("both type I and type II tetrameric complexes" . SPARSER::BIO-COMPLEX)
    ("the second suppressor mutation, S240R," . SPARSER::PROTEIN)
    ("the primary mutations, R273H or R273C," . SPARSER::COLLECTION)
    ("His or Cys" . SPARSER::COLLECTION)
    ("amino acids, histidine and cysteine" . SPARSER::COLLECTION)
    ("the two DNA-contact mutations, R273H or R273C," . SPARSER::COLLECTION)
    ("The unique conformation" . SPARSER::BIO-CONFORMATION)
    ("the tetrameric p53-DNA complex" . SPARSER::BIO-COMPLEX)
    ("tetrameric complexes" . SPARSER::BIO-COMPLEX)
    ("R249S/H168R" . SPARSER::PROTEIN)
    ("type I and type II" . SPARSER::COLLECTION)
    ("the conformational variant" . SPARSER::VARIANT)
    ("the symmetry-related molecule and the thiol" . SPARSER::COLLECTION)
    ("dithiothreitol" . SPARSER::PROTEIN)
    ("A new conformational variant" . SPARSER::VARIANT)
    ("the thermostable core domain," . SPARSER::PROTEIN)
    ("the second-site mutations, T284R or S240R," . SPARSER::COLLECTION)
    ("p53 and the DNA target" . SPARSER::COLLECTION)
    ("a second-site suppressor mutation, T284R or S240R, and their sequence-specific complexes"
     . SPARSER::COLLECTION)
    ("S240R, and their sequence-specific complexes" . SPARSER::COLLECTION)
    ("their sequence-specific complexes" . SPARSER::BIO-COMPLEX)
    ("guanidinium" . SPARSER::MOLECULE) ("DNA-contact" . SPARSER::DNA)
    ("mutational ‘hotspots’," . SPARSER::PROTEIN)
    ("tetramer" . SPARSER::TETRAMER)
    ("a DNA sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("the DNA target and its sequence-specific complex" . SPARSER::COLLECTION)
    ("its sequence-specific complex" . SPARSER::BIO-COMPLEX)
    ("wt" . SPARSER::PROTEIN)
    ("the rescued proteins and their complexes" . SPARSER::COLLECTION)
    ("proteins, the rescued proteins and their complexes"
     . SPARSER::COLLECTION)
    ("histidine or cysteine" . SPARSER::COLLECTION) ("A–F" . SPARSER::PROTEIN)
    ("group C" . SPARSER::PROTEIN) ("C-G" . SPARSER::PROTEIN)
    ("Zn2" . SPARSER::MOLECULE) ("ID 2" . SPARSER::PROTEIN)
    ("g-3" . SPARSER::PROTEIN) ("SFB-Akt1" . SPARSER::COLLECTION)
    ("SFB" . SPARSER::PROTEIN) ("TPP1-Flag" . SPARSER::COLLECTION)
    ("TPP1 and TPP1" . SPARSER::COLLECTION)
    ("TPP1 and TIN2" . SPARSER::COLLECTION)
    ("TPP1 or TIN2" . SPARSER::COLLECTION)
    ("proteins and protein" . SPARSER::COLLECTION)
    ("PI 3-kinase/Akt" . SPARSER::COLLECTION) ("TIFs" . SPARSER::PROTEIN)
    ("full-length and OB-fold" . SPARSER::COLLECTION)
    ("GST-TPP1" . SPARSER::COLLECTION)
    ("GST or MBP-tagged TPP1 OB fold proteins" . SPARSER::COLLECTION)
    ("TPP1-" . SPARSER::PROTEIN) ("Myc-TPP1" . SPARSER::COLLECTION)
    ("Flag-TPP1" . SPARSER::COLLECTION)
    ("Myc- and Flag-tagged TPP1" . SPARSER::COLLECTION)
    ("Myc-" . SPARSER::PROTEIN) ("TPP1-TPP1" . SPARSER::COLLECTION)
    ("TPP1-TIN2" . SPARSER::COLLECTION) ("TIN2-TPP1" . SPARSER::COLLECTION)
    ("RNAi-resistant wild-type Akt1 as well as the kinase-dead Akt1 mutant (Akt1 K179M)"
     . SPARSER::COLLECTION)
    ("Akt2 and Akt3" . SPARSER::COLLECTION) ("Akt1-3" . SPARSER::COLLECTION)
    ("proteins, TPP1 and POT1" . SPARSER::COLLECTION)
    ("triciribine-treated cells ( xref )," . SPARSER::PROTEIN)
    ("TIF" . SPARSER::PROTEIN) ("triciribine" . SPARSER::MOLECULE)
    ("TPP1 and TPP1-POT1 heterodimer" . SPARSER::COLLECTION)
    ("TPP1-POT1" . SPARSER::COLLECTION)
    ("hTERT and TRF1" . SPARSER::COLLECTION) ("hTERT" . SPARSER::PROTEIN)
    ("Akt and telomere regulators" . SPARSER::COLLECTION)
    ("dyskerin" . SPARSER::PROTEIN) ("telosome" . SPARSER::BIO-COMPLEX)
    ("TPP1 and POT1" . SPARSER::COLLECTION) ("OB" . SPARSER::PROTEIN)
    ("PI3-K/Akt" . SPARSER::COLLECTION) ("/Akt" . SPARSER::COLLECTION)
    ("N-term" . SPARSER::PROTEIN)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-binding" . SPARSER::PROTEIN) ("Akt3" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("TIN2" . SPARSER::PROTEIN)
    ("just one IκB" . SPARSER::PROTEIN) ("SARM" . SPARSER::PROTEIN)
    ("A20 and Cezanne" . SPARSER::COLLECTION) ("Cezanne" . SPARSER::PROTEIN)
    ("thymidine kinase or some other protein" . SPARSER::COLLECTION)
    ("reversed fashion," . SPARSER::PROTEIN)
    ("the approximately 1,391 human sequence specific DNA binding transcription factors,"
     . SPARSER::PROTEIN)
    ("regulators -specifically, inhibitors-of NF-κB," . SPARSER::PROTEIN)
    ("IκBα and p100" . SPARSER::COLLECTION)
    ("LRRC8s and NF-κB" . SPARSER::COLLECTION)
    ("LRRC8A and LRRC8C" . SPARSER::COLLECTION)
    ("LRRC8A and LRRC8D" . SPARSER::COLLECTION)
    ("deubiquitylase (DUB)" . SPARSER::DEUBIQUITYLASE)
    ("DUB" . SPARSER::PROTEIN) ("deubiquitylase" . SPARSER::DEUBIQUITYLASE)
    ("a retroviral gene-trap vector," . SPARSER::PROTEIN)
    ("gene-trap" . SPARSER::PROTEIN) ("trap" . SPARSER::PROTEIN)
    ("gene ( BSR )" . SPARSER::GENE)
    ("response element (TRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("blasticidin" . SPARSER::MOLECULE)
    ("toxins or protein surface expression," . SPARSER::COLLECTION)
    ("receptors and cytokine" . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("HAP1" . SPARSER::PROTEIN)
    ("the only currently known negative regulator"
     . SPARSER::NEGATIVE-REGULATOR)
    ("haploid" . SPARSER::PROTEIN) ("CYP4B1" . SPARSER::PROTEIN)
    ("IκBs" . SPARSER::PROTEIN) ("IRAK-M" . SPARSER::PROTEIN)
    ("MyD88" . SPARSER::PROTEIN) ("LRRC8s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LRRC8C" . SPARSER::PROTEIN) ("LRRC8" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("OR1" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN) ("LRRC8D" . SPARSER::PROTEIN)
    ("LRRC8A" . SPARSER::PROTEIN) ("HEATR7A" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) ("wildtype" . SPARSER::PROTEIN)
    ("benign and malignant parts," . SPARSER::PROTEIN)
    ("VE1-antibody" . SPARSER::PROTEIN-PAIR)
    ("-genotype" . SPARSER::COLLECTION) ("BRAF and NRAF" . SPARSER::COLLECTION)
    ("genotype" . SPARSER::PROTEIN) ("BRAF-genotype" . SPARSER::PROTEIN-PAIR)
    ("diagnostic reasons," . SPARSER::PROTEIN)
    ("no junctional component" . SPARSER::COMPONENT)
    ("a junctional component" . SPARSER::COMPONENT)
    ("an associated nevus," . SPARSER::PROTEIN)
    ("BRAF-wildtype" . SPARSER::PROTEIN-PAIR)
    ("signed-rank" . SPARSER::PROTEIN)
    ("S602F (melanoma), S607F (associated nevus), R603Q (control nevus) and one single nucleotide variant"
     . SPARSER::COLLECTION)
    ("S602F (melanoma), S607F (associated nevus), R603Q" . SPARSER::PROTEIN)
    ("Intron" . SPARSER::PROTEIN) ("Glutamine" . SPARSER::AMINO-ACID)
    ("Valine" . SPARSER::AMINO-ACID) ("BRAF/NRAS" . SPARSER::COLLECTION)
    ("dysplastic nevi," . SPARSER::PROTEIN)
    ("BRAF-MEK-ERK" . SPARSER::COLLECTION) ("ERK–MAPK" . SPARSER::COLLECTION)
    ("NRAS or BRAF" . SPARSER::COLLECTION)
    ("BRAF- or NRAS" . SPARSER::COLLECTION) ("IGFBP7" . SPARSER::PROTEIN)
    ("E -protein" . SPARSER::PROTEIN)
    ("replicative cells, typically cancer cells," . SPARSER::PROTEIN)
    ("UV irradiation," . SPARSER::PROTEIN)
    ("available nuclear XPA," . SPARSER::PROTEIN)
    ("Formaldehyde" . SPARSER::MOLECULE)
    ("the same monoclonal anti-XPA antibody" . SPARSER::ANTIBODY)
    ("XPA-importin-α4" . SPARSER::COLLECTION)
    ("UV damage xref ," . SPARSER::PROTEIN)
    ("both importin-α4 and/or importin-α7" . SPARSER::COLLECTION)
    ("importin-α7" . SPARSER::PROTEIN)
    ("XPA-importin-α7" . SPARSER::PROTEIN-PAIR)
    ("different adaptors, importin-α4 and/or importin-α7,"
     . SPARSER::COLLECTION)
    ("importin-α4 and importin-α7" . SPARSER::COLLECTION)
    ("a yeast two-hybrid system XAB1" . SPARSER::PROTEIN)
    ("importin-α4- or importin-α7-beads" . SPARSER::COLLECTION)
    ("importin-α4-" . SPARSER::PROTEIN) ("importin-α4" . SPARSER::PROTEIN)
    ("XPA and importin-α4" . SPARSER::COLLECTION)
    ("importin-α4-XPA" . SPARSER::PROTEIN-PAIR)
    ("associated cellular XPA" . SPARSER::PROTEIN)
    ("the previous observations," . SPARSER::PROTEIN)
    ("a UV-dependent manner," . SPARSER::PROTEIN) ("–c" . SPARSER::COLLECTION)
    ("importin-α5" . SPARSER::PROTEIN-PAIR)
    ("UV treatment, XPA" . SPARSER::PROTEIN)
    ("importins-α4 or -α7" . SPARSER::COLLECTION)
    ("importins-α4" . SPARSER::PROTEIN-PAIR)
    ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the DNA damage-induced XPA" . SPARSER::PROTEIN)
    ("1A–" . SPARSER::PROTEIN) ("TFIIH" . SPARSER::PROTEIN)
    ("the UV-induced XPA" . SPARSER::PROTEIN)
    ("XPA, importin-α4 and importin-α7" . SPARSER::COLLECTION)
    ("complex (NPC)" . SPARSER::BIO-COMPLEX)
    ("Both ATR and free p53" . SPARSER::COLLECTION)
    ("protein and p53" . SPARSER::COLLECTION)
    ("xeroderma pigmentosum (XP)" . SPARSER::PROTEIN)
    ("UV-induced XPA" . SPARSER::PROTEIN) ("Group A (XPA)" . SPARSER::PROTEIN)
    ("DDB2" . SPARSER::PROTEIN)
    ("DNA damage-binding protein 2" . SPARSER::PROTEIN)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN) ("XAB1" . SPARSER::PROTEIN)
    ("ataxia telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("Group A" . SPARSER::PROTEIN)
    ("PAX-8, IL-8, BMPR2, IGF1, Inhibin-A, CyclinD1 and WNT1"
     . SPARSER::COLLECTION)
    ("Decorin and CyclinD1" . SPARSER::COLLECTION)
    ("Decorin" . SPARSER::PROTEIN)
    ("IL-6, IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("Activin/Inhibin" . SPARSER::COLLECTION) ("Inhibin" . SPARSER::PROTEIN)
    ("Activin" . SPARSER::PROTEIN)
    ("several markers typical ARPCs," . SPARSER::PROTEIN)
    ("IL-8 and MCP-1" . SPARSER::COLLECTION) ("inhibin" . SPARSER::PROTEIN)
    ("Specifically, Fzd5" . SPARSER::PROTEIN)
    ("Frizzled family receptors and LRP5/LRP6 coreceptor"
     . SPARSER::COLLECTION)
    ("Canonical WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LRP5/LRP6" . SPARSER::COLLECTION) ("whose target genes" . SPARSER::GENE)
    ("ZO-1 and CK-19" . SPARSER::COLLECTION)
    ("miRNAs and genes" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("MSCs and genes" . SPARSER::COLLECTION)
    ("our previous work xref (GEO Series Accession Number GSE8611),"
     . SPARSER::PROTEIN)
    ("whose putative target genes" . SPARSER::GENE)
    ("the toll-like receptor 2 (TLR2), IL-8, HOXA1, some WNT genes and other chemokines and growth factors ( xref , xref )"
     . SPARSER::COLLECTION)
    ("CD133 and renal embryonic transcription factors PAX2 and PAX8,"
     . SPARSER::COLLECTION)
    ("PAX2 and PAX8" . SPARSER::COLLECTION)
    ("MSCs and 30 miRNAs" . SPARSER::COLLECTION)
    ("MSCs, RPTECs and ARPCs" . SPARSER::COLLECTION)
    ("CD133, CD24, PAX2, BMI-1, Oct-4 and CD44" . SPARSER::COLLECTION)
    ("glomerular and tubular fractions" . SPARSER::COMPONENT)
    ("magnetic sorting," . SPARSER::PROTEIN)
    ("both stem cell differentiation-related miRNAs and their potential target mRNA genes"
     . SPARSER::COLLECTION)
    ("PAX2, CD133 and CD24" . SPARSER::COLLECTION)
    ("glycerol-induced acute renal injury," . SPARSER::PROTEIN)
    ("the last years regenerative medicine" . SPARSER::DRUG)
    ("CD133 and PAX2" . SPARSER::COLLECTION) ("TLR2" . SPARSER::PROTEIN)
    ("miR-1" . SPARSER::PROTEIN) ("small nucleolar RNA" . SPARSER::RNA)
    ("gamma-glutamyl" . SPARSER::MOLECULE) ("Bmi1" . SPARSER::PROTEIN)
    ("WNT1" . SPARSER::PROTEIN) ("BMPR2" . SPARSER::PROTEIN)
    ("Inhibin-A" . SPARSER::PROTEIN) ("PAX-8" . SPARSER::PROTEIN)
    ("Fzd5" . SPARSER::PROTEIN) ("LRP6" . SPARSER::PROTEIN)
    ("LRP5" . SPARSER::PROTEIN) ("SLC6A6" . SPARSER::PROTEIN)
    ("aquaporin 1" . SPARSER::PROTEIN) ("CK-19" . SPARSER::PROTEIN)
    ("cytokeratin-19" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("ERK5" . SPARSER::PROTEIN) ("toll-like receptor 2" . SPARSER::PROTEIN)
    ("hyaluronic acid" . SPARSER::MOLECULE) ("PAX8" . SPARSER::PROTEIN)
    ("Cell Adhesion Molecule 1" . SPARSER::PROTEIN)
    ("CD106" . SPARSER::PROTEIN) ("Oct-4" . SPARSER::PROTEIN)
    ("BMI-1" . SPARSER::PROTEIN) ("-thymidine" . SPARSER::COLLECTION)
    ("pLEX-STAT3α" . SPARSER::COLLECTION) ("pLEX" . SPARSER::PROTEIN)
    ("STAT3 and IL-10" . SPARSER::COLLECTION) ("STAT3α" . SPARSER::PROTEIN)
    ("pLEX-STAT3β" . SPARSER::PROTEIN-PAIR) ("STAT3β" . SPARSER::PROTEIN)
    ("Morin" . SPARSER::DRUG)
    ("Phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("SAR302503" . SPARSER::DRUG) ("Beta-Actin" . SPARSER::PROTEIN)
    ("interleukin 10" . SPARSER::PROTEIN)
    ("IL1RL1-IL18R1" . SPARSER::COLLECTION) ("HLA-DP" . SPARSER::COLLECTION)
    ("ORMDL3-GSDMB" . SPARSER::COLLECTION) ("sib" . SPARSER::DRUG)
    ("Gao" . SPARSER::PROTEIN)
    ("the S allele and the susceptibility" . SPARSER::COLLECTION)
    ("the S allele (≤14 repeats) and the L allele (≥15 repeats)"
     . SPARSER::COLLECTION)
    ("AA and AG" . SPARSER::COLLECTION) ("the exact allele" . SPARSER::ALLELE)
    ("S allele and L allele" . SPARSER::COLLECTION)
    ("short allele ( S ≤14) and long allele ( L ≥15)" . SPARSER::COLLECTION)
    ("Caucasian cohorts," . SPARSER::PROTEIN)
    ("AG and GG" . SPARSER::COLLECTION)
    ("STAT6 and G2964A polymorphism" . SPARSER::COLLECTION)
    ("NOTCH4" . SPARSER::PROTEIN) ("SLC30A8" . SPARSER::PROTEIN)
    ("interleukin-4" . SPARSER::PROTEIN) ("wild control," . SPARSER::PROTEIN)
    ("Similarly, Sufu" . SPARSER::PROTEIN)
    ("cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("p21WAF1/CIP1" . SPARSER::COLLECTION)
    ("ptch and LKB1" . SPARSER::COLLECTION) ("ptch" . SPARSER::PROTEIN)
    ("Sufu and LKB1" . SPARSER::COLLECTION)
    ("Shh, GLI1, Smo, Ptch, Sufu and LKB1" . SPARSER::COLLECTION)
    ("LKB1 and Hh signaling molecules" . SPARSER::COLLECTION)
    ("Cyclopamine" . SPARSER::DRUG) ("Fat" . SPARSER::PROTEIN)
    ("Gli" . SPARSER::PROTEIN) ("Ptch" . SPARSER::PROTEIN)
    ("Shh" . SPARSER::PROTEIN) ("Molecules" . SPARSER::MOLECULE)
    ("GLI1 and PTCH" . SPARSER::COLLECTION)
    ("Patched (PTCH)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("developmental processes," . SPARSER::PROTEIN)
    ("gastrointestinal polyposis," . SPARSER::PROTEIN)
    ("autosomal-dominant inherited Peutz-Jeghers syndrome (PJS),"
     . SPARSER::PROTEIN)
    ("Meanwhile, LKB1 siRNA" . SPARSER::PROTEIN)
    ("cyclopamine" . SPARSER::DRUG)
    ("LKB1 and glioma-associated oncogene" . SPARSER::COLLECTION)
    ("Sufu" . SPARSER::PROTEIN) ("SMO, SHH and GLI1" . SPARSER::COLLECTION)
    (", Sonic hedgehog (SHH) and glioma-associated oncogene homologue 1 (GLI1),"
     . SPARSER::COLLECTION)
    ("Sonic hedgehog (SHH)" . SPARSER::PROTEIN) ("SHH" . SPARSER::PROTEIN)
    ("SMO" . SPARSER::PROTEIN) ("PTCH" . SPARSER::PROTEIN)
    ("Patched" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("/2" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN) ("g 10" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("glioma-associated oncogene" . SPARSER::PROTEIN)
    ("EGFR/FGFR1" . SPARSER::COLLECTION) ("Further, MET" . SPARSER::PROTEIN)
    ("Abl" . SPARSER::PROTEIN) ("PDGFRb" . SPARSER::PROTEIN)
    ("Akt and GSK3" . SPARSER::COLLECTION) ("FGFR1/FGF2" . SPARSER::COLLECTION)
    ("EGFR and FGFR1" . SPARSER::COLLECTION)
    ("FGFR1 and EGFR" . SPARSER::COLLECTION)
    ("conversely, EGFR" . SPARSER::PROTEIN)
    ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("EGF family ligands and FGF family ligands rescue c-Met–dependent cell lines"
     . SPARSER::COLLECTION)
    ("EGF family ligands and HGF rescue FGFR2- and FGFR3-amplified cell lines"
     . SPARSER::COLLECTION)
    ("FGFR1 and c-Met" . SPARSER::COLLECTION)
    ("RTKs or ligands" . SPARSER::COLLECTION)
    ("EGFR and AEW541-" . SPARSER::COLLECTION) ("erlotinib-" . SPARSER::DRUG)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("NTRK2 and PDGFRB" . SPARSER::COLLECTION)
    ("EGFR and IGF1R" . SPARSER::COLLECTION)
    ("EGFR and IGF-1R" . SPARSER::COLLECTION)
    ("receptors and their ligands" . SPARSER::COLLECTION)
    ("FGFR1 or c-Met" . SPARSER::COLLECTION)
    ("RTKs or their ligands" . SPARSER::COLLECTION)
    ("compensatory RTKs" . SPARSER::PROTEIN)
    ("PC1 and PC2" . SPARSER::COLLECTION) ("PC1" . SPARSER::PROTEIN)
    ("Some receptor- and ligand-encoding genes" . SPARSER::COLLECTION)
    ("gene and ligand" . SPARSER::COLLECTION) ("receptor-" . SPARSER::RECEPTOR)
    ("some receptors and the ligands" . SPARSER::COLLECTION)
    ("receptor and ligand" . SPARSER::COLLECTION)
    ("RTK- and ligand-encoding gene" . SPARSER::COLLECTION)
    ("RTK-" . SPARSER::PROTEIN) ("PDGFRB and NTRK2" . SPARSER::COLLECTION)
    ("PDGFRB" . SPARSER::PROTEIN) ("RTKs and ligands" . SPARSER::COLLECTION)
    ("c-Cbl–CaM" . SPARSER::COLLECTION) ("CaM" . SPARSER::PROTEIN)
    ("different biological functions," . SPARSER::PROTEIN)
    ("RTKs and time scales, adjacency matrices" . SPARSER::COLLECTION)
    ("the six RTKs and four time scales," . SPARSER::COLLECTION)
    ("bin" . SPARSER::PROTEIN)
    ("these perturbation-induced effects," . SPARSER::PROTEIN)
    ("indirect effects," . SPARSER::PROTEIN)
    ("scaffold or protein" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION) ("mitogen-" . SPARSER::MITOGEN)
    ("MARCKS" . SPARSER::PROTEIN)
    ("previously validated antibodies" . SPARSER::ANTIBODY)
    ("TrkB" . SPARSER::PROTEIN)
    ("multiple computational network inference approaches," . SPARSER::PROTEIN)
    ("RTK or ligand" . SPARSER::COLLECTION)
    ("an RTK or its cognate ligand" . SPARSER::COLLECTION)
    ("IGF-1R/NTRK2" . SPARSER::COLLECTION)
    ("EGFR/FGFR1/c-Met" . SPARSER::COLLECTION)
    ("six isogenic cell lines," . SPARSER::PROTEIN)
    ("and cytoplasmic domain" . SPARSER::PROTEIN) ("p-S6" . SPARSER::PROTEIN)
    ("A-Raf" . SPARSER::PROTEIN) ("i–1" . SPARSER::PROTEIN)
    ("anti–β" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("PDGF-AB" . SPARSER::PROTEIN) ("neuregulin 1" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("S14" . SPARSER::PROTEIN)
    ("interleukin-1 receptor–associated kinase 1" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase kinase 4"
     . SPARSER::PROTEIN)
    ("MAP4K4" . SPARSER::PROTEIN) ("TANK binding kinase 1" . SPARSER::PROTEIN)
    ("PC2" . SPARSER::PROTEIN) ("NTF4" . SPARSER::PROTEIN)
    ("8B" . SPARSER::PROTEIN) ("son of sevenless" . SPARSER::PROTEIN)
    ("RSK3" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("CAMKK2" . SPARSER::PROTEIN) ("PKCβ" . SPARSER::PROTEIN)
    ("3-phosphoinositide–dependent protein kinase-1" . SPARSER::PROTEIN)
    ("PDPK1" . SPARSER::PROTEIN) ("IGF-1–" . SPARSER::PROTEIN)
    ("ROCK2" . SPARSER::PROTEIN) ("PLC-γ" . SPARSER::PROTEIN-FAMILY)
    ("ErbB1" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor kinase 2" . SPARSER::PROTEIN) ("NTRK2" . SPARSER::PROTEIN)
    ("paranasal sinuses," . SPARSER::PROTEIN)
    ("cutaneous melanoma," . SPARSER::PROTEIN)
    ("mucosal melanoma," . SPARSER::PROTEIN)
    ("cutaneous melanomas," . SPARSER::PROTEIN)
    ("mucosal melanomas," . SPARSER::PROTEIN)
    ("arginine or lysine" . SPARSER::COLLECTION)
    ("the paranasal sinuses," . SPARSER::PROTEIN)
    ("vulvar melanomas," . SPARSER::PROTEIN)
    ("our previous study," . SPARSER::PROTEIN) ("orbit" . SPARSER::DRUG)
    ("imatinib and dasatinib" . SPARSER::COLLECTION)
    ("BRAF, NRAS and KIT" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase and phosphatidylinositol-3"
     . SPARSER::COLLECTION)
    ("kinase-Akt" . SPARSER::COLLECTION)
    ("Approximately 1–2" . SPARSER::PROTEIN)
    ("KIT and BRAF" . SPARSER::COLLECTION)
    ("KIT , NRAS or BRAF" . SPARSER::COLLECTION)
    ("KIT , NRAS and BRAF" . SPARSER::COLLECTION)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("STMN1 and BDNF" . SPARSER::COLLECTION)
    ("both manual and automated amygdala parcellation methods,"
     . SPARSER::PROTEIN)
    ("the manual parcellation," . SPARSER::PROTEIN)
    ("manual tracing," . SPARSER::PROTEIN)
    ("were run" . SPARSER::PROTEIN-FAMILY) ("ENIGMA" . SPARSER::PROTEIN)
    ("MRIs" . SPARSER::PROTEIN) ("Stathmin" . SPARSER::PROTEIN)
    ("gene and amygdala" . SPARSER::COLLECTION) ("oxytocin" . SPARSER::PROTEIN)
    ("the oxytocin receptor ( OXTR ) and stathmin 1 ( STMN1 ) genes,"
     . SPARSER::COLLECTION)
    ("oxytocin receptor ( OXTR )" . SPARSER::PROTEIN)
    ("OXTR" . SPARSER::PROTEIN)
    ("neurologically healthy adults," . SPARSER::PROTEIN)
    ("transporter, oxytocin receptor and stathmin" . SPARSER::COLLECTION)
    ("stathmin and serotonin" . SPARSER::COLLECTION)
    ("manual tracing showed stronger effects," . SPARSER::PROTEIN)
    ("the stathmin (STMN1) and serotonin transporter ( SLC6A4 ) genes,"
     . SPARSER::COLLECTION)
    ("serotonin" . SPARSER::MOLECULE) ("stathmin" . SPARSER::PROTEIN)
    ("stathmin 1" . SPARSER::PROTEIN) ("oxytocin receptor" . SPARSER::PROTEIN)
    ("SLC6A4" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("hematological malignancies," . SPARSER::PROTEIN)
    ("some standard diagnostic methods," . SPARSER::PROTEIN)
    ("bona fide MPNs" . SPARSER::PROTEIN)
    ("highly variable," . SPARSER::PROTEIN)
    ("underwent allogeneic stem cell transplantation," . SPARSER::PROTEIN)
    ("the former generally afforded poorer specificity," . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("a further QC round, Cyclophilin" . SPARSER::PROTEIN)
    ("Cyclophilin" . SPARSER::PROTEIN)
    ("the diagnostic range," . SPARSER::PROTEIN)
    ("-V617F," . SPARSER::COLLECTION) ("ALB" . SPARSER::PROTEIN)
    ("," . SPARSER::PROTEIN) ("allele percentage," . SPARSER::PROTEIN)
    ("QC" . SPARSER::PROTEIN)
    ("the ELN and MPN&MPNr-EuroNet" . SPARSER::COLLECTION)
    ("ELN" . SPARSER::PROTEIN) ("imetelstat" . SPARSER::DRUG)
    ("PMF" . SPARSER::PROTEIN) ("PV" . SPARSER::PROTEIN)
    ("MPNs" . SPARSER::PROTEIN) ("—3" . SPARSER::PROTEIN)
    ("Cyclophilin A" . SPARSER::PROTEIN)
    ("p53 and BRCA1" . SPARSER::COLLECTION)
    ("normal mammary acini" . SPARSER::PROTEIN)
    ("cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("the NRF2 target genes NQO1 ( xref ) and GCLM ( xref )"
     . SPARSER::COLLECTION)
    ("mut and HCC" . SPARSER::COLLECTION)
    ("Gclm and Nqo1" . SPARSER::COLLECTION) ("Greb1" . SPARSER::PROTEIN)
    ("Gclm" . SPARSER::PROTEIN) ("GCLM and HMOX1" . SPARSER::COLLECTION)
    ("GCLM" . SPARSER::PROTEIN)
    ("previously reported ( xref ), c-MYC mRNA" . SPARSER::PROTEIN)
    ("Keap1 and 53bp1" . SPARSER::COLLECTION)
    ("Keap1 or 53bp1" . SPARSER::COLLECTION)
    ("Surprisingly, 53bp1 shRNA" . SPARSER::PROTEIN)
    ("53bp1" . SPARSER::PROTEIN)
    ("scrambled siRNAs (siScr) or Brca1 siRNA (siBrca1)" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN) ("p19/ARF" . SPARSER::COLLECTION)
    ("CK14 and Luc" . SPARSER::COLLECTION) ("luciferin" . SPARSER::MOLECULE)
    ("precleared mammary fat" . SPARSER::PROTEIN)
    ("Antioxidant" . SPARSER::PROTEIN) ("Nrf2 and Keap1" . SPARSER::COLLECTION)
    ("KEAP1 and BRCA1" . SPARSER::COLLECTION)
    ("KEAP1 or BRCA1" . SPARSER::COLLECTION)
    ("HA-tagged WT NRF2 and HA-tagged NRF2 mutants" . SPARSER::COLLECTION)
    ("NRF2 and KEAP1" . SPARSER::COLLECTION) ("DLG" . SPARSER::PROTEIN)
    ("NRF2–KEAP1" . SPARSER::COLLECTION)
    ("Brca1 and Nrf2" . SPARSER::COLLECTION)
    ("Brca1–Nrf2" . SPARSER::COLLECTION) ("Myc-BRCA1" . SPARSER::COLLECTION)
    ("GFP-NRF2" . SPARSER::COLLECTION)
    ("NRF2 and Myc-tagged" . SPARSER::COLLECTION)
    ("BRCA1 and Nrf2" . SPARSER::COLLECTION) ("Trolox" . SPARSER::MOLECULE)
    ("BSO" . SPARSER::DRUG) ("Nqo1 and Hmox1" . SPARSER::COLLECTION)
    ("Hmox1" . SPARSER::PROTEIN) ("CD24 and CD49f" . SPARSER::COLLECTION)
    ("MaSC" . SPARSER::PROTEIN) ("MaSCs" . SPARSER::PROTEIN)
    ("Bf" . SPARSER::MOLECULE) ("a lentiviral shRNA" . SPARSER::PROTEIN)
    ("a doxycycline (dox)-inducible lentiviral shRNA" . SPARSER::PROTEIN)
    ("K14- or K6a-driven cre recombinase" . SPARSER::COLLECTION)
    ("K6a-driven cre recombinase" . SPARSER::PROTEIN)
    ("K14-" . SPARSER::PROTEIN) ("normal MECs" . SPARSER::PROTEIN)
    ("lower intracellular ROS" . SPARSER::PROTEIN)
    ("K-Ras or c-Myc" . SPARSER::COLLECTION)
    ("SOD2, GLS2, and SEPHS1" . SPARSER::COLLECTION)
    ("GCLC and HMOX1" . SPARSER::COLLECTION) ("GCLC" . SPARSER::PROTEIN)
    ("MECs" . SPARSER::PROTEIN) ("Redox" . SPARSER::PROTEIN)
    ("2–4 µ" . SPARSER::PROTEIN) ("NFE2L2" . SPARSER::PROTEIN)
    ("Nfe2l2" . SPARSER::PROTEIN) ("DCF-DA" . SPARSER::DRUG)
    ("CM-H" . SPARSER::MOLECULE) ("ribosomal protein S18" . SPARSER::PROTEIN)
    ("ribosomal protein S9" . SPARSER::PROTEIN) ("Phenol red" . SPARSER::DRUG)
    ("CK14" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("Nqo1" . SPARSER::PROTEIN) ("K6a" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("sensitive to apoptosis" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("KELCH-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("NF-E2–related factor 2" . SPARSER::PROTEIN)
    ("SEPHS1" . SPARSER::PROTEIN) ("GLS2" . SPARSER::PROTEIN)
    ("Nrf2" . SPARSER::PROTEIN) ("MR1-1-PE38" . SPARSER::PROTEIN-PAIR)
    ("IL13-PE38" . SPARSER::COLLECTION)
    ("two glioma-associated antigens" . SPARSER::PROTEIN)
    ("multiple tumor-associated molecules" . SPARSER::MOLECULE)
    ("Monoclonal antibodies" . SPARSER::ANTIBODY)
    ("-ETA" . SPARSER::COLLECTION) ("ETA" . SPARSER::PROTEIN)
    ("currently available EGFR mAbs cetuximab, matuzumab, and panitumumab"
     . SPARSER::COLLECTION)
    ("cetuximab, matuzumab, and panitumumab" . SPARSER::COLLECTION)
    ("Macrophage" . SPARSER::PROTEIN)
    ("both the wild-type EGFR and the mutant EGFRvIII" . SPARSER::COLLECTION)
    ("VII" . SPARSER::PROTEIN)
    ("mAbs or recombinant scFvs" . SPARSER::COLLECTION)
    ("CD133 and D2C7" . SPARSER::COLLECTION)
    ("protein and D2159MG and D270MG" . SPARSER::COLLECTION)
    ("Antigen" . SPARSER::PROTEIN) ("FR" . SPARSER::PROTEIN)
    ("mAbs and scFv" . SPARSER::COLLECTION) ("DT-EGF" . SPARSER::COLLECTION)
    ("TP" . SPARSER::PROTEIN) ("The anti-EGFRwt mAbs EGFR1" . SPARSER::PROTEIN)
    ("transmembrane receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scFv" . SPARSER::PROTEIN) ("immunotoxins" . SPARSER::DRUG)
    ("scFvs" . SPARSER::PROTEIN)
    ("temozolomide or the monoclonal antibody (mAb)" . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG) ("AAs" . SPARSER::MOLECULE)
    ("immunotoxin" . SPARSER::DRUG) ("gene ( EGFR )" . SPARSER::GENE)
    ("homo/heterodimers" . SPARSER::HOMO/HETERODIMER)
    ("diphtheria toxin" . SPARSER::PROTEIN)
    ("transforming growth factor alpha" . SPARSER::PROTEIN)
    ("PE38" . SPARSER::PROTEIN) ("ERα-miRNA18a" . SPARSER::COLLECTION)
    ("miRNA18a" . SPARSER::PROTEIN)
    ("the chemotherapeutic drugs" . SPARSER::DRUG)
    ("a more plausible drug target" . SPARSER::TARGET-PROTEIN)
    ("miRNA 18a" . SPARSER::PROTEIN) ("miRNA18a-ATM" . SPARSER::PROTEIN-PAIR)
    ("antiestrogen" . SPARSER::DRUG) ("Brca1-/2" . SPARSER::PROTEIN-PAIR)
    ("ERα and ATM" . SPARSER::COLLECTION) ("-106a" . SPARSER::COLLECTION)
    ("106a" . SPARSER::PROTEIN) ("miRNA-106a" . SPARSER::COLLECTION)
    ("-18a" . SPARSER::COLLECTION)
    ("simultaneously knocking-down miRNAs-18a" . SPARSER::COLLECTION)
    ("miRNAs-18a" . SPARSER::COLLECTION)
    ("approximately 7 nucleotides" . SPARSER::NUCLEOTIDE)
    ("transiently knocked-down ERα ( xref ) or ERβ ( xref )"
     . SPARSER::COLLECTION)
    ("transiently knocked-down ERα" . SPARSER::PROTEIN)
    ("ER and ATM" . SPARSER::COLLECTION) ("radiomimetic drugs" . SPARSER::DRUG)
    ("regulating (either suppress or stimulate) micro RNAs" . SPARSER::RNA)
    ("AP1 and SP1" . SPARSER::COLLECTION) ("enhancer" . SPARSER::PROTEIN)
    ("anthracycline" . SPARSER::MOLECULE)
    ("ERα and miRNA" . SPARSER::COLLECTION)
    ("18a and 106a" . SPARSER::COLLECTION) ("18a" . SPARSER::PROTEIN)
    ("miRNA-18a and 106a" . SPARSER::COLLECTION)
    ("miRNA-18a" . SPARSER::COLLECTION) ("miRNA-" . SPARSER::PROTEIN)
    ("miRNAs or miRNA" . SPARSER::COLLECTION)
    ("many chemotherapeutic drugs and radiation therapy" . SPARSER::COLLECTION)
    ("many chemotherapeutic drugs" . SPARSER::DRUG) ("PI-3" . SPARSER::PROTEIN)
    ("miR-106a" . SPARSER::MOLECULE) ("β-Estradiol" . SPARSER::MOLECULE)
    ("anti-estrogen" . SPARSER::DRUG) ("IGF-IR/siRNA" . SPARSER::COLLECTION)
    ("IGF-I/IGFBP-3" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs and cytotoxicity" . SPARSER::COLLECTION)
    ("mRNA and P-gp" . SPARSER::COLLECTION)
    ("colon cancer, and MRP" . SPARSER::COLLECTION) ("MRP" . SPARSER::PROTEIN)
    ("Cytokines" . SPARSER::PROTEIN)
    ("STAT3, MEK, Jak2 and PI3-K" . SPARSER::COLLECTION)
    ("MDR1, MRP1, MRP2 and MRP3" . SPARSER::COLLECTION)
    ("IGF-I and IGF-IR" . SPARSER::COLLECTION)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("IGFs and IGF" . SPARSER::COLLECTION) ("VEGFB" . SPARSER::PROTEIN)
    ("siRNA anti-IGF-IR" . SPARSER::ANTIBODY)
    ("a fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("IGF-I and Hospicell" . SPARSER::COLLECTION)
    ("most probably other growth factors" . SPARSER::GROWTH-FACTOR)
    ("taxol or carboplatin" . SPARSER::COLLECTION)
    ("carboplatin or taxol" . SPARSER::COLLECTION)
    ("MRP3 and MRP5" . SPARSER::COLLECTION)
    ("carboplatin and taxol" . SPARSER::COLLECTION)
    ("MDR1 and MRP1" . SPARSER::COLLECTION)
    ("MDR1, MRP1 and MRP2" . SPARSER::COLLECTION)
    ("BCRP and MRP2" . SPARSER::COLLECTION)
    ("Jak2 inhibitor and STAT3 inhibitor" . SPARSER::COLLECTION)
    ("rottlerin" . SPARSER::DRUG) ("MRP1 and MRP3" . SPARSER::COLLECTION)
    ("MRP5 and BCRP" . SPARSER::COLLECTION)
    ("MDR1 and MRP2" . SPARSER::COLLECTION)
    ("IGF-I, IGF-II and IGF-IR" . SPARSER::COLLECTION)
    ("IGF-II and their receptors IGF-IR and IGF-IIR proteins"
     . SPARSER::COLLECTION)
    ("their receptors IGF-IR and IGF-IIR proteins" . SPARSER::COLLECTION)
    ("IIR" . SPARSER::PROTEIN)
    ("IGFs and their receptors" . SPARSER::COLLECTION)
    ("IGFs and their receptors ( xref )" . SPARSER::COLLECTION)
    ("IGFs" . SPARSER::PROTEIN)
    ("IGF-I, IGF-II, IGF-IR and IGF-IIR" . SPARSER::COLLECTION)
    ("IGF-IIR" . SPARSER::COLLECTION)
    ("IGF-I, IGF-II, IGF-IR, IGF-IIR and IGFBP 1" . SPARSER::COLLECTION)
    ("RASA4, STAT2, STAT6, IRF4 and MARK3" . SPARSER::COLLECTION)
    ("cytokine and cytokine" . SPARSER::COLLECTION)
    ("IGFBP10 and ABCC10" . SPARSER::COLLECTION) ("PDGFB" . SPARSER::PROTEIN)
    ("MDR1, MRP1, MRP2 and BCRP" . SPARSER::COLLECTION)
    ("IGF-I and IGF-I" . SPARSER::COLLECTION)
    ("exogenous IGF-I" . SPARSER::PROTEIN)
    ("MDR1, MRP1, MRP2, MRP3, MRP5 and BCRP" . SPARSER::COLLECTION)
    ("picropodophyllin" . SPARSER::DRUG) ("BCRP" . SPARSER::PROTEIN)
    ("Interferon-α" . SPARSER::DRUG) ("PI3-K" . SPARSER::PROTEIN)
    ("Jak 2" . SPARSER::PROTEIN) ("β2-microglobulin" . SPARSER::PROTEIN)
    ("P-gp" . SPARSER::PROTEIN) ("MDR3" . SPARSER::PROTEIN)
    ("ABCB3" . SPARSER::PROTEIN) ("PAR3" . SPARSER::PROTEIN)
    ("MARK3" . SPARSER::PROTEIN) ("IRF4" . SPARSER::PROTEIN)
    ("RASA4" . SPARSER::PROTEIN) ("MRP7" . SPARSER::PROTEIN)
    ("ABCC10" . SPARSER::PROTEIN) ("IGFBP10" . SPARSER::PROTEIN)
    ("IL6 ST" . SPARSER::PROTEIN) ("GPR17" . SPARSER::PROTEIN)
    ("VEGF-B" . SPARSER::PROTEIN) ("TNFSF5" . SPARSER::PROTEIN)
    ("PPP 1" . SPARSER::PROTEIN-FAMILY) ("IGFBP 1" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("AG-3" . SPARSER::PROTEIN) ("IGFBP-3" . SPARSER::PROTEIN)
    ("insulin like growth factor" . SPARSER::PROTEIN)
    ("MRP5" . SPARSER::PROTEIN) ("MRP3" . SPARSER::PROTEIN)
    ("MRP2" . SPARSER::PROTEIN) ("MRP1" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("the multifunctional transcription factor" . SPARSER::PROTEIN)
    ("pathological states" . SPARSER::BIO-STATE) ("RRR" . SPARSER::PROTEIN)
    ("forms of the protein and not all antibodies" . SPARSER::COLLECTION)
    ("detergents and salts" . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE)
    ("The methylation-defective mutant" . SPARSER::MUTANT)
    ("wt-FOXO3" . SPARSER::PROTEIN-PAIR) ("FHRE" . SPARSER::PROTEIN)
    ("complex and infection" . SPARSER::COLLECTION)
    ("FHRE-luciferase" . SPARSER::PROTEIN-PAIR)
    ("FOXO4 and FOXO1" . SPARSER::COLLECTION)
    ("JNK, ERK and p38" . SPARSER::COLLECTION)
    ("HA-FOXO3" . SPARSER::COLLECTION) ("ADH" . SPARSER::PROTEIN)
    ("ethanol" . SPARSER::MOLECULE) ("Ethanol" . SPARSER::PROTEIN)
    ("phosphoserine, acetyl-lysine, methylarginine and ubiquitin"
     . SPARSER::COLLECTION)
    ("anti" . SPARSER::PROTEIN) ("S318" . SPARSER::PROTEIN)
    ("De-" . SPARSER::MOLECULE) ("mL −1" . SPARSER::PROTEIN)
    ("both pediatric and adult IBD" . SPARSER::PROTEIN)
    ("miR-125b directly targets STAT3" . SPARSER::PROTEIN)
    ("miR-125a and miR-125b" . SPARSER::COLLECTION) ("AZA" . SPARSER::DRUG)
    ("both total and phosphorylated STAT3" . SPARSER::PROTEIN)
    ("total and phosphorylated STAT3" . SPARSER::PROTEIN)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("VEGF, BCL2, BCLXL and MMP9" . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION) ("ileal" . SPARSER::PROTEIN)
    ("MiRs" . SPARSER::PROTEIN) ("IL6-STAT3" . SPARSER::COLLECTION)
    ("phosphorylated STAT3 and the genes" . SPARSER::COLLECTION)
    ("VEGF, BCL2, BCLXL, and MMP9" . SPARSER::COLLECTION)
    ("BCLXL" . SPARSER::PROTEIN) ("colonic mucosal miRs" . SPARSER::PROTEIN)
    ("pediatric IBD" . SPARSER::PROTEIN) ("IBD" . SPARSER::PROTEIN)
    ("miR124" . SPARSER::RNA) ("HNF4A" . SPARSER::PROTEIN)
    ("miR-125a" . SPARSER::PROTEIN) ("TNFAIP3" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("Toll-like receptor 4" . SPARSER::PROTEIN) ("MIR124" . SPARSER::RNA)
    ("3 common Ashkenazi mutations BRCA1 (185delAG, 5382insC) and BRCA2 (6174delT)"
     . SPARSER::COLLECTION)
    ("RK" . SPARSER::PROTEIN)
    ("BRCA1, FANCD2 and RAD 51" . SPARSER::COLLECTION)
    ("Mre11-Nbs1-Rad50" . SPARSER::COLLECTION) ("patched" . SPARSER::PROTEIN)
    ("methanol" . SPARSER::MOLECULE)
    ("concordant BRCA1 protein" . SPARSER::PROTEIN)
    ("BRCA1 antibody (K-18) and nucleolin 7G2" . SPARSER::COLLECTION)
    ("protein and nucleolin" . SPARSER::COLLECTION)
    ("moderate or strong BRCA1" . SPARSER::PROTEIN)
    ("ER or PR" . SPARSER::COLLECTION) ("ER/PR" . SPARSER::COLLECTION)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("Ashkenazi Jewish mutations BRCA1 (185delAG, 5382insC) and BRCA2 (6174delT)"
     . SPARSER::COLLECTION)
    ("light and electron" . SPARSER::COLLECTION)
    ("four monoclonal anti-BRCA1 antibodies" . SPARSER::ANTIBODY)
    ("centrosomes and mitochondria" . SPARSER::COLLECTION)
    ("the breast cancer tumor suppressor genes BRCA1 [ xref - xref ] and BRCA2 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("lactating" . SPARSER::MOLECULE)
    ("BRCA1 and nucleolin" . SPARSER::COLLECTION) ("insC" . SPARSER::PROTEIN)
    ("ovarian cancer susceptibility gene" . SPARSER::GENE)
    ("MS 13" . SPARSER::PROTEIN) ("RAD 51" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("K-18" . SPARSER::PROTEIN)
    ("transcription-regulatory proteins" . SPARSER::PROTEIN)
    ("additional cofactors or target gene promoter" . SPARSER::COLLECTION)
    ("gluconeogenic genes" . SPARSER::GENE)
    ("PGC-1α and p300" . SPARSER::COLLECTION)
    ("β-catenin, RUNX3, SMADs and histone" . SPARSER::COLLECTION)
    ("acetylases and methyltranferases" . SPARSER::COLLECTION)
    ("acetylases" . SPARSER::PROTEIN)
    ("antioxidant and cytoprotective genes  xref" . SPARSER::COLLECTION)
    ("the more deacetylated forms" . SPARSER::FORM)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("more highly acetylated forms" . SPARSER::FORM)
    ("Bim, TRAIL and FasL" . SPARSER::COLLECTION)
    ("unique protein conformations" . SPARSER::BIO-CONFORMATION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("JNK, p38 and ERK" . SPARSER::COLLECTION) ("Atg7" . SPARSER::PROTEIN)
    ("Atg" . SPARSER::DRUG) ("particular FOXO3" . SPARSER::PROTEIN)
    ("Beclin-1 and Atg8" . SPARSER::COLLECTION) ("Sirt1" . SPARSER::PROTEIN)
    ("Nampt" . SPARSER::PROTEIN)
    ("FoxO1, FoxO3 and FoxO4" . SPARSER::COLLECTION) ("Tao" . SPARSER::DRUG)
    ("FOXO1/FOXO3" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("the mutated forms" . SPARSER::FORM)
    ("various mutated forms" . SPARSER::FORM)
    ("post-prandial hyperglycemia" . SPARSER::PROTEIN)
    ("apolipoprotein" . SPARSER::MOLECULE)
    ("ApoC-III and microsomal triglyceride" . SPARSER::COLLECTION)
    ("microsomal triglyceride" . SPARSER::MOLECULE) ("MTP" . SPARSER::PROTEIN)
    ("G6Pase and other gluconeogenic genes" . SPARSER::COLLECTION)
    ("other gluconeogenic genes" . SPARSER::GENE)
    ("glucagon" . SPARSER::PROTEIN)
    ("glycogen and lipid" . SPARSER::COLLECTION)
    ("hyperglycemia" . SPARSER::PROTEIN)
    ("two gluconeogenic enzymes" . SPARSER::ENZYME) ("G6Pc" . SPARSER::PROTEIN)
    ("Akt and FOXO1" . SPARSER::COLLECTION)
    ("PEPCK and G-6-Pase" . SPARSER::COLLECTION) ("PEPCK" . SPARSER::PROTEIN)
    ("2 serines and 1 threonine" . SPARSER::COLLECTION)
    ("FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("antioxidant and stress response genes" . SPARSER::COLLECTION)
    ("daf" . SPARSER::PROTEIN) ("exogenous toxins" . SPARSER::MOLECULE)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("MST1" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("NS5a" . SPARSER::PROTEIN)
    ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Beclin-1" . SPARSER::PROTEIN)
    ("SREBP-1" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("SREBP-1c" . SPARSER::PROTEIN)
    ("lipoprotein lipase" . SPARSER::PROTEIN) ("ApoC-III" . SPARSER::PROTEIN)
    ("G6Pase" . SPARSER::PROTEIN) ("O-GlcNAc" . SPARSER::PROTEIN)
    ("XBP-1" . SPARSER::PROTEIN) ("free-radicals" . SPARSER::MOLECULE)
    ("PIP3" . SPARSER::PIP3) ("PI3kinase" . SPARSER::PROTEIN)
    ("Glucose-6-phosphatase catalytic subunit" . SPARSER::PROTEIN)
    ("G-6-Pase" . SPARSER::PROTEIN) ("The dual luciferase" . SPARSER::PROTEIN)
    ("antiviral drugs" . SPARSER::DRUG)
    ("inactive complexes" . SPARSER::BIO-COMPLEX)
    ("NS1 and ADAR1" . SPARSER::COLLECTION)
    ("ADAR1 and NS1" . SPARSER::COLLECTION)
    ("type 1 and Kaposi" . SPARSER::COLLECTION)
    ("proteins, SON and ADAR1" . SPARSER::COLLECTION)
    ("genome-wide siRNA" . SPARSER::PROTEIN)
    ("NS1 or NS2" . SPARSER::COLLECTION)
    ("NS3 and ADAR1" . SPARSER::COLLECTION) ("tryptophane" . SPARSER::MOLECULE)
    ("a 24 nucleotide-long minimal ADAR1 substrate" . SPARSER::SUBSTRATE)
    ("NS1-ADAR-1" . SPARSER::COLLECTION) ("ADAR" . SPARSER::PROTEIN)
    ("Full-length NS1 and NS1 RBD domain efficiently co-precipitated ADAR1"
     . SPARSER::PROTEIN)
    ("NS1 and NS1" . SPARSER::COLLECTION) ("ADAR1-NS1" . SPARSER::COLLECTION)
    ("the major interferon-inducible antiviral effectors" . SPARSER::EFFECTOR)
    ("NS2 mostly targets proteins" . SPARSER::PROTEIN)
    ("ADAR1, ATP6V1G1, BCLAF1, RPL13A and SON" . SPARSER::COLLECTION)
    ("possible direct modulators" . SPARSER::PROTEIN)
    ("ADAR1 and RPSA" . SPARSER::COLLECTION)
    ("ATP6V1G1, RPL13A, EEF1A1 and SON" . SPARSER::COLLECTION)
    ("RPSA" . SPARSER::PROTEIN)
    ("the vacuolar ATPase proton pump" . SPARSER::PROTEIN)
    ("ATP6V1G1 and CSNK2B" . SPARSER::COLLECTION)
    ("these genome-wide siRNA" . SPARSER::PROTEIN)
    ("recent genome-wide siRNA" . SPARSER::PROTEIN) ("SON" . SPARSER::PROTEIN)
    ("highly central proteins" . SPARSER::PROTEIN)
    ("PIK3R1, PIK3R2, MAPK9, CRK and proteins" . SPARSER::COLLECTION)
    ("CRK" . SPARSER::PROTEIN) ("SCRIB" . SPARSER::DRUG)
    ("influenza virus NS1 and/or NS2 proteins" . SPARSER::COLLECTION)
    ("these viral proteins" . SPARSER::PROTEIN)
    ("a bifunctional enzyme" . SPARSER::ENZYME)
    ("protease and helicase" . SPARSER::COLLECTION)
    ("common therapeutic targets as well as broad-spectrum antivirals"
     . SPARSER::COLLECTION)
    ("antivirals" . SPARSER::DRUG) ("nucleoporins" . SPARSER::PROTEIN)
    ("CPSF4 and PABPN1" . SPARSER::COLLECTION)
    ("a pleiotropic virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("the pro-apoptotic PB1-F2 protein and two additional virulence factors"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic PB1-F2 protein" . SPARSER::PROTEIN)
    ("the surface glycoproteins haemagglutinin (HA) and neuraminidase (NA)"
     . SPARSER::COLLECTION)
    ("the matrix proteins (M1 and M2) and the NS2 protein"
     . SPARSER::COLLECTION)
    ("haemagglutinin (HA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NA" . SPARSER::PROTEIN)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral ribonucleoproteins" . SPARSER::PROTEIN)
    ("PA, PB1 and PB2" . SPARSER::COLLECTION)
    ("whose NS3 protein" . SPARSER::PROTEIN)
    ("NS2 or both NS1 and NS2" . SPARSER::COLLECTION)
    ("NS1, NS2 or both NS1 and NS2" . SPARSER::COLLECTION)
    ("13 viral proteins" . SPARSER::PROTEIN)
    ("dengue virus NS3 and influenza virus NS1 proteins" . SPARSER::COLLECTION)
    ("the viral NS3 protein" . SPARSER::PROTEIN)
    ("the 79 NS1 and/or NS2-interacting proteins" . SPARSER::COLLECTION)
    ("proteins and NS1 and NS2" . SPARSER::COLLECTION)
    ("a multifunctional protein and a virulence factor" . SPARSER::COLLECTION)
    ("viral ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("N-acetylneuraminic acid" . SPARSER::MOLECULE) ("AH109" . SPARSER::DRUG)
    ("CPSF30" . SPARSER::PROTEIN) ("p150" . SPARSER::PROTEIN)
    ("CPSF3L" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("DLG4" . SPARSER::PROTEIN)
    ("Amino acid" . SPARSER::AMINO-ACID)
    ("interferon-induced" . SPARSER::PROTEIN) ("BCLAF1" . SPARSER::PROTEIN)
    ("proton pump" . SPARSER::PROTEIN) ("CSNK2B" . SPARSER::PROTEIN)
    ("NUP214" . SPARSER::PROTEIN) ("RPL23A" . SPARSER::PROTEIN)
    ("GMEB1" . SPARSER::PROTEIN) ("ATP6V1G1" . SPARSER::PROTEIN)
    ("ILF3" . SPARSER::PROTEIN) ("TARBP2" . SPARSER::PROTEIN)
    ("MAPK9" . SPARSER::PROTEIN) ("PIK3R2" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("AIMP2" . SPARSER::PROTEIN)
    ("STAU1" . SPARSER::PROTEIN) ("CPSF4" . SPARSER::PROTEIN)
    ("TRIM25" . SPARSER::PROTEIN)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("ADAR1" . SPARSER::PROTEIN) ("RNA 1" . SPARSER::PROTEIN-FAMILY)
    ("adenosine deaminase" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("Hsp27, GRP78, clusterin, and c-FLIP" . SPARSER::COLLECTION)
    ("insulin-like growth factor receptor and epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("PC-3 and LNCaP" . SPARSER::COLLECTION)
    ("Hsp27 or c-FLIP" . SPARSER::COLLECTION)
    ("c-FLIP-3" . SPARSER::COLLECTION) ("c-FLIP-2" . SPARSER::COLLECTION)
    ("c-FLIP-1" . SPARSER::COLLECTION) ("Hsp27-3" . SPARSER::COLLECTION)
    ("Hsp27-2" . SPARSER::COLLECTION) ("Hsp27-1" . SPARSER::COLLECTION)
    ("adrenoceptor" . SPARSER::PROTEIN) ("quinazoline" . SPARSER::MOLECULE)
    ("Doxazosin" . SPARSER::DRUG) ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("Fas, DE4, and DR5" . SPARSER::COLLECTION)
    ("pre- and postmitochondria" . SPARSER::COLLECTION)
    ("pre-" . SPARSER::PROTEIN) ("FLICE" . SPARSER::PROTEIN)
    ("prostein" . SPARSER::PROTEIN)
    ("cabazitaxel or abiraterone acetate" . SPARSER::COLLECTION)
    ("cabazitaxel" . SPARSER::DRUG) ("c-FLIP and Hsp27" . SPARSER::COLLECTION)
    ("Hsp27-" . SPARSER::PROTEIN) ("Hsp27 and C-FLIP" . SPARSER::COLLECTION)
    ("dual gene" . SPARSER::GENE) ("Hsp27 and c-FLIP" . SPARSER::COLLECTION)
    ("doxazosin" . SPARSER::DRUG) ("PC-3" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("c-FLIPs" . SPARSER::PROTEIN) ("DR-5" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("DE4" . SPARSER::PROTEIN)
    ("abiraterone acetate" . SPARSER::DRUG) ("C-FLIP" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN)
    ("their oropharyngeal cohort" . SPARSER::MOLECULE)
    ("TP53 and EGFR" . SPARSER::COLLECTION)
    ("our own cohort" . SPARSER::MOLECULE)
    ("AKT1, PTEN, and PIK3CA" . SPARSER::COLLECTION)
    ("HPV-positive oropharyngeal SCCs" . SPARSER::PROTEIN)
    ("our oropharyngeal subset" . SPARSER::PROTEIN)
    ("TP53 or PIK3CA" . SPARSER::COLLECTION)
    ("the oropharyngeal subset" . SPARSER::PROTEIN)
    ("PIK3CA or AKT1" . SPARSER::COLLECTION) ("cisplatinum" . SPARSER::DRUG)
    ("PIK3CA-AKT1" . SPARSER::COLLECTION) ("entire cohort" . SPARSER::MOLECULE)
    ("vis" . SPARSER::DRUG) ("PIK3CA, and HRAS" . SPARSER::COLLECTION)
    ("the oropharyngeal cohort" . SPARSER::MOLECULE)
    ("PIK3CA/AKT1" . SPARSER::COLLECTION)
    ("PIK3CA and AKT1" . SPARSER::COLLECTION)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("tyrosine-kinase receptor" . SPARSER::PROTEIN)
    ("RANKL/RANK" . SPARSER::COLLECTION) ("RANK" . SPARSER::PROTEIN)
    ("cisplatin and vinorelbine" . SPARSER::COLLECTION)
    ("vinorelbine" . SPARSER::DRUG) ("PS " . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN) ("ribs" . SPARSER::DRUG)
    ("smoke" . SPARSER::MOLECULE) ("cigarettes" . SPARSER::DRUG)
    ("ASP" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("CDKN1A, and FCER2" . SPARSER::COLLECTION)
    ("PRDM-1" . SPARSER::COLLECTION)
    ("BCL6 and /or pSTAT6" . SPARSER::COLLECTION)
    ("JAK2 (TG101348) and BCL6 (79-6)" . SPARSER::COLLECTION)
    ("BS" . SPARSER::PROTEIN)
    ("the BCL6 proximal promoter" . SPARSER::PROMOTER)
    ("STAT6 [reviewed in xref ] and BCL6 [ xref ]" . SPARSER::COLLECTION)
    ("BCL6 and STAT6" . SPARSER::COLLECTION)
    ("BCL6 or vice versa" . SPARSER::COLLECTION)
    ("The BCL6+/pSTAT6− fraction (23.9+/−1.5%) and BCL6−/pSTAT6+ fraction (13.9+/−2.3%)"
     . SPARSER::COLLECTION)
    ("BCL6−" . SPARSER::PROTEIN) ("BCL6 and pSTAT6" . SPARSER::COLLECTION)
    ("Recently developed small molecule inhibitors 79-6 and TG101348 that increases BCL6 target gene expression"
     . SPARSER::COLLECTION)
    ("Recently developed small molecule inhibitors" . SPARSER::INHIBITOR)
    ("considerable fractions" . SPARSER::COMPONENT)
    ("PTPN1" . SPARSER::PROTEIN) ("SOCS-1" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("JAK2 inhibitor TG101348" . SPARSER::DRUG)
    ("FCER2" . SPARSER::PROTEIN) ("Interferon-gamma" . SPARSER::PROTEIN)
    ("BPI" . SPARSER::PROTEIN) ("GFP +" . SPARSER::PROTEIN)
    ("Myc-GFP +" . SPARSER::PROTEIN-PAIR)
    ("retroviral Myc-GFP" . SPARSER::COLLECTION)
    ("Myc-GFP" . SPARSER::COLLECTION)
    ("Bach2 (high) and Myc (low; xref )" . SPARSER::COLLECTION)
    ("Nilotinib" . SPARSER::DRUG) ("Bach2 and Myc" . SPARSER::COLLECTION)
    ("Stat5- and Myc-regulated genes" . SPARSER::COLLECTION)
    ("Stat5-" . SPARSER::PROTEIN) ("RMD" . SPARSER::PROTEIN)
    ("BACH2:BCL6" . SPARSER::BIO-COMPLEX) ("-BCL6" . SPARSER::COLLECTION)
    ("ARF/P53" . SPARSER::COLLECTION) ("Bach2 and Bcl6" . SPARSER::COLLECTION)
    ("Cdkn2a and Tp53" . SPARSER::COLLECTION) ("MLL-AF4" . SPARSER::COLLECTION)
    ("TEL-AML1" . SPARSER::COLLECTION) ("E2A-PBX1" . SPARSER::PROTEIN-PAIR)
    ("PAX5-ETV6" . SPARSER::COLLECTION)
    ("dominant-negative fusion molecules" . SPARSER::MOLECULE)
    ("ARF and TP53" . SPARSER::COLLECTION) ("Bach2-ER" . SPARSER::COLLECTION)
    ("Fragment" . SPARSER::FRAGMENT) ("RAG1 and RAG2" . SPARSER::COLLECTION)
    ("Rag1/Rag2" . SPARSER::COLLECTION) ("Rag1 and Rag2" . SPARSER::COLLECTION)
    ("Rag1" . SPARSER::PROTEIN) ("Il2ra" . SPARSER::PROTEIN)
    ("Imatinib" . SPARSER::DRUG)
    ("Tp53 (p53) and related checkpoint molecules" . SPARSER::COLLECTION)
    ("common Bach2- and Bcl6-target genes" . SPARSER::COLLECTION)
    ("Bcl6 and Bach2" . SPARSER::COLLECTION)
    ("Tp53, Gadd45b, Btg1 and Btg2" . SPARSER::COLLECTION)
    ("Btg1" . SPARSER::PROTEIN) ("Gadd45b" . SPARSER::PROTEIN)
    ("Bach2-" . SPARSER::PROTEIN)
    ("Cdkn2a ( Arf ) and Tp53 ( p53 )" . SPARSER::COLLECTION)
    ("Bach2 +/+ and Bach2  –/– cells" . SPARSER::COLLECTION)
    ("Cdkn2a ( Arf ) and Tp53 ( p53 ) promoters" . SPARSER::COLLECTION)
    ("BCL6 or BACH2" . SPARSER::COLLECTION)
    ("CDKN2A and TP53" . SPARSER::COLLECTION)
    ("Arf and p53" . SPARSER::COLLECTION)
    ("BACH2 and BCL6" . SPARSER::COLLECTION)
    ("CDKN2A (Arf) and TP53 ( p53) and other checkpoint regulators"
     . SPARSER::COLLECTION)
    ("TP53 ( p53) and other checkpoint regulators" . SPARSER::COLLECTION)
    ("BCL6 and BACH2" . SPARSER::COLLECTION)
    ("a strong transcriptional repressor" . SPARSER::REPRESSOR)
    ("pre-BII" . SPARSER::COLLECTION) ("pre-BI" . SPARSER::COLLECTION)
    ("BII" . SPARSER::PROTEIN) ("BI" . SPARSER::PROTEIN)
    ("DNTT" . SPARSER::PROTEIN)
    ("p53 and other checkpoint control genes" . SPARSER::COLLECTION)
    ("fatal leukemia" . SPARSER::PROTEIN) ("IKZF1" . SPARSER::PROTEIN)
    ("AF4" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("IL7" . SPARSER::PROTEIN)
    ("Ly6f" . SPARSER::PROTEIN) ("Btg2" . SPARSER::PROTEIN)
    ("GADD45B" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("Pro-B" . SPARSER::PROTEIN) ("RAG2" . SPARSER::PROTEIN)
    ("RAG1" . SPARSER::PROTEIN) ("IGLL1" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("Pax5" . SPARSER::PROTEIN)
    ("Bach2" . SPARSER::PROTEIN)
    ("that U2AF65 and ASF/SF2" . SPARSER::COLLECTION)
    ("ActD, DRB and TSA" . SPARSER::COLLECTION)
    ("U1A and Tra2β" . SPARSER::COLLECTION) ("SF2-ESE" . SPARSER::PROTEIN-PAIR)
    ("hnRNP I-ISE" . SPARSER::PROTEIN-PAIR)
    ("hnRNP I and U2AF65" . SPARSER::COLLECTION)
    ("purified Flag-tagged U2AF65, hnRNP I and ASF/SF2" . SPARSER::COLLECTION)
    ("the ISE and the ESE" . SPARSER::COLLECTION)
    ("further study binding proteins" . SPARSER::PROTEIN)
    ("AR-V7 splicing through interactions with U2AF65, hnRNP I and ASF/SF2"
     . SPARSER::COLLECTION)
    ("both the ISE and the ESE" . SPARSER::COLLECTION)
    ("U2AF65 and hnRNP I" . SPARSER::COLLECTION)
    ("minigene" . SPARSER::PROTEIN) ("ISE and ESE" . SPARSER::COLLECTION)
    ("minigenes" . SPARSER::PROTEIN) ("AR-V7 minigenes" . SPARSER::PROTEIN)
    ("ISE or ESE" . SPARSER::COLLECTION)
    ("hnRNP I or U2AF65" . SPARSER::COLLECTION) ("ISE" . SPARSER::PROTEIN)
    ("the constitutively active CMV promoter" . SPARSER::PROMOTER)
    ("cis- and trans-element" . SPARSER::COLLECTION)
    ("cis-" . SPARSER::PROTEIN) ("U2AF and p54nrb" . SPARSER::COLLECTION)
    ("PSF (no change) and hnRNP I (decreased recruitment)"
     . SPARSER::COLLECTION)
    ("hnRNP I, PSF and p54nrb" . SPARSER::COLLECTION)
    ("AFS/SF2" . SPARSER::COLLECTION) ("ActD and DRB" . SPARSER::COLLECTION)
    ("DHT or 5uM" . SPARSER::COLLECTION)
    ("benzimidazole (DRB) or trichostatin" . SPARSER::COLLECTION)
    ("benzimidazole" . SPARSER::DRUG) ("AR-V7 regulated genes" . SPARSER::GENE)
    ("UGT2B17 and UBE2C" . SPARSER::COLLECTION)
    ("PSA and TMPSS2" . SPARSER::COLLECTION)
    ("AR-V7 or total AR" . SPARSER::COLLECTION)
    ("AR-V7, and siRNA" . SPARSER::COLLECTION)
    ("DHT and MDV" . SPARSER::COLLECTION) ("DHT or MDV" . SPARSER::COLLECTION)
    ("DHT and/or MDV3100 ( xref )" . SPARSER::COLLECTION)
    ("DHT" . SPARSER::PROTEIN) ("RNA and protein" . SPARSER::COLLECTION)
    ("LNCaP and LNCaP" . SPARSER::COLLECTION)
    ("AR and AR-V7" . SPARSER::COLLECTION)
    ("their associated RNA" . SPARSER::RNA) ("a mitotic form" . SPARSER::FORM)
    ("AR-transcriptome" . SPARSER::PROTEIN-PAIR)
    ("AR (AR)" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CRPC" . SPARSER::PROTEIN)
    ("MDV3100 (enzalutamide) and abiraterone" . SPARSER::COLLECTION)
    ("PCa (CRPC)" . SPARSER::PROTEIN) ("abiraterone" . SPARSER::DRUG)
    ("enzalutamide" . SPARSER::DRUG)
    ("enhancers and their binding proteins (U2AF65 and ASF/SF2)"
     . SPARSER::COLLECTION)
    ("ASF/SF2" . SPARSER::COLLECTION) ("U2AF65" . SPARSER::PROTEIN)
    ("ASF" . SPARSER::PROTEIN) ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("Tra2" . SPARSER::PROTEIN) ("oligo 2" . SPARSER::PROTEIN)
    ("p54nrb" . SPARSER::PROTEIN) ("hnRNP I" . SPARSER::PROTEIN)
    ("U1A" . SPARSER::PROTEIN) ("UBE2C" . SPARSER::PROTEIN)
    ("UGT2B17" . SPARSER::PROTEIN) ("MDV3100" . SPARSER::DRUG)
    ("anti-androgens" . SPARSER::DRUG) ("splicing factor" . SPARSER::PROTEIN)
    ("SF2" . SPARSER::PROTEIN) ("AR-V7" . SPARSER::PROTEIN)
    ("TSC1, TSC2, PTEN, LKB1, or NF2" . SPARSER::COLLECTION)
    ("seizures" . SPARSER::PROTEIN) ("Tp53 or Tsc1" . SPARSER::COLLECTION)
    ("EGFR, and IGF1R" . SPARSER::COLLECTION) ("HGF-MET" . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION) ("PTEN and LKB1" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("NF2, PTEN and LKB1" . SPARSER::COLLECTION)
    ("TSC1 and TSC2" . SPARSER::COLLECTION) ("TSC1/TSC" . SPARSER::COLLECTION)
    ("only small residual foci" . SPARSER::PROTEIN)
    ("both conditional alleles" . SPARSER::ALLELE)
    ("pS6(S235/236) and PCNA" . SPARSER::COLLECTION)
    ("Tsc1 or Tsc2" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("pS6(S240/244) and pS6K(T389)" . SPARSER::COLLECTION)
    ("calretinin and AE1/AE3" . SPARSER::COLLECTION)
    ("calretinin" . SPARSER::PROTEIN)
    ("a reliable Tsc1 antibody" . SPARSER::ANTIBODY)
    ("TSC2 and TSC1" . SPARSER::COLLECTION)
    ("Calretinin, WT-1, AE1/AE3, and D2-40" . SPARSER::COLLECTION)
    ("Calretinin" . SPARSER::PROTEIN)
    ("homozygous conditional alleles" . SPARSER::ALLELE)
    ("tuberin" . SPARSER::PROTEIN) ("asbestos" . SPARSER::MOLECULE)
    ("MPM" . SPARSER::MOLECULE) ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("TSC1/TSC2" . SPARSER::COLLECTION) ("Tsc1 and Tp53" . SPARSER::COLLECTION)
    ("conditional alleles" . SPARSER::ALLELE)
    ("Tp53 and Tsc1" . SPARSER::COLLECTION) ("Tp53" . SPARSER::PROTEIN)
    ("HP-1" . SPARSER::PROTEIN) ("A 20" . SPARSER::PROTEIN)
    ("Torin1" . SPARSER::DRUG) ("EBP1" . SPARSER::PROTEIN)
    ("IP 3" . SPARSER::IP3) ("FKBP12" . SPARSER::PROTEIN)
    ("pS6" . SPARSER::PROTEIN) ("WT-1" . SPARSER::PROTEIN)
    ("GPCRs or SRC" . SPARSER::COLLECTION)
    ("the dual specific phosphatases" . SPARSER::PHOSPHATASE)
    ("EGFR/MAPK" . SPARSER::COLLECTION)
    ("RAS/Rho/ROCK/NF-κB" . SPARSER::COLLECTION)
    ("GPCRs (LPAR in ovarian cancer and gastrin-releasing peptide receptor in head-and-neck cancer) and receptor tyrosine kinases (EGFR)"
     . SPARSER::COLLECTION)
    ("EGF and TGFα" . SPARSER::COLLECTION)
    ("an essential autocrine growth factor" . SPARSER::GROWTH-FACTOR)
    ("exogenous EGF" . SPARSER::PROTEIN)
    ("AKT and p90RSK" . SPARSER::COLLECTION)
    ("LPA and EGF signaling" . SPARSER::COLLECTION)
    ("lowered survival fraction" . SPARSER::COMPONENT)
    ("MEK1/2 and RSK1/2" . SPARSER::COLLECTION)
    ("AREG and YB-1" . SPARSER::COLLECTION)
    ("AREG, glial cell line-derived neurotrophic factor, coagulation factor III and CD26"
     . SPARSER::COLLECTION)
    ("EGF and HB-EGF" . SPARSER::COLLECTION)
    ("EGFR and MEK1/2" . SPARSER::COLLECTION)
    ("LPAR/EGFR" . SPARSER::COLLECTION) ("exogenous AREG" . SPARSER::PROTEIN)
    ("EGF or increase TGFαrelease ( xref )" . SPARSER::COLLECTION)
    ("surprisingly not EGF" . SPARSER::PROTEIN)
    ("AREG, EGF and transforming growth factor-α or TGFα"
     . SPARSER::COLLECTION)
    ("the LPAR and the EGFR" . SPARSER::COLLECTION)
    ("a dual SRC/ABL kinase inhibitor" . SPARSER::INHIBITOR)
    ("SRC/ABL" . SPARSER::COLLECTION)
    ("gefitinib or lapatinib" . SPARSER::COLLECTION)
    ("LPA- and EGF-induced activation of the p44/42MAPK/p90RSK/YB-1 pathway ( xref )"
     . SPARSER::COLLECTION)
    ("Trastuzumab" . SPARSER::DRUG) ("EGF and LPA" . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN) ("LPAR and YB-1" . SPARSER::COLLECTION)
    ("LPAR and the EGFR/ERBB family" . SPARSER::COLLECTION)
    ("EGFR/ERBB" . SPARSER::COLLECTION) ("ERBB" . SPARSER::PROTEIN)
    ("HER2 and IGF1R" . SPARSER::COLLECTION)
    ("the only AKT isoforms" . SPARSER::ISOFORM)
    ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("AKT and phospho-AKT" . SPARSER::COLLECTION)
    ("neither GSK690693 nor MK2206" . SPARSER::COLLECTION)
    ("AKT and YB-1" . SPARSER::COLLECTION)
    ("both LPA- and EGF-induced YB-1 phosphorylation" . SPARSER::COLLECTION)
    ("MEK1/2 or RSK1/2" . SPARSER::COLLECTION)
    ("LPA- and EGF-induced phosphorylation of p44/42MAPK"
     . SPARSER::COLLECTION)
    ("LPA-" . SPARSER::LPA) ("MEK and p90RSK" . SPARSER::COLLECTION)
    ("p70S6K and BAD" . SPARSER::COLLECTION)
    ("IGF-1 receptor (IGF1R) and human epidermal growth factor receptor (HER)-2"
     . SPARSER::COLLECTION)
    ("AKT (at threonine-308 and serine-473) and NF-κB ( xref , Cluster 1a and b)"
     . SPARSER::COLLECTION)
    ("exogenous LPA" . SPARSER::LPA) ("RPPA" . SPARSER::PROTEIN)
    ("p90RSK and YB-1" . SPARSER::COLLECTION)
    ("RAS/MAPK/p90RSK" . SPARSER::COLLECTION)
    ("RSK1 and AKT" . SPARSER::COLLECTION)
    ("p90RSK (3.17 ± 0.40 fold) and AKT (3.71 ± 0.99 fold)"
     . SPARSER::COLLECTION)
    ("p90RSK (2.13 ± 0.18 fold) and AKT (1.74 ± 0.32 fold)"
     . SPARSER::COLLECTION)
    ("EGF and IGF-1" . SPARSER::COLLECTION)
    ("p90RSK and AKT" . SPARSER::COLLECTION)
    ("p90RSK (readout of RAS/MAPK pathway activation) and AKT"
     . SPARSER::COLLECTION)
    ("LPAR and EGFR" . SPARSER::COLLECTION)
    ("EGF and insulin-like growth factor" . SPARSER::COLLECTION)
    ("LPAR/EGFR/YB-1/AREG" . SPARSER::COLLECTION) ("LPAR" . SPARSER::PROTEIN)
    ("LPA2 or LPA3" . SPARSER::COLLECTION)
    ("receptors (LPAR)" . SPARSER::RECEPTOR)
    ("cell-associated autotaxin" . SPARSER::PROTEIN)
    ("autotaxin" . SPARSER::PROTEIN)
    ("lysophosphatidylcholine" . SPARSER::MOLECULE)
    ("AREG/YB-1" . SPARSER::COLLECTION)
    ("amphiregulin (AREG)" . SPARSER::PROTEIN) ("AREG" . SPARSER::PROTEIN)
    ("MAPK/p90 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("receptor (LPAR)" . SPARSER::RECEPTOR) ("/AKT" . SPARSER::COLLECTION)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY) ("MAPK/p90" . SPARSER::COLLECTION)
    ("RSK" . SPARSER::PROTEIN) ("LPA" . SPARSER::LPA)
    ("Growth factors" . SPARSER::GROWTH-FACTOR) ("MK-2206" . SPARSER::MOLECULE)
    ("gastrin-releasing peptide receptor" . SPARSER::PROTEIN)
    ("LPAR2" . SPARSER::PROTEIN) ("coagulation factor III" . SPARSER::PROTEIN)
    ("LPAR1" . SPARSER::PROTEIN) ("Ki16425" . SPARSER::MOLECULE)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MK2206" . SPARSER::DRUG) ("GSK690693" . SPARSER::DRUG)
    ("SL0101" . SPARSER::DRUG) ("GSK1120212" . SPARSER::DRUG)
    ("RSK1" . SPARSER::PROTEIN) ("YBX1" . SPARSER::PROTEIN)
    ("LPA3" . SPARSER::PROTEIN) ("LPA2" . SPARSER::PROTEIN)
    ("p90" . SPARSER::PROTEIN) ("Y-box binding protein-1" . SPARSER::PROTEIN)
    ("PRAK and BNIP3" . SPARSER::COLLECTION) ("PRAK" . SPARSER::PROTEIN)
    ("AMPK or TSC2" . SPARSER::COLLECTION)
    ("AMPK, TSC2 and Raptor" . SPARSER::COLLECTION)
    ("AMPK-TSC" . SPARSER::COLLECTION)
    ("other pro-apoptotic Bcl2 family proteins" . SPARSER::PROTEIN)
    ("AMPK , Lkb1 , Tsc1 or Tsc2" . SPARSER::COLLECTION)
    ("Tsc2" . SPARSER::PROTEIN) ("BNIP3 or FoxOs" . SPARSER::COLLECTION)
    ("BNIP3 or FoxO" . SPARSER::COLLECTION)
    ("either FoxO1 ( P = 1.6 × 10 −3 ; xref ) or FoxO3" . SPARSER::COLLECTION)
    ("FoxO and BNIP3" . SPARSER::COLLECTION)
    ("AMPK or Lkb1" . SPARSER::COLLECTION)
    ("FoxOs and LKB1-AMPK" . SPARSER::COLLECTION)
    ("The most obvious upstream regulator" . SPARSER::REGULATOR)
    ("at least one key downstream target" . SPARSER::TARGET-PROTEIN)
    ("FoxOs and BNIP3" . SPARSER::COLLECTION)
    ("other Bcl2 family prosurvival proteins" . SPARSER::PROTEIN)
    ("BNIP3 and Rheb" . SPARSER::COLLECTION)
    ("BNIP3-Rheb" . SPARSER::COLLECTION)
    ("FoxOs, BNIP3 and mTORC1" . SPARSER::COLLECTION)
    ("72 down-regulated genes (genes are up-regulated upon glucose starvation, and their expression levels are down-regulated in FoxO KO MEFs compared with WT MEFs under glucose starvation) and 10 up-regulated genes (genes are down-regulated upon glucose starvation, and their expression levels are up-regulated in FoxO KO MEFs under glucose starvation)"
     . SPARSER::COLLECTION)
    ("KO primary MEFs" . SPARSER::PROTEIN) ("Tsc1/FoxO" . SPARSER::COLLECTION)
    ("TSC and FoxOs" . SPARSER::COLLECTION)
    ("TSC2, or Raptor" . SPARSER::COLLECTION)
    ("FoxO1 and/or FoxO3" . SPARSER::COLLECTION)
    ("FoxO1 and/or FoxO3 (786-O, UOK101 and A498)" . SPARSER::COLLECTION)
    ("TSC/LKB1" . SPARSER::COLLECTION) ("Tsc1" . SPARSER::PROTEIN)
    ("caspase-3/PARP" . SPARSER::COLLECTION)
    ("LKB1-AMPK-TSC" . SPARSER::COLLECTION)
    ("FoxO1 or FoxO3" . SPARSER::COLLECTION)
    ("FoxO1 and FoxO3" . SPARSER::COLLECTION)
    ("LKB1 and TSC" . SPARSER::COLLECTION)
    ("LKB1, TSC1, TSC2 and FoxOs" . SPARSER::COLLECTION)
    ("FoxO1, FoxO3, and FoxO4" . SPARSER::COLLECTION)
    ("Rag" . SPARSER::PROTEIN)
    ("LKB1, AMPK, TSC1, or TSC2" . SPARSER::COLLECTION)
    ("TSC2 and Raptor" . SPARSER::COLLECTION)
    ("TSC1-TSC2" . SPARSER::COLLECTION)
    ("S6 kinase (S6K) and 4EBP1" . SPARSER::COLLECTION)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR) ("FoxO or BNIP3" . SPARSER::COLLECTION)
    ("FoxO-BNIP3" . SPARSER::COLLECTION)
    ("Rheb and Bcl2" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMPK and TSC" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("AMPK , Lkb1 or Tsc1/2" . SPARSER::COLLECTION)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FoxOs" . SPARSER::PROTEIN-FAMILY) ("FoxO" . SPARSER::PROTEIN-FAMILY)
    ("AMPK, LKB1, TSC1, and TSC2" . SPARSER::COLLECTION)
    ("LC3" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("LKB1-AMPK" . SPARSER::PROTEIN) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("FoxO4" . SPARSER::PROTEIN) ("FoxO3" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("RUVBL1" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("BNIP3" . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("Nonphosphorylatable Slug" . SPARSER::PROTEIN)
    ("nonphosphorylatable Slug" . SPARSER::PROTEIN)
    ("neither FBW7 (data not shown) nor β-trcp" . SPARSER::COLLECTION)
    ("FBW7 and β-trcp" . SPARSER::COLLECTION)
    ("p53-MDM2-Slug" . SPARSER::COLLECTION)
    ("Slug and N-cadherin" . SPARSER::COLLECTION)
    ("Akt and Erk1/2" . SPARSER::COLLECTION)
    ("EGF and p38" . SPARSER::COLLECTION)
    ("Snail, Slug, ZEB1, and β-catenin" . SPARSER::COLLECTION)
    ("the nonphosphorylatable Slug-4SA mutant" . SPARSER::MUTANT)
    ("these cells underwent EMT" . SPARSER::PROTEIN)
    ("those overexpressing nonphosphorylatable Slug-4SA" . SPARSER::PROTEIN)
    ("Slug, occludin and claudin-1" . SPARSER::COLLECTION)
    ("GSK3β-KD" . SPARSER::COLLECTION) ("Slug-4SA" . SPARSER::PROTEIN)
    ("Flag-Slug-4SA" . SPARSER::PROTEIN-PAIR)
    ("ectopically-expressed Flag-tagged Slug" . SPARSER::PROTEIN)
    ("proteasomes" . SPARSER::PROTEIN)
    ("constitutively-active or kinase-inactive" . SPARSER::COLLECTION)
    ("GST-S100" . SPARSER::PROTEIN-PAIR)
    ("recombinant GSK3β and GST-tagged Slug" . SPARSER::COLLECTION)
    ("Slug and GSK3β" . SPARSER::COLLECTION)
    ("ectopically-expressed GSK3β and Slug" . SPARSER::COLLECTION)
    ("GSK3β and Slug" . SPARSER::COLLECTION)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("Ectopically-produced Flag-tagged Slug" . SPARSER::PROTEIN)
    ("VIII" . SPARSER::PROTEIN) ("Akt and MAPK" . SPARSER::COLLECTION)
    ("CFTR" . SPARSER::PROTEIN)
    ("Snail, NF-κB, and cAMP response element binding protein"
     . SPARSER::COLLECTION)
    ("nondegradable Slug" . SPARSER::PROTEIN) ("pSer" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG)
    ("Reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S100A" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-2-like" . SPARSER::PROTEIN) ("pro-oxidant" . SPARSER::MOLECULE)
    ("claudin-1" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("GSK3α" . SPARSER::PROTEIN) ("CL1-5" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("cAMP response element binding protein" . SPARSER::PROTEIN)
    ("Hsc70-interacting protein" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase 3 beta" . SPARSER::PROTEIN)
    ("other monomeric RING and U-box E3s" . SPARSER::MOLECULE)
    ("a multi-subunit Cullin-RING ligase (CRL) and the U-box E4B"
     . SPARSER::COLLECTION)
    ("ligase (CRL)" . SPARSER::LIGASE) ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Several monomeric RING and U-box E3s" . SPARSER::MOLECULE)
    ("other monomeric E3s" . SPARSER::MOLECULE)
    ("several dimeric and monomeric RING E3s" . SPARSER::MOLECULE)
    ("other monomeric RING E3s" . SPARSER::MOLECULE)
    ("Siz1" . SPARSER::PROTEIN) ("the E3 and Ub’s" . SPARSER::COLLECTION)
    ("E3 and Ub" . SPARSER::COLLECTION) ("Ubc9 and SUMO" . SPARSER::COLLECTION)
    ("SUMO" . SPARSER::PROTEIN)
    ("conformation and position Ub’s" . SPARSER::PROTEIN)
    ("conformation and position" . SPARSER::COLLECTION)
    ("pCBL-B LRR K381A and Ub T9A" . SPARSER::COLLECTION)
    ("pCBL-B LRR and wild type Ub ( xref and xref )" . SPARSER::COLLECTION)
    ("helix" . SPARSER::PROTEIN) ("helix–Ub" . SPARSER::PROTEIN-PAIR)
    ("Ub–UbcH5B" . SPARSER::COLLECTION)
    ("these two dimeric RING E3s" . SPARSER::MOLECULE)
    ("the dimeric RING E3s" . SPARSER::MOLECULE)
    ("the dimeric RING E3s BIRC7 and RNF4" . SPARSER::COLLECTION)
    ("BIRC7 and RNF4" . SPARSER::COLLECTION) ("UbcH5–Ub" . SPARSER::COLLECTION)
    ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LRR" . SPARSER::PROTEIN)
    ("precisely position Ub" . SPARSER::PROTEIN) ("DUBA" . SPARSER::PROTEIN)
    ("UbcH5B and ZAP-70" . SPARSER::COLLECTION)
    ("The heterotrimeric protein-peptide complex" . SPARSER::BIO-COMPLEX)
    ("CBL-B and c-CBL" . SPARSER::COLLECTION)
    ("monomeric RING E3-mediated Ub" . SPARSER::PROTEIN)
    ("the terminal glycine of Ub" . SPARSER::PROTEIN)
    ("Cys" . SPARSER::AMINO-ACID)
    ("monomeric RING-mediated Ub" . SPARSER::PROTEIN)
    ("pTyr363 directly contacts Ub’s" . SPARSER::PROTEIN)
    ("pTyr363 directly contacts Ub" . SPARSER::PROTEIN)
    ("UbcH5B–Ub" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and ZAP-70"
     . SPARSER::COLLECTION)
    ("RTKs and non-RTKs" . SPARSER::COLLECTION) ("LHR" . SPARSER::PROTEIN)
    ("c-CBL, CBL-B, and CBL-C" . SPARSER::COLLECTION)
    ("CBL" . SPARSER::PROTEIN) ("optimal Ub" . SPARSER::PROTEIN)
    ("E2 and Ub" . SPARSER::COLLECTION)
    ("dimeric RING E3s" . SPARSER::MOLECULE)
    ("E3, E2 and Ub" . SPARSER::COLLECTION)
    ("cysteine and histidine" . SPARSER::COLLECTION)
    ("the C-terminal glycine of Ub" . SPARSER::PROTEIN)
    ("substrate and E2~Ub" . SPARSER::COLLECTION)
    ("catalytic cysteine and the C-terminal glycine" . SPARSER::COLLECTION)
    ("catalytic cysteine" . SPARSER::AMINO-ACID)
    ("thioester" . SPARSER::MOLECULE) ("E2 and E3" . SPARSER::COLLECTION)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both monomeric and dimeric RING E3s" . SPARSER::MOLECULE)
    ("a monomeric RING E3" . SPARSER::MOLECULE)
    ("monomeric RING E3s" . SPARSER::MOLECULE)
    ("inorganic pyrophosphatase" . SPARSER::PROTEIN) ("A–P" . SPARSER::PROTEIN)
    ("Gly-Ser" . SPARSER::MOLECULE) ("CDC34" . SPARSER::PROTEIN)
    ("RING finger protein" . SPARSER::PROTEIN) ("RBX1" . SPARSER::PROTEIN)
    ("Zn 2+" . SPARSER::MOLECULE) ("Ubc9" . SPARSER::PROTEIN)
    ("RNF4" . SPARSER::PROTEIN) ("BIRC7" . SPARSER::PROTEIN)
    ("UbcH5" . SPARSER::PROTEIN) ("K11" . SPARSER::PROTEIN)
    ("B-E" . SPARSER::PROTEIN) ("E-H" . SPARSER::PROTEIN)
    ("B–E" . SPARSER::PROTEIN) ("UbcH5B" . SPARSER::PROTEIN)
    ("ZAP-70" . SPARSER::PROTEIN) ("CBL-C" . SPARSER::PROTEIN)
    ("CBL-B" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("ERCC1 and RRM1" . SPARSER::COLLECTION)
    ("a larger patient cohort" . SPARSER::MOLECULE)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("BRCA1-BARD1" . SPARSER::COLLECTION)
    ("PDAC" . SPARSER::MOLECULE) ("RRM1" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("AG014699" . SPARSER::DRUG)
    ("BSI-201" . SPARSER::DRUG)
    ("a premature stop codon and non-functional RhoH protein"
     . SPARSER::PROTEIN)
    ("LAD" . SPARSER::PROTEIN)
    ("chemotaxis and superoxide" . SPARSER::COLLECTION)
    ("proteins, Rac2 and RhoH" . SPARSER::COLLECTION)
    ("the putative disease-associated genes" . SPARSER::GENE)
    ("Zap70 and Lck" . SPARSER::COLLECTION) ("NKT" . SPARSER::PROTEIN)
    ("tyrosine kinase (CSK)" . SPARSER::PROTEIN)
    ("c-src" . SPARSER::COLLECTION) ("CSK" . SPARSER::PROTEIN)
    ("Lck" . SPARSER::PROTEIN) ("Syk" . SPARSER::PROTEIN)
    ("Zap70" . SPARSER::PROTEIN) ("TCRβ and CD3ε" . SPARSER::COLLECTION)
    ("CD5 and CD69" . SPARSER::COLLECTION)
    ("RhoH, DN2 and DN3" . SPARSER::COLLECTION)
    ("CD25 and CD44" . SPARSER::COLLECTION) ("histamine" . SPARSER::PROTEIN)
    ("RI" . SPARSER::MOLECULE) ("atypical GTPases" . SPARSER::GTPASE)
    ("Rac2 deletion alone causes defective receptor" . SPARSER::RECEPTOR)
    ("classical severe combined immunodeficiency (SCID)" . SPARSER::PROTEIN)
    ("CD11b/CD18" . SPARSER::COLLECTION)
    ("showed sparse infiltrating neutrophils" . SPARSER::PROTEIN)
    ("a vital component" . SPARSER::COMPONENT)
    ("bactericidal substances" . SPARSER::SUBSTANCE)
    ("Neutrophils" . SPARSER::PROTEIN)
    ("the mutated molecule" . SPARSER::MOLECULE)
    ("FcR" . SPARSER::PROTEIN-FAMILY)
    ("GlyCAM-1 and defective chemotaxis" . SPARSER::COLLECTION)
    ("defective chemotaxis" . SPARSER::PROTEIN)
    ("fMLP, IL8 and LTB4" . SPARSER::COLLECTION)
    ("mature neutrophils" . SPARSER::PROTEIN)
    ("hemoglobin and T cell" . SPARSER::COLLECTION)
    ("phagocytic oxidants" . SPARSER::MOLECULE)
    ("phagocytic cells Rac1 and Rac2" . SPARSER::COLLECTION)
    ("Rac1 and Rac2" . SPARSER::COLLECTION)
    ("agonist and cell type" . SPARSER::COLLECTION)
    ("active (CA)" . SPARSER::ACTIVE) ("Wiscott" . SPARSER::PROTEIN)
    ("RhoB, RhoD, RhoE and RhoH" . SPARSER::COLLECTION)
    ("Rac, RhoA and CDC42" . SPARSER::COLLECTION)
    ("Rac and RhoA" . SPARSER::COLLECTION)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("NFkB, RhoB and RhoH" . SPARSER::COLLECTION) ("RhoB" . SPARSER::PROTEIN)
    ("NFkB" . SPARSER::PROTEIN) ("RhoE" . SPARSER::PROTEIN)
    ("LCK and the LAT signalosome" . SPARSER::COLLECTION)
    ("LAT" . SPARSER::PROTEIN) ("LCK" . SPARSER::PROTEIN)
    ("Rhoh" . SPARSER::PROTEIN) ("hypermutable gene" . SPARSER::GENE)
    ("an atypical Rho GTPase" . SPARSER::PROTEIN)
    ("the phagocytic oxidase complex" . SPARSER::BIO-COMPLEX)
    ("p42/44 and p38 MAPK, JNK and Akt" . SPARSER::COLLECTION)
    ("fMLP" . SPARSER::PROTEIN) ("Phenylalanine" . SPARSER::AMINO-ACID)
    ("Formylmethionyl" . SPARSER::MOLECULE)
    ("Rac1 and Rac3" . SPARSER::COLLECTION)
    ("three highly homologous members Rac1, Rac2 and Rac3"
     . SPARSER::COLLECTION)
    ("Rac1, Rac2 and Rac3" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factors (GEF)" . SPARSER::GEF)
    ("inhibitors (GDI)" . SPARSER::INHIBITOR)
    ("proteins (GAP)" . SPARSER::PROTEIN) ("MIRO" . SPARSER::PROTEIN)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("effectors and regulators" . SPARSER::COLLECTION)
    ("Rac and RhoH" . SPARSER::COLLECTION)
    ("RAC2 and RHOH" . SPARSER::COLLECTION) ("RHOH" . SPARSER::PROTEIN)
    ("an atypical GTPase" . SPARSER::GTPASE)
    ("Rac2 and RhoH" . SPARSER::COLLECTION) ("RhoH" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("CD3ε" . SPARSER::PROTEIN)
    ("TCRβ" . SPARSER::PROTEIN) ("DN4" . SPARSER::PROTEIN)
    ("SDF1" . SPARSER::PROTEIN) ("CD18" . SPARSER::PROTEIN)
    ("anti-microbial" . SPARSER::DRUG) ("LTB4" . SPARSER::PROTEIN)
    ("GlyCAM-1" . SPARSER::PROTEIN) ("p67phox" . SPARSER::PROTEIN)
    ("P29S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZAP70" . SPARSER::PROTEIN)
    ("Rac3" . SPARSER::PROTEIN) ("Ha-Ras" . SPARSER::PROTEIN)
    ("RAC2" . SPARSER::PROTEIN) ("Rac2" . SPARSER::PROTEIN)
    ("ULBP-1 or ULBP-2" . SPARSER::COLLECTION)
    ("ULBP-1 and ULBP-2" . SPARSER::COLLECTION)
    ("antiviral protein SAMHD1" . SPARSER::PROTEIN)
    ("CRL4-DCAF1" . SPARSER::COLLECTION) ("cellular Dicer" . SPARSER::PROTEIN)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("The flock house virus B2 protein more generally targets double stranded RNA"
     . SPARSER::RNA)
    ("The tomato bushy stunt virus protein p19" . SPARSER::PROTEIN)
    ("RNA or protein" . SPARSER::COLLECTION)
    ("a viral protein" . SPARSER::PROTEIN)
    ("Dicer, Vpr and Cul4" . SPARSER::COLLECTION)
    ("Vpr or siRNA-mediated" . SPARSER::COLLECTION)
    ("vpr(+) or vpr(−)" . SPARSER::COLLECTION) ("BaL" . SPARSER::PROTEIN)
    ("specifically targets human Dicer or a non-targeting control siRNA"
     . SPARSER::COLLECTION)
    ("specifically targets human Dicer" . SPARSER::PROTEIN)
    ("primary human monocyte-derived macrophages (MDM)" . SPARSER::PROTEIN)
    ("macrophages and Dicer" . SPARSER::COLLECTION)
    ("shLuc/Vpr" . SPARSER::COLLECTION)
    ("Dicer and the CRL4 DCAF1 complex" . SPARSER::COLLECTION)
    ("Cul4, DCAF1, or DDB1" . SPARSER::COLLECTION)
    ("Cul4A or DCAF1" . SPARSER::COLLECTION)
    ("FLAG-Cul4A neither Dicer nor Vpr" . SPARSER::COLLECTION)
    ("FLAG-Cul4A" . SPARSER::COLLECTION) ("FLAG–Cul4A" . SPARSER::COLLECTION)
    ("Myc-Dicer" . SPARSER::COLLECTION)
    ("Vpr R80A and Vpr R90K" . SPARSER::COLLECTION)
    ("Vpr W54R and Vpr R90K" . SPARSER::COLLECTION)
    ("wild-type Vpr or well-characterized Vpr mutants ( xref )"
     . SPARSER::COLLECTION)
    ("FLAG-epitope-tagged Dicer" . SPARSER::PROTEIN)
    ("epoxomicin" . SPARSER::DRUG)
    ("Vpr and the CRL4 DCAF1 ubiquitin ligase complex" . SPARSER::COLLECTION)
    ("Vpr and/or Vpx" . SPARSER::COLLECTION)
    ("Vpr and Vpx" . SPARSER::COLLECTION)
    ("Dicer and HIV-1 Vpr" . SPARSER::COLLECTION)
    ("FLAG–Vpr" . SPARSER::COLLECTION)
    ("FLAG-epitope-tagged HIV-1 Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the CRL4 ubiquitin ligase complex and both share" . SPARSER::COLLECTION)
    ("Dicer and Vpr" . SPARSER::COLLECTION)
    ("UNG2 and Vpr" . SPARSER::COLLECTION) ("uracil" . SPARSER::DRUG)
    ("Vif, Vpu and Vpx" . SPARSER::COLLECTION)
    ("the viral pre-integration complex (PIC)" . SPARSER::BIO-COMPLEX)
    ("cellular UNG2" . SPARSER::PROTEIN) ("cellular SAMHD1" . SPARSER::PROTEIN)
    ("Vpx" . SPARSER::PROTEIN) ("tetherin/BST-2" . SPARSER::COLLECTION)
    ("viral cytosines" . SPARSER::NUCLEOBASE)
    ("cytosines" . SPARSER::NUCLEOBASE)
    ("the host antiviral factor APOBEC3G" . SPARSER::PROTEIN)
    ("elonginBC-Cul5" . SPARSER::COLLECTION)
    ("primate foamy virus type 1 Tas protein ( xref ) and hepatitis C core protein ( xref )"
     . SPARSER::COLLECTION)
    ("primate foamy virus type 1 Tas protein" . SPARSER::PROTEIN)
    ("the RNA and process" . SPARSER::COLLECTION)
    ("specifically target other viral or cellular RNA" . SPARSER::RNA)
    ("MDMs" . SPARSER::PROTEIN) ("endoribonuclease" . SPARSER::PROTEIN)
    ("UNG2 and SMUG1" . SPARSER::COLLECTION) ("EF-1" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("ULBP-2" . SPARSER::PROTEIN) ("ULBP-1" . SPARSER::PROTEIN)
    ("protein p19" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("Cul4A" . SPARSER::PROTEIN) ("90K" . SPARSER::PROTEIN)
    ("NKG2D" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("cytidine deaminase" . SPARSER::PROTEIN) ("Cul5" . SPARSER::PROTEIN)
    ("SMUG1" . SPARSER::PROTEIN) ("UNG2" . SPARSER::PROTEIN)
    ("DCAF1" . SPARSER::PROTEIN) ("CRL4" . SPARSER::PROTEIN)
    ("IB, JMP, and EP" . SPARSER::COLLECTION)
    ("BP, and MH" . SPARSER::COLLECTION) ("BP" . SPARSER::PROTEIN)
    ("EP" . SPARSER::PROTEIN) ("JMP and IB" . SPARSER::COLLECTION)
    ("JMP" . SPARSER::PROTEIN) ("MH" . SPARSER::MOLECULE)
    ("KL" . SPARSER::PROTEIN) ("MV, DV, IB, and PW" . SPARSER::COLLECTION)
    ("PW" . SPARSER::MOLECULE) ("DV" . SPARSER::MOLECULE)
    ("MV" . SPARSER::PROTEIN)
    ("potential diagnostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("RAS-PI3K-AKT" . SPARSER::COLLECTION) ("subsets" . SPARSER::PROTEIN)
    ("indirect activator" . SPARSER::ACTIVATOR)
    ("CCND1 and E2F1" . SPARSER::COLLECTION)
    ("HOXA1 , HOXA9 , and HOXA3" . SPARSER::COLLECTION)
    ("HOXA3 and HOXD10" . SPARSER::COLLECTION) ("HOXB" . SPARSER::PROTEIN)
    ("GTPases or RHO" . SPARSER::COLLECTION)
    ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RHOC" . SPARSER::PROTEIN)
    ("the pro-metastatic RhoC" . SPARSER::PROTEIN) ("RhoC" . SPARSER::PROTEIN)
    ("RAS [ xref ] and HMGA2 [ xref ]" . SPARSER::COLLECTION)
    ("ZEB1 [ xref ] and ZEB2" . SPARSER::COLLECTION)
    ("Pten and Nf1" . SPARSER::COLLECTION) ("Nf1" . SPARSER::PROTEIN)
    ("onco-miR" . SPARSER::PROTEIN-PAIR)
    ("DGCR8 and/or AGO2" . SPARSER::COLLECTION)
    ("DICER , DROSHA , DGCR8 and AGO2" . SPARSER::COLLECTION)
    ("their previously identified target genes" . SPARSER::GENE)
    ("These paralogous miRNAs" . SPARSER::PROTEIN)
    ("paralogous miRNAs" . SPARSER::PROTEIN)
    ("gene, and miR-19a, miR-18a, miR-20a, and miR-19b" . SPARSER::COLLECTION)
    ("GABRE" . SPARSER::PROTEIN) ("PN1 and PN2" . SPARSER::COLLECTION)
    ("PNF" . SPARSER::PROTEIN) ("ath" . SPARSER::MOLECULE)
    ("TP53 and PTEN" . SPARSER::COLLECTION)
    ("TP53 , RB1 , CDKN2A , TWIST1 , BIRC5 , TOP2A , and SOX9"
     . SPARSER::COLLECTION)
    ("TP53 and RB1" . SPARSER::COLLECTION)
    ("EGFR , HGF , and MET" . SPARSER::COLLECTION)
    ("Neurofibromin" . SPARSER::PROTEIN) ("RAS-GAP" . SPARSER::COLLECTION)
    ("RAS-GTPase-activating protein" . SPARSER::COLLECTION)
    ("neurofibromin" . SPARSER::PROTEIN) ("Lisch" . SPARSER::PROTEIN)
    ("miR-301a" . SPARSER::COLLECTION) ("HOX" . SPARSER::PROTEIN)
    ("RAS-MAPK" . SPARSER::COLLECTION)
    ("the major tumor suppressor gene" . SPARSER::PROTEIN)
    ("TATA box binding protein" . SPARSER::PROTEIN) ("RAF1" . SPARSER::PROTEIN)
    ("HIF1A" . SPARSER::PROTEIN) ("CCNE1" . SPARSER::PROTEIN)
    ("CDX2" . SPARSER::PROTEIN) ("HOXA3" . SPARSER::PROTEIN)
    ("HOXA1" . SPARSER::PROTEIN) ("HOXD10" . SPARSER::PROTEIN)
    ("MiR-10b" . SPARSER::MOLECULE) ("MiR-200c" . SPARSER::MOLECULE)
    ("CDH1" . SPARSER::PROTEIN) ("RREB1" . SPARSER::PROTEIN)
    ("MAP3K8" . SPARSER::PROTEIN) ("AGO2" . SPARSER::PROTEIN)
    ("DGCR8" . SPARSER::PROTEIN) ("HMGA2" . SPARSER::PROTEIN)
    ("MCM7" . SPARSER::PROTEIN) ("SKA2" . SPARSER::PROTEIN)
    ("PN1" . SPARSER::PROTEIN) ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("miR-10" . SPARSER::PROTEIN) ("let-7" . SPARSER::RNA)
    ("miR-200c" . SPARSER::MOLECULE) ("miR-10b" . SPARSER::MOLECULE)
    ("301a" . SPARSER::PROTEIN) ("miR-181a" . SPARSER::MOLECULE)
    ("a popular vaccine target" . SPARSER::TARGET-PROTEIN)
    ("Fas-" . SPARSER::PROTEIN)
    ("Fas (CD95) and Fas ligand (CD95L)" . SPARSER::COLLECTION)
    ("Hck" . SPARSER::PROTEIN) ("viral proteases" . SPARSER::PROTEIN)
    ("Gag–Pol and AIPI" . SPARSER::COLLECTION)
    ("CDC42 and the DOCK2–ELMO1 complex" . SPARSER::COLLECTION)
    ("DOCK2–ELMO1" . SPARSER::COLLECTION) ("Pak-2" . SPARSER::COLLECTION)
    ("Pak" . SPARSER::PROTEIN)
    ("a multifarious molecular adaptor protein" . SPARSER::PROTEIN)
    ("Nef-deleted mutants" . SPARSER::MUTANT)
    ("Pak2, Vav and Rac" . SPARSER::COLLECTION) ("Vav" . SPARSER::PROTEIN)
    ("a tiny (206-amino acid) myristoylated protein" . SPARSER::PROTEIN)
    ("myristoylated" . SPARSER::PROTEIN)
    ("two regulatory genes ( tat and rev ) and four accessory genes ( vif , vpu , vpr and nef )"
     . SPARSER::COLLECTION)
    ("three structural genes ( gag , pol and env ), two regulatory genes ( tat and rev ) and four accessory genes ( vif , vpu , vpr and nef )"
     . SPARSER::COLLECTION)
    ("four accessory genes" . SPARSER::GENE)
    ("pol and env" . SPARSER::COLLECTION)
    ("Bcl-2-associated death promoter" . SPARSER::PROTEIN)
    ("CD95L" . SPARSER::PROTEIN)
    ("actin-depolymerizing factor" . SPARSER::PROTEIN)
    ("sCD23" . SPARSER::PROTEIN) ("Gag–Pol" . SPARSER::PROTEIN)
    ("ELMO1" . SPARSER::PROTEIN) ("DOCK2" . SPARSER::PROTEIN)
    ("Pak2" . SPARSER::PROTEIN)
    ("proteinases and cytokines" . SPARSER::COLLECTION)
    ("plasminogen" . SPARSER::PROTEIN) ("Osx" . SPARSER::PROTEIN)
    ("protein and promoter" . SPARSER::COLLECTION)
    ("regulators of tissue remodeling and repair" . SPARSER::COLLECTION)
    ("mature osteoclasts" . SPARSER::PROTEIN)
    ("receptor (VDR)" . SPARSER::RECEPTOR) ("VDR" . SPARSER::PROTEIN)
    ("calcium and phosphorus" . SPARSER::COLLECTION)
    ("collagen and aggrecan" . SPARSER::COLLECTION)
    ("aggrecan" . SPARSER::PROTEIN) ("Col2a1" . SPARSER::PROTEIN)
    ("beta-gal" . SPARSER::PROTEIN) ("K 5" . SPARSER::PROTEIN)
    ("IgG 1" . SPARSER::BIO-COMPLEX) ("vitamin D" . SPARSER::MOLECULE)
    ("Vitamin D" . SPARSER::MOLECULE) ("Mmp13" . SPARSER::PROTEIN)
    ("collagenase 3" . SPARSER::PROTEIN) ("MMP13" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("cause detrimental DNA" . SPARSER::DNA)
    ("various oxidative metabolites" . SPARSER::PROTEIN)
    ("UV-induced NER" . SPARSER::PROTEIN)
    ("Gadd45a, PCNA and APE1" . SPARSER::COLLECTION)
    ("c-jun and p53" . SPARSER::COLLECTION)
    ("methylguanine" . SPARSER::MOLECULE)
    ("BER-associated proteins" . SPARSER::PROTEIN)
    ("Se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("micronutrient" . SPARSER::MOLECULE) ("purines" . SPARSER::DRUG)
    ("the antioxidant organic selenium" . SPARSER::MOLECULE)
    ("17-mer THF-containing duplex oligonucleotides" . SPARSER::MOLECULE)
    ("mers" . SPARSER::PROTEIN) ("Gadd45a and PCNA" . SPARSER::COLLECTION)
    ("the organic selenium compound SeMet" . SPARSER::DRUG)
    ("APE" . SPARSER::PROTEIN) ("PCNA and APE1/Ref-1" . SPARSER::COLLECTION)
    ("APE1/Ref1" . SPARSER::COLLECTION)
    ("UV-damaged chromatin" . SPARSER::PROTEIN)
    ("Gadd45 (or Gadd45a, growth arrest and DNA damage-inducible gene) and p21 (Waf1/Cip1, a cyclin-dependent kinase inhibitor)"
     . SPARSER::COLLECTION)
    ("p53 and its downstream gene gadd45a" . SPARSER::COLLECTION)
    ("Organic selenium SeMet" . SPARSER::DRUG) ("carotene" . SPARSER::MOLECULE)
    ("the organic forms" . SPARSER::FORM) ("selenide" . SPARSER::MOLECULE)
    ("both the inorganic and organic forms" . SPARSER::FORM)
    ("Gadd45a and repair proteins" . SPARSER::COLLECTION)
    ("the organic selenium" . SPARSER::MOLECULE)
    ("proliferating cell nuclear antigen (PCNA) and apurinic/apyrimidinic endonuclease (APE1/Ref-1)"
     . SPARSER::COLLECTION)
    ("growth arrest and DNA damage-inducible protein 45A" . SPARSER::PROTEIN)
    ("APE1/Ref-1" . SPARSER::COLLECTION)
    ("organic selenium" . SPARSER::MOLECULE) ("SeMet" . SPARSER::DRUG)
    ("Organic selenium" . SPARSER::MOLECULE) ("selenium" . SPARSER::MOLECULE)
    ("c-jun" . SPARSER::PROTEIN)
    ("N-methylpurine DNA glycosylase" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE) ("p48" . SPARSER::PROTEIN)
    ("endonuclease activity" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("Ref1" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gadd45a" . SPARSER::PROTEIN) ("Ref-1" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN) ("Gadd45a" . SPARSER::PROTEIN)
    ("Caspase-3- and -7-dependent" . SPARSER::COLLECTION)
    ("Caspase-3-" . SPARSER::PROTEIN)
    ("important predictive biomarkers" . SPARSER::MOLECULE)
    ("Caspase-3 and -7" . SPARSER::COLLECTION)
    ("Caspase-3 and β -catenin" . SPARSER::COLLECTION)
    ("particular Caspase-3" . SPARSER::PROTEIN)
    ("subsequent PGE 2" . SPARSER::DRUG)
    ("Caspase-3 or Caspase-7" . SPARSER::COLLECTION)
    ("Caspase-3−/− lethally irradiated MEFs" . SPARSER::PROTEIN)
    ("silicone" . SPARSER::MOLECULE) ("fmk" . SPARSER::PROTEIN)
    ("LPC" . SPARSER::PROTEIN) ("Lysophosphatidylcholine" . SPARSER::MOLECULE)
    ("iPLA" . SPARSER::PROTEIN) ("DAMPs" . SPARSER::DAMP)
    ("CYLD" . SPARSER::PROTEIN) ("Caspases" . SPARSER::PROTEIN)
    ("phosphatases and other signalling molecules" . SPARSER::COLLECTION)
    ("kinases, phosphatases and other signalling molecules"
     . SPARSER::COLLECTION)
    ("the key proteases" . SPARSER::PROTEIN)
    ("Caspase-3 and Caspase-7" . SPARSER::COLLECTION) ("PGE 2" . SPARSER::DRUG)
    ("Prostaglandin E 2" . SPARSER::MOLECULE) ("Wnt3" . SPARSER::PROTEIN)
    ("Calcium-independent phospholipase A 2" . SPARSER::PROTEIN)
    ("RIP3" . SPARSER::PROTEIN) ("Caspase-8" . SPARSER::PROTEIN)
    ("DFF45" . SPARSER::PROTEIN)
    ("DNA fragmentation factor" . SPARSER::PROTEIN)
    ("Bax/Bcl-2" . SPARSER::COLLECTION) ("Akt and ER" . SPARSER::COLLECTION)
    ("a multifunctional serine/threonine kinase" . SPARSER::KINASE)
    ("glycogen" . SPARSER::PROTEIN)
    ("the possible critical target-related protein" . SPARSER::PROTEIN)
    ("BIM as well as other BH-3-only proteins" . SPARSER::COLLECTION)
    ("CHOP, BIM, TOM22 and Bax" . SPARSER::COLLECTION)
    ("CHOP and XBP1s" . SPARSER::COLLECTION)
    ("a ER stress-activated protein, and TOM22" . SPARSER::COLLECTION)
    ("protein, and TOM22" . SPARSER::COLLECTION)
    ("p-GSK3 β" . SPARSER::COLLECTION)
    ("a classical apoptosis inducer" . SPARSER::MOLECULE)
    ("the total 172 possible target-related proteins" . SPARSER::PROTEIN)
    ("Protein–protein" . SPARSER::COLLECTION)
    ("≥2 unique peptides" . SPARSER::PEPTIDE)
    ("totally 1999 unique proteins" . SPARSER::PROTEIN)
    ("ER/microsomal vesicles-rich fraction" . SPARSER::COMPONENT)
    ("Further work using siRNA" . SPARSER::PROTEIN)
    ("BIM and PUMA" . SPARSER::COLLECTION) ("GFP-Bax" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("salubrinal" . SPARSER::DRUG) ("PERK, IRE1 and Bip" . SPARSER::COLLECTION)
    ("kinase (PERK)" . SPARSER::KINASE) ("eIF2" . SPARSER::PROTEIN)
    ("p-IRE1" . SPARSER::COLLECTION) ("p-JNK" . SPARSER::COLLECTION)
    ("Bip/GRP78" . SPARSER::COLLECTION) ("CHOP" . SPARSER::PROTEIN)
    ("Bip" . SPARSER::PROTEIN) ("PERK" . SPARSER::PROTEIN)
    ("a ER stress-activated protein" . SPARSER::PROTEIN)
    ("a possible target-related protein" . SPARSER::PROTEIN)
    ("ER and mitochondria" . SPARSER::COLLECTION)
    ("the nucleophilic thiol" . SPARSER::MOLECULE)
    ("proteins and form" . SPARSER::COLLECTION) ("quinine" . SPARSER::DRUG)
    ("triterpene" . SPARSER::MOLECULE)
    ("the most promising medicinal molecules" . SPARSER::MOLECULE)
    ("Hook" . SPARSER::PROTEIN-FAMILY) ("triterpenoid" . SPARSER::MOLECULE)
    ("LiCL" . SPARSER::DRUG)
    ("possible target-related proteins" . SPARSER::PROTEIN)
    ("ER and ER-related fractions" . SPARSER::COLLECTION)
    ("further search possible target-related proteins" . SPARSER::PROTEIN)
    ("Celastrol" . SPARSER::MOLECULE)
    ("Possible target-related proteins" . SPARSER::PROTEIN)
    ("a possible direct target" . SPARSER::TARGET-PROTEIN)
    ("proteins and undirect" . SPARSER::COLLECTION)
    ("celastrol" . SPARSER::MOLECULE) ("TOM20" . SPARSER::PROTEIN)
    ("TOM7" . SPARSER::PROTEIN) ("TOM6" . SPARSER::PROTEIN)
    ("TOM5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PSMB6" . SPARSER::PROTEIN)
    ("MgCL 2" . SPARSER::MOLECULE) ("CCL-2" . SPARSER::PROTEIN)
    ("TOM 22" . SPARSER::PROTEIN) ("IRE1 α" . SPARSER::PROTEIN)
    ("TOM70" . SPARSER::PROTEIN) ("XBP1s" . SPARSER::PROTEIN)
    ("caspase-4" . SPARSER::PROTEIN)
    ("C/EBP-homologous protein" . SPARSER::PROTEIN) ("IRE1" . SPARSER::PROTEIN)
    ("chymotrypsin-like" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("β 5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("z-VAD-FMK" . SPARSER::DRUG)
    ("TOM22" . SPARSER::PROTEIN) ("Tom22" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endoplasmic reticulum protein 29" . SPARSER::PROTEIN)
    ("Notch1 and Notch2" . SPARSER::COLLECTION)
    ("Kras or Trp53 genotype" . SPARSER::COLLECTION)
    ("oncogene or tumor" . SPARSER::COLLECTION)
    ("Notch1 and Notch ligands Jag1/2" . SPARSER::COLLECTION)
    ("ITGB4 and Notch1–4" . SPARSER::COLLECTION)
    ("Notch 1 or Notch 2" . SPARSER::COLLECTION) ("PDX" . SPARSER::PROTEIN)
    ("Kras and EGFR" . SPARSER::COLLECTION)
    ("Notch3 or GFP" . SPARSER::COLLECTION)
    ("Notch1, Notch2 or Notch4" . SPARSER::COLLECTION)
    ("GSIs" . SPARSER::PROTEIN) ("Hes1 and Hey1" . SPARSER::COLLECTION)
    ("inhibitor (GSI)" . SPARSER::INHIBITOR)
    ("Cisplatin or vehicle" . SPARSER::COLLECTION)
    ("a smaller fraction" . SPARSER::COMPONENT)
    ("CD24, ITGB4 and Notch 1–4" . SPARSER::COLLECTION)
    ("the Notch receptors had higher expression of the canonical Notch target genes Hey1 and DTX1"
     . SPARSER::RECEPTOR)
    ("Hey1 and DTX1" . SPARSER::COLLECTION)
    ("Numb and Numb-Like" . SPARSER::COLLECTION) ("Numb" . SPARSER::PROTEIN)
    ("Notch1, Notch2 and Notch4" . SPARSER::COLLECTION)
    ("ITGB4 and Notch3" . SPARSER::COLLECTION) ("Igf1r" . SPARSER::PROTEIN)
    ("insulin growth factor receptor 1( igf1r ), CD133 ( Prominin1) , integrin β4 (CD104, Itgb4 ) and Notch3 ( Notch3)"
     . SPARSER::COLLECTION)
    ("Itgb4" . SPARSER::PROTEIN) ("igf1r" . SPARSER::PROTEIN)
    ("CD133, CD44 and CD166" . SPARSER::COLLECTION)
    ("a semi-solid matrix" . SPARSER::PROTEIN-FAMILY)
    ("KrasG" . SPARSER::PROTEIN)
    ("the lung epithelial markers Nkx2.1 (thyroid transcription factor 1, TTF-1) and Sftpc (surfactant protein C, SP-C)"
     . SPARSER::COLLECTION)
    ("Sftpc" . SPARSER::PROTEIN) ("PECAM" . SPARSER::PROTEIN)
    ("cytometry (FACS)" . SPARSER::PROTEIN)
    ("conditional reporter lines carrying Cre-inducible alleles"
     . SPARSER::ALLELE)
    ("Notch1 and Notch3" . SPARSER::COLLECTION)
    ("a significant desmoplastic stromal component" . SPARSER::COMPONENT)
    ("a residual mesenchymal cell component" . SPARSER::COMPONENT)
    ("CD133, CD44 or CD166" . SPARSER::COLLECTION) ("TPCs" . SPARSER::PROTEIN)
    ("Hey2" . SPARSER::PROTEIN) ("Hes5" . SPARSER::PROTEIN)
    ("Jag1" . SPARSER::PROTEIN) ("Hes-1" . SPARSER::PROTEIN)
    ("Notch 2" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("Notch 1" . SPARSER::PROTEIN) ("Numb-Like" . SPARSER::PROTEIN)
    ("DTX1" . SPARSER::PROTEIN) ("Hey1" . SPARSER::PROTEIN)
    ("Notch4" . SPARSER::PROTEIN) ("Notch2" . SPARSER::PROTEIN)
    ("CD104" . SPARSER::PROTEIN) ("Prominin1" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("SP-C" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("transcription factor 1" . SPARSER::PROTEIN)
    ("Nkx2.1" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("ITGB4" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("Mek, PI3K, and BRAF-inhibitors" . SPARSER::COLLECTION)
    ("p19  Arf or p16  Ink4a" . SPARSER::COLLECTION)
    ("Kras" . SPARSER::PROTEIN) ("PLX4720 and GDC0941" . SPARSER::COLLECTION)
    ("PD0325901 or vehicle" . SPARSER::COLLECTION)
    ("Nod" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Braf/PI3K" . SPARSER::COLLECTION)
    ("PLX4720 and Gefitinib" . SPARSER::COLLECTION)
    ("Gefitinib and PLX4720" . SPARSER::COLLECTION)
    ("Apc, Ctnnb1 , and Lrp1b" . SPARSER::COLLECTION)
    ("Apc , Ctnnb1 , Gsk3b , and Axin2" . SPARSER::COLLECTION)
    ("Lrp8 and Fzd9" . SPARSER::COLLECTION)
    ("Lrp1b and Lrp4" . SPARSER::COLLECTION) ("Lrp4" . SPARSER::PROTEIN)
    ("Lrp1b" . SPARSER::PROTEIN) ("Fzd9" . SPARSER::PROTEIN)
    ("Lrp8" . SPARSER::PROTEIN) ("Gsk3b" . SPARSER::PROTEIN)
    ("Fzd" . SPARSER::PROTEIN-FAMILY) ("Fosl1" . SPARSER::PROTEIN)
    ("Etv4 and Etv5 or cMyc and Ccnd1 , and genes" . SPARSER::COLLECTION)
    ("Etv5 or cMyc and Ccnd1 , and genes" . SPARSER::COLLECTION)
    ("cMyc and Ccnd1 , and genes" . SPARSER::COLLECTION)
    ("Ccnd1 , and genes" . SPARSER::COLLECTION)
    ("Dusp4 , Dusp6 , Spry2 , and Spry4" . SPARSER::COLLECTION)
    ("Dusp4" . SPARSER::PROTEIN) ("Ccnd1" . SPARSER::PROTEIN)
    ("Etv5" . SPARSER::PROTEIN) ("Etv4" . SPARSER::PROTEIN)
    ("pErk" . SPARSER::PROTEIN) ("Cdkn2a" . SPARSER::PROTEIN)
    ("cdkn2a" . SPARSER::PROTEIN) ("Arf/p53" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Braf mutant mSH and WT mucosa" . SPARSER::COLLECTION)
    ("mSH" . SPARSER::PROTEIN)
    ("nonfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BrafV6 37 E-induced mSHs (0.7) and wild-type mucosa (1.0)"
     . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("mSAs-HGD" . SPARSER::COLLECTION)
    ("Only 5/37 mSAs-LGD" . SPARSER::COLLECTION) ("mSAs" . SPARSER::PROTEIN)
    ("mSAs-LGD" . SPARSER::COLLECTION) ("mSHs" . SPARSER::PROTEIN)
    ("p53 and its target gene p21" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN)
    ("the dominant-negative human TP53  R175H" . SPARSER::PROTEIN)
    ("/p53" . SPARSER::COLLECTION) ("MSS or MSI-L" . SPARSER::COLLECTION)
    ("Apc" . SPARSER::PROTEIN) ("p53 or p16" . SPARSER::COLLECTION)
    ("subset" . SPARSER::PROTEIN) ("BrafV" . SPARSER::PROTEIN)
    ("mSA-HGD" . SPARSER::COLLECTION) ("mSA-LGD" . SPARSER::COLLECTION)
    ("HGD" . SPARSER::PROTEIN) ("mSA" . SPARSER::PROTEIN)
    ("human colonic SSAs" . SPARSER::PROTEIN)
    ("TSAs and SSAs" . SPARSER::COLLECTION) ("SSA" . SPARSER::PROTEIN)
    ("crypt elongation and a serrated eosinophilic adenomatous epithelium ( xref B–2E and xref B)"
     . SPARSER::COLLECTION)
    ("Lgr5-Cre" . SPARSER::COLLECTION) ("Tamoxifen" . SPARSER::MOLECULE)
    ("LSL-Braf" . SPARSER::COLLECTION) ("SI" . SPARSER::PROTEIN)
    ("Vil-Cre" . SPARSER::COLLECTION) ("Lox-Stop-Lox" . SPARSER::COLLECTION)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Lox" . SPARSER::PROTEIN)
    ("the protein’s" . SPARSER::PROTEIN) ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("Serrated" . SPARSER::PROTEIN) ("SSAs and TSAs" . SPARSER::COLLECTION)
    ("large left-sided HPs" . SPARSER::PROTEIN)
    ("TSAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SSAs" . SPARSER::PROTEIN)
    ("HPs" . SPARSER::PROTEIN) ("KRAS and TP53" . SPARSER::COLLECTION)
    ("subset " . SPARSER::PROTEIN) ("APC-" . SPARSER::PROTEIN)
    ("PI3K/Braf" . SPARSER::COLLECTION)
    ("Mapk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Braf" . SPARSER::PROTEIN)
    ("p16  Ink4A" . SPARSER::PROTEIN) ("p16 Ink4A" . SPARSER::PROTEIN)
    ("S6E" . SPARSER::PROTEIN-FAMILY) ("IL12R" . SPARSER::PROTEIN)
    ("VX-680" . SPARSER::DRUG) ("GDC0941" . SPARSER::DRUG)
    ("Gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("B–6" . SPARSER::PROTEIN)
    ("Spry4" . SPARSER::PROTEIN) ("Spry2" . SPARSER::PROTEIN)
    ("E–5" . SPARSER::PROTEIN) ("p44 MAPK" . SPARSER::PROTEIN)
    ("Ink4" . SPARSER::PROTEIN) ("p19  Arf" . SPARSER::PROTEIN)
    ("p16 Ink4a" . SPARSER::PROTEIN) ("p16  Ink4a" . SPARSER::PROTEIN)
    ("S152" . SPARSER::PROTEIN) ("p19 Arf" . SPARSER::PROTEIN)
    ("F–3H" . SPARSER::PROTEIN) ("p19  ARF" . SPARSER::PROTEIN)
    ("p16  INK4a" . SPARSER::PROTEIN) ("Msh2" . SPARSER::PROTEIN)
    ("F–2" . SPARSER::PROTEIN) ("B–2" . SPARSER::PROTEIN)
    ("Lgr5" . SPARSER::PROTEIN) ("M–1" . SPARSER::PROTEIN)
    ("I–1" . SPARSER::PROTEIN) ("F–1" . SPARSER::PROTEIN)
    ("TDP-43, α-synuclein, SOD1, tau and Huntingtin" . SPARSER::COLLECTION)
    ("exogenous p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genistein and chlorpromazine" . SPARSER::COLLECTION)
    ("clathrin- and caveolin-dependant" . SPARSER::COLLECTION)
    ("clathrin-" . SPARSER::PROTEIN)
    ("PrP and other prionoid" . SPARSER::COLLECTION)
    ("Tau and SOD1" . SPARSER::COLLECTION)
    ("polyglutamine" . SPARSER::MOLECULE) ("tau" . SPARSER::PROTEIN)
    ("PrP and α-synuclein" . SPARSER::COLLECTION)
    ("protein and cell-to-cell" . SPARSER::COLLECTION)
    ("p53 and prionoids" . SPARSER::COLLECTION)
    ("endogenous soluble p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only extracellular p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble or aggregated p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dynamin and actin" . SPARSER::COLLECTION) ("dynamin" . SPARSER::PROTEIN)
    ("EIPA" . SPARSER::DRUG) ("genistein" . SPARSER::PROTEIN)
    ("chlorpromazine" . SPARSER::DRUG) ("dextran" . SPARSER::DEXTRAN)
    ("DyLight 650-labeled p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("recombinant exogenous wild-type p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("intracellular soluble wild-type p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MOG" . SPARSER::PROTEIN) ("Tau and α-synuclein" . SPARSER::COLLECTION)
    ("Huntingtin" . SPARSER::PROTEIN) ("Tau" . SPARSER::PROTEIN)
    ("soluble cellular PrP c" . SPARSER::PROTEIN)
    ("exogenous prion protein" . SPARSER::PROTEIN)
    ("cellular p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prion" . SPARSER::PROTEIN-FAMILY) ("PrP" . SPARSER::PROTEIN)
    ("prions" . SPARSER::PROTEIN-FAMILY) ("Prion" . SPARSER::PROTEIN-FAMILY)
    ("Na+/H+" . SPARSER::PROTEIN) ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("cytochalasin D" . SPARSER::DRUG) ("M protein" . SPARSER::PROTEIN)
    ("M -1" . SPARSER::PROTEIN) ("cm -1" . SPARSER::PROTEIN)
    ("30 K" . SPARSER::PROTEIN) ("perinuclear region" . SPARSER::PROTEIN)
    ("TDP-43" . SPARSER::PROTEIN) ("α-synuclein" . SPARSER::PROTEIN)
    ("Amyloid-β" . SPARSER::MOLECULE) ("prion protein" . SPARSER::PROTEIN)
    ("EI24 and CHEK1" . SPARSER::COLLECTION) ("MEC" . SPARSER::PROTEIN)
    ("11 ATR and 11 CHEK1 SNPs" . SPARSER::COLLECTION)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EI24 , STT3A , CHEK1 and ACRV1" . SPARSER::COLLECTION)
    ("XRN1 and PLS1" . SPARSER::COLLECTION) ("PLS1" . SPARSER::PROTEIN)
    ("CHEK1 and BRCA1" . SPARSER::COLLECTION) ("shotgun" . SPARSER::PROTEIN)
    ("ATR or CHEK1" . SPARSER::COLLECTION)
    ("ATR (p=7.6x10 -5 ) and rs2155388" . SPARSER::COLLECTION)
    ("ATR and CHEK1" . SPARSER::COLLECTION) ("H3k27ac" . SPARSER::MOLECULE)
    ("k4" . SPARSER::PROTEIN) ("STT3A" . SPARSER::PROTEIN)
    ("EI24" . SPARSER::PROTEIN) ("XRN1" . SPARSER::PROTEIN)
    ("Fanconi Anemia" . SPARSER::PROTEIN) ("CHEK1" . SPARSER::PROTEIN)
    ("Magnolol [ xref ] and others [ xref , xref ]" . SPARSER::COLLECTION)
    ("Magnolol" . SPARSER::DRUG) ("curcumin" . SPARSER::DRUG)
    ("alkaloid" . SPARSER::MOLECULE) ("Tetrandrine" . SPARSER::DRUG)
    ("CREB binding protein (CBP)" . SPARSER::PROTEIN)
    ("β-catenin and TCF4" . SPARSER::COLLECTION)
    ("β-catenin antibody or mouse IgG" . SPARSER::COLLECTION)
    ("total and phosphorylated form" . SPARSER::FORM)
    ("Axin2, Cyclin D1, C-myc and Survivin" . SPARSER::COLLECTION)
    ("Cyclin D1, Survivin, Axin2 and C-myc" . SPARSER::COLLECTION)
    ("C-myc and Cyclin D1" . SPARSER::COLLECTION)
    ("Axin2, Cyclin D1, SP5, DKK1, NOS1, PPARδ and FGF20"
     . SPARSER::COLLECTION)
    ("C-15 or 14β-OH" . SPARSER::COLLECTION)
    ("C-15 and 14β-OH" . SPARSER::COLLECTION) ("oridonin" . SPARSER::DRUG)
    ("ST-Luc" . SPARSER::COLLECTION) ("NF-κB-Luc" . SPARSER::COLLECTION)
    ("henryin and cisplatin" . SPARSER::COLLECTION) ("CCD" . SPARSER::PROTEIN)
    ("substances" . SPARSER::SUBSTANCE)
    ("C-myc [ xref ] and Survivin [ xref ]" . SPARSER::COLLECTION)
    ("β-catenin, APC and Axin2" . SPARSER::COLLECTION)
    ("adenomatous polyposis coli (APC)/Dsh/Axin/Gsk3β" . SPARSER::COLLECTION)
    ("/Dsh/Axin/Gsk3β" . SPARSER::COLLECTION) ("Dsh" . SPARSER::PROTEIN)
    ("soluble β-catenin" . SPARSER::PROTEIN)
    ("β-catenin/TCF4" . SPARSER::COLLECTION)
    ("Cyclin D1 and C-myc" . SPARSER::COLLECTION) ("henryin" . SPARSER::DRUG)
    ("diterpenoid" . SPARSER::MOLECULE) ("Henryin" . SPARSER::DRUG)
    ("TCF 4" . SPARSER::PROTEIN) ("CREB binding protein" . SPARSER::PROTEIN)
    ("FGF20" . SPARSER::PROTEIN) ("PPARδ" . SPARSER::PROTEIN)
    ("NOS1" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("C-15" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("wnt1" . SPARSER::PROTEIN) ("Colon cancer" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("Gsk3β" . SPARSER::PROTEIN)
    ("C-myc" . SPARSER::PROTEIN) ("ent-kaurane" . SPARSER::MOLECULE)
    ("Smo" . SPARSER::PROTEIN)
    ("Numerous Hedgehog-targeted drugs" . SPARSER::DRUG)
    ("specific Hedgehog-targeted drugs" . SPARSER::DRUG)
    ("a more favorable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("capsular penetration and moderate/low nuclear β-catenin"
     . SPARSER::PROTEIN)
    ("Ck5" . SPARSER::PROTEIN) ("Ck" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CK5-" . SPARSER::PROTEIN) ("high percent Ki67" . SPARSER::PROTEIN)
    ("LG (Gleason sum score =6) and HG (Gleason sum score >6)"
     . SPARSER::COLLECTION)
    ("LG and HG" . SPARSER::COLLECTION) ("LG" . SPARSER::MOLECULE)
    ("associated centrosomes" . SPARSER::PROTEIN)
    ("Joubert" . SPARSER::PROTEIN-FAMILY) ("Jouberin" . SPARSER::PROTEIN)
    ("ciliary proteins" . SPARSER::PROTEIN) ("Fatty acid" . SPARSER::MOLECULE)
    ("S6B" . SPARSER::PROTEIN) ("Gli1" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("IgG 2a" . SPARSER::PROTEIN)
    ("Arl13b" . SPARSER::PROTEIN) ("B-1" . SPARSER::PROTEIN)
    ("IgG 2B" . SPARSER::BIO-COMPLEX)
    ("HSP90 and type I" . SPARSER::COLLECTION)
    ("NPM-ALK" . SPARSER::COLLECTION)
    ("inactive and active" . SPARSER::COLLECTION)
    ("the respective kinase inhibitors" . SPARSER::INHIBITOR)
    ("kinase-HSP90" . SPARSER::COLLECTION)
    ("imatinib and nilotinib" . SPARSER::COLLECTION)
    ("nilotinib" . SPARSER::DRUG)
    ("geldanamycin, 17-AAG or 17-DMAG" . SPARSER::COLLECTION)
    ("AAG" . SPARSER::PROTEIN) ("geldanamycin" . SPARSER::DRUG)
    ("ERBB2-KD" . SPARSER::COLLECTION)
    ("erlotinib or WZ-4002" . SPARSER::COLLECTION)
    ("HSP90-ERBB2" . SPARSER::COLLECTION) ("ERBB2-Cdc37" . SPARSER::COLLECTION)
    ("erlotinib and WZ-4002" . SPARSER::COLLECTION)
    ("EGFR/ERBB2" . SPARSER::COLLECTION)
    ("inactive or active" . SPARSER::COLLECTION)
    ("ERBB2-HSP90" . SPARSER::COLLECTION)
    ("kinase-defective ERBB2" . SPARSER::PROTEIN)
    ("active or inactive" . SPARSER::COLLECTION)
    ("kinase-chaperone" . SPARSER::COLLECTION)
    ("the HSP90 chaperone and client kinases" . SPARSER::COLLECTION)
    ("TAE684" . SPARSER::DRUG) ("ERRB2" . SPARSER::PROTEIN)
    ("STUB1" . SPARSER::PROTEIN) ("F-8" . SPARSER::PROTEIN)
    ("anti-ERBB2" . SPARSER::DRUG)
    ("estrogen and testosterone" . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN) ("cAMP/PKA" . SPARSER::COLLECTION)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("chemicals, growth factors and hormones xref" . SPARSER::COLLECTION)
    ("beta-actin, ezrin and moesin" . SPARSER::COLLECTION)
    ("connective tissue growth factor (CTGF) and the interleukins"
     . SPARSER::COLLECTION)
    ("growth factor (EGF)" . SPARSER::GROWTH-FACTOR)
    ("proteins and filamentous actin" . SPARSER::COLLECTION)
    ("Ezrin and moesin" . SPARSER::COLLECTION) ("Ezrin" . SPARSER::PROTEIN)
    ("Actin, myosin, tubulin, and vimentin" . SPARSER::COLLECTION)
    ("whose genes" . SPARSER::GENE) ("moesin and ezrin" . SPARSER::COLLECTION)
    ("ML-1 and CTGH" . SPARSER::COLLECTION) ("pan-actin" . SPARSER::PROTEIN)
    ("actin, tubulin, moesin and ezrin" . SPARSER::COLLECTION)
    ("ITGB1, VIM, MYO9, RDX, IL6, and IL8" . SPARSER::COLLECTION)
    ("CTGF, EZR and RDX" . SPARSER::COLLECTION)
    ("CTGF, IL6, IL8, ITGB1, VIM, TLN1, MYO9B and RDX" . SPARSER::COLLECTION)
    ("IL6 and IL8" . SPARSER::COLLECTION)
    ("MSN, EGF, CTGF, PRKCA, and PRKAA1" . SPARSER::COLLECTION)
    ("CTGF , IL6 , ACTB , MSN, ITGB1 and PRKAA1" . SPARSER::COLLECTION)
    ("ML-1 and CGTH-W1" . SPARSER::COLLECTION)
    ("those encoding growth factors (IL-6, IL-8, EGF, and CTGF) and protein kinases (PRKCA and PRKAA1)"
     . SPARSER::COLLECTION)
    ("IL-6, IL-8, EGF, and CTGF" . SPARSER::COLLECTION)
    ("PRKCA and PRKAA1" . SPARSER::COLLECTION)
    ("actin, myosin, tubulin, vimentin, talin, and integrin"
     . SPARSER::COLLECTION)
    ("ezrin, radixin, and moesin" . SPARSER::COLLECTION)
    ("moesin" . SPARSER::PROTEIN) ("radixin" . SPARSER::PROTEIN)
    ("ezrin" . SPARSER::PROTEIN) ("talin" . SPARSER::PROTEIN)
    ("Genes and Proteins" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION) ("RPM" . SPARSER::PROTEIN)
    ("PKCa" . SPARSER::PROTEIN) ("PKCA" . SPARSER::PROTEIN)
    ("those encoding growth factors ( EGF , CTGF , IL6 , and IL8 ) or protein kinases ( PRKAA1 and PRKCA )"
     . SPARSER::COLLECTION)
    ("ACTB , MYO9 , TUBB , VIM , TLN1 , and ITGB1" . SPARSER::COLLECTION)
    ("EZR , RDX , and MSN" . SPARSER::COLLECTION)
    ("EGF , CTGF , IL6 , and IL8" . SPARSER::COLLECTION)
    ("PRKAA1 and PRKCA" . SPARSER::COLLECTION) ("PRKCA" . SPARSER::PROTEIN)
    ("CTGF" . SPARSER::PROTEIN) ("MSN" . SPARSER::PROTEIN)
    ("RDX" . SPARSER::PROTEIN) ("EZR" . SPARSER::PROTEIN)
    ("VIM" . SPARSER::PROTEIN) ("TUBB" . SPARSER::PROTEIN)
    ("MYO" . SPARSER::PROTEIN) ("ACTB" . SPARSER::PROTEIN)
    ("ML-1 and CGTH" . SPARSER::COLLECTION) ("Arm" . SPARSER::PROTEIN)
    ("PKC-alpha" . SPARSER::PROTEIN)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("MYO9B" . SPARSER::PROTEIN)
    ("1 µL" . SPARSER::PROTEIN) ("PRKAA1" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("ITGB1" . SPARSER::PROTEIN) ("TLN1" . SPARSER::PROTEIN)
    ("P31" . SPARSER::PROTEIN) ("ML-1" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("HIF-1α and NF-κB" . SPARSER::COLLECTION)
    ("A3, and HOXA9" . SPARSER::COLLECTION)
    ("normoxic CTBs" . SPARSER::PROTEIN)
    ("ischemia/hypoxia" . SPARSER::COLLECTION)
    ("HIF-1α and NF-kBp50" . SPARSER::COLLECTION)
    ("pre-miR" . SPARSER::COLLECTION) ("pre" . SPARSER::PROTEIN)
    ("mimic mature endogenous miRs" . SPARSER::PROTEIN)
    ("Pre-miR" . SPARSER::PROTEIN-PAIR)
    ("T helper (Th)-2 lineage-specific transcription factor GATA3"
     . SPARSER::PROTEIN)
    ("STAT6 and the miRSVR" . SPARSER::COLLECTION)
    ("hypoxia and HIF-1α" . SPARSER::COLLECTION) ("Hg" . SPARSER::MOLECULE)
    ("HIF-1α, and NF-κBp50" . SPARSER::COLLECTION)
    ("STAT6/IL-4" . SPARSER::COLLECTION)
    ("homologue (ISCU)" . SPARSER::PROTEIN) ("Ephrin" . SPARSER::PROTEIN)
    ("ISCU" . SPARSER::PROTEIN)
    ("several microarray-based placental miR" . SPARSER::PROTEIN)
    ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("IFNγ, TNFα, and IL-12" . SPARSER::COLLECTION)
    ("cytokines and type I" . SPARSER::COLLECTION)
    ("HIF-1α, NF-κBp50, and miR-210 levels" . SPARSER::COLLECTION)
    ("STAT6 and IL-4" . SPARSER::COLLECTION)
    ("placental HIF-1α" . SPARSER::PROTEIN)
    ("STAT6, and IL-4" . SPARSER::COLLECTION)
    ("HIF-1α and NF-κBp50" . SPARSER::COLLECTION) ("CTBs" . SPARSER::PROTEIN)
    ("proteinuria" . SPARSER::PROTEIN) ("F-10" . SPARSER::PROTEIN)
    ("IL-4Rα" . SPARSER::PROTEIN) ("IL-4 Receptor" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("Poly I:C" . SPARSER::MOLECULE) ("site 2" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("HOXA9" . SPARSER::PROTEIN)
    ("Homeobox A9" . SPARSER::PROTEIN)
    ("hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("IFNγ" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("poly I:C" . SPARSER::MOLECULE) ("JNK and Erk1/2" . SPARSER::COLLECTION)
    ("MAPK/Erk" . SPARSER::COLLECTION) ("c-Raf" . SPARSER::COLLECTION)
    ("c" . SPARSER::PROTEIN) ("Sorafenib" . SPARSER::DRUG)
    ("possible HCV proteins" . SPARSER::PROTEIN)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("Jun-Fos" . SPARSER::COLLECTION) ("JNK1 and p44/42" . SPARSER::COLLECTION)
    ("p53, p38MAPK and NF-κB" . SPARSER::COLLECTION)
    ("−3 , and 8.00×10" . SPARSER::COLLECTION)
    ("mRNA/GAPDH" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("U0126 and SP600125" . SPARSER::COLLECTION)
    ("U0126 or SP600125" . SPARSER::COLLECTION)
    ("c-Fos and JNK1" . SPARSER::COLLECTION) ("Mediators" . SPARSER::PROTEIN)
    ("siRNA, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("a key arm" . SPARSER::PROTEIN) ("eIF2α" . SPARSER::PROTEIN)
    ("cirrhosis" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("Erk1/2 and JNK1" . SPARSER::COLLECTION)
    ("JNK1 and Erk1/2" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION) ("NS5A" . SPARSER::PROTEIN)
    ("Protein kinase R" . SPARSER::PROTEIN) ("Core Protein" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("si-RNA" . SPARSER::RNA)
    ("double-stranded RNA-activated protein kinase" . SPARSER::PROTEIN)
    ("Double-stranded RNA-activated protein kinase" . SPARSER::PROTEIN)
    ("ERK and p53" . SPARSER::COLLECTION)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("chromosomal-bound NF-κB" . SPARSER::PROTEIN)
    ("AP-1, NF-κB, and p53" . SPARSER::COLLECTION)
    ("ERK, c-Jun N-terminal kinase (JNK), and p38 MAPK xref"
     . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("Antioxidants" . SPARSER::DRUG)
    ("U0126 or ROS" . SPARSER::COLLECTION)
    ("p53 or NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and p53" . SPARSER::COLLECTION)
    ("p53 or p65" . SPARSER::COLLECTION) ("NF-κB or p53" . SPARSER::COLLECTION)
    ("PD98059 or U0126" . SPARSER::COLLECTION)
    ("a PKC inhibitor (GF109203X) or JNK inhibitor (SP600125)"
     . SPARSER::COLLECTION)
    ("a PI3K inhibitor (LY294002) or p38 inhibitor (SB203580)"
     . SPARSER::COLLECTION)
    ("PD98059, U0126, or PI3-kinase" . SPARSER::COLLECTION)
    ("thrombomodulin" . SPARSER::PROTEIN) ("epidermal TM" . SPARSER::PROTEIN)
    ("Thrombomodulin" . SPARSER::PROTEIN) ("KLF-2" . SPARSER::PROTEIN)
    ("Factor 2" . SPARSER::PROTEIN) ("GF109203X" . SPARSER::DRUG)
    ("GF 109203X" . SPARSER::DRUG) ("lamin B1" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("M 2" . SPARSER::MOLECULE)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN)
    ("antithrombin III" . SPARSER::PROTEIN) ("Protein C" . SPARSER::DRUG)
    ("protein C" . SPARSER::DRUG) ("activator protein-1" . SPARSER::PROTEIN)
    ("only three variants" . SPARSER::VARIANT)
    ("excessive ubiquitin" . SPARSER::PROTEIN)
    ("placental growth factor" . SPARSER::GROWTH-FACTOR)
    ("TC and CC" . SPARSER::COLLECTION)
    ("an initiator caspase in the apoptotic pathway and a crucial defensive barrier"
     . SPARSER::COLLECTION)
    ("a crucial defensive barrier" . SPARSER::PROTEIN)
    ("alleles, genotypes, and haplotypes" . SPARSER::COLLECTION)
    ("Han" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Caspase 8" . SPARSER::PROTEIN) ("Syntaxin" . SPARSER::PROTEIN)
    ("a mild stimulant" . SPARSER::DRUG) ("stimulant" . SPARSER::DRUG)
    ("α 2 δ-1 auxiliary channel subunit" . SPARSER::FRAGMENT)
    ("basal glucose" . SPARSER::PROTEIN)
    ("syncollin-pHluorin" . SPARSER::PROTEIN-PAIR)
    ("Syncollin" . SPARSER::PROTEIN) ("syncollin" . SPARSER::PROTEIN)
    ("-mCherry" . SPARSER::COLLECTION) ("IAPP" . SPARSER::PROTEIN)
    ("the type 2 diabetic Wistar rat variant" . SPARSER::VARIANT)
    ("Munc18/SNARE" . SPARSER::COLLECTION) ("RRP" . SPARSER::PROTEIN)
    ("dominant–negative mutants" . SPARSER::MUTANT)
    ("Sec6 and Sec8" . SPARSER::COLLECTION)
    ("an octameric protein complex" . SPARSER::BIO-COMPLEX)
    ("Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84"
     . SPARSER::COLLECTION)
    ("Sec10" . SPARSER::PROTEIN) ("Sec8" . SPARSER::PROTEIN)
    ("Sec6" . SPARSER::PROTEIN) ("Sec3" . SPARSER::PROTEIN)
    ("biphasic glucose" . SPARSER::PROTEIN) ("β-cell" . SPARSER::PROTEIN)
    ("VAMP8" . SPARSER::PROTEIN) ("Syntaxin 1A" . SPARSER::PROTEIN)
    ("Munc13-1" . SPARSER::PROTEIN)
    ("Amyloid Precursor Protein" . SPARSER::PROTEIN)
    ("Cell membrane" . SPARSER::PROTEIN) ("EXOC2" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE) ("Munc18" . SPARSER::PROTEIN)
    ("Exo70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sec15" . SPARSER::PROTEIN-FAMILY)
    ("secretory granule" . SPARSER::PROTEIN) ("INS-1" . SPARSER::PROTEIN)
    ("PAK4/LIMK" . SPARSER::COLLECTION)
    ("14-3-3 proteins or other scaffolding proteins" . SPARSER::COLLECTION)
    ("PAK4/SSH1L/LIMK" . SPARSER::COLLECTION)
    ("dimers or multimers [ xref ]" . SPARSER::COLLECTION)
    ("SSH1L and 14-3-3" . SPARSER::COLLECTION)
    ("PAK4 and PKD1" . SPARSER::COLLECTION)
    ("only wildtype PAK4" . SPARSER::PROTEIN)
    ("PAK4 and PAK4" . SPARSER::COLLECTION)
    ("LIMK and SSH1L" . SPARSER::COLLECTION)
    ("LIMK and 14-3-3" . SPARSER::COLLECTION)
    ("PAK4 or mutant" . SPARSER::COLLECTION)
    ("phospho-cofilin" . SPARSER::PROTEIN)
    ("KW and PKD2" . SPARSER::COLLECTION)
    ("PKD1 and PKD2" . SPARSER::COLLECTION)
    ("pS3-cofilin" . SPARSER::COLLECTION)
    ("a Far-Western blot" . SPARSER::PROTEIN)
    ("wildtype PAK4 or the PAK4" . SPARSER::COLLECTION)
    ("PAK4 and 14-3-3γ" . SPARSER::COLLECTION)
    ("PAK4 or PAK4" . SPARSER::COLLECTION)
    ("PAK4 and 14-3-3" . SPARSER::COLLECTION)
    ("PAK4, actin, and 14-3-3" . SPARSER::COLLECTION)
    ("ADF/cofilin" . SPARSER::COLLECTION) ("ADF" . SPARSER::PROTEIN)
    ("PKD2 and PKD3" . SPARSER::COLLECTION)
    ("bacterially-expressed GST-PAK4 fusion proteins" . SPARSER::PROTEIN)
    ("PKD1 and GST-tagged purified kinase-dead PAK4" . SPARSER::COLLECTION)
    ("GST-PAK4" . SPARSER::COLLECTION) ("Net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("slingshot" . SPARSER::PROTEIN)
    ("Slingshot 1L (SSH1L) and 14-3-3 proteins [ xref ]" . SPARSER::COLLECTION)
    ("Lin-11/Isl-1/Mec-3 kinase (LIMK), Slingshot 1L (SSH1L) and 14-3-3 proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("Slingshot" . SPARSER::PROTEIN) ("PAK4 and PAK5" . SPARSER::COLLECTION)
    ("PAK5 and PAK6" . SPARSER::COLLECTION)
    ("Cdc-42, Rac1 and RhoA and play" . SPARSER::COLLECTION)
    ("PAK4/LIMK/PKD1" . SPARSER::COLLECTION)
    ("kinase (LIMK)" . SPARSER::KINASE)
    ("Lin-11/Isl-1/Mec-3" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LIMK1" . SPARSER::PROTEIN)
    ("protein kinase domain" . SPARSER::PROTEIN-FAMILY)
    ("Protein Kinase D" . SPARSER::PROTEIN) ("PF-3758309" . SPARSER::DRUG)
    ("X-Gal" . SPARSER::MOLECULE) ("P-40" . SPARSER::PROTEIN)
    ("pS3" . SPARSER::PROTEIN) ("PKD2" . SPARSER::PROTEIN)
    ("PKD3" . SPARSER::PROTEIN) ("SSH1L" . SPARSER::PROTEIN)
    ("Cdc-42" . SPARSER::PROTEIN) ("PKD1" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("Mec-3" . SPARSER::PROTEIN)
    ("Isl-1" . SPARSER::PROTEIN) ("Lin-11" . SPARSER::PROTEIN)
    ("the more severe types" . TYPE) ("Cigarette" . SPARSER::DRUG)
    ("a reliable biomarker" . SPARSER::MOLECULE) ("Egfr" . SPARSER::PROTEIN)
    ("EGFR and SP-A" . SPARSER::COLLECTION)
    ("foci and Masson" . SPARSER::COLLECTION)
    ("the fibrotic forms" . SPARSER::FORM) ("DL" . SPARSER::MOLECULE)
    ("bleomycin" . SPARSER::DRUG)
    ("EGFR or platelet-derived growth factor" . SPARSER::COLLECTION)
    ("hydroxyproline" . SPARSER::MOLECULE)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("an active homodimer" . SPARSER::HOMODIMER)
    ("c-neu" . SPARSER::PROTEIN-PAIR)
    ("all three fibrotic forms" . SPARSER::FORM)
    ("surfactant" . SPARSER::PROTEIN) ("COP" . SPARSER::PROTEIN)
    ("COL1A2" . SPARSER::PROTEIN) ("SFTPA1" . SPARSER::PROTEIN)
    ("SP-A" . SPARSER::PROTEIN) ("ErbB-3" . SPARSER::PROTEIN)
    ("ErbB-1" . SPARSER::PROTEIN)
    ("epidermal growth factor-receptor" . SPARSER::PROTEIN)
    ("antioxidative enzymes" . SPARSER::ENZYME)
    ("EPA and DHA" . SPARSER::COLLECTION) ("MitoSOX" . SPARSER::DRUG)
    ("essential cellular components" . SPARSER::COMPONENT)
    ("various cell surface receptors [ xref – xref ] and intracellular signaling molecules [ xref ]"
     . SPARSER::COLLECTION)
    ("the well-documented apoptotic inducer p53"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ethanolamine" . SPARSER::DRUG)
    ("Akt-mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("phospholipase A 2 and oxygenases and synthesis" . SPARSER::COLLECTION)
    ("particular docosahexaenoic acid (DHA)" . SPARSER::MOLECULE)
    ("dietary fat" . SPARSER::PROTEIN)
    ("phospho-Akt and phospho-mTOR" . SPARSER::COLLECTION)
    ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("N-acetyl-cysteine (NAC)" . SPARSER::DRUG) ("mitoSOX" . SPARSER::DRUG)
    ("DHA" . SPARSER::MOLECULE) ("LC3-II" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("Microtubule-associated protein" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("phospholipase A 2" . SPARSER::PROTEIN) ("Akt-mTOR" . SPARSER::PROTEIN)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("LC3B" . SPARSER::PROTEIN)
    ("Docosahexaenoic acid" . SPARSER::MOLECULE)
    ("Exogenous truncated APC" . SPARSER::PROTEIN)
    ("homo-oligomers" . SPARSER::PROTEIN) ("APCs" . SPARSER::PROTEIN)
    ("an internal APC fragment" . SPARSER::FRAGMENT)
    ("APC or APCL" . SPARSER::COLLECTION)
    ("a functional APCL" . SPARSER::PROTEIN)
    ("YFP and RFP" . SPARSER::COLLECTION)
    ("the red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("RFP" . SPARSER::PROTEIN) ("APC-APC" . SPARSER::COLLECTION)
    ("APC-APCL" . SPARSER::COLLECTION) ("-ECad" . SPARSER::COLLECTION)
    ("ECad" . SPARSER::PROTEIN) ("-Ecad" . SPARSER::COLLECTION)
    ("Ecad" . SPARSER::PROTEIN) ("APCL and APC" . SPARSER::COLLECTION)
    ("20R1µ" . SPARSER::PROTEIN)
    ("either phosphorylated β-catenin (Pβ-catenin) or total β-catenin ( xref )"
     . SPARSER::COLLECTION)
    ("mutant 20R1 and/or 15Rs" . SPARSER::COLLECTION)
    ("20R1" . SPARSER::PROTEIN) ("bright" . SPARSER::PROTEIN)
    ("the shortest fragment" . SPARSER::FRAGMENT)
    ("also less active" . SPARSER::ACTIVE) ("YFP-APC" . SPARSER::COLLECTION)
    ("YFP-APCL" . SPARSER::COLLECTION)
    ("anti-APC and anti-β-catenin antibodies" . SPARSER::COLLECTION)
    ("APC, APCL and β-catenin" . SPARSER::COLLECTION)
    ("anti-β-catenin" . SPARSER::COLLECTION)
    ("APC and APCL" . SPARSER::COLLECTION) ("MCR" . SPARSER::PROTEIN)
    ("axin/axin2" . SPARSER::COLLECTION) ("FAP" . SPARSER::PROTEIN)
    ("APCL or APC2" . SPARSER::COLLECTION) ("APCL" . SPARSER::PROTEIN)
    ("the adenomatous polyposis coli (APC) gene" . SPARSER::GENE)
    ("Colon Cancer" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("glycogen synthase kinase 3 beta" . SPARSER::PROTEIN)
    ("axin2" . SPARSER::PROTEIN) ("APC2" . SPARSER::PROTEIN)
    ("APC-like" . SPARSER::PROTEIN)
    ("NF-κB inhibitor and siRNA" . SPARSER::COLLECTION)
    ("masks" . SPARSER::PROTEIN) ("Msx2 and OPN" . SPARSER::COLLECTION)
    ("LacZ" . SPARSER::PROTEIN) ("nucleosomal histone" . SPARSER::PROTEIN)
    ("NF-κB, and ACS" . SPARSER::COLLECTION)
    ("IKK-NF-κB" . SPARSER::COLLECTION)
    ("EPA and docosahexaenoic acid" . SPARSER::COLLECTION)
    ("p38-MAPK" . SPARSER::COLLECTION) ("PPAR" . SPARSER::PROTEIN)
    ("peroxisome" . SPARSER::PROTEIN) ("-2 and MMP-9" . SPARSER::COLLECTION)
    ("elastase" . SPARSER::PROTEIN)
    ("ACSL1, ACSL3, ACSL4, ACSL5 and ACSL6" . SPARSER::COLLECTION)
    ("PA and EPA" . SPARSER::COLLECTION) ("bubblegum" . SPARSER::PROTEIN)
    ("stearoyl-CoA or its metabolite" . SPARSER::COLLECTION)
    ("SMC" . SPARSER::PROTEIN) ("proteins and calcium" . SPARSER::COLLECTION)
    ("ACS and IKK, and ACSL3" . SPARSER::COLLECTION)
    ("IKK, and ACSL3" . SPARSER::COLLECTION)
    ("ACSL3- and NF-κB" . SPARSER::COLLECTION) ("ACSL3-" . SPARSER::PROTEIN)
    ("ACSL3-ACSL6" . SPARSER::COLLECTION)
    ("ACSL3 siRNA as well as EPA (15 µM)" . SPARSER::COLLECTION)
    ("EPA and triacsin" . SPARSER::COLLECTION)
    ("PA or PA" . SPARSER::COLLECTION) ("ACSL3 or lacZ" . SPARSER::COLLECTION)
    ("lacZ" . SPARSER::PROTEIN)
    ("BMP-2, Msx2 and osteopontin" . SPARSER::COLLECTION)
    ("ACSL3 and osteoblastic genes" . SPARSER::COLLECTION)
    ("ACSL1 and ACSL4" . SPARSER::COLLECTION)
    ("ACSL5 and ACSL6" . SPARSER::COLLECTION)
    ("PA, and EPA" . SPARSER::COLLECTION)
    ("mRNA and Protein" . SPARSER::COLLECTION)
    ("ACS and NF-κB" . SPARSER::COLLECTION) ("hypoestoxide" . SPARSER::DRUG)
    ("osteoblastic transcription factor Msx2 and bone matrix protein osteopontin"
     . SPARSER::COLLECTION)
    ("the embryonic bone differentiation factor BMP-2, osteoblastic transcription factor Msx2 and bone matrix protein osteopontin"
     . SPARSER::COLLECTION)
    ("osteoblastic transcription factor Msx2" . SPARSER::PROTEIN)
    ("ACSL" . SPARSER::PROTEIN) ("osteoblastic genes" . SPARSER::GENE)
    ("BMP-2, Msx2 and osteopontin, and calcium" . SPARSER::COLLECTION)
    ("osteopontin, and calcium" . SPARSER::COLLECTION)
    ("A variety of chemoattractant and inflammatory mediators"
     . SPARSER::COLLECTION)
    ("chemoattractant protein-1, leptin and FFA" . SPARSER::COLLECTION)
    ("leptin" . SPARSER::PROTEIN) ("warfarin" . SPARSER::DRUG)
    ("EPA or n-3" . SPARSER::COLLECTION) ("fish" . SPARSER::PROTEIN)
    ("PUFA" . SPARSER::MOLECULE) ("Lipid" . SPARSER::LIPID)
    ("PUFAs" . SPARSER::MOLECULE) ("receptor (LXR)" . SPARSER::RECEPTOR)
    ("ACSL3 and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB, and NF-κB" . SPARSER::COLLECTION)
    ("siRNA and ACS" . SPARSER::COLLECTION) ("ACS" . SPARSER::PROTEIN)
    ("BMP-2 and Msx2" . SPARSER::COLLECTION)
    ("synthetase (ACSL)" . SPARSER::PROTEIN)
    ("-2, Msx2 and osteopontin" . SPARSER::COLLECTION)
    ("FFA" . SPARSER::PROTEIN) ("EPA" . SPARSER::PROTEIN)
    ("FFAs" . SPARSER::PROTEIN) ("PPAR-γ" . SPARSER::PROTEIN)
    ("docosahexaenoic acid" . SPARSER::MOLECULE)
    ("stearoyl-CoA" . SPARSER::MOLECULE) ("ACS3" . SPARSER::PROTEIN)
    ("long chain" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("SO 4  " . SPARSER::PROTEIN)
    ("ACSL6" . SPARSER::PROTEIN) ("ACSL5" . SPARSER::PROTEIN)
    ("ACSL4" . SPARSER::PROTEIN) ("ACSL1" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN) ("N-3" . SPARSER::PROTEIN)
    ("n-3" . SPARSER::PROTEIN) ("BMP-2" . SPARSER::PROTEIN)
    ("ACSL3" . SPARSER::PROTEIN) ("Msx2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("palmitic acid" . SPARSER::MOLECULE)
    ("E-cadherin, β-catenin, vimentin, APC, Axin and GSK3"
     . SPARSER::COLLECTION)
    ("E-cadherin and membranous β-catenin" . SPARSER::COLLECTION)
    ("aggressive traits" . SPARSER::PROTEIN)
    ("membranous E-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("a precancerous state" . SPARSER::BIO-STATE)
    ("membranous β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and its associated protein β-catenin" . SPARSER::COLLECTION)
    ("its associated protein β-catenin" . SPARSER::PROTEIN)
    ("proteins and ALCAM" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin and alpha-catenin" . SPARSER::COLLECTION)
    ("SCC-4" . SPARSER::PROTEIN) ("PPV" . SPARSER::MOLECULE)
    ("ALCAM, E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin and ALCAM" . SPARSER::COLLECTION)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("membranous E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("ALCAM-CD6" . SPARSER::COLLECTION) ("ALCAM-ALCAM" . SPARSER::COLLECTION)
    ("/MEMD/CD166" . SPARSER::COLLECTION)
    ("membranous E-cadherin-β-catenin complex" . SPARSER::BIO-COMPLEX)
    ("E-cadherin-β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin, and cytoplasmic/nuclear" . SPARSER::COLLECTION)
    ("β-catenin, and cytoplasmic/nuclear" . SPARSER::COLLECTION)
    ("membranous E-cadherin" . SPARSER::PROTEIN)
    ("E-cadherin-catenin" . SPARSER::PROTEIN-PAIR)
    ("ALCAM/β-catenin" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN)
    ("E-cadherin and β -catenin" . SPARSER::COLLECTION)
    ("ALCAM" . SPARSER::PROTEIN) ("alpha-catenin" . SPARSER::PROTEIN)
    ("1–8" . SPARSER::PROTEIN) ("E-cad" . SPARSER::PROTEIN)
    ("g protein" . SPARSER::PROTEIN) ("AG -3" . SPARSER::PROTEIN)
    ("CD6" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("human primary chondrocytes" . SPARSER::PROTEIN)
    ("MMP-1, MMP-3, MMP-10 and MMP-13" . SPARSER::COLLECTION)
    ("Nox2 or Nox4" . SPARSER::COLLECTION)
    ("Nox2 and Nox4" . SPARSER::COLLECTION) ("hemin" . SPARSER::MOLECULE)
    ("Leucine" . SPARSER::AMINO-ACID) ("functional Nox4" . SPARSER::PROTEIN)
    ("the mature state" . SPARSER::BIO-STATE) ("COMP" . SPARSER::PROTEIN)
    ("osteoarthritic chondrocytes" . SPARSER::PROTEIN)
    ("Nox1 and Nox2" . SPARSER::COLLECTION) ("Nox1" . SPARSER::PROTEIN)
    ("Bilirubin" . SPARSER::MOLECULE) ("/VDAC" . SPARSER::COLLECTION)
    ("Abs" . SPARSER::PROTEIN) ("VDAC" . SPARSER::PROTEIN)
    ("Nox4 and Nox2" . SPARSER::COLLECTION)
    ("Nox2/p22 phox" . SPARSER::COLLECTION)
    ("a mature Nox4/p22 phox complex" . SPARSER::BIO-COMPLEX)
    ("Dimer" . SPARSER::DIMER) ("Catabolism" . SPARSER::PROTEIN)
    ("unpermeabilized tetracycline induced T-REx" . SPARSER::PROTEIN-FAMILY)
    ("succinylacetone (SA)" . SPARSER::MOLECULE)
    ("calnexin" . SPARSER::PROTEIN) ("hemes" . SPARSER::MOLECULE)
    ("the mature heterodimer" . SPARSER::HETERODIMER)
    ("cobalt" . SPARSER::MOLECULE) ("Chondrocytes" . SPARSER::PROTEIN)
    ("cystein" . SPARSER::MOLECULE) ("Tiron" . SPARSER::MOLECULE)
    ("Nox4 and HO-1" . SPARSER::COLLECTION) ("cyt" . SPARSER::MOLECULE)
    ("bilirubin" . SPARSER::MOLECULE) ("osteoclasts" . SPARSER::PROTEIN)
    ("Nox2" . SPARSER::PROTEIN)
    ("hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("bovine chondrocytes" . SPARSER::PROTEIN)
    ("AP-1 and NF-kappaB" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-13" . SPARSER::COLLECTION)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("MMP-1 and DNA" . SPARSER::COLLECTION)
    ("carbon monoxide (CO)" . SPARSER::MOLECULE)
    ("Nox4/p22 phox" . SPARSER::COLLECTION)
    ("succinylacetone" . SPARSER::MOLECULE) ("catabolism" . SPARSER::PROTEIN)
    ("Heme" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("MMP-10" . SPARSER::PROTEIN) ("HO-2" . SPARSER::PROTEIN)
    ("Carbon monoxide" . SPARSER::MOLECULE)
    ("Carbon Monoxide" . SPARSER::MOLECULE) ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("Protoporphyrin-IX" . SPARSER::MOLECULE) ("cm −1" . SPARSER::PROTEIN)
    ("mM −1" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("NADPH Oxidase" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("pcDNA 3.1" . SPARSER::PROTEIN) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("protoporphyrin-IX" . SPARSER::MOLECULE)
    ("cytochrome b" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE) ("MMP-13" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN)
    ("carbon monoxide" . SPARSER::MOLECULE) ("p22 phox" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("Nox4" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("Interleukin-1β" . SPARSER::PROTEIN)
    ("Tran" . SPARSER::PROTEIN-FAMILY) ("Hsc70 and p23" . SPARSER::COLLECTION)
    ("cochaperones" . SPARSER::PROTEIN)
    ("metastable signaling proteins" . SPARSER::PROTEIN)
    ("androgen, estrogen, and progesterone" . SPARSER::COLLECTION)
    ("receptors (FGFR)" . SPARSER::RECEPTOR)
    ("AKT, MAPK and STAT5" . SPARSER::COLLECTION)
    ("EGCG or PKC412" . SPARSER::COLLECTION)
    ("EGCG and PKC412" . SPARSER::COLLECTION)
    ("EGCG-, EGC- or ECG-" . SPARSER::COLLECTION) ("ECG-" . SPARSER::DRUG)
    ("survivin and XIAP" . SPARSER::COLLECTION)
    ("cleaved-caspase-9, cleaved-caspase-3 and cleaved-PARP"
     . SPARSER::COLLECTION)
    ("EGCG, EGC or ECG" . SPARSER::COLLECTION) ("FLT" . SPARSER::PROTEIN)
    ("a client protein" . SPARSER::PROTEIN)
    ("AKT and STAT5" . SPARSER::COLLECTION) ("p-STAT5" . SPARSER::COLLECTION)
    ("EGCG specifically targets mutant FLT3" . SPARSER::PROTEIN)
    ("EGCG, EGC, ECG and C" . SPARSER::COLLECTION)
    ("a cancer preventive drug" . SPARSER::DRUG)
    ("-Catechin" . SPARSER::MOLECULE) ("Catechin" . SPARSER::MOLECULE)
    ("FLT3-TKI" . SPARSER::COLLECTION) ("IMC-EB10" . SPARSER::PROTEIN-PAIR)
    ("EB" . SPARSER::PROTEIN-FAMILY) ("SU5416 and AC220" . SPARSER::COLLECTION)
    ("KW" . SPARSER::MOLECULE) ("MLN" . SPARSER::PROTEIN)
    ("FLT3-TKIs" . SPARSER::COLLECTION)
    ("FLT3-tyrosine kinase" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("kinases, PI3-kinase and STAT5" . SPARSER::COLLECTION)
    ("a glycine and a serine" . SPARSER::COLLECTION)
    ("The last mutation form" . SPARSER::FORM) ("-ITDs" . SPARSER::COLLECTION)
    ("ITDs" . SPARSER::PROTEIN) ("MAPK, AKT and STAT5" . SPARSER::COLLECTION)
    ("EGCG-" . SPARSER::DRUG) ("THP-1" . SPARSER::PROTEIN)
    ("EGCG, EGC and ECG" . SPARSER::COLLECTION)
    ("-epicatechin-3-gallate" . SPARSER::DRUG)
    ("-epigallocatechin-3-gallate" . SPARSER::DRUG) ("ECG" . SPARSER::DRUG)
    ("EGCG" . SPARSER::DRUG) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("p23" . SPARSER::PROTEIN) ("Hsc70" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("v-Src" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("FLK-2" . SPARSER::PROTEIN) ("FLT-3" . SPARSER::PROTEIN)
    ("M5a" . SPARSER::DRUG) ("AC220" . SPARSER::DRUG)
    ("SU5416" . SPARSER::DRUG) ("SU11248" . SPARSER::DRUG)
    ("BAY 43-9006" . SPARSER::DRUG) ("PKC412" . SPARSER::DRUG)
    ("CEP-701" . SPARSER::DRUG)
    ("Fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("epicatechin-3-gallate" . SPARSER::DRUG)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("tea polyphenols" . SPARSER::MOLECULE)
    ("DUSP6 and its substrates" . SPARSER::COLLECTION)
    ("RTK-MAPK-DUSP6" . SPARSER::COLLECTION)
    ("DUSP6, ERK2, and p38alpha" . SPARSER::COLLECTION)
    ("a new ternary complex" . SPARSER::BIO-COMPLEX)
    ("ATM, pTP53, and pERK" . SPARSER::COLLECTION) ("pERK" . SPARSER::PROTEIN)
    ("pTP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHEK2 and ERK1/2" . SPARSER::COLLECTION)
    ("RAS or BRAF" . SPARSER::COLLECTION)
    ("ATM and CHEK2" . SPARSER::COLLECTION) ("ATM-CHEK2" . SPARSER::COLLECTION)
    ("ATM/CHEK2" . SPARSER::COLLECTION) ("pATM" . SPARSER::PROTEIN)
    ("H2AX, ATM, and 53BP1" . SPARSER::COLLECTION)
    ("CHEK2, TP53, 53BP1, and H2AX" . SPARSER::COLLECTION)
    ("Increased phospho-p38 ( xref ; xref ) and phospho-CHEK2 ( xref )"
     . SPARSER::COLLECTION)
    ("cellular DDR" . SPARSER::PROTEIN) ("p38 and CHEK2" . SPARSER::COLLECTION)
    ("MAPK14/p38" . SPARSER::COLLECTION)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("DUSP6 or DUSP7" . SPARSER::COLLECTION)
    ("the DNA-damaging agent CPT11" . SPARSER::PROTEIN)
    ("family, and PDGFR" . SPARSER::COLLECTION) ("EPH" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG)
    ("other DUSPs or cellular phosphatases" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("erlotinib and siRNA" . SPARSER::COLLECTION)
    ("DUSP6 and EGFR" . SPARSER::COLLECTION)
    ("polymerase and caspase 3" . SPARSER::COLLECTION)
    ("the predominant isoform" . SPARSER::ISOFORM)
    ("a valuable biomarker and regulator of responsiveness to a range"
     . SPARSER::COLLECTION)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("ATM–CHEK2" . SPARSER::COLLECTION)
    ("EGFR ( xref ) and FGFR ( xref ) and their downstream effector RAS ( xref )"
     . SPARSER::COLLECTION)
    ("FGFR ( xref ) and their downstream effector RAS ( xref )"
     . SPARSER::COLLECTION)
    ("MKP3 and PYST1" . SPARSER::COLLECTION)
    ("CHEK2 and p38" . SPARSER::COLLECTION)
    ("H2AX, ATM, and CHEK2" . SPARSER::COLLECTION)
    ("EGFR and other targeted inhibitors" . SPARSER::COLLECTION)
    ("siRNA and shRNA" . SPARSER::COLLECTION) ("p38alpha" . SPARSER::PROTEIN)
    ("MAPK14" . SPARSER::PROTEIN) ("ACK1" . SPARSER::PROTEIN)
    ("p53BP1" . SPARSER::PROTEIN) ("GL2" . SPARSER::DRUG)
    ("DUSP7" . SPARSER::PROTEIN) ("L -glutamine" . SPARSER::MOLECULE)
    ("PYST1" . SPARSER::PROTEIN) ("MKP3" . SPARSER::PROTEIN)
    ("DUSP6" . SPARSER::PROTEIN)
    ("Dual specificity phosphatase" . SPARSER::PROTEIN)
    ("alanine, or aspartic acid" . SPARSER::COLLECTION)
    ("RelA or mutant" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("p21 and FMN2" . SPARSER::COLLECTION) ("Oncogene" . SPARSER::ONCOGENE)
    ("p14ARF and FMN2" . SPARSER::COLLECTION)
    ("FMN2 and p14ARF" . SPARSER::COLLECTION)
    ("p53, Hdm2, and HIF-1" . SPARSER::COLLECTION) ("ATR-" . SPARSER::PROTEIN)
    ("p14ARF and different oncogenes" . SPARSER::COLLECTION)
    ("ATR and ATM" . SPARSER::COLLECTION)
    ("p14ARF and ATR" . SPARSER::COLLECTION)
    ("GFP-FMN2-mCherry" . SPARSER::COLLECTION) ("Formin" . SPARSER::PROTEIN)
    ("formin" . SPARSER::PROTEIN) ("Form" . SPARSER::FORM)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("E2F1 and c-Myc" . SPARSER::COLLECTION)
    ("Cyclin-CDK" . SPARSER::COLLECTION)
    ("exogenous FMN2 protein" . SPARSER::PROTEIN)
    ("RelA and E2F1" . SPARSER::COLLECTION) ("tissue type" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("FMN2" . SPARSER::PROTEIN)
    ("BCL2 , MDM2 , MYC , and RAS" . SPARSER::COLLECTION)
    ("adequate IARC TP53" . SPARSER::PROTEIN) ("SRT" . SPARSER::PROTEIN)
    ("TP53 and GLOBOCAN" . SPARSER::COLLECTION) ("a chain" . SPARSER::PROTEIN)
    ("and −1" . SPARSER::PROTEIN) ("19 A" . SPARSER::PROTEIN)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("SMAD3/SNAI2" . SPARSER::COLLECTION) ("TGFβ/SMADs" . SPARSER::COLLECTION)
    ("TGFβ/SMAD" . SPARSER::COLLECTION) ("TGFB-SMAD" . SPARSER::COLLECTION)
    ("TGFB" . SPARSER::PROTEIN) ("Regulator" . SPARSER::REGULATOR)
    ("exogenous TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vimentin, β1-Integrin and N-Cadherin" . SPARSER::COLLECTION)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("Vimentin and N-Cadherin" . SPARSER::COLLECTION)
    ("CHD5 and p73" . SPARSER::COLLECTION) ("pten" . SPARSER::PROTEIN)
    ("TWIST1 and TWIST2" . SPARSER::COLLECTION)
    ("DEAR1 and SNAI1/2" . SPARSER::COLLECTION)
    ("SNAI1 or SNAI2" . SPARSER::COLLECTION)
    ("that DEAR1’s" . SPARSER::PROTEIN)
    ("SNA1 and SNAI2" . SPARSER::COLLECTION) ("SNAI" . SPARSER::PROTEIN-FAMILY)
    ("SNAI1 and SNAI2" . SPARSER::COLLECTION)
    ("SNAIL1 (SNAI1) and SNAIL2 (SNAI2)" . SPARSER::COLLECTION)
    ("SNAIL1 and SNAIL2" . SPARSER::COLLECTION)
    ("TGFβ/SMAD3" . SPARSER::COLLECTION)
    ("SIS3, N-Cadherin and Vimentin" . SPARSER::COLLECTION)
    ("SMAD3-KD" . SPARSER::COLLECTION) ("SMAD3-shRNA" . SPARSER::COLLECTION)
    ("p-SMAD3" . SPARSER::COLLECTION)
    ("SMAD3, and unbridles" . SPARSER::COLLECTION)
    ("aggressive foci" . SPARSER::PROTEIN)
    ("Dear1 and Smad3" . SPARSER::COLLECTION)
    ("DEAR1 and SMAD3" . SPARSER::COLLECTION)
    ("HA-Ubiquitin" . SPARSER::COLLECTION)
    ("GST or GST-DEAR1 fusion proteins" . SPARSER::COLLECTION)
    ("Flag-SMAD3" . SPARSER::COLLECTION) ("GST-DEAR1" . SPARSER::COLLECTION)
    ("SMAD3 and DEAR1" . SPARSER::COLLECTION)
    ("Myc/SMAD3" . SPARSER::COLLECTION) ("Myc/SMAD2" . SPARSER::COLLECTION)
    ("HA/DEAR1" . SPARSER::COLLECTION) ("SMAD2 or SMAD4" . SPARSER::COLLECTION)
    ("the translational inhibitor cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN) ("-shRNA" . SPARSER::COLLECTION)
    ("HA-DEAR1" . SPARSER::COLLECTION) ("the entire exon" . SPARSER::PROTEIN)
    ("control-shRNA (CshRNA) as well as DEAR1-rescue (DR1mut)"
     . SPARSER::COLLECTION)
    ("DEAR1-shRNA" . SPARSER::COLLECTION)
    ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Anoikis" . SPARSER::PROTEIN)
    ("Vimentin and β1-Integrin" . SPARSER::COLLECTION)
    ("β1-Integrin and Vimentin" . SPARSER::COLLECTION)
    ("the mesenchymal marker Vimentin" . SPARSER::PROTEIN)
    ("both 76N-E6 and MCF10A KD" . SPARSER::COLLECTION)
    ("the cellular KD" . SPARSER::PROTEIN)
    ("TGFβ-treated DEAR1-KD" . SPARSER::COLLECTION)
    ("uniform polar acini" . SPARSER::PROTEIN)
    ("the immortal HMEC cell line 76N-E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DEAR1-KD" . SPARSER::COLLECTION) ("p53 and Rb" . SPARSER::COLLECTION)
    ("Our data support DEAR1’s" . SPARSER::PROTEIN)
    ("the provisional TCGA cohort" . SPARSER::MOLECULE)
    ("a classical tumor suppressor" . SPARSER::SUPPRESSOR)
    ("a haploinsufficient tumor suppressor" . SPARSER::SUPPRESSOR)
    ("Dear1  −/− and Dear1  +/− mice" . SPARSER::COLLECTION)
    ("Suppressor" . SPARSER::SUPPRESSOR) ("SMAD2/SMAD3" . SPARSER::COLLECTION)
    ("SMADs" . SPARSER::PROTEIN)
    ("a complex and highly specialized developmental process"
     . SPARSER::COLLECTION)
    ("the earliest pre-invasive forms" . SPARSER::FORM)
    ("an 889 invasive breast cancer cohort" . SPARSER::MOLECULE)
    ("effectors, SNAI1 and SNAI2" . SPARSER::COLLECTION)
    ("DEAR1/SNAI2" . SPARSER::COLLECTION) ("TGFβ-SMAD3" . SPARSER::COLLECTION)
    ("Dear1" . SPARSER::PROTEIN) ("CHD5" . SPARSER::PROTEIN)
    ("TWIST2" . SPARSER::PROTEIN) ("SNA1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN)
    ("Transcriptional Regulators" . SPARSER::PROTEIN-FAMILY)
    ("SNAIL2" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("SIS3" . SPARSER::MOLECULE) ("DR1" . SPARSER::PROTEIN)
    ("PAI-1" . SPARSER::PROTEIN) ("N-Cadherin" . SPARSER::PROTEIN)
    ("β1-Integrin" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SMAD4" . SPARSER::PROTEIN)
    ("TRIM62" . SPARSER::PROTEIN) ("DEAR1" . SPARSER::PROTEIN)
    ("p35" . SPARSER::PROTEIN) ("ACE-associated angioedema" . SPARSER::PROTEIN)
    ("inhibitor-" . SPARSER::INHIBITOR)
    ("neprilysin [ xref ] or DPP4 inhibitors [ xref ]" . SPARSER::COLLECTION)
    ("Angioedema" . SPARSER::PROTEIN)
    ("this polymorphism and ACE inhibitor-associated angioedema"
     . SPARSER::PROTEIN)
    ("OCTAVE" . SPARSER::DRUG)
    ("acute ACE inhibitor-associated angioedema" . SPARSER::PROTEIN)
    ("immunosuppressant" . SPARSER::DRUG)
    ("TH1 (IL-18 and IL-10) and TH2 (IL-4) subsets" . SPARSER::COLLECTION)
    ("IL-10, and IL-4" . SPARSER::COLLECTION)
    ("IL-18 and IL-10" . SPARSER::COLLECTION) ("TH1" . SPARSER::PROTEIN)
    ("the pathogenesis ACE inhibitor-associated angioedema" . SPARSER::PROTEIN)
    ("APP" . SPARSER::PROTEIN)
    ("receptor and angioedema" . SPARSER::COLLECTION)
    ("the B 2 receptor and ACE inhibitor-associated angioedema"
     . SPARSER::PROTEIN)
    ("receptor and ACE" . SPARSER::COLLECTION)
    ("Bradykinin" . SPARSER::BRADYKININ)
    ("ACE and neprilysin" . SPARSER::COLLECTION) ("enalapril" . SPARSER::DRUG)
    ("Enalapril" . SPARSER::DRUG) ("serious adverse drug" . SPARSER::DRUG)
    ("the vasoactive peptides bradykinin" . SPARSER::BRADYKININ)
    ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TEL" . SPARSER::PROTEIN)
    ("the Ongoing Telmisartan" . SPARSER::DRUG)
    ("hereditary angioedema" . SPARSER::PROTEIN)
    ("esterase" . SPARSER::PROTEIN)
    ("bradykinin and substance P [ xref , xref ]" . SPARSER::COLLECTION)
    ("two vasoactive peptide substrates" . SPARSER::SUBSTRATE)
    ("statin" . SPARSER::MOLECULE) ("gene–" . SPARSER::GENE)
    ("immunosuppressants" . SPARSER::DRUG)
    ("vasoactive peptides" . SPARSER::PEPTIDE)
    ("MME and genes" . SPARSER::COLLECTION)
    ("other serious adverse drug" . SPARSER::DRUG)
    ("bradykinin" . SPARSER::BRADYKININ) ("MME" . SPARSER::PROTEIN)
    ("neprilysin" . SPARSER::PROTEIN) ("PRKCQ" . SPARSER::PROTEIN)
    ("Ongoing Telmisartan" . SPARSER::DRUG) ("Ramipril" . SPARSER::DRUG)
    ("Telmisartan" . SPARSER::DRUG)
    ("ACE inhibitor-associated angioedema and 489 ACE" . SPARSER::COLLECTION)
    ("ACE inhibitor-associated angioedema" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme (ACE) inhibitor-associated angioedema"
     . SPARSER::PROTEIN)
    ("angioedema" . SPARSER::PROTEIN) ("ACE" . SPARSER::PROTEIN)
    ("CD26" . SPARSER::PROTEIN) ("TH2" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("interleukin 18" . SPARSER::PROTEIN)
    ("Substance P" . SPARSER::PROTEIN) ("OR 2" . SPARSER::MOLECULE)
    ("TACR1" . SPARSER::PROTEIN) ("NK1 receptor" . SPARSER::PROTEIN)
    ("BDKRB1" . SPARSER::PROTEIN) ("BDKRB2" . SPARSER::PROTEIN)
    ("DPP4" . SPARSER::PROTEIN) ("XPNPEP2" . SPARSER::PROTEIN)
    ("amino-peptidase" . SPARSER::PROTEIN)
    ("Angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("substance P" . SPARSER::PROTEIN) ("ETV6" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("a known stress-inducible transcription factor" . SPARSER::PROTEIN)
    ("IGF-IR/Src/MEK/Erk" . SPARSER::COLLECTION)
    ("a stress-activated cytoprotective chaperone" . SPARSER::PROTEIN)
    ("a secreted heterodimeric isoform" . SPARSER::ISOFORM)
    ("CLU-2" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("a unique metastatic suppressor" . SPARSER::SUPPRESSOR)
    ("Egr1 and DAB2IP" . SPARSER::COLLECTION)
    ("stronger nuclear Egr1 and cytosolic sCLU" . SPARSER::COLLECTION)
    ("weak DAB2IP" . SPARSER::PROTEIN) ("Egr1 or CLU" . SPARSER::COLLECTION)
    ("DAB2IP, Egr1, and sCLU" . SPARSER::COLLECTION)
    ("IGF-I/Egr1" . SPARSER::COLLECTION) ("p65/RelA" . SPARSER::COLLECTION)
    ("RelA" . SPARSER::PROTEIN) ("mRNA and gene" . SPARSER::COLLECTION)
    ("Wnt and IGF-I" . SPARSER::COLLECTION)
    ("β-catenin/T-cell" . SPARSER::COLLECTION)
    ("C4-2 and PZ-HPV-7" . SPARSER::COLLECTION)
    ("Egr1 and sCLU" . SPARSER::COLLECTION)
    ("Egr1 and CLU" . SPARSER::COLLECTION)
    ("IGF-I/IGF-IR" . SPARSER::COLLECTION) ("Egr1-mut" . SPARSER::COLLECTION)
    ("C4-2-Neo" . SPARSER::COLLECTION) ("/ERK" . SPARSER::COLLECTION)
    ("IGF-IR/Src/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("a cytoprotective protein" . SPARSER::PROTEIN)
    ("its mature secretory (sCLU, ~40 kDa) proteins" . SPARSER::PROTEIN)
    ("both intracellular full-length pre-secretory clusterin"
     . SPARSER::PROTEIN)
    ("DAB2IP-KD" . SPARSER::COLLECTION) ("CLU" . SPARSER::PROTEIN)
    ("detectable endogenous DAB2IP and its control subline (i.e., Neo)"
     . SPARSER::COLLECTION)
    ("subline" . SPARSER::PROTEIN) ("epothilone" . SPARSER::MOLECULE)
    ("DAB2IP and Egr1 or sCLU" . SPARSER::COLLECTION)
    ("Egr1 or sCLU" . SPARSER::COLLECTION) ("Egr1" . SPARSER::PROTEIN)
    ("/IGF-IR" . SPARSER::COLLECTION) ("the secretory form" . SPARSER::FORM)
    ("clusterin" . SPARSER::PROTEIN) ("Istodax" . SPARSER::DRUG)
    ("epothilones" . SPARSER::MOLECULE) ("Ras-MAPK" . SPARSER::COLLECTION)
    ("DOC-2/DAB2 interactive protein or ASK1" . SPARSER::COLLECTION)
    ("protein or ASK1" . SPARSER::COLLECTION)
    ("RAS–GTPase activating protein" . SPARSER::COLLECTION)
    ("DAB2IP/AIP1" . SPARSER::COLLECTION) ("DOC-2/DAB2" . SPARSER::COLLECTION)
    ("Docetaxel" . SPARSER::DRUG) ("Egr-1/Clusterin" . SPARSER::COLLECTION)
    ("DAB2IP and Egr-1 or Clusterin" . SPARSER::COLLECTION)
    ("Egr-1 or Clusterin" . SPARSER::COLLECTION)
    ("several chemotherapeutic drugs" . SPARSER::DRUG)
    ("DAB2IP, Clusterin and Egr-1" . SPARSER::COLLECTION)
    ("Clusterin" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("b-MYB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF–κB" . SPARSER::PROTEIN) ("OGX011" . SPARSER::DRUG)
    ("L-CM" . SPARSER::PROTEIN-FAMILY) ("Wnt3A" . SPARSER::PROTEIN)
    ("lithium chloride" . SPARSER::DRUG) ("tyrphostin AG1024" . SPARSER::DRUG)
    ("B-5" . SPARSER::PROTEIN) ("FK228" . SPARSER::DRUG)
    ("early growth response" . SPARSER::PROTEIN)
    ("insulin-like growth factor I" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("DAB2" . SPARSER::PROTEIN)
    ("DOC-2" . SPARSER::PROTEIN) ("OGX-011" . SPARSER::DRUG)
    ("C4-2" . SPARSER::PROTEIN) ("DAB2IP" . SPARSER::PROTEIN)
    ("EGFR-PTEN" . SPARSER::COLLECTION) ("JAK2/EGFRvIII" . SPARSER::COLLECTION)
    ("JAK2, EGFR, and STAT3" . SPARSER::COLLECTION)
    ("wild-type EGFR and intact PTEN" . SPARSER::COLLECTION)
    ("intact PTEN" . SPARSER::PROTEIN) ("EGFR and mTOR" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION) ("VEGFRs" . SPARSER::PROTEIN)
    ("JAK2, EGFR, STAT3, and mTOR" . SPARSER::COLLECTION)
    ("Akt, ERK1, ERK2, and PKCs" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("normal EGFR" . SPARSER::PROTEIN)
    ("the EGFR inhibitor EKB-569 ( xref , xref ) and the JAK2 inhibitor LS104 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("auranofin or hydrogen peroxide" . SPARSER::COLLECTION)
    ("EGFR, ERK, and STAT3" . SPARSER::COLLECTION)
    ("auranofin [a gold complex with strong GSH depletion activity ( xref )] or hydrogen peroxide [to simulate oxidative stress ( xref )]"
     . SPARSER::COLLECTION)
    ("auranofin" . SPARSER::DRUG) ("normal astrocytes" . SPARSER::PROTEIN)
    ("GSH" . SPARSER::DRUG) ("acceptors" . SPARSER::MOLECULE)
    ("receptor and anti-GBM" . SPARSER::COLLECTION)
    ("MEFs or C8-S and C8-D30" . SPARSER::COLLECTION)
    ("LDH" . SPARSER::PROTEIN) ("JAK2-EGFR-STAT3" . SPARSER::COLLECTION)
    ("U87/PTEN" . SPARSER::COLLECTION) ("EGFR-vIII" . SPARSER::PROTEIN-PAIR)
    ("Akt and ERK" . SPARSER::COLLECTION) ("metabolites" . SPARSER::PROTEIN)
    ("PKC, and STAT3" . SPARSER::COLLECTION)
    ("EGFR, rpS6, and 4E-BP1" . SPARSER::COLLECTION)
    ("Akt and ERK1/2" . SPARSER::COLLECTION) ("U87MG-" . SPARSER::PROTEIN)
    ("gefitinib (EGFR inhibitor) or ruxolitinib (JAK2 inhibitor)"
     . SPARSER::COLLECTION)
    ("gefitinib and ruxolitinib" . SPARSER::COLLECTION)
    ("EGFR, STAT3, and rpS6" . SPARSER::COLLECTION)
    ("Lestaurtinib" . SPARSER::DRUG) ("rpS6" . SPARSER::PROTEIN)
    ("rpS" . SPARSER::PROTEIN) ("prolactin (PRL)" . SPARSER::PROTEIN)
    ("JAK2-STAT" . SPARSER::COLLECTION) ("PRL" . SPARSER::PROTEIN)
    ("prolactin" . SPARSER::PROTEIN) ("HC11" . SPARSER::PROTEIN)
    ("STAT3 and EGFR" . SPARSER::COLLECTION)
    ("JAK2 and EGFR" . SPARSER::COLLECTION) ("lestaurtinib" . SPARSER::DRUG)
    ("JAK2 and the drug" . SPARSER::COLLECTION) ("PKD" . SPARSER::PROTEIN)
    ("Partial" . SPARSER::PROTEIN)
    ("JAK2 and biotin-conjugated G5-7" . SPARSER::COLLECTION)
    ("inner membrane protein" . SPARSER::PROTEIN)
    ("zyxin, ataxin 10, annexin A2, and actin" . SPARSER::COLLECTION)
    ("zyxin" . SPARSER::PROTEIN) ("biotin" . SPARSER::PROTEIN)
    ("biotin-conjugated G5-7–associated proteins" . SPARSER::PROTEIN)
    ("biotin-streptavidin" . SPARSER::PROTEIN-PAIR)
    ("PTP1B, EGFR, and mTOR" . SPARSER::COLLECTION)
    ("naphthoquinone" . SPARSER::MOLECULE) ("PTPase" . SPARSER::PROTEIN)
    ("the traditional EGFR inhibitor erlotinib" . SPARSER::DRUG)
    ("4E-BP1 and p70S6K" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION) ("EGFR/STAT3" . SPARSER::COLLECTION)
    ("U87MG/EGFRvIII/PTEN" . SPARSER::COLLECTION)
    ("U87/EGFRvIII" . SPARSER::COLLECTION) ("U87MG/EGFR" . SPARSER::COLLECTION)
    ("aldehyde" . SPARSER::MOLECULE) ("bulky phenyl ester" . SPARSER::MOLECULE)
    ("bis" . SPARSER::PROTEIN)
    ("wild-type EGFR and wild-type PTEN (U87MG/PTEN)" . SPARSER::COLLECTION)
    ("functional PTEN" . SPARSER::PROTEIN)
    ("allosterically binding JAK2" . SPARSER::PROTEIN)
    ("anti-EGFR/EGFRvIII" . SPARSER::COLLECTION)
    ("JAK2-STAT3" . SPARSER::COLLECTION) ("LIF" . SPARSER::PROTEIN)
    ("JAK and STAT" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and a constitutively activated mutant"
     . SPARSER::COLLECTION)
    ("EGFR or JAK2" . SPARSER::COLLECTION)
    ("ligand or adenosine" . SPARSER::COLLECTION)
    ("EGFR (U87MG/EGFRvIII) and human glioblastoma explant neurosphere"
     . SPARSER::COLLECTION)
    ("U87MG/PTEN" . SPARSER::COLLECTION)
    ("U87MG/EGFRvIII" . SPARSER::COLLECTION)
    ("EGFR and STAT3" . SPARSER::COLLECTION) ("NO 3" . SPARSER::PROTEIN)
    ("LS104" . SPARSER::DRUG) ("EKB-569" . SPARSER::DRUG)
    ("extracellular signal–regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("annexin A2" . SPARSER::PROTEIN) ("ataxin 10" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("N-2" . SPARSER::PROTEIN) ("oxygen atom" . SPARSER::MOLECULE)
    ("JSI-124" . SPARSER::DRUG)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("Janus kinase 2" . SPARSER::PROTEIN)
    ("SSP" . SPARSER::PROTEIN) ("DSG" . SPARSER::DRUG)
    ("the complex of catenins and cell cytoskeleton" . SPARSER::COLLECTION)
    ("E-cadherin and different antigens" . SPARSER::COLLECTION)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a calcium-dependent transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("ILC" . SPARSER::PROTEIN) ("acini" . SPARSER::PROTEIN)
    ("Dezenove (76%) casos apresentavam somente citologia e/ou padrão arquitetural misto"
     . SPARSER::DRUG)
    ("dois" . SPARSER::PROTEIN) ("mista" . SPARSER::PROTEIN)
    ("CISM" . SPARSER::DRUG) ("misto (CISM)" . SPARSER::DRUG)
    ("misto" . SPARSER::DRUG) ("dos" . SPARSER::PROTEIN)
    ("muito difícil determinar se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("da" . SPARSER::MOLECULE)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("epithelial cadherin" . SPARSER::PROTEIN)
    ("Epithelial Cadherin" . SPARSER::PROTEIN)
    ("3T3-L1 preadipocytes and Fyn null MEFs" . SPARSER::PROTEIN)
    ("preadipocytes and Fyn" . SPARSER::COLLECTION)
    ("preadipocytes" . SPARSER::PROTEIN) ("Perilipin" . SPARSER::PROTEIN)
    ("GDI" . SPARSER::PROTEIN) ("GDIs" . SPARSER::PROTEIN)
    ("Fyn/mTORC2/Akt" . SPARSER::COLLECTION)
    ("mTOR or Akt" . SPARSER::COLLECTION)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("Fyn or Src" . SPARSER::COLLECTION) ("APN" . SPARSER::PROTEIN)
    ("Akti" . SPARSER::PROTEIN) ("GDP/GTP" . SPARSER::PROTEIN-PAIR)
    ("LARG" . SPARSER::PROTEIN) ("Fyn and vinculin" . SPARSER::COLLECTION)
    ("the FA-associated protein vinculin" . SPARSER::PROTEIN)
    ("vinculin" . SPARSER::PROTEIN) ("kinases and FAK" . SPARSER::COLLECTION)
    ("integrin/FA" . SPARSER::COLLECTION) ("Fyn and FAK" . SPARSER::COLLECTION)
    ("Src and Fyn" . SPARSER::COLLECTION)
    ("soluble growth factors" . SPARSER::GROWTH-FACTOR)
    ("that mTORC2’s" . SPARSER::PROTEIN)
    ("Fyn and mTORC2" . SPARSER::COLLECTION) ("paxillin" . SPARSER::PROTEIN)
    ("New FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTORC2/Akt" . SPARSER::COLLECTION) ("raptor" . SPARSER::PROTEIN)
    ("mechanical cues" . SPARSER::PROTEIN-FAMILY)
    ("a proximal mechanical effector" . SPARSER::EFFECTOR)
    ("peroxisome proliferator-activated receptor gamma, adiponectin, and perilipin"
     . SPARSER::COLLECTION)
    ("perilipin" . SPARSER::PROTEIN) ("adiponectin" . SPARSER::PROTEIN)
    ("mTORC2 or its downstream substrate" . SPARSER::COLLECTION)
    ("Fyn/FAK" . SPARSER::COLLECTION) ("Fyn" . SPARSER::PROTEIN)
    ("marrow-derived MSCs" . SPARSER::PROTEIN)
    ("integrin-FA" . SPARSER::COLLECTION)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("RhoGDI2" . SPARSER::PROTEIN) ("PPAR γ" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("Src-like" . SPARSER::PROTEIN)
    ("glutathione- S -transferase" . SPARSER::PROTEIN)
    ("D-1" . SPARSER::PROTEIN) ("Collagen-I" . SPARSER::PROTEIN)
    ("KU0063794" . SPARSER::DRUG) ("SU6656" . SPARSER::PROTEIN)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::GROWTH-FACTOR) ("GSK3 β" . SPARSER::PROTEIN)
    ("G β L" . SPARSER::PROTEIN) ("mSin1" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("TCI" . SPARSER::PROTEIN) ("the frontal lobe" . SPARSER::PROTEIN)
    ("cerebral cavernous malformations" . SPARSER::PROTEIN)
    ("nucleosomal DNA" . SPARSER::DNA)
    ("DNA-binding proteins and a subunit" . SPARSER::COLLECTION)
    ("ARID1B , ZPLD1 , and METTL4" . SPARSER::COLLECTION)
    ("ARID1B, ZPLD1, and METTL4" . SPARSER::COLLECTION)
    ("the relevant gene" . SPARSER::GENE) ("sep" . SPARSER::PROTEIN)
    ("gene and dysesthesia" . SPARSER::COLLECTION)
    ("ARID1B and ZPLD1" . SPARSER::COLLECTION)
    ("dominant and recessive" . SPARSER::PROTEIN) ("1–1" . SPARSER::PROTEIN)
    ("METTL11A" . SPARSER::PROTEIN) ("CpG binding protein" . SPARSER::PROTEIN)
    ("p11" . SPARSER::PROTEIN)
    ("catechol- O -methyltransferase" . SPARSER::PROTEIN)
    ("methyltransferase like 4" . SPARSER::PROTEIN)
    ("METTL4" . SPARSER::PROTEIN) ("SWI1" . SPARSER::PROTEIN)
    ("AT rich interactive domain 1B" . SPARSER::PROTEIN)
    ("ZPLD1" . SPARSER::PROTEIN) ("ARID1B" . SPARSER::PROTEIN)
    ("PTEN, CDKN2A , and CCND1" . SPARSER::COLLECTION)
    ("CDKN2A (p16) and amplification/overexpression" . SPARSER::COLLECTION)
    ("BRAF or MEK" . SPARSER::COLLECTION)
    ("p16, CKD4 and cyclin D1" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("CDKN2A nor CCND1" . SPARSER::COLLECTION)
    ("a chromosomal arm" . SPARSER::PROTEIN)
    ("BOR and PTEN" . SPARSER::COLLECTION) ("trametinib" . SPARSER::DRUG)
    ("-catenin" . SPARSER::COLLECTION) ("MET and SRC" . SPARSER::COLLECTION)
    ("MET , CTNNB1 and CCND1" . SPARSER::COLLECTION) ("Rb1" . SPARSER::PROTEIN)
    ("SRC" . SPARSER::PROTEIN)
    ("dabrafenib or vemurafenib" . SPARSER::COLLECTION)
    ("vemurafenib" . SPARSER::DRUG) ("BRAF or CRAF" . SPARSER::COLLECTION)
    ("CRAF" . SPARSER::PROTEIN) ("PTEN , and CDKN2A" . SPARSER::COLLECTION)
    ("CDKN2A, CCND1, and mutation/copy" . SPARSER::COLLECTION)
    ("BOR" . SPARSER::PROTEIN) ("dabrafenib" . SPARSER::DRUG)
    ("dacarbazine" . SPARSER::DRUG) ("Dabrafenib" . SPARSER::DRUG)
    ("P95" . SPARSER::PROTEIN) ("MEK2" . SPARSER::PROTEIN)
    ("MAP2K2" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("GSK2118436" . SPARSER::DRUG) ("glutamic acid" . SPARSER::AMINO-ACID)
    ("p66Shc, and p53" . SPARSER::COLLECTION)
    ("S6K1, p66Shc, and p53" . SPARSER::COLLECTION)
    ("S6K1, ERK, JNK, and p66Shc" . SPARSER::COLLECTION)
    ("S6K1 and PKC‐β, ERK, and JNK" . SPARSER::COLLECTION)
    ("p66Shc and S6K1" . SPARSER::COLLECTION)
    ("Arg‐II, S6K1, JNK, ERK, and p66Shc" . SPARSER::COLLECTION)
    ("S6K1 or p66Shc" . SPARSER::COLLECTION)
    ("Arg‐II −/− and p66Shc −/− mice display similar protective phenotypes"
     . SPARSER::COLLECTION)
    ("neither eNOS nor iNOS" . SPARSER::COLLECTION)
    ("p66Shc and p53" . SPARSER::COLLECTION)
    ("S6K1, p66Shc‐S36, p66Shc, p53‐S15, p53, S6‐S235/236, and S6"
     . SPARSER::COLLECTION)
    ("HF" . SPARSER::PROTEIN) ("ERK, JNK, and S6K1" . SPARSER::COLLECTION)
    ("S6K1 and ERK" . SPARSER::COLLECTION)
    ("the ERK inhibitor PD98059 or the JNK inhibitor SP600125 not only inhibited p66Shc‐S36"
     . SPARSER::COLLECTION)
    ("S6K1, JNK, and ERKs" . SPARSER::COLLECTION)
    ("JNK and ERK" . SPARSER::COLLECTION)
    ("Arg‐II or p53" . SPARSER::COLLECTION)
    ("S6K1, ERKs, and JNK" . SPARSER::COLLECTION)
    ("PD98059 or SP600125" . SPARSER::COLLECTION)
    ("S6K1 or p53‐S15" . SPARSER::COLLECTION) ("BEC" . SPARSER::MOLECULE)
    ("S6K1 and p66Shc" . SPARSER::COLLECTION) ("Annexin" . SPARSER::PROTEIN)
    ("gal" . SPARSER::PROTEIN)
    ("eNOS or inducible nitric oxide synthase (iNOS)" . SPARSER::COLLECTION)
    ("NOS" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("DA" . SPARSER::MOLECULE) ("DAF" . SPARSER::PROTEIN)
    ("Arg‐II or the inactive H160F mutant ( xref C)" . SPARSER::COLLECTION)
    ("DCF" . SPARSER::PROTEIN) ("MitoSox" . SPARSER::DRUG)
    ("Arg‐II" . SPARSER::PROTEIN)
    ("various proinflammatory cytokines and MMPs" . SPARSER::COLLECTION)
    ("proinflammatory macrophages" . SPARSER::PROTEIN)
    ("cytokines and MMPs" . SPARSER::COLLECTION)
    ("arginase" . SPARSER::PROTEIN) ("ERK and S6K1" . SPARSER::COLLECTION)
    ("JNKs" . SPARSER::PROTEIN) ("p66Shc or p53" . SPARSER::COLLECTION)
    ("ApoE" . SPARSER::PROTEIN)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("Arginase" . SPARSER::PROTEIN)
    ("argininosuccinate lyase" . SPARSER::PROTEIN)
    ("sodium chloride" . SPARSER::DRUG)
    ("arginase activity" . SPARSER::PROTEIN)
    ("Arginase activity" . SPARSER::PROTEIN)
    ("Arginase Activity" . SPARSER::PROTEIN) ("P23" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ink4" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("p66Shc" . SPARSER::PROTEIN) ("apolipoprotein E" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("continuously binding β-TrCP" . SPARSER::PROTEIN)
    ("a central transcription factor" . SPARSER::PROTEIN)
    ("complex (IKK)" . SPARSER::BIO-COMPLEX)
    ("significant structural homology" . SPARSER::PROTEIN)
    ("monovalent cations" . SPARSER::MOLECULE) ("cations" . SPARSER::MOLECULE)
    ("either full-length recombinant Vpu protein or synthetic peptides"
     . SPARSER::COLLECTION)
    ("homo-oligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("HXB2, MAL, and AD8" . SPARSER::COLLECTION) ("MAL" . SPARSER::PROTEIN)
    ("HXB" . SPARSER::PROTEIN)
    ("independently target BST-2" . SPARSER::PROTEIN)
    ("three different lentiviral proteins" . SPARSER::PROTEIN)
    ("endo-lysosomal" . SPARSER::COLLECTION)
    ("Vpu or Ebola glycoprotein" . SPARSER::COLLECTION)
    ("Vpu and/or Ebola glycoprotein" . SPARSER::COLLECTION)
    ("One possible solution" . SPARSER::MOLECULE)
    ("the cytoplasmic dimeric protein dystrophia myotonica protein kinase"
     . SPARSER::PROTEIN)
    ("artificial BST-2" . SPARSER::PROTEIN) ("rod" . SPARSER::PROTEIN)
    ("glycosyl-phosphatidylinositol" . SPARSER::PROTEIN-PAIR)
    ("anchor" . SPARSER::ANCHOR) ("GPI" . SPARSER::PROTEIN)
    ("a 30–36 kDa type II transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("Vpu and K5" . SPARSER::COLLECTION)
    ("the Kaposi sarcoma-associated herpesvirus K5 protein" . SPARSER::PROTEIN)
    ("a cellular transmembrane protein" . SPARSER::PROTEIN)
    ("CD317, HM1.24, or tetherin" . SPARSER::COLLECTION)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an inert adapter molecule" . SPARSER::MOLECULE)
    ("Vpu and CD4" . SPARSER::COLLECTION) ("TrCP" . SPARSER::PROTEIN)
    ("Vpu or CD4" . SPARSER::COLLECTION)
    ("heterologous transmembrane proteins" . SPARSER::PROTEIN)
    ("Vpu-CD4" . SPARSER::COLLECTION) ("tryptophan" . SPARSER::AMINO-ACID)
    ("CD4 and Vpu" . SPARSER::COLLECTION) ("Env-CD4" . SPARSER::COLLECTION)
    ("trafficking-incompetent complexes" . SPARSER::BIO-COMPLEX)
    ("CD4 and Env" . SPARSER::COLLECTION) ("Vpu and Env" . SPARSER::COLLECTION)
    ("Vpu and the envelope precursor glycoprotein" . SPARSER::COLLECTION)
    ("a single bicistronic mRNA" . SPARSER::PROTEIN)
    ("the viral env gene" . SPARSER::GENE) ("TASK-1" . SPARSER::PROTEIN)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Cos-7" . SPARSER::PROTEIN) ("S23" . SPARSER::PROTEIN)
    ("Env protein" . SPARSER::PROTEIN)
    ("dystrophia myotonica protein kinase" . SPARSER::PROTEIN)
    ("HM1" . SPARSER::PROTEIN) ("CD317" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("β-TrCP" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN) ("BST-2" . SPARSER::PROTEIN)
    ("Ral proteins and their effectors" . SPARSER::COLLECTION)
    ("Exo84 and Sec5" . SPARSER::COLLECTION)
    ("Drp1 [ xref ] and Epsin [ xref ]" . SPARSER::COLLECTION)
    ("CyclinB/Cdk1" . SPARSER::COLLECTION) ("Epsin" . SPARSER::PROTEIN)
    ("CyclinB" . SPARSER::PROTEIN)
    ("both RalBP1 and the exocyst" . SPARSER::COLLECTION)
    ("the transcription factor ZONAB [ xref ] and the important signaling molecules phospholipase D [ xref ] and phospholipase C delta 1 [ xref ]"
     . SPARSER::COLLECTION)
    ("the important signaling molecules phospholipase D [ xref ] and phospholipase C delta 1 [ xref ]"
     . SPARSER::COLLECTION)
    ("ZONAB" . SPARSER::PROTEIN) ("filamin" . SPARSER::PROTEIN-FAMILY)
    ("neither RalBP1 nor the Exocyst components" . SPARSER::COLLECTION)
    ("Exocyst" . SPARSER::BIO-COMPLEX)
    ("ULK1 and Beclin1-VPS34 [ xref ]" . SPARSER::COLLECTION)
    ("Beclin1-VPS34" . SPARSER::COLLECTION)
    ("RalB–Exo84" . SPARSER::COLLECTION)
    ("the atypical IκB kinase TBK1" . SPARSER::PROTEIN)
    ("RalB–Sec5" . SPARSER::COLLECTION)
    ("the full octameric exocyst complex" . SPARSER::BIO-COMPLEX)
    ("RalB and Sec5" . SPARSER::COLLECTION)
    ("RalB and Exo84" . SPARSER::COLLECTION)
    ("Sec5 and Exo84" . SPARSER::COLLECTION)
    ("the octomeric exocyst complex" . SPARSER::BIO-COMPLEX)
    ("exocyst" . SPARSER::BIO-COMPLEX)
    ("RalBP1, Sec5 and Exo84" . SPARSER::COLLECTION)
    ("Sec5" . SPARSER::PROTEIN) ("Ral–RalBP1" . SPARSER::COLLECTION)
    ("small molecule chemotherapeutic drugs" . SPARSER::DRUG)
    ("epidermal growth factor receptor, insulin receptor and transferrin receptor"
     . SPARSER::COLLECTION)
    ("Reps1" . SPARSER::PROTEIN) ("Reps" . SPARSER::PROTEIN)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("RLIP76 or RIP1" . SPARSER::COLLECTION) ("Serines" . SPARSER::AMINO-ACID)
    ("the Lysine and Arginine-rich C-terminal polybasic region [ xref ]"
     . SPARSER::COLLECTION)
    ("Arginine" . SPARSER::AMINO-ACID)
    ("the C-terminal 30 amino acids of RalA fused" . SPARSER::PROTEIN)
    ("RalB–RalA" . SPARSER::COLLECTION) ("RalA or RalB" . SPARSER::COLLECTION)
    ("RalGEF-Ral" . SPARSER::COLLECTION)
    ("blocked both Ras G12V and Ras G12V" . SPARSER::COLLECTION)
    ("MAP Kinase and PI3K" . SPARSER::COLLECTION)
    ("Raf or PI3K" . SPARSER::COLLECTION)
    ("RalGEFs and Ral" . SPARSER::COLLECTION)
    ("MAP kinase and PI3K" . SPARSER::COLLECTION) ("BRaf" . SPARSER::PROTEIN)
    ("RalGDS, RGL, RGL2 and RGL3" . SPARSER::COLLECTION)
    ("at least six guanine nucleotide exchange factors" . SPARSER::GEF)
    ("RGL3, RalGPS1 and RalGPS2" . SPARSER::COLLECTION)
    ("proteins, RalGAP1 and RalGAP2" . SPARSER::COLLECTION)
    ("RGL2/Rlf" . SPARSER::COLLECTION) ("Rlf" . SPARSER::PROTEIN)
    ("RGL" . SPARSER::PROTEIN) ("RalGEFs" . SPARSER::PROTEIN)
    ("Rals" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RalA and RalB" . SPARSER::COLLECTION) ("RalB" . SPARSER::PROTEIN)
    ("RalA" . SPARSER::PROTEIN) ("RalGEF" . SPARSER::PROTEIN)
    ("phospholipase C delta 1" . SPARSER::PROTEIN)
    ("phospholipase D" . SPARSER::PROTEIN) ("VPS34" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Drp1" . SPARSER::PROTEIN)
    ("POB1" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("RLIP76" . SPARSER::PROTEIN)
    ("RalBP1" . SPARSER::PROTEIN) ("GTPase activating" . SPARSER::PROTEIN)
    ("RalGPS2" . SPARSER::PROTEIN) ("RalGPS1" . SPARSER::PROTEIN)
    ("RGL3" . SPARSER::PROTEIN) ("RGL2" . SPARSER::PROTEIN)
    ("IL-21 and STAT3" . SPARSER::COLLECTION)
    ("another homeostatic cytokine" . SPARSER::PROTEIN)
    ("IL-21/STAT3" . SPARSER::COLLECTION)
    ("normal and STAT3-deficient CD8 + T cells either directly ex vivo"
     . SPARSER::PROTEIN)
    ("Socs3 , Tbx21 , Bcl6 and Prdm1" . SPARSER::COLLECTION)
    ("SOCS3 and BCL6" . SPARSER::COLLECTION) ("Prdm1" . SPARSER::PROTEIN)
    ("Tbx21" . SPARSER::PROTEIN) ("Eomes and Bcl-6" . SPARSER::COLLECTION)
    ("T-bet and Blimp-1" . SPARSER::COLLECTION) ("Eomes" . SPARSER::PROTEIN)
    ("IL-15 and/or IL-21" . SPARSER::COLLECTION)
    ("a protective cytotoxic" . SPARSER::PROTEIN)
    ("IL-21R or STAT3" . SPARSER::COLLECTION) ("Gzmb" . SPARSER::PROTEIN)
    ("GZMB" . SPARSER::PROTEIN) ("STATs and cytokines" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("protective anti-viral" . SPARSER::DRUG)
    ("CX3CR1, CD11a and CD11b" . SPARSER::COLLECTION)
    ("Chemokine receptors and adhesion molecules" . SPARSER::COLLECTION)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("CD45RA and CCR7" . SPARSER::COLLECTION) ("PB" . SPARSER::PROTEIN)
    ("IL-21R, STAT1 or STAT3" . SPARSER::COLLECTION)
    ("STAT3 ( xref ) or STAT1 ( xref )" . SPARSER::COLLECTION)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-21 or IL-21/IL-15 co-stimulation" . SPARSER::COLLECTION)
    ("IL-21/IL-15" . SPARSER::COLLECTION)
    ("costimulatory molecules" . SPARSER::MOLECULE)
    ("IL-15/IL-21" . SPARSER::COLLECTION)
    ("IL-2, IL-15 or IL-21" . SPARSER::COLLECTION)
    ("STAT1 , STAT3 and IL21R" . SPARSER::COLLECTION)
    ("IL-2, IL-15 and IL-21" . SPARSER::COLLECTION)
    ("granzyme B and perforin" . SPARSER::COLLECTION)
    ("a functional IL-21R" . SPARSER::PROTEIN)
    ("STAT3 or STAT1" . SPARSER::COLLECTION)
    ("IL-2 or IL-15" . SPARSER::COLLECTION)
    ("STAT3 (n=15) or IL21R (n=3)" . SPARSER::COLLECTION)
    ("STAT1 (n=8), STAT3 (n=15) or IL21R (n=3)" . SPARSER::COLLECTION)
    ("IL-15 and IL-21" . SPARSER::COLLECTION)
    ("IL-21, IL-2 and IL-15" . SPARSER::COLLECTION)
    ("STAT1 or STAT3" . SPARSER::COLLECTION)
    ("IL-2 and IL-15" . SPARSER::COLLECTION)
    ("STAT1 and STAT5" . SPARSER::COLLECTION)
    ("STAT1, STAT3, STAT5, MAPK and Akt" . SPARSER::COLLECTION)
    ("effector and memory CD8 + T cell subsets" . SPARSER::COLLECTION)
    ("granzyme" . SPARSER::PROTEIN-FAMILY)
    ("IFN-γ, IFN-α/β and IFN-λ" . SPARSER::COLLECTION)
    ("PID" . SPARSER::PROTEIN) ("MAPK and Akt" . SPARSER::COLLECTION)
    ("JAK1 and JAK3" . SPARSER::COLLECTION)
    ("STAT1, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("granzyme B, perforin and IFN-γ" . SPARSER::COLLECTION)
    ("IFN-γ, granzyme B and perforin" . SPARSER::COLLECTION)
    ("BCL6 and EOMES" . SPARSER::COLLECTION) ("EOMES" . SPARSER::PROTEIN)
    ("perforin" . SPARSER::PROTEIN) ("IL-7 and IL-15" . SPARSER::COLLECTION)
    ("IL-21R/STAT3" . SPARSER::COLLECTION)
    ("STAT3 and IL21R" . SPARSER::COLLECTION)
    ("STAT1, STAT3 or IL21R" . SPARSER::COLLECTION)
    ("T-bet" . SPARSER::PROTEIN) ("Bcl-6" . SPARSER::PROTEIN)
    ("CD11a" . SPARSER::PROTEIN) ("CX3CR1" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("CD57" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("Autosomal dominant" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("granzyme B" . SPARSER::PROTEIN)
    ("IL-21R" . SPARSER::PROTEIN)
    ("metastatic NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("RET/PTC3" . SPARSER::COLLECTION)
    ("vandetanib and sorafenib" . SPARSER::COLLECTION)
    ("phospho-Akt, phospho-mTOR, and phospho-p70S6K" . SPARSER::COLLECTION)
    ("EGFR and VEGFR" . SPARSER::COLLECTION)
    ("vandetanib and cabozantinib" . SPARSER::COLLECTION)
    ("vandetanib" . SPARSER::DRUG) ("Multi" . SPARSER::PROTEIN)
    ("Tg-RET/PTC3" . SPARSER::COLLECTION) ("MZ-CRC" . SPARSER::COLLECTION)
    ("multi" . SPARSER::PROTEIN) ("a homozygous PTEN" . SPARSER::PROTEIN)
    ("p70-S6 kinase" . SPARSER::COLLECTION)
    ("MTC and PTC" . SPARSER::COLLECTION) ("nib" . SPARSER::DRUG)
    ("metastatic MTC" . SPARSER::PROTEIN) ("sorafenib" . SPARSER::DRUG)
    ("Vandetanib (AZD6474) and cabozantinib (XL184)" . SPARSER::COLLECTION)
    ("cabozantinib" . SPARSER::DRUG) ("Vandetanib" . SPARSER::DRUG)
    ("everolimus" . SPARSER::DRUG) ("NET" . SPARSER::PROTEIN)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ERK/GSK" . SPARSER::COLLECTION)
    ("GSK" . SPARSER::PROTEIN) ("multi-protein" . SPARSER::COLLECTION)
    ("Raptor" . SPARSER::PROTEIN) ("mTOR and RET" . SPARSER::COLLECTION)
    ("MAPK and phosphoinositol" . SPARSER::COLLECTION)
    ("RET/PTC" . SPARSER::COLLECTION) ("the sporadic forms" . SPARSER::FORM)
    ("MTC" . SPARSER::PROTEIN) ("neurotrophic ligands" . SPARSER::LIGAND)
    ("a dual mTORC1 and mTORC2 kinase inhibitor" . SPARSER::INHIBITOR)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("MZ-CRC-1" . SPARSER::COLLECTION) ("TPC-1" . SPARSER::PROTEIN)
    ("RET and mTOR" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN) ("RAF265" . SPARSER::DRUG)
    ("BEZ235" . SPARSER::DRUG) ("4EBP1" . SPARSER::PROTEIN)
    ("PTC3" . SPARSER::PROTEIN) ("4EBP-1" . SPARSER::PROTEIN)
    ("CCDC6" . SPARSER::PROTEIN) ("XL184" . SPARSER::DRUG)
    ("PTC1" . SPARSER::PROTEIN) ("Src-Homology" . SPARSER::PROTEIN)
    ("mTORC1" . SPARSER::PROTEIN) ("INK128" . SPARSER::DRUG)
    ("ras and fas" . SPARSER::COLLECTION) ("sphingomyelin" . SPARSER::MOLECULE)
    ("fas" . SPARSER::PROTEIN) ("TGF-β and TNF" . SPARSER::COLLECTION)
    ("cytometry, TUNEL, and phase" . SPARSER::COLLECTION)
    ("k-ras" . SPARSER::PROTEIN) ("CA 3" . SPARSER::PROTEIN)
    ("PC-2" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("ROCK1-Erk1/2" . SPARSER::COLLECTION)
    ("Mek1/2 and Erk1/2" . SPARSER::COLLECTION)
    ("Mek1/2, RhoA and ROCK1" . SPARSER::COLLECTION)
    ("the very upstream component" . SPARSER::COMPONENT)
    ("Mek/Erk" . SPARSER::COLLECTION) ("family and LIMK" . SPARSER::COLLECTION)
    ("Akt and JNK" . SPARSER::COLLECTION) ("LIMK" . SPARSER::PROTEIN)
    ("ERM" . SPARSER::PROTEIN) ("APL and ATL" . SPARSER::COLLECTION)
    ("ATL" . SPARSER::PROTEIN)
    ("KIT, FMS-like tyrosine kinase-3 (FLT3) and BCR-ABL"
     . SPARSER::COLLECTION)
    ("Multiple haematological disorder-associated oncoproteins"
     . SPARSER::PROTEIN)
    ("FMS" . SPARSER::PROTEIN) ("pathologic states" . SPARSER::BIO-STATE)
    ("a pivotal downstream effector" . SPARSER::EFFECTOR)
    ("Erk1/2 and RhoA" . SPARSER::COLLECTION)
    ("GST-fused" . SPARSER::COLLECTION) ("Erk2-HA" . SPARSER::COLLECTION)
    ("Erk1/2 and selenite" . SPARSER::COLLECTION)
    ("Erk1/2 and ROCK1" . SPARSER::COLLECTION)
    ("phosho-Erk1/2" . SPARSER::COLLECTION)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("analysis showed Erk1/2" . SPARSER::PROTEIN)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("caspase 9 and caspase 3" . SPARSER::COLLECTION)
    ("Selenite" . SPARSER::MOLECULE) ("ROCK1 and Erk1/2" . SPARSER::COLLECTION)
    ("its immediate downstream target" . SPARSER::TARGET-PROTEIN)
    ("pleiotropic effectors" . SPARSER::EFFECTOR) ("ATRA" . SPARSER::DRUG)
    ("APL" . SPARSER::PROTEIN) ("promyelocytic" . SPARSER::PROTEIN)
    ("Mek–Erk" . SPARSER::COLLECTION) ("GST-Erk2" . SPARSER::COLLECTION)
    ("the multimolecular complex" . SPARSER::BIO-COMPLEX)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NB4 and Jurkat" . SPARSER::COLLECTION) ("selenite" . SPARSER::MOLECULE)
    ("Rho-associated coiled-coil-forming kinase" . SPARSER::KINASE)
    ("pRK5" . SPARSER::PROTEIN) ("Anti- β" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("1-1" . SPARSER::PROTEIN) ("MYPT1" . SPARSER::PROTEIN)
    ("myosin phosphatase" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("NB4" . SPARSER::PROTEIN) ("Itch or PIR2" . SPARSER::COLLECTION)
    ("TAp73 and TRIM32" . SPARSER::COLLECTION) ("TA-p73" . SPARSER::COLLECTION)
    ("TRIM32, or TRIM32" . SPARSER::COLLECTION)
    ("promoter-luc" . SPARSER::PROTEIN) ("-full-length" . SPARSER::COLLECTION)
    ("TRIM32/p73" . SPARSER::COLLECTION) ("TAp73" . SPARSER::PROTEIN)
    ("HA-TAp73" . SPARSER::PROTEIN-PAIR) ("GFP-TRIM32" . SPARSER::COLLECTION)
    ("murine-TRIM32 and TAp73 α" . SPARSER::COLLECTION)
    ("TRIM32 and ubiquitin" . SPARSER::COLLECTION)
    ("TAp73 α and DNp73" . SPARSER::COLLECTION)
    ("HA-TRIM32" . SPARSER::COLLECTION) ("Myc-TRIM32" . SPARSER::COLLECTION)
    ("myc-TRIM32" . SPARSER::COLLECTION)
    ("TRIM32 and its regulator" . SPARSER::COLLECTION)
    ("TRIM32 and TAp73" . SPARSER::COLLECTION)
    ("premature embryonic NPCs" . SPARSER::MOLECULE) ("soma" . SPARSER::DRUG)
    ("Tuj-1" . SPARSER::COLLECTION) ("TA- and DN-p73" . SPARSER::COLLECTION)
    ("TA-" . SPARSER::PROTEIN) ("TA and ΔNp73" . SPARSER::COLLECTION)
    ("TA and DN p73 differentially" . SPARSER::COLLECTION)
    ("both ectopic TA and DN p73" . SPARSER::COLLECTION)
    ("TP53 and TP73" . SPARSER::COLLECTION) ("hTRIM32-luc" . SPARSER::PROTEIN)
    ("TRIM32-luc" . SPARSER::PROTEIN-PAIR)
    ("the proximal promoter" . SPARSER::PROMOTER) ("luc" . SPARSER::PROTEIN)
    ("OBs" . SPARSER::PROTEIN)
    ("the neuronal fate determinant TRIM32" . SPARSER::PROTEIN)
    ("TP73 and TRIM32" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("tripartite motif protein" . SPARSER::PROTEIN)
    ("TA and DNp73" . SPARSER::COLLECTION)
    ("a possible therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("p73 and TRIM32" . SPARSER::COLLECTION) ("DNp" . SPARSER::DRUG)
    ("the E3 ubiquitin ligase tripartite motif protein" . SPARSER::PROTEIN)
    ("anti-ERK" . SPARSER::PROTEIN) ("CA5" . SPARSER::PROTEIN)
    ("PIR2" . SPARSER::PROTEIN) ("TAP73 α" . SPARSER::PROTEIN)
    ("p53 Family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAp73 α" . SPARSER::PROTEIN) ("P73" . SPARSER::PROTEIN)
    ("Let-7" . SPARSER::RNA) ("micro-RNAs" . SPARSER::MICRO-RNA)
    ("protein Argonaute-1" . SPARSER::PROTEIN) ("RAR α" . SPARSER::PROTEIN)
    ("TRIM32" . SPARSER::PROTEIN) ("BCL2-proteins" . SPARSER::COLLECTION)
    ("a PKB-phosphorylation-independent FOXO3(A3)ER allele" . SPARSER::ALLELE)
    ("hyperactive PKB" . SPARSER::PROTEIN) ("Tetracyclin" . SPARSER::MOLECULE)
    ("a weak BH3-only protein" . SPARSER::PROTEIN)
    ("Bim, Noxa or tBID" . SPARSER::COLLECTION)
    ("BCL2 and BclxL" . SPARSER::COLLECTION) ("tBID" . SPARSER::PROTEIN)
    ("TRADD" . SPARSER::PROTEIN)
    ("caspase-9 and caspase-8" . SPARSER::COLLECTION)
    ("Dominant-negative FADD" . SPARSER::PROTEIN)
    ("PKB-phosphorylation-independent FOXO3-transgene" . SPARSER::COLLECTION)
    ("FOXO3-transgene" . SPARSER::COLLECTION)
    ("the pro-apoptotic FOXO3-targets Noxa and TRAIL" . SPARSER::COLLECTION)
    ("Noxa and TRAIL" . SPARSER::COLLECTION) ("CEM/p16" . SPARSER::PROTEIN)
    ("ER and CEM/p16-FOXO3" . SPARSER::COLLECTION)
    ("CEM/p16-FOXO3" . SPARSER::COLLECTION)
    ("the PKB-phosphorylation-independent FOXO3(A3)ER fusion protein"
     . SPARSER::PROTEIN)
    ("p16 INK4A and FOXO3" . SPARSER::COLLECTION)
    ("glucocorticoid-" . SPARSER::PROTEIN)
    ("either Bim- or Noxa-specific short-hairpin RNAs (Fig xref , middle and lower panel)"
     . SPARSER::COLLECTION)
    ("Bim or Noxa" . SPARSER::COLLECTION) ("Bim-" . SPARSER::PROTEIN)
    ("TRAIL, Bim or Noxa" . SPARSER::COLLECTION)
    ("TRAIL, Noxa or Bim" . SPARSER::COLLECTION)
    ("TRAIL, Noxa and Bim" . SPARSER::COLLECTION) ("BimEL" . SPARSER::PROTEIN)
    ("BimL" . SPARSER::PROTEIN) ("Noxa and Bim" . SPARSER::COLLECTION)
    ("TRAIL and the BH3-only proteins Bim and Noxa" . SPARSER::COLLECTION)
    ("Bim and Noxa" . SPARSER::COLLECTION)
    ("CEM/FOXO3, Molt3/FOXO3 and Molt4/FOXO3" . SPARSER::COLLECTION)
    ("CEM/FOXO3" . SPARSER::PROTEIN)
    ("the mutated FADD molecule" . SPARSER::MOLECULE)
    ("CrmA (CEM/FOXO3-CrmA) and dnBID (CEM/FOXO3-dnBID)" . SPARSER::COLLECTION)
    ("CEM/FOXO3-CrmA" . SPARSER::PROTEIN-PAIR)
    ("BCL2 and dnFADD" . SPARSER::COLLECTION)
    ("BCL2, dnFADD, dnBID and CrmA" . SPARSER::COLLECTION)
    ("inhibitors of the extrinsic death pathway (caspase-inhibitor CrmA, dominant-negative FADD) or a mutated version"
     . SPARSER::COLLECTION)
    ("BIRC5/Survivin" . SPARSER::COLLECTION)
    ("the cell cycle inhibitors p27 Kip1 and/or p21 Cip1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Jurkat/FOXO3" . SPARSER::COLLECTION) ("CMXRos" . SPARSER::MOLECULE)
    ("AnnexinV" . SPARSER::PROTEIN) ("PGR" . SPARSER::PROTEIN)
    ("PI3K/PKB/FOXO3" . SPARSER::COLLECTION)
    ("CASP3/caspase-3" . SPARSER::COLLECTION)
    ("BCL2 or BclxL" . SPARSER::COLLECTION)
    ("release activator BH3-only proteins as well as BAX and BAK [ xref ]"
     . SPARSER::COLLECTION)
    ("Bid and Bim, and sensitizers" . SPARSER::COLLECTION)
    ("Bim, and sensitizers" . SPARSER::COLLECTION)
    ("BAX and BAK" . SPARSER::COLLECTION)
    ("CASP9/caspase-9" . SPARSER::COLLECTION)
    ("the pro-apoptotic BH3-only proteins (such as Noxa, Bim or BBC3/Puma) and the pro-apoptotic multi-domain proteins BAX, BAK and Bok"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic multi-domain proteins BAX, BAK and Bok"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("BCL2, BclxL or MCL1" . SPARSER::COLLECTION)
    ("BAX, BAK and Bok" . SPARSER::COLLECTION)
    ("BBC3/Puma" . SPARSER::COLLECTION) ("Bok" . SPARSER::PROTEIN)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("CASP8/caspase-8" . SPARSER::COLLECTION) ("DISC" . SPARSER::BIO-COMPLEX)
    ("BCL2L1/BclxL" . SPARSER::COLLECTION) ("BclxL" . SPARSER::PROTEIN)
    ("TRAIL or FASL" . SPARSER::COLLECTION)
    ("BCL2L11/Bim" . SPARSER::COLLECTION) ("PMAIP1/Noxa" . SPARSER::COLLECTION)
    ("PKB-FOXO" . SPARSER::COLLECTION) ("PI3K/PKB" . SPARSER::COLLECTION)
    ("the PI3K or the PKB" . SPARSER::COLLECTION)
    ("BRC-ABL" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("FOXO1, FOXO3, FOXO4, and FOXO6" . SPARSER::COLLECTION)
    ("protein kinase B-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K-PKB" . SPARSER::COLLECTION) ("TRAIL and Noxa" . SPARSER::COLLECTION)
    ("CrmA and dnBID" . SPARSER::COLLECTION) ("FADD" . SPARSER::PROTEIN)
    ("CrmA" . SPARSER::PROTEIN)
    ("the death ligand TRAIL and the BH3-only protein Noxa"
     . SPARSER::COLLECTION)
    ("prednisone" . SPARSER::DRUG) ("Tween20" . SPARSER::MOLECULE)
    ("CD7" . SPARSER::PROTEIN) ("truncated BID" . SPARSER::PROTEIN)
    ("Ly294002" . SPARSER::MOLECULE)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("4OHT" . SPARSER::DRUG)
    ("CASP9" . SPARSER::PROTEIN) ("Cytochrome c" . SPARSER::PROTEIN)
    ("BBC3" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("Bcl6" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("OH-" . SPARSER::MOLECULE)
    ("a potential biomarker of nodal and micrometastatic disease"
     . SPARSER::COLLECTION)
    ("a definitive biomarker" . SPARSER::MOLECULE)
    ("K-Ras, B-Raf and β -catenin" . SPARSER::COLLECTION)
    ("multiple tumour-relevant proteins" . SPARSER::PROTEIN)
    ("robust biomarkers" . SPARSER::MOLECULE)
    ("β -catenin and FOXO3" . SPARSER::COLLECTION)
    ("metastatic CRC" . SPARSER::PROTEIN) ("cMyc" . SPARSER::PROTEIN)
    ("EGFR-targeted monoclonal antibodies" . SPARSER::ANTIBODY)
    ("MnSOD" . SPARSER::PROTEIN)
    ("both exogenous FOXO3 and β -catenin" . SPARSER::COLLECTION)
    ("FOXO3 and β -catenin" . SPARSER::COLLECTION)
    ("FOXO3 and CRC" . SPARSER::COLLECTION) ("primary CRCs" . SPARSER::PROTEIN)
    ("predictive biomarker" . SPARSER::MOLECULE)
    ("primary and metastatic CRC" . SPARSER::PROTEIN)
    ("even diagnostic biomarker" . SPARSER::MOLECULE)
    ("AKT/PI3K" . SPARSER::COLLECTION)
    ("metastasis relevant genes" . SPARSER::GENE)
    ("FOXO1, FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("a novel biomarker of nodal and distant disease spread"
     . SPARSER::COLLECTION)
    ("p27 kip1" . SPARSER::PROTEIN) ("GADD45a" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("Cyclin D2" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("subunit, and HIF-1α" . SPARSER::COLLECTION)
    ("NF-κB/Cox2" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("protein kinase B (PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-2, Bcl-xL, and catalase" . SPARSER::COLLECTION)
    ("PI3K, NF-κB, Akt, and Sonic hedgehog" . SPARSER::COLLECTION)
    ("Bcl-2/Bcl-xL" . SPARSER::COLLECTION) ("Mitochondria" . SPARSER::PROTEIN)
    ("catalase, SOD2 and Prx-1" . SPARSER::COLLECTION)
    ("water-soluble nickel" . SPARSER::MOLECULE)
    ("the water-soluble nickel" . SPARSER::MOLECULE)
    ("water-insoluble nickel" . SPARSER::MOLECULE)
    ("p-Stat3" . SPARSER::COLLECTION) ("NF-κB-p50" . SPARSER::COLLECTION)
    ("c-PARP" . SPARSER::COLLECTION) ("c-caspase 3" . SPARSER::COLLECTION)
    ("Caspase" . SPARSER::PROTEIN) ("SOD2, and Prx-1" . SPARSER::COLLECTION)
    ("SOD1, and Phox47" . SPARSER::COLLECTION) ("Phox" . SPARSER::PROTEIN)
    ("Prx" . SPARSER::PROTEIN) ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and ROS" . SPARSER::COLLECTION)
    ("Bcl-2, and Bcl-xL" . SPARSER::COLLECTION)
    ("components in tumor initiation and progression" . SPARSER::COLLECTION)
    ("the insoluble form" . SPARSER::FORM)
    ("Both the soluble and insoluble forms" . SPARSER::FORM)
    ("oxide and nickel" . SPARSER::COLLECTION) ("oxide" . SPARSER::MOLECULE)
    ("Nickel" . SPARSER::MOLECULE)
    ("Bcl-2, Bcl-xl and catalase" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and catalase" . SPARSER::COLLECTION)
    ("catalase" . SPARSER::PROTEIN) ("nickel" . SPARSER::MOLECULE)
    ("Cox2" . SPARSER::PROTEIN) ("Sonic hedgehog" . SPARSER::PROTEIN)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("Glo 3" . SPARSER::PROTEIN)
    ("FL-2" . SPARSER::PROTEIN) ("FL-1" . SPARSER::PROTEIN)
    ("JC-1" . SPARSER::MOLECULE) ("murine leukemia virus" . SPARSER::PROTEIN)
    ("lamin A/C" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("peroxiredoxin 1" . SPARSER::PROTEIN)
    ("Tip60 and Daxx" . SPARSER::COLLECTION)
    ("Axin/p53/HIPK2/Daxx" . SPARSER::COLLECTION)
    ("death domain-associated protein Daxx" . SPARSER::PROTEIN)
    ("Axin, HIPK2, p53 and Tip60" . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION) ("Axin/HIPK2" . SPARSER::COLLECTION)
    ("Axin/p53" . SPARSER::COLLECTION)
    ("MDM2 and its E3 ligase-dead mutant MDM2 (C464A)" . SPARSER::COLLECTION)
    ("Axin and MDM2" . SPARSER::COLLECTION)
    ("HIPK2-Axin" . SPARSER::COLLECTION)
    ("HIPK2 and Axin" . SPARSER::COLLECTION) ("MID" . SPARSER::PROTEIN)
    ("HIPK2 and p53" . SPARSER::COLLECTION)
    ("MDM2 or its mutant MDM2 (C464A)" . SPARSER::COLLECTION)
    ("both MDM2 and its E3-inactivated mutant MDM2 (C464A)"
     . SPARSER::COLLECTION)
    ("Axin and HIPK2" . SPARSER::COLLECTION)
    ("Axin-HIPK2" . SPARSER::COLLECTION) ("MDM2 or Axin" . SPARSER::COLLECTION)
    ("GST-MDM2Δp53" . SPARSER::PROTEIN-PAIR) ("GST-MDM2" . SPARSER::COLLECTION)
    ("p53 and Axin" . SPARSER::COLLECTION)
    ("neither wildtype MDM2 nor MDM2 (C464A)" . SPARSER::COLLECTION)
    ("MDM2 and Axin" . SPARSER::COLLECTION) ("Axin-p53" . SPARSER::COLLECTION)
    ("MDM2 or MDM2" . SPARSER::COLLECTION)
    ("Both MDM2 and its Mutant MDM2 (C464A)" . SPARSER::COLLECTION)
    ("Axin/p53/HIPK2" . SPARSER::COLLECTION)
    ("MDM2 and MDM2" . SPARSER::COLLECTION)
    ("Axin and p53" . SPARSER::COLLECTION)
    ("at least p53, HIPK2, and Daxx" . SPARSER::COLLECTION)
    ("p53, HIPK2, and Daxx" . SPARSER::COLLECTION) ("Daxx" . SPARSER::PROTEIN)
    ("MDM2 and HIPK2" . SPARSER::COLLECTION)
    ("MDM2 and p53" . SPARSER::COLLECTION)
    ("either wildtype MDM2 or its E3-dead mutant" . SPARSER::COLLECTION)
    ("p53 and HIPK2" . SPARSER::COLLECTION) ("HIPK2/p53" . SPARSER::COLLECTION)
    ("Nutlin 3a" . SPARSER::DRUG) ("Ligase Activity" . SPARSER::PROTEIN)
    ("T-1" . SPARSER::PROTEIN)
    ("Homeodomain-interacting protein kinase 2" . SPARSER::PROTEIN)
    ("Double Minute 2" . SPARSER::PROTEIN)
    ("the rs2274223 gene variant and the ESCC and gastric cancer risk"
     . SPARSER::COLLECTION)
    ("Ras, Rap1 and Rap2" . SPARSER::COLLECTION) ("ADPRT" . SPARSER::PROTEIN)
    ("phospholipase" . SPARSER::PROTEIN)
    ("metalloproteinases 2" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("Phospholipase C epsilon 1" . SPARSER::PROTEIN)
    ("PLCE1" . SPARSER::PROTEIN) ("a very flexible protein" . SPARSER::PROTEIN)
    ("tubulin as well as other proteins" . SPARSER::COLLECTION)
    ("glutamine or arginine" . SPARSER::COLLECTION)
    ("p300 and Gcn5" . SPARSER::COLLECTION) ("TAR" . SPARSER::RNA)
    ("protein (HIC)" . SPARSER::PROTEIN)
    ("HIC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gcn5 and PCAF" . SPARSER::COLLECTION) ("Bromodomain" . SPARSER::PROTEIN)
    ("soluble tubulin or total tubulin" . SPARSER::COLLECTION)
    ("soluble tubulin" . SPARSER::PROTEIN) ("Mutants" . SPARSER::MUTANT)
    ("Brg1, Brm, and bromodomain" . SPARSER::COLLECTION)
    ("Gcn5 and p300/CBP-associated factor" . SPARSER::COLLECTION)
    ("Brg1" . SPARSER::PROTEIN) ("Brm" . SPARSER::PROTEIN)
    ("cysteines" . SPARSER::AMINO-ACID)
    ("alanine, glutamine, and arginine" . SPARSER::COLLECTION)
    ("I-mfa" . SPARSER::PROTEIN) ("K29" . SPARSER::PROTEIN)
    ("K19" . SPARSER::PROTEIN) ("K88" . SPARSER::PROTEIN)
    ("Gcn5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Giantin" . SPARSER::PROTEIN)
    ("TBCs" . SPARSER::BIO-COMPLEX)
    ("These initial polymerized tubulin dimers form" . SPARSER::FORM)
    ("doublecortin (DCX)" . SPARSER::PROTEIN) ("DCX" . SPARSER::PROTEIN)
    ("doublecortin" . SPARSER::PROTEIN)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("HSPB1 or the negative control GFP" . SPARSER::COLLECTION)
    ("a soluble protein fraction" . SPARSER::COMPONENT)
    ("pure tubulin" . SPARSER::PROTEIN) ("TUBB3-GFP" . SPARSER::COLLECTION)
    ("tubulin and HSPB1" . SPARSER::COLLECTION)
    ("tubulin, actin and γ-tubulin" . SPARSER::COLLECTION)
    ("EB1-GFP" . SPARSER::COLLECTION) ("TIP" . SPARSER::PROTEIN)
    ("EB1" . SPARSER::PROTEIN) ("asters" . SPARSER::BIO-COMPLEX)
    ("a distinct centrosomal MT aster" . SPARSER::BIO-COMPLEX)
    ("aster" . SPARSER::BIO-COMPLEX) ("MAPs" . SPARSER::PROTEIN)
    ("AKAP450" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("TUBB3" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN)
    ("the influenza virus polymerase and M1 mRNA" . SPARSER::COLLECTION)
    ("NS1-BP-hnRNP K" . SPARSER::COLLECTION)
    ("A virus RNA polymerase and viral RNAs" . SPARSER::COLLECTION)
    ("NS1-BP/RNP" . SPARSER::COLLECTION)
    ("NS1-BP or hnRNP K" . SPARSER::COLLECTION)
    ("GAPDH, β-actin, and α-tubulin" . SPARSER::COLLECTION)
    ("the associated viral RNAs" . SPARSER::RNA)
    ("hnRNP U and NS1-BP" . SPARSER::COLLECTION)
    ("NS1-BP and the hnRNPs" . SPARSER::COLLECTION)
    ("NS1 and NS2" . SPARSER::COLLECTION) ("M2 and M1" . SPARSER::COLLECTION)
    ("a specific viral mRNA" . SPARSER::PROTEIN)
    ("most viral proteins" . SPARSER::PROTEIN) ("viral RNAs" . SPARSER::RNA)
    ("PB1 and NP" . SPARSER::COLLECTION)
    ("viral NP protein" . SPARSER::PROTEIN)
    ("cellular RNA polymerase II" . SPARSER::PROTEIN)
    ("the largest subunit" . SPARSER::FRAGMENT)
    ("A virus ribonucleoprotein (vRNP) or the heterotrimeric polymerase complex"
     . SPARSER::COLLECTION)
    ("the heterotrimeric polymerase complex" . SPARSER::BIO-COMPLEX)
    ("poly(A)-binding protein, hnRNP M, hnRNP A1, DDX17, Hsp70, and Hsp90"
     . SPARSER::COLLECTION)
    ("antiviral proteins" . SPARSER::PROTEIN)
    ("Hsp70 and Hsp90" . SPARSER::COLLECTION) ("NFAR-2" . SPARSER::COLLECTION)
    ("NFAR" . SPARSER::PROTEIN) ("hnRNP" . SPARSER::PROTEIN)
    ("ribonucleoprotein" . SPARSER::PROTEIN) ("pyrimidines" . SPARSER::DRUG)
    ("CPSF and poly(A) binding protein" . SPARSER::COLLECTION)
    ("CPSF" . SPARSER::PROTEIN) ("interferon" . SPARSER::PROTEIN)
    ("Viral mRNA" . SPARSER::PROTEIN)
    ("the matrix protein (M1) and ion channel (M2)" . SPARSER::COLLECTION)
    ("NEP/NS2" . SPARSER::COLLECTION) ("NEP" . SPARSER::PROTEIN)
    ("PA-N155" . SPARSER::COLLECTION)
    ("a newly identified viral protein" . SPARSER::PROTEIN)
    ("the viral polymerase complex" . SPARSER::BIO-COMPLEX)
    ("viral nucleoprotein (NP)" . SPARSER::PROTEIN)
    ("viral polymerase complex" . SPARSER::BIO-COMPLEX)
    ("PB1, PB2, and PA" . SPARSER::COLLECTION) ("PA" . SPARSER::PROTEIN)
    ("PB1" . SPARSER::PROTEIN)
    ("hemagglutinin (HA) and neuraminidase (NA)" . SPARSER::COLLECTION)
    ("two glycoproteins, hemagglutinin (HA) and neuraminidase (NA)"
     . SPARSER::COLLECTION)
    ("neuraminidase" . SPARSER::PROTEIN)
    ("NS1-BP and hnRNP K" . SPARSER::COLLECTION)
    ("NS1-BP and its interacting partner hnRNP K" . SPARSER::COLLECTION)
    ("the essential viral M2 protein" . SPARSER::PROTEIN)
    ("a key viral protein" . SPARSER::PROTEIN)
    ("NS1-BP-hnRNPK" . SPARSER::COLLECTION) ("hnRNPK" . SPARSER::PROTEIN)
    ("viral M1 mRNA" . SPARSER::PROTEIN)
    ("NS1-BP and heterogeneous nuclear ribonucleoproteins (hnRNPs)"
     . SPARSER::COLLECTION)
    ("heterogeneous nuclear ribonucleoproteins" . SPARSER::PROTEIN)
    ("Two viral RNA" . SPARSER::RNA)
    ("polyadenylate-binding protein" . SPARSER::PROTEIN)
    ("Hsp 70" . SPARSER::PROTEIN) ("Q00839" . SPARSER::PROTEIN)
    ("P09651" . SPARSER::PROTEIN) ("sodium bicarbonate" . SPARSER::DRUG)
    ("hnRNP L" . SPARSER::PROTEIN) ("RPL32" . SPARSER::PROTEIN)
    ("IVNS1ABP" . SPARSER::PROTEIN) ("DHX9" . SPARSER::PROTEIN)
    ("E1B-AP5" . SPARSER::PROTEIN) ("hnRNP U" . SPARSER::PROTEIN)
    ("polymerase II" . SPARSER::PROTEIN) ("hnRNP M" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein" . SPARSER::PROTEIN)
    ("NXF1" . SPARSER::PROTEIN) ("poly(A) binding protein" . SPARSER::PROTEIN)
    ("N155" . SPARSER::PROTEIN) ("PA-X" . SPARSER::PROTEIN)
    ("PB1-F2" . SPARSER::PROTEIN) ("PB2" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("hnRNP K" . SPARSER::PROTEIN) ("NS1-BP" . SPARSER::PROTEIN)
    ("NS2" . SPARSER::PROTEIN) ("NS1" . SPARSER::PROTEIN)
    ("ERα-Src" . SPARSER::COLLECTION)
    ("transient focal ischemia" . SPARSER::PROTEIN)
    ("ER and Src" . SPARSER::COLLECTION)
    ("phosphoinositide 3-kinase and various effectors" . SPARSER::COLLECTION)
    ("Erk, phosphoinositide 3-kinase and various effectors"
     . SPARSER::COLLECTION)
    ("Akt/PKB, Rac, and PKC" . SPARSER::COLLECTION)
    ("staurosporine" . SPARSER::DRUG)
    ("an ERE-driven reporter gene" . SPARSER::GENE) ("Luc" . SPARSER::PROTEIN)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("ER/Src" . SPARSER::COLLECTION)
    ("ERα/Src" . SPARSER::COLLECTION) ("ERα and Src" . SPARSER::COLLECTION)
    ("PP 2 or InhV" . SPARSER::COLLECTION)
    ("c-Src, Stat3, Akt or MEK" . SPARSER::COLLECTION)
    ("LY294002 or PD98059" . SPARSER::COLLECTION)
    ("MEK and inhV" . SPARSER::COLLECTION) ("PI 3 K/Akt" . SPARSER::COLLECTION)
    ("a mutated form" . SPARSER::FORM) ("AF-1 and AF-2" . SPARSER::COLLECTION)
    ("a residual hormone" . SPARSER::MOLECULE)
    ("residual estrogen" . SPARSER::MOLECULE)
    ("different mutated or deleted forms" . SPARSER::FORM)
    ("the heterochromatic promoter" . SPARSER::PROMOTER)
    ("Sp1 or AP-1" . SPARSER::COLLECTION)
    ("protein/protein" . SPARSER::COLLECTION)
    ("c-Src/Stat3" . SPARSER::COLLECTION)
    ("AF-1 or AF-2" . SPARSER::COLLECTION)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT) ("BAG1" . SPARSER::PROTEIN)
    ("BAG3" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("C-Src" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("PP 2" . SPARSER::DRUG)
    ("Membrane-bound" . SPARSER::PROTEIN) ("βGal" . SPARSER::PROTEIN)
    ("B12)" . SPARSER::PROTEIN) ("K-23" . SPARSER::PROTEIN)
    ("Erk 1" . SPARSER::PROTEIN) ("H-1" . SPARSER::PROTEIN)
    ("t-butyl" . SPARSER::MOLECULE) ("PI 3 K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β estradiol" . SPARSER::MOLECULE) ("c-Src" . SPARSER::PROTEIN)
    ("AF-2" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("E 2" . SPARSER::MOLECULE)
    ("the SHP1 phosphatase and shares high homology" . SPARSER::COLLECTION)
    ("GM-CSF/IL-3" . SPARSER::COLLECTION)
    ("K-Ras and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("Ade" . SPARSER::PROTEIN) ("Erk, Akt, and Stat5" . SPARSER::COLLECTION)
    ("Erk, Akt, Jak2, and Stat5" . SPARSER::COLLECTION)
    ("Jak2-Stat5" . SPARSER::COLLECTION)
    ("GM-CSF and IL-3" . SPARSER::COLLECTION)
    ("tryptophans" . SPARSER::AMINO-ACID)
    ("-Nitrophenylphosphate" . SPARSER::MOLECULE) ("NPP" . SPARSER::PROTEIN)
    ("Nitrophenylphosphate" . SPARSER::MOLECULE)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("wild-type (WT) full-length SHP2 and the full-length SHP2 E76K mutant"
     . SPARSER::COLLECTION)
    ("ps" . SPARSER::PROTEIN)
    ("CD45, LAR, MEG2, and TC-PTP" . SPARSER::COLLECTION)
    ("the previously reported parent inhibitors" . SPARSER::INHIBITOR)
    ("other JMML-associated Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factors/cytokines" . SPARSER::COLLECTION)
    ("NF-κB, and mTOR" . SPARSER::COLLECTION)
    ("Jak-Stat" . SPARSER::COLLECTION) ("Ras-Erk" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHP1 and other PTPs" . SPARSER::COLLECTION) ("PTPs" . SPARSER::PROTEIN)
    ("growth factor and cytokine" . SPARSER::COLLECTION)
    ("Gab2" . SPARSER::PROTEIN) ("TC-PTP" . SPARSER::PROTEIN)
    ("MEG2" . SPARSER::PROTEIN) ("PO 3" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("E-4" . SPARSER::PROTEIN)
    ("c-CBL" . SPARSER::PROTEIN) ("three domains" . SPARSER::PROTEIN)
    ("sheds new light" . SPARSER::PROTEIN) ("Card9" . SPARSER::PROTEIN)
    ("ribosomal protein and perhaps" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG)
    ("PTEN, HIF-1alpha, CA9 or pVHL" . SPARSER::COLLECTION)
    ("PTEN or pVHL" . SPARSER::COLLECTION)
    ("Jade-1 and AKT" . SPARSER::COLLECTION) ("CTMP" . SPARSER::PROTEIN)
    ("pro-apoptotic molecule" . SPARSER::MOLECULE)
    ("PTEN and pVHL" . SPARSER::COLLECTION)
    ("genes positively regulated by AKT1 and underexpression"
     . SPARSER::COLLECTION)
    ("Jade-1 ( xref ) or LY294002 ( xref )" . SPARSER::COLLECTION)
    ("dominant-negative AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase activity and downstream targets" . SPARSER::COLLECTION)
    ("Linker" . SPARSER::LINKER) ("double-PHD" . SPARSER::PROTEIN)
    ("full-length, del3 and del4" . SPARSER::COLLECTION)
    ("del1 or del2" . SPARSER::COLLECTION) ("myc-Jade-1" . SPARSER::COLLECTION)
    ("HA-AKT1" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("endogenous AKT and vice versa ( xref )" . SPARSER::COLLECTION)
    ("Jade-1 and pVHL" . SPARSER::COLLECTION)
    ("pFlag-Jade-1" . SPARSER::COLLECTION) ("pFlag" . SPARSER::PROTEIN)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("tetracycline" . SPARSER::DRUG) ("tet" . SPARSER::PROTEIN)
    ("pVHL and Jade-1" . SPARSER::COLLECTION)
    ("VHL and PTEN" . SPARSER::COLLECTION) ("AKT/PKB" . SPARSER::COLLECTION)
    ("Serine/threonine" . SPARSER::COLLECTION)
    ("AKT/AKT1" . SPARSER::COLLECTION) ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("pVHL (VHL)" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN) ("CA9" . SPARSER::PROTEIN)
    ("HIF-1alpha" . SPARSER::PROTEIN) ("TRB3" . SPARSER::PROTEIN)
    ("Tcl1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Jade- 1" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk1" . SPARSER::PROTEIN)
    ("p38γ" . SPARSER::PROTEIN) ("HK-2" . SPARSER::PROTEIN)
    ("pErk1/2" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("P-1" . SPARSER::PROTEIN) ("del3" . SPARSER::PROTEIN)
    ("del2" . SPARSER::PROTEIN) ("del1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("PHF17" . SPARSER::PROTEIN) ("Jade-1" . SPARSER::PROTEIN)
    ("aspartate" . SPARSER::PROTEIN)
    ("even thoughbcl-x −/− MEFs" . SPARSER::PROTEIN)
    ("p53-pRb" . SPARSER::COLLECTION) ("Capn4" . SPARSER::PROTEIN)
    ("lactacystin" . SPARSER::DRUG) ("calpain, and PEST" . SPARSER::COLLECTION)
    ("just calpain" . SPARSER::PROTEIN) ("HTB" . SPARSER::DRUG)
    ("etoposide-" . SPARSER::PROTEIN)
    ("at least 12 amino acids" . SPARSER::AMINO-ACID)
    ("serines, and threonines" . SPARSER::COLLECTION)
    ("histidines, arginines, or lysines" . SPARSER::COLLECTION)
    ("histidines" . SPARSER::AMINO-ACID) ("threonines" . SPARSER::AMINO-ACID)
    ("serines" . SPARSER::AMINO-ACID) ("prolines" . SPARSER::AMINO-ACID)
    ("etoposide and cisplatin" . SPARSER::COLLECTION)
    ("etoposide or cisplatin" . SPARSER::COLLECTION)
    ("polybrene" . SPARSER::MOLECULE) ("Bim or Bax" . SPARSER::COLLECTION)
    ("etoposide and γ-radiation" . SPARSER::COLLECTION)
    ("cisplatin, etoposide, and γ-radiation" . SPARSER::COLLECTION)
    ("labile" . SPARSER::PROTEIN)
    ("the asparagines of the asparagine-glycine" . SPARSER::COLLECTION)
    ("their respective wild-type proteins" . SPARSER::PROTEIN)
    ("alkaline" . SPARSER::PROTEIN)
    ("the only function asparagine-glycine dipeptides" . SPARSER::MOLECULE)
    ("dipeptides" . SPARSER::MOLECULE) ("dipeptide" . SPARSER::MOLECULE)
    ("the amino acids of the proteins" . SPARSER::PROTEIN)
    ("asparagine-glycine" . SPARSER::COLLECTION)
    ("glycines" . SPARSER::AMINO-ACID) ("Asparagine" . SPARSER::AMINO-ACID)
    ("p53-retinoblastoma protein" . SPARSER::COLLECTION)
    ("a small molecule or antisense that selectively inhibits"
     . SPARSER::COLLECTION)
    ("prosurvival proteins" . SPARSER::PROTEIN)
    ("the prosurvival Bcl-2 proteins" . SPARSER::PROTEIN)
    ("the simplest extant metazoans" . SPARSER::PROTEIN-FAMILY)
    ("metazoans" . SPARSER::PROTEIN-FAMILY) ("calpain" . SPARSER::PROTEIN)
    ("isoaspartyl" . SPARSER::MOLECULE) ("asparaginyl" . SPARSER::PROTEIN)
    ("asparagines" . SPARSER::AMINO-ACID) ("SNARF-1" . SPARSER::DRUG)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("BCL2L1" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("calpain inhibitor" . SPARSER::PROTEIN)
    ("ion channel" . SPARSER::PROTEIN-FAMILY) ("PGAM5" . SPARSER::PROTEIN)
    ("bcl-x" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("ASK1 or eNOS" . SPARSER::COLLECTION)
    ("AKT, HSP90 and Cdc37" . SPARSER::COLLECTION)
    ("chaperones and co-chaperones" . SPARSER::COLLECTION)
    ("mTOR, AMPK and EF2" . SPARSER::COLLECTION)
    ("AKT1/AKT2" . SPARSER::COLLECTION)
    ("AKT and elongation factor 2" . SPARSER::COLLECTION)
    ("AKT1- and EF2-specific antibodies" . SPARSER::COLLECTION)
    ("AKT1-" . SPARSER::PROTEIN)
    ("AKT and several glycolytic enzymes" . SPARSER::COLLECTION)
    ("AKT and α-enolase" . SPARSER::COLLECTION)
    ("HIF1-protein" . SPARSER::COLLECTION)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("hexokinase" . SPARSER::PROTEIN)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("AKT2 and GAPDH" . SPARSER::COLLECTION)
    ("AKT and GAPDH" . SPARSER::COLLECTION)
    ("GAPDH, α-enolase and EF2" . SPARSER::COLLECTION)
    ("a classical ER chaperone" . SPARSER::PROTEIN)
    ("the AKT-associated HSP70 proteins" . SPARSER::PROTEIN)
    ("AKT2 and HSP90" . SPARSER::COLLECTION)
    ("This ternary complex" . SPARSER::BIO-COMPLEX)
    ("AKT2-NTag" . SPARSER::PROTEIN-PAIR) ("AKT2/EF2" . SPARSER::COLLECTION)
    ("anti-AKT2- and anti-GAPDH-antibodies" . SPARSER::COLLECTION)
    ("anti-AKT2-" . SPARSER::ANTIBODY) ("anti-Enolase-" . SPARSER::ANTIBODY)
    ("Enolase" . SPARSER::PROTEIN) ("Enzymes" . SPARSER::ENZYME)
    ("GAPDH and α- enolase" . SPARSER::COLLECTION)
    ("MAP- and MBP-experiments" . SPARSER::COLLECTION)
    ("MAP-" . SPARSER::PROTEIN) ("nucleolin" . SPARSER::PROTEIN)
    ("MBP-TAP" . SPARSER::COLLECTION) ("MAP-TAP" . SPARSER::COLLECTION)
    ("MBP-" . SPARSER::PROTEIN)
    ("transiently interacting proteins" . SPARSER::PROTEIN)
    ("MBP and MAP" . SPARSER::COLLECTION) ("MAP" . SPARSER::PROTEIN)
    ("unspecific and low affinity binding proteins" . SPARSER::PROTEIN)
    ("MBP-TAPs" . SPARSER::COLLECTION) ("-L-arginine" . SPARSER::MOLECULE)
    ("TAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAPDH, EF1α, Tubulin, EF2 and α-enolase" . SPARSER::COLLECTION)
    ("HSP70 or GRP78" . SPARSER::COLLECTION)
    ("HSP90/Cdc37" . SPARSER::COLLECTION) ("Sepharose" . SPARSER::MOLECULE)
    ("IGF-1 or PI3-kinase" . SPARSER::COLLECTION)
    ("the endogenous AKT2 and total endogenous AKT" . SPARSER::COLLECTION)
    ("HA-, FLAG-, and StrepII-tags" . SPARSER::COLLECTION)
    ("FLAG-" . SPARSER::PROTEIN-FAMILY) ("HA-" . SPARSER::PROTEIN)
    ("new AKT2" . SPARSER::PROTEIN) ("eNOS" . SPARSER::PROTEIN)
    ("TAP" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("AKT1-3" . SPARSER::COLLECTION) ("PH" . SPARSER::PROTEIN)
    ("phosphatidylinositol-" . SPARSER::PROTEIN)
    ("phosphatidylinositol" . SPARSER::MOLECULE)
    ("NGF-1" . SPARSER::COLLECTION)
    ("protein kinase B or AKT" . SPARSER::COLLECTION)
    ("the kinase and its substrate protein" . SPARSER::COLLECTION)
    ("AKT2 and EF2" . SPARSER::COLLECTION)
    ("AKT2 and α-enolase" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("HSP90 and Cdc37" . SPARSER::COLLECTION)
    ("tubulin, GAPDH, α-enolase and elongation factor 2" . SPARSER::COLLECTION)
    ("Cdc37" . SPARSER::PROTEIN) ("enolase" . SPARSER::PROTEIN)
    ("AKT2-protein" . SPARSER::COLLECTION)
    ("Elongation factor 2" . SPARSER::PROTEIN) ("ASK1" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("G–I" . SPARSER::PROTEIN) ("A–D" . SPARSER::PROTEIN)
    ("E–H" . SPARSER::PROTEIN) ("methylosome protein 50" . SPARSER::PROTEIN)
    ("PRMT5" . SPARSER::PROTEIN) ("L-arginine" . SPARSER::MOLECULE)
    ("ENO1" . SPARSER::PROTEIN) ("eEF2" . SPARSER::PROTEIN)
    ("HCO 3" . SPARSER::MOLECULE) ("Lys-C" . SPARSER::PROTEIN)
    ("Asp-Tyr" . SPARSER::MOLECULE) ("L-Arginine" . SPARSER::MOLECULE)
    ("angiotensin II" . SPARSER::PROTEIN) ("NP 40" . SPARSER::MOLECULE)
    ("GLUT4" . SPARSER::PROTEIN) ("type 4" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EF2" . SPARSER::PROTEIN)
    ("elongation factor 2" . SPARSER::PROTEIN) ("GRP78" . SPARSER::PROTEIN)
    ("glucose regulated protein" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("heat shock protein 70" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AKT2" . SPARSER::PROTEIN)
    ("cancer-associated KD mutants" . SPARSER::MUTANT)
    ("complex and multivariate" . SPARSER::COLLECTION)
    ("receptor and SHP-2" . SPARSER::COLLECTION) ("SCCs" . SPARSER::PROTEIN)
    ("soluble collagen" . SPARSER::PROTEIN) ("chondrocytes" . SPARSER::PROTEIN)
    ("Src or DDR2" . SPARSER::COLLECTION)
    ("DDR2 and SHP-2 " . SPARSER::COLLECTION)
    ("DDR2 (Tyr 481 , Tyr 684 , Tyr 736 and Tyr 740 /Tyr 741 ) and SHP-2 (Tyr 62 )"
     . SPARSER::COLLECTION)
    ("DDR2 and its lung cancer mutants" . SPARSER::COLLECTION)
    ("cancer-associated DDR2 point mutations" . SPARSER::PROTEIN)
    ("lung SCC-associated DDR2 mutants" . SPARSER::MUTANT)
    ("SRM and ELISA" . SPARSER::COLLECTION) ("spiking" . SPARSER::PROTEIN)
    ("DDR2 and integrins" . SPARSER::COLLECTION)
    ("SHP-2, NCK1, LYN and PLCL2" . SPARSER::COLLECTION)
    ("DDR2 and its downstream components SHP-2, NCK1, LYN, PLCL2 and SHIP-2"
     . SPARSER::COLLECTION)
    ("SHP-2, NCK1, LYN, PLCL2 and SHIP-2" . SPARSER::COLLECTION)
    ("ERK1 (extracellular-signal-regulated kinase 1) and PLCL2 (summarized in xref )"
     . SPARSER::COLLECTION)
    ("LYN, PIK3C2A, SHP-2, SHIP-2, ERK1 (extracellular-signal-regulated kinase 1) and PLCL2 (summarized in xref )"
     . SPARSER::COLLECTION)
    ("robustly co-clustered phosphoproteins" . SPARSER::PROTEIN)
    ("both DDR2 and the integrins" . SPARSER::COLLECTION)
    ("Src and TDA" . SPARSER::COLLECTION) ("Src or TDA" . SPARSER::COLLECTION)
    ("recombinant membrane-associated proteins, or fragments"
     . SPARSER::COLLECTION)
    ("proteins, or fragments" . SPARSER::COLLECTION)
    ("insulin receptor and c-Met" . SPARSER::COLLECTION)
    ("pan-specific anti-phosphotyrosine antibodies" . SPARSER::ANTIBODY)
    ("the iTRAQ isobaric reagent" . SPARSER::MOLECULE)
    ("chromogenic substrate" . SPARSER::SUBSTRATE)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("0.5% Nonidet P40 and 120 mM NaCl (pH 7.5)" . SPARSER::COLLECTION)
    ("0.5% Triton X-100 and 6 M urea" . SPARSER::COLLECTION)
    ("10% glycerol and 4.5 mM EDTA" . SPARSER::COLLECTION)
    ("120 mM NaCl and 0.5% Nonidet P40 (pH 7.5)" . SPARSER::COLLECTION)
    ("DDR2, PLCL2, SHIP2 and SHP-2" . SPARSER::COLLECTION)
    ("vac" . SPARSER::PROTEIN) ("modified porcine trypsin" . SPARSER::PROTEIN)
    ("consecutive 50% acetonitrile/50 mM TEAB (triethylammonium bicarbonate) and 50 mM TEAB"
     . SPARSER::COLLECTION)
    ("consecutive 50% acetonitrile/50 mM TEAB" . SPARSER::PROTEIN)
    ("TEAB" . SPARSER::PROTEIN) ("phosphocellulose" . SPARSER::DRUG)
    ("200 μM ATP (with 1.5 μCi of [γ- 32 P]ATP) and 200 μM peptide substrate in AB1"
     . SPARSER::COLLECTION)
    ("substrate (KKSRGDYMTMQIG)" . SPARSER::SUBSTRATE)
    ("Hepes" . SPARSER::MOLECULE) ("Enzyme" . SPARSER::ENZYME)
    ("His-tagged DDR2 and/or Src (see Supplementary Figure S1C atfor sequences)"
     . SPARSER::COLLECTION)
    ("membrane-associated proteins, His-tagged DDR2 and/or Src (see Supplementary Figure S1C atfor sequences)"
     . SPARSER::COLLECTION)
    ("membrane-associated proteins" . SPARSER::PROTEIN)
    ("spiked" . SPARSER::PROTEIN) ("Trap" . SPARSER::PROTEIN)
    ("runs" . SPARSER::PROTEIN-FAMILY)
    ("the pY100 antibody and 30 μl" . SPARSER::COLLECTION)
    ("Sep-Pak" . SPARSER::PROTEIN-PAIR) ("SRM" . SPARSER::PROTEIN)
    ("the peptides identified by checking" . SPARSER::PEPTIDE)
    ("Peptide" . SPARSER::PEPTIDE) ("cysteine and iTRAQ" . SPARSER::COLLECTION)
    ("-NH 2" . SPARSER::MOLECULE) ("tip" . SPARSER::PROTEIN)
    ("iron" . SPARSER::MOLECULE)
    ("the anti-phosphotyrosine antibodies, pY100 (Cell Signaling Technology) and 4G10 (Millipore)"
     . SPARSER::COLLECTION)
    ("acetonitrile" . SPARSER::MOLECULE) ("Sep" . SPARSER::PROTEIN)
    ("Peptides" . SPARSER::PEPTIDE)
    ("the Developmental Studies Hybridoma Bank" . SPARSER::PROTEIN)
    ("IA" . SPARSER::MOLECULE) ("clone FB12" . SPARSER::PROTEIN)
    ("Star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("formaldehyde" . SPARSER::MOLECULE) ("primary mAbs" . SPARSER::DRUG)
    ("PBS/BSA" . SPARSER::COLLECTION)
    ("IgG or anti-mouse" . SPARSER::COLLECTION)
    ("a mouse anti-α-tubulin" . SPARSER::ANTIBODY)
    ("a rabbit anti-(SHP2 p-Tyr 542 ) (Cell Signaling Technology) antibody"
     . SPARSER::PROTEIN)
    ("goat anti-DDR2" . SPARSER::ANTIBODY) ("PY" . SPARSER::MOLECULE)
    ("HEK-293-DDR2 or mutant" . SPARSER::COLLECTION)
    ("protease and phosphatase" . SPARSER::COLLECTION)
    ("pcDNA3.1-DDR2" . SPARSER::COLLECTION)
    ("PLCL2 (phospholipase C-like 2) and PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2α)"
     . SPARSER::COLLECTION)
    ("SHP-2 (Src homology 2 domain-containing protein tyrosine phosphatase 2), NCK1 (non-catalytic region of tyrosine kinase adaptor protein 1), LYN, SHIP-2 [SH2 (Src homology 2)-domain-containing inositol phosphatase 2], PLCL2 (phospholipase C-like 2) and PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2α)"
     . SPARSER::COLLECTION)
    ("collagen and collagen" . SPARSER::COLLECTION) ("DDR" . SPARSER::PROTEIN)
    ("fibrillar collagen" . SPARSER::PROTEIN)
    ("classical growth factor-activated RTKs" . SPARSER::PROTEIN)
    ("fibrillar collagen molecules" . SPARSER::MOLECULE)
    ("α1β1 and α2β1" . SPARSER::COLLECTION)
    ("heterodimeric type 1 transmembrane molecules" . SPARSER::MOLECULE)
    ("integrin and DDR2" . SPARSER::COLLECTION)
    ("DDR2 and SHP-2" . SPARSER::COLLECTION)
    ("PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2α) and PLCL2 (phospholipase C-like 2)"
     . SPARSER::COLLECTION)
    ("SHP-2 (Src homology 2 domain-containing protein tyrosine phosphatase 2), NCK1 (non-catalytic region of tyrosine kinase adaptor protein 1), LYN, SHIP-2 [SH2 (Src homology 2)-domain-containing inositol phosphatase 2], PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2α) and PLCL2 (phospholipase C-like 2)"
     . SPARSER::COLLECTION)
    ("LYN" . SPARSER::PROTEIN) ("integrins and DDR2" . SPARSER::COLLECTION)
    ("the β1 integrins and the DDRs (discoidin domain receptors)"
     . SPARSER::COLLECTION)
    ("DDRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosine-phosphorylation-regulated kinase 1" . SPARSER::PROTEIN)
    ("DYRK1A" . SPARSER::PROTEIN) ("collagen-I" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-13 " . SPARSER::PROTEIN)
    ("SHP-2 " . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("SHIP2" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("AK7" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("α1β1" . SPARSER::PROTEIN) ("type 1" . SPARSER::PROTEIN)
    ("PLCL2" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4-phosphate 3-kinase" . SPARSER::PROTEIN)
    ("PIK3C2A" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("SHIP-2" . SPARSER::PROTEIN) ("NCK1" . SPARSER::PROTEIN)
    ("DDR2" . SPARSER::PROTEIN) ("collagen receptor" . SPARSER::PROTEIN)
    ("YL" . SPARSER::PROTEIN) ("HIV-1 Tat viral protein" . SPARSER::PROTEIN)
    ("promoter and alternative splicing activity" . SPARSER::COLLECTION)
    ("a multi-functional protein" . SPARSER::PROTEIN)
    ("ribonucleoproteins and heat shock proteins" . SPARSER::COLLECTION)
    ("cytoskeletal proteins and skin proteins" . SPARSER::COLLECTION)
    ("skin proteins and two ungrouped protein importin-2α and YB-1"
     . SPARSER::COLLECTION)
    ("cytoskeletal proteins, heat shock proteins, ribonucleoproteins, skin proteins and two ungrouped protein importin-2α and YB-1"
     . SPARSER::COLLECTION)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("Tip110, Tip110ΔNT and Tip110ΔCT" . SPARSER::COLLECTION)
    ("YB-1 and YB-1" . SPARSER::COLLECTION)
    ("Tip110 or YB-1" . SPARSER::COLLECTION)
    ("promoter-driven reporter gene chloramphenicol acetyltransferase (CAT)"
     . SPARSER::PROTEIN)
    ("acetyltransferase (CAT)" . SPARSER::PROTEIN)
    ("chloramphenicol" . SPARSER::DRUG)
    ("the HIV-1 Tat viral protein" . SPARSER::PROTEIN)
    ("Tip110, ΔCT, ΔRRM and ΔNLS" . SPARSER::COLLECTION)
    ("Tip110 and its mutants" . SPARSER::COLLECTION)
    ("anti-Myc or anti-HA" . SPARSER::COLLECTION)
    ("Myc-YB-1" . SPARSER::COLLECTION)
    ("anti-HA or anti-Myc" . SPARSER::COLLECTION)
    ("pYB-1-Myc" . SPARSER::COLLECTION)
    ("YB-1 and Tip110" . SPARSER::COLLECTION)
    ("skin proteins and two ungrouped protein importin-2α and Y box binding protein 1 (YB-1)"
     . SPARSER::COLLECTION)
    ("Those included cytoskeletal proteins" . SPARSER::PROTEIN)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tip110-HA" . SPARSER::COLLECTION) ("pTip" . SPARSER::PROTEIN)
    ("USP" . SPARSER::PROTEIN) ("NANOG" . SPARSER::PROTEIN)
    ("1b" . SPARSER::PROTEIN) ("eukaryotic pre-mRNA" . SPARSER::RNA)
    ("Tip110/YB-1" . SPARSER::COLLECTION)
    ("Tip110 and YB-1" . SPARSER::COLLECTION) ("Pre-mRNA" . SPARSER::RNA)
    ("aa1" . SPARSER::PROTEIN) ("CC-3" . SPARSER::PROTEIN)
    ("USP4" . SPARSER::PROTEIN) ("GATA-2" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN) ("SART3" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN) ("Y-box binding protein 1" . SPARSER::PROTEIN)
    ("Tip110" . SPARSER::PROTEIN) ("TX" . SPARSER::PROTEIN)
    ("Immobilon" . SPARSER::DRUG) ("Glycine" . SPARSER::AMINO-ACID)
    ("these mutational hot" . SPARSER::PROTEIN) ("Exon" . SPARSER::PROTEIN)
    ("TRITC, FITC, and DAPI" . SPARSER::COLLECTION)
    ("phenylindole" . SPARSER::MOLECULE)
    ("biotinylated anti-avidin antibodies (Vector Laboratories, Burlingame, CA, USA) and tetramethylrhodamine B isothiocyanate (TRITC)-conjugated rabbit anti-mouse antibodies"
     . SPARSER::COLLECTION)
    ("TRITC" . SPARSER::MOLECULE) ("isothiocyanate" . SPARSER::MOLECULE)
    ("tetramethylrhodamine" . SPARSER::MOLECULE) ("avidin" . SPARSER::PROTEIN)
    ("digoxigenin" . SPARSER::MOLECULE) ("dUTP" . SPARSER::MOLECULE)
    ("p12" . SPARSER::PROTEIN) ("platinum and taxane" . SPARSER::COLLECTION)
    ("docetaxel" . SPARSER::DRUG) ("taxane-" . SPARSER::DRUG)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("RAS–RAF–MEK–ERK" . SPARSER::COLLECTION)
    ("KRAS/MAPK1" . SPARSER::COLLECTION)
    ("tyrosine and threonine" . SPARSER::COLLECTION) ("OSE" . SPARSER::PROTEIN)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("the prototypic type" . TYPE)
    ("KRAS , BRAF , PTEN , PIK3CA , CTNNB1 , and ARID1A" . SPARSER::COLLECTION)
    ("Drugs" . SPARSER::DRUG) ("platinum-" . SPARSER::MOLECULE)
    ("taxane" . SPARSER::DRUG) ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("KRAS or MAPK1" . SPARSER::COLLECTION)
    ("KRAS and MAPK1" . SPARSER::COLLECTION) ("CA 125" . SPARSER::DRUG)
    ("D11" . SPARSER::PROTEIN) ("RP11" . SPARSER::PROTEIN)
    ("Chr12" . SPARSER::PROTEIN) ("MKP-1" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("p-ERK1" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ARID1A" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PD0325901" . SPARSER::DRUG)
    ("MAPK1" . SPARSER::PROTEIN)
    ("β -catenin, PLK1, Furin, RRM2, Bcl-2 and VEGF" . SPARSER::COLLECTION)
    ("Furin" . SPARSER::PROTEIN) ("OPB" . SPARSER::MOLECULE)
    ("Pyrimethamine" . SPARSER::DRUG)
    ("inhibitors or decoys" . SPARSER::COLLECTION)
    ("mRNA and miR-92a" . SPARSER::COLLECTION)
    ("only two target genes" . SPARSER::GENE)
    ("p21, Bim and JNK2" . SPARSER::COLLECTION)
    ("Antisense" . SPARSER::PROTEIN)
    ("a polycistronic miRNA gene" . SPARSER::GENE)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("RECK and integrin" . SPARSER::COLLECTION)
    ("miR-92a and STAT3" . SPARSER::COLLECTION)
    ("50 or 100  μ  M almost completely inhibited phospho-STAT3"
     . SPARSER::PROTEIN)
    ("phospho-STAT3 and cyclin D1" . SPARSER::COLLECTION)
    ("the constitutively active STAT3 (STAT3C) gene" . SPARSER::GENE)
    ("STAT3 and RECK" . SPARSER::COLLECTION)
    ("MMPs and their inhibitory proteins" . SPARSER::COLLECTION)
    ("metalloproteinases and Reversion-inducing Cysteine-rich protein with Kazal motifs (RECK)"
     . SPARSER::COLLECTION)
    ("metalloproteinases and Reversion-inducing Cysteine-rich protein with Kazal motifs"
     . SPARSER::COLLECTION)
    ("Active STAT3 proteins form homodimer or heterodimer"
     . SPARSER::COLLECTION)
    ("homodimer or heterodimer" . SPARSER::COLLECTION)
    ("cyclin D1 and Bcl-xl" . SPARSER::COLLECTION) ("RECK" . SPARSER::PROTEIN)
    ("RRM2" . SPARSER::PROTEIN) ("N-MYC" . SPARSER::PROTEIN)
    ("DKK3" . SPARSER::PROTEIN) ("DICKKOPF-3" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("surfactant protein C" . SPARSER::PROTEIN) ("b-1" . SPARSER::PROTEIN)
    ("C13orf25" . SPARSER::PROTEIN) ("pre-miRNA" . SPARSER::RNA)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Small nuclear RNA" . SPARSER::RNA) ("MiR-92a" . SPARSER::MOLECULE)
    ("miR-7" . SPARSER::PROTEIN) ("LMP-1" . SPARSER::PROTEIN)
    ("Ki-Ras" . SPARSER::PROTEIN)
    ("Reversion-inducing Cysteine-rich protein with Kazal motifs"
     . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("miR-92a" . SPARSER::MOLECULE)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("GDL and GS" . SPARSER::COLLECTION) ("GQ" . SPARSER::DRUG)
    ("RDT" . SPARSER::PROTEIN) ("DT" . SPARSER::PROTEIN)
    ("GDL" . SPARSER::PROTEIN) ("p " . SPARSER::PROTEIN)
    ("EGFR and pEGFR" . SPARSER::COLLECTION) ("nad" . SPARSER::MOLECULE)
    ("Sentinel" . SPARSER::DRUG) ("erbB4" . SPARSER::PROTEIN)
    ("erbB2" . SPARSER::PROTEIN)
    ("mini-chromosome maintenance 2 protein (MCM2) and geminin [ xref ]"
     . SPARSER::COLLECTION)
    ("ki67, mini-chromosome maintenance 2 protein (MCM2) and geminin [ xref ]"
     . SPARSER::COLLECTION)
    ("periostin" . SPARSER::PROTEIN) ("sentinel" . SPARSER::DRUG)
    ("p-EGFR" . SPARSER::COLLECTION) ("wax" . SPARSER::MOLECULE)
    ("Adjuvant" . SPARSER::DRUG) ("cN1" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::PROTEIN) ("pN1" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN)
    ("mini-chromosome maintenance 2 protein" . SPARSER::PROTEIN)
    ("HN" . SPARSER::PROTEIN) ("p-AKT" . SPARSER::COLLECTION)
    ("PI3K/AKT/FOXO" . SPARSER::COLLECTION)
    ("AICAR or metformin" . SPARSER::COLLECTION)
    ("AMPK/AKT/FOXO3a" . SPARSER::COLLECTION) ("p-AMPKα" . SPARSER::COLLECTION)
    ("thiostrepton" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("exogenous FOXM1" . SPARSER::PROTEIN)
    ("PI3K-PTEN-AKT" . SPARSER::COLLECTION) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("these pharmaceutical activators" . SPARSER::ACTIVATOR)
    ("metformin (25 mM) and A23187 (2 μM)" . SPARSER::COLLECTION)
    ("AKT/FOXO3a/FOXM1" . SPARSER::COLLECTION)
    ("cyclin B1, cyclin D1 and cdc25B" . SPARSER::COLLECTION)
    ("p27 and p21" . SPARSER::COLLECTION)
    ("these pharmaceutical AMPK activators" . SPARSER::ACTIVATOR)
    ("that metformin, AICAR and A23187" . SPARSER::COLLECTION)
    ("pharmaceutical AMPK activators such as AICAR (ATP-dependent) and A23187 (ATP-independent)"
     . SPARSER::COLLECTION)
    ("pharmaceutical AMPK activators" . SPARSER::ACTIVATOR)
    ("p-FOXO3a" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("AKT/FOXO3a" . SPARSER::COLLECTION)
    ("hypoxia and glucose" . SPARSER::COLLECTION)
    ("AICAR and metformin" . SPARSER::COLLECTION) ("metformin" . SPARSER::DRUG)
    ("AICAR" . SPARSER::PROTEIN) ("p-AMPK" . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE) ("class O" . SPARSER::PROTEIN)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("cdc25B" . SPARSER::PROTEIN)
    ("Forkhead Box M1" . SPARSER::PROTEIN) ("DVL3" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN) ("Raf1" . SPARSER::PROTEIN)
    ("PAK1 and PAK2" . SPARSER::COLLECTION)
    ("CDC42 and Rac" . SPARSER::COLLECTION) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("AP-1 and PAK3" . SPARSER::COLLECTION)
    ("cells identified PAK3" . SPARSER::PROTEIN)
    ("PAK3 and cJun" . SPARSER::COLLECTION)
    ("polymeric F-actin" . SPARSER::BIO-COMPLEX) ("Actin" . SPARSER::PROTEIN)
    ("JunB (lane 5) and JunD (lane 6) antibodies" . SPARSER::COLLECTION)
    ("radioactively-labeled (+52/+60) oligomers" . SPARSER::PROTEIN)
    ("CGT" . SPARSER::PROTEIN) ("ACG" . SPARSER::PROTEIN)
    ("TRE" . SPARSER::PROTEIN) ("AP-1-Luc (WT)" . SPARSER::PROTEIN-PAIR)
    ("AP-1-Luc" . SPARSER::PROTEIN-PAIR) ("pCMV-cJun" . SPARSER::COLLECTION)
    ("proteins, PAK1 and PAK2" . SPARSER::COLLECTION)
    ("PAK1 and PAK3" . SPARSER::COLLECTION)
    ("PAK2, PAK4 and PAK6" . SPARSER::COLLECTION)
    ("CDC42 and Rac1" . SPARSER::COLLECTION)
    ("PAK1, PAK2 and PAK3" . SPARSER::COLLECTION)
    ("PAK4, PAK5 and PAK6" . SPARSER::COLLECTION) ("SPARC" . SPARSER::PROTEIN)
    ("SSeCKS" . SPARSER::PROTEIN) ("cJun/AP-1" . SPARSER::COLLECTION)
    ("cJun" . SPARSER::PROTEIN) ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("βPAK" . SPARSER::PROTEIN) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("pGL 3" . SPARSER::PROTEIN)
    ("J4" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("PAK6" . SPARSER::PROTEIN) ("PAK5" . SPARSER::PROTEIN)
    ("PAK4" . SPARSER::PROTEIN) ("PAK2" . SPARSER::PROTEIN)
    ("PAK3" . SPARSER::PROTEIN) ("Activating Protein" . SPARSER::PROTEIN)
    ("COL4A1, COL6A3, DAPK1 and NUAK1" . SPARSER::COLLECTION)
    ("ER alpha gene and GS20656 gene (differently methylated genomic loci in uterine leiomyomas)"
     . SPARSER::COLLECTION)
    ("the uterine leiomyoma group and the myometrium group"
     . SPARSER::COLLECTION)
    ("the uterine leiomyoma group" . SPARSER::MOLECULE)
    ("PI-3K/Akt" . SPARSER::COLLECTION) ("IRS1/ER-alpha" . SPARSER::COLLECTION)
    ("DAPK1 and NUAK1" . SPARSER::COLLECTION)
    ("COL4A1 and COL6A3" . SPARSER::COLLECTION)
    ("COL4A1, COL6A3, DAPK1, and NUAK1" . SPARSER::COLLECTION)
    ("COL4A1, COL4A2, and COL6A3" . SPARSER::COLLECTION)
    ("most predominant components" . SPARSER::COMPONENT)
    ("INSR and IGF1R" . SPARSER::COLLECTION)
    ("IRS1, COL4A1, COL4A2, COL6A3, and GSTM5" . SPARSER::COLLECTION)
    ("X chromosome and gain-of-active" . SPARSER::COLLECTION)
    ("X chromosome and replicate" . SPARSER::COLLECTION)
    ("DAPK1 (death-associated protein kinase 1) and NUAK1 (novel kinase family 1)"
     . SPARSER::COLLECTION)
    ("COL4A1, COL6A3 and GSTM5" . SPARSER::COLLECTION)
    ("response element (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("IRS1 and COL4A1" . SPARSER::COLLECTION) ("INSR" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1 (IRS1) and COL4A1" . SPARSER::COLLECTION)
    ("COL4A1 and COL4A2" . SPARSER::COLLECTION)
    ("principal components" . SPARSER::COMPONENT)
    ("environmental estrogen" . SPARSER::MOLECULE)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("COL4A1, COL4A2 and COL6A3" . SPARSER::COLLECTION)
    ("X Chromosome" . SPARSER::PROTEIN) ("ER-alpha" . SPARSER::PROTEIN)
    ("NUAK1" . SPARSER::PROTEIN)
    ("death-associated protein kinase 1" . SPARSER::PROTEIN)
    ("Alpha-" . SPARSER::PROTEIN)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("X-linked" . SPARSER::PROTEIN)
    ("GSTM5" . SPARSER::PROTEIN) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Y chromosome" . SPARSER::PROTEIN) ("alpha-" . SPARSER::PROTEIN)
    ("COL6A3" . SPARSER::PROTEIN) ("COL4A2" . SPARSER::PROTEIN)
    ("COL4A1" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SH-SH5Y" . SPARSER::COLLECTION)
    ("conditional knockout alleles" . SPARSER::ALLELE)
    ("Crlf1" . SPARSER::PROTEIN) ("perinatal" . SPARSER::PROTEIN)
    ("CNTFR and agonist" . SPARSER::COLLECTION)
    ("gp130/JAK/STAT" . SPARSER::COLLECTION) ("CNTFR" . SPARSER::PROTEIN)
    ("a neuroprotective gene" . SPARSER::GENE)
    ("a potential oxidative stress resistance gene" . SPARSER::GENE)
    ("idiopathic forms" . SPARSER::FORM)
    ("gp130/JAK2/STAT3" . SPARSER::COLLECTION) ("Δ34N" . SPARSER::PROTEIN)
    ("Exogenous CRLF1" . SPARSER::PROTEIN) ("CRLF1-Δ34N" . SPARSER::COLLECTION)
    ("CRLF1-" . SPARSER::PROTEIN) ("exogenous CRLF1" . SPARSER::PROTEIN)
    ("EF" . SPARSER::PROTEIN) ("gp130 and JAK" . SPARSER::COLLECTION)
    ("gp130 or JAK1/2" . SPARSER::COLLECTION)
    ("the neutralizing gp130 antibody (1 µg/mL) nor ruxolitinib (1 µM)"
     . SPARSER::COLLECTION)
    ("PI-3-kinase, MAPK and mTOR" . SPARSER::COLLECTION)
    ("ruxolitinib" . SPARSER::DRUG) ("gp-130/JAK2" . SPARSER::COLLECTION)
    ("CLCF1 and agonist" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("exogenous CLCF1/CRLF1 heterodimeric ligand" . SPARSER::LIGAND)
    ("CLCF1/CRLF1" . SPARSER::COLLECTION)
    ("non-targeting control shRNA (non-targeting, NT-sh) or CRLF1 shRNAs"
     . SPARSER::COLLECTION)
    ("lentiviral short hairpin RNAs" . SPARSER::RNA) ("CLC" . SPARSER::PROTEIN)
    ("odontogenic ameloblast-associated protein ( ODAM ) and cytokine receptor-like factor 1 ( CRLF1 )"
     . SPARSER::COLLECTION)
    ("RA and TPA" . SPARSER::COLLECTION) ("PXDNL" . SPARSER::PROTEIN)
    ("peroxidasin" . SPARSER::PROTEIN) ("UBD" . SPARSER::PROTEIN)
    ("ODAM" . SPARSER::PROTEIN) ("odontogenic" . SPARSER::PROTEIN)
    ("fresh media containing FBS" . SPARSER::PROTEIN)
    ("media (NBA)" . SPARSER::PROTEIN)
    ("media or six-day" . SPARSER::COLLECTION)
    ("FBS, RA or RA/TPA" . SPARSER::COLLECTION)
    ("FBS or RA" . SPARSER::COLLECTION)
    ("β-actin and the mitochondrial chaperone Hsp60" . SPARSER::COLLECTION)
    ("nuclear neuronal protein (NeuN) and neuron-specific enolase (NSE)"
     . SPARSER::COLLECTION)
    ("nuclear neuronal protein" . SPARSER::PROTEIN) ("NSE" . SPARSER::PROTEIN)
    ("RA and RA/TPA" . SPARSER::COLLECTION)
    ("RA or RA/TPA" . SPARSER::COLLECTION) ("TPA" . SPARSER::DRUG)
    ("12-O-tetradecanoylphorbol-13-acetate (TPA)" . SPARSER::DRUG)
    ("neuroprotective genes" . SPARSER::GENE)
    ("the biosynthetic enzymes" . SPARSER::ENZYME)
    ("Transformed neuroblastoma cell lines–in particular SH-SY5Y"
     . SPARSER::PROTEIN)
    ("striatum" . SPARSER::PROTEIN) ("neurotransmitter" . SPARSER::MOLECULE)
    ("pesticides or other environmental toxins" . SPARSER::COLLECTION)
    ("other environmental toxins" . SPARSER::MOLECULE)
    ("pesticides" . SPARSER::MOLECULE) ("decoy receptor" . SPARSER::PROTEIN)
    ("CISS2" . SPARSER::PROTEIN) ("CISS1" . SPARSER::PROTEIN)
    ("PI-3-kinase" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("gp-130" . SPARSER::PROTEIN)
    ("cold-induced sweating syndrome" . SPARSER::PROTEIN)
    ("cardiotrophin-like cytokine factor 1" . SPARSER::PROTEIN)
    ("odontogenic ameloblast-associated protein" . SPARSER::PROTEIN)
    ("INSM2" . SPARSER::PROTEIN) ("ubiquitin-D" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("interleukin-1-beta" . SPARSER::PROTEIN)
    ("P450" . SPARSER::PROTEIN-FAMILY) ("CYP26A1" . SPARSER::PROTEIN)
    ("microtubule-associated protein Tau" . SPARSER::PROTEIN)
    ("neuron-specific enolase" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("CLCF1" . SPARSER::PROTEIN) ("RPL13A" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("Hsp60" . SPARSER::PROTEIN)
    ("BL2" . SPARSER::PROTEIN) ("pLP2" . SPARSER::PROTEIN)
    ("ciliary neurotrophic factor receptor" . SPARSER::PROTEIN)
    ("CRLF1" . SPARSER::PROTEIN)
    ("cytokine receptor-like factor 1" . SPARSER::PROTEIN)
    ("6-OHDA" . SPARSER::MOLECULE) ("6-hydroxydopamine" . SPARSER::DRUG)
    ("EML4-ALK" . SPARSER::COLLECTION) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("EGFR-TK" . SPARSER::COLLECTION) ("afatinib" . SPARSER::DRUG)
    ("a classical protein kinase C inhibitor" . SPARSER::INHIBITOR)
    ("active and inactive" . SPARSER::COLLECTION)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("frozen" . SPARSER::PROTEIN) ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("streptavidin-alkaline phosphatase" . SPARSER::COLLECTION)
    ("TIB" . SPARSER::DRUG) ("PTS" . SPARSER::PROTEIN)
    ("PTCs and QS" . SPARSER::COLLECTION) ("TKIs" . SPARSER::PROTEIN)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("EGFR , KRAS and BRAF" . SPARSER::COLLECTION)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("EML4" . SPARSER::PROTEIN) ("BIBW2992" . SPARSER::DRUG)
    ("ID2 , BCL6 , GATA3 , IL13 , IL33 , TSLP , and IL1RL1"
     . SPARSER::COLLECTION)
    ("TSLP" . SPARSER::PROTEIN)
    ("MICA , PTGER4 , and PLCL1" . SPARSER::COLLECTION)
    ("abacavir" . SPARSER::DRUG) ("HLA-B and HLA-C" . SPARSER::COLLECTION)
    ("FOXA2 and FOXA3" . SPARSER::COLLECTION)
    ("FOXA1 and FOXA2" . SPARSER::COLLECTION)
    ("IL-2 and IL-21" . SPARSER::COLLECTION)
    ("IL2 and IL21" . SPARSER::COLLECTION)
    ("IL-4 and IL-13, and IgE" . SPARSER::COLLECTION)
    ("IL-13, and IgE" . SPARSER::COLLECTION)
    ("PLCL1 , or phospholipase C-like" . SPARSER::COLLECTION)
    ("Variants" . SPARSER::VARIANT)
    ("PTGER4 , or Prostaglandin" . SPARSER::COLLECTION)
    ("Prostaglandin" . SPARSER::PROTEIN)
    ("TLR1 (Toll-Like Receptor 1) and TLR6 (Toll-Like Receptor 6)"
     . SPARSER::COLLECTION)
    ("-DRB" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("IL13 , KIF3A , CARD11 , MIR1208 , and NCF4" . SPARSER::COLLECTION)
    ("IL6R , GAB1 , RAD50 , IL13 , IKZF4 , RORA , and IL2RB"
     . SPARSER::COLLECTION)
    ("their proximal genes" . SPARSER::GENE)
    ("cohort and P" . SPARSER::COLLECTION) ("GSDMB" . SPARSER::PROTEIN)
    ("RORA" . SPARSER::PROTEIN) ("GSDMA" . SPARSER::PROTEIN)
    ("DQ" . SPARSER::MOLECULE)
    ("various other signaling molecules and transcription factors"
     . SPARSER::COLLECTION)
    ("at least one common allergen" . SPARSER::MOLECULE)
    ("allergen" . SPARSER::MOLECULE)
    ("Our study sheds new light" . SPARSER::PROTEIN)
    ("TLR1 , TLR6 , and TLR10" . SPARSER::COLLECTION)
    ("HLA-C and MICA" . SPARSER::COLLECTION) ("LPP" . SPARSER::PROTEIN)
    ("MICA" . SPARSER::PROTEIN) ("SNP2" . SPARSER::PROTEIN)
    ("SNP1" . SPARSER::PROTEIN) ("of pregnancy" . SPARSER::PROTEIN)
    ("IL1RL1" . SPARSER::PROTEIN) ("ID2" . SPARSER::PROTEIN)
    ("CLEC16A" . SPARSER::PROTEIN) ("LRRC32" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FOXA3" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("IL21" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("NFATc2" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("lipoma-preferred partner" . SPARSER::PROTEIN)
    ("inositol 1,4,5-triphosphate" . SPARSER::IP3)
    ("phospholipase C" . SPARSER::PROTEIN)
    ("Toll-Like Receptor 6" . SPARSER::PROTEIN)
    ("Toll-Like Receptor 1" . SPARSER::PROTEIN) ("HLA-DRA" . SPARSER::PROTEIN)
    ("NCF4" . SPARSER::PROTEIN) ("CARD11" . SPARSER::PROTEIN)
    ("KIF3A" . SPARSER::PROTEIN) ("IKZF4" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("GAB1" . SPARSER::PROTEIN)
    ("OVOL1" . SPARSER::PROTEIN) ("IL6R" . SPARSER::PROTEIN)
    ("ORMDL3" . SPARSER::PROTEIN) ("PDE4D" . SPARSER::PROTEIN)
    ("SLC22A5" . SPARSER::PROTEIN) ("IL2RB" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("IL18R1" . SPARSER::PROTEIN)
    ("IL33" . SPARSER::PROTEIN) ("NFATC2" . SPARSER::PROTEIN)
    ("PLCL1" . SPARSER::PROTEIN) ("PTGER4" . SPARSER::PROTEIN)
    ("HLA-C" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TLR10" . SPARSER::PROTEIN)
    ("TLR6" . SPARSER::PROTEIN) ("TLR1" . SPARSER::PROTEIN)
    ("the prostate lineage-specific master regulator" . SPARSER::REGULATOR)
    ("classic AR target genes" . SPARSER::GENE)
    ("establishing ERG 's" . SPARSER::PROTEIN)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("ETV1 and ERG" . SPARSER::COLLECTION)
    ("cistrome and AR" . SPARSER::COLLECTION)
    ("Nkx3-1 , and β-microseminoprotein" . SPARSER::COLLECTION)
    ("Nkx3-1" . SPARSER::PROTEIN) ("Msmb" . SPARSER::PROTEIN)
    ("microseminoprotein" . SPARSER::PROTEIN) ("Pbsn" . SPARSER::PROTEIN)
    ("IPA and DAVID GO  xref  ( xref )" . SPARSER::COLLECTION)
    ("/ERG" . SPARSER::COLLECTION)
    ("1 around both conserved and new AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("new AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and ERG" . SPARSER::COLLECTION)
    ("the new AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GATA" . SPARSER::PROTEIN)
    ("-GT" . SPARSER::COLLECTION) ("GGAA" . SPARSER::PROTEIN)
    ("AR protein or circulating testosterone ( xref , xref )"
     . SPARSER::COLLECTION)
    ("ERG and ETV1" . SPARSER::COLLECTION)
    ("Dusp6 , Tmprss2 , and Fkbp5" . SPARSER::COLLECTION)
    ("Tmprss2" . SPARSER::PROTEIN) ("Dusp6" . SPARSER::PROTEIN)
    ("Dusp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cistrome and transcriptome" . SPARSER::COLLECTION)
    ("cistrome" . SPARSER::PROTEIN)
    ("AR and uniform neuroendocrine" . SPARSER::COLLECTION)
    ("AR, ERG, and CK8" . SPARSER::COLLECTION)
    ("PIN, p63 and CK5" . SPARSER::COLLECTION)
    ("p63 and cytokeratin 5" . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("ERG and AR" . SPARSER::COLLECTION) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("homogenous PIN" . SPARSER::PROTEIN) ("flox" . SPARSER::PROTEIN)
    ("ERG/ERG" . SPARSER::COLLECTION)
    ("ERG or the IRES-linked EGFP" . SPARSER::COLLECTION)
    ("the ventral and dorsolateral lobes" . SPARSER::PROTEIN)
    ("IRES" . SPARSER::PROTEIN)
    ("AR-cistrome and AR-transcriptional" . SPARSER::COLLECTION)
    ("AR-cistrome" . SPARSER::PROTEIN-PAIR) ("probasin" . SPARSER::PROTEIN)
    ("neither ERG nor ETV1" . SPARSER::COLLECTION)
    ("ERG , ETV1 , ETV4 , ETV5 and FLI1" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION)
    ("cohorts, ERG and ETV1" . SPARSER::COLLECTION) ("ERG" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("MACS 1" . SPARSER::PROTEIN)
    ("KLK3" . SPARSER::PROTEIN) ("ETS family" . SPARSER::PROTEIN)
    ("TFF3" . SPARSER::PROTEIN) ("trefoil factor 3" . SPARSER::PROTEIN)
    ("AMPD3" . SPARSER::PROTEIN)
    ("adenosine monophosphate deaminase 3" . SPARSER::PROTEIN)
    ("K4" . SPARSER::PROTEIN) ("K3" . SPARSER::PROTEIN)
    ("GATA2" . SPARSER::PROTEIN) ("Fkbp5" . SPARSER::PROTEIN)
    ("CK8" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("cytokeratin 5" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("FLI1" . SPARSER::PROTEIN) ("ETV5" . SPARSER::PROTEIN)
    ("ETV4" . SPARSER::PROTEIN) ("IKK2 and JNK1" . SPARSER::COLLECTION)
    ("IKK2 and P38" . SPARSER::COLLECTION) ("Ser/Thr" . SPARSER::COLLECTION)
    ("growth factors and mitogens" . SPARSER::COLLECTION)
    ("S6K and S6KS5A" . SPARSER::COLLECTION) ("Ubiquitin" . SPARSER::PROTEIN)
    ("S6KΔC" . SPARSER::PROTEIN) ("HA-S6KΔC" . SPARSER::COLLECTION)
    ("S6K and S6K" . SPARSER::COLLECTION)
    ("IKK inhibitor (15d) or mTOR inhibitor (Rap)" . SPARSER::COLLECTION)
    ("IKK or mTOR" . SPARSER::COLLECTION)
    ("JNK1 and JNK2" . SPARSER::COLLECTION)
    ("c-JUN and S6K" . SPARSER::COLLECTION) ("Anisomycin" . SPARSER::DRUG)
    ("IKK2 or p65" . SPARSER::COLLECTION) ("IKK2/NF-κB" . SPARSER::COLLECTION)
    ("JNK inhibitor (SP) and mTOR inhibitor (Rap)" . SPARSER::COLLECTION)
    ("p38 inhibitor (SB) or ERK inhibitor (PD) ( xref )" . SPARSER::COLLECTION)
    ("mTOR inhibitor (Rap), p38 inhibitor (SB) or ERK inhibitor (PD) ( xref )"
     . SPARSER::COLLECTION)
    ("inhibitor (PD)" . SPARSER::INHIBITOR)
    ("inhibitor (SB)" . SPARSER::INHIBITOR)
    ("inhibitor (SP)" . SPARSER::INHIBITOR) ("HA-S6K" . SPARSER::COLLECTION)
    ("phospho-antibody" . SPARSER::PROTEIN)
    ("IKK2 or p38" . SPARSER::COLLECTION)
    ("IKK2 and p38" . SPARSER::COLLECTION)
    ("phosphor-specific antibodies" . SPARSER::ANTIBODY)
    ("JNK1/S6K" . SPARSER::COLLECTION) ("P38 and IKK2" . SPARSER::COLLECTION)
    ("the classical substrate IkBα" . SPARSER::PROTEIN)
    ("IKK2 and S6K" . SPARSER::COLLECTION)
    ("the classical substrate c-JUN, and p38" . SPARSER::COLLECTION)
    ("c-JUN, and p38" . SPARSER::COLLECTION) ("MBP" . SPARSER::PROTEIN)
    ("GST-S6K" . SPARSER::COLLECTION)
    ("the authentic JNK1 target" . SPARSER::TARGET-PROTEIN)
    ("IKK2 (IKKβ) and NF-κB p65 subunit" . SPARSER::COLLECTION)
    ("IKK2/NF-kB" . SPARSER::COLLECTION) ("a Western blot" . SPARSER::PROTEIN)
    ("JNK1 and IKK2" . SPARSER::COLLECTION) ("ROC1" . SPARSER::PROTEIN)
    ("PP2A and PP1" . SPARSER::COLLECTION) ("phosphatidyl" . SPARSER::MOLECULE)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokine TNF-α" . SPARSER::PROTEIN)
    ("growth factors, mitogens, nutrients and stresses" . SPARSER::COLLECTION)
    ("Ribosomal S6 kinase p70" . SPARSER::PROTEIN)
    ("JNK1 and the phosphorylation makes S6K protein" . SPARSER::COLLECTION)
    ("IkB" . SPARSER::PROTEIN) ("TNF-α or MEKK1" . SPARSER::COLLECTION)
    ("tuberous sclerosis 1" . SPARSER::PROTEIN) ("TCS1" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("JNKK2" . SPARSER::PROTEIN)
    ("pS6K" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("c-JUN" . SPARSER::PROTEIN) ("S6k" . SPARSER::PROTEIN)
    ("2-4" . SPARSER::PROTEIN) ("T-2" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("SP600125" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("S6K1" . SPARSER::PROTEIN)
    ("PDK1" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta)" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("IKK2" . SPARSER::PROTEIN) ("MKK7" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("SE" . SPARSER::PROTEIN)
    ("IL-13 and IL-4" . SPARSER::COLLECTION)
    ("a slightly older age group" . SPARSER::MOLECULE)
    ("IOW and PAPA" . SPARSER::COLLECTION)
    ("IL13 (rs20541) and STAT6 (rs1059513) genes" . SPARSER::COLLECTION)
    ("IL13 (rs20541) and STAT6 (rs1059513) SNP genotypes"
     . SPARSER::COLLECTION)
    ("AG or AA" . SPARSER::COLLECTION) ("RR " . SPARSER::MOLECULE)
    ("IOW" . SPARSER::MOLECULE) ("cohort (IOW)" . SPARSER::MOLECULE)
    ("IL13 and rs1059513" . SPARSER::COLLECTION)
    ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("their respective membrane receptor" . SPARSER::RECEPTOR)
    ("IL-4/IL-13" . SPARSER::COLLECTION)
    ("cytokines, IL-4 and IL-13" . SPARSER::COLLECTION)
    ("interleukin 4 ( IL4 ) and interleukin 13 ( IL13 )" . SPARSER::COLLECTION)
    ("gene ( FLG )" . SPARSER::GENE) ("FLG" . SPARSER::PROTEIN)
    ("filaggrin" . SPARSER::PROTEIN)
    ("food and environmental allergens (i.e., allergic sensitization)"
     . SPARSER::COLLECTION)
    ("environmental allergens" . SPARSER::MOLECULE)
    ("allergens" . SPARSER::MOLECULE) ("food" . SPARSER::MOLECULE)
    ("IL13 (rs20541) and STAT6 (rs1059513)" . SPARSER::COLLECTION)
    ("IL13 (rs20541) and STAT6 (rs1059513) polymorphisms"
     . SPARSER::COLLECTION)
    ("RRs" . SPARSER::MOLECULE) ("PAPA" . SPARSER::PROTEIN)
    ("IL13 and STAT6" . SPARSER::COLLECTION)
    ("IL-13 and transcription factor" . SPARSER::COLLECTION)
    ("Interleukin 13" . SPARSER::PROTEIN) ("Interleukin 4" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 6" . SPARSER::PROTEIN)
    ("IL13  " . SPARSER::PROTEIN) ("β 2  " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-4 receptor" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 6" . SPARSER::PROTEIN)
    ("interleukin 13" . SPARSER::PROTEIN) ("IL4" . SPARSER::PROTEIN)
    ("interleukin 4" . SPARSER::PROTEIN) ("-2 " . SPARSER::PROTEIN)
    ("– 3" . SPARSER::PROTEIN) ("– 2" . SPARSER::PROTEIN)
    ("IL13" . SPARSER::PROTEIN) ("IL-13" . SPARSER::PROTEIN)
    ("eIF4G–eIF4E" . SPARSER::COLLECTION) ("endonuclease" . SPARSER::PROTEIN)
    ("Angel1:eIF4G" . SPARSER::BIO-COMPLEX) ("HA-Angel1" . SPARSER::COLLECTION)
    ("the total cellular mRNAs" . SPARSER::PROTEIN) ("RNP" . SPARSER::PROTEIN)
    ("eIF4E:4E-BP" . SPARSER::BIO-COMPLEX)
    ("eIF4E:Angel1" . SPARSER::BIO-COMPLEX)
    ("GST-Angel1" . SPARSER::COLLECTION)
    ("microsomal and perinuclear fractions" . SPARSER::COMPONENT)
    ("eIF4GI and eIF4E" . SPARSER::COLLECTION)
    ("Angel1 and 4E-BP" . SPARSER::COLLECTION)
    ("4E-BP and Angel1" . SPARSER::COLLECTION)
    ("eIF4E/4E-BP" . SPARSER::COLLECTION)
    ("microsomal fractions" . SPARSER::COMPONENT)
    ("eIF4E and eIF4GI" . SPARSER::COLLECTION)
    ("microsomal (M) fractions" . SPARSER::COMPONENT)
    ("eIF4E, eIF4GI, 4E-BP1 and Angel1" . SPARSER::COLLECTION)
    ("the anti-Angel1 and an anti-GM130 antibody" . SPARSER::COLLECTION)
    ("anti-Calnexin and anti-Angel1" . SPARSER::COLLECTION)
    ("Calnexin" . SPARSER::PROTEIN)
    ("the anti-Angel1 and the anti-eIF4E antibodies" . SPARSER::COLLECTION)
    ("the anti-Angel1" . SPARSER::ANTIBODY)
    ("eIF4G or 4E-BP" . SPARSER::COLLECTION)
    ("eIF4G or 4E-BP—and" . SPARSER::COLLECTION)
    ("Angel1–eIF4E" . SPARSER::COLLECTION) ("Sh" . SPARSER::PROTEIN-FAMILY)
    ("eIF4E and endogenous eIF4GI ( xref D, compare lanes 2 and 3)"
     . SPARSER::COLLECTION)
    ("GST-A1 and GST-A1YA" . SPARSER::COLLECTION)
    ("Angel1 and eIF4GI" . SPARSER::COLLECTION)
    ("eIF4G/eIF4E" . SPARSER::COLLECTION)
    ("the exogenous Angel1 protein" . SPARSER::PROTEIN)
    ("hemagglutinin (HA)-tagged Angel1 and its variant A1YA"
     . SPARSER::COLLECTION)
    ("Angel1/eIF4E" . SPARSER::COLLECTION)
    ("4E-BP1/eIF4E" . SPARSER::COLLECTION)
    ("eIF4GI and 4E-BP1" . SPARSER::COLLECTION)
    ("eIF4E/Angel1" . SPARSER::COLLECTION)
    ("PABP and eIF4E" . SPARSER::COLLECTION)
    ("4E-BP1 and Angel1" . SPARSER::COLLECTION)
    ("Angel1, eIF4GI and 4E-BP1" . SPARSER::COLLECTION)
    ("cellular Angel1 and eIF4E" . SPARSER::COLLECTION)
    ("Angel1 and eIF4E" . SPARSER::COLLECTION)
    ("GTP-sepharose" . SPARSER::NUCLEOTIDE) ("sepharose" . SPARSER::MOLECULE)
    ("the ancestral gene" . SPARSER::GENE)
    ("Angel1 and Angel2" . SPARSER::COLLECTION)
    ("CCR4 or Nocturnin" . SPARSER::COLLECTION)
    ("Nocturnin" . SPARSER::PROTEIN) ("EEP" . SPARSER::PROTEIN)
    ("exonuclease" . SPARSER::PROTEIN) ("GST-eIF4E" . SPARSER::COLLECTION)
    ("methionine" . SPARSER::AMINO-ACID)
    ("effectively binding eIF4E" . SPARSER::PROTEIN)
    ("eIF4Gs or 4E-BPs" . SPARSER::COLLECTION) ("eIF4Gs" . SPARSER::PROTEIN)
    ("BPs" . SPARSER::PROTEIN) ("orthologs" . SPARSER::PROTEIN)
    ("UniProtKb/Swiss-Prot" . SPARSER::COLLECTION) ("Prot" . SPARSER::PROTEIN)
    ("Frodo" . SPARSER::PROTEIN) ("eIF4E and peptides" . SPARSER::COLLECTION)
    ("4E-BP1 and eIF4GI" . SPARSER::COLLECTION) ("eIF4GI" . SPARSER::PROTEIN)
    ("Maskin, Bicoid, DDX3, 4E-T, Gemin5 and GIGYF2" . SPARSER::COLLECTION)
    ("Bicoid" . SPARSER::PROTEIN-FAMILY) ("Maskin" . SPARSER::PROTEIN)
    ("4E-BP or eIF4G" . SPARSER::COLLECTION)
    ("cyclin D1 and ODC" . SPARSER::COLLECTION) ("ODC" . SPARSER::PROTEIN)
    ("the small translational repressor 4E-BP" . SPARSER::PROTEIN)
    ("eIF4E and eIF4G" . SPARSER::COLLECTION)
    ("eIF4G and 4E-BP" . SPARSER::COLLECTION)
    ("a pivotal protein" . SPARSER::PROTEIN)
    ("CAF1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mg 2+" . SPARSER::MOLECULE)
    ("angel1" . SPARSER::PROTEIN) ("PP242" . SPARSER::DRUG)
    ("GST-A1" . SPARSER::PROTEIN) ("GIGYF2" . SPARSER::PROTEIN)
    ("Gemin5" . SPARSER::PROTEIN) ("4E-T" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("CCR4" . SPARSER::PROTEIN) ("Angel1" . SPARSER::PROTEIN)
    ("initiation factor 4E" . SPARSER::PROTEIN)
    ("FOXA1 or other chromatin" . SPARSER::COLLECTION)
    ("liganded" . SPARSER::MOLECULE)
    ("composite response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ERα and NFκB" . SPARSER::COLLECTION)
    ("differentially regulated genes" . SPARSER::GENE)
    ("NFκB and AP1" . SPARSER::COLLECTION) ("GR/AP1" . SPARSER::COLLECTION)
    ("pS2 , PR , and CCND1-" . SPARSER::COLLECTION)
    ("AP1 and GR" . SPARSER::COLLECTION) ("GR and EREs" . SPARSER::COLLECTION)
    ("their respective response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AP1 and NFκB" . SPARSER::COLLECTION)
    ("ERα and its coactivator SRC-3" . SPARSER::COLLECTION)
    ("tethering ERα" . SPARSER::PROTEIN) ("ERα-GR" . SPARSER::COLLECTION)
    ("E2, and luciferase" . SPARSER::COLLECTION)
    ("pSG5-GR" . SPARSER::COLLECTION)
    ("tethering cofactors" . SPARSER::PROTEIN) ("Baf60a" . SPARSER::PROTEIN)
    ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wild-type GR and two GR mutants (R466K and R488Q)" . SPARSER::COLLECTION)
    ("GST-ERα" . SPARSER::COLLECTION)
    ("an effective dominant-negative mutant" . SPARSER::MUTANT)
    ("TAM" . SPARSER::PROTEIN)
    ("a dimeric leucine zipper protein" . SPARSER::PROTEIN)
    ("-TGA" . SPARSER::COLLECTION) ("Fos-Jun" . SPARSER::COLLECTION)
    ("Jun-Jun" . SPARSER::COLLECTION) ("ERα-chromatin" . SPARSER::COLLECTION)
    ("GBR" . SPARSER::PROTEIN) ("siRNA-FOXA1" . SPARSER::COLLECTION)
    ("ERα-SRC3" . SPARSER::COLLECTION)
    ("ERα coregulatory protein" . SPARSER::PROTEIN)
    ("ERα-SRC-3" . SPARSER::COLLECTION) ("GBR-FKBP5" . SPARSER::COLLECTION)
    ("ERα or GR" . SPARSER::COLLECTION) ("GBR-CCND1" . SPARSER::COLLECTION)
    ("EBR-PR" . SPARSER::COLLECTION) ("EBR-pS2" . SPARSER::COLLECTION)
    ("EBR" . SPARSER::PROTEIN)
    ("their respective target genes" . SPARSER::GENE)
    ("pS2 , PR , and Cyclin D1" . SPARSER::COLLECTION)
    ("Cyclin D1 and PR" . SPARSER::COLLECTION) ("GRs" . SPARSER::PROTEIN)
    ("ERα and GR" . SPARSER::COLLECTION) ("GR-ERα" . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION)
    ("FOXA1 and AP1" . SPARSER::COLLECTION)
    ("pS2 and Cyclin D1" . SPARSER::COLLECTION)
    ("GR and ERα" . SPARSER::COLLECTION)
    ("coactivator-associated arginine methyltransferase 1, CARM1 and protein arginine methyltransferase 1"
     . SPARSER::COLLECTION)
    ("hSWI/SNF" . SPARSER::COLLECTION) ("SRCs" . SPARSER::PROTEIN)
    ("coactivators" . SPARSER::PROTEIN) ("GR and ER" . SPARSER::COLLECTION)
    ("glucocorticoid-regulated kinase 1" . SPARSER::COLLECTION)
    ("cortisol" . SPARSER::PROTEIN) ("GCs" . SPARSER::PROTEIN)
    ("anti-estrogens and aromatase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN) ("Estrogen" . SPARSER::MOLECULE)
    ("ERα and FOXA1" . SPARSER::COLLECTION)
    ("ERα and steroid receptor coactivator-3" . SPARSER::COLLECTION)
    ("E2 or Dex" . SPARSER::COLLECTION) ("E2 and Dex" . SPARSER::COLLECTION)
    ("ERα- and glucocorticoid receptor" . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN) ("glucocorticoid" . SPARSER::PROTEIN)
    ("ERα and AP1" . SPARSER::COLLECTION) ("AP1 and ERα" . SPARSER::COLLECTION)
    ("GR" . SPARSER::PROTEIN) ("glucocorticoids" . SPARSER::PROTEIN)
    ("BRG1-associated factor" . SPARSER::PROTEIN) ("e1b" . SPARSER::PROTEIN)
    ("AF2" . SPARSER::PROTEIN) ("AF1" . SPARSER::PROTEIN)
    ("12- O -tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("p160" . SPARSER::PROTEIN) ("FKBP5" . SPARSER::PROTEIN)
    ("E–G" . SPARSER::PROTEIN) ("B–D" . SPARSER::PROTEIN)
    ("PR 3" . SPARSER::PROTEIN) ("SRC-3" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("PRMT1" . SPARSER::PROTEIN)
    ("protein arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("CARM1" . SPARSER::PROTEIN)
    ("coactivator-associated arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("DUSP1" . SPARSER::PROTEIN)
    ("dual specificity phosphatase 1" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("regulated kinase 1" . SPARSER::PROTEIN)
    ("anti-estrogens" . SPARSER::DRUG)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("β-estradiol" . SPARSER::MOLECULE) ("KS, and KS" . SPARSER::COLLECTION)
    ("autosomal dominant or autosomal recessive" . SPARSER::COLLECTION)
    ("IHH/KS" . SPARSER::COLLECTION)
    ("IHH, KS, and Hartsfield" . SPARSER::COLLECTION)
    ("the mutated amino acids" . SPARSER::AMINO-ACID)
    ("available FGFR1" . SPARSER::PROTEIN) ("Bank" . SPARSER::PROTEIN)
    ("RCSB" . SPARSER::PROTEIN)
    ("mainly cleft lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KS" . SPARSER::PROTEIN) ("exon–intron" . SPARSER::COLLECTION)
    ("IHH" . SPARSER::PROTEIN) ("Fgfr1" . SPARSER::PROTEIN)
    ("the ATP's" . SPARSER::ATP) ("the causative variants" . SPARSER::VARIANT)
    ("trio" . SPARSER::PROTEIN)
    ("a single key developmental gene" . SPARSER::GENE)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FGF8" . SPARSER::PROTEIN)
    ("P11362" . SPARSER::PROTEIN) ("P63" . SPARSER::PROTEIN)
    ("GLI2" . SPARSER::PROTEIN) ("SIX3" . SPARSER::PROTEIN)
    ("ZIC2" . SPARSER::PROTEIN) ("p50-p50" . SPARSER::COLLECTION)
    ("Our findings further link NFκB" . SPARSER::PROTEIN)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tie" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BRDU" . SPARSER::DRUG)
    ("BrDU" . SPARSER::DRUG) ("trypan" . SPARSER::DRUG)
    ("complete media" . SPARSER::PROTEIN) ("PDTC" . SPARSER::DRUG)
    ("oxidant" . SPARSER::PROTEIN) ("ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("DUSPs or MAP Kinase" . SPARSER::COLLECTION)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("Phosphatases" . SPARSER::PHOSPHATASE)
    ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stress-activated protein kinase (SAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("cytokine-" . SPARSER::PROTEIN) ("NFκB and MAPK" . SPARSER::COLLECTION)
    ("GPx-1" . SPARSER::PROTEIN) ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UO126" . SPARSER::DRUG)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("18 h" . SPARSER::PROTEIN) ("4–1" . SPARSER::PROTEIN)
    ("NFκ" . SPARSER::PROTEIN) ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-selectin" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP4" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("cytochrome P-450 1A1 [ xref ] and p21 Ser31Arg [ xref ]"
     . SPARSER::COLLECTION)
    ("cytochrome" . SPARSER::PROTEIN)
    ("alleles and haplotypes" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-1, and glutathione S -transferase"
     . SPARSER::COLLECTION)
    ("X-ray cross-complementing group 1 and excision repair cross-complementing group 2 polymorphisms"
     . SPARSER::COLLECTION)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("the histological types" . TYPE) ("Arg/Pro  " . SPARSER::COLLECTION)
    ("Pro  " . SPARSER::AMINO-ACID) ("allele  " . SPARSER::ALLELE)
    ("Arg/Arg" . SPARSER::COLLECTION)
    ("the two polymorphic variants" . SPARSER::VARIANT)
    ("Arg and Pro" . SPARSER::COLLECTION) ("Tobacco" . SPARSER::DRUG)
    ("The histological types" . TYPE) ("Arg/Arg  " . SPARSER::COLLECTION)
    ("Pro/Pro" . SPARSER::COLLECTION) ("Arg  " . SPARSER::AMINO-ACID)
    ("Arg/Pro" . SPARSER::COLLECTION) ("1A1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("microsomal epoxide hydrolase" . SPARSER::PROTEIN)
    ("FAK, MMP14 and MMP9" . SPARSER::COLLECTION)
    ("MMPs and E-cadherin" . SPARSER::COLLECTION)
    ("the soluble E-cadherin" . SPARSER::PROTEIN)
    ("soluble E-cadherin" . SPARSER::PROTEIN)
    ("MMP9, MMP14 or MMP2" . SPARSER::COLLECTION)
    ("MMP14 and other KLF8" . SPARSER::COLLECTION)
    ("MMP9 and E-cadherin" . SPARSER::COLLECTION)
    ("stromal cell-derived factor (SDF-1) and monocyte chemo-attractant protein-3 (MCP-3)"
     . SPARSER::COLLECTION)
    ("ligand (RANKL)" . SPARSER::MOLECULE)
    ("low density lipoprotein receptor-related protein (LRP)"
     . SPARSER::PROTEIN)
    ("mucin, and extracellular matrix metalloproteinase inducer"
     . SPARSER::COLLECTION)
    ("pericentrin" . SPARSER::PROTEIN) ("EMMPRIN" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN) ("integrins" . SPARSER::PROTEIN)
    ("FAK and KLF8" . SPARSER::COLLECTION)
    ("E-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("FAK-KLF8-MMP14" . SPARSER::COLLECTION) ("pY397" . SPARSER::PROTEIN)
    ("10A-iK8 and 231-K8ikd" . SPARSER::COLLECTION)
    ("pY397-FAK" . SPARSER::COLLECTION) ("mmp14" . SPARSER::PROTEIN)
    ("β-catenin and TCF1" . SPARSER::COLLECTION)
    ("its indirect target genes" . SPARSER::GENE)
    ("promoter FOPFlash (FOP)" . SPARSER::PROTEIN) ("FOP" . SPARSER::PROTEIN)
    ("BOP" . SPARSER::PROTEIN)
    ("Hematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE) ("KLF8 or MMP14" . SPARSER::COLLECTION)
    ("KLF8 and MMP14" . SPARSER::COLLECTION) ("BLI" . SPARSER::PROTEIN)
    ("the transactivation-defective mutant mKLF8" . SPARSER::PROTEIN)
    ("mKLF8" . SPARSER::PROTEIN)
    ("proteins, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("several oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("a dual transcription factor" . SPARSER::PROTEIN)
    ("KLF8 and FAK" . SPARSER::COLLECTION) ("kinase (FAK)" . SPARSER::KINASE)
    ("oligonucleotide and chromatin" . SPARSER::COLLECTION)
    ("β-catenin/TCF1" . SPARSER::COLLECTION) ("GAG-3" . SPARSER::PROTEIN)
    ("PF573228" . SPARSER::DRUG) ("Sulfo-NHS" . SPARSER::DRUG)
    ("pKH3" . SPARSER::PROTEIN)
    ("extracellular matrix metalloproteinase inducer" . SPARSER::PROTEIN)
    ("semaphorin 4D" . SPARSER::PROTEIN) ("MCP-3" . SPARSER::PROTEIN)
    ("protein-3" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("derived factor" . SPARSER::PROTEIN)
    ("mannose-binding lectin" . SPARSER::PROTEIN)
    ("proMMP8" . SPARSER::PROTEIN) ("endophilin A2" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("K 3" . SPARSER::PROTEIN)
    ("K 1" . SPARSER::PROTEIN) ("e 1" . SPARSER::MOLECULE)
    ("iK8" . SPARSER::PROTEIN) ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("TCF1" . SPARSER::PROTEIN) ("MMP14" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("KLF8" . SPARSER::PROTEIN) ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor-associated p53 mutants" . SPARSER::MUTANT)
    ("G6PD as well as Cox4il" . SPARSER::COLLECTION)
    ("Cox4i1" . SPARSER::PROTEIN)
    ("oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("either TAp73  −/− MEFs or G6PD-silenced MEFs ( xref and xref )"
     . SPARSER::COLLECTION)
    ("G6PD siRNA or control siRNA" . SPARSER::COLLECTION)
    ("NAC and nucleotides" . SPARSER::COLLECTION)
    ("Nucleosides" . SPARSER::MOLECULE)
    ("N-acetyl-L-cysteine (NAC)" . SPARSER::MOLECULE)
    ("dC" . SPARSER::MOLECULE) ("dA" . SPARSER::MOLECULE)
    ("ribonucleosides" . SPARSER::MOLECULE) ("NAC" . SPARSER::PROTEIN)
    ("the senescence-associated β-galactosidase" . SPARSER::PROTEIN)
    ("p53 and the p53/p73-inducible cell cycle regulator p21"
     . SPARSER::COLLECTION)
    ("siRNA or DHEA" . SPARSER::COLLECTION)
    ("DHEA or G6PD" . SPARSER::COLLECTION)
    ("G6PD siRNA or DHEA-treated TAp73  +/+ MEFs" . SPARSER::COLLECTION)
    ("DHEA-treated TAp73  +/+ MEFs" . SPARSER::PROTEIN)
    ("a G6PD-specific siRNA or the G6PD inhibitor dehydroepiandrosterone (DHEA)"
     . SPARSER::COLLECTION)
    ("dehydroepiandrosterone (DHEA)" . SPARSER::MOLECULE)
    ("DHEA" . SPARSER::DRUG) ("dehydroepiandrosterone" . SPARSER::MOLECULE)
    ("/NADPH" . SPARSER::COLLECTION) ("p53 or TAp63" . SPARSER::COLLECTION)
    ("p53, TAp63a, and ΔNp73" . SPARSER::COLLECTION)
    ("TAp73α and TAp73β" . SPARSER::COLLECTION) ("TAp73α" . SPARSER::PROTEIN)
    ("GFP-p53" . SPARSER::COLLECTION) ("GFP-TAp73α" . SPARSER::PROTEIN-PAIR)
    ("p53 or p63" . SPARSER::COLLECTION)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pyrimidine, and W" . SPARSER::COLLECTION) ("YYY-3" . SPARSER::COLLECTION)
    ("the genotoxic agent etoposide (ETP)" . SPARSER::DRUG)
    ("etoposide (ETP)" . SPARSER::DRUG) ("p73 or ΔNp73" . SPARSER::COLLECTION)
    ("p53 and its target gene p21 ( p53  +/+ )" . SPARSER::COLLECTION)
    ("E1A/Ras V12 -transformed Δ Np73  −/− MEFs" . SPARSER::PROTEIN)
    ("RNA and DNA" . SPARSER::COLLECTION)
    ("lipids and deoxyriboses" . SPARSER::COLLECTION)
    ("deoxyriboses" . SPARSER::MOLECULE)
    ("components and poses" . SPARSER::COLLECTION)
    ("nucleosides" . SPARSER::MOLECULE)
    ("NADPH and ribose" . SPARSER::COLLECTION)
    ("macromolecules" . SPARSER::MOLECULE) ("NADPH" . SPARSER::PROTEIN)
    ("pentose" . SPARSER::MOLECULE)
    ("the pre-eminent tumor suppressor p53" . SPARSER::PROTEIN)
    ("a structural homologue" . SPARSER::PROTEIN) ("g6pd" . SPARSER::PROTEIN)
    ("6PGD" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("G6pd" . SPARSER::PROTEIN) ("N-acetylcysteine" . SPARSER::DRUG)
    ("PKM2" . SPARSER::PROTEIN) ("subunit 4" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE) ("NADP +" . SPARSER::MOLECULE)
    ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("anti-oxidant" . SPARSER::DRUG) ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("these recombination accessory proteins" . SPARSER::PROTEIN)
    ("the anti-recombinase activity" . SPARSER::ANTIBODY)
    ("Csm" . SPARSER::PROTEIN) ("Shu" . SPARSER::PROTEIN)
    ("BLM and RECQL5" . SPARSER::COLLECTION) ("ssDNA" . SPARSER::PROTEIN)
    ("Rad51-ssDNA" . SPARSER::PROTEIN-PAIR) ("BRC" . SPARSER::PROTEIN)
    ("RAD51B and RAD51C" . SPARSER::COLLECTION)
    ("RAD51B(K324) and RAD51C(K328)" . SPARSER::COLLECTION)
    ("the ATP cap residues RAD51(D316), RAD51B(K324) and RAD51C(K328)"
     . SPARSER::COLLECTION)
    ("eukaryotic RAD51 recombinases" . SPARSER::PROTEIN)
    ("recombinases" . SPARSER::PROTEIN)
    ("RAD51 paralogs share only 20-30% homology" . SPARSER::PROTEIN)
    ("paralogs, Rad55 and Rad57" . SPARSER::COLLECTION)
    ("RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("RAD51 and DMC1" . SPARSER::COLLECTION)
    ("HsRAD51 or HsRAD51" . SPARSER::COLLECTION)
    ("RPA and ssDNA" . SPARSER::COLLECTION)
    ("an oligo dT50" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HsRAD51 and HsRAD51B-HsRAD51C" . SPARSER::COLLECTION)
    ("the divalent cation" . SPARSER::MOLECULE)
    ("possible HsRAD51" . SPARSER::PROTEIN)
    ("purified BLM (see xref ) and HsRPA" . SPARSER::COLLECTION)
    ("the subsequent BLM" . SPARSER::PROTEIN) ("NPFs" . SPARSER::PROTEIN)
    ("Sgs1" . SPARSER::PROTEIN) ("RecQ" . SPARSER::PROTEIN-FAMILY)
    ("RAD51B-RAD51C" . SPARSER::COLLECTION) ("NTA" . SPARSER::MOLECULE)
    ("this divalent cation" . SPARSER::MOLECULE)
    ("HSRAD51 and HsRAD51B-HsRAD51C" . SPARSER::COLLECTION)
    ("HsRAD51 and RPA" . SPARSER::COLLECTION)
    ("at least 25 mM salt" . SPARSER::MOLECULE)
    ("KCl and 100mM" . SPARSER::COLLECTION) ("RAD51B-" . SPARSER::PROTEIN)
    ("a functional NPF" . SPARSER::PROTEIN)
    ("HsRAD51(D316), HsRAD51B(K324) and HsRAD51C(K328)" . SPARSER::COLLECTION)
    ("RadA and the ATP γ-phosphate ( xref )" . SPARSER::COLLECTION)
    ("RadA" . SPARSER::PROTEIN)
    ("HsRAD51 and its paralogs" . SPARSER::COLLECTION)
    ("adenosine" . SPARSER::MOLECULE) ("RPA and HsRAD51" . SPARSER::COLLECTION)
    ("the 14th FA complementation group" . SPARSER::MOLECULE)
    ("FANCO" . SPARSER::PROTEIN) ("Fanconi anemia (FA)" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN)
    ("Xrcc2, Rad51D and Rad51B" . SPARSER::COLLECTION)
    ("XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("IR and DNA" . SPARSER::COLLECTION)
    ("irs1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("irs" . SPARSER::PROTEIN)
    ("Five mitotic HsRAD51 paralogs, HsRAD51B, HsRAD51C, HsRAD51D, HsXRCC2 and HsXRCC3"
     . SPARSER::COLLECTION)
    ("paralogs, HsRAD51B, HsRAD51C, HsRAD51D, HsXRCC2 and HsXRCC3"
     . SPARSER::COLLECTION)
    ("the Rad51 presynaptic NPF" . SPARSER::PROTEIN)
    ("Rad51 and RPA" . SPARSER::COLLECTION)
    ("Rad55-Rad57" . SPARSER::COLLECTION)
    ("Rad55 and RAD57" . SPARSER::COLLECTION)
    ("Rad55 or Rad57" . SPARSER::COLLECTION)
    ("Rad55 and Rad57" . SPARSER::COLLECTION)
    ("efficient RAD51" . SPARSER::PROTEIN)
    ("accessory proteins" . SPARSER::PROTEIN)
    ("unusual cationic salts" . SPARSER::DRUG)
    ("an inefficient recombinase activity" . SPARSER::PROTEIN)
    ("HR and forms" . SPARSER::COLLECTION) ("recombinase" . SPARSER::PROTEIN)
    ("BLM" . SPARSER::PROTEIN)
    ("a hypothetical nucleoprotein filament (NPF)" . SPARSER::PROTEIN-FAMILY)
    ("filament (NPF)" . SPARSER::PROTEIN-FAMILY)
    ("HsRAD51, HsRAD51B and HsRAD51C" . SPARSER::COLLECTION)
    ("NPF" . SPARSER::PROTEIN) ("nucleoprotein" . SPARSER::PROTEIN)
    ("RECQL5" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("DMC1" . SPARSER::PROTEIN) ("Rad52" . SPARSER::PROTEIN)
    ("HsRAd51" . SPARSER::PROTEIN) ("Srs2" . SPARSER::PROTEIN)
    ("HSRAD51" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("RAD51C" . SPARSER::PROTEIN) ("RAD51B" . SPARSER::PROTEIN)
    ("Rad51B" . SPARSER::PROTEIN) ("Rad51D" . SPARSER::PROTEIN)
    ("Xrcc2" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("XRCC2" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("Rad57" . SPARSER::PROTEIN) ("Rad55" . SPARSER::PROTEIN)
    ("recombinase activity" . SPARSER::PROTEIN) ("HsRAD51" . SPARSER::PROTEIN)
    ("platinum" . SPARSER::MOLECULE) ("TS" . SPARSER::PROTEIN)
    ("crizotinib" . SPARSER::DRUG)
    ("carboplatin and pemetrexed" . SPARSER::COLLECTION)
    ("taking pemetrexed" . SPARSER::DRUG) ("Proteinuria" . SPARSER::PROTEIN)
    ("initially stage IIIB" . SPARSER::DRUG)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("IIIB" . SPARSER::DRUG) ("Bevacizumab" . SPARSER::DRUG)
    ("carboplatin, pemetrexed, and bevacizumab" . SPARSER::COLLECTION)
    ("pemetrexed and bevacizumab" . SPARSER::COLLECTION)
    ("bevacizumab" . SPARSER::DRUG) ("avid" . SPARSER::DRUG)
    ("pemetrexed" . SPARSER::DRUG) ("Crizotinib" . SPARSER::DRUG)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("anaplastic lymphoma receptor tyrosine kinase" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN) ("c-ros oncogene 1" . SPARSER::PROTEIN)
    ("a clinically diverse cohort" . SPARSER::MOLECULE)
    ("E2F2 and the other downregulated responsive genes" . SPARSER::COLLECTION)
    ("Vcr" . SPARSER::DRUG)
    ("LXR ligands and their anti-proliferative" . SPARSER::COLLECTION)
    ("the 83 universal LXR ligand-responsive genes" . SPARSER::GENE)
    ("distinct LXR" . SPARSER::PROTEIN) ("HER2/neu" . SPARSER::COLLECTION)
    ("DSS" . SPARSER::PROTEIN)
    ("a previously described cohort" . SPARSER::MOLECULE)
    ("CASP3 and EZH2" . SPARSER::COLLECTION)
    ("E2F2 and E2F7" . SPARSER::COLLECTION)
    ("E2F2 and E2F" . SPARSER::COLLECTION)
    ("lipid and cholesterol" . SPARSER::COLLECTION)
    ("ABCA1 and ABCG1" . SPARSER::COLLECTION)
    ("the 193 common LXR ligand-reponsive genes" . SPARSER::GENE)
    ("Only 462 genes" . SPARSER::GENE)
    ("growth-associated genes" . SPARSER::GENE)
    ("LXRs and their ligands" . SPARSER::COLLECTION)
    ("subtypes, LXRα and LXRβ" . SPARSER::COLLECTION)
    ("RXRs" . SPARSER::PROTEIN) ("oxysterols" . SPARSER::MOLECULE)
    ("partial and inverse agonists" . SPARSER::COLLECTION)
    ("antagonists" . SPARSER::MOLECULE) ("NRs" . SPARSER::PROTEIN)
    ("receptor (NR)" . SPARSER::RECEPTOR)
    ("ER-, PR-, and HER2-" . SPARSER::COLLECTION)
    ("monoclonal antibodies (trastuzumab) or tyrosine kinase inhibitors (lapatinib)"
     . SPARSER::COLLECTION)
    ("lapatinib" . SPARSER::DRUG) ("trastuzumab" . SPARSER::DRUG)
    ("neu" . SPARSER::PROTEIN)
    ("estrogen receptor (ER-positive, ER+) and progesterone receptor (PR-positive, PR+)"
     . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG) ("anastrozole" . SPARSER::DRUG)
    ("letrozole" . SPARSER::DRUG) ("fulvestrant" . SPARSER::DRUG)
    ("raloxifene" . SPARSER::PROTEIN) ("Differentially" . SPARSER::PROTEIN)
    ("LXR" . SPARSER::PROTEIN)
    ("glucose, and fatty acid" . SPARSER::COLLECTION)
    ("LXRs" . SPARSER::PROTEIN) ("E2F5" . SPARSER::PROTEIN)
    ("E2F7" . SPARSER::PROTEIN) ("ABCG1" . SPARSER::PROTEIN)
    ("ABCA1" . SPARSER::PROTEIN) ("log-2" . SPARSER::PROTEIN)
    ("LXRβ" . SPARSER::PROTEIN) ("ErbB-2" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("GW3965" . SPARSER::DRUG) ("Eng" . SPARSER::PROTEIN)
    ("AMOs" . SPARSER::PROTEIN) ("oligonucleotide (AMO)" . SPARSER::MOLECULE)
    ("AMO" . SPARSER::PROTEIN) ("a homozygous state" . SPARSER::BIO-STATE)
    ("LGD" . SPARSER::PROTEIN) ("his maternal allele" . SPARSER::ALLELE)
    ("his paternal allele" . SPARSER::ALLELE) ("MPLA" . SPARSER::MOLECULE)
    ("a premature stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGA" . SPARSER::PROTEIN)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHAT" . SPARSER::PROTEIN) ("IgG, IgA, and IgM" . SPARSER::COLLECTION)
    ("IgM" . SPARSER::PROTEIN) ("ATM and ATR" . SPARSER::COLLECTION)
    ("Yan" . SPARSER::PROTEIN) ("thiol" . SPARSER::MOLECULE)
    ("a multifunctional protein kinase" . SPARSER::KINASE)
    ("cerebellar ataxia" . SPARSER::PROTEIN)
    ("very few A-T" . SPARSER::PROTEIN) ("Atm" . SPARSER::PROTEIN)
    ("progressive cerebellar ataxia, oculocutaneous telangiectasia, and immunodeficiency"
     . SPARSER::COLLECTION)
    ("ataxia, oculocutaneous telangiectasia, and immunodeficiency"
     . SPARSER::COLLECTION)
    ("progressive cerebellar ataxia" . SPARSER::PROTEIN)
    ("Ataxia" . SPARSER::PROTEIN) ("RTC13" . SPARSER::DRUG)
    ("family 1" . SPARSER::PROTEIN) ("alpha-fetoprotein" . SPARSER::PROTEIN)
    ("A-T" . SPARSER::PROTEIN) ("PLC" . SPARSER::PROTEIN)
    ("proteins, and p53" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("PCa" . SPARSER::PROTEIN)
    ("Poly (ADP-ribose) polymerase 1 ( PARP-1 ) gene" . SPARSER::GENE)
    ("AIF" . SPARSER::PROTEIN) ("F-2" . SPARSER::PROTEIN)
    ("CASP3" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("mature miRNAs" . SPARSER::PROTEIN)
    ("protein A and ATR-interacting protein" . SPARSER::COLLECTION)
    ("ethynyl" . SPARSER::MOLECULE)
    ("cyclobutane pyrimidine dimers and 6-4 photoproducts"
     . SPARSER::COLLECTION)
    ("cyclobutane" . SPARSER::MOLECULE) ("ATM and Chk1" . SPARSER::COLLECTION)
    ("ATR and pChk1" . SPARSER::COLLECTION)
    ("ATR, ATM and pChk1" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("ATR-3" . SPARSER::COLLECTION)
    ("Targets" . SPARSER::TARGET-PROTEIN)
    ("Six1, RhoA and Cdc42" . SPARSER::COLLECTION)
    ("CD71, CD36 and CD235a" . SPARSER::COLLECTION)
    ("hemoglobin" . SPARSER::MOLECULE) ("erythroid" . SPARSER::PROTEIN)
    ("Hsa" . SPARSER::PROTEIN) ("miRNAs and ATR" . SPARSER::COLLECTION)
    ("ATM- and Rad3-related" . SPARSER::COLLECTION) ("ATM-" . SPARSER::PROTEIN)
    ("rays" . SPARSER::PROTEIN) ("hsa" . SPARSER::PROTEIN)
    ("the phosphoinositide-3-kinase-like protein kinase family and their downstream genes"
     . SPARSER::COLLECTION)
    ("RNase III" . SPARSER::PROTEIN)
    ("DNA topoisomerase II-binding protein 1" . SPARSER::PROTEIN)
    ("ATR-interacting protein" . SPARSER::PROTEIN) ("P185" . SPARSER::PROTEIN)
    ("Six1" . SPARSER::PROTEIN) ("CD36" . SPARSER::PROTEIN)
    ("CD71" . SPARSER::PROTEIN) ("miR-16" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("miR-34a" . SPARSER::MOLECULE)
    ("miR-21" . SPARSER::PROTEIN) ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Skp2 and Stat3" . SPARSER::COLLECTION)
    ("Cdh1 and Skp2" . SPARSER::COLLECTION)
    ("Cdh1 and proteasomal" . SPARSER::COLLECTION)
    ("Skp2–p27Kip1" . SPARSER::COLLECTION)
    ("p27Kip1, p21Cip1, p130Cas, and FOXO1" . SPARSER::COLLECTION)
    ("CDK–cyclin" . SPARSER::COLLECTION)
    ("cyclin D1, and Stat3" . SPARSER::COLLECTION)
    ("c-myc, Skp2, and cyclin D1" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, Mcl-1, and survivin" . SPARSER::COLLECTION)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("Stat3–cyclin D1" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("si-Cont" . SPARSER::COLLECTION) ("Cont" . SPARSER::PROTEIN)
    ("APC/Cdh1" . SPARSER::COLLECTION)
    ("Pim-1, Cdh1, and pVHL" . SPARSER::COLLECTION)
    ("Pim-1, Akt1, and CDK2" . SPARSER::COLLECTION)
    ("Skp2, and salinomycin" . SPARSER::COLLECTION)
    ("p27Kip1 and salinomycin-induced p27Kip1 ( xref )" . SPARSER::COLLECTION)
    ("si-p27Kip1" . SPARSER::COLLECTION) ("si-Skp2" . SPARSER::COLLECTION)
    ("si" . SPARSER::PROTEIN) ("Skp2 or p27Kip1" . SPARSER::COLLECTION)
    ("Skp2 and p27Kip1" . SPARSER::COLLECTION)
    ("EGFR and JAK2" . SPARSER::COLLECTION)
    ("receptor–Janus" . SPARSER::COLLECTION)
    ("Skp2, cyclin D1, and survivin" . SPARSER::COLLECTION)
    ("p53, PTEN, and p130Cas" . SPARSER::COLLECTION)
    ("p16INK4A and p15INK4B" . SPARSER::COLLECTION)
    ("p27Kip1, p21Cip1, and p130Cas" . SPARSER::COLLECTION)
    ("Skp2, cyclin D1, and cyclin" . SPARSER::COLLECTION)
    ("CDKs, cyclins, and CDK" . SPARSER::COLLECTION)
    ("cyclin D1 and Skp2" . SPARSER::COLLECTION)
    ("c-IAP2, XIAP, and Bcl-xL" . SPARSER::COLLECTION)
    ("c-IAP1" . SPARSER::COLLECTION)
    ("phospho-Akt and phospho-Bad" . SPARSER::COLLECTION)
    ("Bad" . SPARSER::PROTEIN) ("iodide (PI)" . SPARSER::PROTEIN)
    ("annexin V and propidium" . SPARSER::COLLECTION)
    ("rhodamine" . SPARSER::PROTEIN)
    ("paclitaxel, etoposide, and cisplatin" . SPARSER::COLLECTION)
    ("Multidrug" . SPARSER::PROTEIN) ("–cyclin D1" . SPARSER::COLLECTION)
    ("rapamycin" . SPARSER::DRUG) ("TRAIL" . SPARSER::PROTEIN)
    ("anaphase-promoting complex (APC)" . SPARSER::PROTEIN)
    ("p21Cip1 and p27Kip1" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("cyclins and CDK" . SPARSER::COLLECTION)
    ("an agricultural antibiotic" . SPARSER::DRUG)
    ("a carboxylic polyether ionophore" . SPARSER::MOLECULE)
    ("ionophore" . SPARSER::MOLECULE)
    ("cell cycle-associated oncogenes" . SPARSER::ONCOGENE)
    ("Stat3, cyclin D1, and Skp2" . SPARSER::COLLECTION)
    ("si-Cdh1" . SPARSER::COLLECTION) ("–Skp2–p27Kip1" . SPARSER::COLLECTION)
    ("Skp2" . SPARSER::PROTEIN)
    ("cyclin D1, Skp2, and survivin" . SPARSER::COLLECTION)
    ("Skp" . SPARSER::PROTEIN) ("salinomycin" . SPARSER::DRUG)
    ("Salinomycin" . SPARSER::DRUG) ("β 2-microglobulin" . SPARSER::PROTEIN)
    ("β -actin" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("β -catenin" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("von Hippel–Lindau protein" . SPARSER::PROTEIN)
    ("Pim-1" . SPARSER::PROTEIN) ("JAK2" . SPARSER::PROTEIN)
    ("S3I-201" . SPARSER::MOLECULE) ("p15INK4B" . SPARSER::PROTEIN)
    ("c-IAP2" . SPARSER::PROTEIN) ("IAP1" . SPARSER::PROTEIN)
    ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ABCB1" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("MDR-1" . SPARSER::PROTEIN)
    ("multidrug resistance protein 1" . SPARSER::PROTEIN)
    ("p27Kip1" . SPARSER::PROTEIN) ("WNT3a or WNT7b" . SPARSER::COLLECTION)
    ("WNT3a" . SPARSER::PROTEIN) ("Ror" . SPARSER::PROTEIN-FAMILY)
    ("Wnt7b" . SPARSER::PROTEIN) ("SP1" . SPARSER::PROTEIN)
    ("a crucial transcription factor" . SPARSER::PROTEIN)
    ("protein and Topflash" . SPARSER::COLLECTION)
    ("FZD1, ALP and Col1 A" . SPARSER::COLLECTION)
    ("pRb/E2F1" . SPARSER::COLLECTION) ("alizarin" . SPARSER::DRUG)
    ("Calcium" . SPARSER::CALCIUM) ("ALP, COL1A or OCN" . SPARSER::COLLECTION)
    ("ALP and COL1A" . SPARSER::COLLECTION)
    ("ALP, COL1A and OCN" . SPARSER::COLLECTION)
    ("ALP, COL1A, OCN and RANKL" . SPARSER::COLLECTION)
    ("RANKL" . SPARSER::PROTEIN) ("TESS" . SPARSER::PROTEIN)
    ("both the full-length promoter (P1) and the truncated promoter P2 ( xref , 12.6-fold relative to β-gal for both)"
     . SPARSER::COLLECTION)
    ("allele (rs2232157, rs2232158) and haplotype (rs2232157/rs2232158)"
     . SPARSER::COLLECTION)
    ("pCMV/E2F1" . SPARSER::COLLECTION)
    ("allele and haplotype" . SPARSER::COLLECTION)
    ("alkaline phosphatase (ALP)" . SPARSER::PROTEIN-FAMILY)
    ("OCN" . SPARSER::PROTEIN) ("osteocalcin" . SPARSER::PROTEIN)
    ("ALP" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("WNT7b" . SPARSER::PROTEIN) ("WNT3" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("PKCδ" . SPARSER::PROTEIN)
    ("Wnt7" . SPARSER::PROTEIN) ("2F1" . SPARSER::PROTEIN)
    ("Ad-E" . SPARSER::MOLECULE)
    ("nuclear factor kappa-B ligand" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("LRP-5" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("FZD1" . SPARSER::PROTEIN) ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("metabolite" . SPARSER::MOLECULE) ("cardiac ischemia" . SPARSER::PROTEIN)
    ("ischemia" . SPARSER::PROTEIN) ("IDH1 or IDH2" . SPARSER::COLLECTION)
    ("causes D-2 hydroxyglutaric aciduria type 2" . SPARSER::PROTEIN)
    ("HGA" . SPARSER::PROTEIN) ("SIRT3 and SIRT5" . SPARSER::COLLECTION)
    ("SDHC" . SPARSER::PROTEIN) ("malonate" . SPARSER::DRUG)
    ("both mitochondrial metabolic enzymes as well as extramitochondrial proteins"
     . SPARSER::COLLECTION)
    ("histones and ribosomes" . SPARSER::COLLECTION)
    ("ascorbate" . SPARSER::MOLECULE) ("SDHB" . SPARSER::PROTEIN)
    ("ubiquinone" . SPARSER::DRUG) ("SDHA–SDHD" . SPARSER::COLLECTION)
    ("SDHD" . SPARSER::PROTEIN) ("SDHA" . SPARSER::PROTEIN)
    ("SIRT5 and E1α" . SPARSER::COLLECTION)
    ("dichloroacetate (DCA)" . SPARSER::MOLECULE) ("DCA" . SPARSER::PROTEIN)
    ("dichloroacetate" . SPARSER::MOLECULE)
    ("lentiviral small hairpin RNA" . SPARSER::RNA)
    ("commercially available PDC" . SPARSER::PROTEIN)
    ("E3bp" . SPARSER::PROTEIN) ("PDC and SDH" . SPARSER::COLLECTION)
    ("Dehydrogenase" . SPARSER::PROTEIN)
    ("both light and heavy form" . SPARSER::COLLECTION)
    ("macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("HMGB1-HMGB2-HSC70-ERP60-GAPDH" . SPARSER::COLLECTION)
    ("ANT" . SPARSER::PROTEIN) ("frataxin" . SPARSER::PROTEIN)
    ("SIRT5 and Lys" . SPARSER::COLLECTION) ("chaperonin" . SPARSER::PROTEIN)
    ("synthetase" . SPARSER::PROTEIN) ("IF" . SPARSER::PROTEIN)
    ("propionate" . SPARSER::MOLECULE) ("Val-Leu-Ile" . SPARSER::COLLECTION)
    ("isomerase" . SPARSER::ISOMERASE)
    ("only 38 Lys-succinylated proteins" . SPARSER::PROTEIN)
    ("Mito" . SPARSER::DRUG) ("extramitochondrial proteins" . SPARSER::PROTEIN)
    ("AK, GK, KF, and KA motifs" . SPARSER::COLLECTION)
    ("GK" . SPARSER::PROTEIN) ("−1 and +1" . SPARSER::COLLECTION)
    ("Gly or Ala" . SPARSER::COLLECTION) ("PKM" . SPARSER::PROTEIN)
    ("Pyruvate" . SPARSER::PROTEIN) ("protein (RAN)" . SPARSER::PROTEIN)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("acetoacetyl" . SPARSER::MOLECULE)
    ("an essential enzyme" . SPARSER::ENZYME) ("HADH" . SPARSER::PROTEIN)
    ("dehydrogenase (HADHA)" . SPARSER::PROTEIN) ("HADHA" . SPARSER::PROTEIN)
    ("hydroxyacyl" . SPARSER::PROTEIN)
    ("protein, peptide, and site" . SPARSER::COLLECTION)
    ("the pyruvate dehydrogenase complex (PDC) and succinate dehydrogenase (SDH)"
     . SPARSER::COLLECTION)
    ("dehydrogenase (SDH)" . SPARSER::PROTEIN)
    ("complex (PDC)" . SPARSER::BIO-COMPLEX) ("SDH" . SPARSER::PROTEIN)
    ("PDC" . SPARSER::PROTEIN)
    ("extramitochondrial cytosolic and nuclear proteins" . SPARSER::PROTEIN)
    ("isocitrate dehydrogenase (IDH) and CPS1" . SPARSER::COLLECTION)
    ("two metabolic enzymes, isocitrate dehydrogenase (IDH) and CPS1"
     . SPARSER::COLLECTION)
    ("dehydrogenase (IDH)" . SPARSER::PROTEIN) ("IDH" . SPARSER::PROTEIN)
    ("oxidase" . SPARSER::PROTEIN) ("urate" . SPARSER::MOLECULE)
    ("synthase" . SPARSER::PROTEIN) ("carbamoyl" . SPARSER::MOLECULE)
    ("SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("the major mitochondrial deacetylase activity" . SPARSER::PROTEIN)
    ("complex and succinate" . SPARSER::COLLECTION)
    ("malonyl and succinyl" . SPARSER::COLLECTION)
    ("malonyl" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("assembly factor 2" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("D-2" . SPARSER::PROTEIN) ("IDH2" . SPARSER::PROTEIN)
    ("K5" . SPARSER::PROTEIN) ("mABC1" . SPARSER::PROTEIN)
    ("ERP60" . SPARSER::PROTEIN) ("HSC70" . SPARSER::PROTEIN)
    ("HMGB2" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("TCP1" . SPARSER::PROTEIN) ("MitoTracker Red" . SPARSER::MOLECULE)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("oxidoreductase activity" . SPARSER::PROTEIN) ("K23" . SPARSER::PROTEIN)
    ("Sirt5" . SPARSER::PROTEIN) ("an 1" . SPARSER::DRUG)
    ("CPS1" . SPARSER::PROTEIN) ("SF" . SPARSER::PROTEIN)
    ("type and Hodgkin" . SPARSER::COLLECTION)
    ("the entire CHEK2" . SPARSER::PROTEIN) ("intron" . SPARSER::PROTEIN)
    ("introns" . SPARSER::PROTEIN) ("insA" . SPARSER::PROTEIN)
    ("three intronic variants" . SPARSER::VARIANT) ("SNAP" . SPARSER::PROTEIN)
    ("progesterone receptor (PR) and epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("six intronic variants" . SPARSER::VARIANT)
    ("exon-intron" . SPARSER::COLLECTION)
    ("TP53, CDC25C, CDC25A and BRCA1" . SPARSER::COLLECTION)
    ("the complete CHEK2" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 and TP53" . SPARSER::COLLECTION)
    ("Cell cycle checkpoint kinase" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("cell cycle checkpoint kinase" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("HLF, and KJL" . SPARSER::COLLECTION)
    ("HLF" . SPARSER::PROTEIN) ("SHC and CYY" . SPARSER::COLLECTION)
    ("SHC" . SPARSER::PROTEIN) ("SYT" . SPARSER::PROTEIN)
    ("Phosphoinositide" . SPARSER::PROTEIN) ("Formalin" . SPARSER::MOLECULE)
    ("pAKT and EGFRvIII" . SPARSER::COLLECTION)
    ("CXCR4 and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("EGFRvIII and PTEN" . SPARSER::COLLECTION)
    ("EGFRvIII or EGFRwt" . SPARSER::COLLECTION)
    ("Examples" . SPARSER::EXAMPLE) ("One possible example" . SPARSER::EXAMPLE)
    ("betel-nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR-PI3K" . SPARSER::COLLECTION)
    ("pAKT or EGFRvIII" . SPARSER::COLLECTION)
    ("EGFRvIII and pAKT" . SPARSER::COLLECTION)
    ("arginine and leucine" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID)
    ("EGFRvIII, PTEN and pAKT" . SPARSER::COLLECTION)
    ("EGFR, EGFRvIII and PTEN" . SPARSER::COLLECTION)
    ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("PI3K and phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("substance" . SPARSER::SUBSTANCE)
    ("the most frequent histological type" . TYPE) ("HNC" . SPARSER::PROTEIN)
    ("EGFR-PI3K-AKT" . SPARSER::COLLECTION)
    ("AKT and EGFRvIII" . SPARSER::COLLECTION)
    ("membranous wild-type EGFR and cytoplasmic phosphorylated AKT"
     . SPARSER::COLLECTION)
    ("membranous wild-type EGFR" . SPARSER::PROTEIN)
    ("-phosphoinositide-3-kinase" . SPARSER::COLLECTION)
    ("PI3K-AKT" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK6 and PIK3CB" . SPARSER::COLLECTION)
    ("HDAC8, THRA, TOP1 and CDK6" . SPARSER::COLLECTION)
    ("HER2-" . SPARSER::PROTEIN) ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAMily" . SPARSER::PROTEIN-FAMILY) ("MTs" . SPARSER::PROTEIN)
    ("BRCA1-ACCA" . SPARSER::COLLECTION) ("ACCA" . SPARSER::PROTEIN)
    ("TRa1" . SPARSER::PROTEIN) ("BRCA1 and THRA" . SPARSER::COLLECTION)
    ("Hormone" . SPARSER::MOLECULE) ("Thyroid" . SPARSER::PROTEIN)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("TOP1 and BRCA1" . SPARSER::COLLECTION) ("topotecan" . SPARSER::DRUG)
    ("the topologic states" . SPARSER::BIO-STATE)
    ("SMC5/SMC6" . SPARSER::COLLECTION) ("strong HIPK2" . SPARSER::PROTEIN)
    ("suppressor and DNA" . SPARSER::COLLECTION)
    ("a translational activator" . SPARSER::ACTIVATOR)
    ("a translational repressor" . SPARSER::REPRESSOR)
    ("regulators or kinases" . SPARSER::COLLECTION)
    ("genes or pathways" . SPARSER::COLLECTION)
    ("HuR, PTB, hnRNP A1 and RBM4" . SPARSER::COLLECTION)
    ("HuR" . SPARSER::PROTEIN) ("IRES-Trans" . SPARSER::PROTEIN-PAIR)
    ("chaperones" . SPARSER::PROTEIN) ("these latter genes" . SPARSER::GENE)
    ("β-actin and α-tubulin" . SPARSER::COLLECTION)
    ("the ATM and/or ATR kinases" . SPARSER::COLLECTION)
    ("SMC6, THRA and TOP1" . SPARSER::COLLECTION)
    ("HIPK2, SMC6, THRA and TOP1" . SPARSER::COLLECTION)
    ("THRA" . SPARSER::PROTEIN) ("Western Blot" . SPARSER::PROTEIN)
    ("Blot" . SPARSER::PROTEIN) ("CBX5, or DDX17" . SPARSER::COLLECTION)
    ("ASH" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("RR " . SPARSER::MOLECULE) ("polysomal mRNA" . SPARSER::PROTEIN)
    ("the polysomal fraction" . SPARSER::COMPONENT)
    ("total cytoplasmic mRNA (totRNA) and the mRNAs" . SPARSER::COLLECTION)
    ("polysomes" . SPARSER::BIO-COMPLEX)
    ("polysome and RNA" . SPARSER::COLLECTION)
    ("polysome-associated mRNA and total cytoplasmic mRNA"
     . SPARSER::COLLECTION)
    ("polysome-associated mRNA" . SPARSER::PROTEIN)
    ("a ribosome-associated protein" . SPARSER::PROTEIN)
    ("PABP1 and eIF4G" . SPARSER::COLLECTION)
    ("sub-polysomal fractions" . SPARSER::COMPONENT)
    ("monosomal or polysomal complexes" . SPARSER::BIO-COMPLEX)
    ("free ribosomal subunits" . SPARSER::PROTEIN)
    ("this ribosomal fraction" . SPARSER::COMPONENT)
    ("eIF4G and PABP1" . SPARSER::COLLECTION)
    ("ribosomal proteins and non-ribosomal proteins" . SPARSER::PROTEIN)
    ("proteins and non-ribosomal" . SPARSER::COLLECTION)
    ("eIF and eEF" . SPARSER::COLLECTION)
    ("the ribosomal fraction" . SPARSER::COMPONENT)
    ("ribosomal fractions" . SPARSER::COMPONENT)
    ("a Ribosome-associated Protein" . SPARSER::PROTEIN)
    ("Ribosome" . SPARSER::BIO-COMPLEX)
    ("polysome-associated RNAs" . SPARSER::RNA)
    ("cell death regulators or transcription factors" . SPARSER::COLLECTION)
    ("all cellular mRNAs" . SPARSER::PROTEIN)
    ("the repair protein RAD51 or the ubiquitin ligase BARD1"
     . SPARSER::COLLECTION)
    ("polysome" . SPARSER::BIO-COMPLEX) ("PIK3CB" . SPARSER::PROTEIN)
    ("HDAC8" . SPARSER::PROTEIN) ("Alpha)" . SPARSER::PROTEIN)
    ("DNA Topoisomerase 1" . SPARSER::PROTEIN) ("SMC5" . SPARSER::PROTEIN)
    ("RBM4" . SPARSER::PROTEIN) ("hnRNP A1" . SPARSER::PROTEIN)
    ("DDX17" . SPARSER::PROTEIN) ("CBX5" . SPARSER::PROTEIN)
    ("TRIB3" . SPARSER::PROTEIN) ("REV1" . SPARSER::PROTEIN)
    ("1L" . SPARSER::PROTEIN) ("SMC6" . SPARSER::PROTEIN)
    ("MAS5" . SPARSER::PROTEIN) ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P40)" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("TOP1" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("RNA helicase A" . SPARSER::PROTEIN)
    ("Poly(A)-Binding Protein" . SPARSER::PROTEIN)
    ("Cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Orc1 and Cdc6" . SPARSER::COLLECTION) ("Cdt1-Mcm6" . SPARSER::COLLECTION)
    ("around DNA" . SPARSER::DNA)
    ("a head-to-head double-hexamer around double-stranded DNA" . SPARSER::DNA)
    ("origin recognition complex (ORC)" . SPARSER::PROTEIN)
    ("ORC" . SPARSER::BIO-COMPLEX) ("Helicase" . SPARSER::PROTEIN)
    ("ATPase activity" . SPARSER::PROTEIN)
    ("Orc1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATPγS" . SPARSER::PROTEIN)
    ("Mcm6" . SPARSER::PROTEIN) ("Cdc10" . SPARSER::PROTEIN)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("pre-RC" . SPARSER::BIO-COMPLEX)
    ("pre-replicative complex" . SPARSER::BIO-COMPLEX)
    ("Tripartite motif protein" . SPARSER::PROTEIN)
    ("Polymerase-associated factor complex" . SPARSER::BIO-COMPLEX)
    ("Micro RNA" . SPARSER::RNA)
    ("Lens epithelial derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Suv39h1" . SPARSER::PROTEIN)
    ("Activating protein-1" . SPARSER::COLLECTION) ("Vpu" . SPARSER::PROTEIN)
    ("Vif" . SPARSER::PROTEIN) ("TrichoStatin" . SPARSER::MOLECULE)
    ("Trapoxin" . SPARSER::DRUG) ("TPX" . SPARSER::PROTEIN)
    ("Effector" . SPARSER::EFFECTOR) ("Phorbol" . SPARSER::DRUG)
    ("Polymerase" . SPARSER::PROTEIN) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("Nucleosome" . SPARSER::PROTEIN) ("LSF" . SPARSER::PROTEIN)
    ("Lymphoid" . SPARSER::PROTEIN) ("IKK" . SPARSER::PROTEIN)
    ("IKB" . SPARSER::PROTEIN) ("Integrase" . SPARSER::PROTEIN)
    ("AcetylTransferase" . SPARSER::PROTEIN)
    ("Phenylacetate" . SPARSER::MOLECULE)
    ("MethylTransferase" . SPARSER::PROTEIN) ("DNMT" . SPARSER::PROTEIN)
    ("Cycline" . SPARSER::PROTEIN-FAMILY) ("Carboxy" . SPARSER::MOLECULE)
    ("Promoter" . SPARSER::PROMOTER) ("APOlipoprotein" . SPARSER::MOLECULE)
    ("further developing such anti-latency drugs" . SPARSER::DRUG)
    ("monocytes-macrophages" . SPARSER::COLLECTION) ("CTL" . SPARSER::PROTEIN)
    ("viral protein" . SPARSER::PROTEIN) ("CTLs" . SPARSER::PROTEIN)
    ("Cajal" . SPARSER::PROTEIN)
    ("the only clinically available PKC agonist" . SPARSER::AGONIST)
    ("FK" . SPARSER::MOLECULE) ("Romidepsin" . SPARSER::DRUG)
    ("panobinostat" . SPARSER::DRUG)
    ("cell-associated unspliced RNA" . SPARSER::RNA)
    ("A far more potent HDACI" . SPARSER::MOLECULE)
    ("vorinostat" . SPARSER::DRUG) ("CCR5 or CXCR4" . SPARSER::COLLECTION)
    ("nuclease" . SPARSER::PROTEIN) ("ribozymes" . SPARSER::RNA)
    ("had undetectable proviral DNA and replication-competent HIV 8–17 several months"
     . SPARSER::COLLECTION)
    ("had undetectable proviral DNA" . SPARSER::DNA)
    ("the major coreceptor" . SPARSER::PROTEIN)
    ("The latter aims" . SPARSER::PROTEIN)
    ("the principal miRNAs" . SPARSER::PROTEIN)
    ("Five cellular miRNAs" . SPARSER::PROTEIN)
    ("the PCAF acetyltransferase [ xref ] and Cyclin T1 [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("The first essential cofactors" . SPARSER::PROTEIN)
    ("essential cellular co-factors" . SPARSER::MOLECULE)
    ("RSS" . SPARSER::PROTEIN) ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cellular miRNAs" . SPARSER::PROTEIN)
    ("PBMCs infected ex vivo" . SPARSER::PROTEIN)
    ("cellular and viral miRNAs" . SPARSER::PROTEIN)
    ("Dicer or Drosha" . SPARSER::COLLECTION)
    ("miRNA-RISC" . SPARSER::COLLECTION)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("the mature form" . SPARSER::FORM) ("RISC" . SPARSER::PROTEIN)
    ("Dicer" . SPARSER::PROTEIN) ("Drosha" . SPARSER::PROTEIN)
    ("post-transcriptional gene" . SPARSER::GENE) ("Micro RNAs" . SPARSER::RNA)
    ("Matrin3/Rev" . SPARSER::COLLECTION)
    ("RRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("the PTB-associated factor PSF and Matrin 3" . SPARSER::COLLECTION)
    ("PSF and Matrin 3" . SPARSER::COLLECTION) ("viral RNA" . SPARSER::RNA)
    ("Crm-1" . SPARSER::COLLECTION)
    ("response element (RRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("The viral protein Rev" . SPARSER::PROTEIN-FAMILY)
    ("genomic unspliced full-length viral RNA" . SPARSER::RNA)
    ("the viral proteins Gag-Pol and Env" . SPARSER::COLLECTION)
    ("subgenomic mRNAs" . SPARSER::PROTEIN)
    ("Gag-Pol and Env" . SPARSER::COLLECTION)
    ("nuclear viral RNA" . SPARSER::RNA) ("INI/SNF5" . SPARSER::COLLECTION)
    ("INI" . SPARSER::PROTEIN) ("INI1/SNF5" . SPARSER::COLLECTION)
    ("BAF and PBAF" . SPARSER::COLLECTION)
    ("BRG1 and INI1" . SPARSER::COLLECTION)
    ("the core SWI/SNF components integrase interactor 1 (INI-1/SNF5) and BRG-1"
     . SPARSER::COLLECTION)
    ("INI-1/SNF5" . SPARSER::COLLECTION)
    ("BAF180, BAF200, and BRD7" . SPARSER::COLLECTION)
    ("the Brahma (BRM) or homologue BRG1 ATPases" . SPARSER::COLLECTION)
    ("Brahma (BRM)" . SPARSER::PROTEIN) ("ATPases" . SPARSER::PROTEIN)
    ("BRM" . SPARSER::PROTEIN) ("Brahma" . SPARSER::PROTEIN)
    ("/SNF" . SPARSER::COLLECTION) ("proto-oncoprotein" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN) ("FRAP" . SPARSER::PROTEIN)
    ("Set7/9" . SPARSER::PROTEIN) ("SWI-SNF" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN)
    ("a new Tat-independent suppressor" . SPARSER::SUPPRESSOR)
    ("prostratin and PHA" . SPARSER::COLLECTION)
    ("RNAPII transcriptional elongation" . SPARSER::PROTEIN)
    ("Bet" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("its transcriptionally inactive complex" . SPARSER::BIO-COMPLEX)
    ("HEXIM1 and 7SK" . SPARSER::COLLECTION) ("MLL" . SPARSER::PROTEIN)
    ("ELL1 and ELL2" . SPARSER::COLLECTION)
    ("ELL1 and its homolog ELL2" . SPARSER::COLLECTION)
    ("the polymerase-associated factor complex" . SPARSER::BIO-COMPLEX)
    ("PAFc" . SPARSER::PROTEIN) ("ENL" . SPARSER::PROTEIN)
    ("snRNP" . SPARSER::BIO-COMPLEX)
    ("the 7SK-specific methyl-phosphate-capping enzyme" . SPARSER::ENZYME)
    ("the inactive complex" . SPARSER::BIO-COMPLEX)
    ("Cyclin T1/cdk9" . SPARSER::COLLECTION) ("MePCE" . SPARSER::PROTEIN)
    ("his" . SPARSER::AMINO-ACID) ("productive elongation" . SPARSER::PROTEIN)
    ("Rrp6" . SPARSER::PROTEIN) ("NELF and DSIF" . SPARSER::COLLECTION)
    ("other viral proteins" . SPARSER::PROTEIN)
    ("down all the possible interactors" . SPARSER::PROTEIN)
    ("Cyclin T1 and CDK9" . SPARSER::COLLECTION)
    ("a promiscuous viral protein" . SPARSER::PROTEIN)
    ("epigenetic inducers" . SPARSER::MOLECULE)
    ("Resveratrol" . SPARSER::PROTEIN)
    ("drugs, decitabine and gemcitabine" . SPARSER::COLLECTION)
    ("ribonucleotide" . SPARSER::MOLECULE) ("gemcitabine" . SPARSER::DRUG)
    ("procainamide, hydralazine and RG108" . SPARSER::COLLECTION)
    ("hydralazine" . SPARSER::DRUG) ("procainamide" . SPARSER::DRUG)
    ("zebularine" . SPARSER::DRUG) ("azacytidine" . SPARSER::DRUG)
    ("nucleoside" . SPARSER::MOLECULE) ("Decitabine" . SPARSER::DRUG)
    ("CpGs" . SPARSER::PROTEIN) ("LTNP/EC" . SPARSER::COLLECTION)
    ("methylated promoters" . SPARSER::PROMOTER)
    ("dinucleotide" . SPARSER::MOLECULE)
    ("MBD2 and HDAC-2" . SPARSER::COLLECTION) ("decitabine" . SPARSER::DRUG)
    ("Aza" . SPARSER::DRUG)
    ("methyl-CpG binding domain protein 2 (MDB2) and HDAC-2"
     . SPARSER::COLLECTION)
    ("MDB" . SPARSER::PROTEIN) ("HDACs and HMTs" . SPARSER::COLLECTION)
    ("MeCPs" . SPARSER::PROTEIN) ("DNMTs" . SPARSER::PROTEIN)
    ("SAM-competitive" . SPARSER::MOLECULE) ("SAH" . SPARSER::MOLECULE)
    ("multiple histone- and DNA-modifying enzymes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("histone-" . SPARSER::PROTEIN)
    ("EZH2 and other chromatin-modifying enzymes" . SPARSER::COLLECTION)
    ("Polycomb" . SPARSER::PROTEIN) ("HMT" . SPARSER::PROTEIN)
    ("LSD1/KDM1/CoREST" . SPARSER::COLLECTION)
    ("the HIV-1 proximal promoter" . SPARSER::PROMOTER)
    ("H3K4 and H3K9" . SPARSER::COLLECTION)
    ("LSD1 and CTIP2" . SPARSER::COLLECTION)
    ("CTIP2 and LSD1" . SPARSER::COLLECTION)
    ("the multienzymatic complex" . SPARSER::BIO-COMPLEX)
    ("LSD-1/KDM1" . SPARSER::COLLECTION) ("Lysine" . SPARSER::AMINO-ACID)
    ("prostratin and chaetocin " . SPARSER::COLLECTION)
    ("chaetocin " . SPARSER::DRUG)
    ("the patient resting memory CD4+ T-cell" . SPARSER::PROTEIN)
    ("SET" . SPARSER::PROTEIN) ("dithio" . SPARSER::MOLECULE)
    ("S-adenosylmethionine (SAM)" . SPARSER::DRUG)
    ("a fungal mycotoxin" . SPARSER::MOLECULE)
    ("mycotoxin" . SPARSER::MOLECULE) ("Chaetocin" . SPARSER::DRUG)
    ("chaetocin and BIX-01294" . SPARSER::COLLECTION)
    ("chaetocin" . SPARSER::DRUG) ("methyltransferase" . SPARSER::PROTEIN)
    ("GLP" . SPARSER::PROTEIN) ("Ding" . SPARSER::PROTEIN)
    ("CTIP2, HP1, MeCP2 and HDAC1" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2 and HP1" . SPARSER::COLLECTION)
    ("HP1gamma (heterochromatin protein 1) and H3K9" . SPARSER::COLLECTION)
    ("Suv39H1, HP1gamma (heterochromatin protein 1) and H3K9"
     . SPARSER::COLLECTION)
    ("HMTs" . SPARSER::PROTEIN) ("methyltransferases" . SPARSER::PROTEIN)
    ("MAPKs and NF-kappaB" . SPARSER::COLLECTION)
    ("prostratin " . SPARSER::MOLECULE)
    ("prostratin and HDACIs" . SPARSER::COLLECTION)
    ("VPA and SAHA" . SPARSER::COLLECTION) ("HLADR-" . SPARSER::PROTEIN)
    ("CD69-" . SPARSER::PROTEIN) ("CD25-" . SPARSER::PROTEIN)
    ("HLADR" . SPARSER::PROTEIN) ("TNFalpha " . SPARSER::PROTEIN)
    ("HDACIs and NF-kappaB" . SPARSER::COLLECTION) ("AV" . SPARSER::MOLECULE)
    ("Panobinostat" . SPARSER::DRUG)
    ("the Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Vorinostat" . SPARSER::DRUG) ("epilepsy" . SPARSER::PROTEIN)
    ("phenylbutyrate" . SPARSER::DRUG) ("coreceptor" . SPARSER::PROTEIN)
    ("neo" . SPARSER::PROTEIN)
    ("efficient cART" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC1, HDAC2 and HDAC3" . SPARSER::COLLECTION)
    ("trapoxin and trichostatin" . SPARSER::COLLECTION)
    ("trapoxin" . SPARSER::DRUG)
    ("The repressive nucleosome nuc-1" . SPARSER::PROTEIN)
    ("PMA or TNFalpha" . SPARSER::COLLECTION)
    ("repressive heterochromatin" . SPARSER::PROTEIN)
    ("the nucleosomal DNA" . SPARSER::DNA)
    ("active euchromatin" . SPARSER::BIO-COMPLEX)
    ("euchromatin" . SPARSER::BIO-COMPLEX) ("HATs" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("chromatin-associated proteins" . SPARSER::PROTEIN)
    ("Histone" . SPARSER::PROTEIN) ("heterochromatin" . SPARSER::PROTEIN)
    ("Euchromatin" . SPARSER::BIO-COMPLEX) ("nuc" . SPARSER::PROTEIN)
    ("dGTP" . SPARSER::DGTP) ("TRIM28 and HDAC2" . SPARSER::COLLECTION)
    ("KRAB-zinc finger" . SPARSER::COLLECTION)
    ("KRAB" . SPARSER::PROTEIN-FAMILY)
    ("the viral integrase" . SPARSER::PROTEIN)
    ("the viral strand DNA" . SPARSER::DNA) ("JAK/STAT5" . SPARSER::COLLECTION)
    ("Staf50" . SPARSER::PROTEIN) ("the Poli’s" . SPARSER::PROTEIN)
    ("Poli" . SPARSER::PROTEIN) ("the active complex" . SPARSER::BIO-COMPLEX)
    ("IL-2, IL-7, IL-15 and granulocyte-macrophage colony-stimulating factor"
     . SPARSER::COLLECTION)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("HDACIs" . SPARSER::MOLECULE) ("Regulators" . SPARSER::REGULATOR)
    ("the repressive nucleosome nuc-1" . SPARSER::PROTEIN)
    ("valproic acid (VPA) or SAHA" . SPARSER::COLLECTION)
    ("VPA" . SPARSER::PROTEIN) ("HDACI" . SPARSER::MOLECULE)
    ("beta-catenin/TCF-4" . SPARSER::COLLECTION)
    ("TCF-4 and beta-catenin" . SPARSER::COLLECTION)
    ("beta-catenin or TCF-4" . SPARSER::COLLECTION)
    ("Wnt/beta-catenin/TCF-4" . SPARSER::COLLECTION)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION)
    ("PTEN and PTEN" . SPARSER::COLLECTION)
    ("acetaldehyde" . SPARSER::MOLECULE) ("DSF" . SPARSER::PROTEIN)
    ("the repressive transcriptional factor YY1" . SPARSER::PROTEIN)
    ("IL-2 and TNF-alpha" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IkappaBs" . SPARSER::PROTEIN)
    ("IkappaB" . SPARSER::PROTEIN) ("IkappaBepsilon" . SPARSER::PROTEIN)
    ("methamphetamine" . SPARSER::DRUG) ("nanoparticles" . SPARSER::MOLECULE)
    ("bryostatin 1 and DPP" . SPARSER::COLLECTION)
    ("the HIV-1 receptor CD4 and the coreceptors CXCR4 and CCR5"
     . SPARSER::COLLECTION)
    ("CXCR4 and CCR5" . SPARSER::COLLECTION) ("coreceptors" . SPARSER::PROTEIN)
    ("the two non tumorigenic phorbol esters prostratin [ xref , xref ] and DPP (12-deoxyphorbol 13-phenylacetate)"
     . SPARSER::COLLECTION)
    ("phenylacetate" . SPARSER::MOLECULE) ("DPP" . SPARSER::MOLECULE)
    ("prostratin" . SPARSER::MOLECULE) ("esters" . SPARSER::MOLECULE)
    ("ingenols" . SPARSER::MOLECULE) ("diacylglycerol" . SPARSER::PROTEIN)
    ("RNAPII" . SPARSER::PROTEIN)
    ("c-Fos, JunB and JunD" . SPARSER::COLLECTION) ("JunD" . SPARSER::PROTEIN)
    ("JunB" . SPARSER::PROTEIN)
    ("the 5103 fragment, the DNase I-hypersensitive site HS7 and the 5105 fragment [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("pol" . SPARSER::PROTEIN) ("NF-kappaB and NFAT" . SPARSER::COLLECTION)
    ("Sp1 and TFIID" . SPARSER::COLLECTION)
    ("NF-kappaB, NFAT and AP-1" . SPARSER::COLLECTION)
    ("the viral Tat protein" . SPARSER::PROTEIN)
    ("this phenomenon further and identified chromatin" . SPARSER::PROTEIN)
    ("cryptic" . SPARSER::PROTEIN) ("active genes" . SPARSER::GENE)
    ("Transportin-3/TNPO3" . SPARSER::COLLECTION)
    ("RanBP2/Nup358" . SPARSER::COLLECTION) ("Transportin" . SPARSER::PROTEIN)
    ("karyopherin" . SPARSER::PROTEIN) ("SWI/SNF" . SPARSER::COLLECTION)
    ("SNF" . SPARSER::PROTEIN-FAMILY) ("SWI" . SPARSER::PROTEIN)
    ("active cellular genes" . SPARSER::GENE)
    ("LEDGF/p75" . SPARSER::COLLECTION) ("LEDGF" . SPARSER::PROTEIN)
    ("the viral enzyme integrase (IN)" . SPARSER::PROTEIN)
    ("integrase (IN)" . SPARSER::PROTEIN)
    ("the linear viral DNA" . SPARSER::DNA)
    ("complex (PIC)" . SPARSER::BIO-COMPLEX) ("PIC" . SPARSER::BIO-COMPLEX)
    ("the viral promoter" . SPARSER::PROMOTER) ("multidrug" . SPARSER::PROTEIN)
    ("BLT" . SPARSER::PROTEIN) ("Van" . SPARSER::PROTEIN)
    ("SAHA" . SPARSER::DRUG) ("TNFalpha" . SPARSER::PROTEIN)
    ("integrase" . SPARSER::PROTEIN)
    ("mCherry-luciferase" . SPARSER::COLLECTION)
    ("CCL19 and CCL21" . SPARSER::COLLECTION)
    ("CD69 and CD25" . SPARSER::COLLECTION)
    ("vif , vpr , vpu and env" . SPARSER::COLLECTION)
    ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("vif" . SPARSER::PROTEIN)
    ("antibodies and IL-2" . SPARSER::COLLECTION) ("BLC" . SPARSER::PROTEIN)
    ("CD25 and CD69" . SPARSER::COLLECTION) ("Env" . SPARSER::PROTEIN)
    ("VSV" . SPARSER::PROTEIN) ("proteins or co-culture" . SPARSER::COLLECTION)
    ("IL-2 and IL-7" . SPARSER::COLLECTION)
    ("a memory state" . SPARSER::BIO-STATE)
    ("IL-2 or IL-7" . SPARSER::COLLECTION)
    ("produced viral proteins" . SPARSER::PROTEIN)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("Tet-ON" . SPARSER::COLLECTION) ("Tet" . SPARSER::PROTEIN)
    ("cytokines or mitogens" . SPARSER::COLLECTION)
    ("mitogens" . SPARSER::MITOGEN) ("vpu" . SPARSER::PROTEIN)
    ("env" . SPARSER::PROTEIN) ("rev" . SPARSER::PROTEIN-FAMILY)
    ("pNL" . SPARSER::PROTEIN) ("viral genes" . SPARSER::GENE)
    ("intracellular IFNgamma (Th1) or CRTH2 and intracellular IL-4 (Th2)"
     . SPARSER::COLLECTION)
    ("CRTH2 and intracellular IL-4 (Th2)" . SPARSER::COLLECTION)
    ("IFNgamma" . SPARSER::PROTEIN) ("CD27-" . SPARSER::PROTEIN)
    ("CCR7-" . SPARSER::PROTEIN)
    ("perivascular macrophages" . SPARSER::PROTEIN)
    ("CD31-" . SPARSER::PROTEIN) ("approximately 1–2" . SPARSER::PROTEIN)
    ("suppressive cART" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD45RA-" . SPARSER::PROTEIN) ("TTM" . SPARSER::PROTEIN)
    ("a replication competent form" . SPARSER::FORM)
    ("Raltegravir" . SPARSER::DRUG)
    ("cell-associated HIV-1 RNA" . SPARSER::RNA)
    ("antiretroviral drugs" . SPARSER::DRUG) ("GALT" . SPARSER::PROTEIN)
    ("NF-kappaB (Nuclear Factor Kappa-light-chain-enhancer of activated B cells) or NFAT (Nuclear Factor of Activated T-cells)"
     . SPARSER::COLLECTION)
    ("NELF (Negative Elongation Factor) and the family" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase 9 (cdk9) and human cyclin T1"
     . SPARSER::COLLECTION)
    ("snRNA" . SPARSER::RNA) ("HMBA" . SPARSER::DRUG)
    ("NELF" . SPARSER::PROTEIN) ("DRB" . SPARSER::PROTEIN)
    ("DSIF" . SPARSER::PROTEIN) ("NFAT" . SPARSER::PROTEIN)
    ("Kappa" . SPARSER::PROTEIN-FAMILY)
    ("these antiretroviral drugs" . SPARSER::DRUG)
    ("the viral Tat trans -activator and its cellular cofactors"
     . SPARSER::COLLECTION)
    ("its cellular cofactors" . SPARSER::PROTEIN)
    ("the viral Tat trans -activator" . SPARSER::ACTIVATOR)
    ("-activator" . SPARSER::ACTIVATOR) ("Valproic Acid" . SPARSER::MOLECULE)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("T-Cell receptor" . SPARSER::PROTEIN)
    ("Suppressor of variegation 3–9 homolog 1" . SPARSER::PROTEIN)
    ("SuberoylAnilide hydroxamic acid" . SPARSER::DRUG)
    ("S-AdenosylMethionine" . SPARSER::DRUG)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("Polypyrimidine tract binding protein" . SPARSER::PROTEIN)
    ("Polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN)
    ("eLongation factor" . SPARSER::PROTEIN)
    ("Methyl-CpG binding protein" . SPARSER::PROTEIN)
    ("Methyl-CpG binding domain protein" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LEF-1" . SPARSER::PROTEIN)
    ("Ini1" . SPARSER::PROTEIN) ("InterLeukin 2" . SPARSER::PROTEIN)
    ("IKappaB kinase" . SPARSER::PROTEIN)
    ("Hepatoma-derived growth factor" . SPARSER::PROTEIN)
    ("Heterochromatin Protein 1" . SPARSER::PROTEIN)
    ("HexaMethylene BisAcetamide" . SPARSER::DRUG)
    ("Histone DeACetylase" . SPARSER::PROTEIN)
    ("Granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("Green fluorescent protein" . SPARSER::PROTEIN)
    ("COUP-TF interacting protein" . SPARSER::PROTEIN)
    ("CTIP-2" . SPARSER::PROTEIN)
    ("v-myc myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 9" . SPARSER::PROTEIN)
    ("Bromodomain-containing protein 4" . SPARSER::PROTEIN)
    ("Adenosine TriPhosphate" . SPARSER::MOLECULE)
    ("Activating protein" . SPARSER::PROTEIN) ("bryostatin-1" . SPARSER::DRUG)
    ("LBH589" . SPARSER::DRUG) ("1–2 " . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN) ("TAR5" . SPARSER::PROTEIN)
    ("miR-29" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("pre-miRNAs" . SPARSER::RNA) ("pri-miRNA" . SPARSER::RNA)
    ("single-stranded RNAs" . SPARSER::RNA) ("Matrin3" . SPARSER::PROTEIN)
    ("Matrin 3" . SPARSER::PROTEIN)
    ("polypyrimidine tract binding protein" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN) ("Gag-Pol" . SPARSER::PROTEIN)
    ("BRG-1" . SPARSER::PROTEIN) ("SNF5" . SPARSER::PROTEIN)
    ("INI-1" . SPARSER::PROTEIN) ("integrase interactor 1" . SPARSER::PROTEIN)
    ("BRD7" . SPARSER::PROTEIN) ("BAF200" . SPARSER::PROTEIN)
    ("BAF180" . SPARSER::PROTEIN) ("ARID1" . SPARSER::PROTEIN)
    ("BAF250" . SPARSER::PROTEIN) ("PAAF1" . SPARSER::PROTEIN)
    ("Hdm2" . SPARSER::PROTEIN) ("Set7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRD2" . SPARSER::PROTEIN) ("MS417" . SPARSER::MOLECULE)
    ("I-Bet151" . SPARSER::MOLECULE) ("Cdk9" . SPARSER::PROTEIN)
    ("Hexamethylene bisacetamide" . SPARSER::DRUG) ("AF9" . SPARSER::PROTEIN)
    ("ELL2" . SPARSER::PROTEIN) ("ELL1" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA) ("min -1" . SPARSER::PROTEIN)
    ("CycT1" . SPARSER::PROTEIN)
    ("bromodomain-containing protein 4" . SPARSER::PROTEIN)
    ("LARP7" . SPARSER::PROTEIN) ("HEXIM2" . SPARSER::PROTEIN)
    ("HEXIM1" . SPARSER::PROTEIN) ("Xrn2" . SPARSER::PROTEIN)
    ("NAP1L1" . SPARSER::PROTEIN) ("assembly factor 1" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN) ("DNMT1" . SPARSER::PROTEIN)
    ("HDAC-2" . SPARSER::PROTEIN)
    ("methyl-CpG binding domain protein 2" . SPARSER::PROTEIN)
    ("GSK126" . SPARSER::DRUG)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("S-adenosyl-L-homocysteine" . SPARSER::MOLECULE)
    ("PRC2" . SPARSER::PROTEIN)
    ("Polycomb Repressive Complex 2" . SPARSER::PROTEIN)
    ("demethylase activity" . SPARSER::PROTEIN) ("WDR5" . SPARSER::PROTEIN)
    ("KDM1" . SPARSER::PROTEIN) ("LSD-1" . SPARSER::PROTEIN)
    ("BIX-01294 " . SPARSER::DRUG) ("S-adenosylmethionine" . SPARSER::DRUG)
    ("BIX-01294" . SPARSER::DRUG) ("MeCP2" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::PROTEIN) ("heterochromatin protein 1" . SPARSER::PROTEIN)
    ("HP1gamma" . SPARSER::PROTEIN) ("G9a" . SPARSER::PROTEIN)
    ("Suv39H1" . SPARSER::PROTEIN) ("IΚBalpha" . SPARSER::PROTEIN)
    ("butyric acid" . SPARSER::MOLECULE) ("MC1293" . SPARSER::DRUG)
    ("ITF2357" . SPARSER::DRUG) ("HDAC4" . SPARSER::PROTEIN)
    ("NELF-E" . SPARSER::PROTEIN) ("SAMHD1" . SPARSER::PROTEIN)
    ("ZBRK1" . SPARSER::PROTEIN) ("TRIM28" . SPARSER::PROTEIN)
    ("Cyclin T1" . SPARSER::PROTEIN) ("TRIM19" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("IL-15" . SPARSER::PROTEIN) ("U3" . SPARSER::PROTEIN)
    ("valproic acid" . SPARSER::MOLECULE) ("SMAR1" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("TCF-LEF" . SPARSER::PROTEIN-FAMILY)
    ("TCF-4" . SPARSER::PROTEIN)
    ("Phosphatase and Tensin homolog" . SPARSER::PROTEIN)
    ("AS601245" . SPARSER::DRUG) ("TNF-alpha" . SPARSER::PROTEIN)
    ("CNS stimulant" . SPARSER::DRUG) ("bryostatin 1" . SPARSER::DRUG)
    ("CXCR4" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("CBF-1" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN) ("RNA polymerase II" . SPARSER::PROTEIN)
    ("TNPO3" . SPARSER::PROTEIN) ("Nup358" . SPARSER::PROTEIN)
    ("RanBP2" . SPARSER::PROTEIN) ("INI1" . SPARSER::PROTEIN)
    ("HRP-2" . SPARSER::PROTEIN)
    ("hepatoma-derived growth factor" . SPARSER::PROTEIN)
    ("lens epithelium-derived growth factor" . SPARSER::PROTEIN)
    ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rag2" . SPARSER::PROTEIN)
    ("CCL21" . SPARSER::PROTEIN) ("CCL19" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("CD69" . SPARSER::PROTEIN)
    ("ACH2" . SPARSER::PROTEIN) ("p24" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("CRTH2" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("CD27" . SPARSER::PROTEIN) ("CCR7" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("7SK" . SPARSER::RNA)
    ("hexamethylene bisacetamide" . SPARSER::DRUG)
    ("HEXIM-1" . SPARSER::PROTEIN) ("cyclin T1" . SPARSER::PROTEIN)
    ("cdk9" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 9" . SPARSER::PROTEIN)
    ("nuc-1" . SPARSER::PROTEIN) ("Elongation Factor" . SPARSER::PROTEIN)
    ("COUP-TF Interacting Protein" . SPARSER::PROTEIN)
    ("CTIP2" . SPARSER::PROTEIN) ("plasma)" . SPARSER::PROTEIN)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("AG and AA" . SPARSER::COLLECTION) ("asparagine" . SPARSER::AMINO-ACID)
    ("TK" . SPARSER::PROTEIN) ("TM" . SPARSER::PROTEIN)
    ("Immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Integrins" . SPARSER::PROTEIN) ("sema" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MET" . SPARSER::PROTEIN) ("sema domain" . SPARSER::PROTEIN)
    ("precursor protein" . SPARSER::PROTEIN) ("SU11274" . SPARSER::DRUG)
    ("ATM or WRN" . SPARSER::COLLECTION)
    ("a dominant-negative TRF2" . SPARSER::PROTEIN)
    ("ATM and WRN" . SPARSER::COLLECTION)
    ("a dominant-negative p73" . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN)
    ("tyrosinase and TRP-1" . SPARSER::COLLECTION)
    ("either anti-p53 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("tyrosinase and TRP-2" . SPARSER::COLLECTION)
    ("MART-1, TRP-1, TRP-2, and tyrosinase" . SPARSER::COLLECTION)
    ("tyrosinase" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("caspase-9, caspase-3, and caspase-7" . SPARSER::COLLECTION)
    ("ATM and p53" . SPARSER::COLLECTION) ("p95/NBS1" . SPARSER::COLLECTION)
    ("proteins, TRF1 and TRF2" . SPARSER::COLLECTION)
    ("the shelterin complex and disruption" . SPARSER::COLLECTION)
    ("p16, pRb, p53, p73 and p21" . SPARSER::COLLECTION)
    ("p95/Nbs1" . SPARSER::COLLECTION) ("SSBs" . SPARSER::PROTEIN)
    ("ATM and its effector protein p53 [ xref , xref ]" . SPARSER::COLLECTION)
    ("TRF1 and TRF2" . SPARSER::COLLECTION)
    ("POT1, TIN1, TPP1 and RAP1" . SPARSER::COLLECTION)
    ("shelterin" . SPARSER::PROTEIN)
    ("TRF1, TRF2, tankyrase-1 and p53" . SPARSER::COLLECTION)
    ("proteins, TRF1, TRF2, and tankyrase-1" . SPARSER::COLLECTION)
    ("MU" . SPARSER::PROTEIN) ("p53, TRF1 and TRF2" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("Ac-DEVD-pNA" . SPARSER::DRUG)
    ("Beta-actin" . SPARSER::PROTEIN) ("Caspase-9" . SPARSER::PROTEIN)
    ("Caspase-7" . SPARSER::PROTEIN) ("telomerase activity" . SPARSER::PROTEIN)
    ("TRP-2" . SPARSER::PROTEIN) ("TRP-1" . SPARSER::DRUG)
    ("MART-1" . SPARSER::PROTEIN) ("caspase-7" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("Nbs1" . SPARSER::PROTEIN) ("p95" . SPARSER::PROTEIN)
    ("XAV939" . SPARSER::DRUG) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("Tankyrase-1" . SPARSER::PROTEIN) ("RAP1" . SPARSER::PROTEIN)
    ("TPP1" . SPARSER::PROTEIN) ("TIN1" . SPARSER::PROTEIN)
    ("POT1" . SPARSER::PROTEIN) ("tankyrase-1" . SPARSER::PROTEIN)
    ("TRF2" . SPARSER::PROTEIN) ("TRF1" . SPARSER::PROTEIN)
    ("the NHS and the HPFS cohorts" . SPARSER::COLLECTION)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("PTGS2, and BRAF" . SPARSER::COLLECTION)
    ("PTGS2, and prostaglandin E2" . SPARSER::COLLECTION)
    ("BRAF-" . SPARSER::PROTEIN) ("IRs" . SPARSER::PROTEIN)
    ("NHS" . SPARSER::PROTEIN) ("RAF, RAS, and PI3K" . SPARSER::COLLECTION)
    ("PIK3CA or KRAS" . SPARSER::COLLECTION)
    ("prostaglandin E2" . SPARSER::MOLECULE)
    ("prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("Rap1–B-Raf–MEK–ERK" . SPARSER::COLLECTION)
    ("AC and Rapgef2" . SPARSER::COLLECTION) ("–AC" . SPARSER::COLLECTION)
    ("GPCR-Gα s" . SPARSER::PROTEIN-PAIR)
    ("cAMP and Ras" . SPARSER::COLLECTION)
    ("Rap1–B-Raf–ERK" . SPARSER::COLLECTION)
    ("cAMP- and cGMP-dependent" . SPARSER::COLLECTION)
    ("B-Raf, ERK, and Elk1" . SPARSER::COLLECTION)
    ("primary endocrine" . SPARSER::PROTEIN)
    ("exogenous Rapgef2" . SPARSER::PROTEIN)
    ("cAMP (8-CPT-cAMP) and a selective Epac activator (8-CPT-2′- O -Me-cAMP)"
     . SPARSER::COLLECTION)
    ("a pan-specific analog" . SPARSER::ANALOG) ("analogs" . SPARSER::ANALOG)
    ("isoproterenol and PACAP" . SPARSER::COLLECTION)
    ("CRE-luciferase" . SPARSER::COLLECTION)
    ("isoproterenol and PMA" . SPARSER::COLLECTION)
    ("isoproterenol" . SPARSER::PROTEIN)
    ("exogenous rPAC 1 receptors and endogenous β 2 -adrenergic receptors (βARs)"
     . SPARSER::COLLECTION)
    ("exogenous rPAC 1 receptors" . SPARSER::RECEPTOR)
    ("-adrenergic" . SPARSER::COLLECTION) ("adrenergic" . SPARSER::PROTEIN)
    ("intact Rapgef2" . SPARSER::PROTEIN)
    ("cAMP-Rap1-ERK" . SPARSER::COLLECTION)
    ("either scrambled shRNA or Rapgef2-specific shRNA" . SPARSER::COLLECTION)
    ("affinity-purifying B-Raf" . SPARSER::PROTEIN)
    ("ERK and Elk1" . SPARSER::COLLECTION)
    ("scrambled shRNA or Rapgef2-specific shRNA" . SPARSER::COLLECTION)
    ("toxin, or forskolin" . SPARSER::COLLECTION)
    ("Rapgef" . SPARSER::PROTEIN-FAMILY) ("cAMP-ERK" . SPARSER::COLLECTION)
    ("a GAL4-Elk1 fusion protein and a GAL4-luciferase gene"
     . SPARSER::COLLECTION)
    ("a cell-permeable analog" . SPARSER::ANALOG)
    ("GAL4-luciferase" . SPARSER::COLLECTION)
    ("GAL4-Elk1" . SPARSER::COLLECTION) ("Elk1" . SPARSER::PROTEIN)
    ("cellular Rap1" . SPARSER::PROTEIN)
    ("trans -farnesylthiosalicylic acid amide" . SPARSER::MOLECULE)
    ("FTS" . SPARSER::PROTEIN) ("-dideoxyadenosine" . SPARSER::DRUG)
    ("dideoxyadenosine" . SPARSER::DRUG) ("RalGDS" . SPARSER::PROTEIN)
    ("neuronal- and endocrine-specific genes" . SPARSER::GENE)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("cAMP and cyclic guanosine monophosphate (cGMP)" . SPARSER::COLLECTION)
    ("cGMP" . SPARSER::PROTEIN)
    ("CNrasGEF, PDZ-GEF1, RA-GEF, and nRapGEP" . SPARSER::COLLECTION)
    ("nRapGEP" . SPARSER::PROTEIN) ("GEF" . SPARSER::GEF)
    ("RA" . SPARSER::PROTEIN) ("CNrasGEF" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the PKA regulatory (RIIβ) subunit"
     . SPARSER::COLLECTION)
    ("previously uncharac-terized cAMP-binding proteins" . SPARSER::PROTEIN)
    ("PACAP and forskolin" . SPARSER::COLLECTION)
    ("100 nM PACAP and 100 μM 8-CPT-cAMP" . SPARSER::COLLECTION)
    ("SQ" . SPARSER::MOLECULE) ("PKA-" . SPARSER::PROTEIN)
    ("PACAP or forskolin" . SPARSER::COLLECTION)
    ("response element (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("PACAP or 8-CPT-cAMP" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("-cAMP" . SPARSER::COLLECTION) ("CPT" . SPARSER::PROTEIN)
    ("galanin" . SPARSER::PROTEIN) ("PKA and Epac" . SPARSER::COLLECTION)
    ("neurito-genesis" . SPARSER::COLLECTION)
    ("pituitary adenylate cyclase–activating polypeptide (PACAP)"
     . SPARSER::PROTEIN)
    ("diterpene" . SPARSER::MOLECULE) ("PACAP" . SPARSER::PROTEIN)
    ("neuropeptide" . SPARSER::PROTEIN)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("Rap1 and Rap2" . SPARSER::COLLECTION)
    ("triphosphatases" . SPARSER::PROTEIN)
    ("Epac1 and Epac2" . SPARSER::COLLECTION) ("Epac1" . SPARSER::PROTEIN)
    ("Epac" . SPARSER::PROTEIN)
    ("further downstream cellular targets" . SPARSER::TARGET-PROTEIN)
    ("B-Raf, MEK, and ERK" . SPARSER::COLLECTION) ("cAMP-" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rap1 and B-Raf" . SPARSER::COLLECTION)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rad 1" . SPARSER::PROTEIN)
    ("C-16" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("NBP1" . SPARSER::PROTEIN) ("gag-pol" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN) ("L-glutamate" . SPARSER::MOLECULE)
    ("p42" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("bis-tris" . SPARSER::MOLECULE) ("B-27" . SPARSER::PROTEIN)
    ("β 2 AR" . SPARSER::PROTEIN) ("family B" . SPARSER::PROTEIN)
    ("Rapgef3" . SPARSER::PROTEIN) ("cGMP-dependent" . SPARSER::PROTEIN)
    ("rPAC 1" . SPARSER::PROTEIN) ("100 kD" . SPARSER::PROTEIN)
    ("PACAP-38" . SPARSER::PROTEIN) ("cAMP–dependent" . SPARSER::PROTEIN)
    ("PLX4720" . SPARSER::DRUG) ("GAL4" . SPARSER::PROTEIN)
    ("CPT-2" . SPARSER::PROTEIN)
    ("guanosine monophosphate" . SPARSER::MOLECULE)
    ("PDZ-GEF1" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("protein kinase kinase" . SPARSER::PROTEIN) ("PACAP-" . SPARSER::PROTEIN)
    ("PAC 1 receptor" . SPARSER::PROTEIN)
    ("pituitary adenylate cyclase–activating polypeptide" . SPARSER::PROTEIN)
    ("Extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rap2" . SPARSER::PROTEIN) ("Epac2" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("NS-1" . SPARSER::PROTEIN) ("Rapgef2" . SPARSER::PROTEIN)
    ("Rap guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("B-Raf" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("G protein" . SPARSER::PROTEIN) ("HCC" . SPARSER::PROTEIN)
    ("SYL" . SPARSER::PROTEIN) ("DHE" . SPARSER::DRUG)
    ("Nicotinamide" . SPARSER::PROTEIN) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("Myc and Ras" . SPARSER::COLLECTION) ("Myc or Ras" . SPARSER::COLLECTION)
    ("Ac­Arg­Gly­Lys" . SPARSER::COLLECTION)
    ("ROS or nutrient" . SPARSER::COLLECTION)
    ("reliable forward and reverse DNA" . SPARSER::DNA)
    ("SIRT3, and SIRT3" . SPARSER::COLLECTION) ("max" . SPARSER::PROTEIN)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("SOD2 and LCAD" . SPARSER::COLLECTION)
    ("dehydrogenase (LCAD)" . SPARSER::PROTEIN) ("LCAD" . SPARSER::PROTEIN)
    ("coenzyme" . SPARSER::MOLECULE) ("HSC-3" . SPARSER::PROTEIN)
    ("antioxidants" . SPARSER::DRUG) ("cellular ROS" . SPARSER::PROTEIN)
    ("Myc and/or RAS" . SPARSER::COLLECTION) ("isocitrate" . SPARSER::PROTEIN)
    ("ketone" . SPARSER::MOLECULE) ("CoA" . SPARSER::MOLECULE)
    ("peptidase" . SPARSER::PROTEIN)
    ("SIRT1, SIRT6, and SIRT7" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4, and SIRT5" . SPARSER::COLLECTION)
    ("NADH" . SPARSER::MOLECULE) ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("homologues" . SPARSER::PROTEIN) ("electrons" . SPARSER::MOLECULE)
    ("DNA, proteins, and lipids, and play important roles in many physiological and pathophysiological conditions"
     . SPARSER::COLLECTION)
    ("proteins, and lipids" . SPARSER::COLLECTION)
    ("superoxide" . SPARSER::MOLECULE) ("nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gremlin" . SPARSER::PROTEIN) ("Ile" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("ROS" . SPARSER::PROTEIN)
    ("HOK" . SPARSER::PROTEIN) ("keratinocytes" . SPARSER::PROTEIN)
    ("redox" . SPARSER::PROTEIN) ("NAD" . SPARSER::MOLECULE)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("Nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("H2O2" . SPARSER::DRUG)
    ("PRSS3" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("SirT3" . SPARSER::PROTEIN) ("signal peptide" . SPARSER::PROTEIN)
    ("ERRα" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("ornithine transcarbamylase" . SPARSER::PROTEIN)
    ("synthase 2" . SPARSER::PROTEIN) ("acyl-CoA" . SPARSER::MOLECULE)
    ("SIRT5" . SPARSER::PROTEIN) ("SIRT4" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("SIRT6" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SIRT3" . SPARSER::PROTEIN)
    ("HG and YZ" . SPARSER::COLLECTION) ("new light" . SPARSER::PROTEIN)
    ("the bimodal transition sharp" . SPARSER::PROTEIN)
    ("CBP/p300" . SPARSER::COLLECTION) ("Chk1/Chk2" . SPARSER::COLLECTION)
    ("TFIIB" . SPARSER::PROTEIN) ("Tubulin" . SPARSER::PROTEIN)
    ("the monotonic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic promoters" . SPARSER::PROMOTER)
    ("both the pro-survival gene p21 and the pro-death gene PUMA"
     . SPARSER::COLLECTION)
    ("PUMA, and BAX" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("CDKN1A (approximately 30-fold increase) and GADD45A (approximately 60-fold)"
     . SPARSER::COLLECTION)
    ("monotonic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDKN1A (p21) and GADD45A" . SPARSER::COLLECTION)
    ("PML and YPEL3" . SPARSER::COLLECTION) ("PUM" . SPARSER::PROTEIN)
    ("XPC" . SPARSER::PROTEIN)
    ("HAUSP [ xref ] and ATM [ xref ]" . SPARSER::COLLECTION)
    ("HAUSP" . SPARSER::PROTEIN) ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("topoisomerase" . SPARSER::PROTEIN) ("p53-Venus" . SPARSER::COLLECTION)
    ("p53-Mdm2" . SPARSER::COLLECTION)
    ("the tumor suppressor protein p53 and its downstream transcriptional targets"
     . SPARSER::COLLECTION)
    ("PARP1" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN) ("HIPK2" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("TP53AIP1" . SPARSER::PROTEIN)
    ("APAF1" . SPARSER::PROTEIN) ("YPEL3" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("nutlin-3" . SPARSER::DRUG)
    ("Special AT-rich binding protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("other histological subtypes" . SPARSER::PROTEIN)
    ("this pooled prospective cohort" . SPARSER::MOLECULE)
    ("the here examined cohort" . SPARSER::MOLECULE)
    ("a global gene regulator" . SPARSER::REGULATOR)
    ("the here studied cohort" . SPARSER::MOLECULE)
    ("ER and PR" . SPARSER::COLLECTION) ("ER or AR" . SPARSER::COLLECTION)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("different histological subtypes" . SPARSER::PROTEIN)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("MCM3, RBM3, Ki67 or SATB1" . SPARSER::COLLECTION)
    ("ER, AR, or Chek2" . SPARSER::COLLECTION) ("Chek2" . SPARSER::PROTEIN)
    ("GGT " . SPARSER::PROTEIN) ("Haematoxylin" . SPARSER::MOLECULE)
    ("val" . SPARSER::AMINO-ACID) ("asp" . SPARSER::AMINO-ACID)
    ("gly" . SPARSER::AMINO-ACID) ("p53 and BRCA1/2" . SPARSER::COLLECTION)
    ("v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) gene"
     . SPARSER::GENE)
    ("RAS/MAPK" . SPARSER::COLLECTION)
    ("novel diagnostic, prognostic, and predictive biomarkers"
     . SPARSER::MOLECULE)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prospective cohort" . SPARSER::MOLECULE)
    ("mucinous histological subtype, and form part" . SPARSER::COMPONENT)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN) ("Type 1" . SPARSER::PROTEIN)
    ("SATB1" . SPARSER::PROTEIN)
    ("special AT-rich sequence-binding protein1" . SPARSER::PROTEIN)
    ("MCM3" . SPARSER::PROTEIN) ("RBM3" . SPARSER::PROTEIN)
    ("RNA-binding motif protein 3" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::PROTEIN) ("GTPase-activating" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("homolog)" . SPARSER::PROTEIN)
    ("Ki-ras" . SPARSER::PROTEIN) ("SCW" . SPARSER::PROTEIN)
    ("a functional Flt-1" . SPARSER::PROTEIN)
    ("VEGF and PlGF" . SPARSER::COLLECTION) ("VEGFR" . SPARSER::PROTEIN)
    ("the soluble isoform" . SPARSER::ISOFORM) ("sFlt-1" . SPARSER::COLLECTION)
    ("mFlt-1" . SPARSER::COLLECTION)
    ("exogenous PlGF recombinant protein" . SPARSER::PROTEIN)
    ("receptor-Flt-1" . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("VEGF-Flt-1" . SPARSER::COLLECTION)
    ("PlGF and VEGF" . SPARSER::COLLECTION) ("p38/ERK" . SPARSER::COLLECTION)
    ("PlGF and Flt-1" . SPARSER::COLLECTION)
    ("the Western blot" . SPARSER::PROTEIN)
    ("exogenous PlGF" . SPARSER::PROTEIN)
    ("PlGF, MMP9, and Flt-1" . SPARSER::COLLECTION)
    ("PlGF, Flt-1, and MMP9" . SPARSER::COLLECTION)
    ("PI and annexin V" . SPARSER::COLLECTION)
    ("LoVo-PlGF and its control LoVo-pcDNA" . SPARSER::COLLECTION)
    ("PlGF, LoVo-PlGF and its control LoVo-pcDNA" . SPARSER::COLLECTION)
    ("Flag and PlGF" . SPARSER::COLLECTION) ("transgene" . SPARSER::PROTEIN)
    ("Exogenous PlGF" . SPARSER::PROTEIN) ("p38-MMP9" . SPARSER::COLLECTION)
    ("Flk-1 and Flt-1" . SPARSER::COLLECTION)
    ("Placental growth factor" . SPARSER::GROWTH-FACTOR)
    ("PlGF and its receptor" . SPARSER::COLLECTION)
    ("PlGF/Flt-1" . SPARSER::COLLECTION)
    ("MMP9, and Flt-1" . SPARSER::COLLECTION)
    ("cohorts, PlGF, MMP9, and Flt-1" . SPARSER::COLLECTION)
    ("a dimeric glycoprotein" . SPARSER::PROTEIN) ("PlGF" . SPARSER::PROTEIN)
    ("p38gamma" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("annexin V" . SPARSER::PROTEIN) ("NaHCO3" . SPARSER::DRUG)
    ("p38α" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG) ("Flk-1" . SPARSER::PROTEIN)
    ("Flt-1" . SPARSER::PROTEIN) ("Placenta growth factor" . SPARSER::PROTEIN)
    ("TN" . SPARSER::PROTEIN) ("Bovine serum albumin" . SPARSER::PROTEIN)
    ("-3/ADAM10" . SPARSER::COLLECTION)
    ("Soluble N-cadherin" . SPARSER::PROTEIN)
    ("extracellular proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins and their ectodomain" . SPARSER::COLLECTION)
    ("fragment (CTF)" . SPARSER::FRAGMENT)
    ("which releases soluble active fragments" . SPARSER::FRAGMENT)
    ("CTF" . SPARSER::PROTEIN) ("cadherin-catenin" . SPARSER::COLLECTION)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GC-4" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN)
    ("P-cadherins" . SPARSER::PROTEIN) ("ADAM10" . SPARSER::PROTEIN)
    ("Neural-cadherin" . SPARSER::PROTEIN)
    ("Ron−pEGFR+" . SPARSER::PROTEIN-PAIR)
    ("Erbitux or IMC-41A10" . SPARSER::COLLECTION)
    ("EGFR and vice versa" . SPARSER::COLLECTION)
    ("Mer2, Tie-2, RYK, DDR1 and ROR2" . SPARSER::COLLECTION)
    ("RYK" . SPARSER::PROTEIN) ("Mer" . SPARSER::PROTEIN)
    ("the western blot" . SPARSER::PROTEIN) ("Ron/EGFR" . SPARSER::COLLECTION)
    ("MSP and EGF" . SPARSER::COLLECTION) ("EGF or MSP" . SPARSER::COLLECTION)
    ("EFS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ron or pEGFR" . SPARSER::COLLECTION)
    ("EGFR and Ron" . SPARSER::COLLECTION)
    ("the previously treated patient cohort" . SPARSER::MOLECULE)
    ("previously treated patient cohorts" . SPARSER::MOLECULE)
    ("Ron, EGFR and pEGFR" . SPARSER::COLLECTION)
    ("the mature functional form" . SPARSER::FORM)
    ("mature Ron" . SPARSER::PROTEIN) ("Mat-Ron" . SPARSER::COLLECTION)
    ("Mat" . SPARSER::PROTEIN) ("polypeptide" . SPARSER::PEPTIDE)
    ("the predominant form" . SPARSER::FORM)
    ("functional Ron" . SPARSER::PROTEIN)
    ("Ron, MSP and MT-SP1" . SPARSER::COLLECTION)
    ("multifunctional tyrosine kinase receptors" . SPARSER::RECEPTOR)
    ("HGFL" . SPARSER::PROTEIN)
    ("a heterodimeric glycoprotein" . SPARSER::PROTEIN)
    ("disulphide" . SPARSER::MOLECULE)
    ("erlotinib (Tarceva) and cetuximab (Erbitux)" . SPARSER::COLLECTION)
    ("gefitinib (Iressa), erlotinib (Tarceva) and cetuximab (Erbitux)"
     . SPARSER::COLLECTION)
    ("Tarceva" . SPARSER::DRUG) ("erlotinib" . SPARSER::DRUG)
    ("Iressa" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("TGF- α and EGFR" . SPARSER::COLLECTION)
    ("EGFR and its ligand" . SPARSER::COLLECTION)
    ("EGFR and its ligands" . SPARSER::COLLECTION)
    ("Ron and pEGFR" . SPARSER::COLLECTION)
    ("exclusively mature functional Ron" . SPARSER::PROTEIN)
    ("Biomarker" . SPARSER::MOLECULE) ("Ron and EGFR" . SPARSER::COLLECTION)
    ("snap-frozen" . SPARSER::PROTEIN-PAIR)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ron" . SPARSER::PROTEIN)
    ("DDR1" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("C20" . SPARSER::PROTEIN) ("COS1" . SPARSER::PROTEIN)
    ("MT-SP1" . SPARSER::PROTEIN) ("T 1-2" . SPARSER::PROTEIN)
    ("α- chain" . SPARSER::PROTEIN) ("TGF- α" . SPARSER::PROTEIN)
    ("ATRX or DAXX" . SPARSER::COLLECTION)
    ("ATRX and DAXX" . SPARSER::COLLECTION) ("DAXX" . SPARSER::PROTEIN)
    ("ATRX" . SPARSER::PROTEIN) ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("PTEN or CDKN2A" . SPARSER::COLLECTION)
    ("larger tumour cohorts" . SPARSER::MOLECULE)
    ("matched constitutional DNA" . SPARSER::DNA) ("ETS" . SPARSER::PROTEIN)
    ("BRAF and NRAS" . SPARSER::COLLECTION) ("SF3B1" . SPARSER::PROTEIN)
    ("termed class 1 (good prognosis) or class 2 (poor prognosis)"
     . SPARSER::COLLECTION)
    ("GNAQ or GNA11" . SPARSER::COLLECTION) ("GNAQ" . SPARSER::PROTEIN)
    ("iris" . SPARSER::PROTEIN) ("CDKN2A and PTEN" . SPARSER::COLLECTION)
    ("KIT" . SPARSER::PROTEIN) ("BAP1" . SPARSER::PROTEIN)
    ("SF3" . SPARSER::PROTEIN) ("Class 1" . SPARSER::PROTEIN-FAMILY)
    ("class 2" . SPARSER::PROTEIN) ("class 1" . SPARSER::PROTEIN-FAMILY)
    ("GNA11" . SPARSER::PROTEIN)
    ("a sizable EGFR fraction" . SPARSER::COMPONENT)
    ("a triple mutant" . SPARSER::MUTANT) ("Cbl or Grb2" . SPARSER::COLLECTION)
    ("Eps15/Eps15R" . SPARSER::COLLECTION)
    ("activated tyrosine phosphorylated EGFR" . SPARSER::PROTEIN)
    ("pY1045 and pY1068/1086" . SPARSER::COLLECTION)
    ("pY1068/1086" . SPARSER::PROTEIN)
    ("Src and HECT-family" . SPARSER::COLLECTION) ("HECT" . SPARSER::PROTEIN)
    ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("phosphatases and de-ubiquitinases" . SPARSER::COLLECTION)
    ("ubiquitinases" . SPARSER::UBIQUITINASE)
    ("Cbl/Grb2" . SPARSER::COLLECTION)
    ("properly position Cbl" . SPARSER::PROTEIN)
    ("pY1045 and pY1068/pY1086" . SPARSER::COLLECTION)
    ("pY1045 and pY1068" . SPARSER::COLLECTION) ("pY1045" . SPARSER::PROTEIN)
    ("EGFR-pY1045 and EGFR-pY1068/1086" . SPARSER::COLLECTION)
    ("EGFR-pY1068/1086" . SPARSER::PROTEIN-PAIR)
    ("EGFR-pY1045" . SPARSER::PROTEIN-PAIR)
    ("Cbl-dynamin 2" . SPARSER::COLLECTION)
    ("clathrin or dynamin 2" . SPARSER::COLLECTION)
    ("the residual fraction" . SPARSER::COMPONENT) ("EGFR–" . SPARSER::PROTEIN)
    ("clathrin-KD" . SPARSER::COLLECTION)
    ("dynamin 2-KD" . SPARSER::COLLECTION) ("filipin" . SPARSER::MOLECULE)
    ("Cbl:EGFR" . SPARSER::BIO-COMPLEX) ("Cbl:Grb2" . SPARSER::BIO-COMPLEX)
    ("GST-Cbl" . SPARSER::COLLECTION) ("EGFR:Cbl" . SPARSER::BIO-COMPLEX)
    ("Grb2-KD" . SPARSER::COLLECTION) ("Cbl2" . SPARSER::PROTEIN)
    ("induces—and possibly stabilizes—an open Cbl conformation"
     . SPARSER::BIO-CONFORMATION)
    ("Grb2 or Shc" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("Cbl and EGFR" . SPARSER::COLLECTION)
    ("c-Cbl and Cbl-b" . SPARSER::COLLECTION)
    ("c-Cbl , Cbl-b and Cbl-c" . SPARSER::COLLECTION)
    ("EGFR-Ub" . SPARSER::COLLECTION) ("EGFR-pY" . SPARSER::COLLECTION)
    ("NR6-EGFR" . SPARSER::COLLECTION) ("IB" . SPARSER::DRUG)
    ("NR6" . SPARSER::PROTEIN) ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("morphogens" . SPARSER::PROTEIN) ("NCE" . SPARSER::PROTEIN)
    ("EGFR-NCE" . SPARSER::PROTEIN-PAIR) ("Cbl" . SPARSER::PROTEIN)
    ("PM" . SPARSER::PROTEIN) ("UbcH5c" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("TiO 2" . SPARSER::MOLECULE)
    ("Oligo 2" . SPARSER::PROTEIN) ("clathrin heavy chain" . SPARSER::PROTEIN)
    ("G10" . SPARSER::PROTEIN) ("I-EGF" . SPARSER::PROTEIN)
    ("Epsin1" . SPARSER::PROTEIN) ("Eps15R" . SPARSER::PROTEIN)
    ("Eps15" . SPARSER::PROTEIN) ("β-PIX" . SPARSER::PROTEIN)
    ("Cbl-c" . SPARSER::PROTEIN) ("Cbl-b" . SPARSER::PROTEIN)
    ("dynamin 2" . SPARSER::PROTEIN) ("its receptor" . SPARSER::PROTEIN)
    ("pyrimidone" . SPARSER::MOLECULE)
    ("a replicative polymerase" . SPARSER::PROTEIN)
    ("DNA primase-Pol" . SPARSER::COLLECTION)
    ("processive replicative DNA polymerases" . SPARSER::PROTEIN)
    ("BPDE" . SPARSER::DRUG)
    ("hydroxyurea or aphidicolin" . SPARSER::COLLECTION)
    ("hydroxyurea" . SPARSER::DRUG)
    ("exogenous DNA damage NER" . SPARSER::PROTEIN)
    ("a mild elevated fraction" . SPARSER::COMPONENT)
    ("under-replicated DNA" . SPARSER::DNA) ("KD" . SPARSER::PROTEIN)
    ("XPA" . SPARSER::PROTEIN) ("NER" . SPARSER::PROTEIN)
    ("Complementing" . SPARSER::PROTEIN)
    ("Cdc45 and Pol" . SPARSER::COLLECTION)
    ("Rad6 and Rad18" . SPARSER::COLLECTION) ("Ub-PCNA" . SPARSER::COLLECTION)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("PCNA and Rad9" . SPARSER::COLLECTION)
    ("25–150 nt-long nascent DNAs" . SPARSER::DNA)
    ("ATR/ATM" . SPARSER::COLLECTION) ("caffeine" . SPARSER::MOLECULE)
    ("ATR/Chk1" . SPARSER::COLLECTION)
    ("lesions physically stall replicative DNA polymerases" . SPARSER::PROTEIN)
    ("Aphidicolin" . SPARSER::PROTEIN)
    ("aphidicolin or UV" . SPARSER::COLLECTION)
    ("aphidicolin" . SPARSER::PROTEIN) ("POL" . SPARSER::PROTEIN)
    ("HU" . SPARSER::DRUG) ("a strong inducer" . SPARSER::PROTEIN)
    ("Hydroxyurea" . SPARSER::DRUG)
    ("the replicative polymerases" . SPARSER::PROTEIN)
    ("Rad1 and Hus1" . SPARSER::COLLECTION)
    ("an 870 amino-acid residue Y-family polymerase" . SPARSER::PROTEIN)
    ("pyrene" . SPARSER::PROTEIN)
    ("the E2 ubiquitin-conjugating enzyme Rad6 and the E3 ubiquitin ligase Rad18"
     . SPARSER::COLLECTION)
    ("Claspin" . SPARSER::PROTEIN) ("Rad9 and TopBP1" . SPARSER::COLLECTION)
    ("RFC" . SPARSER::PROTEIN)
    ("its partner ATRIP (ATR Interacting Protein) as well as the heterotrimeric 9-1-1 complex"
     . SPARSER::COLLECTION)
    ("the heterotrimeric 9-1-1 complex" . SPARSER::|9-1-1|)
    ("ATR-ATRIP" . SPARSER::COLLECTION) ("ATRIP" . SPARSER::PROTEIN)
    ("multicomponent protein" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("DNA, and replication" . SPARSER::COLLECTION)
    ("replicative polymerases" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN) ("H3P" . SPARSER::PROTEIN)
    ("ToPro3" . SPARSER::MOLECULE) ("SP2" . SPARSER::PROTEIN)
    ("1−1" . SPARSER::PROTEIN) ("creatine kinase" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("DNA primase" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("Cdc45" . SPARSER::PROTEIN)
    ("Rad 9" . SPARSER::HUMAN-PROTEIN-FAMILY) ("U20" . SPARSER::PROTEIN)
    ("Hus1" . SPARSER::PROTEIN) ("Rad1" . SPARSER::PROTEIN)
    ("Rad18" . SPARSER::PROTEIN) ("Rad6" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("Rad17" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN)
    ("ATR Interacting Protein" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA polymerase kappa" . SPARSER::PROTEIN)
    ("Src, FAK and RhoA" . SPARSER::COLLECTION)
    ("Rac1 and Cdc 42" . SPARSER::COLLECTION)
    ("share structural homology" . SPARSER::PROTEIN)
    ("various fibrous proteins" . SPARSER::PROTEIN)
    ("Src-FAK" . SPARSER::COLLECTION) ("v-src" . SPARSER::COLLECTION)
    ("-AKT" . SPARSER::COLLECTION) ("src" . SPARSER::PROTEIN)
    ("Tpr" . SPARSER::PROTEIN) ("glycosyltransferases" . SPARSER::PROTEIN)
    ("c-Met and MAPK" . SPARSER::COLLECTION)
    ("activated tyrosine kinase receptors and downstream modulators"
     . SPARSER::COLLECTION)
    ("sulfo" . SPARSER::MOLECULE) ("IV and vitronectin" . SPARSER::COLLECTION)
    ("selectin" . SPARSER::PROTEIN-FAMILY) ("Galactose" . SPARSER::MOLECULE)
    ("glycoproteins and glycolipids" . SPARSER::COLLECTION)
    ("sugar" . SPARSER::MOLECULE)
    ("Src or both Src and c-Met" . SPARSER::COLLECTION)
    ("Src and c-Met" . SPARSER::COLLECTION)
    ("Src and both proteins" . SPARSER::COLLECTION)
    ("sialyltransferase IV and SLe x" . SPARSER::COLLECTION)
    ("Rac1, Cdc42 and RhoA" . SPARSER::COLLECTION)
    ("possible downstream modulators" . SPARSER::PROTEIN)
    ("Rac1, Cdc42, and RhoA" . SPARSER::COLLECTION)
    ("Src and FAK" . SPARSER::COLLECTION)
    ("possible downstream effectors" . SPARSER::EFFECTOR)
    ("Src, FAK, STAT3, AKT and ERK" . SPARSER::COLLECTION)
    ("HGFR/c-Met" . SPARSER::COLLECTION) ("HGFR" . SPARSER::PROTEIN)
    ("formalin" . SPARSER::MOLECULE)
    ("fibronectin or vitronectin" . SPARSER::COLLECTION)
    ("vitronectin" . SPARSER::PROTEIN) ("only MST3Gal IV" . SPARSER::PROTEIN)
    ("GAL" . SPARSER::PROTEIN) ("disaccharides" . SPARSER::MOLECULE)
    ("type 1 (Gal β1,3 GlcNAc) or type 2 (Gal β1,4 GlcNAc) disaccharide"
     . SPARSER::COLLECTION)
    ("disaccharide" . SPARSER::MOLECULE)
    ("ST3Gal III, IV and VI" . SPARSER::COLLECTION)
    ("ST6GalNAc" . SPARSER::PROTEIN) ("ST" . SPARSER::PROTEIN)
    ("oligosaccharide" . SPARSER::MOLECULE) ("CMP" . SPARSER::CMP)
    ("monocytes and neutrophils" . SPARSER::COLLECTION)
    ("selectins" . SPARSER::PROTEIN) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("Gal" . SPARSER::PROTEIN)
    ("glycoproteins or glycolipids" . SPARSER::COLLECTION)
    ("glycolipids" . SPARSER::MOLECULE)
    ("Src, FAK and Cdc42, Rac1 and RhoA" . SPARSER::COLLECTION)
    ("c-Met and Src" . SPARSER::COLLECTION)
    ("FAK and Src" . SPARSER::COLLECTION)
    ("Cdc42, Rac1 and RhoA" . SPARSER::COLLECTION)
    ("tyrosine kinase receptors and their downstream molecular targets"
     . SPARSER::COLLECTION)
    ("ST3GAL3 and ST3GAL4" . SPARSER::COLLECTION) ("CAM" . SPARSER::PROTEIN)
    ("Cdc 42" . SPARSER::PROTEIN) ("Rho GTPase" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN)
    ("Sialic acids" . SPARSER::MOLECULE) ("sialic acids" . SPARSER::MOLECULE)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("AE3" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("5–2" . SPARSER::PROTEIN) ("RAC1" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("PHA-665752" . SPARSER::DRUG)
    ("IGF-IR" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("d11" . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("Tie-1" . SPARSER::PROTEIN) ("ROR2" . SPARSER::PROTEIN)
    ("ROR1" . SPARSER::PROTEIN) ("c20" . SPARSER::PROTEIN)
    ("c-Ret" . SPARSER::PROTEIN) ("M-CSFR" . SPARSER::PROTEIN)
    ("c11" . SPARSER::PROTEIN) ("b22" . SPARSER::PROTEIN)
    ("b18" . SPARSER::PROTEIN) ("b17" . SPARSER::PROTEIN)
    ("b15" . SPARSER::PROTEIN) ("VEGFR3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("b14" . SPARSER::PROTEIN) ("b13" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN) ("b12" . SPARSER::PROTEIN)
    ("VEGFR1" . SPARSER::PROTEIN) ("a20" . SPARSER::PROTEIN)
    ("IgG2B" . SPARSER::BIO-COMPLEX) ("IgG2A" . SPARSER::PROTEIN)
    ("a15" . SPARSER::PROTEIN) ("EphB6" . SPARSER::PROTEIN)
    ("a11" . SPARSER::PROTEIN) ("EphB4" . SPARSER::PROTEIN)
    ("EphB2" . SPARSER::PROTEIN) ("EphB1" . SPARSER::PROTEIN)
    ("a3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("type 1" . SPARSER::PROTEIN)
    ("ST3Gal IV" . SPARSER::PROTEIN) ("ST3Gal III" . SPARSER::PROTEIN)
    ("ST3Gal I" . SPARSER::PROTEIN) ("ST6" . SPARSER::PROTEIN)
    ("ST3" . SPARSER::PROTEIN) ("sialic acid" . SPARSER::MOLECULE)
    ("Rac1" . SPARSER::PROTEIN) ("ST3GAL4" . SPARSER::PROTEIN)
    ("ST3GAL3" . SPARSER::PROTEIN) ("eEF1A1-p53" . SPARSER::COLLECTION)
    ("eEF1A1 and the pro-apoptotic p53 family proteins" . SPARSER::COLLECTION)
    ("the pro-apoptotic p53 family proteins" . SPARSER::PROTEIN)
    ("p53 and HDM2" . SPARSER::COLLECTION) ("p73-HDM2" . SPARSER::COLLECTION)
    ("nutlin" . SPARSER::DRUG)
    ("the eukaryotic translation initiation factor eIF4E" . SPARSER::PROTEIN)
    ("Itch" . SPARSER::PROTEIN) ("p53 and eEF1A1" . SPARSER::COLLECTION)
    ("p73 and p53" . SPARSER::COLLECTION) ("inp53" . SPARSER::PROTEIN)
    ("eEF1A1 and p53 or p73" . SPARSER::COLLECTION)
    ("p53, and p73" . SPARSER::COLLECTION)
    ("eEF1A1 and TAp73" . SPARSER::COLLECTION)
    ("eEF1A1 and p53" . SPARSER::COLLECTION)
    ("camptothecin and doxorubicin" . SPARSER::COLLECTION)
    ("etoposide and doxorubicin" . SPARSER::COLLECTION)
    ("camptothecin or cisplatin" . SPARSER::COLLECTION)
    ("GFP or eEF1A2" . SPARSER::COLLECTION)
    ("p53 and 73-induced" . SPARSER::COLLECTION)
    ("p53 or TAp73α" . SPARSER::COLLECTION) ("poly-ADP" . SPARSER::PROTEIN)
    ("p53-, TAp73α-, and chemotherapy-induced apoptosis" . SPARSER::COLLECTION)
    ("p53 and TAp73α" . SPARSER::COLLECTION) ("HA-p53" . SPARSER::COLLECTION)
    ("p73 and eEF1A1" . SPARSER::COLLECTION)
    ("eukaryotic translation elongation factor 1-alpha 1" . SPARSER::PROTEIN)
    ("anti-p73 antibodies or control antibodies" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("p53 and TAp73" . SPARSER::COLLECTION)
    ("p53 or TAp73" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GDP" . SPARSER::NUCLEOTIDE)
    ("KDa" . SPARSER::PROTEIN) ("eEF1A1 and eEF1A2" . SPARSER::COLLECTION)
    ("kinases and ubiquitin" . SPARSER::COLLECTION)
    ("Hipk" . SPARSER::PROTEIN-FAMILY)
    ("ASPPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PML" . SPARSER::PROTEIN)
    ("itch" . SPARSER::PROTEIN) ("abl" . SPARSER::PROTEIN)
    ("p53, p63 or p73" . SPARSER::COLLECTION)
    ("the various pro-apoptotic TA and anti-apoptotic ΔN p53 family isoforms"
     . SPARSER::ISOFORM)
    ("TA and anti-apoptotic" . SPARSER::COLLECTION)
    ("the full-length transactivation competent (TA) isoforms"
     . SPARSER::ISOFORM)
    ("TAp73, TAp63 and p53" . SPARSER::COLLECTION)
    ("tetramers" . SPARSER::TETRAMER) ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("etc" . SPARSER::PROTEIN) ("p63, and p73" . SPARSER::COLLECTION)
    ("TA" . SPARSER::PROTEIN) ("p53 or p73" . SPARSER::COLLECTION)
    ("the eukaryotic translation elongation factor 1-alpha 1"
     . SPARSER::PROTEIN)
    ("p53 and p73" . SPARSER::COLLECTION) ("PTI-1" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DEC1" . SPARSER::PROTEIN)
    ("EEF1A" . SPARSER::PROTEIN) ("PABP1" . SPARSER::PROTEIN)
    ("von Hippel-Lindau" . SPARSER::PROTEIN) ("caspases 3" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN) ("Caspase-3" . SPARSER::PROTEIN)
    ("eEF1" . SPARSER::PROTEIN) ("VP-16" . SPARSER::PROTEIN)
    ("eEF1A" . SPARSER::PROTEIN) ("EEF1A2" . SPARSER::PROTEIN)
    ("eEF1A2" . SPARSER::PROTEIN) ("elongation factor-1" . SPARSER::PROTEIN)
    ("alpha subunit" . SPARSER::PROTEIN) ("Pirh2" . SPARSER::PROTEIN)
    ("TAp63" . SPARSER::PROTEIN) ("eEF1A1" . SPARSER::PROTEIN)
    ("elongation factor 1-alpha 1" . SPARSER::PROTEIN)
    ("DNA-repair" . SPARSER::DNA) ("allelic variants" . SPARSER::VARIANT)
    ("p53 and mitochondria" . SPARSER::COLLECTION)
    ("respiratory complexes" . SPARSER::BIO-COMPLEX) ("ETC" . SPARSER::PROTEIN)
    ("gene or functional complex" . SPARSER::COLLECTION)
    ("tRNA" . SPARSER::PROTEIN)
    ("the various respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("the various different respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("the mitochondrial respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("cytidine" . SPARSER::MOLECULE)
    ("the 329 unique nucleotide" . SPARSER::NUCLEOTIDE)
    ("329 unique nucleotide" . SPARSER::NUCLEOTIDE)
    ("tRNAs" . SPARSER::PROTEIN)
    ("an arginine (R) or proline (P)" . SPARSER::COLLECTION)
    ("functional mitochondria" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("PP" . SPARSER::PROTEIN)
    ("important oncological biomarkers" . SPARSER::MOLECULE)
    ("replication/repair" . SPARSER::PROTEIN) ("complex I" . SPARSER::PROTEIN)
    ("mono-nucleotide" . SPARSER::MOLECULE) ("a 15" . SPARSER::PROTEIN)
    ("mono- nucleotide" . SPARSER::MOLECULE) ("adjuvant" . SPARSER::DRUG)
    ("fungi" . SPARSER::PROTEIN) ("antibiotic" . SPARSER::DRUG)
    ("Antibiotic" . SPARSER::DRUG) ("only 4 CMC" . SPARSER::PROTEIN-FAMILY)
    ("different bacterial 16S genes" . SPARSER::GENE)
    ("formyl peptide receptor and C5a" . SPARSER::COLLECTION)
    ("Stat1 or Stat3" . SPARSER::COLLECTION) ("Stat1" . SPARSER::PROTEIN)
    ("Stat" . SPARSER::PROTEIN) ("TNF or IFNy" . SPARSER::COLLECTION)
    ("COPD" . SPARSER::PROTEIN) ("STAT1/STAT3" . SPARSER::COLLECTION)
    ("TNF and IFNy" . SPARSER::COLLECTION)
    ("TNF, IFNy and IL-22" . SPARSER::COLLECTION)
    ("IL-1β and IL-17" . SPARSER::COLLECTION)
    ("microbial biomarkers" . SPARSER::MOLECULE)
    ("Mediterranean fever (FMF)" . SPARSER::PROTEIN)
    ("IL-17 and IL-22" . SPARSER::COLLECTION)
    ("autoantibodies" . SPARSER::PROTEIN) ("AIRE" . SPARSER::PROTEIN)
    ("especially Acinetobacter spp" . SPARSER::PROTEIN)
    ("spp" . SPARSER::PROTEIN) ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("CMC" . SPARSER::PROTEIN-FAMILY) ("C5a" . SPARSER::PROTEIN)
    ("formyl peptide receptor" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("SCF-1" . SPARSER::PROTEIN) ("TLR5" . SPARSER::PROTEIN)
    ("NOD2" . SPARSER::PROTEIN) ("Mediterranean fever" . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("autoimmune regulator" . SPARSER::PROTEIN)
    ("5A allele and T allele" . SPARSER::COLLECTION)
    ("MMP9, and elastases" . SPARSER::COLLECTION)
    ("elastases" . SPARSER::PROTEIN)
    ("an endothelial vasodilator" . SPARSER::PROTEIN)
    ("vasodilator" . SPARSER::PROTEIN)
    ("MMP3 and rs3918242" . SPARSER::COLLECTION)
    ("MMP3 and the SNP rs3918242" . SPARSER::COLLECTION)
    ("MMP1, MMP9 and TIMP3" . SPARSER::COLLECTION)
    ("TG and LDL" . SPARSER::COLLECTION) ("LDL" . SPARSER::PROTEIN)
    ("TG" . SPARSER::PROTEIN) ("DBP" . SPARSER::PROTEIN)
    ("SBP" . SPARSER::PROTEIN)
    ("MMP-1, MMP-3, MMP-9 and TIMP-3" . SPARSER::COLLECTION)
    ("vivo" . SPARSER::PROTEIN)
    ("endothelium-derived vasoactive mediators" . SPARSER::PROTEIN)
    ("connective tissue proteins" . SPARSER::PROTEIN)
    ("zinc-dependent enzymes" . SPARSER::ENZYME)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("elastin and collagens" . SPARSER::COLLECTION)
    ("elastin" . SPARSER::PROTEIN) ("MMP3 and MMP9" . SPARSER::COLLECTION)
    ("MMP3 and the T allele" . SPARSER::COLLECTION)
    ("endothelin-1 and nitric oxide" . SPARSER::COLLECTION)
    ("aims" . SPARSER::PROTEIN) ("Nitric Oxide" . SPARSER::MOLECULE)
    ("HDL-cholesterol" . SPARSER::MOLECULE) ("ET-1" . SPARSER::PROTEIN)
    ("Nitric oxide" . SPARSER::MOLECULE) ("TIMP-3" . SPARSER::PROTEIN)
    ("MMP-3" . SPARSER::PROTEIN) ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMP3" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("a further five genes" . SPARSER::GENE)
    ("the functionally most significant gene" . SPARSER::GENE)
    ("Both neuronal and vascular tissue types" . TYPE)
    ("the most relevant gene" . SPARSER::GENE)
    ("the mitochondrial ATP synthase" . SPARSER::PROTEIN)
    ("prostaglandin" . SPARSER::PROTEIN) ("UK" . SPARSER::PROTEIN)
    ("cardiovascular traits" . SPARSER::PROTEIN)
    ("the 12 most proximal genes" . SPARSER::GENE)
    ("TGFBR2 and PHACTR1" . SPARSER::COLLECTION)
    ("TGFBR2 and MEF2D" . SPARSER::COLLECTION) ("HG" . SPARSER::MOLECULE)
    ("the most proximal genes" . SPARSER::GENE)
    ("causative minor alleles" . SPARSER::ALLELE)
    ("basal NgR1" . SPARSER::PROTEIN) ("tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("DFFB and TP73" . SPARSER::COLLECTION) ("DFFB" . SPARSER::PROTEIN)
    ("even clinically asymptomatic forms" . SPARSER::FORM)
    ("a hypothetical protein also known as UFL1" . SPARSER::PROTEIN)
    ("CREM and CREB" . SPARSER::COLLECTION) ("CREM" . SPARSER::PROTEIN)
    ("aura" . SPARSER::PROTEIN)
    ("APOA1BP, TBC1D7, FUT9, STAT6, and ATP5B" . SPARSER::COLLECTION)
    ("migraine" . SPARSER::PROTEIN) ("Migraine" . SPARSER::PROTEIN)
    ("DNAse I" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("glial cell line-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("GFRA2" . SPARSER::PROTEIN) ("TGFBR2" . SPARSER::PROTEIN)
    ("Nogo-66 receptor" . SPARSER::PROTEIN) ("NgR1" . SPARSER::PROTEIN)
    ("MT-MMP" . SPARSER::PROTEIN) ("TP73" . SPARSER::PROTEIN)
    ("UFL1" . SPARSER::PROTEIN) ("KIAA0776" . SPARSER::PROTEIN)
    ("PHACTR1" . SPARSER::PROTEIN) ("TRPM8" . SPARSER::PROTEIN)
    ("MEF2D" . SPARSER::PROTEIN) ("PRDM16" . SPARSER::PROTEIN)
    ("LRP1" . SPARSER::PROTEIN) ("ATP5B" . SPARSER::PROTEIN)
    ("TBC1D7" . SPARSER::PROTEIN) ("APOA1BP" . SPARSER::PROTEIN)
    ("MMP16" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("c7orf10" . SPARSER::PROTEIN) ("TSPAN2" . SPARSER::PROTEIN)
    ("p36" . SPARSER::PROTEIN) ("pY580/pY542" . SPARSER::COLLECTION)
    ("receptor-Ras" . SPARSER::COLLECTION)
    ("Ptp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("/C-SH2" . SPARSER::COLLECTION)
    ("pY542 or pY580" . SPARSER::COLLECTION)
    ("pY580 and C-SH2" . SPARSER::COLLECTION)
    ("C-SH2 and undergoes" . SPARSER::COLLECTION)
    ("tyrosines" . SPARSER::AMINO-ACID) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SWAP" . SPARSER::PROTEIN) ("pY580/C-SH2" . SPARSER::COLLECTION)
    ("the otherwise favored pY580" . SPARSER::PROTEIN)
    ("pY542/C-SH2" . SPARSER::COLLECTION) ("pY580" . SPARSER::PROTEIN)
    ("pY542" . SPARSER::PROTEIN) ("C-SH2 and pY542" . SPARSER::COLLECTION)
    ("Grb2-pY580" . SPARSER::COLLECTION) ("pY542-Grb2" . SPARSER::PROTEIN-PAIR)
    ("Tel-PDGFRβ" . SPARSER::COLLECTION) ("Tel" . SPARSER::PROTEIN)
    ("Grb2RV" . SPARSER::PROTEIN) ("RV" . SPARSER::MOLECULE)
    ("C-SH2 and pY580" . SPARSER::COLLECTION) ("YPet" . SPARSER::PROTEIN)
    ("mutant (RDL)" . SPARSER::MUTANT) ("RDL" . SPARSER::PROTEIN)
    ("Shp2-YPet" . SPARSER::COLLECTION)
    ("nonhydrolysable phosphonomethylene phenylalanine" . SPARSER::AMINO-ACID)
    ("protein tyrosine phosphatase (PTP)" . SPARSER::PROTEIN)
    ("fluorescent proteins" . SPARSER::PROTEIN)
    ("such modular proteins" . SPARSER::PROTEIN)
    ("6,8-difluoro-4-methylumbelliferyl phosphate" . SPARSER::DRUG)
    ("P20" . SPARSER::PROTEIN) ("MgCl2" . SPARSER::MOLECULE)
    ("SHP-2" . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("B15" . SPARSER::PROTEIN) ("Src kinase" . SPARSER::PROTEIN)
    ("phosphotyrosine interaction" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("C-SH2" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("traditional therapeutics" . SPARSER::THERAPEUTICS)
    ("a static state" . SPARSER::BIO-STATE)
    ("SMARCA4/BRG1" . SPARSER::COLLECTION)
    ("CCND1 or CDK4/6" . SPARSER::COLLECTION)
    ("the classical components" . SPARSER::COMPONENT)
    ("pRb and p53" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("p53 +/+ and p53 −/− HCT116 cells" . SPARSER::COLLECTION)
    ("RPE" . SPARSER::PROTEIN) ("the mitotic motor Eg5" . SPARSER::PROTEIN)
    ("Eg5" . SPARSER::PROTEIN) ("monastrol" . SPARSER::DRUG)
    ("CDK6 and/or CDK4 (greater than 8 focal gains of the respective gene)"
     . SPARSER::COLLECTION)
    ("pRB or p53" . SPARSER::COLLECTION)
    ("TP53 , RB1 , and p16/" . SPARSER::COLLECTION)
    ("centromeric FISH" . SPARSER::PROTEIN)
    ("either homozygous mutant" . SPARSER::MUTANT)
    ("p53 , RB1 and CDKN2A" . SPARSER::COLLECTION)
    ("/p14 ARF" . SPARSER::COLLECTION) ("p53 and pRB" . SPARSER::COLLECTION)
    ("MDMX" . SPARSER::PROTEIN) ("a mitotic protein" . SPARSER::PROTEIN)
    ("pRB and p53" . SPARSER::COLLECTION) ("FISH" . SPARSER::PROTEIN)
    ("pRB" . SPARSER::PROTEIN) ("Ndc80" . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("alpha-tubulin" . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN) ("SMARCA4" . SPARSER::PROTEIN)
    ("CDK4/6" . SPARSER::PROTEIN) ("p14Arf" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("p16 INK4A" . SPARSER::PROTEIN)
    ("ribonuclease" . SPARSER::PROTEIN)
    ("the Fab fragments" . SPARSER::FRAGMENT)
    ("EgA1/9G8:EGFR" . SPARSER::BIO-COMPLEX) ("lysozyme" . SPARSER::PROTEIN)
    ("an Fab fragment" . SPARSER::FRAGMENT)
    ("accessible conformations" . SPARSER::BIO-CONFORMATION)
    ("the entire Fab fragment" . SPARSER::FRAGMENT)
    ("a heavy chain only camelid antibody" . SPARSER::ANTIBODY)
    ("cetuximab and matuzumab" . SPARSER::COLLECTION)
    ("antigen" . SPARSER::PROTEIN)
    ("conventional monoclonal antibodies" . SPARSER::ANTIBODY)
    ("antigens" . SPARSER::PROTEIN)
    ("a ligand-competitive inhibitor" . SPARSER::INHIBITOR)
    ("Matuzumab" . SPARSER::DRUG)
    ("EgA1, 9G8, and matuzumab" . SPARSER::COLLECTION)
    ("the VHH:FabC225:sEGFR ternary complex" . SPARSER::BIO-COMPLEX)
    ("antibody:antigen" . SPARSER::PROTEIN-PAIR)
    ("EgA1 and N100b" . SPARSER::COLLECTION)
    ("the first 4 amino acids of mature sEGFR (LEEK)" . SPARSER::PROTEIN)
    ("mature sEGFR (LEEK)" . SPARSER::PROTEIN)
    ("EgA1 and E100i" . SPARSER::COLLECTION)
    ("two arginines of EGFR (R403 and 405)" . SPARSER::PROTEIN)
    ("YY" . SPARSER::MOLECULE) ("Parts" . SPARSER::COMPONENT)
    ("EgA1/9G8" . SPARSER::COLLECTION)
    ("the FabC225:sEGFR and free EgA1" . SPARSER::COLLECTION)
    ("a 9G8:FabC225:sEGFR ternary complex" . SPARSER::BIO-COMPLEX)
    ("9G8:FabC225:sEGFR" . SPARSER::BIO-COMPLEX)
    ("FabC225:sEGFR" . SPARSER::PROTEIN)
    ("the Fab fragment" . SPARSER::FRAGMENT)
    ("the EgA1:FabC225:sEGFR ternary complex" . SPARSER::BIO-COMPLEX)
    ("EgA1:FabC225:sEGFR" . SPARSER::PROTEIN-PAIR)
    ("EgA1 and sEGFR" . SPARSER::COLLECTION) ("EgA1:sEGFR" . SPARSER::PROTEIN)
    ("EgA1 and 9G8" . SPARSER::COLLECTION)
    ("Site 2, and cetuximab" . SPARSER::COLLECTION)
    ("7D12 and cetuximab" . SPARSER::COLLECTION) ("van" . SPARSER::PROTEIN)
    ("EGF, cetuximab, and 7D12" . SPARSER::COLLECTION)
    ("GlcNac" . SPARSER::PROTEIN-FAMILY) ("CDR" . SPARSER::PROTEIN)
    ("MR" . SPARSER::PROTEIN) ("sEGFRd3" . SPARSER::PROTEIN)
    ("7D12:sEGFRd3" . SPARSER::PROTEIN-PAIR)
    ("the biparatopic inhibitor" . SPARSER::INHIBITOR)
    ("EgA1 and 7D12" . SPARSER::COLLECTION)
    ("7D12-EgA1:sEGFR" . SPARSER::PROTEIN-PAIR)
    ("7D12-EgA1" . SPARSER::COLLECTION)
    ("glycine/serine" . SPARSER::COLLECTION) ("glycine" . SPARSER::AMINO-ACID)
    ("7D12" . SPARSER::PROTEIN) ("EgA1" . SPARSER::PROTEIN)
    ("a ternary EgA1:7D12:sEGFR complex" . SPARSER::BIO-COMPLEX)
    ("EgA1:7D12:sEGFR" . SPARSER::COLLECTION)
    ("a trimolecular complex" . SPARSER::BIO-COMPLEX)
    ("SV" . SPARSER::MOLECULE) ("9G8 and EgA1" . SPARSER::COLLECTION)
    ("mAb" . SPARSER::DRUG) ("Antibody" . SPARSER::PROTEIN)
    ("the matuzumab Fab fragment" . SPARSER::FRAGMENT)
    ("the structurally characterized Fab fragments" . SPARSER::FRAGMENT)
    ("streptavidin" . SPARSER::PROTEIN)
    ("the mature protein" . SPARSER::PROTEIN) ("sEGFR" . SPARSER::PROTEIN)
    ("SPR" . SPARSER::PROTEIN)
    ("mouse monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Cetuximab and necitumumab" . SPARSER::COLLECTION)
    ("cetuximab and necitumumab" . SPARSER::COLLECTION)
    ("Fab fragments" . SPARSER::FRAGMENT)
    ("cetuximab, necitumumab and matuzumab" . SPARSER::COLLECTION)
    ("matuzumab" . SPARSER::DRUG) ("necitumumab" . SPARSER::DRUG)
    ("potent multivalent VHH molecules" . SPARSER::MOLECULE)
    ("Ig" . SPARSER::MOLECULE) ("HCAbs" . SPARSER::BIO-COMPLEX)
    ("new or modified mAbs" . SPARSER::DRUG) ("mAbs" . SPARSER::DRUG)
    ("EGFR and other targets" . SPARSER::COLLECTION)
    ("Erbitux" . SPARSER::DRUG)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCP4" . SPARSER::PROTEIN) ("CH2" . SPARSER::MOLECULE)
    ("aa 1" . SPARSER::PROTEIN) ("glutamic acids" . SPARSER::AMINO-ACID)
    ("Site 2" . SPARSER::PROTEIN) ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("ID 3" . SPARSER::PROTEIN) ("pH 3" . SPARSER::MOLECULE)
    ("heavy chain" . SPARSER::PROTEIN) ("9G8" . SPARSER::PROTEIN)
    ("complexes and offers" . SPARSER::COLLECTION)
    ("completely around HDAC1" . SPARSER::PROTEIN)
    ("the receptor and a phosphate group" . SPARSER::COLLECTION)
    ("both biologically relevant signaling molecules" . SPARSER::MOLECULE)
    ("Ins(1,4,5,6)P 4 and Ins(1,4,5)P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P 4 and Ins" . SPARSER::COLLECTION)
    ("a physiologically relevant regulator" . SPARSER::REGULATOR)
    ("HDAC3 and HDAC1" . SPARSER::COLLECTION)
    ("the ubiquitous Sin3A:HDAC1 complex" . SPARSER::BIO-COMPLEX)
    ("Sin3A:HDAC1" . SPARSER::BIO-COMPLEX)
    ("HDAC3:SMRT and HDAC1:MTA1" . SPARSER::COLLECTION)
    ("the demethylase and deacetylase enzymes" . SPARSER::COLLECTION)
    ("HDAC1:ELM2-SANT" . SPARSER::BIO-COMPLEX)
    ("LSD1:RCOR" . SPARSER::BIO-COMPLEX)
    ("a 70-amino-acid linker" . SPARSER::LINKER)
    ("demethylase" . SPARSER::PROTEIN)
    ("RCOR1, RCOR2, and RCOR3" . SPARSER::COLLECTION)
    ("RCOR" . SPARSER::PROTEIN)
    ("nucleosomes and histone" . SPARSER::COLLECTION)
    ("bromo" . SPARSER::MOLECULE) ("RERE" . SPARSER::PROTEIN)
    ("HDAC1 and/or HDAC2 ( xref ; xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("at least 13 human corepressor proteins" . SPARSER::PROTEIN)
    ("both the carboxy- and amino-terminal" . SPARSER::COLLECTION)
    ("carboxy-" . SPARSER::MOLECULE) ("MTA1 and SMRT" . SPARSER::COLLECTION)
    ("SMRT and NCoR" . SPARSER::COLLECTION)
    ("HDAC1 or HDAC2" . SPARSER::COLLECTION) ("homodimer" . SPARSER::HOMODIMER)
    ("the extensive solvent" . SPARSER::MOLECULE)
    ("the related ELM2-SANT-containing corepressor protein MIER1"
     . SPARSER::PROTEIN)
    ("Da" . SPARSER::MOLECULE) ("HDAC1 or MTA1" . SPARSER::COLLECTION)
    ("HDAC3 and SMRT" . SPARSER::COLLECTION)
    ("exogenous Ins(1,4,5,6)P 4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MTA1 and HDAC1" . SPARSER::COLLECTION)
    ("complex " . SPARSER::BIO-COMPLEX)
    ("HDAC1:MTA1-SANT" . SPARSER::BIO-COMPLEX)
    ("Complexes" . SPARSER::BIO-COMPLEX) ("Inositol" . SPARSER::PROTEIN)
    ("ELM2 and SANT" . SPARSER::COLLECTION) ("ELM2" . SPARSER::PROTEIN)
    ("HDAC3:SMRT" . SPARSER::BIO-COMPLEX) ("ELM2-SANT" . SPARSER::COLLECTION)
    ("HDAC1:MTA1" . SPARSER::BIO-COMPLEX) ("Complex" . SPARSER::BIO-COMPLEX)
    ("present nucleosomal substrates" . SPARSER::SUBSTRATE)
    ("MTA1-SANT" . SPARSER::COLLECTION)
    ("HDAC1 and metastasis-associated protein 1 (MTA1)" . SPARSER::COLLECTION)
    ("metastasis-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("corepressors" . SPARSER::PROTEIN) ("SANT" . SPARSER::PROTEIN)
    ("SMRT-SANT" . SPARSER::COLLECTION) ("myo" . SPARSER::PROTEIN)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("SMRT/NCoR" . SPARSER::COLLECTION) ("CoREST" . SPARSER::PROTEIN)
    ("NCoR" . SPARSER::PROTEIN) ("acetyl" . SPARSER::MOLECULE)
    ("acetylase and deacetylase enzymes" . SPARSER::COLLECTION)
    ("acetylase" . SPARSER::PROTEIN) ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("MTA1 wrap completely around HDAC1" . SPARSER::PROTEIN)
    ("a structural cofactor" . SPARSER::MOLECULE) ("Ins" . SPARSER::PROTEIN)
    ("inositol" . SPARSER::PROTEIN) ("SMRT" . SPARSER::PROTEIN)
    ("HDAC1, HDAC2, and HDAC3" . SPARSER::COLLECTION)
    ("deacetylases" . SPARSER::PROTEIN) ("LSD1" . SPARSER::PROTEIN)
    ("RCOR3" . SPARSER::PROTEIN) ("RCOR1" . SPARSER::PROTEIN)
    ("SIR3" . SPARSER::MOLECULE) ("MIER1" . SPARSER::PROTEIN)
    ("A–4" . SPARSER::PROTEIN) ("A–1" . SPARSER::PROTEIN)
    ("Sin3A" . SPARSER::PROTEIN) ("MTA1" . SPARSER::PROTEIN)
    ("P 4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC3" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("Mad2-BubR1-Bub3-Cdc20" . SPARSER::COLLECTION)
    ("Mad2 and/or BubR1" . SPARSER::COLLECTION)
    ("BubR1 and/or Mad2 ( xref )" . SPARSER::COLLECTION)
    ("further open Mad2 molecule" . SPARSER::MOLECULE)
    ("Cdc20-" . SPARSER::PROTEIN) ("Cdc20-Mad2" . SPARSER::COLLECTION)
    ("a functional mitotic checkpoint inhibitor" . SPARSER::INHIBITOR)
    ("the true mitotic checkpoint-derived inhibitor" . SPARSER::INHIBITOR)
    ("BubR1-Bub3-Cdc20" . SPARSER::COLLECTION)
    ("-BubR1-Bub3" . SPARSER::COLLECTION)
    ("the BubR1-Cdc20 mitotic checkpoint inhibitor" . SPARSER::INHIBITOR)
    ("-BubR1" . SPARSER::COLLECTION) ("-Mad2" . SPARSER::COLLECTION)
    ("GST-Cdc20" . SPARSER::COLLECTION)
    ("BubR1 and Cdc20" . SPARSER::COLLECTION)
    ("mitotic checkpoint inhibitor" . SPARSER::INHIBITOR)
    ("Nocodazole" . SPARSER::DRUG) ("Cdc20 or BubR1" . SPARSER::COLLECTION)
    ("APC/C" . SPARSER::PROTEIN) ("BubR1-APC/C" . SPARSER::PROTEIN-PAIR)
    ("Mad2 or BubR1" . SPARSER::COLLECTION)
    ("the Cdc20-associated checkpoint inhibitor" . SPARSER::INHIBITOR)
    ("appropriate siRNAs" . SPARSER::PROTEIN)
    ("Mad2-AID-YFP" . SPARSER::COLLECTION)
    ("GFP-AID-BubR1" . SPARSER::COLLECTION)
    ("BubR1 or Mad2" . SPARSER::COLLECTION)
    ("doxycycline-inducible and RNAi-resistant GFP-AID-tagged BubR1 or AID-YFP-tagged Mad2"
     . SPARSER::PROTEIN)
    ("BubR1 or AID-YFP-tagged" . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN) ("AID" . SPARSER::PROTEIN)
    ("auxin" . SPARSER::MOLECULE) ("BubR1 and Mad2" . SPARSER::COLLECTION)
    ("Cdc20 and Mad3" . SPARSER::COLLECTION)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the sequence-specific HRV 3C (human rhinovirus 3C) protease"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-Cdc20" . SPARSER::COLLECTION)
    ("the checkpoint-produced inhibitor" . SPARSER::INHIBITOR)
    ("substoichiometric Mad2" . SPARSER::PROTEIN)
    ("Mad1-Mad2" . SPARSER::COLLECTION)
    ("Mad2 and BubR1" . SPARSER::COLLECTION)
    ("BubR1 N -Bub3 almost completely inhibited already active APC/C Cdc20"
     . SPARSER::PROTEIN)
    ("Bub3 and a BubR1 variant containing only BubR1’s" . SPARSER::COLLECTION)
    ("Bub3 and a BubR1 variant" . SPARSER::COLLECTION)
    ("Bub3-BubR1" . SPARSER::COLLECTION) ("-Bub3" . SPARSER::COLLECTION)
    ("Bub3 and full length BubR1 (hereafter BubR1 FL )" . SPARSER::COLLECTION)
    ("UbcH10, and ubiquitin" . SPARSER::COLLECTION)
    ("a mitotic checkpoint inhibitor" . SPARSER::INHIBITOR)
    ("BubR1 and BubR1" . SPARSER::COLLECTION)
    ("Mad3-homology" . SPARSER::COLLECTION) ("The BubR1" . SPARSER::PROTEIN)
    ("full-length BubR1 (BubR1 1-1050 ) or a variant (BubR1 1-363 )"
     . SPARSER::COLLECTION)
    ("MycGFP-BubR1" . SPARSER::COLLECTION)
    ("the functional mitotic checkpoint-derived inhibitor"
     . SPARSER::INHIBITOR)
    ("Mad3/BubR1" . SPARSER::COLLECTION) ("KEN" . SPARSER::PROTEIN)
    ("Mad2 of Cdc20’s" . SPARSER::PROTEIN)
    ("Mad2 and Mad3" . SPARSER::COLLECTION)
    ("Mad3 and Cdc20" . SPARSER::COLLECTION)
    ("BubR1, Bub3, and Mad2" . SPARSER::COLLECTION)
    ("the mitotic checkpoint inhibitor" . SPARSER::INHIBITOR)
    ("a diffusible Cdc20 inhibitor" . SPARSER::INHIBITOR)
    ("a stably-bound Mad1/Mad2 complex" . SPARSER::BIO-COMPLEX)
    ("Mad1/Mad2" . SPARSER::COLLECTION) ("Cdc20 or Mad1" . SPARSER::COLLECTION)
    ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an essential mitotic checkpoint protein" . SPARSER::PROTEIN)
    ("yeast), and Mps1" . SPARSER::COLLECTION)
    ("the checkpoint-derived inhibitor" . SPARSER::INHIBITOR)
    ("anaphase-promoting complex or cyclosome" . SPARSER::COLLECTION)
    ("Mad2-Cdc20" . SPARSER::COLLECTION) ("BubR1-Cdc20" . SPARSER::COLLECTION)
    ("the mitotic activator" . SPARSER::ACTIVATOR)
    ("a diffusible anaphase inhibitor" . SPARSER::INHIBITOR)
    ("α-Tubulin" . SPARSER::PROTEIN) ("BB3" . SPARSER::PROTEIN)
    ("cyclin B 1" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("TIR1" . SPARSER::PROTEIN) ("H2B" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("C-6" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("p31 comet" . SPARSER::PROTEIN-FAMILY)
    ("34 kD" . SPARSER::PROTEIN) ("yeast homolog" . SPARSER::PROTEIN)
    ("15 kD" . SPARSER::PROTEIN) ("L13A" . SPARSER::PROTEIN)
    ("UbcH10" . SPARSER::PROTEIN) ("Cdc27" . SPARSER::PROTEIN)
    ("mitotic checkpoint protein" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("Bub1" . SPARSER::PROTEIN)
    ("Mad3" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("a theoretical PSF" . SPARSER::PROTEIN) ("PSF" . SPARSER::PROTEIN)
    ("Puncta" . SPARSER::PROTEIN) ("postsynaptic proteins" . SPARSER::PROTEIN)
    ("MBF" . SPARSER::BIO-COMPLEX) ("Light" . SPARSER::PROTEIN)
    ("at least 35 9.3 µm 2" . SPARSER::MOLECULE) ("osmium" . SPARSER::MOLECULE)
    ("glutaraldehyde" . SPARSER::MOLECULE) ("Electron" . SPARSER::MOLECULE)
    ("EPSC" . SPARSER::PROTEIN) ("PPR" . SPARSER::PROTEIN-FAMILY)
    ("CA3/CA1" . SPARSER::COLLECTION) ("FHC" . SPARSER::PROTEIN)
    ("an internal solution" . SPARSER::MOLECULE)
    ("phosphocreatine" . SPARSER::MOLECULE) ("glucose" . SPARSER::PROTEIN)
    ("ACSF" . SPARSER::PROTEIN) ("The internal solution" . SPARSER::MOLECULE)
    ("Phosphocreatine" . SPARSER::MOLECULE)
    ("25 mM Sucrose and 5 mM HEPES" . SPARSER::COLLECTION)
    ("1 mM MgCl 2 , 5 mM Glucose, 25 mM Sucrose and 5 mM HEPES"
     . SPARSER::COLLECTION)
    ("HEPES" . SPARSER::MOLECULE) ("Sucrose" . SPARSER::MOLECULE)
    ("Glucose" . SPARSER::PROTEIN) ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("a dual human synapsin promoter" . SPARSER::PROMOTER)
    ("GFP and hSYD1A" . SPARSER::COLLECTION) ("synapsin" . SPARSER::PROTEIN)
    ("paraformaldehyde" . SPARSER::DRUG) ("sucrose" . SPARSER::MOLECULE)
    ("PFA" . SPARSER::MOLECULE) ("Soluble proteins" . SPARSER::PROTEIN)
    ("Secondary antibodies" . SPARSER::ANTIBODY)
    ("cyanine" . SPARSER::MOLECULE) ("mouse anti-NeuN" . SPARSER::ANTIBODY)
    ("rabbit anti-calbindin" . SPARSER::ANTIBODY)
    ("rabbit anti-c-myc" . SPARSER::ANTIBODY)
    ("rat anti-HA" . SPARSER::ANTIBODY)
    ("mouse anti-beta-tubulin" . SPARSER::ANTIBODY)
    ("rabbit anti-munc18-1" . SPARSER::ANTIBODY)
    ("rabbit anti-munc13-1" . SPARSER::ANTIBODY)
    ("mouse anti-CASK" . SPARSER::ANTIBODY)
    ("rabbit anti-GAPDH" . SPARSER::ANTIBODY)
    ("mouse anti-VAMP2" . SPARSER::ANTIBODY)
    ("mouse anti-PSD95" . SPARSER::ANTIBODY)
    ("goat anti-cyclinA" . SPARSER::ANTIBODY)
    ("mouse anti-actin" . SPARSER::ANTIBODY) ("MAB" . SPARSER::DRUG)
    ("NeuN" . SPARSER::PROTEIN) ("CB" . SPARSER::PROTEIN)
    ("calbindin" . SPARSER::PROTEIN) ("flag" . SPARSER::PROTEIN-FAMILY)
    ("cyclinA" . SPARSER::PROTEIN) ("goat" . SPARSER::PROTEIN)
    ("peptide (MAEPLLRKTFSRLRGREK)" . SPARSER::PEPTIDE)
    ("synaptogenic cell surface receptors" . SPARSER::RECEPTOR)
    ("eleven major synaptic proteins" . SPARSER::PROTEIN)
    ("conformations" . SPARSER::BIO-CONFORMATION) ("mSYD1A" . SPARSER::PROTEIN)
    ("GAPs and GEFs" . SPARSER::COLLECTION) ("GEFs" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("presynaptic regulator" . SPARSER::REGULATOR)
    ("liprin-mSYD1A" . SPARSER::PROTEIN-PAIR) ("Liprin" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("hippocampal area CA1" . SPARSER::PROTEIN)
    ("CA1" . SPARSER::PROTEIN) ("NGL-3/LAR" . SPARSER::COLLECTION)
    ("the synaptogenic adhesion molecule neuroligin-1" . SPARSER::PROTEIN)
    ("vGluT1 and bassoon puncta" . SPARSER::COLLECTION)
    ("presynaptic LAR" . SPARSER::PROTEIN)
    ("macroscopic complexes" . SPARSER::BIO-COMPLEX)
    ("LAR, liprin-α2, and mSYD1A" . SPARSER::COLLECTION)
    ("liprins" . SPARSER::PROTEIN) ("LAR" . SPARSER::PROTEIN)
    ("at least three different ligands" . SPARSER::LIGAND)
    ("liprin/SYD-2" . SPARSER::COLLECTION) ("SAM" . SPARSER::MOLECULE)
    ("the synaptic vesicle marker vGluT1" . SPARSER::PROTEIN)
    ("the postsynaptic marker PSD95" . SPARSER::PROTEIN)
    ("synaptophysin and PSD95" . SPARSER::COLLECTION)
    ("subdomains" . SPARSER::PROTEIN) ("IDD and GAP" . SPARSER::COLLECTION)
    ("myr" . SPARSER::MOLECULE) ("a functional Rho-GAP" . SPARSER::PROTEIN)
    ("elegans and Drosophila" . SPARSER::COLLECTION)
    ("Lin-2/CASK" . SPARSER::COLLECTION)
    ("postsynaptic scaffolding proteins" . SPARSER::PROTEIN)
    ("homer" . SPARSER::PROTEIN-FAMILY)
    ("synaptophysin-mCherry-positive puncta" . SPARSER::PROTEIN)
    ("puncta" . SPARSER::PROTEIN) ("MIA" . SPARSER::PROTEIN)
    ("synaptophysin-mCherry" . SPARSER::COLLECTION)
    ("synaptic markers vGluT1 and PSD95" . SPARSER::COLLECTION)
    ("vGluT1 and PSD95" . SPARSER::COLLECTION) ("vGluT1" . SPARSER::PROTEIN)
    ("punctate" . SPARSER::PROTEIN)
    ("the Triton X-100 soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("the crude purified synaptosomal fractions" . SPARSER::COMPONENT)
    ("IDD" . SPARSER::PROTEIN) ("Globular proteins" . SPARSER::PROTEIN)
    ("syde2" . SPARSER::PROTEIN) ("/NP" . SPARSER::COLLECTION)
    ("syde1" . SPARSER::PROTEIN) ("NP" . SPARSER::PROTEIN)
    ("several presynaptic proteins" . SPARSER::PROTEIN)
    ("neurexin" . SPARSER::PROTEIN) ("SYG-1 and PTP-3" . SPARSER::COLLECTION)
    ("SYD-2, ELKS-1 and MIG-10/lamellopodin" . SPARSER::COLLECTION)
    ("PTP" . SPARSER::PROTEIN) ("SYD" . SPARSER::PROTEIN)
    ("syd" . SPARSER::HUMAN-PROTEIN-FAMILY) ("elegans" . SPARSER::PROTEIN)
    ("RIM and CAPS proteins" . SPARSER::COLLECTION)
    ("munc18, munc13, RIM and CAPS proteins" . SPARSER::COLLECTION)
    ("RIM" . SPARSER::PROTEIN) ("nsec1/munc18-1" . SPARSER::COLLECTION)
    ("liprin" . SPARSER::PROTEIN)
    ("a complex with presynaptic receptor tyrosine phosphatases and controls tethering"
     . SPARSER::COLLECTION)
    ("presynaptic receptor tyrosine phosphatases" . SPARSER::PHOSPHATASE)
    ("phosphatases" . SPARSER::PHOSPHATASE) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("LSM5" . SPARSER::PROTEIN) ("K 4" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("P11" . SPARSER::PROTEIN) ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-myc" . SPARSER::PROTEIN) ("beta-tubulin" . SPARSER::PROTEIN)
    ("vesicular glutamate transporter 1" . SPARSER::PROTEIN)
    ("VAMP2" . SPARSER::PROTEIN) ("mint1" . SPARSER::PROTEIN)
    ("syntenin-1" . SPARSER::PROTEIN) ("GRIP1" . SPARSER::PROTEIN)
    ("RIM1" . SPARSER::PROTEIN) ("caskin1" . SPARSER::PROTEIN)
    ("neuroligin-1" . SPARSER::PROTEIN) ("NGL-3" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("Mint1" . SPARSER::PROTEIN) ("X11α" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("Lin-2" . SPARSER::PROTEIN)
    ("p50rhoGAP" . SPARSER::PROTEIN) ("munc13-1" . SPARSER::PROTEIN)
    ("SYD1" . SPARSER::PROTEIN) ("1B" . SPARSER::PROTEIN)
    ("Rho-GAP" . SPARSER::PROTEIN) ("MIG-10" . SPARSER::PROTEIN)
    ("SYD-2" . SPARSER::PROTEIN) ("SYG-1" . SPARSER::PROTEIN)
    ("beta-PIX" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("munc13" . SPARSER::PROTEIN) ("munc18" . SPARSER::PROTEIN)
    ("munc18-1" . SPARSER::PROTEIN) ("nsec1" . SPARSER::PROTEIN)
    ("ETP" . SPARSER::PROTEIN)
    ("BCR-ABL-driven chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("protein and FBXW7" . SPARSER::COLLECTION)
    ("c-Myc and Notch1" . SPARSER::COLLECTION)
    ("FBXW7:MYC" . SPARSER::BIO-COMPLEX) ("Brd2" . SPARSER::PROTEIN)
    ("enhancers" . SPARSER::PROTEIN) ("Notch1 and Rbpj" . SPARSER::COLLECTION)
    ("Wang" . SPARSER::PROTEIN) ("Rbpj" . SPARSER::PROTEIN)
    ("Max" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("either Fbxw7  +/+ or Fbxw7  mut/+" . SPARSER::COLLECTION)
    ("CPI" . SPARSER::PROTEIN) ("inhibitors (GSI)" . SPARSER::INHIBITOR)
    ("GSI" . SPARSER::PROTEIN) ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("Myc and Brd4" . SPARSER::COLLECTION)
    ("specifically target BRD4" . SPARSER::PROTEIN)
    ("bromodomain" . SPARSER::PROTEIN) ("Cd4" . SPARSER::PROTEIN)
    ("Il7r" . SPARSER::PROTEIN) ("Fas" . SPARSER::PROTEIN)
    ("Pa2g4" . SPARSER::PROTEIN) ("Bcat1" . SPARSER::PROTEIN)
    ("Chek1" . SPARSER::PROTEIN) ("Ccnb1" . SPARSER::PROTEIN)
    ("NOTCH1 and FBXW7" . SPARSER::COLLECTION) ("TCRb" . SPARSER::PROTEIN)
    ("mCherry" . SPARSER::PROTEIN) ("MUT:WT dimers" . SPARSER::DIMER)
    (":Fbxw7" . SPARSER::BIO-COMPLEX) ("SCF-Fbxw7" . SPARSER::COLLECTION)
    ("Notch1 and Srebp1" . SPARSER::COLLECTION)
    ("Notch1 T-ALL cells ex vivo" . SPARSER::PROTEIN)
    ("a retroviral shRNA" . SPARSER::PROTEIN) ("Tcra" . SPARSER::PROTEIN)
    ("Several Fbxw7 mutant or wild type leukemias" . SPARSER::COLLECTION)
    ("CGH" . SPARSER::PROTEIN)
    ("eventually developed leukemia" . SPARSER::PROTEIN)
    ("Notch1-" . SPARSER::PROTEIN) ("more prominent Ki67" . SPARSER::PROTEIN)
    ("HD" . SPARSER::PROTEIN) ("EIIa-Cre" . SPARSER::COLLECTION)
    ("aggressive leukemia" . SPARSER::PROTEIN)
    ("FBXW7 and NOTCH1" . SPARSER::COLLECTION)
    ("c-Myc:GFP" . SPARSER::BIO-COMPLEX) ("Fbxw7-" . SPARSER::PROTEIN)
    ("/Fbxw7" . SPARSER::COLLECTION) ("Skp1 and Cul1" . SPARSER::COLLECTION)
    ("Eef1a1" . SPARSER::PROTEIN) ("Neo" . SPARSER::PROTEIN)
    ("lox-STOP-lox" . SPARSER::COLLECTION)
    ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cre-lox" . SPARSER::COLLECTION)
    ("lox" . SPARSER::PROTEIN) ("c-Myc and Brd4" . SPARSER::COLLECTION)
    ("Notch1 and Myc" . SPARSER::COLLECTION) ("BET" . SPARSER::PROTEIN)
    ("fluorescent c-Myc fusion proteins" . SPARSER::PROTEIN)
    ("NOTCH1 or FBXW7" . SPARSER::COLLECTION)
    ("arginine" . SPARSER::AMINO-ACID)
    ("pediatric T cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Cyclin E, Notch1, c-Myc and Mcl1" . SPARSER::COLLECTION)
    ("regulatable Fbxw7 mutant alleles" . SPARSER::ALLELE)
    ("e-5" . SPARSER::PROTEIN) ("MACS1" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("gamma-secretase" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("BRD4" . SPARSER::PROTEIN) ("pI-pC" . SPARSER::PROTEIN)
    ("IL-7R" . SPARSER::PROTEIN) ("Slamf1" . SPARSER::PROTEIN)
    ("Suv39h" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("IL-7Rα" . SPARSER::PROTEIN) ("CD −" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("Srebp1" . SPARSER::PROTEIN)
    ("Fbxw 7" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("Eef1" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN)
    ("Brd4" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("Fbxw7" . SPARSER::PROTEIN)
    ("Scrib, Magi-1, Pard3, and ZO-3" . SPARSER::COLLECTION)
    ("tight junction-associated PDZ proteins" . SPARSER::PROTEIN)
    ("claudin and junctional adhesion molecule (JAM) ( xref )"
     . SPARSER::COLLECTION)
    ("junctional adhesion molecule (JAM)" . SPARSER::PROTEIN)
    ("several essential tight junction proteins" . SPARSER::PROTEIN)
    ("a multivalent scaffold" . SPARSER::SCAFFOLD) ("Mupp1" . SPARSER::PROTEIN)
    ("claudin" . SPARSER::PROTEIN)
    ("MUPP1, Pard3, Scrib, Magi-1, Magi-3, ZO-3, and ZO-1"
     . SPARSER::COLLECTION)
    ("Dvl-1, Dvl-3, and TIP-1" . SPARSER::COLLECTION)
    ("Magi-1 and Scrib" . SPARSER::COLLECTION)
    ("Magi-1, Magi-2, Magi-3, and Scrib" . SPARSER::COLLECTION)
    ("Magi-3" . SPARSER::PROTEIN) ("Magi-2" . SPARSER::PROTEIN)
    ("PSD95 and Tiam2" . SPARSER::COLLECTION)
    ("Lin7 and Src" . SPARSER::COLLECTION)
    ("β-catenin and tight junction-associated proteins" . SPARSER::COLLECTION)
    ("Fibrinogen" . SPARSER::PROTEIN) ("mut" . SPARSER::PROTEIN)
    ("β-catenin and TJ-associated PDZ proteins" . SPARSER::COLLECTION)
    ("TJ-associated PDZ proteins" . SPARSER::PROTEIN)
    ("-GWFDTDL-CO 2" . SPARSER::COLLECTION)
    ("Pard3, Scrib, and ZO-3" . SPARSER::COLLECTION)
    ("Magi-1, Pard3, Scrib, and ZO-3" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("Fibronectin or Laminin" . SPARSER::COLLECTION)
    ("Laminin" . SPARSER::PROTEIN)
    ("Fibronectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Collagen" . SPARSER::PROTEIN)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("protein–β-catenin" . SPARSER::COLLECTION)
    ("occludin or Scrib" . SPARSER::COLLECTION)
    ("proteins and β-catenin" . SPARSER::COLLECTION)
    ("occludin" . SPARSER::PROTEIN) ("Occludin" . SPARSER::PROTEIN)
    ("Scrib and Pard3" . SPARSER::COLLECTION)
    ("all four tight junction-associated PDZ proteins" . SPARSER::PROTEIN)
    ("APC/Axin" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("Magi-1, Pard3, ZO-3, and Scrib" . SPARSER::COLLECTION)
    ("Magi-1 and PDZ domain 1" . SPARSER::COLLECTION)
    ("Pard3, ZO-3, and Scrib" . SPARSER::COLLECTION)
    ("E-cadherin, α-catenin, and p120 catenin" . SPARSER::COLLECTION)
    ("Tight Junction-Associated Proteins" . SPARSER::PROTEIN)
    ("Mals2 and OMP25" . SPARSER::COLLECTION)
    ("Dvl3 and Mals2" . SPARSER::COLLECTION) ("Mals2" . SPARSER::PROTEIN)
    ("Dvl3" . SPARSER::PROTEIN)
    ("proteins and Myc-tagged" . SPARSER::COLLECTION)
    ("β-catenin and full-length" . SPARSER::COLLECTION)
    ("Lin7b, Grasp55, Tiam2, PDZk7, Mast1, Dvl3, OMP25, and Scrib"
     . SPARSER::COLLECTION)
    ("Mast1" . SPARSER::PROTEIN) ("Lin7b" . SPARSER::PROTEIN)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IMAC" . SPARSER::PROTEIN)
    ("Proteins" . SPARSER::PROTEIN)
    ("the fluorescent peptide" . SPARSER::PEPTIDE)
    ("scaffolds" . SPARSER::SCAFFOLD) ("axin" . SPARSER::PROTEIN)
    ("multifunctional protein" . SPARSER::PROTEIN)
    ("tight junction-associated proteins" . SPARSER::PROTEIN)
    ("four tight junction-associated PDZ proteins" . SPARSER::PROTEIN)
    ("Magi-1, Pard3, and ZO-3" . SPARSER::COLLECTION)
    ("Pard3" . SPARSER::PROTEIN) ("Magi-1" . SPARSER::PROTEIN)
    ("Scrib" . SPARSER::DRUG)
    ("the newly discovered interactions involved proteins" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY) ("LIN7" . SPARSER::PROTEIN-FAMILY)
    ("adhesion molecule" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("MUPP1" . SPARSER::PROTEIN) ("Dvl-3" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN) ("Tight junction" . SPARSER::PROTEIN)
    ("domain 1" . SPARSER::PROTEIN) ("p120 catenin" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("Tight Junction" . SPARSER::PROTEIN)
    ("OMP25" . SPARSER::PROTEIN) ("PDZk7" . SPARSER::PROTEIN)
    ("Tiam2" . SPARSER::PROTEIN) ("Grasp55" . SPARSER::PROTEIN)
    ("Lin7" . SPARSER::PROTEIN-FAMILY) ("Full-length" . SPARSER::PROTEIN)
    ("MAGI-1" . SPARSER::PROTEIN) ("TIP-1" . SPARSER::PROTEIN)
    ("Dvl-1" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("ZO-3" . SPARSER::PROTEIN) ("tight junction" . SPARSER::PROTEIN)
    ("GSK461364A effectively targets PLK1" . SPARSER::PROTEIN)
    ("PLK" . SPARSER::PROTEIN) ("serine–threonine" . SPARSER::COLLECTION)
    ("PLKs" . SPARSER::PROTEIN) ("potential drug" . SPARSER::DRUG)
    ("Kinases" . SPARSER::PROTEIN) ("– 1" . SPARSER::PROTEIN)
    ("MRC" . SPARSER::PROTEIN) ("LN18" . SPARSER::PROTEIN)
    ("after GSK461364A and radiation" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP)
    ("proteins, DGUOK, PRKD2, IBTK, RPS6KA6 and PLK1" . SPARSER::COLLECTION)
    ("IBTK" . SPARSER::PROTEIN) ("an essential kinase" . SPARSER::KINASE)
    ("the most robust putative target" . SPARSER::TARGET-PROTEIN)
    ("siRNAs or plasmid-encoded short hairpin RNAs (shRNAs)"
     . SPARSER::COLLECTION)
    ("BI2536" . SPARSER::DRUG) ("Polo-like" . SPARSER::PROTEIN)
    ("H3 histone" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN) ("ALK-3" . SPARSER::PROTEIN)
    ("RPS6KA6" . SPARSER::PROTEIN) ("PRKD2" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("Histone H2A.X" . SPARSER::PROTEIN)
    ("annexin-V" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("GSK461364A" . SPARSER::DRUG) ("PLK1" . SPARSER::PROTEIN)
    ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("this multifunctional protein" . SPARSER::PROTEIN)
    ("Upf2 and Upf3B" . SPARSER::COLLECTION)
    ("the NMD core factor Upf1 and its kinase partner Smg1"
     . SPARSER::COLLECTION)
    ("Smg1–Upf1–eRF1–eRF3" . SPARSER::COLLECTION)
    ("eRF1–eRF3" . SPARSER::COLLECTION)
    ("an efficient RNA binding" . SPARSER::PROTEIN)
    ("Ddx5 , Ddx17 and Smg5" . SPARSER::COLLECTION)
    ("Ddx17-Upf3" . SPARSER::COLLECTION)
    ("Upf3A and Upf3B" . SPARSER::COLLECTION)
    ("Smg5, Ddx5 and Ddx17" . SPARSER::COLLECTION)
    ("Ddx5, and hUpf3B" . SPARSER::COLLECTION)
    ("Ddx5-Upf3" . SPARSER::COLLECTION) ("Upf3A" . SPARSER::PROTEIN)
    ("FLAG-Upf3B" . SPARSER::COLLECTION)
    ("the classical EJC" . SPARSER::BIO-COMPLEX)
    ("the mature mRNAs" . SPARSER::PROTEIN)
    ("mRNAs, Ddx5 , Ddx17 and Smg5" . SPARSER::COLLECTION)
    ("Ddx5 and EJC" . SPARSER::COLLECTION)
    ("Ddx5 and hUpf3" . SPARSER::COLLECTION)
    ("Ddx5 and hUpf3B" . SPARSER::COLLECTION) ("Staufen" . SPARSER::PROTEIN)
    ("Smg5-" . SPARSER::PROTEIN) ("PTC-" . SPARSER::PROTEIN)
    ("total cellular Ddx17-" . SPARSER::PROTEIN)
    ("GAPDH–mRNA" . SPARSER::COLLECTION) ("Ddx17-" . SPARSER::PROTEIN)
    ("RIP" . SPARSER::PROTEIN) ("the authentic mRNAs" . SPARSER::PROTEIN)
    ("respective mRNA" . SPARSER::PROTEIN)
    ("Ddx17 , Smg5, Ddx5 and Tram1" . SPARSER::COLLECTION)
    ("Ddx5/Ddx17" . SPARSER::COLLECTION) ("Tram1" . SPARSER::PROTEIN)
    ("Tram" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ddx5, Ddx17 and Smg5" . SPARSER::COLLECTION)
    ("hUpf1 or Ddx5" . SPARSER::COLLECTION)
    ("Ddx5 and/or Ddx17" . SPARSER::COLLECTION)
    ("luciferase/β-globin" . SPARSER::COLLECTION)
    ("hUpf1 or hUpf3" . SPARSER::COLLECTION)
    ("Ddx5 and Upf1, Upf2 and Upf3" . SPARSER::COLLECTION)
    ("Upf1, Upf2 and Upf3" . SPARSER::COLLECTION)
    ("Ddx5 (1.6-fold) and Ddx17 (>2-fold; xref A, lanes 5 and 6)"
     . SPARSER::COLLECTION)
    ("Ddx5-GNT" . SPARSER::PROTEIN-PAIR)
    ("ATPase and RNA" . SPARSER::COLLECTION)
    ("Upf3-Upf2-Upf1" . SPARSER::COLLECTION)
    ("conditionally expressing HA-tagged Ddx5 wild-type (WT) or Ddx5 mutants"
     . SPARSER::COLLECTION)
    ("only Ddx5 siRNA" . SPARSER::PROTEIN)
    ("Ddx5/Ddx17-Upf3" . SPARSER::COLLECTION)
    ("using purified recombinant FLAG-tagged hUpf3B and KT3-tagged Ddx5 deletion variants"
     . SPARSER::COLLECTION)
    ("hUpf1 and hUpf2" . SPARSER::COLLECTION)
    ("Ddx5:Upf3" . SPARSER::BIO-COMPLEX)
    ("Ddx5 and hUpf2" . SPARSER::COLLECTION)
    ("EGFP-hUpf1" . SPARSER::COLLECTION)
    ("FLAG-tagged hUpf3B or EGFP-tagged hUpf1" . SPARSER::COLLECTION)
    ("Ddx5 and Ago2" . SPARSER::COLLECTION)
    ("hUpf1 and KT3 epitope-tagged Ddx5 (labeled by KT3 antibody)"
     . SPARSER::COLLECTION)
    ("cellular Ddx5" . SPARSER::PROTEIN) ("IPs" . SPARSER::PROTEIN)
    ("normal mRNAs" . SPARSER::PROTEIN)
    ("CBP80 and PABPN1" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("these typical mRNP components" . SPARSER::COMPONENT)
    ("CBP80, eIF4E, eIF4G, MAGOH, PABPC1 and PABPN1" . SPARSER::COLLECTION)
    ("Further mRNP components" . SPARSER::COMPONENT)
    ("mRNP" . SPARSER::BIO-COMPLEX) ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("Upf1 and Upf3" . SPARSER::COLLECTION)
    ("hUpf1-hUpf2-hUpf3" . SPARSER::COLLECTION)
    ("hUpf1, hUpf2 and hUpf3" . SPARSER::COLLECTION)
    ("paralogs, hUpf3A and hUpf3B" . SPARSER::COLLECTION)
    ("a monoclonal anti-mouse antibody" . SPARSER::ANTIBODY)
    ("mRNPs" . SPARSER::BIO-COMPLEX) ("Ddx5 and Ddx17" . SPARSER::COLLECTION)
    ("Dbp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("paralogs" . SPARSER::PROTEIN)
    ("two isoforms Ddx17 72 (p72) and Ddx17" . SPARSER::COLLECTION)
    ("MyoD" . SPARSER::PROTEIN)
    ("Upf1 and cytoplasmic poly(A)-binding protein (PABP)"
     . SPARSER::COLLECTION)
    ("poly(A)-binding protein (PABP)" . SPARSER::PROTEIN)
    ("aberrant mRNAs" . SPARSER::PROTEIN)
    ("eRF1 and eRF3" . SPARSER::COLLECTION) ("PABP" . SPARSER::PROTEIN)
    ("Other normal mRNAs" . SPARSER::PROTEIN)
    ("MAGOH, Y14, and eIF4AIII" . SPARSER::COLLECTION)
    ("Smg1, Smg9, Smg8, Upf1, eRF3 and eRF1" . SPARSER::COLLECTION)
    ("Smg8" . SPARSER::PROTEIN) ("Smg9" . SPARSER::PROTEIN)
    ("Smg1" . SPARSER::PROTEIN) ("eIF4AIII" . SPARSER::PROTEIN)
    ("MAGOH" . SPARSER::PROTEIN) ("exon–exon" . SPARSER::COLLECTION)
    ("Aberrant mRNAs" . SPARSER::PROTEIN)
    ("potentially toxic proteins" . SPARSER::PROTEIN)
    ("Ddx17 and Smg5" . SPARSER::COLLECTION) ("Smg5" . SPARSER::PROTEIN)
    ("Ddx17/p72" . SPARSER::COLLECTION) ("Ddx5/p68" . SPARSER::COLLECTION)
    ("EJC" . SPARSER::BIO-COMPLEX) ("complex (EJC)" . SPARSER::BIO-COMPLEX)
    ("Upf2 and Upf3" . SPARSER::COLLECTION) ("Upf3" . SPARSER::PROTEIN)
    ("Upf2" . SPARSER::PROTEIN) ("PTC" . SPARSER::PROTEIN)
    ("Upf1" . SPARSER::PROTEIN) ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S  .  cerevisiae" . SPARSER::PROTEIN) ("pre-mRNAs" . SPARSER::RNA)
    ("β-globin" . SPARSER::PROTEIN)
    ("phosphatidyl-inositol" . SPARSER::MOLECULE)
    ("core protein" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("Poly(A)-binding protein" . SPARSER::PROTEIN)
    ("cap-binding protein" . SPARSER::PROTEIN) ("hUpf3B" . SPARSER::PROTEIN)
    ("hUpf3A" . SPARSER::PROTEIN) ("hUpf3" . SPARSER::PROTEIN)
    ("hUpf2" . SPARSER::PROTEIN) ("hUpf1" . SPARSER::PROTEIN)
    ("m1" . SPARSER::MOLECULE) ("tumor antigen" . SPARSER::DRUG)
    ("NaVO 3" . SPARSER::MOLECULE) ("CBP80" . SPARSER::PROTEIN)
    ("PABPN1" . SPARSER::PROTEIN) ("PABPC1" . SPARSER::PROTEIN)
    ("Ago2" . SPARSER::PROTEIN) ("Upf3B" . SPARSER::PROTEIN)
    ("Runx2" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE)
    ("poly(A)-binding protein" . SPARSER::PROTEIN) ("eRF1" . SPARSER::PROTEIN)
    ("eRF3" . SPARSER::PROTEIN) ("Y14" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("p72" . SPARSER::PROTEIN)
    ("Ddx17" . SPARSER::PROTEIN) ("p68" . SPARSER::PROTEIN)
    ("Ddx5" . SPARSER::PROTEIN) ("most pathogenic variants" . SPARSER::VARIANT)
    ("those developed around candidate gene" . SPARSER::GENE)
    ("incidental (secondary) variants" . SPARSER::VARIANT)
    ("an incidental variant" . SPARSER::VARIANT)
    ("incidental variant" . SPARSER::VARIANT)
    ("the Working Group and external reviewers" . SPARSER::COLLECTION)
    ("genes and types of variants" . TYPE)
    ("genes and types" . SPARSER::COLLECTION)
    ("the psychological state" . SPARSER::BIO-STATE)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genomic medicine" . SPARSER::DRUG) ("mask" . SPARSER::PROTEIN)
    ("all other disease-associated genes" . SPARSER::GENE)
    ("known pathogenic variants" . SPARSER::VARIANT)
    ("a pathogenic variant" . SPARSER::VARIANT)
    ("the relevant associated genes" . SPARSER::GENE)
    ("any and all disease-associated genes" . SPARSER::GENE)
    ("GROUP" . SPARSER::MOLECULE) ("gene or genes" . SPARSER::COLLECTION)
    ("classes or types" . SPARSER::COLLECTION) ("MECP2" . SPARSER::PROTEIN)
    ("Bax or toxins" . SPARSER::COLLECTION)
    ("bacterial toxins" . SPARSER::MOLECULE)
    ("monomeric Bax" . SPARSER::PROTEIN)
    ("receptors, transporters and enzymes" . SPARSER::COLLECTION)
    ("discs" . SPARSER::BIO-COMPLEX)
    ("soluble NSF attachment protein receptor (SNARE) proteins"
     . SPARSER::PROTEIN)
    ("SNARE" . SPARSER::PROTEIN) ("NSF" . SPARSER::PROTEIN)
    ("toxin" . SPARSER::MOLECULE) ("only Bax monomers" . SPARSER::MONOMER)
    ("bare nanodiscs or nanodiscs" . SPARSER::COLLECTION)
    ("nanodiscs or nanodiscs" . SPARSER::COLLECTION)
    ("fluorescent Bid peptide" . SPARSER::PEPTIDE)
    ("monomer" . SPARSER::MONOMER) ("the bare nanodisc" . SPARSER::PROTEIN)
    ("disc" . SPARSER::BIO-COMPLEX) ("hydrated" . SPARSER::MOLECULE)
    ("nanodisc-Bax" . SPARSER::COLLECTION) ("Nanodiscs" . SPARSER::PROTEIN)
    ("phospholipids" . SPARSER::PHOSPHOLIPID) ("nanodisc" . SPARSER::PROTEIN)
    ("nanodiscs" . SPARSER::PROTEIN) ("Bax-nanodisc" . SPARSER::PROTEIN-PAIR)
    ("Bax and nanodiscs" . SPARSER::COLLECTION)
    ("the respective proteins" . SPARSER::PROTEIN)
    ("soluble Bax" . SPARSER::PROTEIN)
    ("soluble full-length human Bax monomers" . SPARSER::MONOMER)
    ("cryo" . SPARSER::PROTEIN)
    ("activator protein (truncated Bid, tBid) or Bid BH3 peptides"
     . SPARSER::COLLECTION)
    ("liposomes" . SPARSER::PROTEIN)
    ("Bid BH3 peptide and Bcl-xL" . SPARSER::COLLECTION)
    ("cryo-EM" . SPARSER::COLLECTION) ("detergent" . SPARSER::MOLECULE)
    ("Inactive" . SPARSER::INACTIVE) ("Bax and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("the pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("proteinaceous components" . SPARSER::COMPONENT)
    ("ions" . SPARSER::MOLECULE) ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("mitochondria-embedded oligomeric form" . SPARSER::FORM)
    ("Bax" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("Bcl-xL" . SPARSER::PROTEIN)
    ("BH3 interacting domain death agonist" . SPARSER::PROTEIN)
    ("bovine serum albumin" . SPARSER::PROTEIN) ("sulfate" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE) ("MEF" . SPARSER::PROTEIN)
    ("these results not only highlight cyclin D1" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("HER2 or Ras" . SPARSER::COLLECTION)
    ("MMTV-driven cyclin D1" . SPARSER::PROTEIN)
    ("p21/cyclin D1" . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hematoxylin" . SPARSER::MOLECULE) ("the mammary fat" . SPARSER::PROTEIN)
    ("thrombospondin 1 and ROCK" . SPARSER::COLLECTION)
    ("primary bone macrophages, mouse embryo fibroblasts (MEFs), and breast cancer cells [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("cyclin D1 or p21" . SPARSER::COLLECTION)
    ("the mitotic inhibitor mitomycin C" . SPARSER::DRUG)
    ("siRNA or cyclin D1" . SPARSER::COLLECTION)
    ("p21 and cyclin D1" . SPARSER::COLLECTION)
    ("MDA and SCP2" . SPARSER::COLLECTION)
    ("cyclin D1 and TGFβ" . SPARSER::COLLECTION) ("MDA" . SPARSER::DRUG)
    ("a universal regulator" . SPARSER::REGULATOR)
    ("cyclin/CDKs" . SPARSER::COLLECTION)
    ("particular cyclin D1" . SPARSER::PROTEIN)
    ("particular cyclin D1 and p21" . SPARSER::COLLECTION)
    ("cyclin D-CDK" . SPARSER::COLLECTION)
    ("cyclin E-CDK" . SPARSER::COLLECTION)
    ("p27KIP1 and p57KIP2" . SPARSER::COLLECTION)
    ("p21CIP1/WAF1" . SPARSER::COLLECTION) ("CDKIs" . SPARSER::DRUG)
    ("cyclins, cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("their respective cyclin-dependent kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("inhibins and TGFβs" . SPARSER::COLLECTION)
    ("inhibins" . SPARSER::PROTEIN) ("activins" . SPARSER::PROTEIN)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("cyclin D1 and p21 proteins" . SPARSER::COLLECTION)
    ("vimentin and F-actin" . SPARSER::COLLECTION) ("fat" . SPARSER::PROTEIN)
    ("mesenchymal intermediate filament vimentin" . SPARSER::PROTEIN)
    ("phalloidin" . SPARSER::MOLECULE)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1/p21" . SPARSER::COLLECTION)
    ("cyclin D1 and p21" . SPARSER::COLLECTION) ("INK4A" . SPARSER::PROTEIN)
    ("thrombospondin 1" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("cyclin D2" . SPARSER::PROTEIN) ("SCP2" . SPARSER::PROTEIN)
    ("p57KIP2" . SPARSER::PROTEIN) ("p27KIP1" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("p21CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p19INK4D" . SPARSER::PROTEIN) ("INK4C" . SPARSER::PROTEIN)
    ("p16INK4A" . SPARSER::PROTEIN) ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 proteins" . SPARSER::PROTEIN) ("NCT" . SPARSER::PROTEIN)
    ("pan-FGFR and multi-kinase" . SPARSER::COLLECTION)
    ("carboplatin, paclitaxel, cisplatin and cetuximab" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("tobacco" . SPARSER::DRUG)
    ("the IIIb isoform and either isoform" . SPARSER::COLLECTION)
    ("pazopanib and dovitinib" . SPARSER::COLLECTION)
    ("Pazopanib" . SPARSER::DRUG) ("Dovitinib" . SPARSER::DRUG)
    ("a selective FGFR kinase inhibitor ( xref ) as well as pazopanib (GW786034)"
     . SPARSER::COLLECTION)
    ("TKI" . SPARSER::PROTEIN) ("dovitinib" . SPARSER::DRUG)
    ("phospho-FGFR, phospho-FRS2, and phospho-Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("which targets imatinib-resistant BCR-ABL" . SPARSER::PROTEIN)
    ("imatinib" . SPARSER::DRUG) ("ponatinib" . SPARSER::DRUG)
    ("clinically relevant FGFR inhibitors" . SPARSER::INHIBITOR)
    ("FGF1 and heparin" . SPARSER::COLLECTION)
    ("PBS or 5 nM FGF1 and 2 μg/mL heparin" . SPARSER::COLLECTION)
    ("RTKs" . SPARSER::PROTEIN) ("disulfide" . SPARSER::MOLECULE)
    ("TP53 (8/10) and PIK3CA (3/10)" . SPARSER::COLLECTION)
    ("a non-canonical KRAS mutation G118S and LUSC-21-5485"
     . SPARSER::COLLECTION)
    ("a previously unreported ERBB2 mutation G1075V" . SPARSER::PROTEIN)
    ("PDGFRA" . SPARSER::PROTEIN) ("FGFR2 or FGFR3" . SPARSER::COLLECTION)
    ("IIIb" . SPARSER::DRUG) ("FGFR and multi-kinase" . SPARSER::COLLECTION)
    ("receptors, isoforms, and ligands" . SPARSER::COLLECTION)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("binding fibroblast growth factor (FGF) and heparan sulfate proteoglycan (HSPG)"
     . SPARSER::COLLECTION)
    ("fibroblast growth factor (FGF)" . SPARSER::PROTEIN-FAMILY)
    ("HSPG" . SPARSER::PROTEIN) ("ECD" . SPARSER::PROTEIN)
    ("EGFR and ALK" . SPARSER::COLLECTION) ("ALK" . SPARSER::PROTEIN)
    ("pazopanib" . SPARSER::DRUG) ("FGFR2 and FGFR3" . SPARSER::COLLECTION)
    ("BCR-ABL" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN) ("FGFR2 IIIb" . SPARSER::PROTEIN)
    ("FGFR2-IIIb" . SPARSER::PROTEIN) ("reducing agent" . SPARSER::MOLECULE)
    ("AZD4547" . SPARSER::DRUG) ("GW786034" . SPARSER::DRUG)
    ("AZD2171" . SPARSER::DRUG) ("TKI258" . SPARSER::DRUG)
    ("IL-3" . SPARSER::PROTEIN) ("Interleukin-3" . SPARSER::PROTEIN)
    ("FGF9" . SPARSER::PROTEIN) ("FGF7" . SPARSER::PROTEIN)
    ("FGF1" . SPARSER::PROTEIN) ("H10" . SPARSER::PROTEIN)
    ("Erk 1/2" . SPARSER::PROTEIN) ("C-8" . SPARSER::PROTEIN)
    ("FRS2" . SPARSER::PROTEIN)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor Receptor" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("DP" . SPARSER::PROTEIN) ("PN" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("BMPs/TGFβ/Activins" . SPARSER::COLLECTION)
    ("Activins" . SPARSER::PROTEIN) ("BMPs" . SPARSER::PROTEIN)
    ("Fgfs" . SPARSER::PROTEIN) ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Forkhead" . SPARSER::PROTEIN) ("Hox" . SPARSER::PROTEIN)
    ("Myc and Sox9" . SPARSER::COLLECTION)
    ("Id4 and Id1" . SPARSER::COLLECTION)
    ("Both Id1 and Id4 share strong sequence homology" . SPARSER::PROTEIN)
    ("Id1 and Id4" . SPARSER::COLLECTION)
    ("pro-tumorigenic target genes" . SPARSER::GENE)
    ("Myc:Nkx3.1" . SPARSER::BIO-COMPLEX)
    ("ki67, Myc and Id1" . SPARSER::COLLECTION)
    ("a potential tumor suppressor" . SPARSER::SUPPRESSOR)
    ("LNCaP-Id4" . SPARSER::COLLECTION)
    ("LNCaP and DU145" . SPARSER::COLLECTION)
    ("p21 and p16" . SPARSER::COLLECTION)
    ("Myc and Nkx3.1" . SPARSER::COLLECTION)
    ("Myc [ xref ] and Id1 [ xref ]" . SPARSER::COLLECTION)
    ("Pten and downstream effectors" . SPARSER::COLLECTION)
    ("pAKt" . SPARSER::PROTEIN-FAMILY) ("p-AKt" . SPARSER::COLLECTION)
    ("AKt" . SPARSER::PROTEIN) ("p-Akt1" . SPARSER::COLLECTION)
    ("Pten:Nkx3.1" . SPARSER::BIO-COMPLEX)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Androgen" . SPARSER::PROTEIN) ("secretory proteins" . SPARSER::PROTEIN)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("subtle PIN" . SPARSER::PROTEIN)
    ("In fact more mPIN" . SPARSER::PROTEIN)
    ("the homogenous chromatin" . SPARSER::PROTEIN)
    ("lobes" . SPARSER::PROTEIN) ("testosterone" . SPARSER::MOLECULE)
    ("GT" . SPARSER::PROTEIN) ("PIN" . SPARSER::PROTEIN)
    ("androgen" . SPARSER::PROTEIN)
    ("B-cell acute lymphoblastic leukemia [ xref ] and B-cell precursor acute lymphoblastic leukemia (BCP-ALL)"
     . SPARSER::COLLECTION)
    ("B-cell precursor acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("B-cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("BCP" . SPARSER::PROTEIN) ("Id1 and Id3" . SPARSER::COLLECTION)
    ("Male" . SPARSER::MOLECULE) ("bHLH and non-bHLH" . SPARSER::COLLECTION)
    ("caveolin" . SPARSER::PROTEIN) ("CASK" . SPARSER::PROTEIN)
    ("Id1, Id2 and Id3" . SPARSER::COLLECTION) ("bHLH" . SPARSER::PROTEIN)
    ("respective response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Myc and Id1" . SPARSER::COLLECTION)
    ("Nkx3.1 and Pten" . SPARSER::COLLECTION)
    ("NKX3.1, Sox9 and PTEN" . SPARSER::COLLECTION)
    ("PTEN, Akt and phospho-AKT" . SPARSER::COLLECTION)
    ("subtle mPIN" . SPARSER::PROTEIN) ("mPIN" . SPARSER::PROTEIN)
    ("DU145 and LNCaP" . SPARSER::COLLECTION)
    ("PTEN, NKX3.1 and Sox9" . SPARSER::COLLECTION)
    ("Pten and Nkx3.1" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("Pten" . SPARSER::PROTEIN) ("androgens" . SPARSER::DRUG)
    ("Inhibitor" . SPARSER::INHIBITOR)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("BCH-1" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("androgen-receptor" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RUNX2" . SPARSER::PROTEIN)
    ("BMP4" . SPARSER::PROTEIN) ("ki67" . SPARSER::PROTEIN)
    ("DU145 " . SPARSER::PROTEIN) ("SOX9" . SPARSER::PROTEIN)
    ("Ink4a" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("J-N" . SPARSER::PROTEIN) ("ADD1" . SPARSER::PROTEIN)
    ("PAX2" . SPARSER::PROTEIN) ("GATA4" . SPARSER::PROTEIN)
    ("ELK1" . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("Id3" . SPARSER::PROTEIN) ("Id2" . SPARSER::PROTEIN)
    ("NKX3.1" . SPARSER::PROTEIN) ("Nkx3.1" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("Sox9" . SPARSER::PROTEIN)
    ("Id1" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("Id4" . SPARSER::PROTEIN) ("two-tailed t" . SPARSER::PROTEIN)
    ("anti-caspase-3 (AAP-113, Stressgen Bioreagents) and HRP-conjugated anti-GAPDH (sc-5778; Santa Cruz)"
     . SPARSER::COLLECTION)
    ("anti-p53 (OP43; Calbiochem), anti-MDM2 (sc-965; Santa Cruz), anti-p21 (556431; BD Biosciences), anti-PARP (9542, Cell Signaling Technology), anti-caspase-3 (AAP-113, Stressgen Bioreagents) and HRP-conjugated anti-GAPDH (sc-5778; Santa Cruz)"
     . SPARSER::COLLECTION)
    ("HRP-conjugated anti-GAPDH" . SPARSER::ANTIBODY)
    ("HRP" . SPARSER::PROTEIN) ("AAP" . SPARSER::PROTEIN)
    ("OP" . SPARSER::MOLECULE)
    ("1 mM sodium orthovanadate and 1µg/ml leupeptin" . SPARSER::COLLECTION)
    ("leupeptin" . SPARSER::DRUG) ("orthovanadate" . SPARSER::MOLECULE)
    ("pyrophosphate" . SPARSER::MOLECULE) ("deoxycholate" . SPARSER::MOLECULE)
    ("NaCl" . SPARSER::PROTEIN) ("PEG" . SPARSER::PROTEIN)
    ("HCT-116 p53 +/+ and HCT-116 p53 –/–" . SPARSER::COLLECTION)
    ("dehydrogenase" . SPARSER::PROTEIN) ("lactate" . SPARSER::LACTATE)
    ("VA" . SPARSER::MOLECULE) ("Type" . TYPE) ("Mixtures" . SPARSER::MOLECULE)
    ("San" . SPARSER::PROTEIN) ("azide" . SPARSER::MOLECULE)
    ("mixtures" . SPARSER::MOLECULE) ("PMDM" . SPARSER::DRUG)
    ("Asn" . SPARSER::AMINO-ACID) ("Glu" . SPARSER::AMINO-ACID)
    ("Aib" . SPARSER::DRUG) ("Met" . SPARSER::AMINO-ACID)
    ("a recombinant human His-tagged MDM2 protein (residues 1–118) and a FAM"
     . SPARSER::COLLECTION)
    ("FAM" . SPARSER::PROTEIN)
    ("removed affording crude free amine" . SPARSER::MOLECULE)
    ("MeOH and water" . SPARSER::COLLECTION)
    ("solvent and TFA" . SPARSER::COLLECTION)
    ("cyclobutyl" . SPARSER::MOLECULE) ("-2-hydroxy-1" . SPARSER::COLLECTION)
    ("oxy" . SPARSER::MOLECULE) ("-3-" . SPARSER::PROTEIN)
    ("hydroxycyclopentyl" . SPARSER::PROTEIN)
    ("-3-hydroxycyclopentyl" . SPARSER::COLLECTION) ("ddd" . SPARSER::MOLECULE)
    ("hydroxycyclobutyl" . SPARSER::PROTEIN)
    ("anhydrous Na 2 SO 4" . SPARSER::PROTEIN) ("THF" . SPARSER::MOLECULE)
    ("-carboxamide" . SPARSER::MOLECULE) ("-pyrrolidine" . SPARSER::DRUG)
    ("-3-hydroxycyclobutyl" . SPARSER::COLLECTION)
    ("pyrrolidine" . SPARSER::DRUG) ("indoline" . SPARSER::MOLECULE)
    ("TFA or MeOH" . SPARSER::COLLECTION)
    ("Commercial reagents and anhydrous solvents" . SPARSER::COLLECTION)
    ("anhydrous solvents" . SPARSER::MOLECULE)
    ("Commercial reagents" . SPARSER::MOLECULE)
    ("solvents" . SPARSER::MOLECULE) ("nitrogen" . SPARSER::MOLECULE)
    ("Teflon" . SPARSER::MOLECULE)
    ("a promising MDM2 inhibitor and warrants extensive evaluation"
     . SPARSER::COLLECTION)
    ("using 2 N NaOH aqueous solution" . SPARSER::MOLECULE)
    ("NaOH" . SPARSER::MOLECULE) ("amine" . SPARSER::MOLECULE)
    ("TFA-CH 2" . SPARSER::COLLECTION) ("-Boc" . SPARSER::COLLECTION)
    ("TFA" . SPARSER::PROTEIN) ("Boc" . SPARSER::PROTEIN)
    ("MeOH" . SPARSER::MOLECULE) ("MeCN" . SPARSER::MOLECULE)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("p53, p21, and MDM2" . SPARSER::COLLECTION)
    ("p21 and MDM2" . SPARSER::COLLECTION)
    ("its isogenic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("MDM2 and p21" . SPARSER::COLLECTION) ("alcohol" . SPARSER::DRUG)
    ("only one hydroxyl group" . SPARSER::MOLECULE)
    ("diol" . SPARSER::MOLECULE) ("MDM2, or HDM2" . SPARSER::COLLECTION)
    ("Phe" . SPARSER::AMINO-ACID) ("MDM2-p53" . SPARSER::COLLECTION)
    ("Phenol Red" . SPARSER::DRUG) ("NH 2" . SPARSER::MOLECULE)
    ("MDM2 protein" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("FN 3" . SPARSER::PROTEIN) ("CH 2" . SPARSER::MOLECULE)
    ("caspase-3" . SPARSER::PROTEIN) ("Nutlin-3a" . SPARSER::DRUG)
    ("RS4" . SPARSER::PROTEIN) ("MI-219" . SPARSER::DRUG)
    ("HDM2" . SPARSER::PROTEIN) ("double minute 2 protein" . SPARSER::PROTEIN)
    ("Tumor suppressor protein" . SPARSER::PROTEIN)
    ("serrated" . SPARSER::PROTEIN) ("Subtypes" . SPARSER::PROTEIN)
    ("a potential new target" . SPARSER::TARGET-PROTEIN)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("hot" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("platelet-derived growth factor (PDGF) or vascular endothelial growth factor (VEGF)"
     . SPARSER::COLLECTION)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("bisphosphonate" . SPARSER::MOLECULE) ("MGMT" . SPARSER::PROTEIN)
    ("Cohort" . SPARSER::MOLECULE) ("p85" . SPARSER::PROTEIN)
    ("RAS-GTP" . SPARSER::PROTEIN) ("1–4 µ" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("a 15 µ" . SPARSER::PROTEIN)
    ("CACNA1G" . SPARSER::PROTEIN) ("NEUROG1" . SPARSER::PROTEIN)
    ("RUNX3" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p110-alpha" . SPARSER::PROTEIN) ("alpha )" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("EMT and iii" . SPARSER::COLLECTION) ("Endo" . SPARSER::PROTEIN)
    ("Snail1, vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("HIF-1α and HIF-2α" . SPARSER::COLLECTION) ("LiCl-" . SPARSER::DRUG)
    ("Snail1 and β–catenin" . SPARSER::COLLECTION)
    ("Snail1 and HIF-1/2" . SPARSER::COLLECTION) ("ADP" . SPARSER::PROTEIN)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("EMT and EndoMT" . SPARSER::COLLECTION)
    ("endothelial vimentin" . SPARSER::PROTEIN)
    ("Intermediary filaments" . SPARSER::PROTEIN-FAMILY)
    ("vimentin and keratins" . SPARSER::COLLECTION)
    ("keratins" . SPARSER::PROTEIN)
    ("the intermediary filament protein vimentin" . SPARSER::PROTEIN)
    ("p53 and NF-κB" . SPARSER::COLLECTION) ("DNA-damage" . SPARSER::DNA)
    ("PARPs" . SPARSER::MOLECULE)
    ("Snail1 and microphthalmia-associated transcription factor (MITF)"
     . SPARSER::COLLECTION)
    ("Snail1 and microphthalmia-associated transcription factor"
     . SPARSER::COLLECTION)
    ("vimentin, PARP-1, Snail1, E-cadherin and MITF" . SPARSER::COLLECTION)
    ("MITF" . SPARSER::PROTEIN) ("Snail1 and E-cadherin" . SPARSER::COLLECTION)
    ("Metastatic foci" . SPARSER::PROTEIN)
    ("the clinically relevant PARP inhibitor olaparib" . SPARSER::DRUG)
    ("both total and phosphorylated VE-cadherin" . SPARSER::PROTEIN)
    ("PJ-34 or KU0058948" . SPARSER::COLLECTION)
    ("kinase (ILK)" . SPARSER::KINASE)
    ("LiCl ( xref ) or exogenous expression of vimentin ( xref )"
     . SPARSER::COLLECTION)
    ("LiCl" . SPARSER::DRUG) ("PARP or vimentin" . SPARSER::COLLECTION)
    ("ILK and GSK-3β" . SPARSER::COLLECTION)
    ("PJ-34 or olaparib" . SPARSER::COLLECTION)
    ("GFP-vimentin" . SPARSER::COLLECTION)
    ("PARP-1 and vimentin" . SPARSER::COLLECTION) ("Axl" . SPARSER::PROTEIN)
    ("KU0058948 (G361 cells, xref ) or PJ-34 (B16-F10 cells, xref )"
     . SPARSER::COLLECTION)
    ("Vimentin and Snail1" . SPARSER::COLLECTION)
    ("Snail1 and vimentin" . SPARSER::COLLECTION)
    ("vimentin and PARP-1" . SPARSER::COLLECTION)
    ("vimentin and Snail1" . SPARSER::COLLECTION)
    ("Snail1 and VE-cadherin" . SPARSER::COLLECTION)
    ("intermediary filaments" . SPARSER::PROTEIN-FAMILY)
    ("mitochondrial ATP synthase ATPB5" . SPARSER::PROTEIN)
    ("member 1, and HSP90AB1" . SPARSER::COLLECTION)
    ("ATPB" . SPARSER::PROTEIN) ("endoplasmin" . SPARSER::PROTEIN)
    ("ILK/GSK-3β" . SPARSER::COLLECTION)
    ("the intermediary filament vimentin" . SPARSER::PROTEIN)
    ("matrix-degrading proteases and mesenchymal-related proteins"
     . SPARSER::COLLECTION)
    ("mesenchymal-related proteins" . SPARSER::PROTEIN)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("the local ECM" . SPARSER::PROTEIN)
    ("vimentin and VE-cadherin" . SPARSER::COLLECTION)
    ("parts" . SPARSER::COMPONENT)
    ("an intermediary filament" . SPARSER::PROTEIN-FAMILY)
    ("HIF-2α" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("β–catenin" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TGFβ1" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("microphthalmia-associated transcription factor" . SPARSER::PROTEIN)
    ("GSk-3β" . SPARSER::PROTEIN) ("PJ-34" . SPARSER::DRUG)
    ("KU0058948" . SPARSER::DRUG) ("H 2 O 2" . SPARSER::DRUG)
    ("HSPD1" . SPARSER::PROTEIN) ("HSP90AB1" . SPARSER::PROTEIN)
    ("class B" . SPARSER::PROTEIN) ("heat shock protein 90" . SPARSER::PROTEIN)
    ("78 kD)" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("70 kD" . SPARSER::PROTEIN) ("PDIA6" . SPARSER::PROTEIN)
    ("disulfide isomerase" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN)
    ("tropomyosin alpha-4 chain" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN) ("cadherin 5" . SPARSER::PROTEIN)
    ("Vascular endothelial" . SPARSER::PROTEIN) ("GSK3-β" . SPARSER::PROTEIN)
    ("immunomodulatory molecules" . SPARSER::MOLECULE)
    ("WNT2B , WNT9B , WLS and CTNNB1" . SPARSER::COLLECTION)
    ("WNT and FZD" . SPARSER::COLLECTION)
    ("the 19 WNT proteins and the 10 FZD receptors" . SPARSER::COLLECTION)
    ("IRF3 and p65" . SPARSER::COLLECTION)
    ("CTNNB1-IRF3" . SPARSER::COLLECTION)
    ("enhanceosome" . SPARSER::BIO-COMPLEX)
    ("AKT/CTNNB1" . SPARSER::COLLECTION)
    ("LRP5/6 and FZD5" . SPARSER::COLLECTION) ("Wnt2b" . SPARSER::PROTEIN)
    ("receptors and LRP" . SPARSER::COLLECTION)
    ("IFNB1 and ISGs" . SPARSER::COLLECTION)
    ("identified potential regulators of the nucleotide-binding and oligomerization domain (NOD) pathway"
     . SPARSER::COLLECTION)
    ("identified potential regulators" . SPARSER::REGULATOR)
    ("PRR" . SPARSER::PROTEIN) ("promoter and gene" . SPARSER::COLLECTION)
    ("a genome-wide gene" . SPARSER::GENE)
    ("FLAG-CTNNB1" . SPARSER::COLLECTION)
    ("exogenous CTNNB1" . SPARSER::PROTEIN) ("FLAG-IRF3" . SPARSER::COLLECTION)
    ("IRF3- and NF-κB-" . SPARSER::COLLECTION)
    ("IRF3 and NF-κB" . SPARSER::COLLECTION) ("NF-κB-" . SPARSER::PROTEIN)
    ("WNT/GSK3/CTNNB1" . SPARSER::COLLECTION)
    ("WNT2B, WNT9B, WLS and CTNNB1" . SPARSER::COLLECTION)
    ("Rluc" . SPARSER::PROTEIN) ("GSK3/CTNNB1" . SPARSER::COLLECTION)
    ("IFNB1 and TNF" . SPARSER::COLLECTION)
    ("WNT2B, WNT9B and CTNNB1" . SPARSER::COLLECTION)
    ("human monocyte-derived macrophages (MDM)" . SPARSER::PROTEIN)
    ("MDM" . SPARSER::PROTEIN) ("WNT2B/WNT9B/CTNNB1" . SPARSER::COLLECTION)
    ("CTNNB1-TCF" . SPARSER::COLLECTION)
    ("CTNNB1 and NF-κB" . SPARSER::COLLECTION)
    ("IFIT1 and TNF" . SPARSER::COLLECTION)
    ("SeV hemagglutinin-neuraminidase (HN) viral proteins" . SPARSER::PROTEIN)
    ("hemagglutinin-neuraminidase (HN)" . SPARSER::PROTEIN)
    ("IFIT1 and DDX58" . SPARSER::COLLECTION) ("NFKBIA" . SPARSER::PROTEIN)
    ("WNTs" . SPARSER::PROTEIN) ("shRNA and siRNAs" . SPARSER::COLLECTION)
    ("IFNB1 , DDX58 and TNF" . SPARSER::COLLECTION)
    ("WNT2B/WNT9B" . SPARSER::COLLECTION)
    ("the cytoplasmic GSK3B/AXIN/adenomatous polyposis coli (APC) destruction complex"
     . SPARSER::BIO-COMPLEX)
    ("WNT/LRP-signalosome" . SPARSER::COLLECTION) ("AXIN" . SPARSER::PROTEIN)
    ("the frizzled family receptor (FZD) and low density lipoprotein receptor-related protein (LRP) 5/6"
     . SPARSER::COLLECTION)
    ("receptor (FZD)" . SPARSER::RECEPTOR) ("DVL" . SPARSER::PROTEIN)
    ("LRP" . SPARSER::PROTEIN) ("FZD" . SPARSER::PROTEIN-FAMILY)
    ("IRF3-" . SPARSER::PROTEIN) ("IFNB1 and IFIT1" . SPARSER::COLLECTION)
    ("-promoter" . SPARSER::PROMOTER) ("TCF/LEF" . SPARSER::COLLECTION)
    ("IFIT1, IFIT2 and DDX58" . SPARSER::COLLECTION) ("WLS" . SPARSER::PROTEIN)
    ("wntless" . SPARSER::PROTEIN-FAMILY) ("pIFNB1" . SPARSER::PROTEIN)
    ("pIFNB1-LUC" . SPARSER::COLLECTION)
    ("IFIT2 (ISG54) and DDX58 (RIG-I)" . SPARSER::COLLECTION)
    ("the virus-induced representative proteins IFIT1 (ISG56), IFIT2 (ISG54) and DDX58 (RIG-I)"
     . SPARSER::COLLECTION)
    ("WNT2B or WNT9B" . SPARSER::COLLECTION)
    ("WNT2B (also called WNT13, NR group IV) and WNT9B (also called WNT15 and WNT14B, NR group IV)"
     . SPARSER::COLLECTION)
    ("WNT15 and WNT14B" . SPARSER::COLLECTION) ("LUC" . SPARSER::PROTEIN)
    ("Wnt2 and Wnt11" . SPARSER::COLLECTION) ("WntD" . SPARSER::PROTEIN)
    ("RELA/p65" . SPARSER::COLLECTION) ("lipids" . SPARSER::LIPID)
    ("RLR-" . SPARSER::PROTEIN) ("NLR" . SPARSER::PROTEIN)
    ("NOD" . SPARSER::PROTEIN) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("Nile" . SPARSER::PROTEIN) ("TBK1/IKBKE" . SPARSER::COLLECTION)
    ("IKBKE" . SPARSER::PROTEIN) ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("proteins and RNA" . SPARSER::COLLECTION) ("rRNAs" . SPARSER::RNA)
    ("nucleoporin like 1 (NUPL1) and Exportin 1" . SPARSER::COLLECTION)
    ("nucleoporin 93 kDa (NUP93), RAN member RAS oncogene family (RAN), nucleoporin like 1 (NUPL1) and Exportin 1"
     . SPARSER::COLLECTION)
    ("member RAS oncogene family (RAN)" . SPARSER::PROTEIN)
    ("RAN" . SPARSER::PROTEIN)
    ("nuclear pore, proteasome and spliceosome" . SPARSER::COLLECTION)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("IRF3 (PR group IV) and the NF-κB subunits REL and RELA (both PR group IV)"
     . SPARSER::COLLECTION)
    ("the signaling components RIG-I (PR group II), MAVS (PR group III), IRF3 (PR group IV) and the NF-κB subunits REL and RELA (both PR group IV)"
     . SPARSER::COLLECTION)
    ("REL and RELA" . SPARSER::COLLECTION) ("RELA" . SPARSER::PROTEIN)
    ("REL" . SPARSER::PROTEIN)
    ("80 PR and 34 NR ( xref and xref )" . SPARSER::COLLECTION)
    ("at least two shRNAs" . SPARSER::RNA)
    ("a phosphomimetic mutant" . SPARSER::MUTANT) ("dsRNA" . SPARSER::RNA)
    ("292 potential PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("≤−1.314" . SPARSER::COLLECTION) ("−1" . SPARSER::PROTEIN)
    ("luciferase and mRNA" . SPARSER::COLLECTION) ("NR" . SPARSER::PROTEIN)
    ("Sigma-Aldrich" . SPARSER::COLLECTION) ("TRC" . SPARSER::PROTEIN)
    ("drosophila" . SPARSER::PROTEIN) ("TRIF and MAVS" . SPARSER::COLLECTION)
    ("TLR3 and RLR" . SPARSER::COLLECTION) ("TRIF" . SPARSER::PROTEIN)
    ("IPS-1, Cardif and VISA" . SPARSER::COLLECTION)
    ("VISA" . SPARSER::PROTEIN) ("Cardif" . SPARSER::PROTEIN)
    ("MAVS" . SPARSER::PROTEIN) ("RLRs" . SPARSER::PROTEIN)
    ("helicases" . SPARSER::PROTEIN) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("components of the innate immune response in virtually all cells and the target"
     . SPARSER::COLLECTION)
    ("IFN" . SPARSER::DRUG)
    ("pro-inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION) ("IFNs" . SPARSER::DRUG)
    ("PAMPs" . SPARSER::PROTEIN) ("PRRs" . SPARSER::PROTEIN)
    ("237 potential modulator genes" . SPARSER::GENE)
    ("an antiviral state" . SPARSER::BIO-STATE)
    ("WNT/CTNNB1" . SPARSER::COLLECTION)
    ("WNT2B and WNT9B" . SPARSER::COLLECTION)
    ("IFNB1 , IFIT1 and TNF" . SPARSER::COLLECTION) ("TNF" . SPARSER::PROTEIN)
    ("RLR" . SPARSER::PROTEIN) ("the first genome-wide gene" . SPARSER::GENE)
    ("SeV" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("phenol-red" . SPARSER::DRUG)
    ("a 3 µ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pEF1" . SPARSER::PROTEIN)
    ("IFNβ" . SPARSER::PROTEIN) ("pcDNA3.1" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("FZD5" . SPARSER::PROTEIN) ("LRP5/6" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("Y-box-binding protein-1" . SPARSER::PROTEIN)
    ("BIO-acetoxime" . SPARSER::DRUG) ("GSK3A" . SPARSER::PROTEIN)
    ("hemagglutinin-neuraminidase" . SPARSER::PROTEIN)
    ("LRRFIP1" . SPARSER::PROTEIN) ("GSK3B" . SPARSER::PROTEIN)
    ("low density lipoprotein receptor-related protein" . SPARSER::PROTEIN)
    ("WNT3A" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("Drosophila)" . SPARSER::PROTEIN) ("ISG54" . SPARSER::PROTEIN)
    ("IFIT2" . SPARSER::PROTEIN) ("ISG56" . SPARSER::PROTEIN)
    ("WNT14B" . SPARSER::PROTEIN) ("WNT15" . SPARSER::PROTEIN)
    ("WNT13" . SPARSER::PROTEIN) ("Wnt11" . SPARSER::PROTEIN)
    ("Wnt2" . SPARSER::PROTEIN) ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("CYP2U1" . SPARSER::PROTEIN) ("zinc finger protein" . SPARSER::PROTEIN)
    ("KLF6" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("RIPK2" . SPARSER::PROTEIN) ("IKKε" . SPARSER::PROTEIN)
    ("TBK1" . SPARSER::PROTEIN) ("DDX3" . SPARSER::PROTEIN)
    ("IFNA1" . SPARSER::PROTEIN) ("XPO1" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN) ("CRM1" . SPARSER::PROTEIN)
    ("Exportin 1" . SPARSER::PROTEIN) ("NUPL1" . SPARSER::PROTEIN)
    ("nucleoporin like 1" . SPARSER::PROTEIN)
    ("member RAS oncogene family" . SPARSER::PROTEIN)
    ("NUP93" . SPARSER::PROTEIN) ("nucleoporin 93" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("EEF1A1" . SPARSER::PROTEIN)
    ("EF1α" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("NLRX1" . SPARSER::PROTEIN) ("NLR family member X1" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("NS3" . SPARSER::PROTEIN)
    ("kappa light polypeptide gene" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN)
    ("interferon regulatory factor 3" . SPARSER::PROTEIN)
    ("IPS-1" . SPARSER::PROTEIN) ("DHX58" . SPARSER::PROTEIN)
    ("LGP2" . SPARSER::PROTEIN) ("IFIH1" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN) ("DDX58" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN) ("IFIT1" . SPARSER::PROTEIN)
    ("WNT9B" . SPARSER::PROTEIN) ("WNT2B" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("IFNB1" . SPARSER::PROTEIN) ("interferon-β" . SPARSER::DRUG)
    ("preferential allelic imbalance met" . SPARSER::AMINO-ACID)
    ("AHR and HDAC9" . SPARSER::COLLECTION) ("only two genes" . SPARSER::GENE)
    ("the causal gene or variants" . SPARSER::COLLECTION)
    ("Alleles" . SPARSER::ALLELE)
    ("group D-complementing" . SPARSER::COLLECTION)
    ("ataxia" . SPARSER::PROTEIN)
    ("both potentially functional amino acids and differential expression"
     . SPARSER::COLLECTION)
    ("AHR and HDAC9 and SNPs" . SPARSER::COLLECTION)
    ("HDAC9 and SNPs" . SPARSER::COLLECTION) ("Hdac9" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor ( AHR ) and histone deacetylase 9 ( HDAC9 )"
     . SPARSER::COLLECTION)
    ("protein ( SYPL )" . SPARSER::PROTEIN)
    ("synaptophysin" . SPARSER::PROTEIN)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AHR" . SPARSER::PROTEIN)
    ("copy-neutral loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("Mus" . SPARSER::PROTEIN) ("DNAs" . SPARSER::DNA)
    ("PAI" . SPARSER::PROTEIN)
    ("copy-neutral loss of heterozygosity" . SPARSER::PROTEIN)
    ("AGR2" . SPARSER::PROTEIN) ("IFRD1" . SPARSER::PROTEIN)
    ("interferon-related developmental regulator 1" . SPARSER::PROTEIN)
    ("diacylglycerol kinase" . SPARSER::PROTEIN) ("ETV1" . SPARSER::PROTEIN)
    ("BCAP29" . SPARSER::PROTEIN) ("family member 3" . SPARSER::PROTEIN)
    ("histone deacetylase 9" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("HDAC9" . SPARSER::PROTEIN) ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("E2 and E2" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("metalloproteinase and CD10" . SPARSER::COLLECTION)
    ("uPA" . SPARSER::PROTEIN) ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WNT–β-catenin" . SPARSER::COLLECTION) ("Amhr2" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN) ("CD3, CD4 and CD11b" . SPARSER::COLLECTION)
    ("E-cadherin and CD10" . SPARSER::COLLECTION)
    ("progesterone (E2 + P4) or P4" . SPARSER::COLLECTION)
    ("Mutant" . SPARSER::MUTANT) ("ovalbumin" . SPARSER::PROTEIN)
    ("Snail and ZEB1" . SPARSER::COLLECTION)
    ("ZEB1 and E-cadherin" . SPARSER::COLLECTION) ("uteri" . SPARSER::PROTEIN)
    ("ZEB1 and SIP1" . SPARSER::COLLECTION) ("Slug" . SPARSER::PROTEIN)
    ("Snail" . SPARSER::PROTEIN) ("phospho-histone" . SPARSER::PROTEIN)
    ("membranous β-catenin" . SPARSER::PROTEIN)
    ("mesenchymal genes" . SPARSER::GENE)
    ("ZEB1, ZEB2, SNAI1, SNAI2, Twist1, Twist2 and E12/E47"
     . SPARSER::COLLECTION)
    ("CTNNB1 or APC" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin–catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("progesterone" . SPARSER::PROTEIN)
    ("Vimentin and COUP-TFII" . SPARSER::COLLECTION)
    ("SNAIL and ZEB1" . SPARSER::COLLECTION) ("SNAIL" . SPARSER::PROTEIN)
    ("Ctnnb1" . SPARSER::PROTEIN) ("PR-Cre" . SPARSER::COLLECTION)
    ("Cre" . SPARSER::PROTEIN) ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Twist2" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("SNAI2" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN) ("GSK-3β" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("CTNNB1" . SPARSER::PROTEIN) ("steroid hormone" . SPARSER::MOLECULE)
    ("COUP-TFII" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("neurotoxic mediators" . SPARSER::PROTEIN)
    ("trophic growth factors" . SPARSER::GROWTH-FACTOR)
    ("peripheral macrophages" . SPARSER::PROTEIN)
    ("fractalkine" . SPARSER::PROTEIN)
    ("neurotransmitters or neuromodulators (Rostene et al., 2007)"
     . SPARSER::COLLECTION)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("Additional immediate downstream genes" . SPARSER::GENE)
    ("RBP-Jk and CBF1" . SPARSER::COLLECTION) ("HEY" . SPARSER::PROTEIN-FAMILY)
    ("CSL" . SPARSER::PROTEIN)
    ("the γ-secretase enzyme complex and a concomitant release of the Notch intracellular domain (NICD)"
     . SPARSER::COLLECTION)
    ("Delta and Jagged-1" . SPARSER::COLLECTION) ("NICD" . SPARSER::PROTEIN)
    ("Delta" . SPARSER::PROTEIN) ("MAPKs and Egr-1" . SPARSER::COLLECTION)
    ("MAPKs" . SPARSER::PROTEIN) ("the endothelial barrier" . SPARSER::PROTEIN)
    ("pro-inflammatory modulators" . SPARSER::PROTEIN)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("Cocaine" . SPARSER::DRUG) ("amyloid" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN) ("a key chemokine" . SPARSER::PROTEIN)
    ("the chemokine monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("ERK and JNK" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("newly migrating macrophages" . SPARSER::PROTEIN)
    ("chemokines and growth factors" . SPARSER::COLLECTION)
    ("gene-" . SPARSER::GENE) ("the tropic factor PDGF-B" . SPARSER::PROTEIN)
    ("morphine" . SPARSER::MOLECULE) ("MicroRNA" . SPARSER::RNA)
    ("PI3K and TRPC" . SPARSER::COLLECTION) ("-GSK3β" . SPARSER::COLLECTION)
    ("yet another PDGF isoform" . SPARSER::ISOFORM)
    ("viral proteins" . SPARSER::PROTEIN)
    ("p70S6K and NF-kB" . SPARSER::COLLECTION)
    ("mTOR/4E-BP" . SPARSER::COLLECTION)
    ("rat hippocampal NPCs" . SPARSER::MOLECULE)
    ("psychostimulants" . SPARSER::DRUG)
    ("an early viral protein" . SPARSER::PROTEIN) ("ART" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN) ("dentate" . SPARSER::PROTEIN)
    ("NPCs" . SPARSER::MOLECULE)
    ("other cytoskeletal proteins" . SPARSER::PROTEIN)
    ("Narp ( xref ) and cpg-2" . SPARSER::COLLECTION)
    ("Homer ( xref ), Narp ( xref ) and cpg-2" . SPARSER::COLLECTION)
    ("immediate-early genes" . SPARSER::GENE) ("Narp" . SPARSER::PROTEIN)
    ("Homer" . SPARSER::PROTEIN-FAMILY) ("LTP" . SPARSER::PROTEIN)
    ("synaptic plasticity gene Arc/Arg3.1" . SPARSER::COLLECTION)
    ("Arc/Arg3.1" . SPARSER::COLLECTION) ("Arc" . SPARSER::PROTEIN)
    ("TRP" . SPARSER::AMINO-ACID) ("Pyk2/ERK/CREB" . SPARSER::COLLECTION)
    ("ERK/CREB" . SPARSER::COLLECTION) ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nonselective cation" . SPARSER::MOLECULE) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("the respective gene" . SPARSER::GENE)
    ("two classical tyrosine kinase receptors" . SPARSER::RECEPTOR)
    ("five dimeric ligands" . SPARSER::LIGAND) ("-BB" . SPARSER::MOLECULE)
    ("BB" . SPARSER::MOLECULE)
    ("yet another neurotrophic factor" . SPARSER::PROTEIN)
    ("BDNF, NGF, and GDNF" . SPARSER::COLLECTION)
    ("the key viral toxins" . SPARSER::MOLECULE) ("toxins" . SPARSER::MOLECULE)
    ("viral and cellular neurotoxins" . SPARSER::PROTEIN)
    ("dopamine" . SPARSER::PROTEIN) ("TRPC" . SPARSER::PROTEIN)
    ("cocaine" . SPARSER::DRUG) ("leukocytes" . SPARSER::PROTEIN)
    ("endothelial barrier" . SPARSER::PROTEIN)
    ("derived growth factor (PDGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("brain derived neurotrophic factor (BDNF)" . SPARSER::PROTEIN)
    ("neurotrophic factor (GDNF)" . SPARSER::PROTEIN)
    ("growth factor (NGF)" . SPARSER::GROWTH-FACTOR)
    ("cellular and viral neurotoxins" . SPARSER::PROTEIN)
    ("GDNF" . SPARSER::PROTEIN) ("NGF" . SPARSER::PROTEIN)
    ("BDNF" . SPARSER::PROTEIN) ("neurotoxins" . SPARSER::PROTEIN)
    ("cART" . SPARSER::HUMAN-PROTEIN-FAMILY) ("barrier" . SPARSER::PROTEIN)
    ("neuroprotective agent" . SPARSER::DRUG) ("CBF1" . SPARSER::PROTEIN)
    ("RBP-Jk" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("Jagged-1" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("miR29b" . SPARSER::RNA) ("miR-29b" . SPARSER::MOLECULE)
    ("GSK3β" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN) ("A-D" . SPARSER::PROTEIN)
    ("GSK 3β" . SPARSER::PROTEIN) ("TRPC 1" . SPARSER::PROTEIN)
    ("PDGF-B" . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("4E-BP" . SPARSER::PROTEIN) ("TRPC1" . SPARSER::PROTEIN)
    ("Egr-1" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("STI-571" . SPARSER::DRUG) ("PDGF-R" . SPARSER::PROTEIN)
    ("Arg3.1" . SPARSER::PROTEIN) ("Pyk2" . SPARSER::PROTEIN)
    ("TRPC 5" . SPARSER::PROTEIN) ("PDGF-A" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN) ("PDGF-BB" . SPARSER::PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN)
    ("brain derived neurotrophic factor" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::DRUG) ("JG and DH" . SPARSER::COLLECTION)
    ("BK" . SPARSER::PROTEIN) ("DH" . SPARSER::PROTEIN)
    ("CR" . SPARSER::PROTEIN) ("FB" . SPARSER::PROTEIN)
    ("the ROCK1 gene and human cardiac malformations" . SPARSER::PROTEIN)
    ("gene and human" . SPARSER::COLLECTION)
    ("human cardiac malformations" . SPARSER::PROTEIN)
    ("a plausible candidate gene" . SPARSER::GENE)
    ("cardiac malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN)
    ("a similarly large cohort" . SPARSER::MOLECULE)
    ("the associated variants" . SPARSER::VARIANT)
    ("our two associated variants" . SPARSER::VARIANT)
    ("mAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ROCK1 and TOF" . SPARSER::COLLECTION)
    ("a causative variant" . SPARSER::VARIANT)
    ("intronic variant" . SPARSER::VARIANT)
    ("a highly evolutionary conserved nucleotide" . SPARSER::NUCLEOTIDE)
    ("a novel rare synonymous variant" . SPARSER::VARIANT)
    ("Variant" . SPARSER::VARIANT)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID)
    ("a strong candidate gene" . SPARSER::GENE) ("EVC" . SPARSER::PROTEIN)
    ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("the principal proteins" . SPARSER::PROTEIN)
    ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("a Wnt protein and a Frizzled (Fz) receptor" . SPARSER::COLLECTION)
    ("genesis" . SPARSER::PROTEIN) ("PCP" . SPARSER::PROTEIN)
    ("Nkx2.5 and Tbx1" . SPARSER::COLLECTION) ("Tbx1" . SPARSER::PROTEIN)
    ("Tbx" . SPARSER::PROTEIN-FAMILY) ("teratogen" . SPARSER::MOLECULE)
    ("the commonest cyanotic CHD" . SPARSER::PROTEIN)
    ("CHD" . SPARSER::PROTEIN) ("a further 209 TOF" . SPARSER::PROTEIN)
    ("TOF" . SPARSER::PROTEIN) ("SrP40" . SPARSER::PROTEIN)
    ("ROCK1 protein" . SPARSER::PROTEIN)
    ("Ellis van Creveld syndrome" . SPARSER::PROTEIN)
    ("protein Dishevelled" . SPARSER::PROTEIN) ("Nkx2.5" . SPARSER::PROTEIN)
    ("OR 1" . SPARSER::PROTEIN) ("ROCK1" . SPARSER::PROTEIN)
    ("non-syndromic" . SPARSER::PROTEIN) ("Bid and BAK" . SPARSER::COLLECTION)
    ("peptides or proteins" . SPARSER::COLLECTION)
    ("these mitochondrial enriched subcellular fractions" . SPARSER::COMPONENT)
    ("either p53 or BH3 proteins" . SPARSER::COLLECTION)
    ("the apoptotic inducer" . SPARSER::PROTEIN)
    ("BAK monomers and non-specific dimer" . SPARSER::COLLECTION)
    ("only BAK dimers" . SPARSER::DIMER) ("monomers" . SPARSER::MONOMER)
    ("monomeric BAK protein" . SPARSER::PROTEIN)
    ("trimers and higher-order" . SPARSER::COLLECTION)
    ("WT BAK and the Y110F mutant" . SPARSER::COLLECTION)
    ("trimers" . SPARSER::TRIMER) ("BMH" . SPARSER::PROTEIN)
    ("crosslinker" . SPARSER::PROTEIN)
    ("sub-cellular fractions" . SPARSER::COMPONENT)
    ("HCT-BAK" . SPARSER::COLLECTION) ("bax" . SPARSER::PROTEIN)
    ("bak" . SPARSER::PROTEIN) ("IMS" . SPARSER::PROTEIN-FAMILY)
    ("Resultant homodimers" . SPARSER::HOMODIMER)
    ("indeed cells lacking both BAK and BAX" . SPARSER::COLLECTION)
    ("Pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("Bid, Bim and Noxa" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("Bim" . SPARSER::PROTEIN)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("BAK:BAK" . SPARSER::BIO-COMPLEX) ("Bid" . SPARSER::PROTEIN)
    ("tBid" . SPARSER::PROTEIN) ("mitochondria" . SPARSER::PROTEIN)
    ("a phosphor-mimetic BAK mutant" . SPARSER::MUTANT)
    ("BAK/BAX" . SPARSER::COLLECTION) ("etoposide" . SPARSER::PROTEIN)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("proteins or p53" . SPARSER::COLLECTION)
    ("BAK and BAX" . SPARSER::COLLECTION) ("MOMP" . SPARSER::PROTEIN)
    ("BAK" . SPARSER::PROTEIN) ("activator protein" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("traditional drugs" . SPARSER::DRUG)
    ("tasocitinib" . SPARSER::DRUG) ("tocilizumab" . SPARSER::DRUG)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("kinase or phosphatase" . SPARSER::COLLECTION)
    ("JAK3, PIM1 and PDGFRα" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN) ("AP1, STAT and SP3" . SPARSER::COLLECTION)
    ("AP1-" . SPARSER::PROTEIN)
    ("the SOCS3 minimal promoter" . SPARSER::PROMOTER)
    ("the full-length −2757 promoter and the −107 minimal promoter ( xref a)"
     . SPARSER::COLLECTION)
    ("the −107 minimal promoter" . SPARSER::PROMOTER) ("ATG" . SPARSER::DRUG)
    ("ERK and the ERK-targeted transcription factors AP1 and SP3"
     . SPARSER::COLLECTION)
    ("the minimal SOCS3 promoter" . SPARSER::PROMOTER)
    ("AP1 and SP3" . SPARSER::COLLECTION)
    ("neither PD184352 nor AZD6244" . SPARSER::COLLECTION)
    ("resveratrol and flavone" . SPARSER::COLLECTION)
    ("ERK and SOCS3" . SPARSER::COLLECTION)
    ("PD184352 and AZD6244" . SPARSER::COLLECTION)
    ("forskolin and IL-6" . SPARSER::COLLECTION)
    ("IL-6 and forskolin" . SPARSER::COLLECTION) ("PKA" . SPARSER::PROTEIN)
    ("rolipram and forksolin demonstrated that rolipram" . SPARSER::COLLECTION)
    ("S3b" . SPARSER::PROTEIN)
    ("flavone, resveratrol and rolipram" . SPARSER::COLLECTION)
    ("flavone and resveratrol" . SPARSER::COLLECTION)
    ("CK2 or PDE4" . SPARSER::COLLECTION) ("S3a" . SPARSER::PROTEIN)
    ("cAMP and ERK" . SPARSER::COLLECTION)
    ("ERK and EPAC1" . SPARSER::COLLECTION)
    ("10 μM forskolin and 10 μM rolipram" . SPARSER::COLLECTION)
    ("ester" . SPARSER::MOLECULE) ("PKC" . SPARSER::PROTEIN)
    ("agonist" . SPARSER::AGONIST) ("AMPK" . SPARSER::PROTEIN)
    ("trans -resveratrol and flavone" . SPARSER::COLLECTION)
    ("the adenylate cyclase activator forskolin and the cAMP-specific PDE (phosphodiesterase) 4 inhibitor rolipram (F/R; xref )"
     . SPARSER::COLLECTION)
    ("PDE" . SPARSER::PROTEIN) ("forskolin" . SPARSER::PROTEIN)
    ("two commercially available JAK inhibitors" . SPARSER::INHIBITOR)
    ("100 μM flavone and 100 μM resveratrol treatment" . SPARSER::COLLECTION)
    ("the atherogenic chemokine MCP1" . SPARSER::PROTEIN)
    ("mRNA and mRNA" . SPARSER::COLLECTION)
    ("the naturally occurring STAT3 inhibitor 100 μM trans -resveratrol"
     . SPARSER::MOLECULE)
    ("dietary naringenin" . SPARSER::DRUG) ("carbohydrate" . SPARSER::MOLECULE)
    ("antioxidant" . SPARSER::PROTEIN) ("radical" . SPARSER::MOLECULE)
    ("apigenin" . SPARSER::DRUG) ("FDA" . SPARSER::PROTEIN)
    ("the minimal human SOCS3 gene promoter" . SPARSER::PROMOTER)
    ("JAK and STAT3" . SPARSER::COLLECTION) ("AMP" . SPARSER::AMP)
    ("cAMP" . SPARSER::PROTEIN) ("ethidium" . SPARSER::MOLECULE)
    ("-GGAGTTTGGGTTTGCTTGTC-3" . SPARSER::COLLECTION)
    ("-GCTCAGCCAGATGCAATCAA-3" . SPARSER::COLLECTION)
    ("-GCCGATCCACACGGAGTACT-3" . SPARSER::COLLECTION)
    ("-CTGGCACCCAGCACAATG-3" . SPARSER::COLLECTION)
    ("-AAGTGTCCCCTGTTTGGAGG-3" . SPARSER::COLLECTION)
    ("-CACATGGCACAAGCACAAGA-3" . SPARSER::COLLECTION)
    ("0.4 mM dNTPs and 0.6 μM" . SPARSER::COLLECTION)
    ("dNTPs" . SPARSER::MOLECULE)
    ("phospho-VASP (Ser 157 ) or phospho-ERK1/2 (extracellular-signal-regulated kinase 1/2)"
     . SPARSER::COLLECTION)
    ("VASP" . SPARSER::PROTEIN) ("ACC" . SPARSER::PROTEIN)
    ("BSA" . SPARSER::PROTEIN) ("nitrocellulose" . SPARSER::MOLECULE)
    ("Bromophenol" . SPARSER::MOLECULE) ("EDTA" . SPARSER::MOLECULE)
    ("mercaptoethanol" . SPARSER::MOLECULE) ("Tris" . SPARSER::MOLECULE)
    ("The resulting minimal promoter fragment" . SPARSER::FRAGMENT)
    ("GGCCGCGAGCAGGGGCTACCCAGCCTCGGC-3" . SPARSER::COLLECTION)
    ("-GCCGAGGCTGGGTAGCCCCTGCTCGCGGCC-3" . SPARSER::COLLECTION)
    ("A minimal promoter" . SPARSER::PROMOTER) ("ON" . SPARSER::PROTEIN)
    ("COS" . SPARSER::MOLECULE) ("Dr" . SPARSER::MOLECULE)
    ("GACCGGCCGGGC-3" . SPARSER::COLLECTION) ("TGT" . SPARSER::PROTEIN)
    ("TC" . SPARSER::PROTEIN) ("ACA" . SPARSER::PROTEIN)
    ("TACTCTGCACTGAAAGGC-3" . SPARSER::COLLECTION)
    ("ACATTACAAGAAGACCGGCCGGGC-3" . SPARSER::COLLECTION)
    ("dSTAT and pSTAT" . SPARSER::COLLECTION) ("dSTAT" . SPARSER::PROTEIN)
    ("-resveratrol" . SPARSER::COLLECTION) ("isoflavone" . SPARSER::MOLECULE)
    ("Aldrich" . SPARSER::PROTEIN) ("chemicals" . SPARSER::MOLECULE)
    ("Sigma–Aldrich and Indofine" . SPARSER::COLLECTION)
    ("Sigma–Aldrich" . SPARSER::COLLECTION) ("-2-" . SPARSER::PROTEIN)
    ("benzenediol" . SPARSER::MOLECULE) ("chroman" . SPARSER::MOLECULE)
    ("Forskolin, rolipram, PMA, compound C and MG132" . SPARSER::COLLECTION)
    ("PMA" . SPARSER::PROTEIN) ("rolipram" . SPARSER::DRUG)
    ("Forskolin" . SPARSER::PROTEIN) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("PBS" . SPARSER::PROTEIN) ("secondary antibodies" . SPARSER::ANTIBODY)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("peroxidase" . SPARSER::PROTEIN)
    ("the structurally related molecule resveratrol and other ‘traditional’ JAK inhibitors"
     . SPARSER::COLLECTION)
    ("other ‘traditional’ JAK inhibitors" . SPARSER::INHIBITOR)
    ("the heterocyclic small molecules naringenin and flavone"
     . SPARSER::COLLECTION)
    ("SOCS3-inducer" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("Cell-permeable forms" . SPARSER::FORM) ("Socs3" . SPARSER::PROTEIN)
    ("SH" . SPARSER::PROTEIN-FAMILY)
    ("pro-inflammatory IL-6-responsive genes" . SPARSER::GENE)
    ("MCP-1 and ICAM1" . SPARSER::COLLECTION) ("soluble forms" . SPARSER::FORM)
    ("sIL" . SPARSER::PROTEIN) ("chemokines" . SPARSER::PROTEIN)
    ("TNFα and IL-1" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and TNFα" . SPARSER::COLLECTION) ("interleukin" . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN)
    ("flavone- and cAMP-dependent" . SPARSER::COLLECTION)
    ("flavone-" . SPARSER::DRUG)
    ("the atherogenic STAT3 target gene MCP1" . SPARSER::PROTEIN)
    ("traditional JAK/STAT3 inhibitors" . SPARSER::INHIBITOR)
    ("JAK/STAT3" . SPARSER::COLLECTION) ("resveratrol" . SPARSER::PROTEIN)
    ("naringenin and flavone" . SPARSER::COLLECTION)
    ("protein, mRNA and promoter" . SPARSER::COLLECTION)
    ("flavone" . SPARSER::DRUG) ("naringenin" . SPARSER::DRUG)
    ("inducers" . SPARSER::MOLECULE)
    ("The atherogenic cytokine IL-6" . SPARSER::PROTEIN)
    ("/STAT3" . SPARSER::COLLECTION) ("anti-neoplastic" . SPARSER::DRUG)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("PIM1" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("S1b" . SPARSER::PROTEIN) ("AZD6244" . SPARSER::DRUG)
    ("PDE4" . SPARSER::PROTEIN) ("casein kinase 2" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("PD184352" . SPARSER::DRUG)
    ("EPAC1" . SPARSER::PROTEIN) ("Gö6983" . SPARSER::DRUG)
    ("AMP-activated" . SPARSER::PROTEIN) ("Compound C" . SPARSER::MOLECULE)
    ("cAMP-specific" . SPARSER::PROTEIN) ("TG101348" . SPARSER::DRUG)
    ("Trans -resveratrol" . SPARSER::MOLECULE) ("de-" . SPARSER::MOLECULE)
    ("STAT3 " . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase 1" . SPARSER::PROTEIN)
    ("vasodilator-stimulated phosphoprotein" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("pGL4" . SPARSER::PROTEIN)
    ("3-1" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("trans -resveratrol" . SPARSER::MOLECULE) ("ICAM1" . SPARSER::PROTEIN)
    ("IL6-R" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("SP3" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("cAMP-dependent" . SPARSER::PROTEIN) ("compound C" . SPARSER::MOLECULE)
    ("MCP1" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("ERK2, CDK2 and DOC-1R" . SPARSER::COLLECTION)
    ("p21, p27 and p57" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("ankyrin" . SPARSER::PROTEIN)
    ("CIP/KIP" . SPARSER::COLLECTION) ("KIP" . SPARSER::PROTEIN)
    ("CIP" . SPARSER::PROTEIN) ("CKI" . SPARSER::PROTEIN)
    ("the monomeric form" . SPARSER::FORM)
    ("DOC-1R-CDK2" . SPARSER::COLLECTION)
    ("two deleted mutants" . SPARSER::MUTANT)
    ("FLAG-CDK2" . SPARSER::COLLECTION) ("pFLAG-CDK2" . SPARSER::PROTEIN-PAIR)
    ("DOC-1R" . SPARSER::PROTEIN) ("GST-DOC-1R" . SPARSER::COLLECTION)
    ("cyclin-CDK" . SPARSER::COLLECTION) ("RAL" . SPARSER::PROTEIN)
    ("monomeric CDK2" . SPARSER::PROTEIN)
    ("antibody or anti-CDK2" . SPARSER::COLLECTION)
    ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("cyclin E or A protein (Fig. xref A)" . SPARSER::COLLECTION)
    ("a monomeric form" . SPARSER::FORM)
    ("activator (CAK)" . SPARSER::ACTIVATOR)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("the essential regulators" . SPARSER::REGULATOR)
    ("the tumor suppressor gene MEN1 and several oncogenes"
     . SPARSER::COLLECTION)
    ("CCND1/cyclin D1/PRAD1" . SPARSER::COLLECTION)
    ("p21, p27, and p53" . SPARSER::COLLECTION) ("ERK2" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("p19" . SPARSER::PROTEIN)
    ("p18" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("CDC25" . SPARSER::PROTEIN) ("reverse transcriptase" . SPARSER::PROTEIN)
    ("tween 20" . SPARSER::MOLECULE)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PRAD1" . SPARSER::PROTEIN)
    ("MEN1" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("DOC-1" . SPARSER::PROTEIN) ("kinase and PP2A" . SPARSER::COLLECTION)
    ("BAF" . SPARSER::PROTEIN) ("MAN1 and RanBP3" . SPARSER::COLLECTION)
    ("PPM1A-MAN1" . SPARSER::COLLECTION)
    ("Smad2 or Smad3" . SPARSER::COLLECTION)
    ("SARA and MAN1" . SPARSER::COLLECTION) ("proline" . SPARSER::AMINO-ACID)
    ("phosphorylated R-Smad and the enzyme" . SPARSER::COLLECTION)
    ("PPM1A and Smad2/3" . SPARSER::COLLECTION)
    ("Myc-Smad3" . SPARSER::COLLECTION) ("HA-Smad4" . SPARSER::COLLECTION)
    ("Flag-MAN1" . SPARSER::COLLECTION) ("Myc-Smad2" . SPARSER::COLLECTION)
    ("R-Smad-Smad4" . SPARSER::COLLECTION)
    ("the MAN1 fragment and the Smad3-Smad4 heterotrimer"
     . SPARSER::COLLECTION)
    ("the phosphomimetic Smad3 fragment (S3LMH2EEE) and S4LMH2 co-eluted ( xref )"
     . SPARSER::COLLECTION)
    ("the phosphomimetic Smad3 fragment" . SPARSER::FRAGMENT)
    ("the phosphomimetic Smad2 fragment S2LMH2EEE and the fragment"
     . SPARSER::COLLECTION)
    ("the phosphomimetic Smad2 fragment S2LMH2EEE" . SPARSER::PROTEIN)
    ("MAN1–Smad2" . SPARSER::COLLECTION)
    ("the homotrimeric forms" . SPARSER::FORM)
    ("the heterotrimeric complexes" . SPARSER::BIO-COMPLEX)
    ("the heteromeric complexes" . SPARSER::BIO-COMPLEX)
    ("Smad3/Smad4" . SPARSER::COLLECTION) ("Smad2/Smad4" . SPARSER::COLLECTION)
    ("Smad2 and FAST1" . SPARSER::COLLECTION)
    ("Myc-FAST1" . SPARSER::COLLECTION) ("Flag-Smad2" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAST1 (LDALFQGVPPNKSIYDVWVSHPRDL)" . SPARSER::PROTEIN)
    ("the Smad2 phosphomimetic triple mutant S2LMH2EEE" . SPARSER::PROTEIN)
    ("FAST1 and MAN1" . SPARSER::COLLECTION)
    ("MAN1 and FAST1" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAN1 and Smad4" . SPARSER::COLLECTION) ("trimer" . SPARSER::TRIMER)
    ("the trimeric Smad2 fragment" . SPARSER::FRAGMENT)
    ("a trimeric Smad2 oligomer" . SPARSER::MOLECULE)
    ("a trimeric oligomer" . SPARSER::MOLECULE)
    ("oligomer" . SPARSER::MOLECULE) ("Gln" . SPARSER::AMINO-ACID)
    ("alanines" . SPARSER::AMINO-ACID) ("Smad2-MAN1" . SPARSER::COLLECTION)
    ("the phosphomimetic triple mutant S2LMH2EEE" . SPARSER::PROTEIN)
    ("S2LMH2EEE" . SPARSER::PROTEIN)
    ("the oligomeric state" . SPARSER::BIO-STATE)
    ("the phosphomimetic triple mutant" . SPARSER::MUTANT)
    ("the trimeric Smad2 protein" . SPARSER::PROTEIN)
    ("the phosphomimetic form" . SPARSER::FORM)
    ("the trimeric form" . SPARSER::FORM) ("EEE" . SPARSER::MOLECULE)
    ("linker" . SPARSER::LINKER)
    ("a phosphomimetic triple mutant" . SPARSER::MUTANT)
    ("Smad anchor for receptor activation (SARA)" . SPARSER::PROTEIN)
    ("SARA" . SPARSER::PROTEIN) ("Lys" . SPARSER::AMINO-ACID)
    ("Asp" . SPARSER::AMINO-ACID) ("Trp" . SPARSER::AMINO-ACID)
    ("FAST1-Smad2" . SPARSER::COLLECTION)
    ("an activated nuclear phosphoprotein and its deactivating phosphatase"
     . SPARSER::COLLECTION)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoprotein" . SPARSER::PROTEIN) ("scaffold" . SPARSER::SCAFFOLD)
    ("MAD" . SPARSER::PROTEIN) ("left-side–specific genes" . SPARSER::GENE)
    ("bone morphogenic protein (BMP)" . SPARSER::PROTEIN)
    ("MAN1 and Smad1 or Smad2 and Smad3" . SPARSER::COLLECTION)
    ("Smad1 or Smad2 and Smad3" . SPARSER::COLLECTION)
    ("BMP" . SPARSER::PROTEIN) ("Smad6 and Smad7" . SPARSER::COLLECTION)
    ("Smad1, Smad2, Smad3, Smad5 and Smad8" . SPARSER::COLLECTION)
    ("Receptors" . SPARSER::RECEPTOR) ("emerin" . SPARSER::PROTEIN)
    ("LEM" . SPARSER::PROTEIN) ("auto-antibodies" . SPARSER::ANTIBODY)
    ("developmental cues" . SPARSER::PROTEIN-FAMILY)
    ("intranuclear regulators" . SPARSER::REGULATOR)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("Smad4, and MAN1" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("Smad3-Smad4" . SPARSER::COLLECTION) ("Smad2-Smad4" . SPARSER::COLLECTION)
    ("activin" . SPARSER::PROTEIN) ("forkhead" . SPARSER::PROTEIN)
    ("MAN1-Smad2" . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("ID 1" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("B12" . SPARSER::PROTEIN) ("67 kD)" . SPARSER::PROTEIN)
    ("mM 3" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("LEM4" . SPARSER::PROTEIN) ("RanBP3" . SPARSER::PROTEIN)
    ("MAN1C" . SPARSER::PROTEIN) ("H- 15" . SPARSER::PROTEIN)
    ("R-Smad" . SPARSER::PROTEIN-FAMILY) ("U7" . SPARSER::PROTEIN)
    ("PDB 1" . SPARSER::PROTEIN) ("SMAD2" . SPARSER::PROTEIN)
    ("A-K" . SPARSER::PROTEIN) ("H-R" . SPARSER::PROTEIN)
    ("Smad anchor for receptor activation" . SPARSER::PROTEIN)
    ("U2AF" . SPARSER::BIO-COMPLEX) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NET25" . SPARSER::PROTEIN) ("Smad6" . SPARSER::PROTEIN)
    ("Smad8" . SPARSER::PROTEIN) ("Smad5" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("R-Smads" . SPARSER::PROTEIN)
    ("LAP2" . SPARSER::PROTEIN) ("envelope protein" . SPARSER::PROTEIN)
    ("PPM1A" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("FAST1" . SPARSER::PROTEIN) ("LEMD3" . SPARSER::PROTEIN)
    ("MAN1" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nutrient" . SPARSER::MOLECULE) ("HIF-" . SPARSER::PROTEIN-FAMILY)
    ("oxygenase" . SPARSER::PROTEIN) ("miRNA and gene" . SPARSER::COLLECTION)
    ("p73 and p63" . SPARSER::COLLECTION)
    ("both hypoxia and the hypoxia-mimetic DMOG" . SPARSER::COLLECTION)
    ("RTK" . SPARSER::PROTEIN) ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("PKB and MAPK" . SPARSER::COLLECTION)
    ("PKB and ERK" . SPARSER::COLLECTION) ("Tyr" . SPARSER::AMINO-ACID)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("hypoxia (when miR-100 levels are low) or anti-miR-100"
     . SPARSER::COLLECTION)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("the robust hypoxia-induced miRNA" . SPARSER::PROTEIN)
    ("bladder urothelial line h-TERT" . SPARSER::PROTEIN)
    ("FGFR3 mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("PHD" . SPARSER::PROTEIN) ("DMOG" . SPARSER::DRUG)
    ("the robust HIF-1 α target gene CAIX" . SPARSER::PROTEIN)
    ("CAIX" . SPARSER::PROTEIN) ("MicroRNAs" . SPARSER::RNA)
    ("LOX" . SPARSER::PROTEIN) ("LDHA" . SPARSER::PROTEIN)
    ("VEGF" . SPARSER::PROTEIN) ("PHDs" . SPARSER::PROTEIN)
    ("prolyl" . SPARSER::PROTEIN) ("normoxia" . SPARSER::PROTEIN)
    ("two possible α -subunits" . SPARSER::COLLECTION)
    ("HIF-1 α or HIF-2 α" . SPARSER::COLLECTION)
    ("-subunit" . SPARSER::FRAGMENT) ("-subunits" . SPARSER::COLLECTION)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("ERK/MAPK" . SPARSER::COLLECTION)
    ("FGFRs" . SPARSER::PROTEIN) ("FGFR" . SPARSER::PROTEIN)
    ("FGFR3 , H-RAS and phosphotidylinositol" . SPARSER::COLLECTION)
    ("TP53 , RB and PTEN" . SPARSER::COLLECTION) ("Hypoxia" . SPARSER::PROTEIN)
    ("MAPK and PKB" . SPARSER::COLLECTION)
    ("the downstream kinases mitogen-activated protein kinase (MAPK) and protein kinase B (PKB)"
     . SPARSER::COLLECTION)
    ("PKB" . SPARSER::PROTEIN) ("siRNA or mimic-100" . SPARSER::COLLECTION)
    ("NMI" . SPARSER::PROTEIN) ("in Chinese hamster" . SPARSER::PROTEIN)
    ("C-MET" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("h-TERT" . SPARSER::PROTEIN) ("FGFR  3" . SPARSER::PROTEIN)
    ("single-stranded RNA" . SPARSER::RNA) ("HIF-2 α" . SPARSER::PROTEIN)
    ("regulated kinase" . SPARSER::PROTEIN) ("H-RAS" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF-1 α" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("Non-muscle" . SPARSER::PROTEIN) ("AK" . SPARSER::PROTEIN)
    ("AF" . SPARSER::PROTEIN)
    ("Constitutive photomorphogenic homolog subunit 5" . SPARSER::PROTEIN)
    ("GAPDH" . SPARSER::PROTEIN) ("Deoxyribonucleoside" . SPARSER::MOLECULE)
    ("dNTP" . SPARSER::MOLECULE) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ribonuclease" . SPARSER::PROTEIN) ("RNase" . SPARSER::PROTEIN)
    ("BAX/BCL2" . SPARSER::COLLECTION) ("P50/P65" . SPARSER::COLLECTION)
    ("caspases" . SPARSER::PROTEIN) ("FASLG" . SPARSER::PROTEIN)
    ("the tumor histological type" . TYPE)
    ("a novel unfavorable and independent tumor biomarker" . SPARSER::MOLECULE)
    ("mSin3a" . SPARSER::PROTEIN) ("HDAC" . SPARSER::PROTEIN)
    ("cytoplasmic heterogeneous nuclear ribonucleoprotein K (HNRNPK) and thymidine phosphorylase (TYMP)"
     . SPARSER::COLLECTION)
    ("heterogeneous nuclear ribonucleoprotein K (HNRNPK)" . SPARSER::PROTEIN)
    ("TYMP" . SPARSER::PROTEIN) ("HNRNPK" . SPARSER::PROTEIN)
    ("another potential biomarker" . SPARSER::MOLECULE)
    ("DROSHA and DICER" . SPARSER::COLLECTION) ("DICER" . SPARSER::PROTEIN)
    ("DROSHA" . SPARSER::PROTEIN) ("Guo" . SPARSER::MOLECULE)
    ("RASSF1 , RARB , and DAPK1" . SPARSER::COLLECTION)
    ("RARB" . SPARSER::PROTEIN)
    ("reliable tissue biomarkers" . SPARSER::MOLECULE)
    ("metastatic NPC" . SPARSER::MOLECULE) ("HR " . SPARSER::PROTEIN)
    ("N2 or N3" . SPARSER::COLLECTION)
    ("undifferentiated type and 42 (47.7%)" . SPARSER::COLLECTION)
    ("novel prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("Several potential NPC biomarkers" . SPARSER::MOLECULE)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("NPC and EBV" . SPARSER::COLLECTION)
    ("BCL2 and BCLX" . SPARSER::COLLECTION)
    ("BH2 and BH3 domains" . SPARSER::COLLECTION)
    ("epsilon" . SPARSER::PROTEIN) ("delta, and sigma" . SPARSER::COLLECTION)
    ("sigma" . SPARSER::PROTEIN-FAMILY) ("delta" . SPARSER::PROTEIN)
    ("BCL2-associated X (BAX) protein" . SPARSER::PROTEIN)
    ("oxidants" . SPARSER::MOLECULE) ("hypoxia" . SPARSER::PROTEIN)
    ("BAX, BAD, BID and BCLX" . SPARSER::COLLECTION)
    ("BCLW" . SPARSER::PROTEIN) ("BCLX" . SPARSER::PROTEIN)
    ("BID" . SPARSER::PROTEIN) ("BAD" . SPARSER::PROTEIN)
    ("BCL2-homology" . SPARSER::COLLECTION) ("pro-" . SPARSER::AMINO-ACID)
    ("apoptosomes" . SPARSER::BIO-COMPLEX)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("a prognostic tumor biomarker" . SPARSER::MOLECULE)
    ("BCL2 and BCL2L12" . SPARSER::COLLECTION)
    ("associated X ( BAX ) gene" . SPARSER::GENE) ("NPC" . SPARSER::MOLECULE)
    ("Nuclear receptor subfamily" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN)
    ("Histone deacetylase" . SPARSER::PROTEIN)
    ("Breast cancer metastasis suppressor 1" . SPARSER::PROTEIN)
    ("Thymidine phosphorylase" . SPARSER::PROTEIN)
    ("Heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN) ("P65" . SPARSER::PROTEIN)
    ("P50" . SPARSER::PROTEIN) ("LMP1" . SPARSER::PROTEIN)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("TMBIM6" . SPARSER::PROTEIN) ("cytochrome C" . SPARSER::PROTEIN)
    ("NR4A1" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN)
    ("nuclear receptor subfamily" . SPARSER::PROTEIN)
    ("COPS5" . SPARSER::PROTEIN) ("subunit 5" . SPARSER::PROTEIN)
    ("BRMS1" . SPARSER::PROTEIN)
    ("breast cancer metastasis suppressor 1" . SPARSER::PROTEIN)
    ("thymidine phosphorylase" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("KRT18" . SPARSER::PROTEIN) ("Cytokeratin-18" . SPARSER::PROTEIN)
    ("DAPK1" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("COX2" . SPARSER::PROTEIN) ("PTGS2" . SPARSER::PROTEIN)
    ("N3" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("of 45" . SPARSER::PROTEIN) ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("alpha isoform" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("BH4" . SPARSER::PROTEIN-FAMILY)
    ("BH2" . SPARSER::MOLECULE) ("BH1" . SPARSER::PROTEIN)
    ("BCL2L12" . SPARSER::PROTEIN) ("a larger cohort" . SPARSER::MOLECULE)
    ("further upregulating type I collagen and TIMP-1" . SPARSER::COLLECTION)
    ("collagen and TIMP-1" . SPARSER::COLLECTION)
    ("TGF-β1, MMPs and TIMP-1" . SPARSER::COLLECTION)
    ("TIMPs" . SPARSER::PROTEIN) ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("cigarette" . SPARSER::DRUG) ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene and protein" . SPARSER::COLLECTION)
    ("significantly higher TGF-β1" . SPARSER::PROTEIN)
    ("IL-1β, and supernatants" . SPARSER::COLLECTION)
    ("Monocytes" . SPARSER::PROTEIN) ("pg" . SPARSER::MOLECULE)
    ("Active" . SPARSER::ACTIVE) ("at least one G allele" . SPARSER::ALLELE)
    ("only one lobe" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("Lobe" . SPARSER::PROTEIN) ("heterozygotes" . SPARSER::PROTEIN)
    ("soluble proteins" . SPARSER::PROTEIN)
    ("fibronectin and tenascin" . SPARSER::COLLECTION)
    ("tenascin" . SPARSER::PROTEIN) ("TGF" . SPARSER::DRUG)
    ("cytokines and/or growth factors" . SPARSER::COLLECTION)
    ("tracheobronchial" . SPARSER::PROTEIN)
    ("pulmonary emphysema" . SPARSER::PROTEIN)
    ("MMP-1 and MMP-12" . SPARSER::COLLECTION) ("emphysema" . SPARSER::PROTEIN)
    ("collagenase/MMP-8" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN) ("Collagenase" . SPARSER::PROTEIN)
    ("The interstitial collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagenase/MMP-1" . SPARSER::COLLECTION)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-9 (gelatinase B) and MMP-12 (macrophage metalloelastase)"
     . SPARSER::COLLECTION)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("cytokines, TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("20 human zinc-dependent proteolytic enzymes" . SPARSER::ENZYME)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("neutrophils" . SPARSER::PROTEIN)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-1 and TGF-β1" . SPARSER::COLLECTION)
    ("at least one MMP-1 (-1607G) allele" . SPARSER::ALLELE)
    ("FEV" . SPARSER::PROTEIN) ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 20 µ" . SPARSER::PROTEIN) ("TIMP-1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("MMP-8" . SPARSER::PROTEIN)
    ("macrophage metalloelastase" . SPARSER::PROTEIN)
    ("MMP-12" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("1 L" . SPARSER::PROTEIN)
    ("MMP-1" . SPARSER::PROTEIN) ("mutant and WT BRAF" . SPARSER::COLLECTION)
    ("Irinotecan" . SPARSER::DRUG) ("serine-threonine" . SPARSER::COLLECTION)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("P3IK-PTEN-AKT" . SPARSER::COLLECTION)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION) ("IK" . SPARSER::PROTEIN)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("targeted Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies"
     . SPARSER::ANTIBODY)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cetuximab and Panitumumab" . SPARSER::COLLECTION)
    ("Panitumumab" . SPARSER::DRUG) ("Cetuximab" . SPARSER::DRUG)
    ("Antibodies" . SPARSER::ANTIBODY)
    ("a predictive biomarker" . SPARSER::MOLECULE) ("MoAbs" . SPARSER::DRUG)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RR" . SPARSER::MOLECULE)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("moAbs" . SPARSER::DRUG) ("mCRC" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk4-Nek2" . SPARSER::COLLECTION) ("Cdk4 or Nek2" . SPARSER::COLLECTION)
    ("Nek2 or Cdk4" . SPARSER::COLLECTION) ("cyclosome" . SPARSER::PROTEIN)
    ("proteasomal" . SPARSER::PROTEIN)
    ("the centrosomal kinase Nek2 protein" . SPARSER::PROTEIN)
    ("Ras, or Ras and Myc" . SPARSER::COLLECTION)
    ("Ras and Myc" . SPARSER::COLLECTION)
    ("E2F3 and p53" . SPARSER::COLLECTION)
    ("oncogene and tumor" . SPARSER::COLLECTION) ("HC" . SPARSER::PROTEIN)
    ("both Nek2 protein as well as GFP ( xref )" . SPARSER::COLLECTION)
    ("GFP-Nek2" . SPARSER::COLLECTION)
    ("Cdk4 and the potential CA regulator" . SPARSER::COLLECTION)
    ("the potential CA regulator" . SPARSER::REGULATOR)
    ("NIMA" . SPARSER::PROTEIN-FAMILY)
    ("regulators in MCF10A cells stably expressing H-Ras G12V or H-Ras G12V and c-Myc xref"
     . SPARSER::COLLECTION)
    ("H-Ras G12V or H-Ras G12V" . SPARSER::COLLECTION)
    ("α-tubulin and DAPI" . SPARSER::COLLECTION) ("DAPI" . SPARSER::DRUG)
    ("HRAS, KRAS, or NRAS" . SPARSER::COLLECTION) ("NRAS" . SPARSER::PROTEIN)
    ("HRAS" . SPARSER::PROTEIN) ("MMTV-" . SPARSER::PROTEIN)
    ("Cdk4/Cdk6" . SPARSER::COLLECTION)
    ("cyclin D and active" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("Cdk2 or Cdk4" . SPARSER::COLLECTION)
    ("cyclin D1/Cdk4" . SPARSER::COLLECTION)
    ("Cdk2 and Cdk4" . SPARSER::COLLECTION)
    ("cyclins, Cdks, CKIs, and E2Fs" . SPARSER::COLLECTION)
    ("CKIs" . SPARSER::PROTEIN) ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("more severe forms" . SPARSER::FORM)
    ("mitotic regulatory kinases" . SPARSER::KINASE)
    ("the two mitotic centrosomes" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN) ("Cdk4 and Nek2" . SPARSER::COLLECTION)
    ("protein can" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("H-Ras" . SPARSER::PROTEIN)
    ("4-1" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("Target cell" . SPARSER::PROTEIN) ("Cdk6" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("Nek2" . SPARSER::PROTEIN) ("p53 and p300" . SPARSER::COLLECTION)
    ("VHL" . SPARSER::PROTEIN)
    ("Cul2, Elongin-B/Elongn-C complex, and von Hippel-Lindau tumor suppressor protein (pVHL)"
     . SPARSER::COLLECTION)
    ("Elongin-B and Elongin-C" . SPARSER::COLLECTION)
    ("pVHL" . SPARSER::PROTEIN) ("Calmodulin" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("calcium" . SPARSER::CALCIUM)
    ("Myeov2 and COP9" . SPARSER::COLLECTION)
    ("Myeov2-COP9 signalosome complex" . SPARSER::COLLECTION)
    ("MDS" . SPARSER::PROTEIN) ("CSN5 and CSN6" . SPARSER::COLLECTION)
    ("p16, p27, p53 and Smad7" . SPARSER::COLLECTION)
    ("CSN5a" . SPARSER::PROTEIN) ("Smap1" . SPARSER::PROTEIN)
    ("other ribosomal proteins" . SPARSER::PROTEIN) ("Uba" . SPARSER::PROTEIN)
    ("protein-protein" . SPARSER::COLLECTION)
    ("enzymes, Nedp1 and COP9" . SPARSER::COLLECTION)
    ("p53 and L11" . SPARSER::COLLECTION) ("EGFP-NPM" . SPARSER::COLLECTION)
    ("ActD" . SPARSER::MOLECULE) ("nucleophosmin (NPM)" . SPARSER::PROTEIN)
    ("EGFP" . SPARSER::PROTEIN) ("L11, and Myeov2ΔFD" . SPARSER::COLLECTION)
    ("HA-CSN5" . SPARSER::COLLECTION) ("HA-Nedp1" . SPARSER::COLLECTION)
    ("Myc-L11" . SPARSER::COLLECTION) ("Talon" . SPARSER::DRUG)
    ("monomeric or multimeric Nedd8" . SPARSER::PROTEIN)
    ("several ribosomal proteins" . SPARSER::PROTEIN)
    ("35kDa" . SPARSER::PROTEIN)
    ("those ribosomal proteins" . SPARSER::PROTEIN)
    ("especially ∼35 kDa protein" . SPARSER::PROTEIN)
    ("Myeov2 and Myeov2ΔFD" . SPARSER::COLLECTION)
    ("around 30∼40 kDa proteins" . SPARSER::PROTEIN)
    ("antiserum" . SPARSER::PROTEIN) ("HA-Nedd8" . SPARSER::COLLECTION)
    ("phenylalanine-aspartic acid" . SPARSER::COLLECTION)
    ("revealed the association of Flag-Myeov2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Flag-CSN5" . SPARSER::COLLECTION) ("HA-Myeov2" . SPARSER::COLLECTION)
    ("signalosome and CRLs" . SPARSER::COLLECTION) ("CRLs" . SPARSER::PROTEIN)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("Flag-Myeov2" . SPARSER::COLLECTION)
    ("Signalosome" . SPARSER::PROTEIN) ("nucleoplasmic L11" . SPARSER::PROTEIN)
    ("Den1" . SPARSER::PROTEIN)
    ("several nucleolar stress-related proteins" . SPARSER::PROTEIN)
    ("another nucleolar protein" . SPARSER::PROTEIN)
    ("p300/CBP" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("nucleolar proteins" . SPARSER::PROTEIN)
    ("PICT1 and Nucleophosmin" . SPARSER::COLLECTION)
    ("INK4a/ARF" . SPARSER::COLLECTION) ("NPM" . SPARSER::PROTEIN)
    ("Nucleophosmin" . SPARSER::PROTEIN) ("ARF" . SPARSER::PROTEIN)
    ("DNA and RNA" . SPARSER::COLLECTION) ("ribosomal DNA" . SPARSER::DNA)
    ("Nedp1" . SPARSER::PROTEIN) ("signalosome" . SPARSER::PROTEIN)
    ("Nedd8" . SPARSER::PROTEIN) ("ribosomal proteins" . SPARSER::PROTEIN)
    ("ribosomal RNA" . SPARSER::RNA) ("NPM1" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("N-20" . SPARSER::PROTEIN)
    ("CUL-1" . SPARSER::PROTEIN) ("Von Hippel-Lindau" . SPARSER::PROTEIN)
    ("von Hippel-Lindau tumor suppressor" . SPARSER::PROTEIN)
    ("Cul2" . SPARSER::PROTEIN) ("Elongin-C" . SPARSER::PROTEIN)
    ("Elongin-B" . SPARSER::PROTEIN) ("protein 3" . SPARSER::PROTEIN)
    ("COP9 signalosome complex" . SPARSER::PROTEIN) ("COP1" . SPARSER::PROTEIN)
    ("CSN3" . SPARSER::PROTEIN) ("MLF1" . SPARSER::PROTEIN)
    ("myeloid leukemia factor 1" . SPARSER::PROTEIN)
    ("Smad7" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("CSN6" . SPARSER::PROTEIN)
    ("Smap2" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("MLN4924" . SPARSER::DRUG) ("cullin family" . SPARSER::PROTEIN-FAMILY)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("CSN5" . SPARSER::PROTEIN)
    ("Cullin family" . SPARSER::PROTEIN-FAMILY) ("CSN8" . SPARSER::PROTEIN)
    ("CSN1" . SPARSER::PROTEIN) ("SENP8" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("PICT1" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("COP9" . SPARSER::PROTEIN) ("Myeov2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myeloma overexpressed" . SPARSER::PROTEIN) ("L11" . SPARSER::PROTEIN)
    ("ribosomal protein L11" . SPARSER::PROTEIN)
    ("TRIM8, TRIM22 and TRIM38" . SPARSER::COLLECTION)
    ("p53 or wnt" . SPARSER::COLLECTION)
    ("cyclin D-Cdk4" . SPARSER::PROTEIN-PAIR)
    ("cyclin D1, p-Rb, CDK4, CDK6 and c-Myc" . SPARSER::COLLECTION)
    ("contained minimal endogenous ATDC" . SPARSER::PROTEIN)
    ("exogenous ATDC" . SPARSER::PROTEIN)
    ("the tripartite motif (TRIM) protein family" . SPARSER::PROTEIN-FAMILY)
    ("RBCC" . SPARSER::PROTEIN)
    ("cyclin D1, c-Myc and p-Rb" . SPARSER::COLLECTION)
    ("IkBa" . SPARSER::PROTEIN) ("β-catenin and active" . SPARSER::COLLECTION)
    ("cyclin D1, CDK4, CDK6, p-Rb and c-Myc" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, CDK2, CDK4, CDK6, p-Rb and c-Myc"
     . SPARSER::COLLECTION)
    ("Cyclin D1 and c-Myc" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("histological types" . TYPE) ("vimentin" . SPARSER::PROTEIN)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("TRIM8, TRIM22, TRIM38 and TRIM40" . SPARSER::COLLECTION)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-IκB" . SPARSER::COLLECTION)
    ("wnt/β-catenin" . SPARSER::COLLECTION)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION) ("MTT" . SPARSER::MOLECULE)
    ("HBE" . SPARSER::PROTEIN) ("histological type" . TYPE)
    ("gene (ATDC)" . SPARSER::GENE) ("oncogene" . SPARSER::ONCOGENE)
    ("ATDC" . SPARSER::PROTEIN) ("complementing" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("NEDD8" . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN) ("Bay 11-7082" . SPARSER::DRUG)
    ("P21" . SPARSER::PROTEIN) ("p-Rb" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("BAY 11-7082" . SPARSER::DRUG)
    ("TRIM29" . SPARSER::PROTEIN) ("TRIM40" . SPARSER::PROTEIN)
    ("TRIM38" . SPARSER::PROTEIN) ("TRIM22" . SPARSER::PROTEIN)
    ("TRIM8" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("FBXO28 and/or MYC" . SPARSER::COLLECTION)
    ("a new potential biomarker" . SPARSER::MOLECULE)
    ("low proliferative luminal" . SPARSER::DRUG) ("luminal" . SPARSER::DRUG)
    ("cohorts" . SPARSER::MOLECULE)
    ("dominant-negative FBXO28" . SPARSER::PROTEIN) ("MYC-" . SPARSER::PROTEIN)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("SKP2, HECTH9 and FBXO28" . SPARSER::COLLECTION)
    ("possibly heterotypic ubiquitin" . SPARSER::PROTEIN)
    ("SKP2-" . SPARSER::PROTEIN) ("distinct CDKs" . SPARSER::PROTEIN)
    ("cyclin E/CDK2" . SPARSER::COLLECTION) ("MYCN" . SPARSER::PROTEIN)
    ("FBXW7 and TRUSS" . SPARSER::COLLECTION)
    ("powerful oncoproteins" . SPARSER::PROTEIN)
    ("at least five E3 ubiquitin ligases" . SPARSER::LIGASE)
    ("HECTH9/HUWE1" . SPARSER::COLLECTION) ("bTRCP" . SPARSER::PROTEIN)
    ("Luminal" . SPARSER::DRUG) ("TMA" . SPARSER::MOLECULE)
    ("RFS" . SPARSER::PROTEIN) ("log-rank" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN) ("fraction (NF)" . SPARSER::COMPONENT)
    ("TMAs" . SPARSER::MOLECULE) ("MYC/p300" . SPARSER::COLLECTION)
    ("MYC-transformed MEFs" . SPARSER::PROTEIN) ("puromycin" . SPARSER::DRUG)
    ("MYC and ΔF-FBXO28" . SPARSER::COLLECTION)
    ("p300 and possibly other cofactors" . SPARSER::COLLECTION)
    ("possibly other cofactors" . SPARSER::PROTEIN)
    ("full-length MYC and a MYC mutant" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID) ("lysines" . SPARSER::AMINO-ACID)
    ("MYC and p300" . SPARSER::COLLECTION) ("p300-MYC" . SPARSER::COLLECTION)
    ("CCND2 and BMI1" . SPARSER::COLLECTION)
    ("MYC and MAX" . SPARSER::COLLECTION) ("MYC/MAX" . SPARSER::COLLECTION)
    ("HAT" . SPARSER::PROTEIN) ("acetyltransferase" . SPARSER::PROTEIN)
    ("cofactor" . SPARSER::MOLECULE)
    ("PTMA , BMI1 and RFC4" . SPARSER::COLLECTION) ("PTMA" . SPARSER::PROTEIN)
    ("CYCLIN D2 ( CCND2 ) and rDNA gene promoters" . SPARSER::COLLECTION)
    ("the ODC1 , CYCLIN D2 ( CCND2 ) and rDNA gene promoters"
     . SPARSER::COLLECTION)
    ("thymidine" . SPARSER::PROTEIN) ("doxycycline" . SPARSER::DRUG)
    ("MYC or ΔF-FBXO28" . SPARSER::COLLECTION) ("salt" . SPARSER::MOLECULE)
    ("the dominant-negative ΔF-FBXO28 mutant" . SPARSER::MUTANT)
    ("a minimal promoter" . SPARSER::PROMOTER)
    ("MYC-p300" . SPARSER::COLLECTION)
    ("a bona fide ubiquitin ligase" . SPARSER::PROTEIN)
    ("CHX" . SPARSER::PROTEIN) ("MYC-FBXO28" . SPARSER::COLLECTION)
    ("phospho-mimetic (SCF S344E-FBXO28 ) SCF complexes"
     . SPARSER::BIO-COMPLEX)
    ("S344A-FBXO28 and SCF" . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("F-box-deleted alleles" . SPARSER::ALLELE)
    ("MYC-ubiquitin" . SPARSER::COLLECTION) ("alleles" . SPARSER::ALLELE)
    ("a major ubiquitin ligase" . SPARSER::PROTEIN)
    ("Yada" . SPARSER::PROTEIN-FAMILY) ("Mapping" . SPARSER::PROTEIN)
    ("usually not part" . SPARSER::COMPONENT) ("von" . SPARSER::PROTEIN)
    ("Serine" . SPARSER::AMINO-ACID) ("MYC and FBXO28" . SPARSER::COLLECTION)
    ("FBXO28 and MYC" . SPARSER::COLLECTION)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("a phosphomimetic S344E mutant" . SPARSER::MUTANT)
    ("dominant-negative (DN) CDK1 or CDK2 mutants" . SPARSER::MUTANT)
    ("CDK1 or CDK2" . SPARSER::COLLECTION)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION) ("alanine" . SPARSER::AMINO-ACID)
    ("the associated CDKs" . SPARSER::PROTEIN)
    ("cyclins, cyclin A2 and cyclin B1" . SPARSER::COLLECTION)
    ("CDKs" . SPARSER::PROTEIN) ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("several previously uncharacterized F-box genes" . SPARSER::GENE)
    ("EdU" . SPARSER::DRUG) ("elongation" . SPARSER::PROTEIN)
    ("MAX" . SPARSER::PROTEIN)
    ("oncoprotein/transcription factor" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("Chen" . SPARSER::PROTEIN)
    ("a potential molecular drug target" . SPARSER::TARGET-PROTEIN)
    ("CDK-FBXO28-MYC" . SPARSER::COLLECTION)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYC and downsteam" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("ligases" . SPARSER::LIGASE)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Galactosidase" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("B/CDK1" . SPARSER::PROTEIN) ("poly-ubiquitin" . SPARSER::PROTEIN)
    ("HUWE1" . SPARSER::PROTEIN) ("HECTH9" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN) ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NK2R" . SPARSER::PROTEIN) ("CA-1" . SPARSER::PROTEIN)
    ("RFC4" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("FAS ligand" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("CYCLIN D2" . SPARSER::PROTEIN) ("ODC1" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("FBXO22" . SPARSER::PROTEIN) ("SKP2" . SPARSER::PROTEIN)
    ("FBXO  28" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("CDK2" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("S-G2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("subunit E" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("FBXO28" . SPARSER::PROTEIN) ("Cul1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("exogenous SCF" . SPARSER::PROTEIN)
    ("HSC maintenance genes and efficiently form clonal multipotent self-renewing mesenspheres"
     . SPARSER::COLLECTION)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NESTIN and SCF" . SPARSER::COLLECTION)
    ("Flt3L and TPO" . SPARSER::COLLECTION)
    ("Flt3L or TPO" . SPARSER::COLLECTION) ("HSPC" . SPARSER::PROTEIN)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("myeloid" . SPARSER::PROTEIN) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("phenotypic HSPCs" . SPARSER::PROTEIN)
    ("SCF, TPO, and Flt3L" . SPARSER::COLLECTION) ("MPPs" . SPARSER::PROTEIN)
    ("TPO" . SPARSER::PROTEIN) ("thrombopoietin" . SPARSER::PROTEIN)
    ("HSCs and progenitors ex vivo" . SPARSER::COLLECTION)
    ("anti-CD51 and anti-NESTIN" . SPARSER::COLLECTION)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("hyaline" . SPARSER::PROTEIN)
    ("human-specific anti-NESTIN" . SPARSER::ANTIBODY)
    ("hydroxyapatite" . SPARSER::MOLECULE)
    ("PDGFRα, CD51, and NESTIN" . SPARSER::COLLECTION)
    ("bona fide MSCs" . SPARSER::PROTEIN)
    ("CXCL12 , VCAM1 , ANGPT1 , OPN , and SCF" . SPARSER::COLLECTION)
    ("OPN" . SPARSER::PROTEIN) ("PDGFRα and/or CD51" . SPARSER::COLLECTION)
    ("NESTIN" . SPARSER::PROTEIN)
    ("CD2, CD3, CD14, CD16, CD19, CD56, and CD235a" . SPARSER::COLLECTION)
    ("CD38, and CD34" . SPARSER::COLLECTION) ("LepR-" . SPARSER::PROTEIN)
    ("LSL" . SPARSER::PROTEIN) ("cre" . SPARSER::PROTEIN)
    ("LepR" . SPARSER::PROTEIN) ("phenotypic HSCs" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::PROTEIN) ("Nes-" . SPARSER::PROTEIN)
    ("Nes" . SPARSER::PROTEIN)
    ("chondrocytic ( xref ) differentiation genes" . SPARSER::GENE)
    ("fractions" . SPARSER::COMPONENT) ("Opn and Scf" . SPARSER::COLLECTION)
    ("Angpt1" . SPARSER::PROTEIN) ("Cxcl12" . SPARSER::PROTEIN)
    ("osteopontin" . SPARSER::PROTEIN) ("Opn" . SPARSER::PROTEIN)
    ("Scf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chemokine" . SPARSER::PROTEIN)
    ("c-Kit, CD135, CD34, CD41, CD48, and CD11b" . SPARSER::COLLECTION)
    ("Ng2 ( xref ) and CD146 ( xref ; xref )" . SPARSER::COLLECTION)
    ("Ng2" . SPARSER::PROTEIN)
    ("CD29, CD44, CD61, CD130, and P75" . SPARSER::COLLECTION)
    ("CD10, CD90, CD166, and CD133" . SPARSER::COLLECTION)
    ("endoglin" . SPARSER::PROTEIN) ("PDGFRα and αV" . SPARSER::COLLECTION)
    ("collagenase" . SPARSER::PROTEIN) ("Nes-GFP" . SPARSER::COLLECTION)
    ("CAR" . SPARSER::PROTEIN) ("multipotent MSCs" . SPARSER::PROTEIN)
    ("vasculature and HSCs" . SPARSER::COLLECTION)
    ("vasculature" . SPARSER::PROTEIN)
    ("human BM stromal MSCs" . SPARSER::PROTEIN)
    ("primitive HSCs" . SPARSER::PROTEIN) ("HSPCs" . SPARSER::PROTEIN)
    ("the adherent fraction" . SPARSER::COMPONENT) ("HSCs" . SPARSER::PROTEIN)
    ("MSC" . SPARSER::PROTEIN) ("MSCs" . SPARSER::PROTEIN)
    ("PDGFRα and CD51" . SPARSER::COLLECTION) ("Nestin" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("CD33" . SPARSER::PROTEIN)
    ("H11" . SPARSER::PROTEIN) ("HM48-1" . SPARSER::PROTEIN)
    ("L4-1" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("F10" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B8)" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN) ("tm2" . SPARSER::PROTEIN-FAMILY)
    ("Tie-2" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD49f" . SPARSER::PROTEIN) ("Flt3L" . SPARSER::PROTEIN)
    ("Flt3 ligand" . SPARSER::PROTEIN) ("ANGPT1" . SPARSER::PROTEIN)
    ("VCAM1" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("CD235a" . SPARSER::PROTEIN) ("CD56" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("VE-cadherin" . SPARSER::PROTEIN) ("leptin receptor" . SPARSER::PROTEIN)
    ("CD150" . SPARSER::PROTEIN) ("stem cell factor" . SPARSER::PROTEIN)
    ("angiopoietin-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("Vcam1" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("CD48" . SPARSER::PROTEIN) ("CD41" . SPARSER::PROTEIN)
    ("c-Kit" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("CD166" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("P75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD130" . SPARSER::PROTEIN)
    ("CD61" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("CD271" . SPARSER::PROTEIN)
    ("Tie2" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("CD146" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("CD51" . SPARSER::PROTEIN) ("PDGFRα" . SPARSER::PROTEIN)
    ("a potential novel candidate protein" . SPARSER::PROTEIN)
    ("HER3, Akt, and mTOR" . SPARSER::COLLECTION)
    ("EGF and sEcad" . SPARSER::COLLECTION)
    ("Canertinib, Lapatinib, Gefitinib, and Mubritinib" . SPARSER::COLLECTION)
    ("receptors and their cognate growth factor ligands" . SPARSER::COLLECTION)
    ("glycoprotein" . SPARSER::PROTEIN)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG)
    ("MDA-MB-231 TNBC cells exogenous sEcad" . SPARSER::PROTEIN)
    ("survivin, cIAP-1, XIAP and livin" . SPARSER::COLLECTION)
    ("Herceptin" . SPARSER::DRUG) ("HER-PI3K/Akt" . SPARSER::COLLECTION)
    ("XIAP, cIAP-1, cIAP-2, and livin" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("ribozyme" . SPARSER::RNA) ("Survivin" . SPARSER::PROTEIN)
    ("survivin, cIAP-1, cIAP-2, XIAP, and livin" . SPARSER::COLLECTION)
    ("wherein exogenous sEcad" . SPARSER::PROTEIN)
    ("p70s6K and 4E-BP1" . SPARSER::COLLECTION) ("p70s6K" . SPARSER::PROTEIN)
    ("HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("sEcad-HER2" . SPARSER::COLLECTION) ("sEcad-HER1" . SPARSER::COLLECTION)
    ("HER2-HER3" . SPARSER::COLLECTION) ("monolayers" . SPARSER::PROTEIN)
    ("membrane-bound intact E-cadherin" . SPARSER::PROTEIN)
    ("the MMP or ADAM-induced sEcad fragment" . SPARSER::COLLECTION)
    ("MMPs or the ADAM family" . SPARSER::COLLECTION)
    ("ADAM" . SPARSER::PROTEIN)
    ("bioactive soluble ectodomain fragments" . SPARSER::FRAGMENT)
    ("proteases" . SPARSER::PROTEIN) ("HER1 and ERK1/2" . SPARSER::COLLECTION)
    ("rhEGF and rhEcad/Fc" . SPARSER::COLLECTION)
    ("equimolar rhEGF" . SPARSER::DRUG) ("sEcad or EGF" . SPARSER::COLLECTION)
    ("rhEGF" . SPARSER::DRUG) ("exogenous ligands" . SPARSER::LIGAND)
    ("sEcad and EGF" . SPARSER::COLLECTION)
    ("Lapatinib and Gefitinib" . SPARSER::COLLECTION)
    ("Mubritinib" . SPARSER::DRUG) ("Gefitinib" . SPARSER::DRUG)
    ("Canertinib" . SPARSER::DRUG) ("microtubules" . SPARSER::PROTEIN)
    ("survivin and livin" . SPARSER::COLLECTION)
    ("survivin, cIAP-1, XIAP, and livin" . SPARSER::COLLECTION)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("the p70S6 kinase (p70S6K) and eIF4E binding protein 1 (4E-BP1)"
     . SPARSER::COLLECTION)
    ("p70S6K" . SPARSER::PROTEIN)
    ("/AKT/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER2, HER3 or HER4" . SPARSER::COLLECTION)
    ("HER3 and HER4" . SPARSER::COLLECTION) ("HER-MAPK" . SPARSER::COLLECTION)
    ("sEcad-HER1–2" . SPARSER::COLLECTION)
    ("both intact E-cadherin and sEcad" . SPARSER::COLLECTION)
    ("HER1 and HER2" . SPARSER::COLLECTION)
    ("both membrane-bound intact E-cadherin and sEcad" . SPARSER::COLLECTION)
    ("E-cadherin and sEcad" . SPARSER::COLLECTION)
    ("these tumors typically lack HER2" . SPARSER::PROTEIN)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("Receptor" . SPARSER::RECEPTOR)
    ("MMP" . SPARSER::PROTEIN) ("MCF-10A" . SPARSER::PROTEIN)
    ("HER-PI3K/Akt/mTOR-IAP" . SPARSER::COLLECTION)
    ("HER1, PI3K, Akt, and ERK1/2" . SPARSER::COLLECTION)
    ("exogenous sEcad" . SPARSER::PROTEIN)
    ("HER2 and HER3" . SPARSER::COLLECTION) ("HER2–HER3" . SPARSER::COLLECTION)
    ("HER1/HER2" . SPARSER::COLLECTION) ("Lapatinib" . SPARSER::DRUG)
    ("HER2 and survivin" . SPARSER::COLLECTION)
    ("The smallest IAP family member survivin" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis (XIAP) and livin [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("cIAP-1 and cIAP-2" . SPARSER::COLLECTION) ("livin" . SPARSER::PROTEIN)
    ("XIAP" . SPARSER::PROTEIN) ("survivin" . SPARSER::PROTEIN)
    ("IAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the HER receptors and/or MAPK, PI3K, and mTOR" . SPARSER::COLLECTION)
    ("HER1 or HER2" . SPARSER::COLLECTION)
    ("MAPK, PI3K, and mTOR" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("HER3 or HER4" . SPARSER::COLLECTION)
    ("HER1 or HER4, and neuregulins-3" . SPARSER::COLLECTION)
    ("HER4, and neuregulins-3" . SPARSER::COLLECTION)
    ("epiregulin" . SPARSER::PROTEIN) ("BTC" . SPARSER::PROTEIN)
    ("betacellulin" . SPARSER::PROTEIN) ("heparin" . SPARSER::PROTEIN)
    ("amphiregulin" . SPARSER::PROTEIN)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN) ("PyMT" . SPARSER::PROTEIN)
    ("metastatic foci" . SPARSER::PROTEIN)
    ("intact E-cadherin" . SPARSER::PROTEIN)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("ADAMs" . SPARSER::PROTEIN) ("metalloproteinase" . SPARSER::PROTEIN)
    ("disintegrin" . SPARSER::PROTEIN) ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("its soluble ectodomain fragment" . SPARSER::FRAGMENT)
    ("sEcad" . SPARSER::PROTEIN)
    ("exogenous recombinant human E-cadherin/Fc chimeric protein"
     . SPARSER::PROTEIN)
    ("MAPK-PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("sEcad-HER" . SPARSER::COLLECTION) ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR" . SPARSER::PROTEIN) ("HER" . SPARSER::PROTEIN)
    ("HER1, HER2, and HER3" . SPARSER::COLLECTION)
    ("MMTV-PyMT" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("min–2" . SPARSER::PROTEIN) ("ADAM15" . SPARSER::PROTEIN)
    ("YM155" . SPARSER::DRUG) ("s6K" . SPARSER::PROTEIN)
    ("p70" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("4E-BP1" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("α-tubulin" . SPARSER::PROTEIN) ("Nonidet P-40" . SPARSER::DRUG)
    ("S6K" . SPARSER::PROTEIN) ("BP1" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pPI3K" . SPARSER::PROTEIN-FAMILY)
    ("GM6001" . SPARSER::DRUG) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("a polypeptide" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis" . SPARSER::PROTEIN)
    ("cIAP-2" . SPARSER::PROTEIN) ("cIAP-1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neuregulins-3" . SPARSER::PROTEIN) ("HB-EGF" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("neuregulins-1" . SPARSER::PROTEIN)
    ("TGFα" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transmembrane protein" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN) ("membrane-bound" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("new targets and cancer-associated mutants" . SPARSER::COLLECTION)
    ("cancer-associated mutants" . SPARSER::MUTANT)
    ("new p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FBXW7 and TP53" . SPARSER::COLLECTION)
    ("several key oncoproteins" . SPARSER::PROTEIN)
    ("Cyclin E1, c-Myc and c-Jun" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN) ("SCF" . SPARSER::PROTEIN)
    ("the only previously identified p53 target" . SPARSER::TARGET-PROTEIN)
    ("Merlin" . SPARSER::PROTEIN)
    ("CDC27 , EPHA5 , NF2 , ABCA12 , ASCC3, CDH10 and SCN2A"
     . SPARSER::COLLECTION)
    ("New p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p63 and p73" . SPARSER::COLLECTION) ("a 20-mer" . SPARSER::COLLECTION)
    ("only 11 genes" . SPARSER::GENE)
    ("DXR, Nutlin, Actinomycin D or Etoposide" . SPARSER::COLLECTION)
    ("DMSO, DXR, Nutlin, Etoposide and Actinomycin D" . SPARSER::COLLECTION)
    ("tri" . SPARSER::PROTEIN) ("p53 and MDM2" . SPARSER::COLLECTION)
    ("nucleosome" . SPARSER::PROTEIN) ("DXR and DMSO" . SPARSER::COLLECTION)
    ("DXR or DMSO" . SPARSER::COLLECTION)
    ("Actinomycin D or Etoposide" . SPARSER::COLLECTION)
    ("Etoposide" . SPARSER::PROTEIN) ("only 20 genes" . SPARSER::GENE)
    ("many new p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ABCA12 , ASCC3 , CDC27 , CDH10 , EPHA5 , FBXW7 and SCN2A"
     . SPARSER::COLLECTION)
    ("seven genes using the breast carcinoma MCF7 cell line stably expressing p53shRNAi and its vector control"
     . SPARSER::COLLECTION)
    ("MCF7" . SPARSER::PROTEIN) ("genuine p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CYP3A7 and EML2" . SPARSER::COLLECTION) ("APOBEC" . SPARSER::BIO-COMPLEX)
    ("CPEB" . SPARSER::PROTEIN)
    ("the 149 potential new p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DMSO, DXR or Nutlin" . SPARSER::COLLECTION)
    ("the usual p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hydrolase" . SPARSER::PROTEIN)
    ("149 potential new p53 target genes" . SPARSER::GENE)
    ("56 previously established p53 responsive genes" . SPARSER::GENE)
    ("219 potential new p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nearly all showing increased H3K4" . SPARSER::PROTEIN)
    ("DXR and 21/27" . SPARSER::COLLECTION)
    ("repressive chromatin" . SPARSER::PROTEIN) ("DXR-" . SPARSER::PROTEIN)
    ("relatively few examples" . SPARSER::EXAMPLE)
    ("examples" . SPARSER::EXAMPLE) ("the associated genes" . SPARSER::GENE)
    ("Only 48 genes" . SPARSER::GENE)
    ("p53 and differentially" . SPARSER::COLLECTION)
    ("GO and KEGG" . SPARSER::COLLECTION) ("only 220 genes" . SPARSER::GENE)
    ("only 416 genes" . SPARSER::GENE)
    ("Nutlin or DXR-treated cells" . SPARSER::COLLECTION)
    ("TP53I3/PIG3" . SPARSER::COLLECTION) ("HSF" . SPARSER::PROTEIN)
    ("Sp1, Sp3 and PITX2" . SPARSER::COLLECTION)
    ("DXR and Nutlin" . SPARSER::COLLECTION)
    ("the basic leucine zipper protein family" . SPARSER::PROTEIN-FAMILY)
    ("AP-1 and FRA1" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY) ("leucine" . SPARSER::AMINO-ACID)
    ("AP-1" . SPARSER::PROTEIN) ("DMSO and Nutlin" . SPARSER::COLLECTION)
    ("CDKN1A (p21) and MDM2" . SPARSER::COLLECTION)
    ("the well-characterized p53 target genes BAX , CDKN1A (p21) and MDM2"
     . SPARSER::COLLECTION)
    ("BAX" . SPARSER::PROTEIN) ("DXR or Nutlin" . SPARSER::COLLECTION)
    ("DXR (0.6 µg/ml) or Nutlin (10 µM)" . SPARSER::COLLECTION)
    ("Genome-wide mapping" . SPARSER::PROTEIN)
    ("adenine or thymine" . SPARSER::COLLECTION)
    ("pyrimidine and N" . SPARSER::COLLECTION) ("pyrimidine" . SPARSER::DRUG)
    ("thymine" . SPARSER::MOLECULE) ("adenine" . SPARSER::NUCLEOBASE)
    ("purine" . SPARSER::DRUG) ("dimers" . SPARSER::DIMER)
    ("dimer" . SPARSER::DIMER)
    ("potential new targets" . SPARSER::TARGET-PROTEIN)
    ("histone" . SPARSER::PROTEIN)
    ("anti-cancer drugs Doxorubicin (DXR) or Nutlin-3 (Nutlin)"
     . SPARSER::COLLECTION)
    ("Doxorubicin (DXR)" . SPARSER::PROTEIN) ("Nutlin" . SPARSER::DRUG)
    ("DXR" . SPARSER::PROTEIN) ("Doxorubicin" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("TP53" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("WD repeat domain" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("p63" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("co-factors" . SPARSER::MOLECULE) ("Actinomycin D" . SPARSER::MOLECULE)
    ("1A" . SPARSER::PROTEIN) ("neurofibromin 2" . SPARSER::PROTEIN)
    ("SCN2A" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("EPHA5" . SPARSER::PROTEIN) ("CDH10" . SPARSER::PROTEIN)
    ("ASCC3" . SPARSER::PROTEIN) ("ABCA12" . SPARSER::PROTEIN)
    ("EML2" . SPARSER::PROTEIN) ("CYP3A7" . SPARSER::PROTEIN)
    ("EBI3" . SPARSER::PROTEIN) ("INPP1" . SPARSER::PROTEIN)
    ("LASS5" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("DYRK3" . SPARSER::PROTEIN) ("SYTL1" . SPARSER::PROTEIN)
    ("ARHGEF3" . SPARSER::PROTEIN) ("TP53I3" . SPARSER::PROTEIN)
    ("PIG3" . SPARSER::PROTEIN) ("PITX2" . SPARSER::PROTEIN)
    ("Sp3" . SPARSER::PROTEIN) ("BACH2" . SPARSER::PROTEIN)
    ("BACH1" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("LBP9" . SPARSER::PROTEIN) ("FRA1" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("β-2-microglobulin" . SPARSER::PROTEIN) ("MyoD1" . SPARSER::PROTEIN)
    ("myogenic differentiation 1" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::PROTEIN) ("H3K4" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-20" . SPARSER::PROTEIN) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("C-11" . SPARSER::PROTEIN) ("Nutlin-3" . SPARSER::DRUG)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("light and IR" . SPARSER::COLLECTION)
    ("cisplatin and inhibitors" . SPARSER::COLLECTION)
    ("DNA-PKcs, Ku86 and Ku70" . SPARSER::COLLECTION)
    ("wortmannin or olaparib" . SPARSER::COLLECTION)
    ("Chromatin-associated H2AX" . SPARSER::PROTEIN)
    ("Chromatin" . SPARSER::PROTEIN)
    ("Nu7026 and Nu7441" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("wortmannin and Nu7026" . SPARSER::COLLECTION)
    ("only one target" . SPARSER::TARGET-PROTEIN)
    ("TIP5 and transcription initiation factor SL1" . SPARSER::COLLECTION)
    ("polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("PARP-1 or DNA-PK" . SPARSER::COLLECTION) ("polycomb" . SPARSER::PROTEIN)
    ("nucleophosmin" . SPARSER::PROTEIN)
    ("mRNA and rRNA" . SPARSER::COLLECTION) ("MEFs" . SPARSER::PROTEIN)
    ("wortmannin, olaparib, Nu7026, Nu7441 and PARP-1" . SPARSER::COLLECTION)
    ("Ku70, Ku86, DNA-PKcs and PARP-1" . SPARSER::COLLECTION)
    ("Neither benzamide nor olaparib" . SPARSER::COLLECTION)
    ("benzamide or olaparib" . SPARSER::COLLECTION)
    ("olaparib" . SPARSER::DRUG) ("benzamide" . SPARSER::DRUG)
    ("the PI3K family as well as C-Abl and p38 MAPK inhibitors"
     . SPARSER::COLLECTION)
    ("PI3K, ATM and Ataxia Telangiectasia and Rad3-Related protein"
     . SPARSER::COLLECTION)
    ("C-Abl and p38" . SPARSER::COLLECTION) ("ATR" . SPARSER::PROTEIN)
    ("Nu7026 or Nu7441" . SPARSER::COLLECTION)
    ("Wortmannin" . SPARSER::PROTEIN) ("protein (ATM)" . SPARSER::PROTEIN)
    ("ATM" . SPARSER::PROTEIN) ("nucleolar SSRP1" . SPARSER::PROTEIN)
    ("wortmannin and shRNA" . SPARSER::COLLECTION)
    ("PARP-1 and DNA-PK" . SPARSER::COLLECTION)
    ("IR and UV" . SPARSER::COLLECTION)
    ("a complex with DNA-PK and the facilitator" . SPARSER::COLLECTION)
    ("Drosophila" . SPARSER::PROTEIN) ("nucleolar PARP-1" . SPARSER::PROTEIN)
    ("Nucleolar PARP-1" . SPARSER::PROTEIN)
    ("the dense fibrillar component" . SPARSER::COMPONENT)
    ("TBP and TFIID" . SPARSER::COLLECTION) ("rDNA" . SPARSER::PROTEIN)
    ("SL1" . SPARSER::PROTEIN) ("wortmannin" . SPARSER::PROTEIN)
    ("DNA-PKcs, histones and PARP-1" . SPARSER::COLLECTION)
    ("subunits" . SPARSER::FRAGMENT)
    ("PARP-2, histones, Ku and DNA-PKcs" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("holoenzyme" . SPARSER::PROTEIN)
    ("Ku70 and Ku86" . SPARSER::COLLECTION)
    ("WRN and SSRP1" . SPARSER::COLLECTION) ("WRN" . SPARSER::PROTEIN)
    ("heterodimer" . SPARSER::HETERODIMER) ("genotoxic drugs" . SPARSER::DRUG)
    ("IR" . SPARSER::PROTEIN)
    ("upstream binding factor (UBF)" . SPARSER::PROTEIN)
    ("protein (TBP)" . SPARSER::PROTEIN) ("UBF" . SPARSER::PROTEIN)
    ("TFIID" . SPARSER::PROTEIN) ("TBP" . SPARSER::PROTEIN)
    ("Ribosomal RNA" . SPARSER::RNA) ("Pol" . SPARSER::PROTEIN)
    ("DNA-PK and PARP-1" . SPARSER::COLLECTION)
    ("the DNA repair proteins DNA-dependent protein kinase (DNA-PK) or poly(ADP-ribose) polymerase"
     . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG) ("cisplatin" . SPARSER::DRUG)
    ("rRNA" . SPARSER::PROTEIN) ("run" . SPARSER::PROTEIN-FAMILY)
    ("A–C" . SPARSER::PROTEIN) ("D–F" . SPARSER::PROTEIN)
    ("TIP5" . SPARSER::PROTEIN) ("G–L" . SPARSER::PROTEIN)
    ("m 2" . SPARSER::MOLECULE) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-Abl" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia and Rad3-Related protein" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("Pol2" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("nuclease activity" . SPARSER::PROTEIN)
    ("anti-PAR" . SPARSER::DRUG) ("Ku80" . SPARSER::PROTEIN)
    ("Green Fluorescent" . SPARSER::PROTEIN) ("NOL1" . SPARSER::PROTEIN)
    ("Nu7441" . SPARSER::MOLECULE) ("Nu7026" . SPARSER::DRUG)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("actinomycin D" . SPARSER::MOLECULE) ("alpha-amanitin" . SPARSER::PROTEIN)
    ("PARP-2" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("SSRP1" . SPARSER::PROTEIN)
    ("Ku86" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("upstream binding factor" . SPARSER::PROTEIN)
    ("PARP-1" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("ErbB2 as well as plexinB1" . SPARSER::COLLECTION)
    ("ErbB2 and ErbB2" . SPARSER::COLLECTION) ("HGF" . SPARSER::PROTEIN)
    ("RasGAP" . SPARSER::PROTEIN) ("Sema6A/plexinA4" . SPARSER::COLLECTION)
    ("ephrin" . SPARSER::PROTEIN) ("plexinB1/Sema4D" . SPARSER::COLLECTION)
    ("ErbB2 and one expressed c-Met (Fig. xref B)" . SPARSER::COLLECTION)
    ("prostatic" . SPARSER::PROTEIN)
    ("PlexinB1, Sema4D, ErbB2, and c-Met" . SPARSER::COLLECTION)
    ("Sema4D/plexinB1" . SPARSER::COLLECTION)
    ("endogenous ErbB2 (Fig. xref B and D) and endogenous Akt (Fig. xref C and E)"
     . SPARSER::COLLECTION)
    ("endogenous ErbB2 and vice versa" . SPARSER::COLLECTION)
    ("versa" . SPARSER::PROTEIN)
    ("a pro-migratory cue" . SPARSER::PROTEIN-FAMILY)
    ("cue" . SPARSER::PROTEIN-FAMILY)
    ("plexinB1, Sema4D and ErbB2" . SPARSER::COLLECTION)
    ("shRNAs" . SPARSER::RNA) ("ErbB2 and DU145" . SPARSER::COLLECTION)
    ("plexinB1 and ErbB2" . SPARSER::COLLECTION)
    ("plexinB1 and c-Met" . SPARSER::COLLECTION)
    ("ErbB2 and c-Met" . SPARSER::COLLECTION) ("LN3" . SPARSER::PROTEIN)
    ("plexinB1 mRNA (Fig. xref A) and protein (Fig. xref B)"
     . SPARSER::COLLECTION)
    ("LNCaP-LN3" . SPARSER::COLLECTION)
    ("plexinB1 and Sema4D" . SPARSER::COLLECTION)
    ("PlexinB1 and Sema4D" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("semaphorins/plexins" . SPARSER::COLLECTION)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RhoD" . SPARSER::PROTEIN)
    ("Sema" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Plexins" . SPARSER::PROTEIN)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY) ("classes" . CLASS)
    ("neuropilins and plexins" . SPARSER::COLLECTION)
    ("neuropilins" . SPARSER::PROTEIN-FAMILY)
    ("ErbB2 and plexinB1" . SPARSER::COLLECTION)
    ("derivative" . SPARSER::DERIVATIVE) ("Thr" . SPARSER::AMINO-ACID)
    ("ErbB2 and Akt" . SPARSER::COLLECTION) ("ErbB2" . SPARSER::PROTEIN)
    ("LNCaP" . SPARSER::PROTEIN) ("inducer or inhibitor" . SPARSER::COLLECTION)
    ("semaphorin/plexin" . SPARSER::COLLECTION) ("plexin" . SPARSER::PROTEIN)
    ("semaphorin" . SPARSER::PROTEIN-FAMILY)
    ("chemotactic cues" . SPARSER::PROTEIN-FAMILY)
    ("plexins" . SPARSER::PROTEIN) ("cues" . SPARSER::PROTEIN-FAMILY)
    ("Semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("Androgen receptor" . SPARSER::PROTEIN) ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("plexinA4" . SPARSER::PROTEIN) ("Sema6A" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("flavoprotein (Fp)" . SPARSER::PROTEIN) ("subunit A" . SPARSER::PROTEIN)
    ("succinate dehydrogenase complex" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("Beta-2-microglobulin" . SPARSER::PROTEIN)
    ("PLXNB1" . SPARSER::PROTEIN) ("Protein-G" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("L-15" . SPARSER::PROTEIN)
    ("Rnd1" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("Sema3E" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("R-Ras" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("class 4" . SPARSER::PROTEIN) ("neuropilin 1" . SPARSER::PROTEIN)
    ("B1-3" . SPARSER::PROTEIN) ("A1-4" . SPARSER::PROTEIN)
    ("PlexinB1" . SPARSER::PROTEIN) ("Sema4D" . SPARSER::PROTEIN)
    ("plexinB1" . SPARSER::PROTEIN) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("cyclin E–Cdk2" . SPARSER::COLLECTION)
    ("the predominant inhibitor" . SPARSER::INHIBITOR)
    ("cyclin–Cdk1" . SPARSER::COLLECTION) ("MAD2-" . SPARSER::PROTEIN)
    ("MCM4 and Mad2" . SPARSER::COLLECTION)
    ("geminin–Cdt1" . SPARSER::COLLECTION)
    ("all mitotic Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("partial" . SPARSER::PROTEIN) ("geminin and Cdt1" . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN)
    ("MG132, geminin and Cdt1" . SPARSER::COLLECTION)
    ("geminin and securin" . SPARSER::COLLECTION) ("SD" . SPARSER::PROTEIN)
    ("L26A" . SPARSER::PROTEIN) ("Cdt1-Venus" . SPARSER::COLLECTION)
    ("fluorescent Cdc6" . SPARSER::PROTEIN)
    ("Cdc6 and Cdt1" . SPARSER::COLLECTION)
    ("cyclin B1 or securin" . SPARSER::COLLECTION)
    ("effectors" . SPARSER::EFFECTOR)
    ("nondegradable geminin" . SPARSER::PROTEIN) ("MUG" . SPARSER::PROTEIN)
    ("wt-geminin" . SPARSER::COLLECTION) ("L26A-geminin" . SPARSER::COLLECTION)
    ("BrdU" . SPARSER::DRUG) ("this nondegradable geminin" . SPARSER::PROTEIN)
    ("Leu" . SPARSER::AMINO-ACID)
    ("live cells expressing nondegradable cyclin B1" . SPARSER::PROTEIN)
    ("securin, cyclin B1, and geminin" . SPARSER::COLLECTION)
    ("roscovitine" . SPARSER::DRUG)
    ("Cdc20, geminin and cyclin B1" . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG) ("pS-Mad2" . SPARSER::COLLECTION)
    ("Mad2" . SPARSER::PROTEIN) ("reversine" . SPARSER::DRUG)
    ("Mad" . SPARSER::PROTEIN)
    ("the spindle checkpoint support geminin’s" . SPARSER::PROTEIN)
    ("Separase" . SPARSER::PROTEIN) ("Cdc20 and Cdh1" . SPARSER::COLLECTION)
    ("geminin and Cdc6" . SPARSER::COLLECTION)
    ("cyclin B1 and geminin" . SPARSER::COLLECTION)
    ("RPE-1-TERT" . SPARSER::COLLECTION) ("Cdc6-Venus" . SPARSER::COLLECTION)
    ("Venus" . SPARSER::PROTEIN) ("geminin-Venus" . SPARSER::COLLECTION)
    ("nocodazole" . SPARSER::DRUG) ("cellular geminin" . SPARSER::PROTEIN)
    ("Geminin" . SPARSER::PROTEIN)
    ("the licensing inhibitor geminin and the MCM loader Cdc6"
     . SPARSER::COLLECTION)
    ("MCM" . SPARSER::PROTEIN) ("cyclin B1–Cdk1" . SPARSER::COLLECTION)
    ("CENP-F and Plk1" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("NEB" . SPARSER::PROTEIN) ("Mcl" . SPARSER::PROTEIN)
    ("substrates" . SPARSER::SUBSTRATE)
    ("the mitotic APC/C activator Cdc20" . SPARSER::PROTEIN)
    ("somatic geminin" . SPARSER::PROTEIN) ("endo" . SPARSER::PROTEIN)
    ("Cul4–DDB1–Cdt2" . SPARSER::COLLECTION) ("PCNA" . SPARSER::PROTEIN)
    ("Cyclin–Cdk1" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("preRC" . SPARSER::BIO-COMPLEX)
    ("chromosome-bound ORC1-6 complexes" . SPARSER::BIO-COMPLEX)
    ("helicase" . SPARSER::PROTEIN) ("Cdc20 , and APC/C" . SPARSER::COLLECTION)
    ("Cyclin B1 and geminin" . SPARSER::COLLECTION)
    ("cyclin B1 and securin" . SPARSER::COLLECTION)
    ("securin" . SPARSER::PROTEIN) ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("geminin and cyclin B1" . SPARSER::COLLECTION)
    ("Cdt1 and Cdc6" . SPARSER::COLLECTION) ("Cdh1" . SPARSER::PROTEIN)
    ("geminin" . SPARSER::PROTEIN) ("Cdh" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("C-22" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("I-19" . SPARSER::PROTEIN)
    ("APC4" . SPARSER::PROTEIN) ("p55CDC" . SPARSER::PROTEIN)
    ("CDC27" . SPARSER::PROTEIN) ("or 2 µ" . SPARSER::MOLECULE)
    ("CDC20" . SPARSER::PROTEIN) ("CDT1" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("RO-3306" . SPARSER::DRUG)
    ("Cyclin E" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("MAD2" . SPARSER::PROTEIN)
    ("MCM4" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN) ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("anti–" . SPARSER::ANTIBODY) ("L26" . SPARSER::PROTEIN)
    ("Mps1" . SPARSER::PROTEIN) ("RPE-1" . SPARSER::PROTEIN)
    ("1 C" . SPARSER::PROTEIN) ("1 B" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("CENP-F" . SPARSER::PROTEIN)
    ("Nek2A" . SPARSER::PROTEIN) ("Cdt2" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("Cul4" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("ORC1" . SPARSER::PROTEIN)
    ("MCM2" . SPARSER::PROTEIN) ("ATP-dependent" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN) ("Cdc6" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cyclin B1" . SPARSER::PROTEIN)
    ("Cdc20" . SPARSER::PROTEIN)
    ("activators and repressors" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("promoters" . SPARSER::PROMOTER) ("ERα-ERβ" . SPARSER::COLLECTION)
    ("associated genes" . SPARSER::GENE) ("cofactors" . SPARSER::PROTEIN)
    ("ERα and ERβ, and ERβ-only" . SPARSER::COLLECTION)
    ("ERβ, and ERβ-only" . SPARSER::COLLECTION)
    ("ERα and SRC3" . SPARSER::COLLECTION) ("agonists" . SPARSER::AGONIST)
    ("this included RIP140 as well as other genes" . SPARSER::COLLECTION)
    ("tamoxifen" . SPARSER::MOLECULE) ("endocrine" . SPARSER::PROTEIN)
    ("complemented" . SPARSER::PROTEIN) ("ER-" . SPARSER::PROTEIN)
    ("ribosomal proteins RPL22 , RPLP1 , and RPS15" . SPARSER::COLLECTION)
    ("ALDH3A2 , GLUD1 , PRDX3 , and GPX4" . SPARSER::COLLECTION)
    ("RPL22 , RPLP1 , and RPS15" . SPARSER::COLLECTION)
    ("BNIP3L , DICER1 , and TCEAL1" . SPARSER::COLLECTION)
    ("RAD17 , CREBL2 , and CGRRF1" . SPARSER::COLLECTION)
    ("TTC3 and UBE3A" . SPARSER::COLLECTION) ("modifiers" . SPARSER::MOLECULE)
    ("oxidoreductases" . SPARSER::PROTEIN) ("ERβ-" . SPARSER::PROTEIN)
    ("ERβ and RIP140" . SPARSER::COLLECTION)
    ("triglyceride" . SPARSER::MOLECULE) ("triglycerides" . SPARSER::MOLECULE)
    ("pS2 or OTUB2" . SPARSER::COLLECTION)
    ("gene and cell" . SPARSER::COLLECTION)
    ("RIP140 and SRC3" . SPARSER::COLLECTION)
    ("DDIT3, FOXO1A, and MEF2A" . SPARSER::COLLECTION)
    ("adipocytes" . SPARSER::PROTEIN) ("MAP3K1-MEKK1" . SPARSER::COLLECTION)
    ("MAP2K1-MEK1" . SPARSER::COLLECTION)
    ("withE2-stimulated genes" . SPARSER::GENE)
    ("SRC3 or RIP140" . SPARSER::COLLECTION) ("PgR" . SPARSER::PROTEIN)
    ("EC" . SPARSER::PROTEIN) ("TFF1/pS2" . SPARSER::COLLECTION)
    ("ERα, ERβ, SRC3 and RIP140" . SPARSER::COLLECTION)
    ("example" . SPARSER::EXAMPLE) ("SRC3-" . SPARSER::PROTEIN)
    ("the E2-regulated genes harbored at least one receptor binding site"
     . SPARSER::GENE)
    ("ER and coregulator cistromes" . SPARSER::COLLECTION)
    ("/ER β" . SPARSER::COLLECTION)
    ("SRC3 and/or RIP140" . SPARSER::COLLECTION) ("GO" . SPARSER::PROTEIN)
    ("GATA3 and FOXA1" . SPARSER::COLLECTION) ("FOXA1-" . SPARSER::PROTEIN)
    ("the classic estrogen-regulated genes" . SPARSER::GENE)
    ("/pS2" . SPARSER::COLLECTION)
    ("either SRC3 and/or RIP140" . SPARSER::COLLECTION)
    ("either ERα and/or ERβ" . SPARSER::COLLECTION)
    ("FOXA1 and GATA3" . SPARSER::COLLECTION)
    ("nearly three nucleosomes" . SPARSER::BIO-COMPLEX)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("ER α , ER β , SRC3, and RIP140" . SPARSER::COLLECTION)
    ("ERα and/or ERβ" . SPARSER::COLLECTION)
    ("ERα- or ERβ-only" . SPARSER::COLLECTION) ("ERα-" . SPARSER::PROTEIN)
    ("ERα or ERβ" . SPARSER::COLLECTION)
    ("ERα and/or ERβ protein" . SPARSER::COLLECTION)
    ("ERα/ERβ" . SPARSER::COLLECTION)
    ("ER α , ER β , SRC3 and RIP140" . SPARSER::COLLECTION)
    ("estradiol" . SPARSER::PROTEIN) ("heterodimers" . SPARSER::HETERODIMER)
    ("FOXA1, GATA3, and PBX1" . SPARSER::COLLECTION)
    ("Sp1 and AP1" . SPARSER::COLLECTION) ("ERs" . SPARSER::PROTEIN)
    ("AP1" . SPARSER::PROTEIN)
    ("ERα and ERβ, and mapping" . SPARSER::COLLECTION)
    ("ERβ, and mapping" . SPARSER::COLLECTION) ("mapping" . SPARSER::PROTEIN)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY) ("homodimers" . SPARSER::HOMODIMER)
    ("nearly 100% amino acid sequence homology" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN) ("estrogens" . SPARSER::MOLECULE)
    ("hormone" . SPARSER::MOLECULE) ("ERβ and SRC3" . SPARSER::COLLECTION)
    ("ERα and ERβ" . SPARSER::COLLECTION)
    ("SRC3 and RIP140" . SPARSER::COLLECTION) ("chromatin" . SPARSER::PROTEIN)
    ("estrogen" . SPARSER::MOLECULE) ("RNAse A" . SPARSER::PROTEIN)
    ("PA1" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("cancer-1" . SPARSER::PROTEIN)
    ("UBE3A" . SPARSER::PROTEIN) ("TTC3" . SPARSER::PROTEIN)
    ("RAD17" . SPARSER::PROTEIN) ("TCEAL1" . SPARSER::PROTEIN)
    ("DICER1" . SPARSER::PROTEIN) ("BNIP3L" . SPARSER::PROTEIN)
    ("RPS15" . SPARSER::PROTEIN) ("RPLP1" . SPARSER::PROTEIN)
    ("RPL22" . SPARSER::PROTEIN) ("GPX4" . SPARSER::PROTEIN)
    ("PRDX3" . SPARSER::PROTEIN) ("GLUD1" . SPARSER::PROTEIN)
    ("ALDH3A2" . SPARSER::PROTEIN) ("MEF2A" . SPARSER::PROTEIN)
    ("FOXO1A" . SPARSER::PROTEIN) ("DDIT3" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("fatty acid" . SPARSER::MOLECULE)
    ("pERK1/2" . SPARSER::PROTEIN) ("MEKK1" . SPARSER::PROTEIN)
    ("MAP3K1" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("MAP2K1" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("OTUB2" . SPARSER::PROTEIN) ("otubain2" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("GREB1" . SPARSER::PROTEIN) ("trefoil factor 1" . SPARSER::PROTEIN)
    ("pS2" . SPARSER::PROTEIN) ("TFF1" . SPARSER::PROTEIN)
    ("ER β" . SPARSER::PROTEIN) ("ER α" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("PBX1" . SPARSER::PROTEIN)
    ("GATA3" . SPARSER::PROTEIN) ("FOXA1" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("E2" . SPARSER::MOLECULE) ("17β-estradiol" . SPARSER::PROTEIN)
    ("RIP140" . SPARSER::PROTEIN) ("SRC3" . SPARSER::PROTEIN)
    ("ERβ" . SPARSER::PROTEIN) ("ERα" . SPARSER::PROTEIN)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("light" . SPARSER::PROTEIN) ("inducer" . SPARSER::PROTEIN)
    ("ideal potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("bad" . SPARSER::PROTEIN) ("phospho-Cofilin" . SPARSER::PROTEIN)
    ("Cofilin" . SPARSER::PROTEIN) ("Paxillin" . SPARSER::PROTEIN)
    ("HA" . SPARSER::PROTEIN) ("Matrigel" . SPARSER::PROTEIN)
    ("Astrocytes" . SPARSER::PROTEIN) ("mitogen" . SPARSER::MITOGEN)
    ("the MES markers fibronectin (FN) and smooth muscle alpha actin (SMA, encoded by the Acta2 gene; xref ; p-value < 1×10 −4 )"
     . SPARSER::COLLECTION)
    ("fibronectin (FN)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Acta2" . SPARSER::PROTEIN) ("actin" . SPARSER::PROTEIN)
    ("FN" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("Acta1, Acta2, Ctgf, Tnc, SerpinE1, Itga7, Osmr and C1rl"
     . SPARSER::COLLECTION)
    ("Itga7" . SPARSER::PROTEIN) ("Tnc" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Acta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("transmembrane transporter activity" . SPARSER::PROTEIN)
    ("GTPases" . SPARSER::GTPASE) ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The next two top genes" . SPARSER::GENE)
    ("ERBB2 , COL1A1 and ITGB3" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR) ("ple" . SPARSER::PROTEIN)
    ("the many genes known to influence these signaling pathways ( xref )"
     . SPARSER::GENE)
    ("p53/RB" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("genes and signaling pathways" . SPARSER::COLLECTION)
    ("drugs" . SPARSER::DRUG) ("glial" . SPARSER::PROTEIN)
    ("TAZ" . SPARSER::PROTEIN) ("STAT3 and C/EBP β" . SPARSER::COLLECTION)
    ("new malignant foci" . SPARSER::PROTEIN) ("foci" . SPARSER::PROTEIN)
    ("a master regulator of cell migration and invasion" . SPARSER::COLLECTION)
    ("MES" . SPARSER::MOLECULE) ("Transcription Factor" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA) ("Rac-1" . SPARSER::PROTEIN)
    ("Rho family" . SPARSER::PROTEIN) ("SerpinE1" . SPARSER::PROTEIN)
    ("transporter activity" . SPARSER::PROTEIN) ("ITGB3" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NP40" . SPARSER::MOLECULE) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("MD2" . SPARSER::PROTEIN) ("l-glutamine" . SPARSER::MOLECULE)
    ("Rhophilin 2" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("C/EBP β" . SPARSER::PROTEIN) ("RHPN2" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK" . SPARSER::COLLECTION) ("RAS/RAF" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTEN and tensins" . SPARSER::COLLECTION)
    ("phosphoinositide-dependent kinase-1 (PDK-1) and downstream of tyrosine kinase 2 (Dok-2)"
     . SPARSER::COLLECTION)
    ("PI3 kinase, p130Cas, focal adhesion kinase, phosphoinositide-dependent kinase-1 (PDK-1) and downstream of tyrosine kinase 2 (Dok-2)"
     . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("growth factor, fibroblast growth factor, hepatocyte growth factor, macrophage colony-stimulating factor 1, neutrophin, and insulin"
     . SPARSER::COLLECTION)
    ("c-Cbl and PAK-interacting exchange factor" . SPARSER::COLLECTION)
    ("PAK1 and Cdc42" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID) ("ligase" . SPARSER::LIGASE)
    ("DAK" . SPARSER::PROTEIN) ("cetuximab" . SPARSER::DRUG)
    ("CTEN and pY774" . SPARSER::COLLECTION)
    ("protein and ERK1/2" . SPARSER::COLLECTION)
    ("peptides" . SPARSER::PEPTIDE) ("phenylalanine" . SPARSER::AMINO-ACID)
    ("a prominent substrate of EGFR tyrosine kinase and tyrosine 674 (AIY 674 SLAAR)"
     . SPARSER::COLLECTION)
    ("GST-PTB" . SPARSER::COLLECTION)
    ("PhosphoTyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("PTB" . SPARSER::PROTEIN) ("Homology" . SPARSER::PROTEIN)
    ("Src" . SPARSER::PROTEIN) ("c-Cbl-CTEN" . SPARSER::COLLECTION)
    ("Recombinant CTEN and its associated proteins" . SPARSER::COLLECTION)
    ("its associated proteins" . SPARSER::PROTEIN)
    ("CTEN and c-Cbl" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("c-Cbl and EGFR" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("c-Cbl-EGFR" . SPARSER::COLLECTION)
    ("pY992, pY1045, pY1068, and pY1173" . SPARSER::COLLECTION)
    ("pY" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("these findings closely link CTEN" . SPARSER::PROTEIN)
    ("K-RAS and B-RAF" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and HER2" . SPARSER::COLLECTION) ("ubiquitin" . SPARSER::PROTEIN)
    ("Ligand" . SPARSER::LIGAND) ("CTEN and EGFR" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN) ("CTEN" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DLC1" . SPARSER::PROTEIN)
    ("Dok-2" . SPARSER::PROTEIN)
    ("downstream of tyrosine kinase 2" . SPARSER::PROTEIN)
    ("PDK-1" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("PI3 kinase" . SPARSER::PROTEIN)
    ("macrophage colony-stimulating factor 1" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdc42" . SPARSER::PROTEIN) ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("βPIX" . SPARSER::PROTEIN)
    ("PAK-interacting exchange factor" . SPARSER::PROTEIN)
    ("Sprouty 1" . SPARSER::PROTEIN) ("AIP4" . SPARSER::PROTEIN)
    ("protein-4" . SPARSER::PROTEIN) ("atrophin-1" . SPARSER::PROTEIN)
    ("SHP1" . SPARSER::PROTEIN) ("phosphatase-1" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("Beta)" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("protein A" . SPARSER::PROTEIN)
    ("NP-40" . SPARSER::DRUG) ("beta-actin" . SPARSER::PROTEIN)
    ("CO2" . SPARSER::PROTEIN) ("s 5A" . SPARSER::PROTEIN)
    ("full-length" . SPARSER::PROTEIN) ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("B-RAF" . SPARSER::PROTEIN)
    ("K-RAS" . SPARSER::PROTEIN) ("TNS3" . SPARSER::PROTEIN)
    ("tensin 3" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzymes" . SPARSER::PROTEIN-FAMILY)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNS4" . SPARSER::PROTEIN) ("IL-2-IL-2R-STAT5" . SPARSER::COLLECTION)
    ("the pro-apoptotic factor BCL-X" . SPARSER::PROTEIN)
    ("collectively essential regulators" . SPARSER::REGULATOR)
    ("lymphoid" . SPARSER::PROTEIN)
    ("FOXP3, IGF1 , and IL-2R" . SPARSER::COLLECTION)
    ("siRNA or STAT5A" . SPARSER::COLLECTION)
    ("Stat5A and Stat5B" . SPARSER::COLLECTION) ("Stat5A" . SPARSER::PROTEIN)
    ("IL-2R, BCL-X, and IGF1" . SPARSER::COLLECTION) ("sham" . SPARSER::DRUG)
    ("Protein" . SPARSER::PROTEIN) ("mRNAs" . SPARSER::PROTEIN)
    ("FOXP3, IGF-1, and IL-2R" . SPARSER::COLLECTION)
    ("at least STAT5B" . SPARSER::PROTEIN)
    ("undetectable STAT5B" . SPARSER::PROTEIN) ("IgE" . SPARSER::PROTEIN)
    ("carboxy" . SPARSER::MOLECULE)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("transducers" . SPARSER::PROTEIN)
    ("STAT5B and STAT5A" . SPARSER::COLLECTION)
    ("STAT5A or STAT5B" . SPARSER::COLLECTION)
    ("FOXP3 and IL-2R" . SPARSER::COLLECTION)
    ("highly homologous proteins" . SPARSER::PROTEIN)
    ("STAT5A and STAT5B" . SPARSER::COLLECTION) ("Blimp-1" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("Stat5B" . SPARSER::PROTEIN) ("Stat5" . SPARSER::PROTEIN)
    ("BCL-X" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("UCHL1" . SPARSER::PROTEIN) ("CD45RO" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("SK3" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("G-2" . SPARSER::PROTEIN) ("β -glucuronidase" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN) ("CD127" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("IL-2R" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("MSS and MSI-H" . SPARSER::COLLECTION) ("CRCs" . SPARSER::PROTEIN)
    ("MSI and KRAS" . SPARSER::COLLECTION) ("Group" . SPARSER::MOLECULE)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("enzymes" . SPARSER::ENZYME)
    ("arm" . SPARSER::PROTEIN) ("panitumumab" . SPARSER::DRUG)
    ("MSI and MSS" . SPARSER::COLLECTION)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("Drug" . SPARSER::DRUG) ("Food" . SPARSER::MOLECULE)
    ("KRAS or BRAF" . SPARSER::COLLECTION) ("-mutant" . SPARSER::MUTANT)
    ("components" . SPARSER::COMPONENT) ("medicine" . SPARSER::DRUG)
    ("the more predominant mutant allele" . SPARSER::ALLELE)
    ("GGC" . SPARSER::PROTEIN) ("GAT" . SPARSER::PROTEIN)
    ("GGT" . SPARSER::PROTEIN) ("MSS" . SPARSER::PROTEIN)
    ("KRAS/BRAF" . SPARSER::COLLECTION) ("Gly" . SPARSER::AMINO-ACID)
    ("cohort and male" . SPARSER::COLLECTION)
    ("MSI and EGFR" . SPARSER::COLLECTION) ("cohort" . SPARSER::MOLECULE)
    ("HR" . SPARSER::PROTEIN) ("fluorouracil" . SPARSER::DRUG)
    ("HNPCC" . SPARSER::PROTEIN) ("MLH1" . SPARSER::PROTEIN)
    ("gold" . SPARSER::MOLECULE) ("ras (KRAS)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK/ERK" . SPARSER::COLLECTION)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("triphosphatase" . SPARSER::PROTEIN) ("guanosine" . SPARSER::MOLECULE)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("oncogenes" . SPARSER::ONCOGENE)
    ("States" . SPARSER::BIO-STATE) ("Allele" . SPARSER::ALLELE)
    ("KRAS and MSI" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("male" . SPARSER::MOLECULE)
    ("allele" . SPARSER::ALLELE) ("MSI" . SPARSER::PROTEIN)
    ("DNA" . SPARSER::DNA) ("KRAS , BRAF , or mismatch" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN) ("mismatch" . SPARSER::PROTEIN)
    ("BRAF" . SPARSER::PROTEIN) ("KRAS" . SPARSER::PROTEIN)
    ("MAP-kinase" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("autosomal dominant" . SPARSER::PROTEIN)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("clathrin" . SPARSER::PROTEIN) ("Kir6.2 and GPR15" . SPARSER::COLLECTION)
    ("DAT" . SPARSER::PROTEIN) ("type" . TYPE)
    ("a G-protein coupled receptor GPR15 as well as KCNK3 and KCNK9"
     . SPARSER::COLLECTION)
    ("low external K + media" . SPARSER::PROTEIN)
    ("high external K +" . SPARSER::MOLECULE)
    ("the high external K +" . SPARSER::MOLECULE)
    ("KCNK3 and Wt" . SPARSER::COLLECTION)
    ("14-3-3 and COPI" . SPARSER::COLLECTION) ("Ala" . SPARSER::AMINO-ACID)
    ("Ser" . SPARSER::AMINO-ACID) ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COOH" . SPARSER::MOLECULE)
    ("low oxygen and low serum [ xref ]" . SPARSER::COLLECTION)
    ("oxygen" . SPARSER::MOLECULE) ("KCNK3 and KCNK9" . SPARSER::COLLECTION)
    ("prone" . SPARSER::PROTEIN-FAMILY)
    ("high external KCl" . SPARSER::MOLECULE)
    ("Our flow cytometry (FCM) and western blot" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN) ("cytometry (FCM)" . SPARSER::PROTEIN)
    ("FCM" . SPARSER::MOLECULE) ("aa" . SPARSER::MOLECULE)
    ("K + and Na +" . SPARSER::COLLECTION) ("salts" . SPARSER::DRUG)
    ("cation" . SPARSER::MOLECULE) ("Kir2.1-fused" . SPARSER::COLLECTION)
    ("-ATPase" . SPARSER::COLLECTION) ("antiporter" . SPARSER::PROTEIN)
    ("ATPase" . SPARSER::PROTEIN) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("cis" . SPARSER::PROTEIN) ("Trk" . SPARSER::PROTEIN)
    ("transporters" . SPARSER::PROTEIN) ("complement" . SPARSER::PROTEIN)
    ("protein (COP)" . SPARSER::PROTEIN)
    ("ion channels and receptors" . SPARSER::COLLECTION)
    ("coatomer" . SPARSER::BIO-COMPLEX) ("‘RXR’" . SPARSER::PROTEIN)
    ("subunit" . SPARSER::FRAGMENT) ("ATP" . SPARSER::ATP)
    ("RXR" . SPARSER::PROTEIN) ("Arg" . SPARSER::AMINO-ACID)
    ("ion" . SPARSER::MOLECULE) ("fused" . SPARSER::PROTEIN)
    ("KCNK3 or KCNK9" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION)
    ("dopamine transporter" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN) ("EAG1" . SPARSER::PROTEIN)
    ("voltage-gated" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("LT1" . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("F-12" . SPARSER::PROTEIN) ("β-COP" . SPARSER::PROTEIN)
    ("potassium chloride" . SPARSER::MOLECULE)
    ("amino acid" . SPARSER::AMINO-ACID) ("amino acids" . SPARSER::AMINO-ACID)
    ("ura3" . SPARSER::PROTEIN) ("trp1" . SPARSER::PROTEIN)
    ("leu2" . SPARSER::PROTEIN) ("LEU2" . SPARSER::PROTEIN)
    ("nha1" . SPARSER::PROTEIN) ("1-4" . SPARSER::PROTEIN)
    ("pCDNA3.1" . SPARSER::PROTEIN)
    ("sodium-dependent dopamine transporter" . SPARSER::PROTEIN)
    ("GPR15" . SPARSER::PROTEIN) ("GAL1" . SPARSER::PROTEIN)
    ("Na +  / H +" . SPARSER::PROTEIN) ("Na +" . SPARSER::MOLECULE)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("G-protein" . SPARSER::PROTEIN)
    ("Trk2" . SPARSER::PROTEIN) ("Kir6.2" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("Ion channels" . SPARSER::PROTEIN-FAMILY) ("14-3-3" . SPARSER::PROTEIN)
    ("KCNK9" . SPARSER::PROTEIN) ("KCNK3" . SPARSER::PROTEIN)
    ("Kir2.1" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("an essential component" . SPARSER::COMPONENT) ("maps" . SPARSER::PROTEIN)
    ("the nearby caspase-10" . SPARSER::PROTEIN) ("BIM" . SPARSER::PROTEIN)
    ("NOXA" . SPARSER::PROTEIN) ("phorbol" . SPARSER::DRUG)
    ("an essential outer mitochondrial membrane protein" . SPARSER::PROTEIN)
    ("map" . SPARSER::PROTEIN) ("caspase" . SPARSER::PROTEIN)
    ("rare highly penetrant variants" . SPARSER::VARIANT)
    ("variants" . SPARSER::VARIANT) ("accurate HLA" . SPARSER::PROTEIN)
    ("HLA" . SPARSER::PROTEIN) ("met" . SPARSER::AMINO-ACID)
    ("part" . SPARSER::COMPONENT) ("component" . SPARSER::COMPONENT)
    ("TERT" . SPARSER::PROTEIN) ("CASP10/CASP8" . SPARSER::COLLECTION)
    ("ACTA2/FAS" . SPARSER::COLLECTION) ("ACOXL" . SPARSER::PROTEIN)
    ("QPCT" . SPARSER::PROTEIN) ("BMF" . SPARSER::PROTEIN)
    ("orf" . SPARSER::PROTEIN) ("FAS" . SPARSER::PROTEIN)
    ("p22" . SPARSER::PROTEIN) ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("X chromosome" . SPARSER::PROTEIN) ("BCL-6" . SPARSER::PROTEIN)
    ("PRKD3" . SPARSER::PROTEIN) ("protein kinase D3" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("lymphoid enhancer-binding factor 1" . SPARSER::PROTEIN)
    ("caspase-10" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bcl-2" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor superfamily" . SPARSER::PROTEIN)
    ("BCL2L11" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("ODF1" . SPARSER::PROTEIN) ("PMAIP1" . SPARSER::PROTEIN)
    ("CDKN2B" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("CASP8" . SPARSER::PROTEIN) ("CASP10" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("ACTA2" . SPARSER::PROTEIN)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("antibodies" . SPARSER::ANTIBODY)
    ("classical signaling G-proteins" . SPARSER::PROTEIN)
    ("PDB" . SPARSER::MOLECULE)
    ("this competitive tTG inhibitor" . SPARSER::INHIBITOR)
    ("the only mutant form" . SPARSER::FORM) ("inactive" . SPARSER::INACTIVE)
    ("other classical G-proteins" . SPARSER::PROTEIN)
    ("proteins and lysine" . SPARSER::COLLECTION)
    ("‘acceptor’" . SPARSER::MOLECULE) ("lysine" . SPARSER::AMINO-ACID)
    ("acceptor" . SPARSER::MOLECULE) ("glutamine" . SPARSER::AMINO-ACID)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("PTEN" . SPARSER::PROTEIN)
    ("EGFR-adaptor protein" . SPARSER::COLLECTION)
    ("GTP-binding protein and Ca 2+" . SPARSER::COLLECTION)
    ("Myc" . SPARSER::PROTEIN)
    ("the GTP-binding-defective tTG R580K mutant" . SPARSER::MUTANT)
    ("trypsin" . SPARSER::PROTEIN) ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("x-ray" . SPARSER::COLLECTION) ("peptide" . SPARSER::PEPTIDE)
    ("a ‘closed’ conformational state" . SPARSER::BIO-STATE)
    ("guanine" . SPARSER::PROTEIN)
    ("two distinct conformational states" . SPARSER::BIO-STATE)
    ("ray" . SPARSER::PROTEIN) ("the fluorescent GTP-analog" . SPARSER::ANALOG)
    ("BODIPY" . SPARSER::DRUG) ("analog" . SPARSER::ANALOG)
    ("GST-c-Cbl" . SPARSER::COLLECTION) ("agarose" . SPARSER::MOLECULE)
    ("glutathione" . SPARSER::DRUG) ("GST" . SPARSER::PROTEIN)
    ("His" . SPARSER::AMINO-ACID)
    ("a GTP-binding-defective tTG mutant" . SPARSER::MUTANT)
    ("a transamidation-defective mutant" . SPARSER::MUTANT)
    ("valine" . SPARSER::AMINO-ACID) ("cysteine" . SPARSER::AMINO-ACID)
    ("mutants" . SPARSER::MUTANT) ("MDC or Z-Don" . SPARSER::COLLECTION)
    ("EGFRvIII" . SPARSER::PROTEIN)
    ("c-Jun ( xref , second panel from the top) and ERK ( xref , third panel from the top)"
     . SPARSER::COLLECTION)
    ("c-Jun, ERK and Akt" . SPARSER::COLLECTION)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transfectants" . SPARSER::PROTEIN)
    ("MDC and doxorubicin" . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN) ("MDC and Z-Don" . SPARSER::COLLECTION)
    ("siRNAs" . SPARSER::PROTEIN) ("MDC" . SPARSER::PROTEIN)
    ("dansyl" . SPARSER::DRUG) ("BPA" . SPARSER::PROTEIN)
    ("GTPase and acyl" . SPARSER::COLLECTION) ("GTPase" . SPARSER::GTPASE)
    ("a specific GTP-induced conformational state" . SPARSER::BIO-STATE)
    ("state" . SPARSER::BIO-STATE) ("lysosomal" . SPARSER::PROTEIN)
    ("both normal astrocytes" . SPARSER::PROTEIN)
    ("astrocytes" . SPARSER::PROTEIN)
    ("eleven metastasis-associated proteins" . SPARSER::PROTEIN)
    ("traits" . SPARSER::PROTEIN) ("conformation" . SPARSER::BIO-CONFORMATION)
    ("EGF-receptors" . SPARSER::COLLECTION) ("EGFRs" . SPARSER::PROTEIN)
    ("EGF" . SPARSER::PROTEIN) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("phospho-ERK" . SPARSER::PROTEIN) ("G418" . SPARSER::MOLECULE)
    ("protein-G" . SPARSER::PROTEIN) ("G-proteins" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("adaptor protein" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPγS" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("Myc-tagged" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Cbl" . SPARSER::PROTEIN) ("U87" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN)
    ("Tissue transglutaminase" . SPARSER::PROTEIN)
    ("promoter and inhibitor" . SPARSER::COLLECTION)
    ("basic fibroblast growth factor and vascular endothelial"
     . SPARSER::COLLECTION)
    ("types" . TYPE) ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("forms" . SPARSER::FORM) ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methotrexate" . SPARSER::DRUG) ("MBD2 and HDAC1" . SPARSER::COLLECTION)
    ("HDAC1-maspin" . SPARSER::COLLECTION)
    ("MBD2-maspin" . SPARSER::COLLECTION)
    ("HDAC1 and MBD2" . SPARSER::COLLECTION)
    ("MBD2 and HDACs" . SPARSER::COLLECTION) ("HDACs" . SPARSER::PROTEIN)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("trichostatin" . SPARSER::MOLECULE) ("DAC" . SPARSER::PROTEIN)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("cytosine" . SPARSER::NUCLEOBASE) ("bisulfite" . SPARSER::MOLECULE)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("CpG" . SPARSER::PROTEIN)
    ("MSP" . SPARSER::PROTEIN) ("which causes gene" . SPARSER::GENE)
    ("repressor" . SPARSER::REPRESSOR)
    ("MBD2 and readily-detectable miR-221" . SPARSER::COLLECTION)
    ("readily-detectable miR-221" . SPARSER::PROTEIN)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("inhibitor and miR-224 inhibitor" . SPARSER::COLLECTION)
    ("potential target proteins" . SPARSER::PROTEIN)
    ("miR-224 inhibitors as well as their mimics ( xref )"
     . SPARSER::COLLECTION)
    ("matrigel" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("sera" . SPARSER::PROTEIN)
    ("inhibitor or miR-224 inhibitor" . SPARSER::COLLECTION)
    ("inhibitor and miR-224 inhibitor (synthetic RNA duplex, Dharmacon, see methods)"
     . SPARSER::COLLECTION)
    ("SW480-GFP" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("MiRa" . SPARSER::PROTEIN) ("the primary CRC" . SPARSER::PROTEIN)
    ("IV" . SPARSER::PROTEIN) ("II" . SPARSER::PROTEIN)
    ("DLD" . SPARSER::PROTEIN) ("maspin" . SPARSER::PROTEIN)
    ("RNA" . SPARSER::RNA) ("MiRNAs" . SPARSER::PROTEIN)
    ("states" . SPARSER::BIO-STATE) ("mediators" . SPARSER::PROTEIN)
    ("genes and gene" . SPARSER::COLLECTION)
    ("novel prognostic biomarkers" . SPARSER::MOLECULE)
    ("TNM" . SPARSER::MOLECULE) ("nodal" . SPARSER::PROTEIN)
    ("therapeutic reagents or biomarkers" . SPARSER::COLLECTION)
    ("reagents or biomarkers" . SPARSER::COLLECTION)
    ("biomarkers" . SPARSER::MOLECULE) ("reagents" . SPARSER::MOLECULE)
    ("Maspin" . SPARSER::PROTEIN) ("miRs and miR" . SPARSER::COLLECTION)
    ("CRC" . SPARSER::PROTEIN) ("miRs" . SPARSER::PROTEIN)
    ("Aims" . SPARSER::PROTEIN) ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("group III" . SPARSER::PROTEIN) ("group I" . SPARSER::PROTEIN)
    ("MiR-221" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("U44" . SPARSER::PROTEIN) ("MBD2" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN)
    ("the ligand S1P and the receptor S1P 2" . SPARSER::COLLECTION)
    ("hepatocytes" . SPARSER::PROTEIN) ("myoblasts" . SPARSER::PROTEIN)
    ("ICAM-1/VCAM-1" . SPARSER::COLLECTION) ("monocytes" . SPARSER::PROTEIN)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("sphingolipids" . SPARSER::MOLECULE)
    ("a critical proinflammatory cytokine" . SPARSER::PROTEIN)
    ("S1P-S1P 3" . SPARSER::COLLECTION) ("S1P-S1P 1" . SPARSER::COLLECTION)
    ("VCAM-1 or ICAM-1" . SPARSER::COLLECTION)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pcDNA3.1-S1P 1" . SPARSER::PROTEIN-PAIR)
    ("S1P-S1P 2" . SPARSER::COLLECTION) ("CHO" . SPARSER::PROTEIN)
    ("-NFκB" . SPARSER::COLLECTION)
    ("S1P 2 , VCAM-1 and ICAM-1" . SPARSER::COLLECTION)
    ("S1P 1 or S1P 2" . SPARSER::COLLECTION) ("sh-S1P 2" . SPARSER::COLLECTION)
    ("sh-S1P 1" . SPARSER::COLLECTION) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("S1P 1 or S1P 3" . SPARSER::COLLECTION)
    ("TNFα up-regulated ICAM-1" . SPARSER::PROTEIN)
    ("antagonist" . SPARSER::MOLECULE)
    ("Triton X-100 and KCl" . SPARSER::COLLECTION) ("KCl" . SPARSER::MOLECULE)
    ("isoform" . SPARSER::ISOFORM) ("SphK1 and SphK2" . SPARSER::COLLECTION)
    ("kinases" . SPARSER::PROTEIN) ("isoforms" . SPARSER::ISOFORM)
    ("media" . SPARSER::PROTEIN) ("TNFα/SphK/S1P" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S1P 2 , VCAM-1, and ICAM-1" . SPARSER::COLLECTION)
    ("proinflammatory cytokine" . SPARSER::PROTEIN)
    ("proinflammation-associated adhesion molecules" . SPARSER::MOLECULE)
    ("apoE" . SPARSER::PROTEIN) ("macrophage" . SPARSER::PROTEIN)
    ("S1P 1 and S1P 2" . SPARSER::COLLECTION)
    ("cellular chemotaxis" . SPARSER::PROTEIN)
    ("S1P 1 and S1P 3" . SPARSER::COLLECTION) ("chemotaxis" . SPARSER::PROTEIN)
    ("S1P 1 , S1P 2 , and S1P 3" . SPARSER::COLLECTION)
    ("polypeptides" . SPARSER::PEPTIDE)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SphK" . SPARSER::PROTEIN)
    ("lipid" . SPARSER::LIPID)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("VCAM-1/ICAM-1" . SPARSER::COLLECTION) ("S1P/S1P 2" . SPARSER::COLLECTION)
    ("VCAM-1 and ICAM-1" . SPARSER::COLLECTION)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("IkBα" . SPARSER::PROTEIN) ("β-galactosidase" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("serum albumin" . SPARSER::PROTEIN) ("Triton X-100" . SPARSER::MOLECULE)
    ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("Sphingosine kinase" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("SphK2" . SPARSER::PROTEIN)
    ("SphK1" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("C-3" . SPARSER::PROTEIN)
    ("endothelial cell growth factor" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG) ("p65" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("CD54" . SPARSER::PROTEIN)
    ("Anti-" . SPARSER::ANTIBODY) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-S" . SPARSER::ANTIBODY) ("E1" . SPARSER::MOLECULE)
    ("monoclonal antibody" . SPARSER::DRUG) ("−3" . SPARSER::PROTEIN)
    ("EDG-1" . SPARSER::PROTEIN) ("S1P 3" . SPARSER::PROTEIN)
    ("S1P 1" . SPARSER::PROTEIN) ("G protein-coupled" . SPARSER::PROTEIN)
    ("sphingosine kinase" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN)
    ("cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("VCAM-1" . SPARSER::PROTEIN) ("sphingosine kinase 1" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("S1P 2" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("Sphingosine-1-phosphate" . SPARSER::DRUG)
    ("JAK/STAT genes and NHL" . SPARSER::COLLECTION)
    ("STAT1, STAT5a and SOCS1" . SPARSER::COLLECTION)
    ("tyrosine" . SPARSER::AMINO-ACID)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("macrophages and CD8+" . SPARSER::COLLECTION)
    ("macrophages" . SPARSER::PROTEIN) ("STAT1-" . SPARSER::PROTEIN)
    ("-GP130-JAK" . SPARSER::COLLECTION) ("kappaB" . SPARSER::PROTEIN)
    ("AA" . SPARSER::MOLECULE) ("AC" . SPARSER::PROTEIN)
    ("STAT3 (rs12949918 and rs6503695) and STAT4 rs932169"
     . SPARSER::COLLECTION)
    ("subtypes" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("–1" . SPARSER::PROTEIN)
    ("SOCS1, SOCS2 , and SOCS4" . SPARSER::COLLECTION)
    ("SOCS1 and STAT5A" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("interleukins" . SPARSER::PROTEIN) ("cytokines" . SPARSER::PROTEIN)
    ("STAT3 (rs12949918 and rs6503695) and STAT4 ( rs932169 )"
     . SPARSER::COLLECTION)
    ("JAK3, STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, STAT6, SCOS1, SCOS2, SCOS3, and SCOS4"
     . SPARSER::COLLECTION)
    ("STAT5a" . SPARSER::PROTEIN) ("JAK/STAT" . SPARSER::COLLECTION)
    ("STAT" . SPARSER::PROTEIN) ("JAK" . SPARSER::PROTEIN)
    ("activator" . SPARSER::ACTIVATOR) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("kinase activity" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("GP130" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("SOCS4" . SPARSER::PROTEIN) ("SOCS2" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("STAT2" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("LZ" . SPARSER::PROTEIN) ("LKB1, and SIRT1" . SPARSER::COLLECTION)
    ("an essential upstream regulator" . SPARSER::REGULATOR)
    ("circumvent anoikis" . SPARSER::PROTEIN) ("promoter" . SPARSER::PROMOTER)
    ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("EZH2, Cox-2, Mcl-1, and Fos" . SPARSER::COLLECTION)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY) ("regulators" . SPARSER::REGULATOR)
    ("regulator" . SPARSER::REGULATOR) ("Class" . CLASS)
    ("GC" . SPARSER::PROTEIN) ("EMT and anoikis" . SPARSER::COLLECTION)
    ("FITC" . SPARSER::MOLECULE) ("HEMA" . SPARSER::PROTEIN)
    ("E-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("SiRNA" . SPARSER::PROTEIN) ("mRNA and protein" . SPARSER::COLLECTION)
    ("GCCs" . SPARSER::PROTEIN) ("BCG" . SPARSER::DRUG)
    ("mer" . SPARSER::PROTEIN) ("miRNA" . SPARSER::PROTEIN)
    ("Target" . SPARSER::TARGET-PROTEIN) ("MiR" . SPARSER::PROTEIN)
    ("Robo1 and Slit2" . SPARSER::COLLECTION) ("trigger" . SPARSER::PROTEIN)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ZEB1, ZEB2, and ERRFI-1" . SPARSER::COLLECTION)
    ("EGFR" . SPARSER::PROTEIN) ("suppressor" . SPARSER::SUPPRESSOR)
    ("miRNAs" . SPARSER::PROTEIN) ("microRNAs" . SPARSER::RNA)
    ("SIRT1-LKB1" . SPARSER::COLLECTION)
    ("the epithelial mesenchymal transition (EMT)-associated genes"
     . SPARSER::GENE)
    ("EMT" . SPARSER::PROTEIN) ("mRNA" . SPARSER::PROTEIN)
    ("luciferase" . SPARSER::PROTEIN)
    ("SIRT1, Vimentin, E-Cadherin, LKB1, and β-actin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("Annexin V/PI" . SPARSER::COLLECTION)
    ("anoikis" . SPARSER::PROTEIN) ("PI" . SPARSER::PROTEIN)
    ("BGC" . SPARSER::PROTEIN) ("Luciferase" . SPARSER::PROTEIN)
    ("miR" . SPARSER::PROTEIN) ("microRNA" . SPARSER::RNA)
    ("p13" . SPARSER::PROTEIN) ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("Snail1" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("Cox-2" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("miR-221" . SPARSER::PROTEIN) ("histone deacetylase" . SPARSER::PROTEIN)
    ("TGF-β1" . SPARSER::PROTEIN) ("chemo-attractant" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("U6" . SPARSER::PROTEIN) ("penicillin G" . SPARSER::MOLECULE)
    ("down-regulated in gastric cancer" . SPARSER::PROTEIN)
    ("Slit2" . SPARSER::PROTEIN) ("Robo1" . SPARSER::PROTEIN)
    ("ERRFI-1" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("β-actin" . SPARSER::PROTEIN) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-Cadherin" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN) ("MVK and GM" . SPARSER::COLLECTION)
    ("GM" . SPARSER::PROTEIN) ("MVK" . SPARSER::PROTEIN)
    ("VRP" . SPARSER::PROTEIN) ("IGFBP2 and IGFBP5" . SPARSER::COLLECTION)
    ("IGFBP2 [ xref ] and β-catenin" . SPARSER::COLLECTION)
    ("FAK and IGF1R" . SPARSER::COLLECTION)
    ("IGF1R or integrin" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("TCF" . SPARSER::PROTEIN) ("variety" . SPARSER::VARIETY)
    ("HEK" . SPARSER::PROTEIN) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("mutant" . SPARSER::MUTANT) ("p53 and Wnt" . SPARSER::COLLECTION)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER" . SPARSER::PROTEIN)
    ("a heterogeneous mixture" . SPARSER::MOLECULE)
    ("IGF1R inhibitor or FAK inhibitor" . SPARSER::COLLECTION)
    ("FAK" . SPARSER::PROTEIN)
    ("IGF1R inhibitor (PPP, 10 μM) and Focal Adhesion Kinase inhibitor (PP2, 10 μM)"
     . SPARSER::COLLECTION)
    ("Kinase" . SPARSER::KINASE) ("receptors" . SPARSER::PROTEIN)
    ("effector" . SPARSER::EFFECTOR) ("SRPRB" . SPARSER::PROTEIN)
    ("Genes" . SPARSER::GENE) ("MCAM, SP5 and IGF1" . SPARSER::COLLECTION)
    ("MCAM" . SPARSER::PROTEIN)
    ("CDC42, GATA 3, SYT13 and SFRP2 and TMEM49" . SPARSER::COLLECTION)
    ("SFRP2 and TMEM49" . SPARSER::COLLECTION)
    ("IGFBP2, NR4A2 and SFRP2" . SPARSER::COLLECTION)
    ("predominantly either IGFBP2" . SPARSER::PROTEIN)
    ("differentially expressed genes" . SPARSER::GENE)
    ("cytokine-cytokine" . SPARSER::COLLECTION) ("ECM" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::RECEPTOR) ("cytokine" . SPARSER::PROTEIN)
    ("Chemokine" . SPARSER::PROTEIN) ("MAPK" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("RNAs" . SPARSER::RNA)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("IGF1R, IGF2, TOP2A, p53, CCND1 and FOXM1" . SPARSER::COLLECTION)
    ("GSEA" . SPARSER::PROTEIN) ("differentially" . SPARSER::PROTEIN)
    ("shRNA" . SPARSER::PROTEIN) ("ILK" . SPARSER::PROTEIN)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pro" . SPARSER::AMINO-ACID)
    ("thyroid" . SPARSER::PROTEIN) ("proteins (IGFBP)" . SPARSER::PROTEIN)
    ("IGF-I and IGF-II" . SPARSER::COLLECTION)
    ("IGFBP2 and β-catenin" . SPARSER::COLLECTION)
    ("kinase and Wnt" . SPARSER::COLLECTION) ("kinase" . SPARSER::KINASE)
    ("Map" . SPARSER::PROTEIN) ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin and IGFBP2" . SPARSER::COLLECTION)
    ("IGF1R and integrin" . SPARSER::COLLECTION)
    ("integrin" . SPARSER::PROTEIN) ("Inhibitors" . SPARSER::INHIBITOR)
    ("IGF" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("RPL 35" . SPARSER::PROTEIN) ("ribosomal protein L35a" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("Tween 20" . SPARSER::MOLECULE)
    ("-3 " . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("IGFBP5" . SPARSER::PROTEIN) ("RGD motif" . SPARSER::PROTEIN)
    ("T-cell" . SPARSER::PROTEIN) ("IGFBP4" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::DRUG) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("KCNN4" . SPARSER::PROTEIN) ("ARHGEF4" . SPARSER::PROTEIN)
    ("POPDC3" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("LMO2" . SPARSER::PROTEIN) ("FN1" . SPARSER::PROTEIN)
    ("ID1" . SPARSER::PROTEIN) ("FBLN1" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN) ("SP5" . SPARSER::PROTEIN)
    ("NR4A2" . SPARSER::PROTEIN) ("TMEM49" . SPARSER::PROTEIN)
    ("SFRP2" . SPARSER::PROTEIN) ("SYT13" . SPARSER::PROTEIN)
    ("GATA 3" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("Cyclin D1" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("FOXM1" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("TOP2A" . SPARSER::PROTEIN) ("IGF2" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("colon cancer" . SPARSER::PROTEIN)
    ("Insulin like growth factor binding protein 2" . SPARSER::PROTEIN)
    ("IGF-II" . SPARSER::PROTEIN) ("IGF-I" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("Insulin like Growth Factor" . SPARSER::PROTEIN)
    ("β- catenin" . SPARSER::PROTEIN) ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN)
    ("Insulin like growth factor" . SPARSER::PROTEIN) ("EM" . SPARSER::PROTEIN)
    ("JG" . SPARSER::PROTEIN) ("AG" . SPARSER::PROTEIN)
    ("AI" . SPARSER::PROTEIN) ("JK" . SPARSER::PROTEIN)
    ("fragment" . SPARSER::FRAGMENT)
    ("the consecutive breast cancer patient group" . SPARSER::MOLECULE)
    ("group and 0.51%" . SPARSER::COLLECTION)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY) ("seven" . SPARSER::PROTEIN)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("consecutive patients group" . SPARSER::MOLECULE)
    ("sporadic cancer group" . SPARSER::MOLECULE) ("delC" . SPARSER::PROTEIN)
    ("delG" . SPARSER::PROTEIN) ("melting" . SPARSER::DRUG)
    ("exon" . SPARSER::PROTEIN) ("variant" . SPARSER::VARIANT)
    ("hereditary cancer families" . SPARSER::PROTEIN-FAMILY)
    ("HOC" . SPARSER::PROTEIN) ("gene" . SPARSER::GENE)
    ("NCCN" . SPARSER::MOLECULE) ("families" . SPARSER::PROTEIN-FAMILY)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("genes" . SPARSER::GENE) ("ovarian cancer group" . SPARSER::MOLECULE)
    ("family" . SPARSER::PROTEIN-FAMILY) ("group D" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("reagent" . SPARSER::MOLECULE)
    ("horseradish-conjugated secondary antibody" . SPARSER::PROTEIN)
    ("antibody" . SPARSER::PROTEIN)
    ("caspase 3 and PARP" . SPARSER::COLLECTION) ("PVDF" . SPARSER::DRUG)
    ("polyacrylamide" . SPARSER::DRUG) ("SDS" . SPARSER::PROTEIN)
    ("GTP" . SPARSER::NUCLEOTIDE) ("EGTA, and 5%" . SPARSER::COLLECTION)
    ("glycerol" . SPARSER::PROTEIN) ("EGTA" . SPARSER::MOLECULE)
    ("cytometry" . SPARSER::PROTEIN) ("citrate" . SPARSER::PROTEIN)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("EtOH" . SPARSER::MOLECULE) ("Prism" . SPARSER::PROTEIN)
    ("diphenyl" . SPARSER::DRUG) ("streptomycin" . SPARSER::DRUG)
    ("pyruvate" . SPARSER::PROTEIN) ("FBS" . SPARSER::PROTEIN)
    ("RPMI" . SPARSER::PROTEIN)
    ("trifluoromethanesulfonyl" . SPARSER::MOLECULE)
    ("naphthalenecarboxamide" . SPARSER::PROTEIN)
    ("-2-naphthalenecarboxamide" . SPARSER::COLLECTION)
    ("t" . SPARSER::PROTEIN) ("carboxamide" . SPARSER::MOLECULE)
    ("-1" . SPARSER::PROTEIN) ("water" . SPARSER::MOLECULE)
    ("Ether" . SPARSER::MOLECULE) ("Water" . SPARSER::MOLECULE)
    ("mixture" . SPARSER::MOLECULE) ("Chemical" . SPARSER::MOLECULE)
    ("DMSO-" . SPARSER::MOLECULE) ("DMSO" . SPARSER::MOLECULE)
    ("State" . SPARSER::BIO-STATE) ("hexane" . SPARSER::MOLECULE)
    ("Solvents" . SPARSER::MOLECULE) ("flame" . SPARSER::PROTEIN)
    ("Chemicals" . SPARSER::MOLECULE) ("fragments" . SPARSER::FRAGMENT)
    ("solution" . SPARSER::MOLECULE) ("class" . CLASS)
    ("cytotoxic" . SPARSER::PROTEIN)
    ("novel tubulin and Hsp27 dual inhibitor" . SPARSER::INHIBITOR)
    ("The parental compound nimesulide" . SPARSER::DRUG)
    ("more Hsp27 client proteins" . SPARSER::PROTEIN)
    ("the four Hsp27 client proteins" . SPARSER::PROTEIN)
    ("many client proteins" . SPARSER::PROTEIN)
    ("eIF4E, Stat3, and Hsp70" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("several representative proteins" . SPARSER::PROTEIN)
    ("eIF" . SPARSER::PROTEIN) ("the Hsp27 client proteins" . SPARSER::PROTEIN)
    ("its client proteins" . SPARSER::PROTEIN)
    ("vinblastine and paclitaxel" . SPARSER::COLLECTION)
    ("paclitaxel" . SPARSER::DRUG) ("vinblastine" . SPARSER::DRUG)
    ("phosphorylated Hsp27 (pHsp27) and total Hsp27" . SPARSER::COLLECTION)
    ("chemical" . SPARSER::MOLECULE) ("weaker" . SPARSER::PROTEIN)
    ("tubulin and Hsp27" . SPARSER::COLLECTION)
    ("Hsp27 and the unfolded B chain" . SPARSER::COLLECTION)
    ("DTT" . SPARSER::MOLECULE) ("Dithiothreitol" . SPARSER::PROTEIN)
    ("substrate" . SPARSER::SUBSTRATE) ("nimesulide" . SPARSER::DRUG)
    ("inhibitor" . SPARSER::INHIBITOR) ("enzyme" . SPARSER::ENZYME)
    ("caspase 3 and its downstream protein poly ADP-ribose polymerase (PARP)"
     . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("PARP" . SPARSER::PROTEIN)
    ("polymerase" . SPARSER::PROTEIN)
    ("possibly more active" . SPARSER::ACTIVE)
    ("antimitotic" . SPARSER::MOLECULE) ("sulfonamides" . SPARSER::DRUG)
    ("-hexyl" . SPARSER::MOLECULE) ("hexyl" . SPARSER::MOLECULE)
    ("solvent" . SPARSER::MOLECULE) ("ether" . SPARSER::MOLECULE)
    ("DMF" . SPARSER::DRUG) ("nitrophenol" . SPARSER::MOLECULE)
    ("the methylsulfonamide group or a trifluoromethyl group"
     . SPARSER::COLLECTION)
    ("a very strong electron-withdrawing group" . SPARSER::MOLECULE)
    ("electron" . SPARSER::MOLECULE) ("group" . SPARSER::MOLECULE)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("aryl" . SPARSER::PROTEIN)
    ("-hexyl group" . SPARSER::MOLECULE) ("active" . SPARSER::ACTIVE)
    ("targets" . SPARSER::TARGET-PROTEIN) ("amide" . SPARSER::MOLECULE)
    ("pure Hsp27 or tubulin inhibitors" . SPARSER::INHIBITOR)
    ("Hsp27 or tubulin" . SPARSER::COLLECTION) ("ligands" . SPARSER::LIGAND)
    ("a cellular biomarker" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE) ("inhibitors" . SPARSER::INHIBITOR)
    ("modulators" . SPARSER::PROTEIN)
    ("oligonucleotides (ASO)" . SPARSER::MOLECULE) ("siRNA" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE) ("antisense" . SPARSER::PROTEIN)
    ("target" . SPARSER::TARGET-PROTEIN)
    ("oligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("leukemia" . SPARSER::PROTEIN) ("molecules" . SPARSER::MOLECULE)
    ("oligomers" . SPARSER::PROTEIN) ("complexes" . SPARSER::BIO-COMPLEX)
    ("form" . SPARSER::FORM) ("kDa" . SPARSER::PROTEIN)
    ("Jurkat" . SPARSER::PROTEIN) ("fraction" . SPARSER::COMPONENT)
    ("molecule" . SPARSER::MOLECULE) ("complex" . SPARSER::BIO-COMPLEX)
    ("apoptosome" . SPARSER::BIO-COMPLEX) ("pro" . SPARSER::AMINO-ACID)
    ("proteins" . SPARSER::PROTEIN) ("derivatives" . SPARSER::DERIVATIVE)
    ("ligand" . SPARSER::LIGAND) ("Hsp27 and tubulin" . SPARSER::COLLECTION)
    ("tubulin" . SPARSER::PROTEIN) ("drug" . SPARSER::DRUG)
    ("chaperone" . SPARSER::PROTEIN) ("protein" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("RNase A" . SPARSER::PROTEIN) ("CO 2" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("F 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    (NIL . SPARSER::PROTEIN) ("O 6" . SPARSER::PROTEIN)
    ("-3" . SPARSER::PROTEIN) ("O 5" . SPARSER::PROTEIN)
    ("Cl 2" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN) ("Tf 2" . SPARSER::DRUG)
    ("3d" . SPARSER::PROTEIN-FAMILY) ("CH 3" . SPARSER::MOLECULE)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hsp70" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin B chain" . SPARSER::PROTEIN) ("B chain" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("cyclooxygenase 2" . SPARSER::PROTEIN)
    ("JCC76" . SPARSER::DRUG) ("ADP-ribose" . SPARSER::MOLECULE)
    ("G 2 /M" . SPARSER::PROTEIN) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("as 2" . SPARSER::PROTEIN) ("hexyl group" . SPARSER::MOLECULE)
    ("NSC751382" . SPARSER::DRUG) ("OGX-427" . SPARSER::DRUG)
    ("caspase 3" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN) ("Hsp27" . SPARSER::PROTEIN)))